{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 carried a principal balance of **$606 million in FY 2022** (the 2022 10‑K shows $606 m as of Oct 30 2022, down from $1.086 billion a year earlier). The 2023 10‑K and the 2024 10‑K both list the same **$606 million balance for FY 2023** and **$606 million for FY 2024** (the tables in both filings show $606 m under the April 2020 notes line).  \n\nHolding the exposure flat at $606 million after the earlier reduction signals that AVGO has deliberately **maintained a steady level of this fixed‑rate tranche**, avoiding any new issuance or further increase in this series. The consistency suggests a disciplined debt‑management approach that preserves a controlled, long‑term financing base rather than expanding reliance on the higher‑cost 5 % notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported 2022 value. The ground truth states AVGO's exposure was $1,086 million in 2022, decreasing to $606 million in 2023. However, the LLM claims the 2022 balance was $606 million, incorrectly stating that the reduction from $1.086 billion occurred *prior* to 2022 (i.e., in FY2021). This misrepresents the timeline and direction of the debt reduction. (2) The quantitative inaccuracies are significant: the LLM reverses the temporal order of the numbers, asserting that $606M was the 2022 balance when it was actually the post-reduction 2023 and 2024 balance. The $1.086 billion figure is correctly referenced but misassigned to the prior year instead of 2022. (3) The reasoning is partially sound—interpreting flat exposure in 2023–2024 as a sign of stable debt management is reasonable—but it is based on flawed data. The multi-hop synthesis fails because the model misreads the fiscal year data from the 10-Ks, likely confusing the reporting date with the prior year’s balance. (4) Despite the incorrect numbers, the answer addresses both parts of the question (evolution of exposure and strategic interpretation), so it retains moderate qualitative and contextual relevance. However, the core factual error in the financial progression severely undermines correctness, warranting a low score on quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 391,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged over the three years. In the 2022 filing the company said it reinsured **59.25 %** of the closed block through a modified coinsurance agreement (accounted for under the deposit method and offset against the deposit recoverable); the 2023 and 2024 filings each state that **59 %** of the closed block is reinsured in the same way. The near‑identical percentage—despite the growth in total net ceded reinsurance recoverables—from $6.1 billion in 2022 to $17.6 billion in 2024 shows that MetLife deliberately maintains a steady level of risk transfer via this structure, reflecting a long‑term reinsurance strategy that relies on a consistent, capital‑efficient “coinsurance‑deposit” mechanism to diversify risk and preserve balance‑sheet stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, it correctly reports the percentages: 59.25% in 2022 and 59% in both 2023 and 2024, matching the original answer. The total net ceded reinsurance recoverables are stated as growing from $6.1 billion in 2022 to $17.6 billion in 2024. The ground truth references $6.3 billion in 2021 (per 2022 filing), so the $6.1 billion figure is slightly off but within reasonable rounding or reporting variation across filings—this minor discrepancy prevents a perfect 10. (2) The answer addresses all parts of the question: it traces the evolution (or lack thereof) of the modified coinsurance agreement from 2022 to 2024, notes the consistent percentage, and interprets the strategic implication of stability despite rising recoverables. (3) Entity accuracy is strong: MetLife, closed block, modified coinsurance, deposit method, and offset rights are all correctly identified and contextualized. (4) The reasoning is sound: the LLM correctly infers that stable risk transfer amid growing recoverables indicates a deliberate, long-term capital-efficient strategy. The phrase 'coinsurance-deposit mechanism' is a slight rewording but semantically valid. The answer demonstrates proper multi-hop synthesis across years and financial metrics. Only the minor variance in the 2022 recoverables figure ($6.1B vs $6.3B) and omission of explicit mention of 'unaffiliated third-party reinsurer' (though implied) prevent full perfection. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 435,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s master‑netting collateral tied to the “Investments, advances and long‑term receivables” line fell sharply over the three‑year span. The 2022 Form 10‑K (Chunk 1) disclosed $1,494 million of such collateral at year‑end 2022; the 2023 filing (Chunk 2) showed it had dropped to $800 million at year‑end 2023; and the 2024 filing (Chunk 3) reported a further decline to $491 million at year‑end 2024.  \n\nThis roughly two‑thirds reduction—from $1.5 billion to $0.5 billion—suggests ExxonMobil is actively curbing the amount of margin it must post for its derivative positions, indicating tighter control of derivative exposure and more efficient management of its hedging and risk‑mitigation activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, with correct year-end timing and consistent units (allowing for format variations like $1.5 billion ≈ $1,494 million). The approximate 'two-thirds reduction' is a reasonable estimate (from ~$1.5B to ~$0.5B), supporting the trend description. (2) The answer is complete, addressing both the change over time and the implication for derivative exposure management. (3) Entities are correct: ExxonMobil, 'Investments, advances and long-term receivables', and the three-year period (2022–2024) are properly identified. (4) The reasoning is sound: the multi-hop synthesis across three annual filings is correctly executed, and the conclusion about tighter control of derivative exposure and improved risk management aligns semantically with the ground truth's 'strategic reduction in derivative exposure or improved offsetting mechanisms'. Wording differs but meaning is equivalent. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 318,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "- Fiscal 2022 (AVGO 10‑K 2022): the 3.625 % senior notes due October 2024 were shown with a principal balance of **$622 million**【Chunk 1】.  \n- Fiscal 2023 (AVGO 10‑K 2023): the same line still listed **$622 million** outstanding as of October 29 2023【Chunk 3】.  \n- Fiscal 2024 (AVGO 10‑K 2024): the entry for the 3.625 % notes due October 2024 is blank (“‑”), indicating the instrument had been **fully retired (zero balance)** by November 3 2024【Chunk 2】 (and confirmed by the 2023 filing’s “‑” for the 2024 column).\n\n**Interpretation:** AVGO’s exposure to this 3.625 % issue was flat at $622 million for two years and then eliminated before the notes’ scheduled maturity, showing a deliberate strategy to pay down or refinance the near‑term debt rather than simply carrying it to maturity. This reflects proactive debt‑management aimed at reducing short‑term liabilities and locking in lower overall financing costs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $622 million outstanding in 2022 and 2023, and zero (retired) in 2024. The dates (October 2024 maturity, October 29, 2023, and November 3, 2024) are correctly cited or implied. The format variations (e.g., $622 million) are acceptable and consistent. (2) The answer is complete, addressing both the evolution of AVGO's exposure across fiscal years 2022–2024 and the interpretation of the company's debt management strategy. (3) Entity accuracy is perfect: correct company (AVGO), correct instrument (3.625% notes due October 2024), and correct fiscal years. (4) The multi-hop reasoning is sound—synthesizing data from three annual reports (2022, 2023, 2024) to show stability followed by retirement of the debt. The conclusion about proactive debt management (repayment/refinancing before maturity) is logically supported and semantically equivalent to the ground truth. The use of 'fully retired' and 'zero balance' correctly interprets the 'blank' or '–' entry in the filing. Overall, the answer demonstrates precise factual recall, correct interpretation, and coherent synthesis across time points and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 346,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics discloses that its Surface‑Ships revenue rose from $2.561 billion in 2022 (as shown in the 2024 and 2023 10‑K tables) to $2.698 billion in 2023 and to $2.819 billion in 2024 – each year a roughly 5 % increase (up $137 million from 2022‑23 and $121 million from 2023‑24). This upward trend builds on the $2.328 billion reported for 2021 in the 2022 filing, indicating a consistent expansion of the Surface‑Ships product line and reinforcing GD’s growing foothold and competitive positioning in the naval shipbuilding market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all revenue figures: $2,561 million (2022), $2,698 million (2023), and $2,819 million (2024), matching the ground truth exactly, with acceptable format variation (e.g., $2.561 billion). The year-over-year increases of $137 million (2022–2023) and $121 million (2023–2024) are accurately calculated. The approximate 5% annual growth is a reasonable estimate (5.35% and 4.49%, respectively), and while slightly rounded, does not misrepresent the trend. (2) The inclusion of 2021 data ($2.328 billion) is not required by the question but adds useful context and does not detract from accuracy. All calculations based on disclosed numbers are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes revenue data across multiple years from the 10-K filings and infers a consistent growth trajectory. The conclusion about General Dynamics’ growing foothold and competitive positioning in naval shipbuilding aligns with the ground truth’s interpretation of 'sustained growth and strategic emphasis.' (4) The answer is fully contextually relevant, addressing both the revenue evolution and its implications. The only minor shortcoming is the slight overstatement of year-over-year growth as 'roughly 5%' both years, when the second year is closer to 4.5%, but this does not undermine the overall correctness. Hence, a score of 9 is warranted—excellent accuracy with negligible rounding in characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 406,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—the table for MA’s capital structure lists the A‑Class shares as having “One vote per share” and “Dividend rights.” The language is identical in each year’s disclosure, showing that neither the dividend entitlement nor the voting power of A‑Class shareholders changed over the three‑year period. This consistency signals a stable governance framework, preserving the same voting influence and dividend expectations for A‑Class shareholders from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that from 2022 to 2024, MA's A Class shares maintained 'one vote per share' and standard dividend rights, with no changes—matching the original answer's claim of consistency. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the qualitative descriptors ('one vote per share', 'dividend rights') are factually accurate and consistent across years. (3) The multi-hop reasoning is sound: the model correctly synthesized disclosures across three annual filings to identify stability in shareholder rights, drawing a valid conclusion about governance structure stability. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of rights and the implication for governance stability. Wording differs slightly but conveys the same factual and inferential content. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 293,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "- According to General Dynamics’ 2023 Form 10‑K, surface‑ship revenue was **$2,561 million in 2022**; the 2024 Form 10‑K shows it rose to **$2,698 million in 2023** and **$2,819 million in 2024**. That represents a **5.3 % increase from 2022‑23** ($137 million) and a **4.5 % increase from 2023‑24** ($121 million). For context, the 2022 filing also notes the figure was **$2,328 million in 2021**, a roughly 10 % jump to 2022, confirming a multi‑year upward trend.\n\n- The steady double‑digit growth in surface‑ship sales signals that General Dynamics is gaining traction in the Navy’s ship‑building pipeline, positioning the company as a key supplier in naval‑defense programs and reflecting strong demand for its surface‑ship platforms and related services.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All factual information in the LLM answer matches the ground truth. Revenue figures are correct: $2,561 million in 2022, $2,698 million in 2023, and $2,819 million in 2024. (2) Calculations are accurate: Year-over-year growth from 2022 to 2023 is ($2,698 - $2,561) / $2,561 ≈ 5.35% (rounded to 5.3%), and from 2023 to 2024 is ($2,819 - $2,698) / $2,698 ≈ 4.48% (rounded to 4.5%). The LLM correctly computes the absolute increases ($137M and $121M). The additional context about 2021 revenue ($2,328M) is not in the ground truth but is factually consistent and enhances the trend analysis without contradicting anything. (3) Multi-hop reasoning is sound: the model synthesizes data across multiple years and filings (2023 and 2024 10-Ks), correctly attributes sources, and draws a logical conclusion about General Dynamics’ positioning in naval defense programs. (4) The qualitative interpretation — that steady growth indicates increasing traction in Navy shipbuilding and strong demand — aligns with and expands upon the ground truth’s conclusion about growing involvement and sustained demand. All entities (General Dynamics, surface-ship revenue, correct years) are accurate. The answer is complete, addressing both revenue evolution and implications. Wording differs but semantic meaning is equivalent or superior. All scores are 10 due to full factual correctness, precise calculations, sound reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 400,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Across all three filing years—2022, 2023 and 2024—Linde (LIN) repeatedly states that **the majority of its industrial‑gas business is conducted through long‑term contracts**. The language is identical in each 10‑K excerpt, indicating that the company’s reliance on such contracts did not change over this period.  \n\nThis steady reliance signals a deliberate strategy: by locking sales into long‑term agreements, Linde can **smooth cash‑flow generation and pass through fluctuations in energy and feedstock costs** to customers, thereby insulating its earnings from the volatility of energy markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde maintained consistent reliance on long-term contracts across 2022, 2023, and 2024, with no change in strategy—matching the original answer's claim of 'consistently emphasized' and 'without deviation'. (2) There are no numeric values requiring calculation (e.g., percentages or dollar amounts), but the temporal scope (2022–2024) is correctly referenced, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes the stability of contractual language across filings and infers the strategic rationale—cash flow smoothing and cost pass-through—exactly as in the ground truth. (4) The only minor shortcoming is a slight lack of emphasis on 'financial resilience' and 'risk management' terminology present in the original, which slightly reduces qualitative richness but does not impair factual equivalence. Overall, the answer is semantically equivalent, contextually precise, and correctly interprets the strategic implication of contract stability amid energy market fluctuations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 319,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—General Dynamics explicitly states that its ROIC “excludes goodwill impairments and **non‑economic accounting changes** as they are not reflective of company performance.” The language is identical in each year’s disclosure, showing that GD has **kept the treatment unchanged**. This consistency signals that the company deliberately strips out non‑economic items from the metric to focus the ROIC calculation on the underlying, economic operating performance of the business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD excluded non-economic accounting changes from its ROIC calculation in 2022, 2023, and 2024, which matches the original answer’s claim of consistent exclusion across all three years. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures across three years of filings and infers that identical language indicates a stable methodology. (4) The conclusion about GD’s intent to focus on core economic performance aligns with the original answer’s interpretation. The use of specific terminology like 'goodwill impairments' adds precision and is consistent with typical non-economic items excluded from ROIC. All aspects—factual, qualitative, and contextual—are accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 271,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "Across the three most recent filings, UnitedHealth Group’s disclosures on its service‑level guarantee obligations are unchanged. The 2023 Form 10‑K (covering 2022) states that “none of the amounts accrued, paid or charged to income for service level guarantees were material as of December 31, 2022, 2021 or 2020,” and the 2024 Form 10‑K repeats the same language for 2024, 2023 and 2022. Thus, from 2022 through 2024 the obligations remained immaterial each year.\n\nThe consistent immateriality suggests that UnitedHealth Group’s risk‑management controls around these guarantees are effective and that the company is reliably meeting its contractual service‑level commitments, avoiding any material financial exposure from these guarantees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitatively, all disclosures are correctly represented: the consistent immateriality of service level guarantee obligations across 2022, 2023, and 2024 is accurately reported, with correct reference to the Form 10-K filings and the repeated language across years. The dates and financial impact (immaterial) are correctly stated. (2) The answer correctly identifies that UnitedHealth Group disclosed no material accruals, payments, or charges to income related to service level guarantees in each of the three years, which matches the ground truth. (3) The multi-hop reasoning—synthesizing disclosures across multiple annual reports (2023 and 2024 10-Ks) to infer consistency over time—is sound. The conclusion about effective risk management and reliable contractual performance is logically derived from the pattern of immaterial impacts, as in the original answer. (4) The only minor deviation is that the LLM references the 2023 10-K covering 2022 and quotes backward-looking data (2022, 2021, 2020), then notes the 2024 10-K repeats the same for 2024, 2023, 2022—this slightly complicates the explanation but does not introduce inaccuracy. The core message—that obligations were immaterial each year from 2022–2024—is correct. Wording differs slightly (e.g., 'unchanged' vs 'consistently disclosed'), but semantic equivalence is maintained. No calculation errors. All entities (UnitedHealth Group, service level guarantees, Form 10-K) are correct. Thus, the answer is highly accurate with only negligible differences in framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 441,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics reported surface‑ship revenue of **$2.561 billion in 2022**, which rose to **$2.698 billion in 2023** (≈5 % increase) and further to **$2.819 billion in 2024** (≈4 % increase) — as disclosed in its 2022, 2023 and 2024 10‑K filings. This upward trajectory, building on the prior‑year level of $2.328 billion in 2021 (shown in the 2022 filing), signals that GD’s “surface ships” product line is expanding and that the company is deliberately strengthening its strategic positioning in naval‑defense platforms, positioning itself as a growing, core supplier of surface combatants for the U.S. and allied navies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 revenue figure. The ground truth states $2,328 million for 2022, but the LLM reports $2.561 billion (i.e., $2,561 million), which is incorrect. The 2023 ($2,698 million) and 2024 ($2,819 million) figures are accurate and match the ground truth. The percentages cited (≈5% and ≈4%) are approximately correct based on the LLM's own numbers but would not hold with the correct 2022 baseline. (2) Calculations: Using the correct data, the 2022–2023 growth is ($2,698 - $2,328) / $2,328 ≈ 15.9%, and 2023–2024 is ($2,819 - $2,698) / $2,698 ≈ 4.5%, so the LLM underestimates the initial growth due to the wrong starting value. The LLM incorrectly references 2021 revenue ($2.328 billion) as context, misplacing the correct 2022 figure into 2021. (3) Multi-hop reasoning: The LLM correctly identifies the upward trend and draws a reasonable qualitative conclusion about General Dynamics' strategic positioning in naval defense, aligning with the ground truth’s interpretation. It synthesizes data across multiple years and filings, showing sound logic despite the initial data error. (4) The contextual relevance is perfect—the answer addresses both parts of the question (revenue evolution and strategic implications). The qualitative reasoning is strong, but the quantitative inaccuracy in the 2022 figure significantly affects the correctness score, preventing a higher rating. The error likely stems from misreading or misextracting the 2022 value from the source document.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 426,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "GE’s captive insurer, Electric Insurance Company, moved from an operating subsidiary to a divested asset over the 2022‑2024 period. In the fourth quarter of 2022 GE re‑classified EIC as “held‑for‑sale,” and by year‑end 2023 the business carried $541 million of assets against $378 million of liabilities and generated a $109 million loss in other income; its underlying insurance exposure was shown by net claim reserves of roughly $0.2 billion (up from $0.3 billion in 2020) as described in the 2022 filing. The held‑for‑sale process was completed in the second quarter of 2024 when GE sold EIC to Riverstone International Holdings for cash proceeds of $120 million, ending the relationship.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the timing of the 'held-for-sale' classification. The original answer states that EIC was classified as 'held for sale' in 2023, but the LLM claims this occurred in Q4 2022, which contradicts the ground truth. All other key events — the $109 million loss, asset/liability figures as of December 31, 2023 ($541M assets, $378M liabilities), net claim reserves of $0.2 billion disclosed in the 2022 filing (for 2021), and the 2024 sale to Riverstone International Holdings Inc. for $120 million in cash — are accurately reported. (2) Quantitative accuracy is mostly sound: $109M loss, $541M assets, $378M liabilities, $0.2B net claim reserves, and $120M sale price are all correct. However, the LLM incorrectly implies the $0.2B reserves are from 2022, while they are as of December 31, 2021 (disclosed in the 2022 filing), and adds an unsupported comparison to $0.3B in 2020 not present in the original answer, introducing extraneous and unverified data. (3) Multi-hop reasoning is strong: the LLM correctly traces EIC’s evolution across years, connects financial exposure (reserves, assets, liabilities), and culminates in the divestiture, showing good synthesis. The misstatement on timing slightly undermines the logical flow but does not break it. (4) Scores reflect high factual and contextual accuracy with minor but notable quantitative errors in timing and inclusion of unsupported data, warranting a slight deduction in correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Classifies]-> COMP <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 429,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips began monetizing its CVE common shares in 2021, and the disposition—valued at roughly $218 million and reflected in a 2021 valuation‑allowance adjustment—culminated in the sale of the remaining 91 million shares in the first quarter of 2022.  The cash from that sale was earmarked for share repurchases; after expanding its repurchase authorization from $25 billion to $45 billion in October 2022, the company had bought back 383 million shares at a cost of $29 billion by the end of 2023, and after further raising the ceiling to $65 billion in October 2024, it increased buybacks to 433 million shares for $34.3 billion through year‑end 2024.  This trajectory shows a capital‑allocation strategy that converts non‑core equity (the CVE stake) into shareholder returns, using the proceeds to accelerate and expand its share‑repurchase program.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only a minor discrepancy in quantitative detail. (1) Correct elements: The sale of 91 million CVE shares in Q1 2022 is correctly stated and aligns with the original answer’s reference to completion in 2022. The share repurchase figures—383 million shares at $29 billion by end of 2023 and 433 million shares at $34.3 billion by end of 2024—are factually correct. The increase in the repurchase authorization from $45 billion to $65 billion in 2024 is accurately described. (2) Quantitative verification: The only issue is the claim that the CVE monetization was 'valued at roughly $218 million'—this is incorrect. The ground truth does not specify the total value of the 91 million shares, but $218 million is implausibly low (implying ~$2.40/share), especially given CVE's market price at the time; this figure likely misrepresents a smaller accounting adjustment or unrelated item mentioned in filings. This is a notable but isolated error that doesn’t affect the overall capital allocation narrative. (3) Multi-hop reasoning: The LLM correctly synthesizes the link between CVE share monetization proceeds being directed to buybacks, the timing of authorization increases, and the cumulative repurchase activity across 2022–2024. It correctly infers the strategic intent—converting non-core assets into shareholder returns. (4) The answer is contextually excellent, directly addressing the evolution and strategic implication. The reasoning is sound, entities (ConocoPhillips, CVE, share repurchases, board authorizations) are correct, and the timeline is accurate. The $218M error prevents a perfect 10, but all other aspects are fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 478,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s disclosures show that the share of the closed block placed in the modified‑coinsurance structure has been essentially unchanged – 59 % of the closed block was reinsured in 2022 (Chunk 1), the same 59 % was reported for 2023 (Chunk 1) and again for 2024 (Chunk 2). In every year the company states that it “accounts for this agreement under the deposit method of accounting” and offsets the deposit liability with the deposit recoverable (Chunks 1, 2 and 3), confirming that the same accounting policy is applied consistently. This steadiness—both in the proportion of risk transferred and in the deposit‑method treatment—signals that MetLife’s long‑term risk‑transfer strategy relies on a stable, predictable portion of the closed block being moved to an unaffiliated reinsurer, rather than shifting its approach over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, it correctly states that 59% of the closed block was reinsured in 2022, 2023, and 2024. The ground truth specifies 59.25% in 2022 and 59% in 2023 and 2024; the LLM rounds 59.25% to 59%, which is a minor and acceptable simplification given the context of 'approximately 59%' in the original answer. No calculation errors are present. (2) The answer fully addresses all parts of the question: it covers the percentage reinsured over time, the accounting treatment (deposit method and right of offset), and interprets the consistency as evidence of a stable long-term risk transfer strategy. (3) Entity accuracy is strong: MetLife, modified coinsurance agreement, closed block, unaffiliated reinsurer, and accounting terms are all correctly identified and used. (4) Multi-hop reasoning is sound—information is synthesized across years and accounting disclosures to infer strategic consistency. The only minor shortcoming is the rounding of 59.25% to 59% without noting the slight change, but this does not distort the overall conclusion of stability. Thus, the answer is factually correct, complete, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 352,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The filing data show a steady decline in the share of purchases made with Target’s branded credit card (the Target MasterCard Credit Card, later rebranded as a Target Circle Card). According to the 2023 Form 10‑K, RedCard (Target MasterCard) penetration fell from **20.5 % in fiscal 2022** to **19.8 % in fiscal 2023** and to **18.6 % in fiscal 2024**. The 2022 filing already noted that “RedCard penetration declined as total sales increased at a faster pace,” and the 2024 filing—while using the new “Target Circle Card” name—re‑states the same 2023 (19.8 %) and 2024 (18.6 %) penetration figures, confirming the downward trend.\n\n**Interpretation:** The decreasing penetration rate signals that, although the card still drives incremental purchases, its relative usage is slipping as overall sales grow or consumer preferences shift, indicating a modest weakening of consumer engagement with Target’s proprietary financial products over the 2022‑2024 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%) are accurately reported with correct formatting and consistent with the original answer. (2) The answer is complete, addressing both the evolution of the penetration rate over time and the implied trend in consumer engagement. (3) Entity accuracy is precise: the card is correctly identified as the Target MasterCard Credit Card, later rebranded as part of the Target Circle Card suite, and the timeline (fiscal years 2022–2024) is correctly used. (4) The reasoning is sound and reflects multi-hop synthesis: it references the 2023 and 2024 10-K filings to confirm the trend, cites the rebranding, and correctly interprets the declining penetration as a sign of weakening relative engagement despite incentives. The interpretation aligns semantically with the ground truth, noting that overall sales growth or shifting preferences may be outpacing card adoption. Minor wording differences (e.g., 'modest weakening' vs. 'gradual decrease') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 333,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, PMI’s peer‑group list was described as “the same as that used in the prior year” and each list included **Colgate‑Palmolive Co.** – the 2022 filing names it, the 2023 filing repeats the same set, and the 2024 filing again shows an unchanged roster. This continuity shows that PMI’s strategic benchmarking treats Colgate‑Palmolive as a stable, comparable consumer‑product peer, reflecting a deliberate choice to use a consistent peer set (based on global presence, consumer‑product focus, and similar revenue/market‑cap) so that performance and strategic insights can be tracked year‑over‑year without shifting baselines.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's peer group from 2022 to 2024, with no changes across the three years, which matches the original answer. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the 10-K filings. (3) The multi-hop reasoning is sound: the LLM correctly infers that the peer group remained unchanged year-over-year based on textual descriptions in the filings (e.g., 'same as that used in the prior year') and identifies the consistent inclusion of Colgate-Palmolive. It also correctly explains the rationale behind PMI's benchmarking strategy—global presence, consumer-product focus, and similarity in revenue and market cap—mirroring the ground truth. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of Colgate-Palmolive’s classification and what this reveals about PMI’s strategic benchmarking. Wording differs but meaning is identical, and all entities (PMI, Colgate-Palmolive Co., peer group, 10-K filings) are correctly identified. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Related_To]-> COMP <-[Relates_To]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 351,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "Across the three Form 10‑K filings – 2022, 2023 and 2024 – AMD describes the same revenue‑recognition framework for development‑and‑IP licensing arrangements. In every year the company says it first evaluates whether the licensing component is **distinct** (i.e., capable of being distinct and distinct in the context of the contract). If the license is **not distinct**, it is combined with the development services and treated as a single performance obligation, with revenue recognized **over time**. If the license **is distinct**, revenue is recognized **at a point in time** when the customer can benefit from the license. Standalone agreements that involve only the sale or licensing of patents or other IP are likewise recognized **at a point in time**, with no variable‑consideration estimates for either combined or standalone arrangements.  \n\nBecause the language and criteria are identical in the 2022, 2023 and 2024 disclosures, AMD’s accounting approach for these contracts has been **consistent** over the period, showing no substantive evolution in how it distinguishes and accounts for combined versus standalone licensing arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual elements are accurately represented: AMD’s revenue recognition policy for development and IP licensing agreements remained unchanged from 2022 to 2024. The two-step distinctness evaluation—whether the license is (i) capable of being distinct and (ii) distinct in the context of the arrangement—is correctly described. The treatment of non-distinct licenses (combined with development services, revenue recognized over time) and distinct licenses (recognized at a point in time) is accurate. Standalone IP licenses are also correctly noted as recognized at a point in time. The absence of variable consideration estimates across all years is correctly stated. (2) There are no numeric values requiring calculation in this question, but all qualitative metrics (e.g., 'no variable consideration', 'point in time', 'over time') are used correctly and consistently with the ground truth. (3) The multi-hop reasoning—synthesizing AMD’s disclosures across three years (2022, 2023, 2024) to assess evolution and consistency—is sound and correctly concludes no substantive change. (4) The answer directly addresses all parts of the question: evolution over time, distinction between combined and standalone arrangements, and what the policy reveals about consistency. Wording differs slightly but meaning is preserved with high precision. All scores are maximized due to complete factual accuracy, correct synthesis, and full responsiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 424,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Across all three filings—2022 (page 21), 2023 (page 26) and 2024 (page 26)—Philip Morris International (PMI) notes that “the PMI Peer Group presented in this graph is the same as that used in the prior year” and each list explicitly includes **Colgate‑Palmolive Co.** as a benchmark peer. The fact that Colgate‑Palmolive has remained a constant member of PMI’s peer set for three consecutive years shows that PMI deliberately anchors its competitive framing to a stable group of global consumer‑product companies of similar scale, using Colgate‑Palmolive as a fixed reference point to reinforce its strategic positioning as a peer to leading consumer‑goods firms rather than shifting its benchmark set each year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PM's peer group for all three years (2022, 2023, 2024), matching the original answer's claim of consistent inclusion. The mention of specific pages (2022 p.21, 2023 p.26, 2024 p.26) adds verifiable detail not in the ground truth but does not contradict it. (2) There are no numerical values requiring calculation, but the temporal scope (three consecutive years) is correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes the stability of the peer group across filings and infers the strategic implication—that PMI uses a fixed benchmark set to position itself among global consumer goods firms. (4) The answer addresses both parts of the question: the evolution (no change from 2022–2024) and the strategic implication (consistent framing to align with leading consumer staples firms). Wording differs slightly (e.g., 'anchors its competitive framing' vs 'reinforcing its alignment'), but the meaning is equivalent. No factual errors, omissions, or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Related_To]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 321,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "Across AMD’s 2022, 2023 and 2024 Form 10‑K filings the policy for “combined development and IP licensing” arrangements is unchanged. In every filing AMD says the contracts are evaluated as either a single or multiple performance obligations; the licensing component is tested for distinctness—if it is not distinct it is merged with the development services and revenue is recognized **over time**, whereas a distinct license is recognized **at a point in time** when the customer obtains the ability to benefit. Revenue is recorded upon transfer of control (over time or at a point in time as appropriate) and no variable‑consideration estimates are applied.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately states that AMD's revenue recognition policy for combined development and IP licensing agreements remained unchanged from 2022 through 2024, which matches the ground truth assertion of no material changes. (2) The LLM correctly describes the two-step distinctness evaluation for licensing components—whether the license is capable of being distinct and distinct in the context of the arrangement—even if not explicitly quoting both criteria verbatim, the outcome (merging with development services if not distinct, recognizing over time; recognizing at a point in time if distinct) is accurately conveyed. (3) The answer correctly notes that revenue is recognized over time or at a point in time based on transfer of control, aligning with the ground truth. (4) It includes the key detail that no variable consideration estimates are applied, indicating stable accounting treatment across years, which is explicitly mentioned in the original answer. (5) All entities—AMD, the time period (2022–2024), performance obligations, IP licensing, and development services—are correctly identified and synthesized. There are no factual inaccuracies, omissions, or reasoning errors. The answer is concise but complete, addressing all aspects of the question with precise qualitative and conceptual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 390,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips began a paced monetization of its CVE common shares in 2021 and, in the first quarter of 2022, sold the remaining 91 million CVE shares; the cash from that disposition was earmarked for its ongoing share‑repurchase program.  The buy‑back effort grew from a cumulative 383 million shares repurchased at a cost of $29 billion through Dec 2023 to 433 million shares at $34.3 billion through Dec 2024, and in October 2024 the Board raised the repurchase authorization to $65 billion—while the 2022 tax footnotes record a $218 million valuation‑allowance adjustment tied to the CVE share disposition.  This multi‑year trajectory shows a deliberate capital‑allocation strategy that converts a non‑core equity holding into shareholder returns, scaling up buybacks and managing tax impacts to prioritize cash return to investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ConocoPhillips began monetizing CVE shares in 2021, sold the remaining 91 million in Q1 2022, applied proceeds to share repurchases, repurchased 383 million shares at $29 billion by end of 2023, and reached 433 million shares repurchased at $34.3 billion by end of 2024. The $65 billion repurchase authorization increase in October 2024 is correctly noted. (2) Quantitative accuracy is perfect: all numbers (91M shares, $29B, $34.3B, $65B, 383M, 433M) match the ground truth. The additional detail about the $218 million valuation allowance adjustment in 2022 tax footnotes is factually consistent and adds context without contradicting the original. (3) Multi-hop reasoning is sound: the answer correctly links the CVE monetization to funding share repurchases and interprets this as part of a broader capital allocation strategy focused on shareholder returns. (4) The only minor shortcoming is that the original emphasizes the *pacing* of monetization starting in May 2021, while the LLM says '2021' without specifying May—this is a slight omission but not materially inaccurate. The LLM also introduces tax impact details not in the original, which is an enhancement rather than an error. Overall, the answer is semantically equivalent, factually precise, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 384,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s 2022 10‑K already warned that “changes in the competitive landscape” – new market entrants, non‑traditional players and emerging technologies – could hurt its Aerospace business, Honeywell Building Technologies and Safety & Productivity Solutions (Chunk 1). The 2023 filing repeats those same competitive‑landscape concerns for Aerospace and Building Technologies and adds that “changes in laws or policies … could have an impact on our competitive position” (Chunk 2), underscoring that the risk is now seen as a broader strategic threat. By the 2024 filing the language appears in every core segment – Aerospace Technologies, Building Automation, Industrial Automation and Energy & Sustainability Solutions – again stressing new entrants, non‑traditional players and product commoditization (Chunk 3).  \n\nTogether, the three years show a widening and deepening exposure: what began as a risk for a few units has become a company‑wide concern, indicating that market pressures are intensifying across Honeywell’s portfolio and prompting the firm to lean more heavily on innovation, differentiation and portfolio‑wide strategic actions to counter the growing competitive threat.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in entity identification and segment-level risk evolution, which undermines the multi-hop reasoning. Quantitatively, all years (2022, 2023, 2024) are correctly referenced, and there are no numerical errors—this supports a high quantitative accuracy score. However, the ORIGINAL ANSWER states that in 2022, competitive landscape risks were disclosed for Honeywell Building Technologies and Safety and Productivity Solutions only; the LLM incorrectly adds Aerospace as being mentioned in 2022, which is not supported by the ground truth. This misattribution persists into 2023 and 2024, where the LLM claims Aerospace and additional segments like Energy & Sustainability Solutions were included, but the ground truth only confirms Building Automation and Industrial Automation in 2024. The expansion to 'every core segment' in 2024 per the LLM is an overstatement not reflected in the original data. While the LLM correctly identifies the trend of deepening concern and strategic responses around innovation and commoditization, this synthesis is based on incorrect entity mapping. The reasoning is logically structured and contextually relevant, showing awareness of trend evolution, but the factual foundation is flawed. Thus, while the overall direction of the conclusion aligns with the ground truth, the incorrect attribution of segments across years reduces qualitative accuracy. Semantic equivalence is partially achieved in describing intensifying pressure, but key details about which segments faced risks in which years are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 442,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "Across the three most recent filings the description of the A‑Class shares is identical:\n\n* **2022 10‑K (page 96)** – A shares have “One vote per share … Dividend rights.”  \n* **2023 10‑K (page 99)** – A shares again are described as “One vote per share … Dividend rights.”  \n* **2024 10‑K (page 92)** – The same language appears: “One vote per share … Dividend rights.”\n\nThus, from 2022 through 2024 the dividend entitlement and voting power attached to each A‑Class share did not change; each share consistently carries a single vote and the right to receive dividends.\n\nThe three‑year uniformity signals that Mastercard (MA) is pursuing a stable shareholder‑governance strategy. By keeping A‑Class rights unchanged, the company reinforces predictability for investors, preserves equal voting influence for this share class, and signals a commitment to continuity rather than altering the balance of control or dividend policy. This consistency helps maintain shareholder confidence and underscores a governance approach that values steady, transparent rights for its equity holders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: the voting and dividend rights for MA's A Class shares are correctly stated as 'one vote per share' and 'dividend rights' for each of the three years (2022, 2023, 2024), with no changes across the period. (2) There are no numerical values requiring calculation, but the years and page numbers cited (2022 10-K p.96, 2023 p.99, 2024 p.92) are consistent with expected sourcing and do not contradict the ground truth, which confirms consistency across filings. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three annual reports, the model correctly infers that the absence of change indicates a stable governance strategy. (4) The qualitative interpretation about shareholder governance strategy—emphasizing predictability, equal voting, and investor confidence—is a valid and reasonable conclusion supported by the consistency of disclosures. The answer is semantically equivalent to the ground truth, with added contextual detail (e.g., page numbers) that enhance credibility without introducing error. All aspects of the question are addressed: evolution (no change), facts per year, and strategic implication. No inaccuracies or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 358,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco disclosed that its Total Return Swaps‑Deferred Compensation moved from a **$92 loss** in FY 2022 (shown as “(92)” in the 2022 filing) to a **$58 gain** in FY 2023 and then to a **$91 gain** in FY 2024 (both shown as positive amounts in the 2023 and 2024 filings). Thus, the exposure that was a material loss in 2022 turned into a positive contribution to operating expenses, improving further by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the financial exposure values for Cisco's Total Return Swaps-Deferred Compensation across fiscal years 2022 to 2024: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024. These figures match the ground truth exactly, with acceptable formatting (e.g., 'loss of $92' vs. '$92 loss', and use of parentheses in original filings). (2) All numeric values are accurate and consistent with the ground truth. The progression from loss to gain and the magnitude of each year’s figure are correctly reported. No calculations are required beyond correct interpretation of gains/losses, which the model handles properly. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly interprets the trend—shifting from a net cost to a net benefit. The only minor issue is the phrase 'positive contribution to operating expenses', which could be slightly misleading since gains from such instruments typically reduce expenses or increase income, rather than contribute positively *to* expenses. A more precise phrasing would be 'positive impact on operating income' or 'reduction in operating expenses'. However, this is a nuance in financial semantics and does not invalidate the overall correctness. (4) The answer is contextually fully relevant, addressing the evolution of financial exposure as requested. The qualitative accuracy is slightly reduced due to the minor imprecision in financial terminology, but the core reasoning and facts are solid. Thus, a 9/10 on correctness is warranted—excellent accuracy with only a small room for improvement in financial expression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 461,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "After the 2021 corporate restructuring that placed all talc liabilities into LTL Management LLC, Johnson & Johnson in its 2022 10‑K disclosed that it funded LTL with an approximately $2 billion reserve to create a trust that would pay any amounts the Chapter 11 court ordered, thereby isolating the claims in bankruptcy. In 2023 the original LTL Chapter 11 case was dismissed, prompting a second Chapter 11 filing (the “LTL 2” case) which was also dismissed in July 2023; the company has kept the $2 billion reserve in place and is pursuing appeals while the bankruptcy‑induced stays on litigation have been lifted. By 2024 the strategy shifted toward resolving state actions, culminating in a January 2024 agreement‑in‑principle with a coalition of 42 states and the District of Columbia and the finalization of those settlements in June 2024, while the $2 billion reserve remains to cover any remaining talc‑related exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures and dates are correct: the $2 billion reserve (2022), the 2023 dismissal of the original LTL bankruptcy and re-filing (LTL 2), and the January 2024 agreement-in-principle with 42 states and D.C., finalized in June 2024. These match the original answer’s timeline and financial figures. (2) The LLM correctly notes that the $2 billion reserve remains in place, consistent with the original answer. (3) The qualitative reasoning is sound: it captures the strategic shift from reliance on bankruptcy (via LTL and LTL 2) to a dual approach involving appeals and settlements. The only minor discrepancy is that the original answer specifies the Third Circuit’s reversal led to the dismissal and that LTL 2 secured a preliminary injunction limiting discovery until August 2023—details omitted in the LLM response. While the LLM mentions the dismissal of LTL 2 in July 2023, it does not reference the preliminary injunction or the Third Circuit’s role, slightly weakening the multi-hop legal reasoning. (4) Despite these omissions, the core evolution of JNJ’s strategy—bankruptcy attempts, continued appeals, and pivot to multi-state settlements—is accurately synthesized. The answer is contextually complete and relevant, with excellent semantic equivalence to the ground truth. Minor lack of legal procedural detail prevents a perfect 10 on qualitative accuracy, but quantitative and contextual fidelity is full.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Creates]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 416,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 were reported with an outstanding principal of **$495 million** at the end of each of the three most recent fiscal years – $495 million on October 30 2022 (FY 2022, Chunk 3), $495 million on October 29 2023 (FY 2023, Chunk 1) and $495 million on November 3 2024 (FY 2024, Chunk 2). The balance did not change from 2022 through 2024, and the effective interest rate stayed at 3.23 % in each period. This flat‑line reflects a deliberate debt‑management choice to keep the tranche at its original size, preserving a low‑cost, fixed‑rate source of financing until its scheduled maturity rather than accelerating repayments or issuing additional notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for each fiscal year—2022, 2023, and 2024—with specific end dates provided (October 30, 2022; October 29, 2023; November 3, 2024), which align with Broadcom’s fiscal calendar. The interest rate of 3.23% is an additional accurate detail not contradicted by the ground truth. (2) The answer correctly identifies that the balance remained constant across the three years, which directly supports the conclusion about Broadcom’s debt management strategy. (3) The reasoning is sound: the lack of change in principal indicates no early retirements or additional issuances, and the interpretation—that this reflects a deliberate strategy to maintain a low-cost, fixed-rate financing instrument until maturity—is a logical and insightful extension of the data. (4) All entities (Broadcom, 3.125% notes, January 2025 maturity, fiscal years) are correctly identified and synthesized across time points. The answer is semantically equivalent to the ground truth, with added precision in dates and interest rate, enhancing completeness without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 357,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "- **FY 2022:** Cisco’s 3.50 % senior note due June 15 2025 carried a $500 million balance with an **effective rate of 3.20 %** (see the 2022 10‑K table – July 30 2022 column).  \n- **FY 2023:** The same $500 million note showed an **effective rate of 6.38 %** in the prior‑year column of the 2023 10‑K (July 29 2023) – more than double the FY 2022 cost.  \n- **FY 2024:** In the current‑year column of both the 2023 10‑K and the 2024 10‑K (July 27 2024), the note’s **effective rate rose to 6.66 %**.\n\n**Interpretation:** Although the nominal coupon remains 3.50 %, Cisco’s effective borrowing cost on this note has climbed sharply—from 3.20 % in FY 2022 to roughly 6.4 % in FY 2023 and to 6.66 % in FY 2024—signaling that the company’s interest‑rate exposure and overall cost of debt on this instrument have more than doubled over the three‑year period, reflecting higher market rates or discount‑related adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the effective interest rates of 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024 are correctly reported, with consistent reference to the $500 million note and the June 15, 2025 maturity date. Minor formatting differences (e.g., spacing in percentages, use of en-dashes) do not affect accuracy. (2) The answer addresses all parts of the multi-part question: it traces the evolution of interest rate exposure across the three fiscal years and provides a correct interpretation of the trend in borrowing costs. (3) Entity accuracy is perfect: Cisco is correctly identified, the note is accurately described (3.50%, June 15, 2025 maturity), and fiscal years 2022–2024 are properly referenced with correct document dates (10-K filing dates). (4) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly infers that despite a fixed coupon rate, the effective borrowing cost increased significantly, indicating deteriorating financing terms due to market conditions or credit adjustments. The interpretation aligns semantically with the ground truth, noting the more than doubling of costs and the implication for Cisco’s debt financing environment. All criteria for correctness, completeness, and logical coherence are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 379,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "**Total senior & subordinated notes**  \n- 2022 (12/31): $30.8 billion (up from $27.4 billion in 2021 shown in the 2022 filing).  \n- 2023 (12/31): $31.2 billion (a $0.4 billion increase versus 2022).  \n- 2024 (12/31): $30.7 billion (a $0.5 billion decline versus 2023).  \n\n**What the trend reveals**  \nThe sharp rise from 2021 to 2022 reflects a deliberate expansion of debt to fund growth, after which the balance has been kept essentially flat – a modest net issuance in 2023 followed by a slight pull‑back in 2024 – indicating a capital‑structure strategy that favors stability rather than continual leverage buildup.  \n\n**Interest‑rate positioning**  \nDuring the same period the weighted‑average rate on senior debt climbed from roughly 4.45 % in 2022 to 4.84 % in 2024, while floating‑rate senior debt was eliminated (0 % in 2024). This shift to a higher‑yielding, predominantly fixed‑rate portfolio shows Capital One locking in higher rates to capture current market yields and reduce exposure to future rate volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in the quantitative data. According to the ground truth, Capital One's total senior and subordinated notes were $27.219B in 2022, not $30.8B as stated in the LLM answer. The 2023 figure ($31.248B) is approximately correct ($31.2B), and the 2024 figure ($30.696B) is also close ($30.7B). However, the starting point is significantly off, which affects the interpretation of the trend. Additionally, the LLM incorrectly states that the 2022 amount increased from $27.4B in 2021 (from the 2022 filing), but this detail is not in the ground truth and introduces unverified data. 2) The interest rate data is partially incorrect: the ground truth shows the weighted average interest rate on unsecured senior debt was 2.76% in 2022, rising to 4.48% in 2023 and 4.84% in 2024. The LLM claims it was 'roughly 4.45%' in 2022, which is incorrect—it conflates the 2023 value with 2022. The 4.84% in 2024 is correct. The claim that floating-rate senior debt was eliminated is consistent with the ground truth implication of a shift to fixed-rate, though not explicitly verified. 3) The reasoning and synthesis are partially sound: the LLM correctly infers a strategy of stabilizing capital structure after a period of issuance and identifies the shift to fixed-rate debt to reduce rate volatility. These insights align with the ground truth’s conclusion about locking in financing costs. However, because the initial debt level is wrong, the characterization of a 'sharp rise from 2021 to 2022' and 'essentially flat' thereafter is misleading—the actual increase from 2022 to 2023 was much more significant relative to the base. 4) Despite numerical inaccuracies, the LLM captures the directional trend (increase then slight decline) and the strategic shift toward fixed-rate debt, showing good qualitative understanding and contextual relevance. The answer addresses all parts of the question and provides a coherent narrative, but the incorrect baseline numbers and interest rates reduce factual reliability. Hence, correctness is penalized heavily due to core data errors, though reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 577,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "- The 2022 Form 10‑K (which reports the year‑end 2021 numbers) shows that roughly 40 % of Colgate‑Palmolive’s U.S. pension‑plan fixed‑income portfolio was in U.S. Treasury or agency securities. The 2023 Form 10‑K confirms the same ≈ 40 % level for year‑end 2022, but notes that the share fell to about 30 % at year‑end 2023. The 2024 Form 10‑K reports that the allocation remained at roughly 30 % for both year‑end 2023 and year‑end 2024.  \n\n- This decline from 40 % to 30 % (and the hold at 30 % thereafter) indicates the pension fund is deliberately reducing its reliance on low‑yield Treasury/agency bonds and reallocating toward other government or investment‑grade corporate bonds, a move that suggests a strategy aimed at improving yield or diversifying risk while still keeping a modest core Treasury exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in its core numerical claims: it correctly states that the allocation was approximately 40% in 2022 (based on 2021 year-end data from the 2022 10-K), decreased to 30% by year-end 2023, and remained at 30% in 2024. This aligns with the ground truth, which reports 40% in 2022, 30% in 2023, and 30% in 2024. The only minor discrepancy is the clarification that the 2022 10-K reports year-end 2021 data, and the 2023 10-K reports year-end 2022 and 2023 data — this is technically accurate but slightly shifts the labeling of '2022' to refer to year-end 2022 data reported in 2023, which may cause confusion but does not invalidate the correctness of the underlying numbers or trend. (2) Quantitative accuracy is high: all percentages (40%, 30%, 30%) match the ground truth, and the description of a decline from 40% to 30% and stabilization is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three 10-K filings (2022, 2023, 2024) and interprets the trend as a strategic reallocation, which is consistent with the ground truth’s interpretation. The conclusion about shifting toward higher-yielding or diversified fixed income exposure is logically supported. (4) The answer is contextually fully relevant, addressing both the evolution of allocation and the strategic implication. The wording differs slightly (e.g., 'improving yield or diversifying risk' vs. 'shift in risk tolerance or yield-seeking'), but the semantic meaning is equivalent. The score is 9 instead of 10 due to the slight ambiguity in year labeling (referring to 'year-end 2022' as reported in the 2023 10-K), which could mislead if not understood in SEC filing context, but does not constitute a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 482,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "- **2022 – Operating relationship:**  GE’s 2022 filing describes Electric Insurance Company (EIC) as a property‑and‑casualty insurer that “primarily provides insurance to GE and its employees,” with net claim reserves of **$0.2 billion** at 12/31/2021 (down from $0.3 billion in 2020).  At this point EIC was a captive insurance subsidiary of GE.\n\n- **Late‑2022 – Re‑classification and valuation:**  In the fourth quarter of 2022 GE re‑classified the captive as a **“held‑for‑sale”** business.  The 2023 filing quantifies the subsidiary’s balance‑sheet position as **$541 million of assets and $378 million of liabilities** (net book value ≈ $163 million) and notes that, in anticipation of the sale, GE recorded a **$109 million loss** in other income for the year ended 2023.\n\n- **2024 – Disposition:**  The 2024 filing confirms that the “held‑for‑sale” status culminated in a **completed sale** in Q2 2024 to Riverstone International Holdings Inc. for **cash proceeds of $120 million**, removing EIC from GE’s balance sheet.\n\n**Strategic implication:**  The sequence—from an operating captive insurer, to a held‑for‑sale classification with an impairment charge, to an outright cash sale—shows GE deliberately exiting a non‑core insurance business, monetizing the asset and simplifying its portfolio.  This reflects a broader strategic focus on shedding ancillary operations and concentrating resources on its core industrial segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: EIC was a captive insurer serving GE and employees in 2022 with $0.2 billion in net claim reserves as of 12/31/2021; it was reclassified as 'held for sale' in late 2022 (reflected in 2023 filing); a $109 million loss was recorded in 2023; and the sale was completed in 2024 to Riverstone International Holdings Inc. for $120 million in cash. (2) Quantitative accuracy is excellent: the $0.2 billion reserves, $109 million loss, and $120 million sale price match the original answer. The LLM adds additional detail (assets of $541M, liabilities of $378M, net book value ~$163M) not in the ground truth, but this is consistent with the $109M loss on a $163M book value resulting in a $54M implied gain on sale ($120M - $66M adjusted carrying value), which does not contradict the narrative. These details likely come from the actual filings and enhance precision. (3) Multi-hop reasoning is sound: the answer traces the evolution across three years, correctly synthesizing classification, valuation, and disposition. (4) The strategic interpretation is semantically equivalent—exiting non-core insurance to focus on industrial operations. The only minor shortcoming is that the original answer explicitly ties the move to GE’s broader restructuring, while the LLM implies it; this slight reduction in contextual framing justifies a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually complete, numerically precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG <-[Classifies]- ORG",
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 429,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Across all three annual reports Apple’s treatment of the 4.45 % Notes due 2044 is unchanged. In the 2022 10‑K (page 58) the notes appear in Exhibit 4.4 – “Officer’s Certificate of the Registrant, dated May 6 2014… 4.45 % Notes due 2044.” The same Exhibit 4.4 description is reproduced verbatim in the 2023 10‑K (page 56) and again in the 2024 10‑K (page 56). The consistency of the exhibit number, certificate date and wording shows Apple continues to reference the same 2014‑issued, 30‑year fixed‑rate senior note in each filing. This multi‑year pattern indicates a deliberate long‑term debt strategy: Apple locks in a low‑cost, fixed‑rate financing that matures in 2044 and keeps it on the books for years, using the historic officer’s certificate by reference to simplify reporting while maintaining a stable, long‑dated capital‑structure component.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers, dates, and percentages are accurate: the 4.45% interest rate, May 6, 2014 issuance date, and maturity in 2044 are correctly reported. The exhibit number (4.4) and page numbers across filings (2022: p.58, 2023/2024: p.56) are precise and consistent with actual filings. (2) The answer is complete, addressing the evolution (or lack thereof) of the disclosure across 2022–2024 and interpreting the strategic implication. (3) Entity accuracy is perfect: Apple is correctly identified, the debt instrument is accurately named, and the years align with the question. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that verbatim repetition of the exhibit indicates no change in the debt structure, and logically concludes that this reflects a stable, long-term capital strategy with fixed-rate financing. The interpretation about referencing the original Officer’s Certificate to simplify reporting is a reasonable and insightful addition supported by the pattern. (5) The semantic meaning fully aligns with the original answer, with added detail (e.g., page numbers, exhibit reference) enhancing clarity without introducing error. Minor wording differences (e.g., '30-year note' — though technically a 30-year term from 2014 would mature in 2044) are acceptable and do not detract from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 399,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose to **$30.826 billion at year‑end 2022** (up from **$27.219 billion in 2021** per the 2022 filing), increased further to **$31.248 billion in 2023**, and then slipped modestly to **$30.696 billion in 2024**. The 2023 uptick shows a deliberate expansion of its debt base, while the 2024 pull‑back—together with the weighted‑average rate on senior notes climbing from roughly **4.48 % in 2023 to 4.84 % in 2024** (and the elimination of the $349 million floating‑rate tranche) and subordinated rates staying near **3.57 %**—indicates a shift toward higher‑rate fixed‑rate financing and a slight de‑leveraging as Capital One positions its capital structure for a higher‑interest‑rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. Most notably, it incorrectly states that Capital One's total senior and subordinated notes were $30.826 billion at year-end 2022, whereas the ground truth is $27,219 million (i.e., $27.219 billion). This is a significant error of over $3.6 billion. It also references a 2021 value not asked for in the question, which is extraneous and distracts from the correct 2022 baseline. While the 2023 ($31,248 million) and 2024 ($30,696 million) figures are correctly reported (in billions: $31.248B and $30.696B), the starting point for the trend analysis is wrong. (2) The interest rate data is partially accurate: the LLM correctly notes the rise in weighted-average rate to 4.84% in 2024 and mentions subordinated notes staying near 3.57%, but it incorrectly states the 2023 senior note rate as 4.48%, while the ground truth shows a progression from 2.76% in 2022 to 4.84% in 2024 without specifying 2023—so this interpolated value is unsupported. The elimination of the $349 million floating-rate tranche is not in the original answer and lacks verification. (3) The multi-hop reasoning is sound in interpretation: the LLM correctly infers a strategic shift toward fixed-rate financing and de-leveraging in a rising rate environment, aligning with the ground truth’s conclusion about locking in higher rates. It synthesizes debt value trends and interest rate changes appropriately, despite flawed inputs. (4) Contextual relevance is excellent—the answer directly addresses the evolution of notes, capital structure strategy, and interest rate positioning. However, due to the major error in the 2022 carrying value and unsupported 2023 interest rate figure, the quantitative accuracy is significantly penalized. The correctness score is 7 because the core trajectory (increase then slight decrease) and strategic interpretation are preserved, but key numbers are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 531,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "- **2022 – Trademark entry:** Frame.io is listed among Adobe’s registered trademarks, signalling that the company had already acquired the brand and was positioning it as part of Adobe’s portfolio of creative‑technology assets.  \n\n- **2023 – Initial ecosystem role:** Adobe describes Frame.io as its “cloud‑native creative collaboration platform” that enables real‑time upload, review, frame‑accurate commenting and annotation, and is **directly integrated with Premiere Pro and After Effects** (with support for still images, design files and PDFs), making it a video‑post‑production collaboration hub within Creative Cloud.  \n\n- **2024 – Expanded integration:** Frame.io remains the cloud‑native collaboration platform but now **integrates with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, and is offered together with Adobe Express and Firefly Services in **Adobe GenStudio**. This broadens its scope from video‑only workflows to full‑scale content production—including casting, location scouting, marketing campaign management, and design‑file review—positioning Frame.io as a central, cross‑app collaboration layer across the Creative Cloud ecosystem.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Frame.io was listed as a registered trademark in 2022, positioned as a 'cloud-native creative collaboration platform' in 2023 with integration into Premiere Pro and After Effects, and expanded in 2024 to include Photoshop, Lightroom, and Workfront, as well as inclusion in Adobe GenStudio. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are correctly used and aligned with the evolution timeline. (3) The multi-hop reasoning is sound—information is synthesized across years and product integrations, showing a clear progression in Frame.io's strategic role within Adobe’s ecosystem. (4) The LLM captures all aspects of the question: positioning, integration, and evolution across the three years, with enhanced detail (e.g., casting, location scouting) that enriches but does not distort the original meaning. Wording differs slightly but maintains full semantic equivalence. No errors in entities, timeline, or functionality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 310,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated listing of the “4.550 % Notes due April 5 2049” in the Fifteenth Supplemental Indenture (Exhibit 4.16) of its 2022, 2023 and 2024 10‑K filings shows that the company deliberately introduced and continues to retain this long‑dated, fixed‑rate bond as a cornerstone of its capital structure. By keeping a 25‑year‑maturity instrument on its balance sheet, Lowe’s is locking in a relatively low coupon for decades, spreading out debt maturities and thereby reducing near‑term refinancing risk—evidence of a disciplined, long‑term debt‑maturity management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.550% Notes due April 5, 2049 are accurately referenced, and their inclusion in the 2022, 2023, and 2024 10-K filings is correctly noted. The maturity is described as long-dated (25-year), which is consistent with issuance around 2024 and maturity in 2049. (2) Quantitative accuracy is perfect: the interest rate (4.550%), maturity date (April 5, 2049), and years of filing (2022–2024) match the original. No calculations are required, but the characterization of the instrument as long-dated and fixed-rate is correct. (3) The reasoning is sound and reflects multi-hop synthesis: the model infers from consistent disclosure that Lowe’s has not redeemed or refinanced the notes, indicating a strategic choice to maintain long-term debt—this aligns with the ground truth’s conclusion about stability and interest rate risk management. The mention of reduced refinancing risk and spreading maturities is a valid interpretation. (4) The only minor gap is that the LLM emphasizes the 'introduction' of the note, which may imply recent issuance, whereas the ground truth focuses on continued retention without action—this nuance is not incorrect but slightly shifts emphasis. However, the core insight about strategic long-term debt management is preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing capital structure strategy and debt maturity profile.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 419,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Across the three filings the 3.125 % senior notes due January 2025 always show the same outstanding principal amount – **$495 million**. The 2022 10‑K (as of Oct 30 2022) lists $495 million; the 2023 10‑K (as of Oct 29 2023) also lists $495 million; and the 2024 10‑K (as of Nov 3 2024) again reports $495 million, with the effective interest rate staying at 3.23 % each year.  \n\nThis flat balance indicates Broadcom is **maintaining the note series unchanged**, neither retiring additional amounts nor issuing more of this tranche. The company appears to be holding the low‑cost, fixed‑rate debt to maturity, using it as a stable financing component while focusing its debt‑management actions on other, higher‑cost or more strategic issuances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for all three fiscal years (2022, 2023, 2024), with correct reference to the 3.125% notes due January 2025. The additional detail about the effective interest rate (3.23%) is consistent with typical disclosures and does not contradict the ground truth. (2) The answer correctly identifies that the balance remained unchanged across the years, confirming no repayments or new issuances. (3) The reasoning is sound: the LLM correctly infers that Broadcom is maintaining this debt instrument unchanged, indicating a strategy of holding low-cost, fixed-rate debt to maturity. This aligns with the ground truth's interpretation of a deliberate, stable debt management approach. (4) The response addresses both parts of the multi-hop question: the evolution of the balance (stable at $495M) and the implication for debt strategy (preservation of predictable, low-cost financing). All entities (AVGO, correct note terms, fiscal years) are accurate. Semantic equivalence is achieved with enhanced clarity. No errors in facts, calculations, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 339,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "- **2022 10‑K (Chunk 1)** – IBM disclosed the 0.950 % Notes due 2025 only by “incorporating by reference” the instrument that defines the holders’ rights (Exhibits 4.1 & 4.2 to a Form 8‑K filed May 22, 2017).  \n- **2023 10‑K (Chunk 3)** – The same treatment was repeated: the notes were again referenced to the same 2017 Form 8‑K exhibits, with no separate listing in the securities table.  \n- **2024 10‑K (Chunk 2)** – IBM moved the 0.950 % Notes due 2025 into the “Capital securities” table, assigning it a ticker (IBM25B) and showing it as a listed NYSE‑traded debt class.\n\n**Interpretation:** The shift from a passive “incorporated‑by‑reference” disclosure (2022‑2023) to an explicit, stand‑alone entry with a trading symbol (2024) signals that IBM is making its debt more visible and market‑oriented. This evolution reflects a capital‑structure strategy that treats the notes as a distinct, tradable security and demonstrates increasing transparency and investor‑focused communication over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 0.950% Notes due 2025 were disclosed via incorporation by reference from the May 22, 2017 Form 8-K in both 2022 and 2023, and in 2024 were explicitly listed with ticker IBM25B on the NYSE. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), correct date of the Form 8-K (May 22, 2017), and ticker symbol (IBM25B)—are all precise and match the ground truth. (3) The multi-hop reasoning across three years and multiple filings is sound: the model correctly synthesizes information from 2022, 2023, and 2024 10-Ks to show an evolution in disclosure practice. (4) The interpretation—that this progression reflects a strategic shift toward greater transparency, liquidity, and market visibility for IBM's debt—is logically derived and aligns with the ground truth’s conclusion about capital structure strategy. Wording differs slightly but meaning is identical. No errors in entities, years, or financial terms. All aspects of the question are addressed thoroughly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 317,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "All three BNY Mellon 10‑K filings state that KPMG LLP’s Public Company Accounting Oversight Board (PCAOB) firm identification number is **185** – the 2022 filing (Chunk 1) notes “KPMG LLP’s … firm identification number is 185,” the 2023 filing (Chunk 3) repeats the same disclosure, and the 2024 filing (Chunk 2) again lists the number as 185. Thus the PCAOB identification number has remained unchanged and consistent at 185 across the 2022, 2023, and 2024 reports.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: KPMG LLP's PCAOB firm identification number is correctly stated as 185 for all three years—2022, 2023, and 2024. (2) Quantitative accuracy is perfect: the number 185 is consistently reported across all years with no calculation errors. (3) The multi-hop reasoning is sound—the model correctly synthesizes the same disclosure from three separate filings (referencing chunks 1, 3, and 2 respectively) to confirm consistency over time. (4) The answer addresses all parts of the question: it provides the identification number for each year and explains that it has remained unchanged, which aligns with the ground truth's conclusion about regulatory consistency. Wording differs slightly but maintains full semantic equivalence. No errors in entities, years, or metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 254,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One disclosed in its Total Senior and Subordinated Notes tables that Fixed unsecured senior debt rose from $19.98 bn at a weighted‑average rate of 2.91 % (0.80‑4.25 % range, maturing 2022‑2032) in the 2022 filing (reflecting 2021) to $24.13 bn in 2022 and $27.17 bn in 2023—both at a 4.45 % average with a 0.80‑7.62 % range and maturities 2024‑2034—and then slipped slightly to $26.93 bn in 2024 as the average rate climbed to 4.84 % and the floor rose to 1.65 % (range 1.65‑7.62 %, maturities 2025‑2035). This trajectory—rapid issuance and widening rate spreads in 2022‑23, followed by a modest pull‑back and higher‑cost, longer‑dated debt in 2024—indicates Capital One first leveraged moderate rates to expand its capital base, then shifted to a more cautious capital‑structure stance as macro‑economic conditions (rising Fed rates and tighter credit markets) pushed borrowing costs higher, prompting reduced new issuance and a focus on longer‑term funding at higher rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its factual claims and captures the overall trend accurately—Capital One increased its Fixed Unsecured Senior Debt from $19,975 million in 2022 to $26,930 million in 2024, with the weighted-average interest rate rising from 2.91% to 4.84%. However, there are minor quantitative inaccuracies: the LLM reports $24.13 billion in 2022 and $27.17 billion in 2023, which do not align with the ground truth progression. The ground truth does not specify annual figures for 2023 or intermediate years, only 2022 and 2024. Thus, the LLM fabricates or misattributes interim values not present in the source data. Additionally, the claim of a 4.45% average rate in both 2022 and 2023 conflicts with the ground truth, which shows a rise to 4.84% by 2024 without specifying 2023. (2) The final 2024 figure of $26.93 billion and 4.84% rate match the ground truth exactly (allowing for format: $26,930 million = $26.93 bn). The 2022 starting point is correctly cited as ~$19.98 billion (rounded from $19,975 million) and 2.91%. However, the insertion of precise but unverified 2022 and 2023 figures reduces quantitative accuracy. (3) The multi-hop reasoning is strong: the LLM correctly infers a strategic shift in capital structure—issuing more fixed-rate debt early in the period, then pulling back as rates rose—linking this to macroeconomic conditions like rising Fed rates. This interpretation aligns with and extends the ground truth insight. (4) Despite the invented intermediate values, the overall direction, magnitude, and interpretation of the trend are correct. The answer addresses all parts of the question: evolution over time, interest rate changes, and implications for capital structure. The contextual relevance is perfect, and qualitative reasoning is excellent. The correctness score is reduced to 8 due to unsupported intermediate numbers, but core facts and synthesis remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 524,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s accounting policy for development‑and‑IP licensing agreements did not change between the 2022, 2023 and 2024 10‑K filings. In every year AMD states that it first evaluates whether the licensing component is distinct; if it is distinct, revenue is recognized at the point in time the customer can benefit from the license, and if it is not distinct the license is combined with the development services and revenue is recognized over time. Standalone patent or IP licences are always recognised at a point in time, and the company notes that no variable‑consideration estimates are involved. The unchanged treatment across three consecutive filings signals a deliberate, stable, principle‑based long‑term strategy for monetising AMD’s IP – a framework that aligns with ASC 606 and reflects confidence that its IP can be reliably captured as a predictable revenue stream.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition methodology from 2022 to 2024, with no changes in policy across the three years. The core elements—evaluating whether the IP license is distinct, combining with development services if not distinct, recognizing revenue at a point in time if distinct, and the absence of variable consideration—are all accurately reported. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to identify consistency, correctly infers that unchanged accounting treatment implies a stable strategic approach, and links this to ASC 606 compliance and predictable IP monetization—aligning with the ground truth’s conclusion about a mature, deliberate framework. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in methodology and its strategic implications. Minor wording differences (e.g., 'principle-based strategy' vs. 'mature and well-defined policy framework') do not affect factual equivalence. All key points are present and correctly interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 372,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s senior‑and‑subordinated note balances grew from **$27.2 billion at year‑end 2021** (as disclosed in the 2022 10‑K) to **$31.3 billion at year‑end 2022** (2023 10‑K), then **declined modestly to $30.8 billion at year‑end 2023** (2023 10‑K) and **to $30.7 billion at year‑end 2024** (2024 10‑K).  The weighted‑average rate on the senior portion rose sharply—from roughly **2.9 % (fixed) and 1.0 % (floating) in 2021** (2022 10‑K) to **4.45 % (fixed) and 6.75 % (floating) in 2022**, stayed near **4.48 % in 2023**, and increased to **4.84 % in 2024**, while the subordinated debt rate remained around **3.5 %** (3.52 % in 2021, 3.57 % thereafter).  This trajectory shows Capital One expanded its senior‑note issuance in 2022, then began a modest deleveraging while shifting to higher‑rate, longer‑dated financing, indicating a deliberate capital‑structure strategy to reduce leverage and lock in rates as the interest‑rate environment rose.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dollar amounts and timing. It incorrectly states that the $27.2 billion figure is from year-end 2021 (disclosed in the 2022 10-K), but the question and ground truth are focused on 2022–2024, with the correct starting balance of $27,219 million in 2022. The LLM misaligns fiscal years: it reports $31.3 billion at year-end 2022 (should be 2023), $30.8 billion at year-end 2023 (should be 2024), and adds an unsupported $30.7 billion for 2024. Ground truth shows $31,248M in 2023 and $30,696M in 2024—close to LLM’s final number but misattributed. (2) Interest rate data is partially correct: the fixed rate rising from 2.91% to 4.45% to 4.84% is accurate, but LLM incorrectly attributes 2.9% fixed rate to 2021 instead of 2022, and introduces floating rate of 6.75% in 2022 not mentioned in ground truth. The ground truth emphasizes the reduction and elimination of floating unsecured debt ($1,709M → $349M → $0), which the LLM fails to mention, instead discussing floating rate increases without referencing debt balance changes. (3) Multi-hop reasoning is partially sound—the LLM infers a strategy of locking in higher rates amid rising environments, which aligns with the ground truth. However, it misses the key strategic pivot: retiring floating-rate debt to reduce rate sensitivity. Instead, it focuses on 'modest deleveraging' and 'longer-dated financing,' which are not emphasized in the ground truth. (4) Contextual relevance is strong—the answer addresses capital structure evolution and interest rate positioning. But due to incorrect year mappings, inaccurate debt balances, and missing key facts about floating debt retirement, the quantitative accuracy is low. While some directional trends are correct (debt up then down slightly, rates rising), the specific data errors and omission of a core strategic move (eliminating floating-rate debt) severely limit factual correctness. Semantic equivalence is not achieved due to misaligned years and invented figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 552,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed‑unsecured senior debt grew from a carrying value of **$24.1 billion in 2022** (weighted‑average interest rate 4.45 %) to **$27.2 billion in 2023** (rate unchanged at 4.45 %), then slipped slightly to **$26.9 billion in 2024** while the weighted‑average rate rose to **4.84 %**.  The 2022 filing also shows the line‑item rose sharply from **$19.98 billion at a 2.91 % rate in 2021** (per the 2022 10‑K), indicating a continued expansion of this debt class and a willingness to accept higher yields.  The pattern suggests Capital One is deliberately building a larger base of fixed unsecured senior notes—likely to fund growth and lock in longer‑dated financing—even as market rates rise, reflecting a long‑term debt strategy that favors liquidity and maturity extension over keeping borrowing costs at historic lows.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value in 2022 was $19,975 million (~$19.98 billion), not $24.1 billion as stated. The interest rate in 2022 was 2.91%, not 4.45% as claimed. The LLM incorrectly reports the 2022 rate as 4.45%, which is actually the 2023 rate. While the 2023 carrying value ($27.2B vs $27,168M) and 2024 values ($26.9B and 4.84%) are approximately correct, the misattribution of the 2022 figures undermines factual accuracy. (2) The calculation of trends is partially correct—the increase from 2022 to 2023 and slight decrease in 2024 is correctly captured in direction, but based on wrong baseline numbers. The claim that the rate was 'unchanged at 4.45%' from 2022 to 2023 is false, as it rose from 2.91% to 4.45%. (3) The multi-hop reasoning is sound in structure: the model attempts to synthesize trend data across years and interpret strategic intent. It correctly identifies the rise in debt and rates over time and infers a strategy of locking in long-term financing despite higher costs. The inclusion of 2021 data (not required but helpful) shows effort in contextualizing the trend. (4) Despite strong qualitative reasoning and contextual relevance—correctly interpreting the strategic implication—the answer is penalized heavily on quantitative accuracy due to incorrect core data points. The misstatement of 2022 values as $24.1B and 4.45% introduces a fundamental error, dragging the correctness score down to 6. The answer is partially correct but not reliable on key facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 436,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s revenue‑recognition approach for development‑plus‑IP contracts has been unchanged from 2022 through 2024. In each filing (2022 10‑K p. 59; 2023 10‑K p. 64; 2024 10‑K p. 63) AMD states that it first evaluates whether the licensing component is **distinct**. If the license is **not distinct**, the license is combined with the development services into a single performance obligation and revenue is recognized **over time**. If the license **is distinct**, or if the arrangement involves only a **stand‑alone IP sale or license**, revenue is recognized **at a point in time** when the customer can benefit from the license. The company also notes that there are **no variable‑consideration estimates** for either combined or standalone IP arrangements in any of the three years. Thus, the policy has remained consistent, with the same distinction and timing rules applied throughout 2022‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures AMD's consistent revenue recognition policy from 2022 to 2024, correctly explaining the distinction between 'distinct' and 'not distinct' licenses and the resulting timing of revenue recognition (over time vs. point in time). (2) There are no numerical inaccuracies—while no specific dollar amounts are involved, the qualitative financial accounting treatment (e.g., no variable consideration estimates) is correctly stated and matches the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings (2022, 2023, 2024), correctly identifying that the policy remained unchanged and citing the relevant evaluation criteria each year. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in policy and the key distinction between combined development/IP arrangements and standalone IP licenses. Minor wording differences (e.g., 'stand-alone IP sale or license' vs. 'standalone IP licenses') do not affect factual accuracy. All key elements—distinctness evaluation, combination of performance obligations, timing of recognition, and absence of variable consideration—are correctly and completely conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 364,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "COF’s total short‑term borrowings and long‑term debt increased from **$48.7 billion at year‑end 2022** (up from $43.1 billion in 2021, per the 2022 filing) to **$49.9 billion at year‑end 2023**, then **declined to $45.6 billion at year‑end 2024**. Over the three‑year span the firm added roughly $5.8 billion of debt through 2023 and subsequently trimmed the balance by about $4.3 billion in 2024, a pattern that reflects a strategy of refinancing higher‑cost, variable‑rate borrowings (the floating senior debt was eliminated) and shifting toward more fixed‑rate senior notes—whose weighted‑average rate rose modestly from ~4.45% to ~4.84%—while the rate on other borrowings fell from 6.51% to 5.72%, indicating an effort to curb total leverage and moderate interest‑rate exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086B in 2022, not $48.7B as stated in the LLM response. The 2023 figure is reported as $49.9B by the LLM, but the correct value is $48.715B. The 2024 figure is closer ($45.6B vs. $45.551B), with minor rounding acceptable. The LLM incorrectly states that $48.7B was the 2022 year-end value, when that number actually reflects a misreading—likely conflating the 2023 value with 2022. Additionally, the LLM references a 2021 value not asked for and irrelevant to the 2022–2024 trend. (2) Calculations are flawed: the LLM claims COF added $5.8B through 2023, but from correct data, the increase from 2022 to 2023 is only ~$5.6B. The decrease from 2023 to 2024 is reported as $4.3B, but actual reduction is ~$3.164B. Interest rate data is partially correct: the LLM states the fixed-rate senior notes rose from ~4.45% to ~4.84%, but the ground truth shows the weighted-average interest rate on long-term debt started at 2.76% in 2022, not ~4.45%. The LLM omits this key initial rate and misrepresents the starting point of the rate trend. While it correctly notes the 2024 rate of 4.84%, it fails to capture the full 2.76% → 4.48% → 4.84% progression. The mention of other borrowings falling from 6.51% to 5.72% is not in the ground truth and appears fabricated. (3) Multi-hop reasoning is partially sound: the LLM correctly infers a strategy of reducing leverage and shifting to fixed-rate debt, which aligns with the ground truth’s conclusion about stabilizing financing costs. However, this reasoning is based on incorrect numerical foundations, weakening its validity. The elimination of floating senior debt is plausible but not confirmed in the ground truth. (4) Despite factual errors, the answer addresses all parts of the question—debt evolution, trend interpretation, and implications for debt management and interest rate exposure—making it contextually relevant. The qualitative reasoning is reasonable but built on inaccurate data, leading to a moderate score. Overall, the answer is partially correct but undermined by major quantitative inaccuracies in key financial figures and interest rate baselines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 609,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing arrangements has not changed from 2022 through 2024. In each filing the company states that it first evaluates whether the licensing component is **distinct** (i.e., capable of being distinct and distinct in the context of the contract). If the license is **not distinct**, it is combined with the development services into a **single performance obligation** and revenue is recognized **over time**; if the license **is distinct**, revenue is recognized **at a point in time** when the customer can benefit from the license. Standalone patent or IP licensing deals are treated as a single performance obligation with point‑in‑time revenue recognition, and no variable‑consideration estimates are applied. The 2023 and 2024 10‑Ks repeat the same language, indicating the policy remained consistent over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD's revenue recognition policy for development and IP licensing agreements remained consistent from 2022 to 2024, which aligns with the ground truth. The key concepts—distinct vs. not distinct licenses, combination with development services into a single performance obligation, over-time vs. point-in-time recognition, and treatment of standalone licenses—are all accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) and policy descriptions are correct and consistent with the source. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s consistent application of ASC 606 principles across years, distinguishes between combined and standalone arrangements, and correctly notes the absence of variable consideration estimates—exactly as stated in the ground truth. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in policy, performance obligations, and the distinction between arrangement types. Minor wording differences (e.g., 'combined into a single performance obligation' vs. 'assessed for whether they constituted a single or multiple') do not affect meaning and are semantically equivalent. No errors or omissions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 409,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "All three annual reports list the same document – the “Certificate of Designations of Series B Convertible Participating Preferred Stock of Visa Inc.” – as an exhibit incorporated by reference (2022 Exhibit 4.5, 2023 Exhibit 4.4, 2024 Exhibit 4.4). Because Visa (V) is the entity that introduced this financial instrument and the certificate in turn identifies Visa as the issuer, the repeated filing of the same certificate shows that the Series B preferred stock has not been altered, retired or replaced. Thus, the instrument is a stable, continuing component of Visa’s capital structure and remains materially relevant to the company’s financing and governance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Certificate of Designations for Series B Convertible Participating Preferred Stock is correctly identified as being consistently referenced across Visa's 2022, 2023, and 2024 filings, with accurate exhibit numbers (2022 Exhibit 4.5, 2023 and 2024 Exhibit 4.4). The issuer is correctly identified as Visa Inc., and the implication that no changes were made is logically sound. (2) Quantitatively, all exhibit numbers and years are correct; although the LLM does not explicitly mention the June 21, 2016 filing date (a minor omission), this does not affect the correctness of the conclusion about stability. (3) The multi-hop reasoning is strong: the model correctly infers from the repeated inclusion of the same document that the instrument has not been altered, retired, or replaced, indicating ongoing relevance and structural stability. (4) The answer is contextually fully relevant, directly addressing the question about stability and ongoing relevance. The only reason for not scoring a 10 is the omission of the specific 2016 filing date, which is part of the ground truth and reinforces the longevity of the instrument. However, this does not undermine the overall correctness, as the conclusion about stability remains fully supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 381,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—RTX (through its Pratt & Whitney unit) reported the same ownership and economic exposure in the International Aero Engines AG (IAE) joint venture: a 61 % program‑share interest and a 49.5 % equity ownership, which translates to a net 57 % program‑share (economic) interest after accounting for sub‑collaborator shares. The unchanged figures demonstrate that RTX has deliberately maintained a stable, dominant position as the primary beneficiary of the V2500 engine program, preserving both control and upside participation over multiple years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: RTX's Pratt & Whitney maintained a 61% program-share interest, 49.5% ownership interest, and a net 57% program-share interest in IAE across 2022–2024. These values match the original answer exactly, satisfying quantitative accuracy. (2) The answer correctly identifies the entities (RTX, Pratt & Whitney, IAE, V2500 engine program) and time frame (2022–2024), with no factual or naming errors. (3) The multi-hop reasoning is sound—synthesizing consistent stake data over three years to infer strategic continuity—and the conclusion about stable strategic positioning is logically supported. The LLM slightly strengthens the interpretation by describing RTX as the 'primary beneficiary' and emphasizing 'deliberate' maintenance of position, which is a reasonable inference but not explicitly stated in the ground truth. This minor interpretive addition does not distort the facts but adds a subtle emphasis not present in the original, hence a 9 instead of 10 on qualitative accuracy. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) of stake and economic exposure, and what it indicates about strategic positioning. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 373,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Across the three most recent 10‑K filings Medtronic repeatedly references the same “Form of Non‑Employee Director Deferred Unit Award Agreement” that is tied to its 2008 Stock Award and Incentive Plan. In the 2022 filing the agreement appears twice (exhibits 10.41 and 10.52), while in the 2023 and 2024 filings it is listed once (exhibit 10.52) each year. The fact that the agreement is consistently disclosed in every fiscal year – even if the 2022 filing duplicated the reference – shows that Medtronic maintains a stable, ongoing use of deferred‑unit awards for its non‑employee directors, signalling a long‑term compensation strategy that relies on deferred equity to align director interests with the company’s sustained performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only a minor discrepancy in exhibit details for 2022. The ground truth states that the agreement was referenced once in 2022 (Exhibit 10.41), while the LLM claims it appears twice (Exhibits 10.41 and 10.52). However, the 2023 and 2024 references to Exhibit 10.52 are correct, and the key point—that the same form of agreement was consistently used across all three years under the 2008 plan—is accurately captured. The LLM correctly identifies the continuity in Medtronic’s use of the deferred unit award agreement and draws a valid inference about long-term director compensation strategy, emphasizing stability and alignment of director incentives with long-term performance. The reasoning is sound, entities (Medtronic, 2008 Stock Award and Incentive Plan, non-employee directors) are correctly identified, and the multi-hop synthesis across fiscal years 2022–2024 is well executed. The slight overstatement of exhibit references in 2022 does not undermine the overall factual correctness or strategic interpretation, warranting a high score but not perfect due to the exhibit count inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 334,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "LMT’s variable‑interest‑rate swaps are used as **fair‑value hedges** that convert fixed‑rate borrowings into variable‑rate borrowings. According to the 2022 filing the aggregate notional amount of those swaps was **$500 million** (2021) and, as disclosed in the 2023 filing, it rose to **$1.3 billion** at the end of **2022** and remained **$1.3 billion** at the end of **2023** and **2024** (both the 2023 and 2024 filings repeat the $1.3 billion figure).  \n\nThe jump from $500 million to $1.3 billion shows LMT deliberately expanded its hedge program to cover a much larger portion of its fixed‑rate debt, and the flat‑lined notional thereafter signals a **steady, long‑term interest‑rate risk‑management strategy**—the company set a sizable hedge level and has chosen to maintain it rather than continually adjust the size of its swaps.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, with only a minor discrepancy in the timeline. (1) Quantitatively, the numbers are correct: $500 million in 2022 (referenced from 2022 filing as 2021 data), rising to $1.3 billion by end of 2022 (as per 2023 filing), and remaining at $1.3 billion through 2023 and 2024. However, the original answer states the $500M figure was for 2022, while the LLM interprets it as 2021 based on the 2022 filing. This creates a one-year misalignment in the transition (from 2021 to 2022 vs. 2022 to 2023), which slightly affects temporal precision but does not alter the core trend. (2) The calculation of a significant increase (from $500M to $1.3B) is accurate and correctly interpreted as a strategic expansion. (3) The reasoning is sound: the LLM correctly identifies the use of fair-value hedges to convert fixed to variable rates, infers a deliberate and stabilized hedging strategy, and supports this with consistent notional amounts post-increase—matching the original answer’s conclusion about maturation of risk management. (4) All entities (LMT, variable interest rate swaps, notional amounts, years) are correctly identified. The answer fully addresses both parts of the question: evolution over time and strategic implications. Wording differs but semantic meaning is equivalent. The minor timing misattribution prevents a perfect 10, but overall correctness, logic, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses for Hedging]-> FIN_INST <-[Depends_On]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 403,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "All three annual reports spell out the same anti‑takeover rule: AbbVie’s amended and restated certificate of incorporation and bylaws limit stock‑holder removal of directors to “for cause.” The 2022 Form 10‑K lists this provision, the 2023 Form 10‑K repeats the identical language, and the 2024 Form 10‑K again contains the unchanged clause. The three‑year continuity shows that AbbVie has deliberately kept this director‑removal restriction intact, reinforcing a consistent, defensive governance posture that deters hostile bids and preserves board stability as a core element of its takeover‑defense strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that AbbVie's governance provision allowing director removal only 'for cause' remained unchanged from 2022 through 2024, citing the consistent language in each year's Form 10-K—this matches the original answer's timeline and factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced as a continuous period with no changes, which aligns with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings and draws a valid conclusion about strategic posture—namely, that the consistency reflects a deliberate, defensive governance strategy aimed at deterring hostile takeovers and preserving board stability. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the provision and its implication for takeover defenses. It references the relevant governing documents (certificate of incorporation and bylaws) and correctly interprets the strategic significance. Wording differs slightly from the original but conveys the same meaning with equal or greater specificity (e.g., mentioning 'amended and restated' documents adds precision). All entities—AbbVie, the years, the governance mechanism—are accurate. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 390,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "- **Allocation trend:** AbbVie reported $12 million in money‑market funds and time deposits in 2022, increased the balance to $21 million in 2023, and then reduced it to $10 million in 2024.  \n- **Context of cash balances:** Cash and cash equivalents rose from $8.45 billion (2022) to $9.20 billion (2023) and fell sharply to $5.52 billion (2024).  \n- **Implication:** The company expands its money‑market and time‑deposit holdings when cash is abundant (2023) to earn a modest return while keeping funds highly liquid, and contracts those holdings when cash declines (2024) to preserve immediate liquidity—indicating a flexible short‑term liquidity strategy that adjusts to fluctuating cash balances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $12 million (2022), $21 million (2023), and $10 million (2024) for money market funds and time deposits align with the original answer. Cash balances are correctly reported as $8.45 billion (2022), $9.20 billion (2023), and $5.52 billion (2024), which are equivalent to $8,449 million, $9,201 million, and $5,524 million in the original—minor rounding differences are acceptable and common in financial reporting. (2) The answer is complete, addressing both the evolution of the allocation and its implication for AbbVie’s short-term liquidity strategy. (3) Entities—AbbVie, money market funds, time deposits, cash and equivalents, and the years 2022–2024—are correctly identified and used. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that increased allocation in 2023 coincided with higher cash levels, and reduced allocation in 2024 aligned with lower cash, suggesting a flexible, responsive liquidity strategy. The interpretation is semantically equivalent to the original and adds slight elaboration (e.g., 'earn a modest return') that is reasonable and consistent with the data. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 363,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "All three filings – the 2022, 2023 and 2024 Form 10‑K – describe the same anti‑takeover rule: the certificate of incorporation and bylaws state that **stockholders may remove directors only “for cause.”** The language of this provision is unchanged from the 2022 filing through the 2024 filing, showing no evolution in the rule.  \n\nThis continuity signals that AbbVie is deliberately preserving a core defensive mechanism; by limiting director removal to cause, the company makes it harder for activists or hostile bidders to replace the board, reinforcing a long‑term strategy to deter coercive takeover attempts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that AbbVie's governance provision allowing director removal only 'for cause' remained unchanged across the 2022, 2023, and 2024 10-K filings, which matches the original answer's claim of consistency over the three years. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited and aligned with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the lack of change in the provision over time indicates a deliberate, sustained anti-takeover strategy, linking governance mechanics to strategic intent. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the provision and its implication for long-term takeover defense. Wording differs slightly but conveys identical meaning, with accurate entity identification (AbbVie), correct time frame, and proper interpretation of governance implications. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 308,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "- In the 2022 filing Intel first **introduced PowerVia** as a future process‑and‑packaging technology alongside the upcoming Intel 3 and Intel 20A nodes. By the 2023 filing the company was **positioning PowerVia as a breakthrough “back‑side power” feature of the Intel 20A node**, promising up to a 15 % performance‑per‑watt gain by removing front‑side power routing. In the 2024 filing Intel **shifted PowerVia into the Intel 18A node**, describing it as the **first high‑volume commercial implementation of backside‑power delivery** and noting that the 20A node was cancelled in favor of 18A, which will ship in 2025.\n\n- This evolution—from a roadmap concept (2022) to a highlighted breakthrough for a planned node (2023) and finally to a high‑volume, production‑ready feature in the next‑generation node (2024)—shows Intel’s strategy of **accelerating and mainstreaming backside power delivery** as a core differentiator for its advanced logic processes, aiming to improve performance‑per‑watt, reduce front‑side routing complexity, and strengthen its competitive edge in leading‑edge nodes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurate: PowerVia was introduced in 2022 as a future technology, positioned in 2023 as a breakthrough for Intel 20A, and then shifted to Intel 18A in 2024 with plans for high-volume manufacturing in 2025. The cancellation of Intel 20A in favor of Intel 18A is correctly noted, which is consistent with Intel's realigned roadmap. (2) Quantitative claims are accurate: the 15% performance-per-watt gain is correctly attributed to PowerVia’s removal of front-side power routing, and the 2025 timeline for volume production matches the original answer. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly tracing the evolution of PowerVia from concept to production, and infers the strategic intent behind the shift—accelerating backside power delivery as a competitive differentiator. (4) The answer is semantically equivalent to the ground truth, with added contextual detail (e.g., performance-per-watt gain) that enhances completeness without introducing errors. All entities—Intel, PowerVia, Intel 20A, Intel 18A, backside power delivery—are correctly identified and contextualized. The conclusion about Intel’s strategy is well-supported and insightful, reflecting a prioritization of practical implementation and foundry competitiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 386,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s 2022 filing simply said that the Black‑Scholes model “requires management to make assumptions … volatility of the Company’s stock price,” but it did not explain how that volatility was derived. In the 2023 filing the company added that “expected volatility is based on a blend of historical volatility and an implied volatility of the Company’s ordinary shares,” with the implied component coming from market‑traded options. The 2024 filing repeats the same blended‑historical‑plus‑implied approach.\n\nThis shift from a generic volatility assumption in 2022 to a disclosed, market‑informed blend in 2023‑2024 suggests that MDT is refining its methodology and becoming more transparent, using both historical price movements and market‑derived implied volatility to more accurately value its non‑qualified stock options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the evolution of MDT's volatility assumptions: from no explicit methodology disclosed in 2022 (only a generic statement), to a blended historical and implied volatility approach starting in 2023, which was maintained in 2024. This aligns with the ground truth, which notes that in 2022, MDT used only historical volatility (though the LLM interprets this as 'not explained'—a minor discrepancy in interpretation, not fact). The LLM correctly notes the source of implied volatility (market-traded options) and the continuity in 2024. (2) There are no numeric values to verify, but dates (2022, 2023, 2024) are correct and consistently applied. (3) The multi-hop reasoning is sound: the model synthesizes changes across three years and infers a trend toward greater market sensitivity and transparency, which matches the ground truth's conclusion about aligning with market expectations. (4) The only minor shortcoming is that the LLM states the 2022 assumption was not explained, while the ground truth clarifies it was based solely on historical volatility. This is a small factual omission, but not a major error, as the key progression—toward a more sophisticated and market-informed model—is correctly captured. Hence, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 404,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "Intel first **introduced PowerVia in 2022** as a future process‑and‑packaging technology at the Intel Accelerated event, describing it as a novel “back‑side power delivery” concept that would eliminate front‑side power routing. In the **2023 filing** Intel disclosed that PowerVia would be a key breakthrough of the planned Intel 20A node, expected to contribute up to a 15 % performance‑per‑watt gain over Intel 3 and to be part of the node’s two new technologies (RibbonFET and PowerVia). By **2024**, after canceling Intel 20A, Intel positioned PowerVia as one of the two flagship innovations in the upcoming **Intel 18A** node—the first high‑volume commercial implementation of backside power—signaling that PowerVia has moved from a roadmap concept to a core pillar of Intel’s advanced‑process strategy and will drive performance‑per‑watt and signal‑integrity improvements in its next‑generation products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, emphasized in 2023 as delivering up to 15% performance-per-watt improvement over Intel 3 alongside RibbonFET, and retained in 2024 under Intel 18A after the cancellation of Intel 20A. (2) Quantitative accuracy is perfect: the 15% performance-per-watt gain is correctly cited, and all years (2022, 2023, 2024) align with the original answer. (3) Multi-hop reasoning is sound—LLM correctly synthesizes the evolution across three years and two process nodes, showing how PowerVia transitioned from a roadmap concept to a core pillar despite the node name change. (4) The answer fully addresses the question’s two parts: the evolution of PowerVia from 2022–2024 and its strategic role in Intel’s advanced process roadmap. Wording differs slightly but meaning is preserved, including the significance of PowerVia becoming a flagship innovation in Intel 18A and enabling performance and signal integrity gains. No factual errors, omissions, or misstatements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 317,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "- 2022 MDT’s 10‑K simply said that the Black‑Scholes fair‑value calculation “requires management to make assumptions regarding projected employee stock‑option exercise behaviors, risk‑free interest rates, volatility of the Company’s stock price, and expected dividends,” without detailing how volatility was measured.  \n- In the 2023 filing the company added that “expected volatility is based on a blend of historical volatility and an implied volatility of the Company’s ordinary shares,” with the implied component taken from market‑traded options, while still noting the same set of assumptions for employee exercise behavior, rates and dividends.  \n- The 2024 filing repeats the 2023 language, keeping the blended historical‑plus‑implied volatility approach and the unchanged focus on projected employee exercise behavior.  \n\n**Interpretation:** MDT moved from a generic, qualitative volatility assumption in 2022 to a more quantitative, market‑informed method by 2023 and retained it in 2024, indicating a maturing, data‑driven approach to estimating stock‑price volatility. At the same time, the consistent emphasis on employee‑exercise assumptions shows the company’s ongoing commitment to modeling employee behavior, even though the methodology for that input has not materially changed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the evolution of MDT's Black-Scholes assumptions from 2022 to 2024: in 2022, no specific method for volatility was detailed; in 2023, the company introduced a blend of historical and implied volatility based on market-traded options; and in 2024, the same blended approach was retained. The treatment of employee exercise behavior, risk-free rates, and dividends remained consistent. (2) There are no numeric values requiring calculation (e.g., percentages or dollar amounts), but the years (2022, 2023, 2024) are correctly referenced and aligned with changes in methodology. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, and the conclusion about increasing reliance on market-informed data is logically derived. (4) The interpretation correctly infers that the addition of implied volatility reflects a more sophisticated, data-driven approach to volatility estimation, while the unchanged treatment of exercise behavior shows continuity in modeling employee behavior. All entities (MDT, Black-Scholes model, non-qualified stock options, implied and historical volatility) are correctly identified. The answer is fully contextually relevant and captures both the factual progression and its strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Holds]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 380,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements that is reflected in the “Other assets, including intangibles – net” line dropped sharply – from **$1.494 billion in 2022** (the figure disclosed in the 2023 filing) to **$0.491 billion in 2024**, a decline of roughly **$1.0 billion (about 67 %)**.  The 2022 filing also shows the prior‑year levels were $641 million in 2021 and $504 million in 2020, underscoring that 2022 was a peak that has since been reversed.  This downward trend suggests ExxonMobil has been reducing the amount of collateral needed for its derivatives—either by scaling back derivative positions or by improving net‑ting and margin efficiency—indicating tighter management of its derivative exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in collateral under master netting arrangements from 2022 to 2024 and provides a reasonable interpretation of the trend. However, there are significant quantitative inaccuracies. The ground truth states the values were $1,494 million in 2022, $800 million in 2023, and $491 million in 2024. The LLM answer skips the 2023 value entirely and incorrectly states the 2024 figure as being directly from 2022 to 2024, claiming a drop to $0.491 billion in 2024 without acknowledging the intermediate $800 million in 2023. This omission affects the accuracy of the trend description. Additionally, the claimed decline of $1.0 billion (about 67%) is based on a direct drop from $1.494B to $0.491B, which would be accurate only if 2023 were ignored, but the correct three-year trend includes a stepwise decline. (2) The LLM introduces data not present in the original answer—specifically, $641 million in 2021 and $504 million in 2020—which were not part of the ground truth and may be factually correct but are extraneous and distract from the required 2022–2024 focus. (3) The reasoning about derivative exposure management is sound and aligns with the original answer’s interpretation—reduced collateral suggests tighter management, possibly due to reduced positions, improved netting, or lower market volatility. This shows good qualitative synthesis and logical inference. (4) Contextual relevance is high because the answer addresses both parts of the question: the change in collateral and its implication for derivative exposure management. Despite missing the 2023 data point and introducing irrelevant prior years, the core conclusion remains aligned with the ground truth. The correctness score is 7 due to accurate overall direction and interpretation but penalized for missing a key data point and miscalculating the trend path.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 514,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "From the 2022 filing (covering 2021) NextEra reported Options‑primarily‑gas assets of $356 million and liabilities of $347 million, with implied volatilities of 17 % (asset side) and 295 % (liability side) (weighted‑average 36 %); by 2023 the exposure had been trimmed to $100 million of assets versus $97 million of liabilities, with volatilities of 20 % and 233 % (weighted‑average 50 %); in 2024 the book was essentially flat at $100 million of assets and $102 million of liabilities, with volatilities of 15 % and 150 % (weighted‑average 52 %). This trajectory shows a dramatic reduction in the size of the gas‑options position, a shift from a modest net‑asset to a slight net‑liability stance, and a marked decline in liability‑side volatility while overall volatility assumptions rise, indicating that NextEra is scaling back its gas‑derivative exposure but still pricing in heightened market volatility, positioning the company more conservatively yet with a still‑significant risk posture in gas derivatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the fair value figures for assets and liabilities are correct ($356M/$347M in 2022, $100M/$97M in 2023, $100M/$102M in 2024), the volatility breakdowns are incorrect. The original answer states a single weighted-average implied volatility of 36% in 2022, 50% in 2023, and 52% in 2024. However, the LLM introduces split figures (e.g., 17%/295% in 2022) and then derives a weighted average of 36%, which is not supported by the ground truth. These side-specific volatility numbers (17%, 295%, 20%, 233%, etc.) are entirely fabricated and not present in the original data. (2) The calculation of weighted averages from these incorrect component values further compounds the error. The ground truth does not provide asset/liability-side volatility splits—only the aggregate weighted average. The LLM invents granular data that doesn't exist, undermining factual reliability. (3) The multi-hop reasoning is partially sound in interpreting the trend: decreasing notional exposure (correctly noted) and rising overall volatility assumptions (correct trend in weighted average). However, the conclusion that 'liability-side volatility declined' is based on false data and contradicts the actual trend of increasing overall volatility. The interpretation of 'still-pricing in heightened market volatility' is plausible given rising weighted averages, but the supporting data is invalid. (4) Contextually, the answer addresses all parts of the question—evolution of fair value, volatility, and risk positioning—so relevance is high. However, due to major factual errors in volatility figures and invented data points, the correctness score is low despite accurate fair value numbers and reasonable qualitative directionality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 488,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "- **2022 filing (Chunk 1):** Unsecured Notes – 35A were listed with a **face amount of $750 million** (‑ $750,000 thousands) and an **annual debt‑service payment of $19.875 million** (‑ $19,875 thousands).  \n- **2023 filing (Chunk 3):** The same note still shows a **$750 million face amount** and **$19.875 million annual debt service**.  \n- **2024 filing (Chunk 2):** The figures remain unchanged – **$750 million face amount** and **$19.875 million annual debt service**.\n\nThe unchanged size and payment on the 35A issuance across three consecutive years indicates that Simon Property Group is deliberately keeping this tranche of long‑dated, low‑coupon (2.65 %) unsecured debt stable. By locking in a fixed rate through 2030 and maintaining a predictable service cost, SPG’s long‑term debt strategy emphasizes capital‑structure stability and cash‑flow predictability rather than frequent refinancing or scaling of this particular note.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face amount and annual debt service for Unsecured Notes - 35A across 2022, 2023, and 2024. However, there is a unit discrepancy: the ground truth reports $750,000 and $19,875, while the LLM interprets these as $750 million and $19.875 million, likely due to misreading 'thousands' notation (e.g., $750,000 thousands = $750 million). This is a known formatting convention in SEC filings, so the LLM’s interpretation is contextually accurate and commonly accepted. Thus, the numbers are factually correct given the source format.\n\n2) All numeric values align with the ground truth when adjusted for unit interpretation. The face amount ($750,000 thousands = $750 million) and annual debt service ($19,875 thousands = $19.875 million) are mathematically accurate. No calculations were required beyond unit conversion, which the model handled appropriately.\n\n3) The multi-hop reasoning is sound: the model synthesizes data from three different years (2022, 2023, 2024) across multiple chunks, correctly observes no change over time, and infers a strategic emphasis on stability and predictability in SPG’s long-term debt management. It adds contextual insight (low coupon rate of 2.65%, maturity through 2030) that enriches the conclusion without contradicting the ground truth.\n\n4) The answer is semantically equivalent and even enhances the original by explaining the strategic rationale more fully. The core facts, trends, and implications match the ground truth. The slight unit ambiguity does not constitute a factual error in the context of financial reporting conventions. Therefore, the answer is highly accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 458,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Across the three MD&A sections (2022, 2023 and 2024) Texas Instruments repeatedly frames its business model as “focused on analog and **embedded‑processing products**” and builds its four sustainable competitive advantages – manufacturing foundation, broad product portfolio, market‑channel reach and product diversity – around that same portfolio. The wording and emphasis are essentially unchanged from 2022 to 2024, showing that TI’s stake in embedded‑processing products has been reinforced rather than shifted. This continuity signals that TI is deliberately positioning itself for the long term as a premier analog‑and‑embedded‑processing semiconductor company, using that focus to drive free‑cash‑flow growth and to differentiate itself from peers in the industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing products from 2022 to 2024 as part of its core business model and competitive advantages. The answer correctly identifies that the language and strategic focus remained unchanged across the three years, which matches the original answer’s claim of consistency in 10-K filings. (2) There are no numeric values, dates, or calculations in the question or answers that require verification—only qualitative descriptions of strategic emphasis—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model synthesized information across three years of filings (2022–2024), correctly identifying continuity in strategic language and linking it to long-term positioning in the semiconductor industry. It accurately reflects that embedded processing is tied to TI’s four sustainable competitive advantages (manufacturing foundation, broad portfolio, market-channel reach, product diversity), which is consistent with the knowledge graph. (4) The only minor shortcoming is that the LLM answer does not explicitly mention how embedded processing supports customer diversity, channel reach, and long-term investment returns—specific benefits noted in the original answer. However, it captures the essence by linking the focus to free cash flow and differentiation. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 443,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "Across the three filings, Comcast has kept its shared‑data wireless plans tied to a qualifying broadband bundle. In the 2022 10‑K the company noted that wireless service “is only offered as part of our bundled service offerings” and that customers could pick an unlimited‑data plan, a shared‑data plan or a per‑gigabyte plan (with device financing options). The 2023 filing repeats the same bundled‑only positioning and the same three‑way pricing menu (unlimited, shared, per‑GB). By 2024 the bundled‑only requirement remains, but Comcast expands the menu by launching a prepaid unlimited‑data product under the NOW brand, adding a new payment option while still offering the shared‑data plan alongside unlimited and per‑gigabyte choices.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA maintained shared data plans as part of bundled offerings from 2022 to 2024, offered three plan types (unlimited, shared, per-gigabyte), and introduced a prepaid unlimited plan under the NOW brand in 2024. There are no incorrect numbers, dates, or entities. (2) Quantitative accuracy is perfect—no numerical values are misstated, and while the answer doesn't include explicit dollar amounts or percentages, it correctly describes plan structures and financing terms (e.g., device financing over 24 months is implied in the context of bundles, though not explicitly mentioned in the LLM answer; however, this omission does not affect correctness as the focus is on plan types and bundling). (3) Multi-hop reasoning is sound: the model correctly synthesizes information across 2022, 2023, and 2024 filings to show continuity in bundling and plan options, and identifies the 2024 expansion with the NOW prepaid offering as a strategic evolution. (4) The answer addresses all parts of the question: positioning within bundled services (consistently bundle-only), and evolution in payment/plan options (addition of prepaid in 2024). Wording differs slightly but meaning is identical. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 375,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock has risen each year: it was **$51.3 million** (451 shares) at the end of 2022, grew to **$60.4 million** (475 shares) at the end of 2023, and reached **$71.4 million** (497 shares) at the end of 2024.  This increase follows the same upward path seen in earlier years (e.g., $36.7 million in 2020 and $32.2 million in 2019), indicating that Mastercard has been steadily using cash to repurchase its own shares.  The pattern suggests a capital‑allocation strategy that prioritizes returning excess capital to shareholders through buybacks, thereby reducing equity and supporting per‑share earnings and shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the reported values for Class A Treasury Stock. The ground truth states that Mastercard's investment was $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024 (negative values indicating treasury stock as a contra-equity account). In contrast, the LLM reports positive values of $51.3 million, $60.4 million, and $71.4 million—off by a factor of approximately 1,000 (mixing millions with actual reported figures likely in thousands or misreading units). Additionally, the LLM incorrectly presents the figures as positive asset-like balances rather than negative equity reductions. (2) The quantitative accuracy is severely compromised: the 2022 figure is entirely wrong ($51.3M vs $36,658M), and while $60.4M and $71.4M are numerically close to the correct magnitudes (60,429 and 71,431), they are off by orders of magnitude and lack the correct negative sign. The mention of share counts (451, 475, 497) is not in the original answer and appears fabricated or misinterpreted. (3) The reasoning about capital allocation strategy—increasing buybacks and returning value to shareholders—is qualitatively sound and aligns with the trend interpretation in the ground truth. The model correctly infers strategic intent from increasing buyback activity, showing valid multi-hop logic. (4) Despite correct directional interpretation and relevance to the question, the extreme numerical inaccuracies severely undermine factual correctness. The model fails on core data fidelity, warranting a low correctness score. Contextual relevance is high as it addresses both parts of the question and attempts trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 465,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics reported $1,169 million of revenue from its Repair and other services segment in 2022; that amount fell to $1,132 million in 2023 and stayed at $1,132 million in 2024—a drop of $37 million (about 3 %). The 2022 figure was a peak relative to the $1,017‑$1,081 million range seen in 2019‑2021 (see the 2021‑2019 data), and the subsequent flat‑line at $1,132 million indicates the service business has stalled after its 2022 high, showing a modest contraction and a plateau in growth through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all revenue figures: $1,169 million in 2022, $1,132 million in 2023, and $1,132 million in 2024, matching the ground truth exactly. The dollar decrease of $37 million and the approximate 3% decline are accurate calculations (37/1169 ≈ 3.16%, which rounds to about 3%). (2) The quantitative accuracy is perfect—numbers, years, and calculations are correct. The slight rounding of 3.2% to 'about 3%' is acceptable and common in financial communication. (3) The reasoning is sound and adds contextual value by referencing prior-year data (2019–2021) to show that 2022 was a peak, reinforcing the conclusion of stagnation. While this extra context is not in the ground truth, it does not contradict it and strengthens the analysis. The conclusion of 'stalled' and 'modest contraction and plateau' aligns semantically with 'stagnation or potential contraction' in the original answer. (4) The only minor deviation is the slightly simplified percentage (3% vs 3.2%), but this does not affect factual correctness. All parts of the question are addressed: revenue change from 2022 to 2024 and the pattern's implication. The multi-hop synthesis is appropriate and accurate. Thus, the answer is factually excellent with only negligible wording-level simplification, warranting a 9/10 overall for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 375,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "CVS’s residential‑mortgage‑backed securities portfolio has been shrinking each year: the 2022 10‑K shows $721 million of fair‑value holdings (543 securities) with $89 million of unrealized losses (the product‑supporting segment view reports $629 million fair value and $10 million loss), the 2023 filing reports $614 million of fair value (494 securities) and $60 million of unrealized losses, and the 2024 summary lists only $71 million of fair‑value holdings (71 securities) with no unrealized‑loss amount disclosed. This consistent decline in both the size of the position and the associated losses indicates that CVS is actively de‑risking its exposure to residential mortgage‑backed securities, positioning the company with markedly lower market‑risk vulnerability in this asset class.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has discrepancies in the 2022 fair value and unrealized losses. The ground truth states $629 million fair value and $10 million unrealized losses, while the LLM reports two figures: $721 million (with $89 million losses) and notes a segment-level figure of $629 million and $10 million, implying inconsistency in source interpretation. This suggests confusion between total portfolio and segment-specific disclosures. The 2023 and 2024 fair values ($614M and $71M) match the ground truth and are correctly presented. However, the inclusion of higher 2022 numbers without clear qualification misrepresents the overall exposure. (2) Calculations: The trend of decreasing fair value is accurate—$629M → $614M → $71M—but the LLM’s primary citation of $721M for 2022 is incorrect per ground truth. The increase in unrealized losses from $10M to $60M is correctly captured, though the LLM adds an unverified $89M loss figure for 2022 not present in the original answer. The absence of 2024 unrealized loss data is appropriately noted. (3) Multi-hop reasoning is sound: the model correctly identifies a downward trend in holdings and infers de-risking, synthesizing data across three years and linking it to risk positioning. The conclusion about active de-risking aligns with the original answer’s interpretation. (4) Scores justified as follows: Correctness at 7 due to accurate trajectory and correct 2023/2024 numbers, but penalized for introducing conflicting 2022 data. Quantitative accuracy at 6 due to significant deviation in 2022 figures. Qualitative accuracy at 8 due to strong reasoning and correct interpretation despite data inconsistency. Contextual relevance is 10—answer fully addresses the question’s scope and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 488,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "In the 2022 filing Linde only described the on‑site delivery model for its atmospheric gases (oxygen, nitrogen, argon, rare gases) – plants built on or next to a customer’s site and pipelines used to supply large, steady‑demand users – and noted that the distribution method “generally determines the contract terms” without spelling out the contract length or pricing formula. By the 2023 10‑K the company had formalized those terms: on‑site supply contracts are “total‑requirement” agreements that run 10‑20 years, contain minimum‑purchase requirements and price‑escalation provisions tied to external price indices, and include variable‑consideration components that are treated as constrained. The 2024 filing repeats the same 10‑20‑year total‑requirement contracts, minimum‑purchase and index‑linked pricing, and constrained variable pricing, showing that the detailed contractual and pricing framework introduced in 2023 remained unchanged through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Linde's on-site contracts range from 10–20 years, include minimum purchase requirements, price escalation tied to indices, and constrained variable consideration. The evolution from 2022 (no detailed pricing) to 2023 (explicit disclosure of pricing mechanisms) to 2024 (unchanged structure) is correctly captured. (2) Quantitative accuracy is perfect: durations (10–20 years), timing (2022, 2023, 2024), and financial terms (index-linked pricing, constrained variable consideration) match the original. Format variations (e.g., 'price-escalation provisions' vs 'price escalation provisions') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes changes across three years of filings, identifying the introduction of pricing detail in 2023 and its continuation in 2024. It accurately infers increased transparency under ASC 606, though it does not explicitly mention the 'practical expedient for measuring progress' or 'revenue recognition aligned with invoicing rights'—a minor omission that prevents a perfect 10 on qualitative accuracy. (4) Contextual relevance is excellent: every part of the question—contractual structure, pricing mechanisms, on-site agreements, variable pricing components, and evolution from 2022–2024—is addressed directly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 389,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra’s net exposure to forward‑gas contracts was:\n\n* **2022 filing (fair‑value at 12/31/2021)** – Assets $191 m vs Liabilities $31 m → **Net ≈ $160 m**.  \n* **2023 filing (fair‑value at 12/31/2023)** – Assets $377 m vs Liabilities $77 m → **Net ≈ $300 m**.  \n* **2024 filing (fair‑value at 12/31/2024)** – Assets $296 m vs Liabilities $46 m → **Net ≈ $250 m**.\n\nOver the three‑year span the net forward‑gas position roughly doubled from about $160 million to $300 million and then eased to $250 million. The rise through 2023 shows NextEra deliberately increasing its forward‑gas hedge (or speculative) exposure, while the modest pull‑back in 2024 suggests the company is tempering that exposure, moving toward a more balanced risk posture in the natural‑gas market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all financial figures from the ground truth: 2022 net exposure ($191M - $31M = $160M), 2023 ($377M - $77M = $300M), and 2024 ($296M - $46M = $250M). All numbers, including assets, liabilities, and derived net exposures, are accurate. The years are correctly aligned with the respective filings and fair-value dates, with appropriate clarification (e.g., 2022 filing reflecting 12/31/2021 values). Minor wording variation in time references does not affect factual correctness.\n\n2) Quantitative accuracy is perfect: all dollar amounts match the ground truth, calculations are correct, and net exposures are accurately derived. Format variations (e.g., 'm' for million, ≈ symbol) are acceptable and do not misrepresent data.\n\n3) The multi-hop reasoning is sound—LLM synthesizes data across three annual filings, computes net exposures, identifies the trend (increase then partial decline), and infers strategic intent. The conclusion about increased exposure in 2023 followed by a pullback in 2024 aligns with the ground truth. Only minor difference: original answer mentions 'strategic shift toward greater gas market exposure before reducing positions as market conditions evolved,' while LLM refers to 'tempering exposure' and 'more balanced risk posture.' This is semantically equivalent with slightly different framing—no factual deviation.\n\n4) The answer fully addresses both parts of the question: evolution of net exposure (with exact figures) and interpretation of risk positioning. Contextual relevance is excellent, with precise, focused response using correct entities (NextEra Energy, forward gas contracts, net exposure) and appropriate financial terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 464,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across the three years AVGO kept **industrial‑fiber‑optics** as a core part of its industrial portfolio, but the way it was presented shifted from a broad narrative to a focused, tabular listing.  \n\n* **2022 10‑K:** The product is mentioned in a paragraph that groups it with optocouplers, motion encoders, LEDs and Ethernet ICs and says the industrial line serves a very wide set of markets – industrial automation, power generation/distribution, medical systems, defense/aerospace and EV‑related subsystems (power‑train, infotainment, ADAS).  \n* **2023 10‑K:** The company moves the same set of products into a dedicated “Industrial” table, still listing industrial‑fiber‑optics alongside optocouplers, sensors, encoders, LEDs and Ethernet PHYs, but now ties the segment to three specific application clusters – factory automation, renewable energy and automotive electronics.  \n* **2024 10‑K:** The table is unchanged; industrial‑fiber‑optics remains listed with the same complementary products and is again linked to factory‑automation, renewable‑energy and automotive‑electronics applications, showing a stable, mature positioning.  \n\nThus, AVGO’s industrial‑fiber‑optics evolved from a broadly described component of a diverse industrial mix in 2022 to a consistently highlighted, core offering within a more narrowly defined industrial segment (factory automation, renewable energy, automotive) in 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Industrial Fiber Optics is consistently positioned as part of AVGO's industrial product offerings across 2022–2024, grouped with optocouplers, sensors, motion encoders, LEDs, and Ethernet ICs/PHYs. Application markets evolve from a broad list in 2022 (industrial automation, power generation, medical, defense, aerospace, automotive/EV subsystems) to a more focused set in 2023–2024 (factory automation, renewable energy, automotive electronics), which matches the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) and document types (10-K) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the presentation and framing of the product evolved across years, noting the shift from narrative to tabular format and narrowing of application focus, while maintaining the core strategic role. (4) The only minor deviation from the original answer is the emphasis on 'presentation shift' (narrative to table), which is an accurate observation but not explicitly mentioned in the ground truth; however, this detail is consistent with plausible inference from SEC filing trends and does not contradict the core conclusion of stable strategic positioning. Thus, the answer is semantically equivalent and factually correct, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 436,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "- **2022 filing (Chunk 1):** Unsecured Notes ‑ 31B carry a 3.25 % coupon, a face amount of **$750 million** (‑ $750,000 thousand) and an annual debt‑service (interest) of **$24.375 million** (‑ $24,375 thousand), maturing 11/30/26.  \n- **2023 filing (Chunk 3):** The same note still shows a **$750 million** face amount and **$24.375 million** of annual interest expense, with the 3.25 % rate and 11/30/26 maturity unchanged.  \n- **2024 filing (Chunk 2):** The table again lists Unsecured Notes ‑ 31B at a **$750 million** face amount, **$24.375 million** annual interest, 3.25 % coupon and a 11/30/26 maturity.\n\n**Interpretation:** Across 2022‑2024 SPG kept the 31B tranche completely static—no increase or reduction in principal and no change in the 3.25 % fixed‑rate interest cost. This consistency signals a deliberate long‑term debt strategy: the company locks in a low‑cost, fixed‑rate tranche with a set 2026 maturity to provide predictable financing costs and limit refinancing risk, rather than repeatedly issuing or retiring this portion of its unsecured debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the face amount of $750 million (i.e., $750,000,000), annual interest obligation of $24.375 million (i.e., $24,375,000), and a fixed interest rate of 3.25% are consistent across 2022, 2023, and 2024. The maturity date (11/30/26) is correctly included, though not in the original answer—it adds context without introducing error. (2) Quantitative accuracy is perfect: $750 million × 3.25% = $24.375 million, confirming the interest calculation is correct each year. Format variations (e.g., $750 million vs $750,000,000) are acceptable and commonly used in financial reporting. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and filings (Chunk 1, 2, 3), showing no change in the note’s structure over time. (4) The interpretation correctly infers SPG’s long-term debt strategy: maintaining a fixed-rate, long-term note to ensure predictable financing costs and avoid refinancing risk. This aligns with and even enriches the original answer’s conclusion. All aspects of the question—evolution of obligations and strategic implications—are fully addressed with precise, consistent, and logically sound analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 356,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ reported “aggregate expense for the U.S. defined‑contribution plans” rose each year: $70 million in 2022 (shown in the 2023 10‑K and reiterated in the 2024 10‑K), $75 million in 2023 (2023 10‑K and 2024 10‑K), and $76 million in 2024 (2024 10‑K). The $5 million jump from 2022 to 2023 (≈7 % increase) and the additional $1 million rise to 2024 (≈1 % increase) reflect a steady upward trajectory, indicating that Texas Instruments is progressively increasing its funding of employee retirement benefits and underscoring a growing commitment to supporting its workforce’s retirement security.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. The year-over-year increases ($5M and $1M) and approximate percentage changes (≈7%, ≈1%) are accurately calculated and consistent with the data. (2) Quantitative accuracy is perfect: all numbers, years, and financial figures are correct, and the calculations (e.g., 7% increase from 70 to 75, ~7.14%; 1% from 75 to 76, ~1.33%) are reasonably approximated as '≈7%' and '≈1%', which is acceptable given rounding. The total increase from 2022 to 2024 is $6M, which is ~8.57%, and while the LLM does not explicitly state the total percentage increase, it conveys a 'steady upward trajectory', which aligns with the ground truth's 'slightly growing commitment'. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across multiple 10-K filings (2023 and 2024) and tracks the expense trend over three years. It identifies the source documents appropriately, showing awareness of how SEC filings report prior-year data. (4) The only minor shortcoming is that the LLM does not explicitly quantify the total 8.6% increase over the three years, which was included in the ground truth and would have strengthened completeness. However, the qualitative interpretation — 'progressively increasing' and 'growing commitment' — is logically supported and semantically equivalent to the original answer’s conclusion. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for overall correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 463,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "Across all three filings GD’s approach to non‑economic accounting changes in its ROIC metric stayed the same. The 2022 10‑K notes that “ROIC excludes goodwill impairments **and non‑economic accounting changes** as they are not reflective of company performance,” the 2023 filing repeats that language, and the 2024 filing again states “ROIC excludes goodwill impairments **and non‑economic accounting changes** as they are not reflective of company performance.” This unchanged treatment shows that GD deliberately strips out non‑economic items from its ROIC calculation each year, indicating a performance‑evaluation methodology that consistently focuses on pure economic returns on invested capital rather than accounting adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, which matches the original answer's claim of methodological stability. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings to identify a consistent pattern in GD’s ROIC methodology, demonstrating proper cross-document analysis. (4) The LLM provides direct quotes from each year’s 10-K, reinforcing the accuracy and traceability of its conclusion. The qualitative interpretation — that this consistency reflects a disciplined focus on economic performance — is semantically equivalent to the original answer’s assertion about a stable, performance-oriented evaluation methodology. All aspects of the question are addressed with precise, factually correct, and contextually appropriate information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 316,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "**Evolution of the Separate‑Accounts balance**\n\n| Year (as of Dec 31) | Separate‑Accounts assets (in $ millions) |\n|---------------------|------------------------------------------|\n| 2022 * – disclosed in the 2023 10‑K (Chunk 1) | **$3,311 m** |\n| 2023 * – disclosed in the 2024 10‑K (Chunk 2) | **$3,250 m** |\n| 2024 * – disclosed in the 2024 10‑K (Chunk 2) | **$3,311 m** |\n\n*(The 2022 figure is taken from the “Separate Accounts financial assets at December 31, 2023 and 2022” table in the 2023 filing.)*\n\n**What the three‑year trend tells us**\n\n- After a sharp drop from $5,087 m in 2021 (Chunk 3) to $3,311 m in 2022, the separate‑accounts balance slipped slightly in 2023 (‑$61 m, about ‑2 %).  \n- In 2024 the balance rebounded to the 2022 level, erasing the 2023 dip.\n\nThis pattern shows that CVS has largely **stabilized** its pool of assets set aside for long‑term insurance contracts. The modest 2023 decline followed by a recovery in 2024 suggests a cautious but consistent investment positioning—maintaining a steady capital base in its separate‑account portfolio rather than aggressively expanding or contracting it.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the reported values for CVS's Separate Accounts Assets. According to the ground truth, the asset value was $5,087 million in 2022, $3,250 million in 2023, and $3,311 million in 2024. However, the LLM incorrectly reports 2022 as $3,311 million (confusing it with the 2024 value), and introduces a non-ground-truth 2021 figure of $5,087 million as if it were 2022. This misalignment invalidates the core quantitative narrative. (2) The calculation of a '2% decline' from $3,311m to $3,250m is numerically accurate (~1.8%), but it's based on incorrect starting points. The actual drop from 2022 to 2023 was from $5,087m to $3,250m—a much more significant 36% decrease—making the LLM's characterization of a 'slight' decline factually wrong. The recovery to $3,311m in 2024 is correctly noted, but the interpretation misses the larger downward trend since 2022. (3) The multi-hop reasoning fails because the model did not correctly identify or sequence the data across filings: it used the 2022 value from the 2023 10-K but mislabeled it, and conflated years in its analysis. The introduction of 2021 data (not requested) further distorts the 3-year trend from 2022–2024. (4) While the qualitative interpretation of 'stabilization' after a dip has some merit given the 2023–2024 flat movement, it overlooks the major drop from 2022 to 2023, leading to an overly optimistic conclusion. The ground truth suggests a strategic reduction or market-driven devaluation, not stabilization. Contextual relevance is high as the structure and intent align with the question, but factual inaccuracies severely undermine correctness. Quantitative accuracy is low due to wrong base figures; qualitative reasoning is partially sound but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 486,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement with TD Bank USA, N.A. (and Target Enterprise, Inc.) was originally executed on October 22 2012 and first amended on February 24 2015—both of which are listed in the 2022, 2023 and 2024 10‑K filings. A second amendment dated November 19 2019 appears in the 2022 filing (Chunk 3) and is again shown in the 2024 filing (Chunk 2) but is not included in the 2023 excerpt (Chunk 1), indicating that by 2024 the agreement had been amended twice and the 2019 amendment remains a key contractual milestone.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All dates—October 22, 2012 (original agreement), February 24, 2015 (first amendment), and November 19, 2019 (second amendment)—are correctly stated, meeting quantitative accuracy. (2) The answer correctly observes that the second amendment appears in the 2022 and 2024 10-K filings but not in the 2023 excerpt, which is consistent with the data available and explains the visibility across years without implying the amendment occurred during the 2022–2024 window. (3) The multi-hop reasoning is sound: it synthesizes information across three years of filings to confirm the agreement's continuity and amendment history. (4) While the original answer emphasizes the strategic evolution and sustained partnership, the LLM focuses more on document presence than interpretation, slightly reducing qualitative depth—but no factual errors are present. The omission of the 'strategic alignment' narrative does not detract from factual correctness. Semantic equivalence is maintained. Contextual relevance is full, as all parts of the question (amendments, milestones, evolution from 2022–2024) are addressed with precise evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 337,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "From the 2022 filing Linde simply listed rare gases (krypton, neon, xenon) as one of the “atmospheric gases” it sells alongside oxygen, nitrogen and argon, with no special emphasis on how they are made or why they matter strategically. The 2023 filing repeated that description – rare gases remained a standard line‑item in the industrial‑gases portfolio and were treated the same as the other atmospheric and process gases. By the 2024 filing Linde had repositioned rare‑gas production as a differentiated, technology‑driven capability: it highlights its market‑leadership in non‑cryogenic air‑separation technologies that generate rare gases as a by‑product of its proprietary air‑separation platforms (e.g., VPSA and membrane‑based systems) and notes that these gases are produced in the same plants that make oxygen, nitrogen and argon and are bundled with its equipment‑design, plant‑building and integrated distribution services. The KG triplet reinforces this evolution – Linde (LIN) produces rare gases, a dedicated Rare‑Gases entity also produces them, and that entity is itself a product of Linde – showing that rare‑gas production has become an internally integrated, technology‑focused business line rather than a peripheral product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: rare gases (krypton, neon, xenon) are atmospheric gases produced via air separation; in 2022 and 2023 they were treated as standard portfolio items; by 2024, Linde emphasized technological differentiation through non-cryogenic air separation (VPSA, membrane systems) and integration with on-site plants and services. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly tracing the evolution across three years and synthesizing Linde’s shift from product-centric to technology- and integration-driven strategy. The mention of proprietary platforms and bundling with equipment design and distribution services adds depth consistent with the original answer. The only minor gap is the reference to a 'KG triplet' and 'a dedicated Rare-Gases entity... a product of Linde,' which is not in the original answer and slightly overinterprets the knowledge graph structure without explicit support—this prevents a perfect 10 but does not undermine the core accuracy. (4) The answer is fully contextually relevant, directly addressing Linde’s production evolution, technological differentiation, and integration with other product lines from 2022 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 366,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil reported that the amount of collateral posted under master‑netting arrangements – which is not offset against its derivative positions and is primarily tied to the initial‑margin requirements for advances to equity companies – fell sharply over the three‑year span. The 2023 filing shows $1.494 billion of such collateral at 12/31/2022; the 2023 and 2024 filings show it had dropped to $800 million at 12/31/2023 and further to $491 million at 12/31/2024. This downward trajectory indicates that the company’s exposure to derivative liabilities arising from its equity‑company relationships is decreasing, as progressively less collateral is needed to support those positions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: collateral amounts of $1,494 million in 2022, $800 million in 2023, and $491 million in 2024 are correctly stated, with appropriate time points (12/31 of each year). Minor formatting differences ($1.494 billion vs $1,494 million) are acceptable and numerically equivalent. (2) Quantitative accuracy is perfect: all values match the original answer, and the downward trend is correctly characterized. (3) The reasoning is sound—reduced collateral implies reduced derivative exposure, which aligns with the original interpretation of de-risking or portfolio optimization. The LLM correctly infers the implication of the trend without overreaching. (4) The answer addresses both parts of the multi-hop question: the evolution over time and the interpretation regarding exposure to derivative liabilities. Entities (ExxonMobil, master netting arrangements, equity company advances) are correctly identified and contextualized. No irrelevant or extraneous information is included, maintaining high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 321,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "- In the 2022 filing (covering Dec 31 2021) NEER reported that **≈ 92 %** of its net‑generating capacity was already committed under long‑term bilateral contracts.  \n- The 2023 filing (covering Dec 31 2023) shows that share had risen to **≈ 94 %**, and the 2024 filing (covering Dec 31 2024) confirms the same **≈ 94 %** level.\n\n**Interpretation:** NEER has modestly increased the proportion of capacity locked into long‑term contracts and then held it steady, indicating that the company is deliberately using long‑term bilateral contracts as a core risk‑mitigation tool. By securing nearly all of its output under fixed‑price, multi‑year agreements—and hedging the remaining spot‑market exposure with shorter‑term contracts—NEER reduces price volatility and market‑risk exposure in increasingly competitive wholesale markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts for 2022 (92%), 2023 (94%), and 2024 (94%), matching the ground truth exactly. The slight use of '≈' (approximate) is acceptable given typical reporting conventions and does not detract from accuracy. 2) All numbers are factually correct and consistent with the original answer. The progression from 92% to 94% to 94% is accurately represented, and no calculations are required beyond correct interpretation of the data. 3) The reasoning is sound: the LLM correctly infers that the increasing and sustained high level of long-term contracting reflects a strategic focus on risk mitigation and revenue stability. It appropriately notes the use of shorter-term contracts to hedge remaining exposure, which aligns with the ground truth. The only minor shortcoming is that the LLM does not explicitly state that the trend 'suggests a strategic emphasis on revenue stability' using those exact terms, but the interpretation is semantically equivalent. 4) The answer fully addresses both parts of the question—evolution over time and implications for risk mitigation—and synthesizes information across three years and filings correctly. Wording differences are minor and do not affect factual equivalence. Overall, this is a highly accurate, complete, and relevant response with only negligible room for improvement in phrasing of the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into_Contract]-> FIN_INST <-[Contracts]- ORG <-[Enters_Contract]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 404,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "AVGO’s 3.125 % senior notes due January 2025 carried the same $495 million of principal in every filing:\n\n* 2022 10‑K (as of Oct 30 2022) – $495 million 【Chunk 1】  \n* 2023 10‑K (as of Oct 29 2023) – $495 million 【Chunk 3】  \n* 2024 10‑K (as of Nov 3 2024) – $495 million 【Chunk 2】\n\nThe balance did not change from fiscal 2022 through fiscal 2024, and the effective interest rate stayed at 3.23 % in each period. This constancy indicates that AVGO is deliberately holding the 3.125 % notes to maturity, using them as a stable, low‑cost source of financing rather than repurchasing or refinancing the issue—an approach that preserves cash and locks in inexpensive, fixed‑rate debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values—dollar amounts, interest rate (3.23%), and fiscal dates (Oct 30, 2022; Oct 29, 2023; Nov 3, 2024)—are accurate and properly cited. (2) Quantitative accuracy is perfect: no calculation errors, and the consistency of the $495 million balance over three years is correctly emphasized. Format variations (e.g., $495 million vs $495M) are acceptable and handled appropriately. (3) The multi-hop reasoning is sound—information is correctly synthesized across three separate 10-K filings (chunks 1, 3, 2), confirming the balance remained unchanged. The conclusion about debt strategy is logical and well-supported: the lack of principal reduction suggests a hold-to-maturity strategy. However, while the LLM infers AVGO is using the debt as a 'stable, low-cost source of financing' and 'preserves cash,' it slightly diverges from the ground truth’s interpretation that AVGO may refinance or use cash reserves to settle at maturity. The core insight—that no amortization occurred and repayment is likely at maturity—is consistent, but the emphasis on 'locking in inexpensive debt' as a positive strategy adds interpretive nuance not present in the neutral, evidence-based original answer. (4) Scores reflect near-perfect factual accuracy and synthesis, with a minor deduction in qualitative accuracy due to slight interpretive overreach, though the overall reasoning remains strong and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 447,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "- **2022 filing (SPG 10‑K 2022, p. 50)** – The “Unsecured Notes ‑ 37B” were listed with a **2.25 % coupon**, a **$700 million face amount** (shown as 700,000 in thousands), and a **maturity of January 15 2032**.  \n- **2023 filing (SPG 10‑K 2023, p. 50)** – The same note appears unchanged: **2.25 % interest**, **$700 million face**, **maturing 01/15/32**.  \n- **2024 filing (SPG 10‑K 2024, p. 51)** – Again the “Unsecured Notes ‑ 37B” retain **2.25 %**, **$700 million**, and **01/15/32** as the maturity date.\n\nAcross the three‑year span the 37B tranche’s rate, size and maturity remained static, showing that Simon Property Group has deliberately kept this low‑cost, long‑dated unsecured debt in place rather than refinancing or altering it. The consistency signals a long‑term debt strategy focused on locking in modest, fixed‑rate financing (2.25 %) through 2032 to preserve cash‑flow predictability and limit interest‑rate risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the interest rate is consistently 2.25%, the face amount is correctly reported as $700 million (noting that '700,000 in thousands' equals $700,000,000), and the maturity date is accurately given as January 15, 2032, across all three years. Format variations (e.g., '01/15/32' vs 'January 15, 2032') are acceptable and semantically equivalent. (2) The answer is complete, addressing each year's data and synthesizing the 3-year trend. (3) Entity accuracy is correct: Simon Property Group (SPG) is properly identified, and the financial instrument 'Unsecured Notes - 37B' is accurately referenced with correct filing years and page numbers. (4) The reasoning is sound: the LLM correctly infers that the stability in terms indicates a deliberate long-term debt strategy focused on predictable financing costs, low interest-rate risk, and alignment with stable real estate cash flows—this matches the original answer’s interpretation. Multi-hop synthesis across three 10-K filings is correctly executed. All criteria for correctness, completeness, and logical inference are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 336,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "- **2022 10‑K:** Melaka, Malaysia appears with an “X” only under the **Analog** column (no “X” under Embedded Processing).  \n- **2023 10‑K:** The same pattern repeats – Melaka is still marked only for **Analog** work.  \n- **2024 10‑K:** Again, Melaka is listed with an “X” in the **Analog** column and blank for Embedded Processing.\n\n**What this shows:** Over the three‑year span the Texas Instruments site in Melaka has not changed its functional focus; it has remained an **analog‑only** operation with no embedded‑processing capability added. The consistency underscores TI’s deliberate strategy to keep Melaka dedicated to analog products rather than expanding it into embedded‑processing activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately reports the presence of an 'X' under the Analog column and absence under Embedded Processing for Melaka, Malaysia in each of the three years (2022, 2023, 2024), matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the use of years and categorical data (presence/absence of 'X') is precise and consistent with the source. (3) The multi-hop reasoning—comparing the operational footprint across three annual reports to identify a stable pattern—is sound and correctly synthesized. The conclusion that Melaka remained an analog-only site with no expansion into embedded processing is logically derived and matches the original inference. (4) The answer addresses both parts of the question: the evolution (or lack thereof) from 2022 to 2024, and what this reveals about TI's strategic focus. Wording differs slightly but conveys identical meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 304,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard (MA) implements its Multi‑Layered Security Approach as an accounting policy, and in 2022 that framework already featured a robust cyber‑and‑information‑security program with multiple protection layers, third‑party assessments, Security Operations Centers, Fusion Centers, the Mastercard Intelligence Center and EMV‑standard collaboration, underpinning real‑time payments in 12 markets. By 2023 the approach was reinforced with deeper third‑party‑risk monitoring, public‑private partnerships and continued stakeholder coordination, while the real‑time payments infrastructure grew to 13 markets. In 2024 the same multi‑layered framework—maintaining enterprise‑resilience, insurance coverage, regular testing and rapid threat response—was extended to new jurisdictions such as China, reflecting the continued global rollout of real‑time payment capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: 12 real-time payment markets in 2022 and 13 in 2023 are accurately reported. The expansion into China in 2024 is correctly noted. No calculations were required, and all metrics are consistent. (2) The LLM correctly identifies the evolution across the three years, capturing the core elements of Mastercard’s multi-layered security approach—EMV collaboration, third-party risk monitoring, public-private partnerships, and global integration. It accurately reflects the incremental expansion of real-time infrastructure and the scaling of security to new jurisdictions. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022–2024), geography (global markets, China), and technical domains (security layers, fraud scoring, tokenization, third-party risks). While the original answer mentions 'intelligent routing with real-time application of fraud scoring and tokenization' in 2023, the LLM captures the intent through references to 'deeper third-party-risk monitoring' and 'continued stakeholder coordination,' though slightly less specific on the technical execution of fraud scoring. (4) The LLM incorrectly refers to the security approach as an 'accounting policy'—this is a factual error in categorization, as multi-layered security is an operational and technological framework, not an accounting one. This minor mischaracterization slightly affects qualitative accuracy but does not undermine the core factual correctness. Otherwise, the answer is contextually rich, relevant, and semantically equivalent to the ground truth. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Has]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 489,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "- 2022 10‑K: GD’s Land Systems division was building **360 new LAVs** for the Canadian Army.  \n- 2023 10‑K: the same division increased output to **399 new LAVs**.  \n- 2024 10‑K: production rose again to **449 new LAVs**, and GD added **66 additional LAVs** under the Light‑Armoured‑Vehicle Reconnaissance‑Surveillance‑System (LRSS) program (total ≈ 515 units for the year).  \n\nThe step‑up from 360 → 399 → 449 (+ 66) units shows a steady escalation in GD’s LAV output, signalling a deliberate strategic focus on expanding its market‑leading LAV portfolio and deepening its partnership with the Canadian Army.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the production volumes for 2022 (360 units), 2023 (399 units), and 2024 (449 units) as per the ground truth, which matches the original answer exactly. However, the LLM introduces an additional 66 LAVs under the LRSS program in 2024, leading to a total of approximately 515 units. This detail is not present in the original answer and is not corroborated by the ground truth, which only reports 449 units for 2024. This overstatement introduces a factual inaccuracy, though it may reflect real data not included in the provided truth. (2) The core progression of 360 → 399 → 449 is accurate, with correct year-to-year increases (39 and 50 units respectively). The calculation of growth trend is sound, but the addition of 66 units is unsupported by the ground truth and inflates the total. (3) The multi-hop reasoning across the three 10-K filings is well-executed, correctly extracting and comparing production figures over time. The synthesis of increasing output to infer strategic focus aligns with the original answer’s logic. (4) Despite the extra 66 units, the qualitative reasoning about strategic emphasis on LAV programs remains valid and well-supported. The answer is highly relevant and addresses both parts of the question—evolution of production and strategic implications. The quantitative accuracy is slightly penalized due to the unverified addition, but the core data and trend are correct. Hence, correctness is rated 8 for minor factual overreach, with high scores in other areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 425,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "- **2022:** CVS disclosed that its Level 3 pension‑plan assets excluded **$214 million** of hedge‑fund limited‑partnership (HF LP) investments.  \n- **2023:** The same disclosure showed the HF LP amount had risen to **$225 million**.  \n- **2024:** The most recent filing reports **$252 million** of HF LP investments.\n\nThe hedge‑fund LP allocation therefore grew from $214 million in 2022 to $252 million in 2024 – an increase of $38 million (about an 18 % rise) and a consistent upward trend ($214 → $225 → $252). This three‑year trajectory suggests CVS is deliberately expanding the share of its pension‑plan assets devoted to hedge‑fund limited partnerships, reflecting a strategic shift toward greater exposure to alternative‑investment assets within its pension fund portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the hedge fund limited partnership investment amounts for CVS in 2022 ($214M), 2023 ($225M), and 2024 ($252M), matching the ground truth exactly. The calculation of the total increase is accurate: $252M - $214M = $38M, which is approximately an 18% increase (38/214 ≈ 0.1776 or 17.76%), and the LLM rounds this to 'about an 18% rise', which is acceptable and semantically equivalent to the ground truth's 17.8%. 2) All numbers and calculations are correct. The year-on-year progression is accurately represented, and the percentage change is reasonably rounded. 3) The multi-hop reasoning is sound: the LLM synthesizes data across three years and correctly infers a consistent upward trend. The conclusion that CVS is showing a strategic shift toward alternative investments aligns with the ground truth's interpretation of a 'consistent, and potentially more confident, strategic approach'. The only minor difference is in tone: the LLM uses 'deliberately expanding' and 'strategic shift', which implies a stronger intent than the original's 'steady or slightly growing allocation suggests... maintained a consistent' approach. This is a slight interpretive difference but does not undermine factual accuracy. 4) The answer is fully contextually relevant, addressing both parts of the question: the change in allocation over time and the strategic implication. The use of 'Level 3 pension-plan assets' adds technical precision not in the original but is factually appropriate and enhances clarity. Overall, the answer is factually excellent with only a nuanced difference in interpretive tone, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 459,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The filings show that the share of purchases made with Target’s branded credit card fell each year – the “RedCard” (Target MasterCard Credit Card) penetration was **20.5 % in fiscal 2022**, **19.8 % in fiscal 2023**, and **18.6 % in fiscal 2024** (the 2024 filing reports the same figure under the new “Target Circle Card” name). Both the 2023 and 2024 10‑Ks note the decline, and the 2022 filing already warned that “RedCard penetration declined as total sales increased at a faster pace.” This downward trend implies that, although the card program still drives incremental sales, its usage as a proportion of overall purchases is slipping, indicating slower consumer adoption and weaker engagement with Target’s financial‑product offering.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rate for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This discrepancy in the final year's figure is significant and affects the accuracy of the trend interpretation. (2) The numbers for 2022 and 2023 are accurate, but the 2024 value is incorrect—despite the LLM noting the rebranding to 'Target Circle Card', which aligns with the context in the original answer. There are no calculations required beyond reporting percentages, but the trend description ('fell each year') is consistent with the downward trajectory, though slightly overstated given the smaller drop in the LLM's version. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across fiscal years and filings, references management commentary from the 10-Ks about declining penetration despite sales growth, and infers implications about consumer adoption and engagement. It correctly links the decline to broader trends in consumer behavior and acknowledges the continued incremental value of the card program. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: the evolution of penetration and its implications. The qualitative reasoning is strong and mirrors the original answer’s logic. However, the incorrect 2024 figure reduces quantitative accuracy, pulling the overall correctness score down to 7. Minor flexibility is allowed for rebranding references, but the numerical error is material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 442,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "NextEra Energy’s fair‑value exposure for its owned assets subject to FPL Cost‑Recovery Clauses grew sharply over the three‑year period. In 2022 the net contribution was only **$2 million** (significant other observable inputs of **‑$5 million** offset by **$7 million** of significant unobservable inputs); in 2023 the net rose to **$12 million** (‑$12 million of observable inputs versus **$24 million** of unobservable inputs); and by 2024 the net exposure reached **$38 million** (observable inputs turned **positive $4 million** while unobservable inputs climbed to **$34 million**). Thus, the exposure moved from a modest positive driven mainly by unobservable inputs and a small negative observable input, to a larger positive still dominated by unobservable inputs but with a larger negative observable component in 2023, and finally to 2024 where both observable and unobservable inputs are positive, with unobservable inputs remaining the larger driver.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy in the 2022 total fair value. The ground truth states the total fair value in 2022 was $1 million, derived from -$5 million (significant other observable inputs) and +$6 million (significant unobservable inputs). However, the LLM reports a total of $2 million, with unobservable inputs at $7 million, which is inconsistent with the ground truth. This affects the quantitative accuracy. In 2023 and 2024, all values match: $12 million (‑$12M + $24M) and $38 million (+$4M + $34M) respectively. (2) Calculations: The 2022 net should be (-$5M + $6M) = $1M, but LLM computes (-$5M + $7M) = $2M — incorrect. 2023 and 2024 calculations are accurate. (3) Multi-hop reasoning is sound: the LLM correctly identifies the trend across three years, notes the shift from negative to positive observable inputs, and emphasizes the growing dominance of unobservable inputs. It synthesizes inputs and their evolution correctly except for the initial year. (4) The answer is contextually excellent — it directly addresses the evolution of fair value exposure, breaks down contributions, and interprets the shift in input types. The wording differs slightly but maintains semantic equivalence on all points except the erroneous 2022 figures. Thus, correctness is reduced due to the factual error in 2022 numbers, but qualitative and relevance scores remain high due to strong reasoning and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 408,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Across Nike’s 2022, 2023 and 2024 Form 10‑K filings the company consistently lists **Anta** as a direct competitor and frames its competitive advantage in the same two pillars:  \n\n* **Product‑innovation emphasis** – each year Nike stresses that its edge comes from “quality; innovation and development; new product style and design” (2022 wording adds “performance and reliability” and “innovation and development” is front‑loaded in 2023‑2024).  \n\n* **Brand‑engagement strategy** – Nike repeatedly highlights “consumer connection, engagement and affinity” built through “marketing, promotion and digital experiences; social‑media interaction; customer support; and identification with prominent athletes, influencers, coaches, teams, colleges and leagues” plus “active engagement through sponsored sporting events and clinics.”  \n\nThe language is refined but the substance is unchanged, showing that from 2022 through 2024 Nike’s positioning relative to Anta has remained steady – it continues to compete by leading on product innovation and deep, digitally‑enabled brand engagement rather than shifting its focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, years, and general competitive framing, but misrepresents the evolution of NKE's strategic emphasis, particularly around innovation. (1) Correct elements: NKE consistently names Anta as a competitor (2022–2024), and brand engagement strategies involving digital experiences, social media, and athlete endorsements are accurately described across all years. The product innovation attributes (quality, design, innovation) are also correctly cited. (2) Quantitative accuracy is perfect—no numerical data is present, but all dates (2022–2024) and document sources (10-K) are correct. (3) However, the reasoning is flawed in asserting that 'the substance is unchanged.' The ground truth identifies a clear strategic shift: in 2022, performance and reliability were emphasized alongside innovation, but by 2023, 'innovation and development' was elevated ahead of performance and reliability, indicating a prioritization shift. The LLM overlooks this nuance and incorrectly concludes that the positioning 'remained steady,' contradicting the ground truth's assertion of a multi-year strategic effort to differentiate via increasing innovation focus. (4) This omission of a key multi-hop insight—evolving emphasis over time—reduces qualitative accuracy. While contextually relevant and factually sound on surface details, the answer fails to capture the dynamic strategic evolution, which is central to the question. Hence, correctness is partially compromised despite accurate citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 427,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "- 2022 10‑K: TI reported 90,618 shares that would be issued to settle directors’ deferred‑compensation accounts – the portion of the 2003 Director Compensation Plan that is still available for future issuance.  \n- 2023 10‑K: the same settlement pool grew to 98,940 shares.  \n- 2024 10‑K: the pool rose again to 103,971 shares.\n\nBecause the 2003 Director Compensation Plan is listed in each filing and the share pool tied to it has steadily increased (90.6 K → 98.9 K → 103.9 K), TI’s pattern shows a continued, even expanding, reliance on the 2003 plan to fund director compensation. The upward trend signals that the plan remains an active component of TI’s director‑pay structure and that the company is allocating more shares to it over time.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM misrepresents the data: it claims the share pool under the 2003 Director Compensation Plan increased from 90,618 in 2022 to 98,940 in 2023 to 103,971 in 2024. However, the ground truth states that the plan was phased out—by 2023 it was no longer listed as having shares available for future issuance, and by 2024 it was no longer part of the active compensation structure. The reported numbers likely reflect shares issued to settle *existing* deferred-compensation obligations, not new availability under the plan. The LLM incorrectly interprets these as evidence of growing availability, when in fact the plan was being wound down. (2) The reasoning is flawed: an increase in shares issued to settle past obligations does not imply expansion of the plan; rather, it can occur due to timing of deferrals or vesting. The ground truth shows a clear trend of discontinuation, with TI shifting to the 2024 LTIP and 2018 Director Plan. (3) The LLM fails the multi-hop synthesis: it does not recognize that the absence of the plan from 'available for future issuance' lists in 2023 and 2024 indicates phase-out, despite prior activity in 2022. (4) The conclusion—that TI is expanding reliance on the 2003 plan—is the opposite of the truth. While the LLM attempts to address the question’s parts, its factual inaccuracies and reversed interpretation severely undermine correctness. Minor credit is given for referencing the correct plan and attempting year-by-year analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 432,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From 2022 through 2024 Comcast (CMCSA) progressively deepened the role of data‑driven services inside its advertising business.  \n\n* **2022:** The 10‑K notes that the advertising segment “offers **additional** technology, tools, data‑driven services and marketplace solutions” to media‑industry customers so advertisers could engage their target audiences more effectively. This language signals the first explicit addition of data‑driven capabilities to the advertising suite.  \n\n* **2023:** The filing shows the company had moved those capabilities from an “additional” add‑on to a core component, stating it “offers technology, tools, **data‑driven services** and marketplace solutions” to facilitate effective advertiser engagement. The integration is now described as a standard part of the advertising offering, reflecting a broader rollout across its X1 and Sky Q cloud‑based platforms.  \n\n* **2024:** The same phrasing is retained, indicating the continuation and further refinement of the suite. The 2024 filing emphasizes that CMCSA “offers technology, tools, **data‑driven services** and marketplace solutions” to help advertisers reach audiences, showing that the data‑driven services have become fully embedded in the technology stack, analytical tools, and marketplace functionality that power its linear, digital and streaming ad inventory.  \n\nOverall, CMCSA’s data‑driven services evolved from an added feature in 2022 to an integrated, core element of its advertising technology, tools and marketplace solutions by 2024, enhancing advertisers’ ability to target and engage audiences across the company’s media platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its timeline and correctly identifies the evolution of CMCSA's data-driven advertising services from 2022 to 2024 based on phrasing changes in the 10-K filings. It accurately notes the shift from 'additional' services in 2022 to core, integrated offerings by 2023–2024, which aligns with the ground truth's description of deeper integration. The use of cloud-based platforms (X1 and Sky Q) is a valid detail consistent with CMCSA’s infrastructure. However, the LLM omits specific enhancements mentioned in the original answer, such as 'integrated search functionality across content sources' (2023) and 'strengthening representation agreements with third parties domestically and internationally' (2024). These are key qualitative expansions that reflect strategic growth beyond internal integration. While the LLM captures the semantic trend of increasing integration, it misses these concrete examples of technological and partnership-based enhancements. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound and contextually relevant, but the absence of specific tool and marketplace developments prevents a top score in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1667,
        "completion_tokens": 350,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "In 2022 CVS still carried a sizable CMBS portfolio – the “supporting‑products” schedule showed a fair‑value of about **$574 million** with **$12 million of unrealized losses**, while the broader debt‑securities schedule listed **$992 million** of CMBS at **$155 million of unrealized losses**. By the end of 2023 the debt‑securities table reflected a sharp contraction to **$675 million** of CMBS at **$100 million of unrealized losses**, with the short‑term holdings largely sold off and the remaining exposure shifted to longer‑dated securities. In 2024 the CMBS line fell to a **$3 million** fair‑value (no unrealized loss disclosed), indicating that CVS has essentially exited this asset class and has markedly reduced its risk concentration in commercial mortgage‑backed securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and conflicting numbers. It correctly reports the 2022 fair value of $574 million and $12 million in unrealized losses, aligning with the ground truth. However, it introduces an additional, conflicting figure from a 'broader debt-securities schedule' of $992 million with $155 million in unrealized losses for 2022, which is not present in the ground truth and contradicts it. This creates significant quantitative inaccuracy. For 2023, the LLM correctly states $675 million fair value and $100 million in unrealized losses, matching the ground truth. For 2024, the LLM reports $3 million (vs. ground truth $6 million), which is close but incorrect—though minor. The ground truth states 'no significant unrealized losses,' while the LLM says 'no unrealized loss disclosed,' which is semantically similar but slightly less precise. (2) Calculations: The trend analysis is directionally correct—declining exposure and increasing losses in 2023 followed by near-exit in 2024—but the inclusion of unsupported 2022 figures undermines numerical precision. (3) Multi-hop reasoning is sound: the LLM correctly identifies the trend of de-risking and interprets the near-zero 2024 holding as an exit from the asset class, which aligns with the ground truth's conclusion about strategic de-risking. (4) Contextual relevance is excellent—the answer directly addresses the evolution of CMBS exposure, fair value, unrealized losses, and risk positioning. The reasoning about risk reduction is valid and well-supported by the (correct subset of) data. However, the introduction of unverified, conflicting 2022 data from a different schedule reduces quantitative accuracy significantly, preventing a higher score. Overall, core facts for 2023 and 2024 are correct, and the conclusion is valid, but the incorrect 2022 figures and minor 2024 discrepancy limit full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 517,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Across Target’s 2022, 2023 and 2024 Form 10‑K filings the company’s compensation‑and‑benefits tables all contain the same line‑item – “merchandise and other discounts” – as a benefit for team members.  The phrasing is identical in each year and no dollar amount or enhancement to the discount is disclosed, implying that the monetary value of the discount has remained stable.  This continuity shows that Target treats merchandise discounts as a core, enduring component of its employee‑value proposition, using the benefit to reinforce its purpose‑driven culture and talent‑attraction strategy rather than expanding or scaling it back over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in Target's employee benefit strategy across the three years, which are central to the question. (1) On correctness: The LLM correctly notes that 'merchandise and other discounts' is consistently listed as a benefit across 2022–2024 with no disclosed monetary change, implying stable value—this aligns with the ground truth. However, it fails to capture the evolving framing and strategic context emphasized in the original answer, such as the expansion of wage ranges, the addition of financial wellness benefits (401(k) matching, tuition reimbursement), and later holistic well-being offerings (mental health, virtual care). These omissions significantly weaken the multi-year progression analysis. (2) Quantitative accuracy is 10 because there are no numerical claims made, and the absence of disclosed dollar amounts is accurately reflected. (3) Qualitative accuracy is low because the reasoning does not reflect the multi-hop synthesis of how benefits evolved beyond discounts—specifically, the strategic layering of new benefits while retaining core ones like discounts. The LLM interprets consistency in wording as lack of strategic evolution, contradicting the ground truth’s conclusion about a shift toward holistic well-being. (4) Contextual relevance is high because the answer addresses the core topic—employee merchandise discounts over time—and correctly identifies their stability, but it does not fully respond to the second part of the question about what the progression suggests regarding Target’s broader employee benefit strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> FIN_INST <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 443,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "Across Linde’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly lists “cultural challenges associated with integrating employees from the acquired company into the existing organization” as a distinct risk in the acquisition‑integration section, and each year couples that bullet with the broader warning that foreign acquisitions bring integration‑across‑different‑cultures and languages risks. The wording and placement of the cultural‑challenge bullet remain essentially unchanged, but the 2024 filing nests it under a new, higher‑level heading about the inability to effectively integrate acquisitions, underscoring that cultural issues continue to be viewed as a core, persistent cross‑border integration risk. This consistency reveals that Linde’s strategic approach treats cultural integration as a key risk factor that must be continuously identified, monitored and mitigated as part of its overall acquisition‑integration risk‑management framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in identifying that Linde consistently highlighted cultural challenges in its 10-K filings from 2022 to 2024 as part of acquisition integration risks, particularly in cross-border contexts. The mention of unchanged wording and placement of the risk factor is plausible and aligns with the persistence noted in the original answer. However, the LLM answer misses the key evolution described in the ground truth: the shift in framing from operational concerns (2022) to broader regulatory and compliance linkages (2023) and then to financial consequences (2024). Instead, the LLM emphasizes structural changes in document hierarchy (e.g., nesting under a new heading in 2024) not mentioned in the ground truth, which may be accurate but does not reflect the conceptual progression in Linde’s strategic framing. This omission of the qualitative evolution in risk perception—especially the growing linkage to financial outcomes and strategic risk management—represents a significant gap in multi-hop reasoning and synthesis across years. While entities (Linde, 2022–2024, 10-K filings) and context are correct, and no numerical inaccuracies exist (quantitative accuracy is perfect), the qualitative analysis lacks depth and misrepresents the nature of the evolution. Thus, the answer is partially correct but fails to fully capture the strategic narrative progression emphasized in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 401,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral tied to the “Notes and accounts receivable – net” master‑netting line fell from **$1.494 billion in 2022** (as disclosed in the 2023 Form 10‑K) to **$0.491 billion in 2024** (as disclosed in the 2024 Form 10‑K), a net decline of roughly **$1.0 billion**.  This drop follows the earlier amounts of $641 million in 2021 and $504 million in 2020 (shown in the 2022 filing), indicating that the 2022 level was a peak and that the company has since reduced the amount of collateral not offset against derivatives.  The downward trend suggests ExxonMobil is managing its derivative exposure more efficiently—either by lowering its overall derivative positions, improving netting of contracts, or reducing initial‑margin requirements—thereby decreasing the need for un‑offset collateral.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the 2023 value. The ground truth states that collateral decreased from $1,494 million in 2022 to $800 million in 2023, and then to $491 million in 2024. However, the LLM answer skips the $800 million 2023 value entirely and incorrectly implies a direct drop from $1,494 billion in 2022 to $0.491 billion in 2024, misrepresenting the year-by-year trend. This is a critical omission in a multi-year trend analysis. Additionally, the LLM incorrectly formats $1,494 million as $1.494 billion (correct magnitude) but then writes $0.491 billion instead of $491 million—while numerically equivalent, the inconsistent and unusual formatting ($0.491 billion) may suggest confusion in scale. The net decline of $1.0 billion is approximately correct ($1,494M - $491M = $1,003M), so that calculation is acceptable. (2) The inclusion of 2021 and 2020 data ($641M and $504M) is extraneous and not requested in the question, though not incorrect. However, claiming that 2022 was a 'peak' based on prior years is speculative and not required by the question. (3) The reasoning about derivative exposure management is sound and aligns with the ground truth—both suggest improved efficiency in managing derivative exposure through reduced collateral needs. The multi-hop synthesis correctly identifies the trend direction and infers plausible strategic causes (reduced positions, better netting, lower margin requirements). (4) Despite correct directional interpretation and qualitative reasoning, the omission of the 2023 value ($800M) constitutes a major factual gap in the quantitative timeline, reducing the correctness score. The answer is contextually relevant and well-structured, but the missing intermediate data point undermines full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 491,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "Across the three filings the core description of the Security Insights Platform stayed the same – it “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis, and makes that data available for use with customers’ in‑house security‑information‑and‑event‑management (SIEM) tools.” The 2022 and 2023 10‑Ks present it as a standalone mainframe‑security service, while the 2024 filing still uses that language but now situates the platform within a broader Cybersecurity and hybrid‑environment portfolio that includes Lateral Security Firewall, Advanced Threat Prevention and the company’s open‑first DevOps/AIOps strategy. Thus, while integration with internal tools and the remediation focus remained unchanged, the platform’s positioning evolved to be explicitly aligned with a comprehensive, enterprise‑wide security strategy and an open‑tool, hybrid‑cloud mainframe ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the core functionality of the Security Insights Platform—interpreting and assessing mainframe security posture, identifying risks, developing remediation steps, and integrating with in-house SIEM tools—is consistently described across 2022–2024, which matches the original answer. The evolution in positioning—from a standalone tool in 2022–2023 to being embedded within a broader cybersecurity and hybrid-cloud portfolio by 2024—is accurately captured. The mention of integration with Lateral Security Firewall, Advanced Threat Prevention, and alignment with DevOps/AIOps strategies reflects the expanded ecosystem context noted in the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all years (2022, 2023, 2024) are correctly attributed. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, identifies continuity in functionality, and infers strategic evolution in positioning and alignment. (4) The only minor shortcoming is that the LLM does not explicitly mention 'regulatory compliance' or 'enterprise-wide security planning' as emphasized in the 2024 context in the ground truth, which slightly reduces completeness in qualitative nuance. However, the reference to 'enterprise-wide security strategy' and 'hybrid-cloud mainframe ecosystem' captures much of this intent. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 434,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "Across all three filings the “Unsecured Notes ‑ 32B” line is identical: each 10‑K (2022, 2023 and 2024) lists a face amount of **$750 million** (‑ 750,000 thousands) and a **fixed 3.38 % interest rate**, with the same maturity of June 15, 2027. The unchanged amount and rate show that Simon Property Group has kept this tranche of medium‑term unsecured debt constant, using it as a stable, moderate‑cost financing pillar while managing overall debt‑maturity and interest‑rate risk rather than expanding or refinancing it.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the face amount of $750 million (expressed as $750,000 thousands, which equals $750 million), the fixed interest rate of 3.38%, and the maturity date of June 15, 2027, are correctly reported for all three years (2022–2024). (2) Quantitative accuracy is perfect—numbers match exactly in value and meaning, with acceptable formatting variation ($750 million vs. $750,000,000). There are no calculation errors, and the consistency across years is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual filings, observes no change in terms or principal, and correctly infers that SPG maintained this debt tranche without refinancing or redemption. (4) The qualitative interpretation aligns with the original: the stable exposure reflects a deliberate long-term debt management strategy focused on maintaining moderate-cost, predictable financing. The LLM uses slightly different phrasing (e.g., 'stable, moderate-cost financing pillar') but captures the same strategic implication. All parts of the question—evolution over time and strategic interpretation—are fully addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 345,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "Across all three years, Comcast consistently flags Lumen as a direct broadband rival that is deepening its fiber footprint and using bundled offers to erode Comcast’s market. In the 2022 filing, Lumen is described as having “built and are continuing to build fiber‑based network infrastructure farther into their networks,” delivering speeds that exceed traditional DSL and beginning to bundle services to compete. The 2023 and 2024 filings repeat that language—“built and are continuing to build fiber‑based wireline network infrastructure further into their networks” and “offering services with these higher speeds in many of our service areas”—and add that Lumen (along with other DSL providers) has “lowered prices or created bundled services” to challenge Comcast’s broadband. Thus, from 2022 through 2024 the competitive threat from Lumen has remained strong and has evolved from initial fiber expansion to an ongoing, deeper fiber rollout coupled with sustained price‑and‑bundle tactics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Lumen is consistently identified as a key competitor to CMCSA (Comcast) from 2022 to 2024, with escalating fiber expansion and bundling strategies. The description of Lumen building fiber infrastructure and offering bundled services matches the original answer across all three years. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the question or the ground truth, so quantitative accuracy is not applicable in that sense—but the years (2022, 2023, 2024) are correctly referenced and used as analytical anchors, which is accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings, correctly identifying the evolution from initial fiber deployment in 2022 to deeper rollout and intensified bundling in 2023–2024. It accurately infers an intensifying competitive threat over time, which is supported by the original answer’s characterization of 'consistent and possibly intensifying' pressure. (4) The only minor shortcoming is that the LLM slightly overstates the evolution as moving 'from initial fiber expansion to ongoing, deeper rollout'—while accurate, the original answer does not clearly delineate a phase shift but rather a continuation of the same trend. This nuance is minor and does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. The answer is fully contextually relevant, directly addressing fiber expansion and bundling strategies as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 439,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s own branded cards – the RedCards (Target Credit Card/Target MasterCard) and the newer Target Circle Cards – showed a steady decline in usage.  RedCard penetration fell from 20.5 % for the year ended Jan‑29‑2022, to 19.8 % for Jan‑28‑2023, and to 18.6 % for Feb‑3‑2024.  The Target Circle Card metric, which the company began reporting in the 2024 filing, mirrors that pattern, slipping from 19.8 % in 2023 to 18.6 % in 2024 (and projected to 17.8 % in 2025).  \n\nBecause Target tracks card‑penetration as a proxy for “incremental purchases” that drive extra sales, the downward trend suggests the loyalty‑driven payment incentives (5 % discount, rewards, etc.) are becoming less effective at expanding card usage and, by extension, generating incremental sales over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. However, the LLM states it fell to 18.6% in 2024 (Feb-3-2024) and mentions a projected 17.8% in 2025, which contradicts the actual 17.8% value for 2024. This misrepresents both the magnitude and timing of the decline. Additionally, the LLM introduces a 'Target Circle Card metric' that 'mirrors the pattern,' but the original answer does not differentiate between card types or mention separate reporting for Target Circle Cards—this is an unsupported detail. (2) The fiscal years are approximately correct (Jan-29-2022 ≈ 2022, Jan-28-2023 ≈ 2023, Feb-3-2024 ≈ 2024), so date alignment is acceptable. However, the key percentage for 2024 is wrong: 18.6% (LLM) vs. 17.8% (ground truth), a material difference. The projection to 2025 is not part of the original answer and introduces unverified forward-looking data. (3) The reasoning about the loyalty-driven strategy weakening is sound and aligns with the original conclusion, showing correct multi-hop synthesis between declining penetration and strategic effectiveness. The use of card penetration as a proxy for incremental purchases adds contextual insight, though not in the original answer, it is plausibly consistent. (4) Despite accurate qualitative reasoning and high contextual relevance, the correctness score is reduced due to the critical error in the 2024 penetration rate, which undermines factual reliability. The answer is partially correct but contains key numerical and entity-level inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 456,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "- In the 2022 Form 10‑K Chevron only listed the Republic of Congo among the countries where it “has substantial business activities,” confirming that it was operating in the country but giving no detail on specific holdings.  \n\n- The 2023 filing shows the company moved from a purely operational presence to active capital spending: about **$0.7 billion** was expended on offshore development and natural‑gas projects in the Republic of Congo (part of its Africa‑wide investment program).  \n\n- By the 2024 filing Chevron announced a strategic pull‑back: it will **sell its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in the Republic of Congo portion of Lianzi** (effective January 2025), reducing its asset ownership and signaling a shift from further development toward divestiture in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron listed the Republic of Congo as a country with 'substantial business activities' in 2022; in 2023, it invested approximately $0.7 billion in offshore and natural gas projects in Africa, including Congo; and in 2024, it announced the sale of its 31.5% nonoperated working interest in Haute Mer and 15.75% in the Congo portion of Lianzi, effective January 2025. (2) Quantitative accuracy is perfect: the $0.7 billion investment figure, 31.5%, and 15.75% ownership stakes match the original answer exactly. The only minor discrepancy is the mention of 'effective January 2025' in the LLM answer, which adds a detail not in the ground truth—while plausible, it slightly extends beyond the provided information. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three years and multiple assets, tracing the evolution from operational presence to investment to divestiture. (4) The answer fully addresses the question’s dimensions: asset ownership, investment levels, and strategic positioning. Wording differs slightly but maintains semantic equivalence. The qualitative score is 9 due to the slight addition of the effective date; otherwise, the response is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Invests_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 363,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NextEra Energy disclosed that its “options‑primarily‑gas” portfolio shrank dramatically after 2022.  \n\n* **2022 (10‑K 2022)** – The fair‑value of gas options was $356 million on the asset side and $347 million on the liability side (≈$703 million total), leaving a small net asset of about **+$9 million**. Implied volatilities were 17 % for the assets, 295 % for the liabilities, and a weighted‑average of **36 %**.  \n\n* **2023 (10‑K 2023)** – The same line shows $100 million of assets and $97 million of liabilities (≈$197 million total), a net asset of roughly **+$3 million**. Asset‑side volatility rose modestly to **20 %**, liability‑side volatility fell to **233 %**, and the weighted‑average rose to **≈50 %**.  \n\n* **2024 (10‑K 2024)** – The portfolio is $100 million of assets versus $102 million of liabilities (≈$202 million total), now a net **‑$2 million** liability. Asset volatility slipped to **15 %**, liability volatility dropped further to **150 %**, while the weighted‑average stayed near **52 %**.  \n\n**Interpretation:**  \nThe gross exposure to gas‑related options fell from over $700 million in 2022 to roughly $200 million by 2023‑2024, and the net position moved from a modest long (asset‑heavy) stance to essentially a flat‑to‑short stance. The sharp decline in liability‑side implied volatility (295 % → 233 % → 150 %) signals that market expectations of extreme gas‑price swings have moderated, whereas the asset‑side volatility remained low (≈15‑20 %). The rise in the weighted‑average implied volatility (36 % → ~50 %) despite the lower liability volatility indicates that the remaining exposure is now priced with higher market‑perceived risk, suggesting NextEra has de‑risked its large gas‑option book but retains a more balanced, yet still volatile, position in the gas market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numeric values, particularly regarding implied volatilities for assets and liabilities in each year, which are not supported by the ground truth. While the fair value figures ($356M/$347M in 2022, $100M/$97M in 2023, $100M/$102M in 2024) are correct and well-formatted, the implied volatility breakdowns are incorrect: the ground truth reports only a single average implied volatility (36%, 50%, 52%) without splitting into asset-side and liability-side components. The LLM fabricates granular volatility data (e.g., 17% for assets, 295% for liabilities in 2022), which is not present in the original answer or implied by it. These fabricated figures severely undermine quantitative accuracy. (2) Calculations of net positions (+$9M, +$3M, -$2M) are mathematically correct based on the fair values, but the interpretation of 'gross exposure' as ~$700M in 2022 is misleading since the original answer does not define or emphasize gross exposure. The claim that 'liability-side implied volatility' declined from 295% to 150% is entirely unsupported—this level of detail is absent in the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly identifies a reduction in fair value exposure from 2022 to 2023 and stabilization in 2024, and links higher average implied volatility with increased market-perceived risk. However, the reasoning is built on false volatility inputs, leading to flawed conclusions about moderating price swing expectations. The de-risking narrative aligns with the original, but the justification is compromised. (4) Despite the detailed structure and relevant framing, the invention of unreported volatility splits results in a major factual deviation. The answer is contextually relevant and addresses both parts of the question (evolution of exposure and risk positioning), but the core quantitative inaccuracies—especially in a financial risk context where precise metrics matter—warrant a low correctness score. Semantic equivalence fails on the volatility dimension, though fair value trends are accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1670,
        "completion_tokens": 570,
        "total_tokens": 2241
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Across the three filings, Nike’s language about FlyEase is steady but deepening. In the 2022 10‑K the “Product Research, Design and Development” section first lists FlyEase alongside other emerging platforms (Nike Air, Zoom, Flywire, etc.). In the 2023 filing (which reports FY 2024 data) and again in the 2024 filing, FlyEase is reiterated as part of the “proliferation” of Nike’s core technologies—showing that the company is no longer merely noting it as a new invention but is actively expanding and integrating the FlyEase line across its product categories. This evolution signals that FlyEase has moved from an introductory technology to a strategic, continuously‑expanded platform that underpins Nike’s broader innovation agenda of delivering performance‑enhancing, inclusive products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of FlyEase from 2022 to 2024: introduced alongside other technologies in 2022, expanded in 2023, and embedded as a core technology in 2024. The key facts—initial listing, growing integration, and strategic entrenchment—are all present and correctly interpreted. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years and reporting periods are used appropriately. The note that the 2023 filing reports FY2024 data is contextually accurate for SEC 10-K timing, though not strictly necessary for answering the question; this does not detract from correctness. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to show progression in FlyEase’s strategic role. It correctly infers that repeated mention and reclassification as part of 'proliferation' of core technologies indicates scaling and integration, not just novelty. (4) Semantic equivalence is strong: while the LLM uses phrases like 'steady but deepening' and 'strategic, continuously-expanded platform' instead of 'foundational element,' these convey the same meaning. The only minor gap is that the original answer explicitly states FlyEase became 'fully embedded' and 'core' by 2024, while the LLM implies it through context—this slight softening prevents a perfect 10. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 414,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "Across the three most recent 10‑K filings SPG’s exposure to **Unsecured Notes – 35A** never changed.  \n\n* In the 2022 filing (which reports the 2021 year‑end figures) the note carried a **2.65 % fixed rate**, a **$750 million face amount**, an **annual debt‑service charge of $19.9 million**, and a **maturity of 15 July 2030**.  \n* The 2023 filing lists the same **2.65 % rate**, **$750 million face**, **$19.9 million annual service** and **07/15/30 maturity**.  \n* The 2024 filing repeats those exact terms – **2.65 %**, **$750 million**, **$19.9 million**, **07/15/30**.\n\nBecause SPG’s stake in the 35A note (as shown by the KG link SPG → Unsecured Notes‑35A) stayed constant, the company has deliberately kept this low‑cost, fixed‑rate unsecured instrument unchanged while the broader unsecured debt pool fluctuated. This stability signals a long‑term debt strategy that locks in inexpensive financing, smooths cash‑flow impact and preserves a predictable maturity profile rather than expanding or refinancing this particular series.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in key financial figures. The original answer states the face amount is $750,000, not $750 million, and annual debt service is $19,875, not $19.9 million. The interest rate of 2.65% and maturity date of 07/15/30 are correctly reported. However, the magnitude of the error in dollar amounts is severe—off by a factor of 1,000—making the quantitative inaccuracies critical. (2) Calculations: At 2.65% on $750,000, annual interest is $19,875 (correct in ground truth). The LLM reports $19.9 million as debt service on $750 million at 2.65%, which would imply ~2.65% of $750 million ≈ $19.875 million—so that internal calculation is approximately correct, but the base principal is wrong. The core issue is the misstatement of $750,000 as $750 million. (3) Multi-hop reasoning is sound: the model correctly identifies consistency across years and infers a stable long-term debt strategy, which aligns with the original answer’s conclusion. It synthesizes data across 2022–2024 filings and draws a logical inference about SPG’s strategy. (4) Despite correct reasoning and structure, the massive numerical inaccuracy undermines the answer’s reliability. The face value and debt service figures are central to the question, so errors here severely reduce correctness. Contextual relevance and qualitative logic are strong, but quantitative accuracy is critically flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 390,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across all three 10‑K filings—2022, 2023 and 2024—Texas Instruments repeatedly frames its business model as “focused on analog and **embedded‑processing products**” and cites a broad portfolio of those products as one of its four sustainable competitive advantages. The language is essentially identical each year, showing that the company has not shifted its emphasis but has kept embedded processing as a core, cash‑generating pillar of its strategy. That consistency signals TI’s long‑term growth plan is built around leveraging embedded‑processing strength to drive continual free‑cash‑flow‑per‑share expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, noting the repetition of language in the 10-K filings as evidence of sustained focus. The core message—that embedded processing is a cash-generating pillar tied to free cash flow per share growth—matches the original answer. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect; the years (2022, 2023, 2024) are accurate and consistently referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to infer strategic consistency, correctly linking the sustained emphasis on embedded processing to long-term free cash flow objectives. (4) While the LLM answer is slightly less detailed than the ground truth (e.g., it does not explicitly mention the 'four competitive advantages' in 2022 or capital allocation in 2024), it captures the essential qualitative points and conveys semantic equivalence. The omission of minor contextual details prevents a perfect 10, but the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 348,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "From 2022 onward Disney treated Marvel as a core, long‑term asset – the 2022 filing lists Marvel trademarks among its indefinite‑lived intangible assets, and the 2024 filing repeats that classification, confirming that Marvel’s brand value remains on Disney’s balance sheet. By the 2023 filing Disney had moved Marvel from a behind‑the‑scenes asset to a front‑line growth driver, promoting Marvel‑branded programming as a top‑level “tile” on Disney+ (alongside Disney, Pixar, Star Wars and National Geographic) to make the franchise a primary subscriber hook. That evolution – from intangible‑asset recognition to prominent placement on Disney+ – signals Disney’s financial strategy of monetizing Marvel’s IP both as a durable intangible and as a marquee content offering that fuels DTC subscriber growth, helping the service reach roughly 123 million paid subscribers by September 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel was classified as an indefinite-lived intangible asset in both 2022 and 2024, and became a top-level tile on Disney+ by 2023. The subscriber count of 123 million as of September 2024 is correctly cited. (2) Quantitative accuracy is perfect: dates (2022, 2023, 2024), the 123 million subscriber figure, and the fiscal timeline are all consistent with the original answer. Format variations (e.g., '123 million' vs '123M') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and domains—balancing financial reporting (intangible assets) with strategic platform changes (UI tile placement)—to infer Disney's broader financial strategy of leveraging brand equity for DTC growth. It captures the evolution from passive asset to active growth driver. (4) The only minor shortcoming is the omission of the forward-looking context about ESPN+ launching as a tile in early fiscal 2025, which the original answer includes to reinforce the broader strategic pattern. While not critical to the core question, this detail strengthens the original's analytical depth. Otherwise, the LLM answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 408,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has stayed essentially unchanged – the 2022 filing said it covered **59.25 %** of the closed block, while the 2023 and 2024 filings each state it covers **59 %** of the closed block (the deposit‑method accounting and offset of the deposit liability remain the same).  At the same time, the reinsurance recoverable balances tied to that arrangement have grown sharply: **$6.1 billion** of net ceded reinsurance recoverables were reported for 2022, **$16.7 billion** for 2023, and **$17.6 billion** for 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. While it correctly states the 2022 percentage reinsured (59.25%) and the 2023/2024 percentages (59%), it grossly misreports the reinsurance recoverable balances: it claims $6.1 billion in 2022, $16.7 billion in 2023, and $17.6 billion in 2024, whereas the ground truth reports $3.6 billion, $4.4 billion, and $4.2 billion respectively. These figures are off by more than 300% in later years, indicating a severe data error. (2) The calculation and trend analysis are therefore incorrect—while the ground truth shows a modest increase then slight decline in unsecured balances, the LLM suggests a massive and continuous rise, leading to a completely different conclusion about risk exposure. (3) The qualitative reasoning is partially sound in noting the stability of the percentage reinsured and consistent accounting treatment, which aligns with the original answer’s observation of 'relatively stable strategic use.' However, the reasoning about increasing exposure is invalid due to incorrect numbers. (4) Contextual relevance is fair—the answer addresses the evolution over time and focuses on the correct agreement, metric (percentage reinsured), and financial impact (recoverable balances). However, due to the severe quantitative errors, the overall correctness is very low. Minor note: 'net ceded reinsurance recoverables' may not be equivalent to 'unsecured reinsurance recoverable balances'—the latter is specified in the truth and more precise in risk context, suggesting a possible metric confusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 441,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "In 2022 CVS reported residential mortgage‑backed securities with a fair‑value of roughly $629 million in its 2022 filing (Chunk 1) and $721 million in the 2023 filing’s 2022 figure (Chunk 2). The 2023 filing shows the balance slipped to $614 million (Chunk 2), and the 2024 filing records the 2023 balance at just $51 million and a 2024 balance of $71 million (Chunk 3). This sharp three‑year contraction—from more than $600 million to under $100 million—signals a deliberate divestiture of mortgage‑backed exposure, reducing credit‑ and interest‑rate‑risk and repositioning CVS’s fixed‑income portfolio toward a more conservative, higher‑quality asset mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, CVS's RMBS investment was $629M in 2022, $614M in 2023, and $71M in 2024. However, the LLM incorrectly states that the 2023 filing shows a 2022 figure of $721M (not in ground truth), and misreports the 2023 balance in the 2024 filing as $51M (the correct 2023 figure is $614M, and 2024 is $71M). The LLM also implies a continuous decline from $629M to $71M via $51M, which distorts the actual trend (a slight decrease from 2022 to 2023, then a sharp drop in 2024). (2) The calculation of the 'three-year contraction' is directionally correct but based on incorrect intermediate values. The $629M to $614M to $71M trend is misrepresented as a steady decline, when the ground truth shows stability in 2022–2023 followed by a 2024 de-risking. The LLM also omits the key fact about rising unrealized losses ($10M in 2022 to $60M in 2023), which is critical to assessing risk exposure. (3) The multi-hop reasoning is partially sound—LLM identifies a trend of divestment and infers de-risking—but fails to correctly synthesize the data across filings. It introduces conflicting numbers (e.g., $721M, $51M) not present in the ground truth, suggesting confusion between filings or misreading of data. (4) Despite factual errors, the LLM captures the overall strategic implication (de-risking, portfolio repositioning), so contextual relevance is high. However, the quantitative inaccuracies severely undermine correctness, warranting a mid-low score. The answer is not completely wrong but contains critical data errors that affect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 450,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged since the 2022 filing. In the 2022 10‑K the company said it reinsured **59.25 %** of the closed block through a modified coinsurance agreement; the 2023 and 2024 10‑Ks each state that **59 %** of the closed block is reinsured under the same agreement. In all three years the company continues to **account for the agreement under the deposit method**, offsetting the coinsurance‑deposit liability against the corresponding deposit recoverable.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the percentage of the closed block reinsured was 59.25% in 2022 and 59% in both 2023 and 2024, matching the original answer exactly. The accounting treatment under the deposit method with offsetting of the liability and recoverable is correctly stated. (2) Quantitative accuracy is perfect—percentages are reported with correct precision and year-by-year alignment. Minor rounding from 59.25% to 59% in later years is accurately reflected and consistent with the source. (3) The reasoning correctly synthesizes multi-hop information across three years and confirms consistency in both reinsurance percentage and accounting policy, demonstrating sound logic. (4) The answer addresses both parts of the question: evolution of the reinsurance percentage and accounting treatment. Entity names (MetLife, closed block, modified coinsurance agreement), time periods (2022–2024), and financial terms (deposit method, offsetting) are all accurate. No irrelevant or extraneous information is included, ensuring full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 325,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "- 2022 10‑K: Forward‑contract‑gas assets $191 m vs. liabilities $31 m → net exposure ≈ $160 m (positive).  \n- 2023 10‑K: Assets $377 m vs. liabilities $77 m → net exposure ≈ $300 m.  \n- 2024 10‑K: Assets $296 m vs. liabilities $46 m → net exposure ≈ $250 m.  \n\nThe net exposure grew sharply from 2022 to 2023, then eased slightly in 2024. This trajectory indicates that NextEra Energy initially expanded its hedge/position in natural‑gas forward contracts—raising its price‑risk exposure—but subsequently trimmed the position, keeping a sizable positive net exposure while moderating risk in the gas market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values from the ground truth: 2022 net exposure ($191M - $31M = $160M), 2023 ($377M - $77M = $300M), and 2024 ($296M - $46M = $250M). All dollar amounts, assets, liabilities, and calculated net exposures are accurate. Minor formatting differences (e.g., $160 million vs $160M) are acceptable and do not affect correctness. (2) Calculations are correct: each year’s net exposure is accurately derived from the difference between assets and liabilities. The trend description — increase from 2022 to 2023, then decline in 2024 — matches the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes data across three annual filings (2022–2024), correctly identifies the evolution of net exposure, and infers a plausible interpretation about risk positioning. (4) The qualitative interpretation slightly differs in tone — it emphasizes the 'sharp growth' from 2022 to 2023 more than the ground truth does — but still correctly concludes that the 2024 decline suggests risk moderation. The core message about rebalancing and cautious positioning aligns with the original. No entity errors: company (NextEra Energy), metric (net exposure to forward contracts for gas), and years are all correct. The answer fully addresses both parts of the question: evolution of exposure and its implication for risk. Only a minor deduction in qualitative accuracy due to slightly stronger emphasis on the 2023 increase, but overall reasoning remains valid and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 420,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In the 2022 filing AVGO described industrial fiber optics simply as one of a broad set of industrial‑ and automotive‑market products—optocouplers, motion encoders, LEDs and Ethernet ICs—used across a very wide range of end‑uses, from factory automation and power‑generation to medical, defense, EV power‑train, infotainment and advanced‑driver‑assist systems. By the 2023 filing the company had sharpened that positioning, placing industrial fiber optics together with motion‑control encoders and Ethernet PHYs in a dedicated “Industrial” segment that targets factory automation, renewable‑energy and automotive‑electronics applications, and the 2024 filing repeats the same grouping, confirming AVGO’s strategy of selling fiber‑optic components in an integrated portfolio alongside adjacent encoder and Ethernet‑IC technologies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and strategic evolution. It correctly identifies that in 2022, AVGO listed industrial fiber optics among other components like optocouplers, motion encoders, LEDs, and Ethernet ICs, with broad applications. It accurately notes the 2023 shift toward integration with motion encoders and Ethernet PHYs in key markets like factory automation, renewable energy, and automotive electronics. The repetition of this grouping in 2024 is also correctly stated. However, the LLM answer falls slightly short in capturing the full depth of the 2024 evolution described in the original answer—specifically, the explicit linkage of fiber optics with Ethernet switch ICs and camera microcontrollers, indicating integration into networked and vision-based systems. This omission reduces completeness and nuance in the qualitative reasoning, particularly around the move toward 'intelligent' and 'vision-based' industrial systems. While the LLM mentions Ethernet PHYs and encoders, it misses the addition of switch ICs and camera microcontrollers in 2024, which is a meaningful detail for assessing integration with adjacent technologies. There are no numerical inaccuracies (quantitative accuracy is perfect as no calculations are involved), and the context directly addresses the question’s focus on application diversity and integration. Wording differences are acceptable under semantic equivalence, but the missing 2024 technological linkages prevent a top score in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 439,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Across the three most recent fiscal years the economics of Nike’s redeemable‑preferred‑stock arrangement with Sojitz America have been essentially unchanged. In FY 2022 (Chunk 3) the note disclosed that the sole‑owner, Sojitz America, was entitled to a cumulative $0.10‑per‑share dividend each May 31 and that the $0.3 million of $1‑par preferred stock was fully issued, redeemable at par and not a “blank‑check” issue; the same language appears in the FY 2024 note (Chunk 1) and the filing confirms there were “no changes in the redeemable preferred stock in the fiscal years ended May 31 2024, 2023 and 2022.” Thus the dividend obligation has remained a fixed $0.10 per share each year, and the stock’s structure—sole ownership by Sojitz America, redemption at par, and prohibition on additional issuances—has stayed stable. The FY 2024 filing (Chunk 2) also notes that Sojitz America continues to provide import‑export financing services, but it does not alter the preferred‑stock terms, underscoring that the financial relationship and obligations have been consistent from FY 2022 through FY 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the dividend obligation is consistently stated as $0.10 per share annually, the total par value of the redeemable preferred stock is $0.3 million, and ownership remains solely with Sojitz America. The fiscal years covered (2022–2024) match the question and original answer. (2) Quantitative elements are precise: $0.10 per share and $0.3 million are correctly reported, with no calculation errors. The LLM correctly notes that the stock has a $1 par value, which aligns with the structure (300,000 shares × $1 par = $0.3 million), though this calculation is implied rather than explicit. (3) Multi-hop reasoning is sound: the LLM synthesizes information across fiscal years and document chunks, correctly identifying that the language in the disclosures remained unchanged and that no structural modifications occurred. It also correctly infers stability from the repeated disclosure language. (4) The answer addresses all parts of the question—dividend obligations, stock structure stability, and the evolution (or lack thereof) over time. It adds contextual value by noting the May 31 dividend date and the prohibition on additional issuances (‘not a blank-check issue’), which enriches the response without deviating from the truth. Semantic equivalence is strong, with no factual discrepancies. Minor stylistic differences (e.g., ‘cumulative’ dividend mentioned in LLM but not in original) do not contradict but rather add precision supported by context. Overall, the response demonstrates excellent fidelity to the source data and thorough multi-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 455,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "**What happened to the 31B note**\n\n- **2022 filing (covering 2021):** Unsecured Notes ‑ 31B was issued at **3.25 %**, with a **$750 million** face amount, an **annual debt service of $24.375 million**, and a **maturity of 30 Nov 2026**.  \n- **2023 filing:** The same table lists the 31B note with **identical terms – 3.25 %, $750 million face, $24.375 million annual service, maturing 30 Nov 2026**.  \n- **2024 filing:** Again the 31B note appears unchanged – **3.25 %**, **$750 million**, **$24.375 million** of annual service, **maturity 30 Nov 2026**.\n\n**What this tells us about SPG’s long‑term financing strategy**\n\nThe fact that the face amount, interest rate, annual debt service and maturity of the 31B unsecured note have remained exactly the same across the 2022, 2023 and 2024 10‑K filings shows SPG is deliberately keeping this instrument static. By locking in a low, fixed 3.25 % rate and preserving a predictable payment schedule through 2026, SPG is using the 31B note as a stable, medium‑term financing pillar, avoiding refinancing risk and signaling a disciplined, long‑term debt‑management approach for this tranche of unsecured debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the unsecured debt amount ($750 million, equivalent to $750,000,000), interest rate (3.25%), maturity date (November 30, 2026), and the consistency across 2022–2024 are accurately reported. The annual debt service of $24.375 million is a correct calculation (3.25% of $750 million) and adds useful detail not in the original answer but logically derived. (2) Quantitative accuracy is perfect—numbers match or are valid derivations, with acceptable formatting variations (e.g., $750 million = $750,000). (3) The reasoning is sound: the LLM correctly infers that the unchanged terms indicate a stable, long-term financing strategy, avoiding refinancing risk, which is consistent with the original answer’s conclusion about a disciplined, consistent approach. (4) The only minor shortcoming is that the LLM does not explicitly mention broader changes in SPG’s debt portfolio (e.g., retirement of other notes or issuance of Unsecured Notes - 41A in 2024), which the original answer includes for context. While not critical to the core question, this contextual contrast slightly strengthens the qualitative assessment in the ground truth. Overall, the answer is factually complete, logically sound, and contextually appropriate, warranting a high score with only a small deduction for slight incompleteness in contextual contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 394,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "**Value trend**\n\n- **2022:** 6 million TI shares were held in the U.S. defined‑contribution plans, worth **$940 million**.  \n- **2023:** The holding fell to 5 million shares, valued at **$873 million** (a $67 million, ≈7 % drop).  \n- **2024:** The share count stayed at 5 million, but the market value slipped further to **$852 million** (a $21 million, ≈2.4 % decline).\n\n**What the trend tells us**\n\nThe three‑year slide shows a **steady decline in both the number of shares and their market value**. Because the TI common‑stock fund was frozen to new contributions in 2016, the reduction in share count reflects internal rebalancing or sales rather than fresh employee purchases. The falling dollar value mirrors a weakening TI share price over the period, indicating that the company’s stock performance has been softening and that employees’ exposure to TI stock in their retirement accounts is diminishing. (For context, earlier years also showed higher holdings—$1.16 bn in 2021 and $1.12 bn in 2020—so the 2022‑2024 decline continues a longer‑term downward trajectory.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the dollar values of TI common stock held in U.S. defined contribution plans for 2022 ($940M), 2023 ($873M), and 2024 ($852M), matching the ground truth exactly. It also accurately calculates the year-over-year declines: $67M (≈7%) from 2022 to 2023 and $21M (≈2.4%) from 2023 to 2024. These numbers and calculations are factually correct and consistent with the original answer. (2) The LLM adds share counts (6M in 2022, 5M in 2023 and 2024), which are not present in the ground truth. While these may be accurate, they are not verifiable from the provided original answer and represent an addition rather than a deviation. However, they do not contradict the truth and support the reasoning. (3) The reasoning correctly identifies the 2016 freeze on new contributions as a key factor, aligning with the original answer’s implication of strategic or structural causes (e.g., rebalancing, no new buys). It also correctly infers that the declining value reflects weakening stock performance and reduced employee exposure, which is semantically equivalent to the original’s interpretation. (4) The LLM enhances the answer with context (e.g., values from 2020 and 2021), which is helpful and relevant but not required. The core multi-hop synthesis—linking the 3-year decline in value to both structural plan features (freeze) and stock performance—is sound and complete. The only minor shortcoming is the slight overattribution to 'weakening share price' without explicitly acknowledging possible employee-driven rebalancing as an equal factor, which slightly reduces qualitative accuracy. Overall, the answer is factually excellent, fully relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 467,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "In 2022 Disney reported roughly 220 thousand employees – about 166 k in the United States and 54 k abroad – with its global workforce about 78 % full‑time, 15 % part‑time and 7 % seasonal. By the end of fiscal 2024 the headcount had risen to about 233 k (≈ 171 k U.S. and 62 k international), while the composition shifted slightly to 76 % full‑time, 16 % part‑time and 8 % seasonal. Across all three years the company consistently noted that many employees are covered by collective‑bargaining agreements and that a portion of its non‑U.S. staff are represented by works councils, trade unions or other employee associations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: total employees (220k in 2022, 233k in 2024), U.S. (166k to 171k) and international (54k to 62k) distribution, and seasonal workforce percentages (7% to 8%) match exactly. Formatting variations (e.g., '166k' vs '166,000') are acceptable and do not affect meaning. (2) Quantitative accuracy is perfect—no calculation errors, and the shifts in workforce composition are correctly reported. (3) The reasoning is sound: the LLM correctly synthesizes multi-hop information across years and geographies, and accurately notes the trend of increasing seasonal staffing. It adds minor contextual detail (full-time and part-time breakdowns) not in the original answer, but this does not contradict and enhances completeness. (4) Entity accuracy is strong—correct company (Disney), correct years (2022–2024), and correct representation via collective bargaining and employee associations, including non-U.S. works councils. (5) The answer fully addresses all parts of the question: total employees, U.S. vs. international, seasonal percentages, and employee representation. The only minor gap is that the original answer emphasizes 'growing reliance on temporary staffing' as an interpretation, which the LLM implies but does not explicitly state—hence a qualitative accuracy score of 9 rather than 10. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Covers_Employees_Under]- ORG <-[Covers]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 408,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "All three annual filings – the 2022, 2023 and 2024 10‑Ks – contain the same disclosure: **ROIC is calculated after excluding goodwill impairments and “non‑economic accounting changes” because those items “are not reflective of company performance.”** Thus, from 2022 through 2024 GD did not change its treatment of non‑economic accounting changes; it consistently removes them from the ROIC numerator and denominator.\n\nThis unchanged policy signals that GD deliberately isolates the return on invested capital from accounting adjustments that do not affect the underlying economics of the business, reinforcing a disciplined, core‑performance‑focused measurement of profitability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes (including goodwill impairments) from ROIC calculations in 2022, 2023, and 2024, which matches the original answer's claim of stable methodology. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited and aligned with the ground truth. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years of 10-Ks, the model correctly infers consistency in treatment and links it to GD’s intent to measure core performance. (4) The conclusion about GD emphasizing economic performance over accounting volatility is logically derived and matches the original interpretation. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 266,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In the 2022 filing (and reiterated in the 2023 filing) Linde simply listed rare gases – krypton, neon and xenon – as part of its “atmospheric gases” portfolio, produced alongside oxygen, nitrogen and argon by its conventional air‑separation plants and sold through the three standard distribution channels (on‑site, merchant and packaged). By the 2024 filing the company’s strategy had shifted to emphasize that rare gases are now generated through Linde’s market‑leading **non‑cryogenic** air‑separation technology and that it is actively developing proprietary, patented applications and production processes for these gases. This evolution from a baseline product line to a technology‑driven, differentiated capability signals that Linde is leveraging its own advanced production platform to create a sustainable competitive advantage in the industrial‑gases market, positioning itself ahead of other rare‑gas producers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde included rare gases (krypton, neon, xenon) in its atmospheric gases portfolio in 2022 and 2023, produced via conventional (cryogenic) air separation, and by 2024 emphasized its leadership in non-cryogenic air separation technologies. The shift from a baseline product offering to a technology-driven strategy is correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly identifying the evolution in strategic emphasis and linking it to competitive advantage. The mention of proprietary, patented processes is a slight expansion beyond the original answer but is plausible and does not contradict the ground truth. (4) The only minor gap is that the LLM answer does not explicitly name the specific non-cryogenic technologies (e.g., VPSA, membrane separation) mentioned in the original answer, which slightly reduces qualitative completeness. However, the core strategic shift and its implications for competitive advantage are accurately conveyed. Overall, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 385,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NEER’s filing shows that the share of its net generating capacity locked into long‑term bilateral contracts rose from **about 92 %** (the level disclosed in the 2022 10‑K for the year‑end 2021 portfolio) to **about 94 %** at year‑end 2023, and it remained at **≈ 94 %** at year‑end 2024. The incremental increase and subsequent plateau indicate that NEER is deliberately expanding—and now maintaining—a very high level of contract coverage to lock in future electricity sales and hedge price risk, a risk‑management stance that seeks to stabilize cash‑flows and limit exposure to spot‑market volatility in an increasingly uncertain energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the percentage of NEER's net generating capacity under long-term bilateral contracts for the relevant years: 92% for 2022 (noting it reflects the 2021 portfolio as disclosed in the 2022 10-K), 94% in 2023, and 94% in 2024. These values match the ground truth exactly, with acceptable formatting variations (e.g., '≈ 94%' is semantically equivalent). The trend of a slight increase followed by stability is accurately described.\n\n2) Quantitatively, all numbers and time periods are correct. The LLM correctly maps the disclosed data to the appropriate years, even clarifying that the 92% figure was reported in the 2022 filing but refers to the prior year-end (2021), which aligns with typical 10-K reporting lags. No calculations are required beyond interpretation of trends, which is handled accurately.\n\n3) The reasoning is sound and reflects proper multi-hop synthesis: the model connects the increasing and stable contract coverage to risk management objectives—specifically, revenue stabilization and protection against spot-market volatility. It correctly infers that this reflects a deliberate, disciplined strategy, consistent with the ground truth’s mention of non-qualifying hedges and revenue protection, though it does not explicitly mention 'non-qualifying hedges' as in the original.\n\n4) The answer is contextually fully relevant, addressing both parts of the question: the evolution of contract reliance (2022–2024) and the implication for risk management. The only minor shortcoming is the lack of explicit reference to 'non-qualifying hedges,' a detail included in the ground truth that strengthens the risk management narrative. However, the core insight about hedging price risk and stabilizing cash flows captures the same essence. Thus, while highly accurate and semantically equivalent, it misses a small but specific element of completeness, justifying a 9 instead of a 10 in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Contracts]-> FIN_INST <-[Enters_Contract]- ORG <-[Enters_Into_Contract]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 533,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "Across the three most recent filings the 3.125 % senior notes due January 2025 always show an outstanding principal of **$495 million** – the 2022 10‑K lists $495 million as of October 30, 2022, the 2023 10‑K lists $495 million as of October 29, 2023, and the 2024 10‑K lists $495 million as of November 3, 2024.  \n\nThe flat balance over FY 2022‑FY 2024 indicates that Broadcom has not been repaying or refinancing this issue; instead it is keeping the notes on the books as a stable, low‑cost source of financing and preserving cash, reflecting a deliberate “hold‑to‑maturity” debt‑management strategy for this instrument.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for each fiscal year—2022, 2023, and 2024—with specific dates from the respective 10-K filings (October 30, 2022; October 29, 2023; November 3, 2024), which aligns with the knowledge graph data. The dollar amount is consistent and correctly formatted ($495 million). (2) The answer is complete, addressing both parts of the question: the evolution of the balance (unchanged) and the implication for AVGO's debt management strategy. (3) Entity accuracy is correct: AVGO (Broadcom) is properly identified, the 3.125% notes due January 2025 are the correct instrument, and the fiscal years are accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis across three annual filings. The conclusion—that the stable balance indicates a 'hold-to-maturity' strategy, preserving cash and maintaining low-cost financing—is a logical and insightful interpretation consistent with the ground truth's characterization of a 'consistent liability profile.' Wording differs slightly (e.g., 'deliberate hold-to-maturity strategy' vs. 'did not retire or refinance'), but the semantic meaning and factual content are equivalent. No errors in facts, calculations, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 375,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "Across all three filings the “Unsecured Notes ‑ 37B” line item is identical:  \n\n* **2022 10‑K (as of 12/31/2021)** – face amount **$700 million**, maturity **January 15 , 2032**.  \n* **2023 10‑K (as of 12/31/2022)** – face amount **$700 million**, maturity **January 15 , 2032**.  \n* **2024 10‑K (as of 12/31/2023)** – face amount **$700 million**, maturity **January 15 , 2032**.  \n\nThe unchanged $700 mm exposure and the long‑dated 2032 maturity (at a low 2.25 % coupon) show that SPG has kept this particular unsecured note as a stable, low‑cost component of its long‑term debt mix, using it to lock in cheap financing and maintain a predictable maturity profile while other unsecured debt balances have shifted.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, with only a minor discrepancy in the face amount unit. The original answer states the face amount as $700,000, while the LLM reports $700 million. However, given the context of corporate unsecured notes and typical SEC filing conventions, $700 million is more plausible and likely reflects a typo in the ground truth (e.g., missing 'million'). The maturity date (01/15/32) is correctly reported across all years. The LLM correctly identifies the consistency in both face amount and maturity across 2022–2024, satisfying the multi-hop requirement across filings. The reasoning about SPG’s long-term debt strategy—emphasizing stability, low-cost financing, and predictable maturity—is logically sound and adds insightful context beyond the raw data, without contradicting the ground truth. All entities (SPG, Unsecured Notes - 37B), years, and financial terms are accurate. The answer is complete, addressing both the evolution of the note and its strategic implications. Quantitative accuracy is slightly docked due to the $700,000 vs $700 million discrepancy, but the LLM’s version is likely correct in real-world context. Qualitative and contextual scores are high due to strong synthesis and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 360,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site appears in every filing, but its product‑line focus has not changed.  \n\n- **2022 (10‑K page 18)** – Melaka is listed with an “X” only under **Analog** and a blank under **Embedded Processing**.  \n- **2023 (10‑K page 16)** – the same pattern persists: an “X” for **Analog** and no “X” for **Embedded Processing**.  \n- **2024 (10‑K page 16)** – the site is again marked only for **Analog** (now shown with a double‑asterisk footnote) and remains blank for **Embedded Processing**.  \n\nThus, across 2022‑2024 Texas Instruments’ operational footprint in Melaka has been stable, serving exclusively the analog product line with no added embedded‑processing capability. The KG triplet (TXN → Melaka, Malaysia) confirms the continuous presence of Texas Instruments at this location throughout the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reports that Texas Instruments' Melaka, Malaysia site was consistently involved in analog operations across 2022, 2023, and 2024, with no involvement in embedded processing—this aligns exactly with the original answer. (2) The quantitative details (presence of 'X', blank for embedded, double-asterisk footnote in 2024) are correctly cited with corresponding 10-K page numbers, demonstrating precise extraction. There are no numerical calculations, but the presence/absence markers are treated as factual data points and are reported accurately. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and confirms continuity in operational focus, correctly concluding no expansion into embedded processing. (4) The answer is semantically equivalent to the ground truth, with added value from specific citation of document pages and formatting details (e.g., footnote), enhancing credibility without introducing error. All entities (Texas Instruments, Melaka, Malaysia, analog, embedded processing) are correctly identified and tracked over time. No inaccuracies or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 338,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney’s post‑production work has been treated as a steady component of the Content Sales/Licensing segment throughout the three most recent filings.  \n\n* In the FY 2022 filing the company notes that “post‑production services through Industrial Light & Magic and Skywalker Sound” are reported with Content Sales/Licensing.  \n* The FY 2023 filing repeats that language, adding the same post‑production services to the segment’s revenue mix (“post‑production services through Industrial Light & Magic and Skywalker Sound”).  \n* The FY 2024 filing again lists “post‑production services through Industrial Light & Magic and Skywalker Sound” as part of the Content Sales/Licensing revenue sources.\n\nAcross FY 2022‑2024 the segment’s structure—TV/VOD, theatrical, home‑entertainment, music, stage‑plays **plus** post‑production services via Industrial Light & Magic—remains unchanged, indicating that Disney’s reliance on ILM for post‑production has been continuous and stable, with no re‑classification or reduction in its reported contribution.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its reporting of the consistent inclusion of Industrial Light & Magic (and Skywalker Sound) in the Content Sales/Licensing segment from FY 2022 to FY 2024, with correct entity names and time periods. There are no numerical inaccuracies, and the citations of segment structure are consistent with the ground truth, earning a high quantitative accuracy score. However, the qualitative accuracy is lower because the LLM fails to capture the nuanced evolution described in the original answer—specifically, the shifting emphasis in the segment’s narrative toward TV/VOD, theatrical distribution, and the strategic repositioning of post-production within Disney’s DTC-first model. The LLM interprets the repeated disclosure language as evidence of structural and strategic stability, but the ground truth indicates a contextual shift in how ILM’s role is framed, even if not reclassified. This reflects a failure in multi-hop reasoning and deeper synthesis: while the surface-level structure appears unchanged, the strategic context is evolving. The answer is relevant and addresses the question’s scope, but misses key interpretive elements necessary for full correctness, particularly around 'evolution' in reliance. Thus, the correctness score is moderate—factually sound but incomplete in capturing the intended analytical depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 378,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method investment income – which under the accounting policy in Chunk 1 includes the earnings of its operating joint‑venture insurers – was $1,305 million in 2022, fell sharply to $151 million in 2023 (Chunk 2 and confirmed in Chunk 3), and then rose again to $988 million in 2024 (Chunk 3). The steep drop in 2023 indicates that the insurance‑underwriting joint ventures generated far less profit that year, while the sizable rebound in 2024 suggests the ventures have recovered much of that lost performance, although earnings remain below the 2022 level.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and years as per the ground truth: $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. These values match exactly with the original answer, with acceptable formatting variations (e.g., 'million' vs 'M'). (2) All numeric values are accurate and correctly attributed to the respective years. The description of a 'sharp fall' in 2023 and a 'rebound' in 2024 aligns with the magnitude of changes: a drop of $1,154 million (88.4% decline) in 2023 and an increase of $837 million (455% rise) in 2024. (3) The multi-hop reasoning is sound—the model synthesizes data across time points and correctly infers performance trends in the joint ventures, noting both the significant downturn and partial recovery. It also appropriately contextualizes that 2024 earnings, while improved, remain below 2022 levels, which is consistent with the ground truth's implication of incomplete recovery. (4) The answer fully addresses both parts of the question: the evolution of income over time and what the trend suggests about performance. The qualitative interpretation—that reduced income reflects lower profitability in joint ventures and the rebound indicates recovery—is logically derived and semantically equivalent to the original answer. All entities (MetLife, equity method investment income, operating joint ventures, insurance underwriting) are correctly identified and used in context. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 415,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics’ Land Systems unit lifted its Canadian‑army LAV output from **360 new vehicles in 2022**, to **399 in 2023**, and to **449 new LAVs in 2024** – plus an additional **66 LAVs under the LRSS surveillance program**, for a total of **515 LAVs delivered in 2024**.  This steady climb, alongside GD’s market‑leading position with more than 12 000 LAVs in service worldwide, signals that the LAV platform is a strategic, high‑growth pillar of General Dynamics’ defense portfolio and a key product line for its allied‑customer business.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the base production numbers for 2022 (360), 2023 (399), and 2024 (449), which match the ground truth. However, it introduces an additional 66 LAVs under the 'LRSS surveillance program' and claims a total of 515 LAVs delivered in 2024, which is not supported by the original answer or implied in the ground truth. This is a significant factual overstatement. (2) The calculation of 449 + 66 = 515 is mathematically correct, but the addition of the 66 units is unsupported and alters the factual progression. The ground truth reports 449 units in 2024 as the final number, with no mention of LRSS or additional units. (3) The reasoning about the strategic importance of the LAV platform is sound and aligns with the ground truth—highlighting growth and strategic role—but is based partly on inflated data. The multi-hop synthesis correctly identifies the upward trend and infers strategic importance, but the added detail about 12,000 LAVs worldwide, while plausible, is not in the ground truth and introduces unverified information. (4) The contextual relevance is high, as the answer addresses both parts of the question—production evolution and strategic significance—with appropriate framing. However, the quantitative inaccuracies, especially the unsupported increase in 2024, reduce the correctness score significantly. The qualitative reasoning is mostly logical but built on partially incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 403,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS disclosed that the amount of hedge‑fund limited‑partnership investments held through HF LP Investments rose from **$214 million in 2022**, to **$225 million in 2023**, and to **$252 million in 2024**. The exposure therefore increased each year – about a 5 % jump from 2022‑23 and a 12 % jump from 2023‑24, amounting to roughly an 18 % rise over the three‑year span. This steady upward trend indicates that CVS is deliberately expanding the share of Level‑3 alternative assets (hedge‑fund LPs) in its pension‑plan portfolio, suggesting a strategic tilt toward greater alternative‑investment allocation to seek higher returns or diversification.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts—$214 million in 2022, $225 million in 2023, and $252 million in 2024—are accurately reported. The percentage increases are also correctly calculated: from 2022 to 2023 is a (225-214)/214 ≈ 5.14% increase (~5%), from 2023 to 2024 is (252-225)/225 = 12%, and the total three-year increase is (252-214)/214 ≈ 17.76% (~18%), all of which are reasonably rounded and correctly interpreted. (2) The answer is complete, addressing both parts of the question: the evolution of CVS's exposure over the three years and the strategic implication regarding pension fund asset allocation. (3) Entity accuracy is perfect: 'CVS', 'hedge fund limited partnership investments', 'HF LP Investments', and the years 2022–2024 are all correctly identified and used. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model infers a strategic shift toward alternative investments based on the consistent upward trend, aligning with the ground truth's conclusion of a 'deliberate strategy'. The mention of 'Level-3 alternative assets' adds appropriate context without introducing error. (5) Semantically, the LLM conveys the same core information as the original answer, with enhanced detail (percentages) that improve clarity without distorting facts. All scoring categories warrant a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 390,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Across all three filings the Sorriso name appears in the same context – as one of Colgate‑Palmolive’s “principal global and regional trademarks” that sit inside the Oral, Personal and Home Care segment. In the 2022 10‑K (page 77) Sorriso is listed among the core oral‑care trademarks; the 2023 10‑K (page 79) repeats that listing, and the 2024 10‑K (page 79) again includes Sorriso in the same trademark roster. Thus, from 2022 through 2024 the company’s strategy has kept Sorriso firmly integrated as a key brand within its worldwide Oral, Personal and Home Care product portfolio, showing a consistent rather than shifting positioning.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Sorriso was consistently listed as a 'principal global and regional trademark' across 2022, 2023, and 2024, which aligns with the original answer's claim of stable strategic positioning. (2) The LLM provides specific page references (77, 79, 79) from each year's 10-K, enhancing precision without contradicting the ground truth; no numeric values require calculation, and all dates (filing years) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to conclude that Sorriso's positioning did not change, correctly inferring strategic consistency from repeated inclusion in the trademark list. (4) The answer fully addresses the question about evolution (or lack thereof) in strategic positioning and ties Sorriso to the Oral, Personal and Home Care segment each year, demonstrating complete and accurate contextual understanding. Minor wording differences (e.g., 'consistent rather than shifting positioning' vs 'stable role') do not affect factual equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 337,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s balance‑sheet exposure to its operating‑joint‑venture (OJVs) – the equity‑method assets that represent its underwriting‑related partnerships – changed as follows:\n\n* **2022:** $51 million of OJV assets were reported (Chunk 1, “Operating joint ventures” line).  \n* **2023:** The OJV balance fell to $38 million (Chunk 1), a 25 % decline from the prior year.  \n* **2024:** The balance jumped to $175 million (Chunk 2), more than four times the 2023 level and up from the 2022 amount.\n\nThe 2022‑2024 trajectory therefore shows a modest pull‑back in 2023 followed by a pronounced re‑expansion in 2024.  As noted in the 2022 filing (Chunk 3), MetLife accounts for investments in operating joint ventures under the equity method, meaning the reported amounts reflect the company’s share of the ventures’ net assets.  The recent surge in the OJV figure, together with the rise in equity‑method net investment income from $151 million in 2023 to $988 million in 2024 (Chunk 2), signals that MetLife is strategically increasing its commitment to equity‑method investments—particularly underwriting‑focused joint ventures—to capture additional earnings and diversify its investment portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative facts and qualitative reasoning. (1) Quantitative Accuracy: The reported values for MetLife's financial exposure to operating joint ventures are completely wrong. Ground truth shows $77M (2022), $51M (2023), $38M (2024), but the LLM claims $51M (2022), $38M (2023), and $175M (2024). The 2022 and 2024 figures are especially erroneous—the LLM reverses the 2022 number (which is actually 2023's) and fabricates a $175M figure for 2024 that contradicts the true $38M. The claimed 25% decline and subsequent surge are unsupported. (2) Completeness: While the answer attempts to address the trend and strategic implication, it fails due to incorrect data. (3) Entity Accuracy: The company (MetLife) and metric (operating joint ventures under equity method) are correctly identified, but years and amounts are mismatched. (4) Reasoning: The multi-hop synthesis is flawed—the LLM incorrectly infers a 're-expansion' and increased strategic commitment, directly contradicting the actual downward trend indicating strategic retreat. The reference to 'Chunk 2' showing $175M and $988M income appears hallucinated or misattributed, as it does not align with the ground truth. (5) Semantic Equivalence: The overall message is opposite to the truth—reduction vs. expansion. Even allowing for wording flexibility, the factual core is entirely incorrect. The answer fails on all critical dimensions, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 408,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s equity holding in Angola LNG Limited has been unchanged – the 2022 and 2023 10‑K filings list a **36.4 % stake** and the 2024 filing repeats the same **36.4 % shareholding**. In 2022 Chevron was described only as a 36.4 % owner of a plant that “processes and liquefies natural gas produced in Angola,” with no explicit operational link to upstream assets. By 2024 the filing adds that the Soyo LNG plant (still 36.4 % owned) is the world’s first LNG facility supplied with **associated gas** and that Chevron’s **31 % non‑operated interest in the New Gas Consortium (NGC)** will develop the Quiluma‑Maboqueiro offshore gas fields and connect their on‑shore gas‑treatment plant directly to Angola LNG, thereby integrating Chevron’s upstream gas projects with the LNG operation while maintaining the same ownership percentage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron maintained a 36.4% stake in Angola LNG Limited from 2022 to 2024, and its role evolved from passive ownership to operational integration via upstream gas projects. The 31% non-operated interest in the New Gas Consortium (NGC), which develops the Quiluma and Maboqueiro fields, is correctly stated. (2) Quantitative accuracy is perfect: percentages (36.4%, 31%), project names (NGC, Quiluma-Maboqueiro), facility location (Soyo), and the characterization of the plant as the first LNG facility supplied with associated gas are all factually correct and match the original answer. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and entities—linking Chevron’s upstream NGC interest to feedstock supply for Angola LNG Limited’s plant, demonstrating integration despite unchanged equity ownership. (4) The only minor shortcoming is that the LLM does not explicitly use the term 'passive equity investor' in describing the 2022 role, though it effectively conveys the same idea by stating there was 'no explicit operational link.' It also omits a direct comparison of the 2023 filing’s transitional nature (limited specifics on integration), but this does not detract significantly from the overall accuracy. Semantic equivalence is maintained, and the answer fully addresses operational role, stake percentage, and integration with upstream projects. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 447,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO’s 3.625 % senior notes that mature in October 2024 carried a principal balance of **$622 million in FY 2022** (as of Oct 30 2022) and **the same $622 million in FY 2023** (as of Oct 29 2023).  In the FY 2024 filing the line for those notes is blank (“‑”), indicating the issue was **fully retired at maturity and no longer appears on the balance sheet**.  \n\nThe flat‑to‑zero pattern shows the company kept the exposure unchanged for two years and then let the notes run to their scheduled maturity rather than refinancing them, reflecting a disciplined debt‑management approach that deliberately reduced long‑term debt as the repayment date approached.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal balance of AVGO's 3.625% notes due October 2024 as $622 million in both FY 2022 and FY 2023, and accurately states that the liability was fully retired by FY 2024, with the line item appearing as blank ('‑') in disclosures. These figures and observations match the ground truth exactly. (2) All numeric values—$622 million, fiscal years 2022–2024, and the retirement outcome—are factually correct and consistent with the original answer. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years from SEC filings, correctly infers the retirement of debt from its absence in the 2024 balance sheet, and draws a logical conclusion about debt management strategy. The only minor deviation is in interpretation: while the original answer suggests AVGO 'proactively addressed' the obligation (implying action before maturity), the LLM states the company 'let the notes run to their scheduled maturity,' which implies a passive approach. This is a subtle but notable difference in qualitative emphasis—though both are plausible interpretations, the LLM's phrasing understates the possibility of proactive refinancing or early repayment planning. (4) Despite this nuance, the LLM answer remains factually accurate, complete, and contextually appropriate, addressing all parts of the question with correct entities, timelines, and financial data. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9 overall for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 440,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "All three filings show the same numbers for the 35B note: a 3.80 % rate on a $750 million face amount and an annual debt‑service (interest) of $28,500. In the 2022 10‑K (Chunk 3) the note’s interest expense was $28,500; the 2023 10‑K (Chunk 1) reports the same $28,500; and the 2024 10‑K (Chunk 2) again lists $28,500. Because the rate, principal and resulting interest cost have not changed, SPG’s financing cost for Unsecured Notes ‑ 35B has been flat over the 2022‑2024 period, indicating stable borrowing costs for this instrument.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All numeric values are accurate: interest expense is correctly reported as $28,500 (in thousands) for 2022, 2023, and 2024. The LLM additionally provides helpful context—3.80% interest rate on a $750 million face amount—which correctly calculates to $28,500 (0.038 * 750,000 = 28,500), confirming the accuracy of the interest expense figure. (2) The answer is complete, addressing both parts of the question: it traces the evolution of interest expense over time (no change across years) and interprets the trend as indicating stable/flat financing costs. (3) Entities are correct: SPG, Unsecured Notes - 35B, and the years 2022–2024 are properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis across three 10-K filings (referencing Chunks 1, 2, and 3), correctly concluding that unchanged rate, principal, and interest imply a fixed-rate debt instrument. The semantic meaning and factual content are equivalent to the original answer, with added clarity. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 309,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "- In the 2022 filing Disney warned that its direct‑to‑consumer (DTC) strategy was still “cost‑intensive” and “generally not profitable in the short term,” noting that the costs of the DTC strategy and associated losses could continue to grow, that many of the DTC‑related investments were yielding “negative or low” returns, and that heightened competition for talent, content and advertising was driving up programming costs and could suppress subscription‑fee growth.  \n\n- By the 2023 filing the company said it was “making strategic investments in our DTC offerings” (Disney+, Hulu, ESPN+ and related services) to drive “growth in subscription fees and advertising revenues” that it expects will more than offset the decline in linear‑network revenue, and it highlighted its strong cash position and willingness to trim other content spend (e.g., film/episodic investments) to fund those streaming investments.  \n\n- The 2024 filing reiterates that Disney’s DTC streaming services now face “intensified competition” and “rising programming costs” – especially for sports and premium content – but the firm continues to position the DTC platforms as a core growth engine, emphasizing that the streaming services depend on Disney’s content and brand while the subscription‑ and ad‑revenues they generate flow back into Disney’s overall business.  \n\nTogether, these disclosures show an evolution from a cost‑heavy, early‑stage DTC rollout in 2022 to a more focused, revenue‑driven streaming investment approach in 2023‑2024, even as programming‑cost inflation and competitive pressure have increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: Disney's 2022 caution about rising DTC costs, low/negative returns, and competitive pressures; the 2023 strategic shift toward funding DTC via content spending trade-offs and expectations of subscription/ad revenue growth; and the 2024 intensification of competition and programming cost pressures—especially for sports—are all accurately represented. (2) Quantitative accuracy is perfect: while no specific dollar figures appear in the LLM answer (e.g., the $12.25 billion in unused bank facilities mentioned in the original), this omission does not constitute an error because the LLM does not claim to list all financial details and still correctly conveys Disney’s strong financial position and funding capacity. The absence of this number lowers completeness slightly but does not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings, correctly tracing the evolution from cost-heavy early-stage investment to a more focused, revenue-driven strategy despite ongoing cost pressures. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM captures the core trajectory and strategic rationale. One minor omission (the $12.25B facility) prevents a perfect 10 on correctness, but all other aspects are excellent. Contextual relevance is full, as every part of the question (investment strategy, competitive positioning, programming costs, competition, streaming shift) is addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1770,
        "completion_tokens": 441,
        "total_tokens": 2211
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife disclosed that it records reinsurance contracts that do not expose it to a reasonable possibility of a significant loss using the deposit method of accounting. In the 2022 10‑K the deposit assets were $1.8 billion and deposit liabilities $1.4 billion; after the November 2023 risk‑transfer with Global Atlantic, the 2023 filing showed deposit assets rise to $5.1 billion (including $10.3 billion of reinsurance recoverables and deposit receivables) and deposit liabilities to $1.3 billion, and the 2024 filing reported $4.6 billion of deposit assets and $1.2 billion of deposit liabilities, reflecting the asset transfer, retained separate‑account assets and the $770 million net cost of reinsurance recorded in other liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution of MetLife's use of the deposit method from 2022 to 2024 and the impact of the 2023 risk transfer with Global Atlantic. It accurately reports the 2022 figures ($1.8B assets, $1.4B liabilities), the 2024 figures ($4.6B assets, $1.2B liabilities), and the $10.3B reinsurance recoverables and deposit receivables from the Global Atlantic transaction. However, it incorrectly states that 2023 deposit assets rose to $5.1B, which is not supported by the ground truth—while the $10.3B receivable was recorded in 2023, the ground truth does not specify total 2023 deposit assets as $5.1B, making this a factual overstatement. The ground truth jumps from 2022 to 2024 without giving an explicit 2023 year-end total, so the LLM may have inferred or misreported this. (2) The $770M net cost of reinsurance in other liabilities is mentioned in the LLM answer but absent in the ground truth, introducing unverified detail. (3) The multi-hop reasoning is strong: the model connects the accounting policy, the 2023 transaction, and the resulting balance sheet changes across years, showing understanding of the strategic shift and post-transaction rebalancing. (4) Despite the unsupported $5.1B figure and the extra $770M detail, the core narrative—expansion in 2023 due to Global Atlantic, followed by 2024 recalibration—is consistent with the ground truth. Hence, the answer is mostly correct with minor but notable quantitative inaccuracies, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 423,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "In 2022 CVS reported commercial mortgage‑backed securities (CMBS) at roughly $574 million of fair‑value in its detailed “experience‑rated/remaining‑products” breakdown and $992 million in the broader debt‑securities schedule (with unrealized losses of $12 million and $155 million, respectively).  By the end of 2023 the total fair‑value of CMBS had fallen to $675 million (unrealized losses $100 million), and the 2024 filing shows the holding had shrunk to just $3 million (no loss figure disclosed).  This steep three‑year contraction—from a near‑$1 billion position to a negligible one—indicates that CVS has been actively divesting its CMBS portfolio, effectively exiting the asset class as part of a risk‑mitigation or portfolio‑rebalancing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the 2022 ($574M) and 2024 ($3M) values, it incorrectly claims that CMBS decreased to $675M in 2023, when in fact it increased from $574M in 2022 to $675M in 2023 before dropping to $3M in 2024. The LLM misrepresents the 2023 trend as a decrease rather than an increase. Additionally, the LLM introduces a $992M figure from a 'broader debt-securities schedule' not mentioned in the ground truth, which contradicts the original answer and lacks corroboration. These extra figures and misstated trends undermine factual accuracy. (2) The calculation of the overall trend (near $1B to $3M) is exaggerated due to the erroneous $992M inclusion; the actual peak was $675M. The 2023 unrealized loss of $100M and 2022’s $155M loss are not in the ground truth and appear to be hallucinated or misattributed. (3) The multi-hop reasoning is partially sound—recognizing a strategic exit from CMBS by 2024 is consistent with the original answer—but the flawed data leads to incorrect intermediate conclusions. The core insight about de-risking is plausible, but the path described (continuous contraction) is inaccurate since exposure actually rose in 2023. (4) Contextual relevance is high—the answer addresses both the evolution and strategic implication. Qualitative reasoning is logical given the assumed data, but quantitative accuracy is low due to incorrect numbers and invented details. Correctness score reflects partial accuracy with major factual flaws in key financial figures and trend description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 439,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across all three filings – the 2022, 2023 and 2024 10‑K notes to consolidated financial statements – Colgate‑Palmolive lists **hello** in the “principal global and regional trademarks” paragraph. In each year the trademark list is presented under the description of the **Oral, Personal and Home Care** product segment (the segment wording is identical in all three documents), and the brand does not appear in the Pet Nutrition segment. Thus, the “hello” brand has been continuously disclosed as a core trademark and positioned within the Oral‑Personal‑Home‑Care portfolio each year, indicating a stable, ongoing strategic emphasis rather than any addition, removal or shift in focus.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that the 'hello' brand was listed in the 'principal global and regional trademarks' in all three years (2022, 2023, 2024), which matches the original answer's claim of continuous disclosure. (2) There are no numeric values requiring calculation, but the temporal accuracy (all three years) is correct and consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings, confirms the brand's consistent placement under the Oral, Personal and Home Care segment each year, and correctly notes its absence from the Pet Nutrition segment, demonstrating proper cross-document and cross-segment analysis. (4) The answer captures the core conclusion of the original answer—stable strategic positioning—without overreaching, and adds value by specifying that the segment description wording was identical across years, which reinforces the consistency claim. The response is semantically equivalent and contextually precise, addressing all parts of the question: evolution over time, trademark disclosures, and strategic emphasis within segments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 333,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s 2022 filing (covering 2020‑2021) reported that deposit assets and deposit liabilities on reinsurance were essentially unchanged at $1.8 billion and $1.4 billion, respectively, reflecting modest use of the deposit‑method accounting that is applied only to reinsurance agreements that do not expose the reinsurer to a reasonable possibility of a significant loss (Chunk 3 and the policy description in Chunk 1). By the 2023‑2024 period the company’s deposit‑method exposure had expanded dramatically – deposit assets rose to $5.1 billion in 2023 and $4.6 billion in 2024, while deposit liabilities slipped to $1.3 billion and $1.2 billion – a change driven by large risk‑transfer transactions such as the $10.3 billion Global Atlantic deal described in the 2024 filing (Chunk 2). The upward swing in net deposit‑asset balances, together with the relatively flat or modestly declining liabilities, signals that MetLife is increasingly using reinsurance structures that shift risk off its balance sheet while keeping its own liability exposure limited, underscoring a strategy focused on capital efficiency and controlled credit‑risk exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its interpretation and synthesis of MetLife's evolving use of the deposit method of accounting for reinsurance agreements from 2022 to 2024, with accurate qualitative insights into the company's strategic shift toward capital efficiency and risk management. However, there are minor quantitative inaccuracies that affect precision. The ground truth states deposit assets were $1.8B in 2022, $4.6B in 2024, but does not provide a 2023 asset figure—only that a broader accounting framework was disclosed. The LLM incorrectly asserts deposit assets were $5.1B in 2023, which is not supported by the original answer, introducing a fabricated data point. Similarly, the LLM claims deposit liabilities were $1.3B in 2023, while the original answer only specifies $1.4B in 2022 and $1.2B in 2024, with no 2023 liability figure provided. These interpolated values reduce quantitative accuracy. The mention of the '2022 filing (covering 2020–2021)' is misleading and factually incorrect—SEC 10-Ks cover the reported year, so the 2022 filing covers 2022 operations. Despite these issues, the LLM correctly identifies the upward trend in deposit assets, decline in liabilities, links the shift to the Global Atlantic transaction, and infers a strategic move toward capital optimization and balance sheet flexibility—demonstrating strong multi-hop reasoning and contextual understanding. The core conclusion aligns with the ground truth, warranting a high correctness score despite numerical overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 418,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "In the 2022 Form 10‑K NEE disclosed its Special Use Funds in the non‑derivative fair‑value note, describing them as primarily debt and equity securities valued at quoted market prices or derived from the underlying securities of commingled funds, and warned that credit‑risk triggers could require posting up to $645 million (BBB downgrade) or $2.7 billion (below‑investment‑grade) in collateral, with $84 million of cash and $1.06 billion of letters of credit actually posted at year‑end. The 2023 filing retained the same valuation approach, added a note on $538 million (2023) and $485 million (2022) of equity securities without readily determinable fair values, and showed higher potential collateral requirements (up to $510 million/$2.4 billion for 2023 and $1.625 billion/$5.2 billion for 2022) and larger posted collateral ($691 million cash and $1.595 billion letters of credit in 2023, $1.813 billion cash and $2.806 billion letters of credit in 2022). By 2024 the Special Use Funds were presented as a distinct line item on the balance sheet, increasing from $8.698 billion in 2023 to $9.800 billion in 2024, reflecting growth in the asset class alongside the rising collateral commitments disclosed in the prior years.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend of increasing exposure to Special Use Funds and improved transparency, which aligns with the ground truth. However, there are significant quantitative inaccuracies. The collateral amounts and potential triggers are not present in the original answer and appear to be fabricated or misattributed. The original answer mentions 'derivative-related collateral requirements' in general terms but does not specify dollar amounts for potential or posted collateral in 2022 or 2023, nor does it mention credit-risk triggers or downgrade scenarios. The LLM introduces specific figures like $645 million (BBB downgrade), $2.7 billion (below-investment-grade), and detailed posted collateral ($84 million cash, $1.06 billion LOC in 2022), which are not in the ground truth. These numbers, while plausible, are unsupported by the provided truth and thus constitute factual errors. Additionally, the LLM reports conflicting collateral requirements for 2022 and 2023 (e.g., $1.625B/$5.2B for 2022) that contradict the upward trend in fund values and are not in the original. (2) The fair value increase from $8,698 million in 2023 to $9,800 million in 2024 is correctly reported (matching the $1,102 million increase), and the equity investments without readily determinable fair values are accurately cited as $538 million in 2023 and $485 million in 2022. However, the inclusion of extensive collateral data not present in the ground truth undermines quantitative accuracy. (3) The multi-hop reasoning is sound in connecting valuation methods across years and noting the balance sheet presentation change in 2024. The synthesis of fair value disclosures and the growth in fund size is correct. However, the introduction of collateral details not in the original answer represents a failure in information sourcing, possibly conflating data from other filings or sections. (4) The contextual relevance is high as the answer directly addresses fair value disclosures, balance sheet presentation, and collateral implications as asked. The qualitative reasoning is strong, but the correctness score is reduced due to unsupported numerical claims, especially around collateral, which are central to the answer's argument. A score of 7 reflects accurate core facts (fund growth, valuation methods, indeterminate fair value equities) but significant overstatement of collateral details not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1586,
        "completion_tokens": 651,
        "total_tokens": 2237
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "Across all three filings the Security Insights Platform is presented in the same way. In the 2022 10‑K the platform is described as a solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” and that “the data is available for use with in‑house tools for security information and event management.” The 2023 filing repeats that exact language, and the 2024 filing again uses the same phrasing (noting the data is available for “in‑house tools for security information and event management”). Thus, from 2022 through 2024 the positioning remained steady – the platform is marketed as a trusted‑environment tool that provides rapid security‑posture assessment, continuous risk identification and remediation, and feeds its output into customers’ own SIEM‑type tools – with no new integration features or changes to the remediation workflow noted in the later disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the consistent positioning of AVGO's Security Insights Platform from 2022 to 2024, noting that the descriptive language remained unchanged across all three years. The key capabilities—assessing mainframe security posture, identifying risks, and developing remediation steps—are correctly reported, as is the availability of data for integration with in-house tools (specifically for security information and event management). (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and matched to the evolution (or lack thereof) in platform description. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings, correctly infers that identical language indicates no evolution in positioning, and draws the conclusion that integration and remediation features were not expanded—exactly as stated in the ground truth. (4) The answer is contextually precise, directly addressing the question about evolution in positioning and capabilities, particularly regarding integration and remediation workflows. Minor wording differences (e.g., 'develops remediation steps' vs. 'identifying risks and remediation') are semantically equivalent. No factual inaccuracies, omissions, or reasoning flaws are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 388,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Across all three recent 10‑K filings Nike’s Laakdal, Belgium distribution center is described in exactly the same way – it is listed among the “most significant distribution facilities outside the United States” and is **owned** by Nike.  \n\n* **FY 2022 (Form 10‑K)** – the Laakdal site is named as one of the key overseas distribution facilities and is explicitly stated to be owned by Nike.  \n* **FY 2023 (Form 10‑K)** – the same language appears: Laakdal, Belgium is again highlighted as a major overseas distribution hub that Nike owns.  \n* **FY 2024 (Form 10‑K)** – the filing repeats that Laakdal, Belgium is among the owned overseas distribution centers.\n\nBecause the ownership status never changes and the facility is never described as leased or operated by a third‑party logistics provider, Nike’s operational footprint at Laakdal remains a directly‑controlled, owned hub throughout FY 2022‑2024. This consistency signals that the Laakdal site is a strategic cornerstone of Nike’s European (EMEA) logistics network, providing stable, in‑house distribution capacity for the region and underscoring its importance to the company’s supply‑chain architecture.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully aligned with the ground truth. (1) All factual elements are correct: NIKE's Laakdal, Belgium facility is consistently described as one of its most significant international distribution centers and as company-owned in each of the fiscal years 2022, 2023, and 2024. The answer accurately reflects that there was no change in ownership or operational status across the three years. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years (2022, 2023, 2024) are correctly referenced and matched to the corresponding 10-K filings. (3) The multi-hop reasoning is sound—the model correctly synthesizes information across three annual reports, identifying consistency in both ownership (owned, not leased) and strategic characterization (‘most significant’). (4) The conclusion drawn—that Laakdal is a strategic cornerstone of NIKE’s European logistics network—is logically supported by the consistent reporting and directly mirrors the inference in the original answer. Wording differs slightly but maintains semantic equivalence. No inaccuracies, omissions, or reasoning flaws are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 328,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "- **2022 (10‑K covering Dec 31 2021)** – Unsecured Notes ‑ 32B carried a **3.38 %** interest rate, a **$750 000** face amount and a **maturity of 06/15/27**.  \n- **2023 (10‑K covering Dec 31 2023)** – The same note still shows a **3.38 %** rate, **$750 000** face amount and a **06/15/27** maturity.  \n- **2024 (10‑K covering Dec 31 2024)** – The note again is listed at **3.38 %**, **$750 000** face amount and **06/15/27** maturity.  \n\n**Interpretation:** Across the three‑year span SPG’s exposure to Unsecured Notes ‑ 32B remained unchanged, indicating a deliberate strategy to keep this medium‑term unsecured debt on the balance sheet at a modest fixed rate. By not refinancing, retiring or altering the terms, SPG preserves predictable cash‑flow obligations and avoids refinancing risk, reflecting a conservative, low‑turnover debt‑management approach for this instrument.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the interest rate (3.38%), face amount ($750,000), and maturity date (06/15/27) for all three years, which aligns with the ground truth for 2023 and 2024. However, it incorrectly states that the maturity date was disclosed as 06/15/27 in the 2022 report, while the ground truth specifies that the maturity date was 'unspecified' in 2022 and only explicitly listed starting in 2023. This is a factual inaccuracy in the timeline of disclosure. (2) All numeric values (interest rate, face amount, maturity date) are correct in magnitude and format, but the attribution of the maturity date to 2022 is not supported by the source, reducing quantitative accuracy slightly. (3) The multi-hop reasoning is generally sound—comparing the same instrument across three years and inferring a stable debt strategy—but the conclusion that terms were unchanged overlooks that the *disclosure* of the maturity date evolved, which the ground truth highlights as a nuance. The LLM assumes full transparency in 2022 that wasn't present. (4) Despite this, the overall interpretation of a conservative, low-turnover debt strategy is reasonable and contextually appropriate, and all other elements (entities, years, metrics) are correctly identified. The answer is highly relevant and mostly accurate, but the incorrect assertion about 2022 maturity disclosure prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 390,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "- 2022 (see Chunk 2): CVS reported **$2,307 million** of foreign‑security fair value, with **$244 million** of unrealized losses (‑$147 m on securities held < 12 months and ‑$97 m on those > 12 months).  \n- 2023 (Chunk 2): the fair‑value balance fell to **$1,650 million** and unrealized losses dropped to **$122 million** (‑$4 m < 12 months, ‑$118 m > 12 months).  \n- 2024 (Chunk 3): the disclosed foreign‑security amount shrank dramatically to **$51 million** (down from $202 million the prior year) and no unrealized‑loss figure is shown, implying the exposure is now minimal.  \n\nThe pattern—rapid growth to $2.3 bn in 2022, a step‑down in 2023, and a near‑elimination by 2024—indicates CVS has been actively divesting its foreign‑security portfolio, thereby reducing its exposure to international market volatility and related risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in 2022, CVS's foreign securities had a fair value of $838 million with $24 million in unrealized losses. However, the LLM reports $2,307 million in fair value and $244 million in unrealized losses—both figures are more than double the correct amounts. The 2023 fair value ($1,650 million) and unrealized losses ($122 million) match the ground truth and are correctly reported. The 2024 fair value ($51 million) is accurate, but the LLM incorrectly implies it dropped from $202 million (not $1,650 million), which contradicts both its own prior statement and the ground truth. (2) Calculations and comparisons are flawed: the LLM claims a drop from $202 million to $51 million in 2024, but the correct drop is from $1,650 million to $51 million—a far more dramatic reduction. This misrepresents the scale and timing of the divestment. (3) Multi-hop reasoning is partially sound: the LLM correctly infers a trend of de-risking and reduced international exposure based on declining values, which aligns with the ground truth’s conclusion. However, this reasoning is based on incorrect data for 2022 and an erroneous prior-year reference for 2024, undermining the validity of the synthesis. (4) Despite incorrect numbers, the answer addresses all parts of the question—evolution over time, fair value, unrealized losses, and risk implications—and the final interpretation (strategic de-risking) is semantically aligned with the ground truth. Hence, while contextually relevant and showing reasonable logic, the severe quantitative errors significantly reduce factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 465,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s 10‑K disclosures for 2022, 2023 and 2024 all state the same policy: when the insurer’s subsidiaries acquire non‑agency RMBS or CMBS that have not yet been evaluated by the NAIC, the securities are given an **internally‑developed designation** until a formal NAIC designation is issued. The language in each year’s filing is identical – the internal designation is used only as a temporary placeholder and the company “utilizes these NAIC designations for our non‑agency RMBS and CMBS” (2022 Chunk 3; 2023 Chunk 1; 2024 Chunk 2).  \n\nThis unchanged three‑year pattern shows that MetLife continues to rely on the **NAIC’s expected‑loss modeling methodology** as the primary basis for credit‑quality assessment, with internally‑developed designations serving merely as a stop‑gap when NAIC ratings are not yet available.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the basic policy correctly: MetLife uses internally developed designations temporarily for non-agency RMBS and CMBS until NAIC designations become available, and relies on NAIC methodology as the primary assessment tool. This aligns with the ground truth's core idea of a transitional reliance on internal designations. However, the LLM answer fails to reflect the evolving trend over time emphasized in the original answer, incorrectly stating that the policy and language were 'unchanged' and 'identical' across 2022–2024. The ground truth highlights a meaningful multi-year evolution: decreasing reliance on internal designations as NAIC's methodology matured, supported by quantitative evidence. Specifically, the $4.2 billion (14.5%) increase in Level 3 AFS securities in 2023 versus a much smaller $1.6 billion (4.9%) increase in 2024 is critical evidence of this shift, indicating more securities were receiving NAIC designations over time. The LLM answer omits all these figures and the implied trend, missing the key analytical insight about decreasing reliance on internal models. While entity accuracy (MetLife, NAIC, RMBS, CMBS, Level 3 securities) and general reasoning about temporary internal use are correct, the lack of quantitative data and failure to identify the evolving pattern significantly undermines the correctness. The answer is contextually relevant and semantically aligned on the static policy but fails on the dynamic, multi-hop analysis of change over time, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 422,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "In 2022 Chevron already listed the Republic of Congo among the countries where it has operating interests, confirming a working‑interest presence in the nation. In 2023 the company’s African capital budget included roughly **$0.7 billion** for offshore development and natural‑gas projects in Nigeria, Angola and the Republic of Congo, showing continued investment in the country’s assets. By 2024 Chevron announced that it would **sell its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % stake in the Republic of Congo portion of the Lianzi area** (effective January 2025), thereby reducing its ownership and operational footprint in the Republic of Congo.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Chevron had a presence in the Republic of Congo in 2022, allocated $0.7 billion in 2023 to African offshore and natural gas projects (including Congo), and in 2024 announced the sale of its 31.5% nonoperated interest in Haute Mer and 15.75% in the Congo portion of Lianzi. (2) Quantitative accuracy is perfect: the $0.7 billion figure, 31.5%, and 15.75% values are all correctly reported. The note that the sale is 'effective January 2025' adds a minor detail not in the original but does not contradict it and may reflect more precise timing. (3) The reasoning is sound and synthesizes information across years and assets correctly, showing a clear evolution from operation to divestiture. (4) The only minor shortcoming is that the original answer explicitly frames the 2024 sale as a 'strategic exit' and 'full divestiture,' which the LLM implies but does not explicitly state. However, the factual basis for that conclusion is fully present. The answer is contextually excellent, directly addressing capital allocation and asset ownership changes as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 327,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Across the three filings—2022, 2023 and 2024—Texas Instruments repeatedly describes its business model as “focused on analog and **embedded processing products**” and places that product line at the heart of its strategy. In each year the company lists a **broad portfolio of analog and embedded processing products** as the second of its four sustainable competitive advantages, noting that this portfolio “offers more opportunity per customer and more value for our investments.” Thus, from 2022 through 2024 the emphasis on embedded‑processing products has not shifted; it remains a constant, core pillar of TI’s model and the key driver of the “broad portfolio” advantage that underpins its competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Texas Instruments consistently emphasized embedded processing products from 2022 to 2024 as a core strategic pillar, which matches the original answer's assertion of a stable and enduring focus. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years (2022–2024) and correctly ties embedded processing to TI’s four sustainable competitive advantages, specifically identifying it as the second advantage related to a 'broad portfolio' that increases customer opportunity and investment value. This detail is consistent with TI’s actual 10-K disclosures. (4) While the original answer emphasizes evolving language around market insight and customer reach, the LLM captures the essential continuity and strategic centrality. The only minor shortcoming is that the LLM does not mention the slight evolution in narrative (e.g., 'deepening market insight' in 2023 or 'diversified, long-term returns' in 2024), but it correctly concludes the emphasis has not shifted. Thus, the answer is semantically equivalent in strategic thrust, though slightly less detailed in year-by-year nuance. All entities—Texas Instruments, embedded processing products, analog products, competitive advantages—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 420,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "- In FY 2022 Cisco reported $500 million of its 3.50 % senior note (maturing June 15 2025) with an **effective rate of 3.20 %** (Chunk 1).  \n- By FY 2023 the same $500 million carried an **effective rate of about 6.38 %** (the prior‑year column) and in FY 2024 the rate was **6.66 %** (Chunks 2 & 3).  \n\nThe effective rate more than doubled from 2022 to 2023 and rose slightly again in 2024, indicating that Cisco’s borrowing cost on this fixed‑rate note has risen sharply over the period, reflecting higher market‑derived discount rates and a greater overall interest‑expense exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key factual information: the $500 million 3.50% Senior Note maturing June 2025, effective interest rates of 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024. These match the ground truth exactly. (2) All numbers, percentages, and dates are accurate. The progression—more than doubling from 3.20% to 6.38% and a slight increase to 6.66%—is correctly described. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly identifies the same note across three fiscal years and synthesizes the changing effective rates over time. It appropriately infers rising borrowing costs, linking the rate increases to market-derived discount rates and greater interest expense exposure, which aligns with the ground truth interpretation about market rate increases or risk perception shifts. (4) The only minor shortcoming is that the LLM slightly generalizes the cause as 'higher market-derived discount rates' without explicitly mentioning 'investor risk perception' as in the original, but the core reasoning and conclusion about sharply rising borrowing costs are correct and well-supported. Wording differs slightly but meaning is semantically equivalent. Thus, high scores across all categories with a 9 on correctness due to near-perfect accuracy and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 372,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "Across the three most recent 10‑K filings BNY Mellon repeatedly warned that **its ability to return capital to shareholders is at the Board’s discretion but can be capped by U.S. banking laws and regulations that govern capital planning and related Delaware‑law provisions**. In the 2022 filing this limitation was presented alongside a general note that failure to meet “well‑capitalized” and “well‑managed” standards could restrict activities; the 2023 filing restated the same cap and added that a material downgrade of the Bank of New York Mellon’s credit rating would raise funding costs and further constrain capital returns; the 2024 filing again emphasized the legal ceiling while explicitly linking it to the need for effective liquidity management and the parent’s reliance on subsidiary dividends and credit extensions. Taken together, the three‑year progression shows a **steady, unchanged exposure to U.S. banking‑law constraints that act as a ceiling on shareholder payouts, while the growing focus on credit‑rating and liquidity risks indicates that the firm’s strategic flexibility to allocate capital is increasingly bounded by both the same regulatory framework and the necessity of preserving financial strength**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns is consistently described across 2022–2024. The 2022 filing notes general regulatory oversight and the impact of failing to meet 'well-capitalized' and 'well-managed' standards. The 2023 filing adds Delaware law and preferred stock dividend obligations, which the LLM captures in substance by referencing Delaware-law provisions and credit-rating impacts (a related but not identical point). The 2024 emphasis on liquidity management and subsidiary reliance is accurately reflected. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly identifies the evolving emphasis on regulatory constraints, liquidity, and credit risk. One minor deviation: the ground truth highlights Delaware law and preferred stock dividends in 2023, while the LLM emphasizes credit rating downgrades—this is a related risk but not the exact same disclosure. This slight shift in emphasis prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of regulatory constraints and strategic flexibility. Overall, the LLM conveys semantic equivalence with strong fidelity to the original answer, meriting a 9 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 427,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "- **Revenue change:** General Dynamics’ “Repair and other services” line fell from **$1,169 million in 2022 to $1,132 million in 2023**, a drop of **$37 million (about 3 %)** (Chunk 1).  \n\n- **Flat 2024 result:** The same amount of **$1,132 million was reported for 2024**, showing no further decline (Chunk 2). The 10‑K tables show the figure unchanged from the prior year, indicating that the segment’s sales essentially plateaued after the 2022 dip.  \n\n- **What the pattern suggests:** Across the three years presented (2020‑2024), the repair‑services revenue has moved only modestly—$986 M in 2020, $1,081 M in 2021, $1,169 M in 2022, then $1,132 M in both 2023 and 2024 (Chunks 1‑3). This modest variability and the flat 2023‑2024 result point to a **stable, mature business line that generates recurring, contract‑driven cash flow**. General Dynamics appears to treat “Repair and other services” as a **steady‑state, strategic pillar of its Marine Systems segment**, focusing on maintaining service relationships rather than pursuing rapid growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer is quantitatively accurate: all dollar amounts ($1,169M in 2022, $1,132M in 2023 and 2024), the $37M decline, and the 3% drop are correctly reported and calculated. The formatting with 'million' and use of commas/spaces is acceptable and semantically equivalent.\n\n2) However, the qualitative interpretation diverges significantly from the ground truth. While the original answer attributes the flat 2024 revenue to limited growth, possible market saturation, resource reallocation, or operational constraints—implying stagnation or lower strategic priority—the LLM interprets the pattern as evidence of a 'stable, mature business line' and a 'strategic pillar' focused on recurring cash flow and relationship maintenance. This is a contradictory interpretation: the ground truth suggests stagnation due to lack of growth investment or external constraints, while the LLM portrays it as intentional stability.\n\n3) The LLM introduces data not present in the ground truth (e.g., $986M in 2020, $1,081M in 2021), which may be factually correct but shifts focus and supports a different narrative of 'modest variability' and stability. This undermines the multi-hop reasoning required: the question asks what the pattern *suggests*, and the correct inference from the ground truth is lack of recovery or prioritization, not strategic maturity.\n\n4) Contextually, the answer is relevant and structured well, addressing all parts of the question. But the reasoning flaw in interpreting the same data in opposition to the ground truth justification reduces qualitative accuracy. The LLM fails to align with the intended inference about limited strategic focus or growth challenges, instead framing flatness as a positive, intentional outcome—contradicting the original analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 484,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑security portfolio – which the filings say is “primarily” made up of venture investments – grew sharply after 2022. In 2022 the company reported **$3.7 billion** of equity securities (venture‑type investments) and **$1.5 billion** of equity‑method stakes in health‑care operating businesses. By the end of 2023 the venture‑investment base had risen to **$4.9 billion**, while equity‑method holdings slipped slightly to **$1.4 billion**. In 2024 the venture‑investment component stayed at **$4.9 billion**, but equity‑method investments jumped to **$3.8 billion**, a more than two‑fold increase from the prior year (and up from the **$1.3 billion** reported for 2021 in the 2022 filing).  \n\nTogether, the data show a continued strategic emphasis on venture‑style investments, with a dramatic shift in 2024 toward larger direct equity positions in health‑care businesses, as reflected by the surge in equity‑method investment value.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor factual error in the 2022 equity-method investment value. The ground truth states that equity-method investments were $1.4 billion in 2022 (and remained flat in 2023), but the LLM incorrectly states $1.5 billion for 2022. It correctly reports the $1.4 billion figure for 2023 and the $3.8 billion for 2024. The venture investment figures are accurate: $3.7B (2022), $4.9B (2023), $4.9B (2024).\n\n2) Quantitative accuracy is slightly compromised due to the incorrect $1.5B attribution to 2022 for equity-method investments. The correct progression is $1.4B (2022) → $1.4B (2023) → $3.8B (2024). The LLM reverses the 2022 and 2023 values, stating equity-method investments 'slipped' to $1.4B in 2023 from $1.5B in 2022, which contradicts the ground truth showing stability at $1.4B in both years before the 2024 jump. The mention of $1.3B for 2021 is extraneous and not requested, though not incorrect.\n\n3) The multi-hop reasoning is sound: the LLM correctly identifies the strategic shift in 2024 toward larger equity-method investments despite stable venture funding. It synthesizes trends across three years and distinguishes between venture-style (equity securities) and equity-method investments, aligning with the strategic emphasis asked in the question.\n\n4) Contextual relevance is excellent—the response directly addresses both dollar-value evolution and strategic emphasis. The qualitative interpretation of a 'dramatic shift' in 2024 is consistent with the ground truth's 'strategic shift toward deeper, more integrated investments.' Despite the minor numerical misplacement, the overall conclusion is valid and well-supported. Hence, correctness is rated 8 for minor factual inaccuracy, with high scores in reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 487,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Across all three filing years PMI treated Colgate‑Palmolive the same way – it was named as a member of the “PMI Peer Group” in the 2022, 2023 and 2024 10‑K tables. Each filing explicitly says the peer group “is the same as that used in the prior year” and repeats the full list of peers, which consistently includes Colgate‑Palmolive Co. This uninterrupted inclusion shows that PMI’s benchmarking framework is deliberately stable: the company applies an unchanged set of selection criteria (global presence, consumer‑product focus, comparable net revenues and market‑cap, plus the primary international tobacco firms) and sticks with the same peer set year‑over‑year to ensure consistent, comparable performance analysis and strategic insight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. was consistently included in the PMI Peer Group across 2022, 2023, and 2024, which matches the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound: the LLM correctly infers from the repeated peer group disclosure that PMI maintains a stable benchmarking framework, based on consistent criteria like global presence, consumer-product focus, net revenues, and market cap. It accurately reflects that the peer group is reused year-over-year with explicit confirmation in each filing. (4) The only minor deviation is the phrase 'plus the primary international tobacco firms'—this slightly misrepresents the ground truth, which emphasizes that PMI excluded direct tobacco peers and instead benchmarked against consumer product companies like Colgate-Palmolive. This does not invalidate the overall reasoning but introduces a small inaccuracy in entity classification. Otherwise, the answer is semantically equivalent, complete, and contextually precise, addressing both the evolution (no change) and strategic implication (stable framework).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Related_To]-> COMP <-[Has_Stake_In]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 376,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s 10‑K filings show that abusive‑behavior risk has been a constant, but its scope has broadened as the firm’s credit portfolio has grown. In 2022 the company already warned that “failure to deal effectively with fraud, abusive behaviors… could increase our loss rate” and that third‑parties were repeatedly creating fictitious accounts or using stolen identities; by 2023 the risk narrative expanded to note that new BNPL loan receivables, forward‑flow arrangements and other credit products would be funded through a growing web of unaffiliated lenders, asset‑sale facilities and other third‑party structures, thereby increasing the avenues for abuse; the 2024 filing repeats the same third‑party‑dependency language, adds regulatory uncertainty around loan‑receivable sales, and again expects continued abusive attempts at scale. The repeated emphasis that fraud‑mitigation measures are “complex, require continuous improvement, and may not be effective” suggests that, while PayPal is aware of the heightened exposure, its mitigation effectiveness has not demonstrably improved and remains challenged as credit products and third‑party reliance expand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of abusive behaviors from 2022 to 2024 is accurately described, including the increasing complexity tied to PayPal's expanding credit products and third-party dependencies. The 2022 focus on stolen identities and fictitious accounts, the 2023 expansion into BNPL and forward-flow arrangements with third parties, and the 2024 concerns about regulatory uncertainty in loan receivable sales are all correctly represented. (2) Quantitative accuracy is perfect: while no specific numerical values (e.g., dollar amounts) are cited in the LLM answer, the ground truth mentions a €40 billion agreement, which the LLM does not include. However, this omission does not distort the meaning or introduce inaccuracy—it's a minor detail absent but not contradicted. The LLM correctly captures the structural and risk implications of third-party funding mechanisms without misrepresenting scale. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years and connects expanding credit products (especially BNPL) with increased third-party risk and persistent fraud mitigation challenges. It correctly infers that despite awareness and controls, mitigation effectiveness has not kept pace with risk growth. (4) Semantic equivalence is strong: the LLM uses different phrasing (e.g., 'fictitious accounts', 'forward-flow arrangements', 'unaffiliated lenders') that accurately reflect the original concepts. The conclusion that fraud-mitigation measures 'may not be effective' despite continuous improvement mirrors the ground truth’s implication of outpaced defenses. The only reason for not scoring a 10 is the omission of the €40 billion figure, which adds quantitative specificity but does not undermine the overall correctness or reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1615,
        "completion_tokens": 507,
        "total_tokens": 2123
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s 10‑K filings show that the amount of natural‑gas options it used for hedging was 214 mmBtu for the parent (and 93 mmBtu for Southern Company Gas) at 12/31/2022, rose to 339 mmBtu (and 102 mmBtu) at 12/31/2023, and then fell to 176 mmBtu (and 83 mmBtu) at 12/31/2024.  This three‑year swing follows an earlier high of 574 mmBtu of options in 2020 and 253 mmBtu in 2021 (as disclosed in the 2022 filing), indicating that after a long‑term decline the company briefly intensified its option‑based hedge in 2023 before scaling it back in 2024.  The pattern suggests a risk‑management strategy that is responsive to market conditions—ramping up option positions when natural‑gas price volatility appears elevated (2023) and pulling back when the outlook stabilizes or when other instruments such as swaps become preferred (2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in the quantitative data compared to the ground truth. The ground truth states that Southern Company had 253 million mmBtu in natural gas options in 2022, but the LLM reports 214 mmBtu for the parent and 93 mmBtu for Southern Company Gas, totaling 307 mmBtu—this total is already inconsistent with the stated 253 mmBtu in the original answer. Similarly, while the 2023 figure of 339 mmBtu matches the ground truth, the LLM breaks it into parent and subsidiary components not present in the original, introducing unverified detail. The 2024 number (176 mmBtu) matches the ground truth, though again split into components. These discrepancies in magnitude and structure reduce confidence in the numerical accuracy. (2) The LLM introduces data not present in the ground truth—such as subsidiary-level breakdowns and references to 2020 (574 mmBtu) and 2021 (253 mmBtu)—which, while possibly true, are not part of the verified knowledge graph and distract from the core 2022–2024 trend. The inclusion of these figures suggests overreach beyond the provided context. (3) Despite numerical inconsistencies, the qualitative reasoning is sound: the LLM correctly identifies a spike in 2023 followed by a drop in 2024 and interprets this as a responsive risk management strategy to volatility, aligning with the original answer’s conclusion. It correctly infers a strategic shift possibly toward swaps and contextualizes the changes as market-condition-driven. (4) The answer is contextually relevant and addresses both parts of the question—evolution over time and implications for risk management—using logical multi-hop reasoning. However, the quantitative inaccuracies, especially the incorrect 2022 figure and unsupported breakdowns, prevent a higher score. Minor formatting differences (mmBtu vs million mmBtu) are acceptable, but the mismatched values are not. Overall, core trends are correct, but precision is lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 533,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ reported expense for its U.S. defined‑contribution plans rose each year after 2022 – $70 million in 2022, $75 million in 2023 and $76 million in 2024 (up from $63 million in 2021 and $61 million in 2020‑2019). This steady increase, shown in the 2022‑2024 10‑K disclosures, signals that the company is allocating more resources to its defined‑contribution and enhanced‑defined‑contribution offerings. Because the non‑qualified defined‑benefit pension plan is described as unfunded and closed to new participants, the growing expense on defined‑contribution plans suggests a long‑term strategy of shifting away from expanding traditional defined‑benefit obligations and instead emphasizing flexible, employee‑driven retirement benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. Although the LLM adds context about earlier years ($63M in 2021, $61M in 2020–2019), these do not contradict the ground truth and are likely accurate based on broader filing data, so they do not detract from correctness. (2) All numbers and years are accurate, with proper formatting and consistent units. No calculation errors are present. (3) The reasoning correctly identifies the strategic shift from the non-qualified defined benefit pension plan—closed to new participants—to an increased focus on defined contribution plans. The synthesis between the rising expenses and the company’s long-term benefit strategy is sound and aligns with the ground truth. The only minor shortcoming is that the LLM does not explicitly mention the 1997 closure date of the defined benefit plan to new participants, which is part of the original answer and adds historical context to the strategy. However, it does correctly note the plan is closed, so the core multi-hop reasoning (linking expense trend to strategic shift due to plan structure) is intact. (4) The answer is highly relevant, directly addressing both parts of the question: the evolution of expenses and the implication for long-term strategy. The added context about prior years enhances understanding without introducing error. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth due to one omitted detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 447,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "- In the 2022 filing GM noted that the weighted‑average long‑term rate of return on assets for its U.S. defined‑benefit pension plans had fallen to **5.4 % at 12/31/2021** (down from 5.6 % at 12/31/2020).  \n- The 2023 filing reported that the **rate was 6.3 % for 12/31/2022 and remained unchanged at 6.3 % for 12/31/2023**.  \n- The 2024 filing then showed the assumption **increased to 6.5 % at 12/31/2024**.  \n\nThis trajectory—moving from a lower rate, stabilizing at a higher 6.3 % for two years, and then edging up to 6.5 %—indicates that GM’s strategic‑mix accounting policy is becoming more optimistic about future asset performance and is willing to tolerate slightly higher risk in its pension‑plan investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor discrepancy in the interpretation of timing. The original answer states that the 5.4% rate was for 2022 (i.e., as of 12/31/2021), which the LLM correctly notes as being effective at 12/31/2021. However, the original answer refers to this as the '2022' assumption, consistent with fiscal reporting conventions (i.e., reported in 2022 for the prior year). The LLM’s phrasing — 'in the 2022 filing GM noted... 5.4% at 12/31/2021' — is factually accurate and aligns with SEC filing practices, so this is not an error but a more precise temporal clarification. The 2023 rate of 6.3% is correctly reported as unchanged from 2022 to 2023, and 2024’s 6.5% is accurate. (2) All percentages (5.4%, 6.3%, 6.5%) and dates (12/31/2021, 12/31/2022, 12/31/2023, 12/31/2024) are quantitatively correct. The LLM correctly tracks the evolution across years. (3) The multi-hop reasoning — synthesizing data from three consecutive years’ filings — is sound. The conclusion about increasing optimism and risk tolerance is logically supported by the upward trend and matches the original answer’s interpretation. (4) The answer is contextually fully relevant, addressing both the numerical evolution and the implied shift in risk tolerance. The only reason for not scoring 9–10 is that the original answer emphasizes the trend from 5.4% to 6.5% as continuous upward movement, while the LLM highlights a jump to 6.3% (which is correct), but does not explicitly note that 5.4% was lower than the subsequent 6.3%, potentially understating the magnitude of the increase. Still, the overall factual and interpretive accuracy is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 457,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco reported a **$92 million loss** on its total‑return‑swap‑deferred‑compensation program in fiscal 2022 (shown in the 2022 10‑K and repeated in the 2023 and 2024 filings).  The next two years reversed that result – a **$58 million gain** in fiscal 2023 and a **$91 million gain** in fiscal 2024 (both listed under “Operating expenses and other” in the 2023 and 2024 10‑Ks).  The swing from a sizable loss to growing gains suggests Cisco has tightened its management of the market risk embedded in these swaps – likely by adjusting hedge structures or aligning the swaps more closely with its deferred‑compensation obligations – turning what was once a cost into a net benefit and reflecting a more disciplined compensation‑funding strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported figures—$92 million loss in fiscal 2022, $58 million gain in fiscal 2023, and $91 million gain in fiscal 2024—are accurate and correctly attributed to the respective fiscal years. The formatting variations (e.g., $92 million) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of financial exposure (loss to gains) and the implication for Cisco's risk management and compensation strategy. (3) Entities—Cisco, total return swaps, deferred compensation, fiscal years 2022–2024—are correctly identified and contextualized. (4) The reasoning is sound: the multi-hop synthesis across three fiscal years is accurate, and the conclusion about improved risk management and strategic alignment (e.g., adjusting hedges or compensation funding) is a reasonable inference supported by the trend. The mention of disclosure location (10-Ks, 'Operating expenses and other') adds contextual precision without introducing error. Overall, the answer demonstrates full factual correctness, logical synthesis, and appropriate interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 332,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "Across all three years PayPal’s margin‑risk profile stayed essentially the same. In 2022 the filing already stated that, as the principal on each payment, PayPal “controls the service of completing payments,” has “full discretion in determining the fee charged… independent of the costs we incur when we may utilize payment processors or other financial institutions,” and therefore “bear full margin risk” with the processor fees recorded as a transaction expense. The 2023 notes repeat that language verbatim—again emphasizing volume‑based, tiered pricing that is not a future material right, no capitalized contract balances, and full margin‑risk exposure despite using third‑party processors whose fees are expensed. The 2024 filing likewise re‑affirms the same stance, adding that the newly adopted segment‑reporting guidance has no material impact on the treatment. Thus, from 2022 through 2024 PayPal’s exposure to margin risk did not evolve; it consistently retained full control over pricing, bore the full margin risk, and recognized third‑party processor fees as transaction expense in each period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) All factual elements are accurately represented: PayPal consistently bore full margin risk across 2022, 2023, and 2024; it maintained control over pricing independent of costs; it used third-party processors whose fees were recognized as transaction expenses; and it reiterated that tiered pricing did not constitute a future material right. The 2024 update noting no material impact from new segment reporting is also correctly included. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but all years (2022, 2023, 2024) are correctly referenced and aligned with the corresponding disclosures. (3) The multi-hop reasoning is sound—information is synthesized correctly across three years and filings, showing consistency in accounting treatment and risk exposure over time. (4) The LLM captures all key nuances: principal role in transactions, discretion in fee setting, treatment of processor fees, and lack of change due to reporting updates. Wording differs slightly but meaning is preserved with high precision. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Bears]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 338,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s share of natural‑gas production from affiliates that include Angola LNG rose each year – 570 million cubic feet per day in 2022 (as disclosed in the 2022 10‑K), 596 million cf/d in 2023 (2023 10‑K), and 609 million cf/d in 2024 (2024 10‑K). This steady increase, together with higher total “as‑sold” gas volumes, shows Chevron’s expanding output from its Angola LNG stake and underscores a strategic move to deepen its presence in the global liquefied natural‑gas market.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Chevron's natural gas production volumes associated with Angola LNG from 2022 to 2024 and accurately reports the 2023 (596 million cf/d) and 2024 (609 million cf/d) figures, matching the ground truth. However, the 2022 value is reported as 570 million cf/d, whereas the ground truth states 592 million cf/d—a significant discrepancy. This error affects quantitative accuracy but does not alter the overall directional conclusion. (2) Number verification: 2022 value is incorrect (570 vs 592), likely due to misattribution or misreading of affiliate production data; 2023 and 2024 values are correct. No calculations were required beyond trend interpretation, which was handled correctly. (3) Multi-hop reasoning is sound: the model synthesizes data across three annual 10-K filings, correctly attributes the volumes to Chevron’s stake in Angola LNG, and infers strategic intent from the trend. It also appropriately links increasing production to Chevron’s broader LNG market positioning, consistent with the original answer. (4) Despite the incorrect 2022 figure, the core trend and strategic interpretation remain valid, warranting a high qualitative and contextual score. The correctness score is reduced due to the material numerical inaccuracy in the earliest year, but not severely penalized because the overall trajectory and strategic implication are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 399,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In the 2022 10‑K Southern Power said that the undiscounted cash flows from outdoor‑lighting contracts that are accounted for as operating leases were “immaterial” and therefore were not shown in the lease‑payment tables – the payments were treated as contingent rents and omitted. By the 2023 filing the company had begun to disclose the scheduled payments from those contracts in a maturity‑analysis schedule, presenting them alongside tolling arrangements and other PPAs and including the lease income in wholesale revenue. The 2024 filing repeats that presentation (now also for Georgia Power) and explicitly lists the scheduled payments to be received under the contracts’ initial terms in the maturity analysis, indicating that the contracts have moved from an immaterial footnote to a material, structurally important component of Southern Power’s lease‑income reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, outdoor lighting contract cash flows were deemed immaterial and excluded from lease tables; in 2023, Southern Power began including scheduled payments in maturity analyses alongside tolling and PPAs, and included lease income in wholesale revenue; by 2024, the presentation was repeated and expanded to Georgia Power, with explicit listing of initial term payments. These developments correctly reflect the growing materiality and structural integration of these contracts. (2) There are no numeric inaccuracies—though no specific dollar amounts are mentioned in either answer, the qualitative descriptions of materiality changes are consistent and correctly dated across 2022, 2023, and 2024. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosure changes across three years and infers increasing importance, correctly identifying the shift from immaterial footnote treatment to inclusion in core lease income reporting. (4) The only minor shortcoming is that the LLM mentions Georgia Power in 2024, which is not in the original answer—this may be a factual overextension if not supported by the source, but it does not contradict the main conclusion about growing materiality. Otherwise, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 386,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across all three years Texas Instruments’ Melaka, Malaysia location was listed only under the Analog segment. In the 2022 filing the Melaka row shows an “X” in the Analog column and a blank in Embedded Processing; the 2023 filing repeats the same pattern (Analog = X, Embedded Processing = blank); and the 2024 filing again shows an “X” for Analog with no entry for Embedded Processing. Thus, TXN’s footprint in Melaka remained stable—focused solely on Analog production with no Embedded Processing activity from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the use of years (2022, 2023, 2024) is correct and consistent with the question and ground truth. The description of the 'X' markings and blanks in the filings provides additional contextual precision without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings (2022–2024) for the same location and maps segment involvement consistently over time, concluding stability in operations. (4) The answer is contextually relevant, directly addressing the evolution (or lack thereof) in TXN’s operational footprint in Melaka. Wording differs slightly from the original answer but conveys the same meaning with high fidelity. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 324,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "- **2022 filing (Chunk 1):** AMT reported $700 million of 1.600 % senior notes, with interest payable semi‑annually on **April 15 and October 15** and a **par‑call date of March 15, 2026**.  \n- **2023 filing (Chunk 2):** The same $700 million balance is shown, the interest‑payment dates remain **April 15 and October 15**, and the **par‑call remains March 15, 2026**; only a modest adjustment entry (‑$2.6 million) is noted, which does not change the headline amount.  \n- **2024 filing (Chunk 3):** The notes still carry an **aggregate principal of $700 million**, the **interest schedule stays April 15 and October 15**, and the **par‑call date is unchanged at March 15, 2026**, with a small further adjustment (‑$1.5 million).\n\n**Interpretation:** Over the three‑year period the principal amount, payment cadence and call provision for the 1.600 % notes remained essentially constant, showing that AMT has chosen to retain this low‑coupon, long‑dated financing without early redemption. This consistency signals a disciplined debt‑management strategy that prioritizes cost‑efficient, predictable financing and avoids unnecessary refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the aggregate principal amount of $700 million is consistently reported for 2022–2024; the adjustments of (2.6) in 2023 and (1.5) in 2024 are correctly stated (with appropriate negative signs and units in millions); interest payment dates (April 15 and October 15) and par call date (March 15, 2026) are precisely matched across years. (2) The answer is complete, addressing all three dimensions of the question—principal amount, interest payment schedule, and par call date—across the full 2022–2024 period. (3) Entity accuracy is perfect: AMT is correctly identified, the 1.600% Notes are accurately referenced, and all years align with the filings. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that despite minor adjustment entries, the core terms of the debt remained unchanged, leading to a valid conclusion about AMT’s stable and disciplined debt management strategy focused on predictable, low-cost financing. The interpretation aligns semantically with the ground truth, using slightly different but equivalent phrasing (e.g., 'retained this low-coupon, long-dated financing' vs. 'stable approach to managing this specific debt instrument'). No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Debt]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 381,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco’s 5.90 % senior note has stayed at the same $2 billion face amount in each filing, but its share of the company’s debt has fallen as total borrowings have more than doubled. In FY 2022 the note represented $2 bn of $8.915 bn of reported debt (≈22 % of total debt and of the $9 bn of senior notes), while in FY 2023 – and unchanged in FY 2024 – it still equals $2 bn but now accounts for only about $20.109 bn of total debt (≈10 % of senior notes and total debt). The effective interest rate on the note has remained constant at 6.11 % in all three years. This pattern shows Cisco keeping the 5.90 % note as a stable, long‑dated, fixed‑rate anchor while expanding its overall debt portfolio with additional issuances, indicating a long‑term financing strategy that diversifies maturity and rate exposure but retains a core low‑cost, long‑term funding source.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly states that the 5.90% Note remained at $2,000 million (i.e., $2 billion) across all three fiscal years and that the effective interest rate was consistently 6.11%, matching the original answer. It also accurately reflects the increase in total debt: from $8,915 million in 2022 (sum of long-term $8,416M + short-term $499M ≈ $8,915M) to $20,109 million in 2024 (long-term $19,621M + short-term $488M ≈ $20,109M). The percentages cited (~22% in 2022, ~10% in 2024) are reasonable approximations given the total debt figures. (2) The only minor discrepancy is that the original answer specifies long-term debt growth from $8,416M to $19,621M, while the LLM aggregates total debt (long-term + short-term), which is a valid interpretation but slightly shifts focus. However, this does not introduce error, as total debt indeed more than doubled. (3) The reasoning is sound: the LLM correctly infers that while the absolute amount of the 5.90% Note remained constant, its relative weight declined due to broader debt issuance, indicating a strategy of diversifying maturities and rates while maintaining a stable fixed-rate core. This aligns with the original conclusion about a long-term financing strategy focused on stabilizing costs. (4) All entities (Cisco, 5.90% Note, fiscal years 2022–2024) are correct, and the multi-hop synthesis—linking note value, total debt composition, and strategic implication—is logically coherent and complete. The answer is contextually excellent, directly addressing all parts of the question with precise, relevant analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 454,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics – through its Land Systems division, the company that “produces” Light Armored Vehicles (LAVs) – has been raising the volume of LAVs it builds for the Canadian Army each year. In the 2022 filing Land Systems was producing **360 new LAVs** for Canada; the 2023 filing shows that figure rose to **399 new LAVs**; and the 2024 filing reports **449 new LAVs** plus an additional **66 LAVs** under the LRSS surveillance program (a total of **515 LAVs** for 2024). This year‑over‑year increase signals a clear strategic emphasis on expanding GD’s LAV manufacturing capacity, reinforcing its market‑leading position in light‑armored vehicles and deepening its partnership with the Canadian Army.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the production volumes for 2022 (360 units) and 2023 (399 units) as per the ground truth. However, it misrepresents the 2024 total by stating that 449 LAVs plus an additional 66 under the LRSS program results in a total of 515 LAVs for 2024. The original answer does not state that the 66 LRSS LAVs are in addition to the 449, but rather that the 449 units include or are associated with the expansion driven by programs like LRSS. Thus, the total for 2024 should be 449, not 515. This is a significant quantitative error. (2) Number verification: 360 (2022) ✓, 399 (2023) ✓, 449 (2024) ✓ as a standalone figure, but incorrect summation of 449 + 66 = 515 implies double-counting or misunderstanding of the relationship between the LRSS vehicles and the total. The ground truth presents the 66 LRSS units as part of the broader 2024 context, not as additive to the 449. (3) Multi-hop reasoning is mostly sound: the model correctly tracks production across three years and links the increase to strategic focus and the LRSS program. It synthesizes information across time and programs appropriately, though with a misinterpretation of how the LRSS units relate numerically. (4) The qualitative reasoning and strategic interpretation are strong and align well with the original answer—emphasizing growing strategic focus, manufacturing expansion, and partnership with Canada. Contextual relevance is excellent, addressing both parts of the question. Due to the material calculation error in total 2024 volume, correctness and quantitative accuracy are penalized, but not severely, as core trends and entities are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 454,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth’s 10‑K filings show that the company’s exposure to Medicare Advantage risk‑adjustment payment changes was first highlighted in 2022 and then reiterated in the 2023 and 2024 reports – each year CMS is described as “periodically making changes to the way it calculates Medicare Advantage risk‑adjustment payments,” confirming that the risk remained a material, ongoing funding pressure throughout the three‑year span.  In response, UnitedHealth consistently employed the same set of mitigation tactics: it selectively adjusted members’ benefits and premiums, stopped offering certain plans in specific counties, and intensified both medical‑cost and operating‑cost management programs, while noting that these actions may not fully offset the continued funding pressures.  Thus, the exposure persisted unchanged from 2022‑2024, and the strategic adjustments – benefit/premium tweaks, plan withdrawals and heightened cost‑control – were applied each year to blunt the impact of the payment‑adjustment risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth faced ongoing exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 due to CMS methodology shifts, and responded with consistent strategies including benefit and premium adjustments, county-level plan withdrawals, and intensified cost management. The LLM correctly notes that these pressures were reiterated annually and described as material and ongoing. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the continuity of risk and response strategies. It captures the evolving yet persistent nature of CMS changes and UnitedHealth’s sustained operational response. (4) The only minor shortcoming is that the LLM states the exposure 'persisted unchanged,' which slightly oversimplifies the original answer’s nuance that the risk evolved—particularly in 2024 with emphasis on beneficiary health status data submissions. The original highlights a developing focus on data submission processes, which the LLM omits. This is a small but relevant detail in the evolution of the risk. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 408,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PYPL’s outstanding balance of the fixed‑rate 2.850 % notes was $1,500 million in each of the three years covered – $1.5 bn in 2022 (2023 10‑K), unchanged at $1.5 bn in 2023 (both the 2023 10‑K and the 2024 10‑K tables), and still $1.5 bn in 2024 (2024 10‑K). The notes mature on 10 Oct 2029 and carry an effective 2.96 % rate, and the fact that this tranche has remained flat for several years shows PYPL is deliberately keeping a stable, medium‑term fixed‑rate component in its capital structure to lock in modest borrowing costs and diversify its long‑dated debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the carrying value of PYPL's 2.850% notes is accurately reported as $1.5 billion (or $1,500 million) for 2022, 2023, and 2024, matching the ground truth. The maturity date (October 10, 2029) and effective interest rate (2.96%) are correctly included, though the latter was not in the original answer but is consistent with SEC filings and adds context without contradicting. 2) All numeric values are accurate and correctly formatted; $1,500 million = $1.5 billion, and the consistency across years is properly noted. The references to 10-K filings for each year support the data provenance. 3) The multi-hop reasoning is sound: the model synthesizes data across three annual reports (2022–2024) and correctly infers that the unchanged balance indicates a deliberate long-term debt strategy. The conclusion about maintaining a stable fixed-rate component aligns with the ground truth’s interpretation of strategic intent. 4) The LLM adds slight elaboration (e.g., 'lock in modest borrowing costs', 'diversify long-dated debt profile') that is reasonable and consistent with the implications in the original answer, though slightly more interpretive. This does not detract from accuracy but adds nuance. The core message — stable exposure indicating strategic consistency — is preserved. Minor deduction in qualitative accuracy due to added interpretation beyond the original, but not incorrect. Overall, the answer is quantitatively precise, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Notes]-> FIN_INST <-[Issues_Debt]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 429,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron has kept a steady 36.4 % equity stake in Angola LNG Limited in each of its recent filings – the 2022 10‑K (Chunk 3) and the 2023 10‑K (Chunk 1) both state the same shareholding, and the 2024 10‑K (Chunk 2) repeats the 36.4 % figure while adding that the on‑shore plant in Soyo can process 1.1 billion cubic feet of gas per day and is the world’s first LNG facility fed by associated‑gas from oil production.  In 2024 Chevron also highlighted new upstream moves – a 31 % PSC in deep‑water Block 14, a 31 % non‑operated interest in the New G as Consortium (NGC) with Q&M fields slated to feed Angola LNG, and added acreage in Blocks 49 and 50 – showing that its stake in the LNG company is being paired with a growing supply base.  This multi‑year consistency of ownership combined with expanding gas‑supply projects reveals a deliberate, long‑term strategy to monetize Angola’s associated natural gas through a secured downstream liquefaction platform and export capability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains one key factual discrepancy that affects the completeness of the upstream portfolio description. (1) Quantitatively, the 36.4% ownership stake is accurately reported for all three years (2022–2024), and the additional technical detail about the Soyo plant’s 1.1 billion cubic feet per day capacity and its status as the first LNG facility fed by associated gas is factually consistent with public disclosures. However, the LLM incorrectly states Chevron holds a 31% PSC in Block 14, which is not mentioned in the ground truth and contradicts the correct focus on Blocks 49 and 50 and the New Gas Consortium (NGC). The correct upstream developments are the Quiluma and Maboqueiro (Q&M) fields in the NGC, where Chevron has a 31% non-operated interest—this part is accurate. (2) The calculation of ownership percentage is consistent and correctly repeated across years. (3) Multi-hop reasoning is strong: the model correctly infers that maintaining a stable equity stake while expanding upstream supply (via NGC and new acreage) indicates an integrated gas monetization strategy. It correctly identifies the strategic shift from standalone LNG export to an integrated hub model, even if it misattributes one upstream asset (Block 14). (4) Contextually, the answer is highly relevant, addressing both the evolution of Chevron’s positioning and the implications for long-term strategy. The core conclusion—that Chevron is building a secured supply chain for gas monetization via downstream infrastructure paired with upstream growth—is semantically equivalent to the ground truth. The error in mentioning Block 14 slightly undermines entity accuracy but does not invalidate the overall reasoning. Hence, a score of 8 is warranted: core facts and strategy interpretation are correct, but with a notable omission and minor factual error in upstream asset details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 522,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company’s 10‑K filings show that its trust holdings of **domestic equity** fell from **$1,016 million** in 2021 (the 2022 filing) to **$829 million** at year‑end 2022, then rose to **$1,099 million** at year‑end 2024 – a roughly **33 % increase** from 2022.  Its **private‑equity** exposure grew more modestly, from **$150 million** in 2021 to **$161 million** in 2022 and to **$181 million** in 2024 (about a **12 % rise** since 2022).  The rebound and expansion of domestic‑equity positions, together with a steady incremental boost to private‑equity, indicate that Southern Company is deliberately shifting capital toward larger, higher‑return equity investments while maintaining a consistent, diversified foothold in private‑equity for long‑term value creation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in dates and data mapping. It incorrectly refers to the 2022 filing as '2021 data', misrepresenting the time periods. According to the ground truth, 2022 values are $1,016M (domestic equity) and $150M (private equity), but the LLM claims these figures are from 2021, which is incorrect. The 2023 data point ($829M domestic equity, $161M private equity) is omitted entirely, reducing completeness. While the 2024 figures ($1,099M and $181M) are correct, the LLM incorrectly calculates the domestic equity change as a '33% increase from 2022'—while $1,099M is indeed higher than $829M, the base year comparison is flawed because it skips 2023 and mislabels years. The private equity increase from $150M to $181M is stated as a 12% rise since 2022, but the LLM uses $150M (2022 value) as the base instead of correctly referencing the 2022–2024 progression through 2023. (2) Correct numbers per ground truth: 2022: $1,016M domestic, $150M PE; 2023: $829M domestic, $161M PE; 2024: $1,099M domestic, $181M PE. LLM reports correct dollar amounts but assigns them to wrong years. (3) The multi-hop reasoning is partially sound—LLM identifies a strategic shift toward higher-return equities and long-term value via private equity—but omits the intermediate 2023 data point, weakening the synthesis. The conclusion about a 'deliberate shift' is plausible but overreaches slightly given the fluctuation pattern. (4) Scores justified: Correctness 7 due to accurate final-year numbers and reasonable interpretation despite incorrect year labeling and missing 2023 data; Quantitative Accuracy 6 due to misaligned years and flawed percentage calculations; Qualitative Accuracy 8 for logical reasoning and correct overall trend interpretation; Contextual Relevance 10 as the answer directly addresses the evolution and strategic implications as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 515,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "In 2022 GM’s eliminations / reclassifications reduced total net sales and revenue by **$107 million** (up from a $105 million reduction reported for 2021), while by 2024 the same adjustment had grown to a **$296 million** reduction. The near‑tripling of this negative impact over the two‑year span shows that GM’s internal reporting and consolidation work has become far more extensive, with larger inter‑segment eliminations and reclassifications across its automotive, Cruise and GM Financial businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key factual error in the 2022 elimination amount, stating $107 million instead of the correct $105 million (per ground truth). It correctly reports the 2024 figure as $296 million. However, it introduces a 2021 value ($105 million) not mentioned in the original question or ground truth, which is extraneous and potentially misleading. The 2023 value is omitted entirely, breaking the three-year trend analysis requested. (2) Quantitative accuracy is compromised due to the swapped 2022 and 2023 figures—ground truth shows $105M (2022), $107M (2023), $296M (2024), but LLM states $107M for 2022 and skips 2023. The 'near-tripling' claim over two years compares 2022 to 2024 but ignores the intermediate year, and while $107M to $296M is roughly a 2.76x increase, the baseline is wrong. (3) The reasoning about increasing complexity in internal reporting is sound and aligns with the upward trend, and the mention of Cruise and GM Financial shows appropriate multi-hop synthesis across segments. However, omitting 2023 weakens the longitudinal analysis. (4) Despite the numerical inaccuracies, the answer remains contextually relevant and captures the overall trend direction and business implications correctly, warranting a moderate score. The core insight about growing internal adjustments is preserved, but precision fails on key data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 391,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "In the 2022 Form 10‑K the Performance Bonus Plan appears only as a legacy proxy exhibit (Exhibit 10.6 – Def 14A, filed April 28 2014).  By the 2023 filing Netflix had filed an “Amended and Restated Performance Bonus Plan” as Exhibit 10.5 on an 8‑K (dated December 9 2022), and the same amended plan is again incorporated by reference in the 2024 Form 10‑K (Exhibit 10.5, 8‑K Dec 9 2022).  The shift from a dated proxy filing to a current‑report amendment—and its placement alongside the 2011/2020 Stock Plans, RSU award agreements and other executive compensation documents—shows that the plan was formally updated, re‑documented and now operates as part of Netflix’s integrated compensation framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, the Performance Bonus Plan was a legacy exhibit (Exhibit 10.6†) from April 28, 2014; in 2023, it was amended and restated as Exhibit 10.5† with a filing date of December 9, 2022; and in 2024, the same amended version was carried forward. (2) Quantitative accuracy is perfect: dates (April 28, 2014; December 9, 2022), exhibit numbers (10.6, 10.5), and filing types (Def 14A, 8-K) match the ground truth. Minor formatting differences (e.g., '8-K' vs '8‑K') are acceptable. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years, identifies the evolution from legacy to active status, and infers integration with broader compensation frameworks (e.g., stock plans, RSU agreements). (4) The answer addresses all parts of the question: documentation status (legacy → amended → stable) and integration with compensation frameworks (explicitly noted in the final sentence). Wording differs slightly but meaning is preserved and enhanced with contextual insight (e.g., 'integrated compensation framework'). No omissions or errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 334,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "Across all three years BK has treated the “Business Relationships and Related Party Transactions Policy” the same way. In the 2022, 2023 and 2024 Form 10‑K Item 13 the policy is listed as a proxy‑referenced disclosure together with “Director Independence,” and the filing points to the same set of committee charters – the Audit Committee, the Corporate Governance/Nominating/Social Responsibility Committee and the Human Resources & Compensation Committee. Because the language, the referenced sections and the committee structure are unchanged from 2022 through 2024, the filings show a consistent corporate‑governance approach, with no material evolution in how the related‑party policy, director independence and committee oversight are disclosed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully aligned with the ground truth. (1) It correctly identifies that BK disclosed its 'Business Relationships and Related Party Transactions Policy' consistently across 2022, 2023, and 2024 in Item 13 of the Form 10-K, linked to 'Director Independence' and the same set of committee charters. (2) There are no numeric values requiring calculation, but the years (2022–2024) are accurately referenced. (3) The multi-hop reasoning is sound: the model synthesizes information across three years, connects the policy to corporate governance disclosures, and correctly infers that the lack of change indicates consistency in governance practices. (4) The answer conveys semantic equivalence to the original—using slightly different phrasing (e.g., 'proxy-referenced disclosure', 'unchanged language') but preserving all key facts: consistent placement, linkage to director independence, and stable committee structure. No omissions or inaccuracies are present, and the conclusion about stable governance is logically supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 297,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth Group reports that the **total fair value of its Debt Securities – Held‑to‑Maturity (HTM) fell each year**:\n\n| Year‑end | Total Fair Value ( $ millions) | Total Carrying Value ( $ millions) |\n|----------|------------------------------|-----------------------------------|\n| 2022 ( disclosed in the 2023 10‑K) | **$679** | **$696** |\n| 2023 ( disclosed in the 2024 10‑K) | **$596** | **$603** |\n| 2024 ( disclosed in the 2024 10‑K) | **$508** | **$512** |\n\n**Trend and implication**\n\n- Both fair‑value and carrying‑value amounts have **declined steadily** – fair value dropped about 12 % from 2022 to 2023 and another 15 % to 2024; carrying value fell roughly 13 % and then 15 % over the same periods.  \n- Fair value has been **slightly below** carrying value each year (e.g., $679 M vs $696 M in 2022), indicating that UNH’s valuation assumptions are modest and that no significant impairment has been recognized.  \n- The consistent downward movement suggests UNH is **shrinking its HTM portfolio**, likely as securities mature or the company reallocates capital to other investments. The close alignment of fair and book values reflects a conservative approach to valuation—using market‑observable inputs (Level 1/2) and modest unobservable adjustments—while maintaining the HTM classification.\n\nOverall, the three‑year pattern points to a deliberate reduction in HTM debt‑security holdings and a valuation stance that treats the remaining securities at values only marginally lower than their amortized cost.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value in 2022 was $643 million, not $679 million as stated in the LLM answer. Similarly, the carrying value in 2022 was $641 million, not $696 million. The 2023 and 2024 values for fair and carrying values ($596M/$603M and $508M/$512M) match the ground truth. These errors in 2022 values affect all subsequent percentage calculations: the claimed 12% drop from 2022 to 2023 in fair value is incorrect (actual drop: (643-596)/643 ≈ 7.3%), and the 13% drop in carrying value is also inaccurate (actual: (641-603)/641 ≈ 5.9%). (2) The LLM incorrectly cites the 2022 figures from the 2023 10-K, but the ground truth implies these values are from the 2022 report (disclosed in the 2023 10-K for prior year comparison), which is standard, but the numbers themselves are wrong. (3) The qualitative reasoning is sound: the LLM correctly identifies the downward trend, interprets the narrowing gap between fair and carrying values as a sign of conservative valuation, and infers a strategic reduction in the HTM portfolio. It also correctly notes the implication of using more observable inputs (Level 1/2), aligning with the ground truth’s mention of reduced reliance on Level 3 inputs. (4) Contextually, the answer is well-structured and addresses all parts of the question—evolution over time, trend, and strategic implications—making it highly relevant. However, the major numerical errors in the base year undermine the factual foundation, warranting a moderate correctness score despite strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 447,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In its 2022 filing PayPal warned that “bad transactions” – fraud, abusive behavior and defaults on its credit and merchant‑financing products – could raise its loss rate, but it did not single out any BNPL‑specific exposure. By June 2023 the company identified its U.K. and European buy‑now‑pay‑later loan portfolio as a material source of that risk and entered a multi‑year agreement to sell up to €40 billion of those receivables (the sale of the bulk of the portfolio began in October 2023); the 2024 filing repeats the same agreement and stresses that the forward‑flow sale of future eligible loans is conditional, so any delay would leave some BNPL exposure on the books. Taken together, the evolution shows PayPal moving from retaining BNPL‑related bad‑transaction risk in 2022 to actively off‑loading it through a large‑scale asset‑sale and forward‑flow arrangement, a clear risk‑mitigation strategy that reduces its direct exposure while still monitoring residual risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk disclosure on bad transactions (fraud, defaults, abusive behavior), the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and the conditional nature of the sale noted in 2024. The mention of the sale beginning in October 2023 is an additional detail not in the original answer but does not contradict it and is plausible context. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no calculations are required. Dates (2022, June 2023, 2024) are accurate. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes PayPal’s evolving risk strategy across three years, identifying the shift from retaining BNPL risk to offloading it via asset sales and forward-flow arrangements. It infers the strategic intent behind the sale—risk mitigation—consistent with the original answer. (4) The only minor gap is that the LLM does not explicitly note that the 2024 filing still emphasized ongoing risks even after the sale, though it does mention that delays would leave 'some BNPL exposure on the books,' which captures the same idea. Wording differs slightly but maintains semantic equivalence. The answer is fully relevant, directly addressing the evolution of risk exposure and PayPal’s mitigation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 386,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s Myanmar upstream output fell modestly from 2022 to 2023 – the 10‑K shows a share of ≈ 17 thousand barrels per day (oil‑equivalent) and 94 MMCFD of oil‑equivalent gas in 2022, dropping to ≈ 15 thousand barrels per day and 87 MMCFD in 2023.  In the 2024 filing Chevron disclosed that it **withdrew from Myanmar in April 2024**, so its production there fell to zero.  This decline and ultimate cessation reflect a strategic decision to exit Myanmar’s upstream operations, shifting resources away from that country’s assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in Chevron's upstream production in Myanmar from 17 MBD in 2022 to 15 MBD in 2023, and the complete withdrawal in April 2024, aligning with the ground truth. The mention of gas volumes (94 MMCFD and 87 MMCFD) is additional detail not present in the original answer but does not contradict it; however, the core metric of interest—barrels per day—is accurate. The zero production post-April 2024 is correctly inferred. (2) All key numbers (17 MBD, 15 MBD, April 2024 exit) are factually correct and match the ground truth. The gas volumes are plausible but not required for correctness; their inclusion doesn't detract as long as oil-equivalent barrels are accurately reported. No calculation errors. (3) The multi-hop reasoning is sound: the model connects year-over-year production data from filings and synthesizes the strategic implication of the full exit. The conclusion about strategic shift—exiting upstream operations and reallocating resources—is semantically equivalent to 'portfolio optimization and risk management' in the original. (4) The answer is highly relevant, directly addressing both the quantitative evolution and the strategic implication. The slight addition of gas data does not distort meaning. Only minor deduction from perfect score due to inclusion of unverified gas volumes, but core facts and synthesis remain fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 393,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "In Texas Instruments’ filings, PC & Notebooks are listed as a product line within the Personal‑electronics market, which made up 24 % of total revenue in 2022, fell to 15 % in 2023, and rose again to 20 % in 2024. The drop from 2022‑23 reduced the relative weight of the PC‑notebook business, while the 2024 rebound shows the segment regaining importance. This pattern suggests TI’s exposure to consumer‑computing applications contracted in 2023 but is now being re‑emphasized, indicating a strategic shift to strengthen its position in the PC and notebook market.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage contributions of the Personal Electronics segment to TI's revenue in 2022 (24%), 2023 (15%), and 2024 (20%), which matches the ground truth exactly—this satisfies quantitative accuracy. (2) However, the qualitative interpretation and reasoning are significantly flawed. While the original answer states that the trend suggests a strategic shift *away* from PC & Notebooks—with the category appearing lower in priority in 2024 despite the segment's partial recovery—the LLM incorrectly interprets the 2024 increase as a 're-emphasis' and 'strategic shift to strengthen its position' in the PC and notebook market. This is the opposite of the ground truth implication, which emphasizes TI's pivot toward Automotive and Industrial markets and reduced focus on consumer computing. (3) The multi-hop reasoning fails because the LLM does not synthesize the contextual clue that PC & Notebooks are 'appearing lower in the list of priorities' in 2024, even within the rebounding Personal Electronics segment. Thus, the conclusion misrepresents the strategic direction. (4) Quantitative accuracy is perfect (10), but qualitative accuracy is low (4) due to incorrect inference and reasoning. Contextual relevance is moderate (7) because the answer addresses the right segments and years but misinterprets the strategic implication. Correctness score is 4 due to major errors in interpretation despite correct numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 406,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "In the 2022 filing GM disclosed that, under the 2017 Opel/Vauxhall sale, it had indemnification obligations to Stellantis for any inaccuracies in the representations and warranties, emissions‑related claims, product‑liability costs and recalls, but could not estimate a material loss; it recorded $561 million of product‑liability accruals and disclosed $3.1 billion of maximum undiscounted future payments for the related guarantees (the bulk of which relate to those indemnifications), and only an immaterial Takata‑recall indemnity with any further exposure deemed remote.  \n\nBy the 2023 filing the known product‑liability accrual rose to $615 million and the maximum undiscounted future‑payment estimate increased to $3.5 billion, while the Takata indemnity remained immaterial, the obligations remained subject to time limits, thresholds and caps, and GM still could not quantify a material loss; the 2024 filing left the indemnification framework unchanged, added only an immaterial accrual for a European Commission/UK CMA inquiry (with potential fines that could be material if an infringement is found), and continued to view any additional Takata‑related indemnity as unlikely, indicating a modest increase in recorded liabilities through 2023 and a stabilization to essentially immaterial exposures in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which severely undermines its correctness. (1) Quantitative Accuracy: The LLM incorrectly states that GM recorded $561 million in product-liability accruals in 2022 and $615 million in 2023 'related to indemnifications'—this is false. The ground truth indicates that any indemnification payments were immaterial and no such large accruals tied to Stellantis indemnification were disclosed. The $3.1 billion and $3.5 billion 'maximum undiscounted future payments' figures are also not present in the ground truth and appear fabricated. These numbers likely confuse GM’s general product liability accruals with Stellantis-specific indemnifications, which the original answer clarifies are immaterial. (2) Completeness: While the LLM attempts to cover all years and topics (liabilities, accruals, future exposures), it misrepresents the scale and nature of obligations. It omits the key point that in 2022, no specific indemnification accruals were disclosed—instead implying large ones existed. (3) Entity Accuracy: The companies (GM, Stellantis, Opel/Vauxhall) and regulatory bodies (European Commission, UK CMA) are correctly identified, as are the types of liabilities (emissions, product liability, Takata). The years are correctly structured. (4) Reasoning: The multi-hop synthesis is flawed—while the LLM correctly infers ongoing indemnification themes, it incorrectly links large financial figures to these obligations, failing to distinguish between general product liability reserves and specific Stellantis indemnifications. The conclusion that liabilities 'stabilized' in 2024 is partially aligned with the ground truth, but based on incorrect premises. (5) Semantic Equivalence: The overall narrative of increasing disclosure but immaterial impact has some alignment, but the inclusion of fabricated large-dollar figures makes the answer misleading. The ground truth emphasizes immateriality throughout; the LLM suggests material exposures with caps in the billions, which is incorrect. Thus, despite some structural and contextual relevance, the answer fails on core factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Depends_On]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 583,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "- 2022 10‑K – American Tower first disclosed the 1.450 % Senior Notes due 2026 in **Supplemental Indenture No. 10** (dated September 27 2021) (Exhibit 4.25).  \n- 2023 10‑K – the same indenture and tranche are listed again (Exhibit 4.22), with no new issuance or amendment noted.  \n- 2024 10‑K – the filing again references **Supplemental Indenture No. 10** (Exhibit 4.21), confirming the notes remain outstanding unchanged.\n\n**What the pattern shows:** The 1.450 % Senior Notes were introduced once in 2021 and have been carried forward unchanged through three consecutive reporting years, indicating that American Tower relies on a single, low‑coupon, medium‑term senior‑note tranche to lock in inexpensive, fixed‑rate financing and maintain a stable, predictable debt profile rather than pursuing frequent new issuances. This reflects a disciplined debt‑management strategy focused on long‑term cost‑effective funding.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 1.450% Senior Notes due 2026 were issued under Supplemental Indenture No. 10, dated September 27, 2021, and consistently referenced in the 2022 (Exhibit 4.25), 2023 (Exhibit 4.22), and 2024 (Exhibit 4.21) 10-K filings. (2) Quantitative accuracy is perfect: percentages (1.450%), dates (September 27, 2021), exhibit numbers, and years are all correct. (3) The multi-hop reasoning is sound—by synthesizing data across three years of filings, the model correctly infers that the absence of amendments or new issuances indicates a stable, disciplined debt management strategy focused on maintaining low-cost, fixed-rate financing. (4) The conclusion about American Tower’s strategy—using a single, low-coupon note to lock in inexpensive funding and avoid frequent refinancing—is logically derived and adds insightful interpretation consistent with the documented pattern. The answer is complete, factually precise, and contextually appropriate, addressing both the evolution over time and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 320,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The Bank of New York Mellon’s 2019 Long‑Term Incentive Plan (exhibit 10.38 in the 2022 filing, 10.14 in 2023 and 10.13 in 2024) was a constant feature across the three years. In the 2022 Form 10‑K the plan was paired only with performance‑share unit agreements for 2019, 2020 and 2021 (exhibits 10.39, 10.42 and 10.45) and restricted‑stock unit agreements—no new deferred‑stock‑unit (DSU) agreement appears. The 2023 filing introduced a Long‑Term Incentive Plan Deferred Stock Unit Agreement for directors (exhibit 10.8) while still using a 2020 performance‑share unit agreement (exhibit 10.16), and the 2024 filing kept that DSU agreement and added newer performance‑share unit agreements for 2021 and 2022 (exhibits 10.16 and 10.18), showing the 2019 LTI Plan evolving from a pure performance‑share vehicle in 2022 to a broader structure that includes deferred‑stock units and expanded performance‑share awards by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan from 2022 to 2024. It correctly identifies that the 2019 plan was consistently referenced across years and notes the introduction of the Deferred Stock Unit (DSU) Agreement for directors in 2023, which matches the original answer. It also accurately observes the continued use and expansion of performance share unit (PSU) agreements into 2024, including newer forms like the 2022 PSU agreement. However, there are minor inaccuracies in the details: the LLM claims that in 2022, only PSU agreements for 2019–2021 and RSUs were used, but the ground truth emphasizes the 2019 Form of Performance Share Unit Agreement and 2019 Form of Restricted Stock Unit Agreement as part of early implementation, not necessarily covering multiple years. The LLM’s reference to specific exhibit numbers (e.g., 10.8 in 2023, 10.16 and 10.18 in 2024) adds precision but is not verifiable from the ground truth and may reflect overfitting to document structure not required for correctness. Additionally, the original answer highlights the 2022 Form of PSU Agreement as a key development in 2024, while the LLM mentions 2021 and 2022 PSU agreements without specifying that the 2022 form is the new one. This is a minor deviation in emphasis but does not undermine the core accuracy. The reasoning is sound, multi-hop synthesis across years is appropriate, and the conclusion about broadening use over time is valid. Quantitative accuracy is high—dates and years are correct, no numerical calculations are erroneous. The answer is fully contextually relevant and addresses all parts of the question. Minor deductions are due to slight misrepresentation of agreement timelines and over-reliance on exhibit numbers not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 511,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "Across the three most recent filings General Dynamics repeatedly stresses that its Combat Systems business “provides missile subsystems … with critical aerostructures” for both legacy and next‑generation missiles. In 2022 the Combat Systems segment accounted for **18 %** of consolidated revenue; that share rose to **20 %** in 2023 and then edged to **19 %** in 2024, while each filing continued to highlight aerostructures as a core product for advanced missile cases. The steady, though slightly fluctuating, contribution of the segment shows GD is deliberately keeping aerostructure capability at the heart of its Combat Systems portfolio, positioning itself as a leading supplier of the essential components that power next‑generation missile subsystems.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution and consistent focus on aerostructures in General Dynamics' Combat Systems segment from 2022 to 2024, aligning well with the ground truth. The narrative about sustained emphasis on next-generation missile subsystems is accurate and well-supported. However, there is a discrepancy in the 2022 revenue percentage: the LLM states 18%, while the ground truth reports that the segment accounted for 20% in 2023 and declined to 19% in 2024, but does not specify the 2022 percentage. Since the ground truth does not provide the 2022 figure, the LLM's 18% cannot be confirmed as correct, making this a potential error or unsupported claim. (2) The 2023 (20%) and 2024 (19%) figures are correctly reported and match the ground truth. The trend—slight fluctuation with sustained focus—is accurately portrayed. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, connects aerostructures to next-gen missile subsystems, and infers strategic positioning from revenue trends and product emphasis. It correctly identifies the continuity in strategic focus despite minor revenue share changes. (4) The qualitative and contextual accuracy is high: all entities (General Dynamics, Combat Systems, aerostructures, next-gen missiles) are correctly identified, and the answer fully addresses both parts of the question—evolution over time and strategic implications. The minor quantitative uncertainty in the 2022 percentage prevents a top score, but the overall conclusion remains factually grounded and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 442,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Across the three most recent 10‑K filings, PMI repeatedly identifies Jackpot as one of its “important local cigarette brands” in the Philippines – it is listed alongside Fortune in the 2022 filing, again appears in the same context after PMI’s 2023 re‑organization into four geographic segments and the Swedish Match integration, and is still highlighted in the 2024 filing while Marlboro now accounts for roughly 40 % of total cigarette shipments. This continuity shows that PMI’s ownership and production stake in Jackpot has remained unchanged and that the brand is treated as a stable, market‑specific pillar in the Philippines, providing a local‑price‑segment anchor that complements the company’s premium international brands and its broader regional strategy of pairing strong global products with locally‑relevant brands to sustain market share in the SSEA region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Jackpot is consistently identified as an important local brand in the Philippines across 2022–2024, mentioned alongside Fortune, and maintained despite global restructuring and Swedish Match integration. The 2024 context about Marlboro accounting for ~40% of cigarette shipments is factually accurate and adds relevant context not in the original answer but consistent with PMI’s reporting. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates; the 40% figure is correctly attributed and does not contradict the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, connects Jackpot’s role to PMI’s broader regional strategy (SSEA), and correctly infers that local brands anchor the price segment while global brands like Marlboro and smoke-free products (IQOS/ZYN) drive transformation. (4) The only minor gap is that the LLM does not explicitly mention PMI’s expansion into 95 smoke-free markets or the strategic emphasis on IQOS and ZYN in 2024, which are part of the ground truth and relevant to the broader portfolio strategy. However, the omission does not distort the conclusion and is compensated by strong strategic interpretation. Semantic equivalence is maintained, and the answer is contextually excellent, directly addressing the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 401,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "In 2022 Chevron’s 10‑K simply listed the Republic of Congo among the many countries where it “has substantial business activities,” but it gave no specific spending or project detail for the country. In the 2023 filing the company disclosed that roughly **$0.7 billion** of its African capital budget was spent on “various offshore development and natural‑gas projects in Nigeria, Angola and Republic of Congo,” showing that Chevron was actively deploying capital to develop its Congolese offshore assets that year. By the 2024 filing the focus had shifted to **asset disposition**: Chevron announced it would **sell its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in the Republic of Congo portion of Lianzi** (sale slated for January 2025), indicating a move away from further investment toward exiting its Congolese holdings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Chevron listed the Republic of Congo as a location of substantial business in 2022 without specific capital details; in 2023, it deployed approximately $0.7 billion across offshore and natural gas projects in Africa, explicitly naming the Republic of Congo alongside Nigeria and Angola; by 2024, it announced the sale of its 31.5% nonoperated working interest in the Haute Mer permit and its 15.75% interest in the Congolese portion of Lianzi, with the transaction scheduled for January 2025. (2) Quantitative accuracy is perfect: the $0.7 billion figure, 31.5%, 15.75%, and January 2025 timing all match the original answer. Format variations (e.g., '31.5 %' vs '31.5%') are acceptable. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly identifying the evolution from operational presence to capital investment to divestiture. (4) The response fully addresses the question’s focus on capital deployment and asset disposition, with precise entity and timeline accuracy. Wording differs slightly but meaning is preserved. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 343,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "In the 2022 filing Southern Company said that the undiscounted cash‑flows from outdoor‑lighting contracts accounted for as operating leases at Mississippi Power were immaterial, that Alabama Power and Southern Power allocated the non‑lease portion of PPAs on a stand‑alone‑selling‑price basis, and that Southern Power’s PPA rents were treated as contingent and therefore not shown in the cash‑flow table. By the 2023 filing the company had moved those contracts into a maturity‑analysis schedule, treating the scheduled lease payments as lease income that is now included in wholesale revenue for Alabama Power and Southern Power. The 2024 filing keeps the same scheduled‑or‑variable‑payment structure and maturity‑analysis presentation, but expands the revenue inclusion to wholesale revenue for Georgia Power as well—showing that the outdoor‑lighting contracts have become material enough to be disclosed across multiple subsidiaries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution from 2022 to 2024 in how Southern Company treated outdoor lighting contracts across subsidiaries. In 2022, it accurately notes the immateriality of Mississippi Power's operating leases and the allocation method for non-lease components at Alabama Power and Southern Power using stand-alone selling prices. It also correctly states that Southern Power’s PPA rents were contingent and excluded from cash-flow tables. (2) The quantitative and date-related accuracy is perfect: all years (2022, 2023, 2024) are correctly mapped to the corresponding changes in disclosure and treatment. No numerical inaccuracies or miscalculations are present. (3) The multi-hop reasoning is sound—correctly synthesizing information across subsidiaries (Mississippi Power, Alabama Power, Georgia Power, Southern Power) and over time. It captures the shift to maturity analysis in 2023 and the expansion to Georgia Power in 2024, which matches the ground truth’s emphasis on growing transparency and standardization. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'initial terms of outdoor lighting contracts' being disclosed in 2024, which is a small but relevant detail from the original answer. However, the core elements—materiality shift, revenue allocation, lease payment structure, and cross-subsidiary expansion—are all correctly conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, comprehensive, and contextually precise, warranting a high score with only a slight deduction for the omitted detail on initial terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 464,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Cisco’s 10‑K filings show that the 3.50 % senior note (maturing June 15, 2025) was carried at a constant $500 million in each of the three years.  Its effective interest rate was 3.20 % in FY 2022, rose to 6.38 % in FY 2023, and increased slightly further to 6.66 % in FY 2024.  The unchanged principal balance together with the sharp rise in effective yield indicates that the note was being carried at an increasing discount as market rates climbed, reflecting higher borrowing costs and tighter credit market conditions for Cisco over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying amount of $500 million is correctly reported for all three fiscal years (2022, 2023, 2024), and the effective interest rates—3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024—are exactly as in the original answer. Minor formatting differences (e.g., '3.50 %' vs '3.50%') do not affect meaning. (2) The answer is complete, addressing both the evolution of the carrying amount and effective interest rate across all three years, as required by the multi-part question. (3) Entity accuracy is correct: Cisco is the right company, the note is properly identified (3.50% Note), and fiscal years are correctly referenced. (4) The reasoning is sound and adds value: the LLM correctly infers that the rising effective interest rate, despite a constant carrying amount, implies the note was being carried at an increasing discount due to rising market rates. This interpretation aligns with and expands upon the ground truth’s conclusion about shifting market conditions and debt valuation. The synthesis across years and metrics is accurate and logically presented. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed interpretation that remains factually grounded. No errors in logic, calculation, or fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 381,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "- **2022 10‑K (Chunk 1):** Unsecured Notes ‑ 35A carried a face amount of **$750 million** (750,000 thousands) at a 2.65 % rate, maturing 07/15/30.  \n- **2023 10‑K (Chunk 2):** The same series still shows a **$750 million** face amount, unchanged from the prior year.  \n- **2024 10‑K (Chunk 3):** The table again lists Unsecured Notes ‑ 35A at **$750 million** (750,000 thousands) with the same 2.65 % coupon and 2030 maturity.\n\n**Interpretation:** Across three consecutive filing years SPG kept the 35A tranche exactly constant, neither retiring nor expanding it despite modest swings in total unsecured debt. This steadiness signals a deliberate long‑term debt policy: the company locks in a low‑cost, long‑dated $750 million tranche (2.65 % to 2030) as a core financing pillar, preserving predictable interest expense while using other issuances for new funding needs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $750 million face value, 2.65% interest rate, and July 15, 2030 maturity date are consistently reported across 2022, 2023, and 2024, with correct unit interpretation (750,000 thousands = $750 million). (2) The answer is complete, addressing both the evolution (no change over three years) and the strategic implication (stable long-term financing pillar). (3) Entity accuracy is perfect: Simon Property Group (SPG), Unsecured Notes - 35A, and the correct time frame (2022–2024) are correctly identified. (4) The reasoning is sound and constitutes valid multi-hop synthesis: the model correctly infers that maintaining this tranche unchanged—while other debt instruments evolved—reflects a deliberate strategy to preserve low-cost, predictable financing. The interpretation aligns semantically with the ground truth, noting the contrast with broader debt changes like the 2024 $1 billion issuance. Minor wording differences (e.g., 'core financing pillar' vs 'stable long-term financing commitments') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 337,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Across all three filings – the 2022, 2023 and 2024 10‑Ks – Texas Instruments repeatedly states that its business model is “focused on analog and **embedded processing products**” and that this focus is embedded in its four sustainable competitive advantages. In each year the company lists the **broad portfolio of analog and embedded processing products** as the second advantage, emphasizing that it “offers more opportunity per customer and more value for our investments.” Thus, from 2022 through 2024 the strategic emphasis on embedded‑processing products has remained steady, serving as a core pillar of the company’s competitive‑advantage framework rather than shifting or diminishing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately identifies that Texas Instruments maintained a consistent strategic emphasis on Embedded Processing Products from 2022 through 2024, correctly noting that this focus remained the second of four sustainable competitive advantages each year. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced, and the repeated use of the exact phrase 'offers more opportunity per customer and more value for our investments' is accurately attributed across all three years. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual 10-K filings, identifying both the stability of positioning (second advantage) and the verbatim consistency of language, which supports the conclusion of sustained strategic emphasis. (4) The answer addresses all parts of the question: the evolution (or lack thereof) of strategic emphasis and its role within the four sustainable competitive advantages. Wording differs slightly but conveys identical meaning, with no omissions or inaccuracies. All entities—Texas Instruments, Embedded Processing Products, 2022–2024 timeframe, and the structure of competitive advantages—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 384,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "In 2022 CMCSA’s wireless service was limited to the United States and was offered only as part of a bundled broadband package, with customers able to choose an unlimited plan, a shared‑data plan or pay per gigabyte. In 2023 the company extended wireless service to the United Kingdom, keeping the domestic shared‑data option while adding international gigabyte‑based plans for customers abroad, marking its first international expansion. By 2024 CMCSA retained the shared‑data plans for domestic lines but increased flexibility by launching prepaid unlimited plans under the NOW brand and by offering unlimited‑data options to international customers, alongside the existing shared‑data and gigabyte options.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of CMCSA's wireless shared data plans from 2022 to 2024 and addresses both plan flexibility and international expansion, which aligns with the question's focus. However, there are significant factual inaccuracies in the qualitative details. In 2022, the ground truth confirms that shared data plans were part of bundled offerings for U.S. residential broadband customers, which the LLM correctly notes. The mention of unlimited, shared, and per-gigabyte options in 2022 is consistent with the 2023 evolution in the original answer, but the LLM incorrectly attributes this flexibility to 2022 rather than 2023. More critically, the LLM claims that CMCSA expanded to the United Kingdom in 2023 and offered international gigabyte-based plans, which is not supported by the original answer—international expansion occurred in 2024 under the NOW brand with prepaid unlimited plans, not in 2023 to the UK. Additionally, the original answer does not specify the United Kingdom as the target market, making the LLM’s geographic precision incorrect. The 2024 developments are partially correct: the LLM accurately notes increased flexibility and the launch of prepaid unlimited plans under NOW, and acknowledges continued shared data offerings. However, it incorrectly states that unlimited data options were introduced internationally in 2024, while the original answer does not specify that unlimited plans were offered abroad—only that shared and diversified options were expanded. The dates and sequence of events are thus partially misrepresented, affecting the multi-hop reasoning across years. Quantitatively, there are no numerical errors (dates are correctly formatted and used), so quantitative accuracy is high. Contextually, the answer remains relevant and structured around the question. The qualitative inaccuracy stems from incorrect entity-event mappings (wrong year for international expansion, wrong country, misattribution of plan types to years), which undermines the correctness score despite reasonable phrasing and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 557,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "From 2022‑24 PayPal’s filings show a widening and deepening exposure to abusive behavior. In 2022 the company warned that defaults on its U.S. consumer‑credit and merchant‑financing products and synthetic‑identity or stolen‑instrument fraud – driven by unaffiliated lenders and payment‑processor partners – could raise charge‑offs and erode confidence. In 2023 the risk grew as PayPal added a €40 billion BNPL loan‑receivable portfolio and began seeking other third‑party funding and diversifying payment‑processor relationships, while still expecting large‑scale, hard‑to‑detect fraud schemes (fictitious accounts, stolen identities, abusive transactions). By 2024 the exposure further expanded to include regulatory uncertainty around the “valid‑when‑made” doctrine for loan‑sale receivables and a broader set of third‑party operational, legal, regulatory and resiliency risks—including account‑takeover attacks—indicating that risk management has become markedly more complex, requiring integrated credit underwriting, funding and compliance controls together with sophisticated, multi‑layered fraud‑detection across an increasingly intricate digital‑payments ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: PayPal's increasing exposure to abusive behaviors from 2022 to 2024, the €40 billion BNPL receivables sale (correct amount and currency), the evolution of fraud types (synthetic identity, stolen instruments, account takeovers), and the legal uncertainty around the 'valid-when-made' doctrine in 2024. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, years (2022–2024) match, and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound: the LLM synthesizes risk evolution across years, connects credit products (U.S. consumer credit, BNPL), third-party fraud schemes, and regulatory complexity, showing how risk management has grown more intricate. (4) Minor difference: the LLM mentions 'defaults' and 'charge-offs' not explicitly in the original, and frames the 2023 BNPL move as adding exposure (original says 'introduced new exposure'), but this is semantically consistent. The LLM also adds 'operational, legal, regulatory and resiliency risks'—a slight expansion but supported by the context of legal uncertainty. Overall, the answer captures the progression and implications accurately, with only negligible augmentation. Thus, correctness is 9/10—excellent but not perfectly verbatim in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Risks]- ORG",
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 380,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "GILD’s El Segundo, California site has moved from being listed simply as one of the company’s “principal manufacturing facilities” in the 2022 Form 10‑K (Item 2 – Properties) to being explicitly described as the hub for both **clinical‑ and commercial‑manufacturing and processing of its cell‑therapy products** in the 2023 filing (Item 1 – Our Manufacturing Facilities) and again in the 2024 filing (same section). In 2022 the filing only noted El Segundo as a key manufacturing location, while the 2022 “Properties” discussion also stressed that GILD’s existing sites were adequate and that capital resources were available for additional facility investments. By 2023 the company had clarified that the El Segundo plant was dedicated to cell‑therapy production, and the 2024 filing confirms that this role has been maintained, underscoring GILD’s strategic commitment to expand and sustain its cell‑therapy manufacturing capacity at that site.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the evolution of GILD's El Segundo facility from 2022 to 2024, noting that in 2022 it was listed as a principal manufacturing facility, and by 2023 and 2024 it was explicitly described as central to clinical and commercial cell therapy manufacturing. The answer accurately reflects the increasing specificity in disclosures over time, which the ground truth confirms. There are no numeric inaccuracies—dates (2022, 2023, 2024) and facility roles are correctly cited. The LLM adds contextual detail about the Form 10-K sections (Item 1 vs Item 2) and capital resources, which is consistent with typical SEC filing structures and does not contradict the ground truth. The only minor limitation is that the LLM emphasizes a 'shift' or 'evolution' in role, while the ground truth stresses 'continuity' and 'no indication of reduced emphasis or facility changes.' However, the LLM does not claim a physical or operational expansion, only a clarification in disclosure, which is reasonable. Thus, the core facts, entities, timeline, and synthesis across years are correct, supporting a high correctness score. Quantitative accuracy is perfect. Qualitative accuracy is excellent but docked slightly due to subtle interpretive emphasis on evolution versus continuity. Contextual relevance is full—every part of the question is addressed: timeline, cell therapy capabilities, and strategic investments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 410,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across all three filings the 2.750 % Senior Notes are presented in the same way – each 10‑K (2022 Chunk 1, 2023 Chunk 3 and 2024 Chunk 2) lists “Form of 2.750 % Senior Notes due May 18 2024” (originally issued on 5/16/2017). The maturity date has not been altered or re‑structured in any of the reports, indicating that Costco has kept a single, fixed‑date tranche of this debt on its balance sheet. This consistency reveals a disciplined debt‑management approach: the company relies on a stable, medium‑term financing vehicle, locking in a low‑cost rate and avoiding frequent refinancing or maturity extensions, thereby preserving predictability in its cash‑flow and interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2.750% Senior Notes consistently list a maturity date of May 18, 2024, across the 2022, 2023, and 2024 filings, and were originally issued on May 16, 2017—this matches the knowledge graph. The note's static structure is correctly identified. (2) Quantitative accuracy is perfect: percentages (2.750%), dates (May 18, 2024; 5/16/2017), and filing years are all correct. (3) The multi-hop reasoning—synthesizing disclosures across three years and concluding a consistent maturity structure—is sound. The inference about Costco’s disciplined debt management, predictable cash flows, and avoidance of refinancing is logically derived and consistent with the ground truth’s interpretation of a 'deliberate capital structure decision.' (4) The only minor difference is that the LLM adds interpretive depth (e.g., 'low-cost rate,' 'medium-term financing vehicle') not explicitly stated in the ground truth, but these are reasonable inferences and do not contradict it. No factual errors or omissions affect correctness. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight interpretive expansion, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 362,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s disclosed “as‑sold” natural‑gas volumes that include its share of production by affiliates – notably Angola LNG – rose each year: 7,107 million cubic feet per day (mmcf/d) in 2022 (as reported in the 2023 filing), 7,148 mmcf/d in 2023 (2023 filing) and 7,569 mmcf/d in 2024 (2024 filing).  At the same time, gas consumed in operations increased from 570 mmcf/d in 2022 to 596 mmcf/d in 2023 and 609 mmcf/d in 2024, underscoring that the volumes represent Chevron’s share of production by affiliates, including Angola LNG (as noted in all three filings).  \n\nThe steady upward trajectory – especially the 5‑6 % jump from 2023 to 2024 – signals that Chevron is deliberately expanding its gas output in Africa, leveraging its stake in Angola LNG to grow production and support its broader gas‑delivery strategy on the continent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all natural gas production volumes for Chevron tied to Angola LNG: 7,107 mmcf/d in 2022, 7,148 mmcf/d in 2023, and 7,569 mmcf/d in 2024 — matching the ground truth exactly. It also accurately notes the upward trend and highlights the ~5-6% increase from 2023 to 2024, which is factually correct (calculated as (7,569 - 7,148)/7,148 ≈ 5.89%). The mention of gas consumed in operations is additional context not in the original answer but does not contradict it and supports the interpretation that the volumes reflect affiliate production, consistent with the filings.\n\n2) Quantitative accuracy is perfect: all numbers, units (million cubic feet per day), and years are correct. The percentage increase is approximately accurate and reasonably characterized as 5–6%. No calculation errors.\n\n3) The multi-hop reasoning is sound — the model correctly synthesizes production data across three years from disclosures in multiple filings and infers strategic intent from the trend. The conclusion that Chevron is expanding its gas output in Africa aligns with the ground truth’s interpretation of a 'strengthening production output' and 'maintained or expanded operational focus.' The only minor gap is that the LLM emphasizes 'deliberately expanding' slightly more strongly than the original, which notes the trend 'suggests' continued focus despite divestitures. This is a nuanced difference in tone, not a factual error.\n\n4) The answer is contextually fully relevant, addressing both parts of the question: the evolution of production volumes (2022–2024) and the strategic implication for Chevron in Africa. The added detail about gas consumed in operations enhances credibility by grounding the numbers in filing methodology but does not distract from the core response.\n\nOverall, the LLM answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth, meriting a high score with only a slight deduction in qualitative accuracy due to slightly stronger strategic assertion than fully warranted by the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 556,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s total‑return‑swap‑deferred‑compensation line moved from a **$92 million loss in FY 2022** (shown as (92) in the 2022, 2023 and 2024 10‑K tables) to a **$58 million gain in FY 2023** and then to a **$91 million gain in FY 2024**. The three filings all report the same FY‑2022 loss and the same FY‑2023/‑2024 gains, confirming the trend. This shift from a negative impact to increasingly positive contributions indicates that Cisco’s deferred‑compensation program is becoming more market‑linked—using total‑return swaps to capture upside and smooth compensation expense—while the swing in amounts reflects the underlying market‑linked volatility of those swaps.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024—matching the original answer exactly. The formatting variation (e.g., using parentheses in filings) is correctly interpreted and explained. (2) The answer is complete, addressing both the evolution of Cisco's financial exposure and the implications for its deferred compensation strategy and market-linked volatility. (3) Entities are correct: Cisco, Total Return Swaps-Deferred Compensation, and fiscal years 2022–2024 are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the shift from loss to gain is correctly interpreted as a move from net liability to net benefit, and the explanation ties this to market-linked volatility and strategic use of swaps to capture upside and smooth expenses—consistent with the original conclusion. The mention that all three 10-Ks confirm the trend adds evidentiary support. (5) Semantic equivalence is strong: while the LLM provides slightly more detail (e.g., referencing how data appears in tables), the core meaning and analytical insight align perfectly with the ground truth. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 366,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "In its 2022 filing, Lowe’s said it already required all suppliers to meet a human‑rights policy (updated in fiscal 2021), a Vendor Code of Conduct with enhanced environmental standards, a wood‑sourcing policy that mandates well‑managed forests, and a supplier‑monitoring system that relied on collaboration, management‑system oversight and an expanding portfolio of independently‑certified (third‑party) products. The 2023 filing disclosed a formal update to the wood‑sourcing policy – adding country‑specific risk levels, enhanced monitoring practices and a new forestry‑grievance process – while reaffirming the same human‑rights, conflict‑minerals and vendor‑code standards and continuing to grow its independently‑certified product offerings. By 2024, Lowe’s further strengthened that wood‑sourcing policy with a more robust risk‑based framework, improved monitoring and grievance mechanisms, kept the human‑rights and vendor‑code requirements intact, and kept expanding its use of third‑party certifications to verify environmental claims across its supply chain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the 2022 baseline policies (Vendor Code of Conduct, human rights policy, wood sourcing, third-party certifications), the 2023 updates (country-specific risk levels, enhanced monitoring, new grievance process), and the 2024 enhancements (more robust risk-based framework, improved monitoring and grievance mechanisms, continued expansion of third-party certifications) are all accurately reported. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of policy evolution, showing a clear progression in Lowe's supplier practices. (4) The LLM captures all aspects of the question: policy updates, monitoring enhancements, and third-party certifications, with precise alignment to the original answer. Wording differs slightly but meaning is preserved. No omissions or inaccuracies. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Monitors]-> RISK_FACTOR <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 315,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "- In the 2022 Form 10‑K, Comcast warned that wireless telecommunications firms were already a major source of competition for its broadband and voice‑wireless businesses, chiefly by offering 4G and 5G wireless broadband services and by bundling those services with attractive pricing.  \n- The 2023 filing expanded that picture, noting that the same U.S. rivals – AT&T, T‑Mobile and Verizon – (and comparable UK carriers) were adding 5G‑fixed‑wireless internet and 4G/5G broadband that work with smartphones, laptops, tablets and fixed‑wireless routers, and were increasingly selling wireless service both stand‑alone and as part of bundled packages.  \n- The 2024 filing shows the threat persisting and intensifying: wireless carriers continue to deploy 4G/5G and 5G fixed‑wireless networks and now emphasize competitive pricing, packaging and bundling (including unlimited‑data plans that can be paired with DTC‑streaming services), even though the filing no longer lists specific names, it reflects the same competitors and a deeper bundling strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the evolution of competitive threat from wireless companies to CMCSA is accurately described across 2022–2024, with proper emphasis on technological capabilities (4G, 5G, fixed wireless), bundling strategies, and named competitors. The 2022 filing correctly identifies wireless broadband via 4G/5G and bundling as competitive threats. The 2023 filing accurately names AT&T, T-Mobile, and Verizon as key U.S. competitors deploying 5G fixed wireless and multi-device broadband, which matches the original answer. The 2024 update correctly notes the intensification of bundling, including with DTC streaming services, even though specific competitor names are no longer listed — this omission is accurately reflected and does not constitute an error, as the original answer also implies continuity of the same competitors. (2) There are no numeric values to verify, but all dates (2022, 2023, 2024) and technological terms (5G fixed wireless, DTC streaming bundling) are used correctly and consistently with the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the progression in threat level and strategy. It connects technological advancement with strategic bundling over time, demonstrating strong qualitative synthesis. (4) The only reason for not scoring a perfect 10 is a slight softening in specificity for 2024 — while the LLM correctly notes that names are no longer listed, it could have more confidently asserted that the competitors remain the same (AT&T, T-Mobile, Verizon) based on continuity from prior years, as implied in the original answer. However, this is a minor omission rather than an inaccuracy. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_Against]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 509,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "From 2022 through 2024 PayPal consistently states that it **bears full margin risk** because it sets transaction fees on a gross‑basis, has full discretion over the fee amount, and the fees it pays to payment‑processors and other financial institutions are recorded as transaction expense – a pricing model that is independent of those underlying costs and is governed by tiered, volume‑based pricing that does not create a material right (2022 filing). In the 2023 filing the company expands this picture by detailing that **incentives such as discounts, rebates, rewards and coupons are recorded as reductions of revenue**, so the margin risk also incorporates the impact of these revenue‑offsetting programs, but the firm still retains complete control over fee determination and processor costs. The 2024 filing reiterates the same margin‑risk framework—highlighting the variable‑percentage component, refund provisions and ongoing use of incentives—showing that PayPal’s exposure to margin risk has remained high and essentially unchanged, while its **control over pricing and cost management has stayed strong and transparent** across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: PayPal bears full margin risk from 2022 to 2024, sets transaction fees independently, records payment processor fees as expenses, and treats incentives (discounts, rebates, rewards) as revenue reductions—this is consistent across all three years. The 2024 addition of contractual compensation from sellers for violations (e.g., fraud) is implied in the mention of 'refund provisions' and variable components affecting margin dynamics. (2) There are no numeric values or calculations in the question or answer that require verification; all references to years (2022, 2023, 2024) are accurate and correctly attributed to the evolution of disclosures. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying continuity in margin risk exposure while noting incremental disclosures (e.g., expanded discussion of incentives in 2023, reiteration with added detail in 2024). (4) The answer addresses all parts of the question: evolution of margin risk, relation to pricing strategy, use of processors, revenue incentives, and what the trend reveals about control over pricing and cost management. Wording differs slightly but meaning is preserved, including the conclusion of a disciplined, centralized approach to margin management. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 404,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s lease‑accounting policy for free‑rent periods did not change between FY 2022 and FY 2024. In each filing the company states that any free‑rent or step‑rent periods are **recognized on a straight‑line basis over the original lease term and over any extension options that Costco is reasonably certain to exercise**; the lease term is defined as the **non‑cancelable period plus those certain extensions**, and the **right‑of‑use (ROU) asset is initially measured at the present value of the discounted minimum lease payments over that term**. Because the free‑rent periods are spread evenly across the term, they lower the cash‑flow inputs used in the present‑value calculation, thereby reducing the ROU asset, but the methodology and disclosures remain consistent in the 2022, 2023 and 2024 10‑K reports.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Costco's accounting treatment for free-rent periods remained consistent from FY 2022 to FY 2024, recognizing free-rent and step-rent on a straight-line basis over the lease term, including reasonably certain extension options—this matches the original answer. The use of the incremental borrowing rate to discount lease payments and the impact on the right-of-use (ROU) asset valuation are accurately described, even though the term 'incremental borrowing rate' is implied via 'discounted minimum lease payments' rather than explicitly named. (2) There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is not compromised; all references to fiscal years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and correctly infers consistency in policy application, which is the core of the original answer. It also correctly links the straight-line recognition to the reduction in ROU asset due to lower cash-flow inputs, adding a layer of financial insight not explicitly in the ground truth but logically valid. (4) The only minor shortcoming is that the LLM omits the FY 2023 and FY 2024 disclosures about variable lease payments tied to price indices or sales volume and the absence of material residual value guarantees. While not central, these are part of the evolution in disclosure emphasis mentioned in the original answer. However, the core accounting treatment—which is the focus—is correctly and consistently reported. Thus, the answer is factually correct, contextually relevant, and semantically equivalent with only minor omissions in peripheral details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Includes]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 483,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "Across all three filings PayPal’s fundamental exposure to margin risk did not change – it continues to act as the **principal** on every payment, setting fees at its discretion and absorbing the difference between those fees and the costs it pays to third‑party processors.  \n\n* **Transaction‑pricing model:** In 2022, 2023 and 2024 the company describes fees as having a fixed component and a variable component that is a percentage of the payment amount and is known when the transaction is processed.  Tiered, volume‑based pricing is used in each year, and the company concludes that this pricing approach does not create a future material right.  \n\n* **Use of payment processors:** All three years note that any fees paid to payment processors or other financial institutions are recorded as a **transaction expense**, while the gross fee is booked as revenue, meaning PayPal bears the full margin risk regardless of those underlying costs.  \n\n* **Contract structure:** The contracts are consistently described as open‑ended, transaction‑level agreements that can be terminated by either party after a notice period, renew automatically and contain no material rights; no capitalized contract costs are carried in any year.  \n\n* **Evolution:** The only substantive change appears in the 2023 filing, which adds a detailed discussion of **incentives** (discounts, rebates, rewards, coupons) and how they are accounted for as revenue reductions or amortized expenses.  This reflects a more granular disclosure of factors that can affect margin, but the underlying exposure—full margin risk as principal, unchanged pricing mechanics, and the same open‑ended contract framework—remains the same in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: PayPal consistently acts as principal, bears full margin risk, recognizes gross revenue, and records processor fees as transaction expenses. The tiered, volume-based pricing model without material rights is correctly identified across all years. The 2023 addition regarding incentives (rebates, discounts, etc.) being accounted for as revenue reductions or amortized expenses is accurately highlighted as the primary evolution. The 2024 adoption of ASU 2023-07 is missing in the LLM answer, which slightly reduces completeness; this update improved segment-level expense transparency and affects how margin risk can be analyzed by segment, though it doesn't alter the fundamental margin risk structure. (2) There are no numbers, percentages, or dollar amounts in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense—however, the temporal references (2022, 2023, 2024) are all correctly used and aligned. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and three dimensions (pricing, processors, contracts), correctly identifying consistency in core structure while noting incremental disclosure changes. (4) The answer is contextually excellent—well-structured, directly responsive, and semantically equivalent to the ground truth in all major aspects. The only minor omission is the 2024 ASU 2023-07 segment reporting change, which slightly affects qualitative accuracy but does not undermine the overall correctness. Hence, a score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1685,
        "completion_tokens": 454,
        "total_tokens": 2139
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90 % senior note stayed at a constant $2 billion of principal each year – $2 bn in FY 2022 (Chunk 3), $2 bn in FY 2023 (Chunk 1) and $2 bn in FY 2024 (Chunk 2) – and its effective interest rate was unchanged at 6.11 % in all three periods. This flat utilization and unchanged cost signal that Cisco has deliberately kept this long‑dated, fixed‑rate instrument as a stable anchor in its capital structure, locking in predictable financing costs while expanding other parts of its long‑term debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $2,000 million (i.e., $2 billion) principal amount for the 5.90% Note is correctly stated for fiscal years 2022, 2023, and 2024, and the effective interest rate is correctly given as 6.11% across all three years. Format variations ($2 billion vs $2,000 million) are acceptable and convey the same value. (2) Quantitative accuracy is perfect—no calculation errors or misstatements of figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and multiple document chunks (as noted in the answer) to confirm consistency in both utilization and interest rate. (4) The interpretation—that Cisco has maintained this debt instrument as a stable component of its capital structure, locking in predictable financing costs—is logically derived and aligns with the ground truth’s conclusion about consistent long-term debt strategy. The answer addresses all parts of the question: evolution over time (no change), and implications for debt strategy and financing costs. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 335,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "Across all three filings, Lowe’s has repeatedly highlighted Kobalt as a core private‑brand product that it owns, maintains and protects through its trademark and patent portfolio. In the fiscal‑2022 10‑K the IP section lists “private brand product names ‘Kobalt’, ‘STAINMASTER’ and ‘allen+roth’,” and the fiscal‑2023 and fiscal‑2024 disclosures use the same language—“private brand product names, such as ‘Kobalt’, ‘STAINMASTER’ and ‘allen+roth’”—showing no change in wording or emphasis. This consistent, year‑over‑year mention signals a stable, ongoing strategic focus on Kobalt rather than a shift in positioning.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully aligned with the ground truth. (1) It correctly identifies that Kobalt was consistently mentioned across fiscal 2022, 2023, and 2024 as a key private brand in Lowe's intellectual property disclosures, with no change in strategic emphasis. (2) There are no numerical values requiring calculation, but the fiscal years (2022, 2023, 2024) are accurately referenced and matched to the correct filings. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of disclosures, noting the identical or near-identical wording in each year’s 10-K, and draws the valid conclusion that this reflects a stable strategic role rather than an evolving one. (4) The answer captures all key elements from the original: the consistent mention of Kobalt alongside STAINMASTER and allen+roth, the lack of increased prominence, and the implication of ongoing strategic importance without expansion in emphasis. Wording differs slightly but maintains full semantic equivalence. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Owns]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 306,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "**Evolution of Unsecured Notes – 37B**\n\n- **2022 filing (as of 12/31/2021)** – The note carried a **2.25 % fixed rate**, a **$700 million face amount** (shown as $700,000 thousand) and was set to mature on **January 15, 2032**【Chunk 1】.  \n- **2023 filing (as of 12/31/2023)** – The same terms re‑appeared: **2.25 % interest**, **$700 million face**, **maturity 01/15/32**【Chunk 2】.  \n- **2024 filing (as of 12/31/2024)** – The note again shows **2.25 %**, **$700 million**, **maturity 01/15/32**【Chunk 3】.  \n\n**Implication for SPG’s financing strategy**\n\nThe unchanged interest rate, face amount, and long‑dated maturity across three consecutive years indicate that Simon Property Group is deliberately preserving this tranche as a stable, low‑cost source of capital. By locking in a modest 2.25 % rate for a decade‑plus horizon, SPG signals a long‑term financing strategy that relies on fixed‑rate, long‑maturity unsecured debt to provide predictable funding while it adds newer issuances (e.g., 38B, 39A‑B, 40A‑B, 41A) to diversify its capital structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: the interest rate of 2.25%, face amount of $700 million (correctly interpreted as $700,000 thousand), and maturity date of January 15, 2032 (formatted as 01/15/32) are consistent across 2022, 2023, and 2024. Minor formatting differences (e.g., $700 million vs $700,000) are semantically equivalent and acceptable. (2) The answer is complete, addressing all parts of the multi-hop question: evolution over time (year-by-year), each financial term (interest rate, face amount, maturity), and the implication for long-term financing strategy. (3) Entity accuracy is perfect: Simon Property Group (SPG), Unsecured Notes - 37B, and correct fiscal years (filings as of 12/31/2021, 12/31/2023, 12/31/2024) are correctly identified and contextualized. (4) The reasoning is sound and adds value beyond the ground truth by noting SPG’s use of newer note series (e.g., 38B, 39A-B) to diversify its capital structure, which is a logical inference consistent with the stable core strategy. This demonstrates strong multi-hop synthesis and qualitative insight. All scores are maximized due to factual precision, completeness, and coherent, contextually grounded interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 358,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site appears in each of the three 10‑K tables and its segment assignment never changes.  \n\n- **2022** – the Melaka row shows an “X” only in the **Analog** column (no X for Embedded Processing).  \n- **2023** – the same pattern: an “X” under **Analog** and a blank under Embedded Processing.  \n- **2024** – again an “X” for **Analog** with no X for Embedded Processing.  \n\nThus, across 2022‑2024 the Melaka facility remained a steady Analog‑only operation, with no expansion into the Embedded Processing business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes Texas Instruments' operational footprint in Melaka, Malaysia across 2022, 2023, and 2024, correctly stating that the site was involved exclusively in the Analog business segment each year, with no involvement in Embedded Processing. (2) There are no numerical inaccuracies—while no specific financial figures are involved, the presence/absence of 'X' markers in the 10-K tables is correctly interpreted across all years. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings (2022–2024) and correctly infers consistency in operational focus over time. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TXN's Melaka operations with respect to the two business segments. Minor wording differences (e.g., 'steady Analog-only operation' vs. 'stable, specialized role') do not affect factual equivalence. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 298,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "Across all three filings the amount of the September 2019 issuance of fixed‑rate 2.850 % notes remained unchanged – $1.5 billion in 2022 (Chunk 1), $1.5 billion in 2023 (Chunk 2) and $1.5 billion in 2024 (Chunk 3), each maturing on 10 Oct 2029 with an effective rate of about 2.96 %.  \n\nThe flat exposure signals that PayPal is deliberately keeping a stable tranche of long‑dated, low‑cost fixed‑rate debt on its balance sheet, using the 2.850 % notes to lock in relatively inexpensive financing and to smooth interest‑rate risk over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 through 2024, matching the ground truth exactly. The maturity date (October 10, 2029) and effective rate (~2.96%) are accurate and consistent with the knowledge graph. All numeric values—dollar amount, interest rate, and dates—are correct, satisfying quantitative accuracy. (2) The answer addresses both parts of the question: the evolution (no change) and the implication for long-term debt strategy. It correctly infers that maintaining this tranche indicates a deliberate strategy to keep low-cost, long-dated debt to manage interest rate risk, which aligns with the ground truth’s interpretation. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly concludes stability in this liability, even amid broader debt activity. However, it omits a key contrast mentioned in the original answer—specifically, that PYPL retired its 1.350% notes by 2023 and issued new high-interest notes in 2024, which strengthens the inference about selective debt management. This contextual nuance is missing, slightly weakening the qualitative depth. (4) Despite this omission, the LLM conveys the core factual and strategic meaning, with full numerical accuracy and high relevance. The absence of the comparative debt actions prevents a perfect 10, but the answer remains substantially correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Has_Stake_In]- ORG <-[Issues_Notes]- ORG",
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 409,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Gilead (GILD) operates the Hoofddorp, Netherlands site. In the 2022 Form 10‑K the Hoofddorp plant is listed among Gilead’s “principal manufacturing facilities,” indicating its inclusion in the company’s global manufacturing footprint. By the 2023 filing the company states that the Hoofddorp facility “is utilized for commercial manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats this description, showing that the site has evolved from a general principal plant in 2022 to a dedicated commercial cell‑therapy manufacturing hub in 2023 and 2024 within Gilead’s worldwide manufacturing strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Hoofddorp was listed as a principal manufacturing facility in 2022, then explicitly described as being used for commercial manufacturing and processing of cell therapy products in both 2023 and 2024. The evolution from a general principal facility to a dedicated cell therapy hub is correctly interpreted. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the progression in facility utilization. (3) The multi-hop reasoning across three years of filings is sound—LLM correctly synthesizes the increasing specificity and strategic focus on cell therapy at Hoofddorp over time. (4) The answer is fully contextually relevant, directly addressing how the facility’s role evolved within Gilead’s global manufacturing strategy for cell therapy. Wording differs slightly but meaning is preserved and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 287,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco’s 1.375 % Senior Notes due June 2027 were reported at the same $1.25 billion amount in each filing and were always shown as part of long‑term debt, never moving into the current‑portion line. In 2022 the notes sat within $6.59 billion of total long‑term debt (with a $73 million current portion that did not include them); in 2023 the total long‑term debt was $6.48 billion and the current portion jumped to $1.081 billion because other notes became due, but the 1.375 % notes remained long‑term; by 2024 total long‑term debt fell to $5.92 billion and the current portion shrank to $103 million after those other notes matured, while the 1.375 % notes stayed unchanged in the long‑term debt category.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct quantitative information but makes a critical factual error in reasoning and entity classification. (1) Quantitatively, the principal amount of $1.25 billion (i.e., $1,250 million) for the 1.375% Senior Notes is correctly stated across all years, and the total current portion of long-term debt values—$73M in 2022, $1,081M in 2023, and $103M in 2024—match the ground truth. However, the LLM incorrectly asserts that the 1.375% notes 'remained long-term' and 'never moved into the current-portion line,' which directly contradicts the ground truth: the spike in the current portion in 2023 ($1,081M) is largely due to the reclassification of this specific note as a current liability as it approached maturity. By 2023, with the note due in June 2027 still three years away, a reclassification to current debt would typically not occur unless there was an acceleration or refinancing issue—however, the ground truth implies a significant shift in classification pattern, which the LLM fails to acknowledge. (2) The numbers themselves are mostly accurate in format and magnitude, earning a moderate quantitative accuracy score, but the interpretation is flawed. (3) Qualitatively, the reasoning is unsound: the explanation attributes the 2023 jump in current portion to 'other notes becoming due' and claims the 1.375% notes stayed in long-term debt, which contradicts the expected behavior of debt classification as maturities approach and the specific evolution described in the ground truth. The multi-hop synthesis—linking the same principal amount over time while tracking its classification shift—is missing. (4) Contextually, the answer addresses the right question and uses appropriate financial terminology, so relevance is high. However, the core factual claim about classification is incorrect, severely undermining the answer's correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 509,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "Across the three most recent filings PayPal’s Fixed‑rate 2.850 % notes have stayed exactly the same – a $1.5 billion tranche maturing on 10 Oct 2029 with an effective interest rate of 2.96 % is reported in the 2022 10‑K (showing $1,500 m in the 2022 column), again in the 2023 10‑K (‑$1,500 m for both 2022 and 2023), and in the 2024 10‑K (‑$1,500 m for both 2023 and 2024).  \n\nThe unchanged balance, rate and maturity indicate that PayPal is deliberately keeping this low‑cost, long‑dated fixed‑rate liability on its balance sheet rather than refinancing or retiring it, using the notes to lock in predictable financing costs and hedge interest‑rate risk as part of a disciplined long‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.5 billion carrying amount of the 2.850% fixed-rate notes, the October 1, 2029 maturity date (phrased as '10 Oct 2029'), and the effective interest rate of 2.96% are all accurately reported. The consistency across 2022, 2023, and 2024 is correctly noted. (2) Quantitative accuracy is perfect: dollar amounts ($1.5 billion = $1,500 million), interest rates, and dates match the original answer exactly, with acceptable formatting variations. (3) The reasoning is sound: the LLM correctly infers that the unchanged obligation reflects a strategic decision to retain low-cost, long-term fixed-rate debt to manage interest rate risk and maintain predictable financing costs. This aligns with the ground truth's conclusion about capital structure stability and selective refinancing. (4) The only minor shortcoming is that the LLM does not explicitly mention the broader context that PayPal *did* engage in refinancing other tranches during this period, which strengthens the inference that the retention of this tranche was deliberate. While implied, this multi-hop synthesis is slightly less explicit than in the original. However, the core insight about strategic debt management is preserved. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Has_Stake_In]- ORG <-[Issues_Notes]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 391,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "**Evolution of the gas‑option book**  \n- **2022:** “Options – primarily gas” carried $356 million of assets and $347 million of liabilities (a net ≈ +$9 million) and the models used a weighted‑average implied volatility of **≈ 36 %** (range up to 295%).  \n- **2023:** The fair‑value exposure collapsed to $100 million of assets and $97 million of liabilities (net ≈ +$3 million) while the volatility assumption rose to a weighted‑average of **≈ 50 %** (range up to 233%).  \n- **2024:** The exposure remained roughly flat at $100 million of assets versus $102 million of liabilities (net ≈ ‑$2 million) and the volatility assumption stayed elevated at **≈ 52 %** (range up to 150%).  \n\n**What the trend reveals**  \nThe three‑year pattern shows a **substantial reduction in the size of the gas‑option position** (fair‑value assets fell by about 72 % from 2022 to 2023 and stayed level thereafter) while the **volatility inputs used in the option models have risen steadily** (36 % → 50 % → 52 %). This combination indicates that NextEra has trimmed its direct exposure to gas price movements but is pricing the remaining exposure for a more volatile gas market, reflecting a more conservative, risk‑averse stance in the gas‑related segment of its portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key financial figures for fair value of gas-related options are correct: $356M assets and $347M liabilities in 2022, $100M assets and $97M liabilities in 2023, and $100M assets and $102M liabilities in 2024. These match the original answer exactly. (2) Implied volatility assumptions are correctly reported as 36% in 2022, 50% in 2023, and 52% in 2024—consistent with the ground truth. The LLM correctly notes the rising trend in volatility assumptions despite a reduction in exposure, which is a key insight. (3) The reasoning is sound: the LLM identifies the significant reduction in fair value (≈72% drop in assets from 2022 to 2023) and interprets the increasing volatility inputs as a sign of more conservative risk modeling, indicating strategic de-risking—this matches the original answer’s conclusion about reduced exposure and more cautious positioning. (4) Minor point: the original answer states volatility declined from 36% to 50% to 52%, but 'declined' is a clear error in the ground truth—volatility increased, and the LLM correctly interprets this upward trend. Thus, the LLM actually corrects an error in the original answer. The inclusion of ranges (e.g., up to 295%) adds detail not in the ground truth but plausibly derived from filings and does not contradict. Overall, the answer is factually correct, well-reasoned, and contextually complete—justifying a high score. Only a perfect 10 is withheld due to slight formatting of net positions not being explicitly asked, but this enhances clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 436,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s 2022 filing simply lists its available‑for‑sale (AFS) debt holdings in a summary table, but does not call out a specific effect on earnings. In contrast, the 2023 and 2024 10‑Ks both say that “higher losses in our available‑for‑sale debt investments” were the primary driver of the decline in other income (loss), net for those years (with foreign‑exchange impacts also weighing in and gains on equity and private‑investment positions only partially offsetting the hit). The repeat of “higher losses” across two consecutive years shows that Cisco’s AFS debt portfolio was a source of earnings volatility, turning from a disclosed asset class in 2022 into a material, loss‑generating component of other income in 2023‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in fiscal 2022, Cisco only disclosed the composition of AFS debt investments without specifying an earnings impact, which matches the original answer's statement about 'active portfolio management' without explicit loss reporting. In 2023 and 2024, the LLM accurately notes that 'higher losses in AFS debt investments' were a primary driver of declines in other income (loss), net—consistent with the ground truth. It also correctly mentions partial offsetting gains from equity and private investments, as well as foreign exchange impacts (additional context not in the original but not contradictory). (2) There are no numerical values to verify (e.g., dollar amounts or percentages), but the temporal references (fiscal years 2022–2024) are correct and consistent. (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years, correctly infers increasing volatility from two consecutive years of losses, and contrasts the shift from passive disclosure in 2022 to material financial impact in 2023–2024. (4) The semantic meaning fully matches the original: it conveys the growing volatility in Cisco’s investment portfolio due to AFS debt losses affecting non-operational income. The only minor shortcoming is slightly less emphasis on the term 'volatility' in the conclusion compared to the original, but the concept is clearly implied through 'repeat of higher losses' and 'material, loss-generating component.' Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 446,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Across the three most recent Form 10‑K filings – the 2022, 2023 and 2024 reports – Lowe’s Companies, Inc. repeatedly lists the same 4.550 % Notes in Exhibit 4.16 (the “Fifteenth Supplemental Indenture” dated April 5 2019) and identifies them as a series of notes due April 5 2049. In each filing the notes are described in identical language – a form of 4.550 % Notes due 2049 – showing that no new issuance was made after the 2019 indenture; instead the company continues to document and retain this long‑dated, fixed‑rate instrument in its debt portfolio. The three‑year consistency signals a deliberate long‑term debt strategy: Lowe’s introduced the 4.550 % Notes as a long‑maturity financing tool and is now using it to lock in a fixed rate for decades, emphasizing stable, multi‑decade funding rather than frequent new issuances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049, were issued under the Fifteenth Supplemental Indenture dated April 5, 2019, and consistently referenced in Lowe's 2022, 2023, and 2024 Form 10-K filings. The LLM correctly notes that the same exhibit (4.16) and identical language were used across all three years, indicating no changes in terms or new issuances. (2) Quantitative elements—interest rate (4.550%), issue date (April 5, 2019), maturity date (April 5, 2049)—are all precisely accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer a stable, long-term debt strategy focused on fixed-rate, long-maturity financing without modifications or redemptions. (4) The conclusion about Lowe's deliberate strategy to lock in fixed-rate funding for decades is well-supported and aligns with the original answer’s interpretation. Wording differs but meaning and factual content are identical. No errors in entities, years, or financial terms. All aspects of the question—evolution over time and strategic implication—are fully addressed with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 343,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "- **2022 (10‑K Chunk 1):** Unsecured Notes ‑ 35B carried a 3.80 % coupon and a face amount of **$750,000 (thousands)** (≈ $750 million).  \n- **2023 (10‑K Chunk 2):** The same tranche still showed a **3.80 % interest rate** and **$750,000 (thousands)** of face value.  \n- **2024 (10‑K Chunk 3):** The note again appears with a **3.80 % rate** and **$750,000 (thousands)** face amount, maturing on **July 15 2050**.\n\n**Interpretation:** SPG has kept the size and coupon of the 35B unsecured note unchanged for three consecutive years, indicating a deliberate strategy to lock in a moderate, fixed‑rate, long‑dated financing. By maintaining this stable $750 million, 3.80 % tranche, SPG secures predictable interest‑costs and long‑term liquidity, reflecting a focus on a steady, low‑cost debt profile rather than frequent refinancing or altering its long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face value ($750,000 thousands = $750 million), interest rate (3.80%), and maturity date (July 15, 2050) for Unsecured Notes - 35B across 2022–2024, matching the ground truth exactly in all quantitative aspects. The formatting of '$750,000 (thousands)' is standard SEC reporting and correctly interpreted as $750 million. 2) All numbers are accurate: face value, rate, and maturity date are consistent with the original answer. The extension of the maturity date is correctly noted as unchanged from 2022 to 2024 (i.e., still maturing in 2050), which aligns with the ground truth’s observation about no refinancing. 3) The multi-hop reasoning is sound—information is synthesized correctly across three years and filings, and the conclusion about SPG’s stable long-term debt strategy is logically supported. The LLM infers a deliberate strategy to lock in fixed-rate financing, which is semantically equivalent to the ground truth’s statement about 'stable long-term financing approach' and 'confidence in managing long-dated liabilities.' 4) The only minor gap is that the LLM does not explicitly state that the maturity date was 'extended' (implying a prior change before 2022), but it correctly notes the date remains the same through 2024, which is consistent with available data. This omission does not detract significantly from the overall correctness. All other elements—factual, numerical, and interpretive—are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 407,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "From 2022 through 2024 PayPal repeatedly flagged **bad‑transaction risk** as a direct threat to its **credit‑product portfolio**, its **cross‑border trade revenue**, and its **extensive third‑party ecosystem**. In 2022 the filing warned that defaults on consumer‑credit and merchant‑financing loans, fraud on cross‑border payments and abuse by network, bank and processor partners could raise loss rates and erode confidence. By 2023 the company began to **mitigate** that exposure – it entered a multi‑year €40 billion BNPL‑receivable sale, pursued alternative funding (asset sales, securitizations, forward‑flow arrangements) and announced a **diversification of payment‑processor relationships** to reduce reliance on a small set of partners. In the 2024 filing the same bad‑transaction concerns remain, but the narrative adds **regulatory uncertainty around loan‑receivable transfers (the “valid‑when‑made” doctrine)** and a heightened focus on **operational resiliency** and the risk of over‑reliance on third‑party providers. The three‑year trend shows PayPal moving from broad risk identification toward structural mitigation—selling credit assets, broadening and managing third‑party dependencies, and bolstering resiliency—while acknowledging that bad‑transaction risk continues to be an ongoing operational challenge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: PayPal's 2022 risk disclosures on credit defaults, fraud, and third-party dependencies; the 2023 multi-year €40 billion BNPL receivable sale (correct currency and amount); and 2024's emphasis on the 'valid-when-made' doctrine and operational resilience. The narrative correctly traces a strategic shift from internal risk absorption to external mitigation. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited (matches ground truth's €40 billion), years (2022–2024) are accurate, and no calculations are required. Format (€ vs EUR) is semantically equivalent. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and domains (credit products, cross-border trade, third-party dependencies) and correctly infers a strategic evolution in risk management. It adds value by explicitly naming 'diversification of payment-processor relationships' and 'alternative funding' mechanisms, which are consistent with but not explicitly detailed in the ground truth. (4) Minor deduction in qualitative accuracy due to slight expansion beyond the original answer—e.g., mentioning 'merchant-financing loans' and 'forward-flow arrangements'—which are plausible but not specified in the ground truth. However, these do not contradict and are contextually reasonable. Overall, the answer is comprehensive, factually correct, and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Risks]- ORG",
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 415,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Across all three annual reports—2022, 2023 and 2024—Costco consistently lists **BJ’s Wholesale Club** as a direct warehouse‑club competitor. In each filing the company repeats the same strategic message about its **Kirkland Signature** private‑label brand: it is positioned as high‑quality, priced below national brands, helps lower costs, differentiates Costco’s merchandise and yields higher margins, and Costco “expects to continue to increase the sales penetration of our private‑label items.” Thus, from 2022 through 2024 Costco’s competitive stance relative to BJ’s remained unchanged—BJ’s is a core rival—and the emphasis on Kirkland Signature as a key differentiator was reaffirmed each year, underscoring a stable (and arguably deepening) reliance on the private‑label strategy to set Costco apart.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that from 2022 to 2024, Costco consistently listed BJ's Wholesale Club as a direct competitor and maintained a stable strategic emphasis on Kirkland Signature as a differentiator—highlighting its high quality, lower price compared to national brands, cost efficiency, and contribution to higher margins. (2) There are no numeric values requiring calculation in this question; all references to years (2022, 2023, 2024) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying both the continuity of competitive framing and the unchanging role of Kirkland Signature. (4) The answer fully addresses all parts of the question—evolution (or lack thereof) of competitive positioning and the role of private-label branding—and conveys the same conclusion as the ground truth: no significant shift, with consistent reaffirmation of strategy. Wording differs slightly but meaning is preserved, and the addition of 'deepening reliance' is a reasonable interpretive extension supported by the repeated emphasis in filings. All entities (Costco, BJ's Wholesale Club, Kirkland Signature) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 375,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "NextEra Energy reported the following fair‑value balances for its natural‑gas forward contracts:  \n\n- **2022:** assets $191 million and liabilities $31 million (net exposure ≈ $160 million).  \n- **2023:** assets rose to $377 million while liabilities climbed to $77 million (net ≈ $300 million).  \n- **2024:** assets fell to $296 million and liabilities fell to $46 million (net ≈ $250 million).  \n\nThe data show a sharp expansion of gas‑forward positions in 2023 – both the asset and liability sides roughly doubled – followed by a modest contraction in 2024, leaving the net exposure still higher than in 2022 but lower than the 2023 peak. This three‑year trajectory suggests that NextEra initially increased its hedge against natural‑gas price risk (perhaps anticipating higher demand or volatility) and then began to scale back that exposure in 2024, reflecting a more balanced risk posture as market expectations or its generation mix evolved.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the 2022 figures ($191M assets, $31M liabilities) and 2024 figures ($296M assets, $46M liabilities) match the ground truth, the 2023 liability value is incorrect: LLM reports $77M, but the ground truth is $46M. The asset value for 2023 ($377M) is correct. This error affects the net exposure calculations: LLM computes $300M net in 2023, but with correct liabilities, net should be $331M, not $300M. The 2024 net exposure is also miscalculated due to incorrect prior liability. (2) Calculations: The LLM’s net exposures are based on wrong inputs. For example, 2023 net exposure: $377M - $77M = $300M (math is correct but based on false liability). However, using ground truth ($377M - $46M), net should be $331M. This indicates a failure in data retrieval or synthesis for the 2023 liability. (3) Multi-hop reasoning is generally sound—LLM correctly identifies the trend of expansion in 2023 and partial reversal in 2024, and infers strategic hedging and risk management evolution. The interpretation of increasing then moderating exposure aligns with the ground truth’s implication of growing but more balanced risk positioning. (4) Despite strong contextual relevance and reasonable qualitative logic, the quantitative inaccuracy—especially the $77M vs $46M liability error in a key year—substantially undermines factual correctness. This is not a formatting issue but a factual discrepancy. Therefore, while the narrative is plausible and addresses all question parts, the core data flaw limits correctness to partial credit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 441,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "In the 2022 filing Lowe’s already disclosed that forward‑interest‑rate swaps were designated as cash‑flow hedges, with the impact of both matured and outstanding contracts recorded in other comprehensive income and earnings. The 2023 10‑K still listed those swaps as a Level‑2 current‑asset with a $251 million fair‑value, confirming they remained active for hedging forecasted debt issuances. By the 2024 filing the forward‑swap line is blank (no balance) and the company only references the swaps as of February 3 2023, indicating they had been settled or replaced by fixed‑to‑floating swaps that are now held as fair‑value hedges. This progression—from active forward‑swap hedging in 2022‑23 to their disappearance by 2024—shows Lowe’s dynamically managing interest‑rate risk: initially locking in rates for anticipated borrowing, then shifting to hedge existing debt or reduce forward exposure as market conditions and its financing plans evolved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $251 million fair value as of February 3, 2023, matches the original answer, and the timeline (2022, 2023, 2024 filings) is accurately represented. The absence of forward swaps in the 2024 filing as of January 31, 2025, is correctly inferred. (2) The LLM correctly identifies the use of forward interest rate swaps as cash flow hedges in 2022 and their presence on the balance sheet in 2023, demonstrating proper synthesis across years. (3) The reasoning is sound: the progression from active hedging of forecasted debt to the disappearance of these instruments by 2024 is logically interpreted as a strategic shift in response to market conditions or refinancing. The suggestion that they may have been replaced by fixed-to-floating swaps serving as fair value hedges is a reasonable inference, though slightly more speculative than the original answer’s neutral phrasing about 'unwind or replacement.' This adds insight but isn't explicitly confirmed in the ground truth, warranting a minor deduction in qualitative accuracy. (4) The answer fully addresses the multi-part question—evolution over time and strategic implications—with excellent contextual relevance and semantic equivalence to the original. Minor deduction only for the slight over-interpretation of swap replacement type.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Holds]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 392,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "In the 2022 Form 10‑K Comcast already flagged Lumen as a primary wireline rival – “certain wireline telecommunications companies such as AT&T, Frontier, **Lumen** and Verizon have built and are continuing to build fiber‑based network infrastructure farther into their networks… and are offering services with these higher speeds in many of our service areas.” The filing warned that Lumen’s expanding fiber‑to‑the‑home (FTTH) and bundled video‑phone offerings could pull demand away from Comcast’s broadband and video services in overlapping markets.  \n\nThe 2023 and 2024 10‑Ks repeat the same competitive portrait, again noting that **Lumen** (along with AT&T, Frontier and Verizon) “have built and are continuing to build fiber‑based wireline network infrastructure further into their networks… offering services with these higher speeds in many of our service areas.” Both later reports add that this fiber expansion now co‑exists with other fiber‑or satellite‑based entrants and with federal/state broadband‑deployment funding, underscoring that Lumen’s network build‑out remains a sustained pressure point for Comcast.  \n\nThus, from 2022 through 2024 Comcast’s positioning relative to Lumen has stayed consistent: Lumen is a direct competitor that is continuously extending high‑speed fiber infrastructure into the same geographic footprints, forcing Comcast to defend its broadband and video offerings through network upgrades, bundled packages and pricing tactics to retain customers in those overlapping markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies Lumen as a key competitor to CMCSA (Comcast) from 2022 through 2024, with consistent emphasis on fiber-based broadband infrastructure expansion in overlapping markets. All entities—CMCSA, Lumen, and the relevant time frame—are accurate. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not applicable beyond correct referencing of years (2022, 2023, 2024), which are all correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly noting the continuity in Comcast’s competitive assessment of Lumen’s fiber expansion and its implications on service offerings (e.g., bundled services, pricing, network upgrades). (4) The LLM enhances the original answer with direct quotes from the 10-Ks, adding evidentiary support without introducing inaccuracies. It captures the evolving yet consistent competitive dynamic, including external factors like federal/state funding, which aligns with and enriches the ground truth. All aspects of the question—competitive positioning, fiber expansion, service offerings, overlapping markets—are addressed with high precision and contextual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 382,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "From 2022 – the 10‑K highlighted “creating seamless checkout experiences” as a core growth pillar and described a payments platform that let consumers send money in more than 200 markets, use > 100 currencies, withdraw in 56 currencies and hold balances in 25 currencies. By 2023 the same focus remained, but the platform’s global reach was expanded to roughly 150 supported currencies for sending payments (still 56 for withdrawals) and the technology was further hardened to support those checkout flows at scale. In the 2024 filing the checkout experience is now fully integrated with PayPal’s consumer‑credit suite—Buy‑Now‑Pay‑Later, PayPal‑ and Venmo‑branded credit cards and PayPal Credit—while the merchant side is offered an omnichannel solution (Zettle‑by‑PayPal POS, Braintree, PayPal Complete Payments) that lets merchants capture sales online, in‑app and in‑store with a single, frictionless checkout.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies PayPal's evolving focus on seamless checkout from 2022 to 2024, covering integration with consumer credit, global currency support, and omnichannel merchant solutions. (2) Quantitatively, it states that in 2022 PayPal supported transactions in over 100 currencies, which matches the original answer; in 2023, it correctly notes expansion to approximately 150 currencies for sending payments (with 56 for withdrawals and 25 for holding balances), consistent with the knowledge graph. The only minor discrepancy is the mention of 'more than 200 markets' in 2022, which is plausible but not present in the ground truth—this is not incorrect, just more detailed. (3) The multi-hop reasoning is sound: it traces the evolution across years, correctly linking 2024 developments to deeper integration of BNPL, PayPal Credit, and branded credit cards, as well as omnichannel solutions via Zettle, Braintree, and PayPal Complete Payments. (4) The answer captures all key elements: global currency expansion, consumer credit integration (BNPL, credit/debit cards), and merchant omnichannel solutions. Wording differs slightly (e.g., 'technology hardened' vs 'platform enhancements'), but semantic meaning is equivalent. One point deducted from correctness due to slight overprecision on market count not in source, but no factual errors in core claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> PRODUCT <-[Produces]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 396,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "The Target Debit Card— which the 2022 filing notes gives card‑holders a 5 % discount and free shipping—has seen its purchase‑payment penetration slip from roughly 20.5 % of all purchases in fiscal 2022 to 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024 (the 2024 filing, after rebranding the cards as Target Circle Cards, reports the same trend at 19.8 %, 18.6 % and 17.8 % for those years). Because Target explicitly monitors this “RedCard/Target Circle Card” penetration, stating that incremental purchases made with the card translate into incremental sales, the gradual decline indicates that the debit card’s contribution to driving extra sales is modestly decreasing even though it remains a significant sales‑driving lever.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 18.6% in 2023 and 17.8% in 2024. However, the LLM states it dropped to 19.8% in 2023 and 18.6% in 2024, which misrepresents both the 2023 and 2024 figures. The LLM also incorrectly claims that the 2024 filing reports 19.8%, 18.6%, and 17.8% for the respective years, which contradicts the original data—those values are not aligned with the correct year-by-year progression. (2) The calculation of the trend is therefore flawed: the actual decline is 20.5% → 18.6% → 17.8%, a consistent drop of 1.9 and then 0.8 percentage points, whereas the LLM implies a drop of only 0.7 points from 2022 to 2023 and another 1.2 points to 2024, altering the perceived trajectory. (3) Qualitatively, the reasoning is sound: the LLM correctly identifies that Target monitors card penetration as a proxy for incremental sales and interprets the decline as indicating a weakening role in driving sales, which aligns with the ground truth’s conclusion. It also accurately references the 5% discount and rebranding to Target Circle Cards, showing proper multi-hop synthesis across filings and contextual understanding. (4) Contextually, the answer is highly relevant and addresses both parts of the question—evolution of penetration and implications for sales—though based on incorrect numbers. The explanation of the card’s role and strategic importance is well-reasoned and semantically aligned with the original. However, due to the critical errors in reported percentages, especially for 2023 and 2024, the correctness score is limited to 6, as the core numerical facts are partially wrong despite otherwise strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 484,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "Across the three filings—2022, 2023 and 2024—AMD’s policy for development‑and‑IP licensing contracts stayed the same. In each year the company first determines whether the licensing component is “distinct” (i.e., capable of being distinct and distinct in the context of the arrangement); if it is not distinct, the license is combined with the development services and revenue is recognized over time, whereas a distinct license is accounted for at a point in time when the customer can benefit. Stand‑alone patent or IP licensing arrangements are always treated as a single performance obligation and recognized at that point‑in‑time moment, and no variable‑consideration estimates are applied to either combined or standalone deals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures AMD's consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements. The distinction between distinct and non-distinct licenses is correctly explained: non-distinct licenses are combined with development services and recognized over time, while distinct licenses are recognized at a point in time when the customer can benefit. Standalone licensing arrangements are correctly identified as being recognized at a point in time, which matches the original answer. There are no numeric values in the question or answer that require verification (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10. The qualitative reasoning is sound, demonstrating correct multi-hop synthesis across the three years and between combined vs. standalone arrangements. The only minor limitation is that the LLM answer does not explicitly mention the absence of disclosed quantitative metrics (e.g., revenue splits or specific deal values), which was noted in the original answer as context for the stability of the policy. However, this omission does not affect the core accuracy of the revenue recognition methodology described. The answer remains semantically equivalent and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 374,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Nike first highlighted FlyEase in its FY 2022 filing as one of a growing “proliferation” of new technologies—listed together with Air, Zoom, Flyknit, Dri‑Fit, etc.—signaling its introduction into the company’s innovation pipeline. By FY 2023 (the 2023 10‑K) and again in FY 2024, the same “proliferation of … FlyEase … technologies” language appears, showing that FlyEase has moved from a newly‑launched concept to a recurring, core element of Nike’s portfolio that is continuously leveraged across product categories; the KG links (Nike → FlyEase (product), FlyEase (product) → FlyEase (org), FlyEase (org) → Nike) further illustrate that the technology has matured into an internal capability that expands Nike’s product offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its interpretation of FlyEase's evolution, which undermines the qualitative accuracy. Quantitatively, there are no errors in dates or fiscal years (FY 2022, 2023, 2024 are correctly referenced), and the entities (Nike, FlyEase) are accurate. Contextually, the response is relevant and addresses the strategic positioning question. However, the key flaw lies in reasoning: the LLM claims that the exact same 'proliferation of ... FlyEase ... technologies' language appears in both FY 2023 and FY 2024 as in FY 2022, which contradicts the ground truth. According to the original answer, FlyEase evolved from being a new innovation (2022) to being grouped with established technologies like Air and Zoom (2023), and then to being listed among mature technologies like React and Air Max (2024)—indicating a clear progression in strategic positioning. The LLM’s assertion that the same descriptive language was used across all three years incorrectly implies stagnation rather than evolution, failing to capture the multi-hop progression in FlyEase’s maturity. This misrepresents the synthesis across years and results in a misleading conclusion about FlyEase becoming a 'recurring, core element' based on repeated phrasing, when in fact the changing context of its mention (from emerging to mature) is the critical signal. Thus, while the answer is well-structured and contextually relevant, the core reasoning and qualitative accuracy are flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Expands]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 428,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "Across the three most recent 10‑K filings AMT’s 1.250 % senior notes have been shrinking: the 2022 filing lists an aggregate principal of **$609.1 million**, the 2023 filing shows **$551.9 million**, and the 2024 filing reports **$517.7 million**. Because AMT (the issuer) discloses these notes in each filing, the steady decline in the outstanding principal indicates that the company is actively paying down or retiring this low‑coupon debt—either through scheduled amortization, early repayments or refinancing—signalling a deliberate strategy to reduce its leverage and manage its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the principal amounts for AMT's 1.250% Notes across 2022 ($609.1 million), 2023 ($551.9 million), and 2024 ($517.7 million), matching the ground truth exactly. These values show a consistent downward trend, which the model accurately interprets as a sign of active debt reduction. The reasoning about possible mechanisms—scheduled amortization, early repayments, or refinancing—is logically sound and consistent with the observed trend.\n\n2) All numeric values are correct and match the ground truth. The dollar amounts are reported with precise figures and consistent formatting (allowing for bolding and spacing variations). There are no calculation errors, and the temporal sequence (2022 → 2023 → 2024) is correctly followed.\n\n3) The multi-hop reasoning is strong: the model synthesizes data from three consecutive 10-K filings to identify a trend over time, linking year-over-year decreases to a strategic debt management approach. It correctly attributes the changes to the issuer (AMT) and infers intent (reducing leverage, managing capital structure), which aligns with the qualitative interpretation in the ground truth.\n\n4) The only minor shortcoming is that the LLM omits mention of the interest payment terms (payments due in May, maturity in February 2033), which were included in the original answer and provide additional context about the stability of the debt instrument despite principal reduction. While not critical to the core trend analysis, this detail supports the 'managed' nature of the strategy. Otherwise, the semantic meaning and factual content are equivalent to the ground truth. Hence, a score of 9/10 on correctness and qualitative accuracy is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Financial_Instruments]-> FIN_INST <-[Discloses]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 469,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "- In FY 2022 NVIDIA disclosed the 3.50 % Notes Due 2040 as a Level 2‑measured liability with a fair‑value of **$1.066 billion** (Jan 30 2022); the fair value fell to **$870 million** in FY 2023 (Jan 29 2023) and to **$851 million** in FY 2024 (Jan 28 2024), showing a steady market‑price decline.  \n\n- The FY 2024 filing, however, shows the same notes carried at an **amortized (net‑carrying) amount of $1.0 billion**, classified as long‑term debt with a **3.54 % effective interest rate** and an **≈15‑year remaining term**, indicating that NVIDIA continues to treat the 2040 notes as a stable, low‑cost source of financing and does not adjust the book value to short‑term fair‑value swings.  \n\n**What this reveals:** NVIDIA’s long‑term debt strategy is to lock in inexpensive, long‑dated financing (the 3.50 % coupon) and keep the notes on the balance sheet at amortized cost, while market‑value fluctuations are disclosed but do not drive changes to the carrying amount.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the FY 2023 fair value as $870 million, whereas the ground truth states $851 million. However, it correctly reports the FY 2022 value as $1.066 billion (equivalent to $1,066 million) and the FY 2024 amortized carrying amount as $1.0 billion. The effective interest rate of 3.54% and the long-term classification are accurately stated.\n\n2) Quantitative verification: \n   - FY 2022: $1.066 billion = $1,066 million → Correct\n   - FY 2023: LLM says $870 million vs. ground truth $851 million → Incorrect (off by $19 million)\n   - FY 2024: Fair value mentioned as $851 million (correct), but this was actually the FY 2023 value in the ground truth; however, the LLM conflates this with FY 2024 fair value, which is not provided in the original answer. The original only specifies the FY 2024 *carrying amount* as $1,000 million. Thus, the LLM incorrectly assigns the $851 million fair value to FY 2024, when the original does not state that figure for that year. This is a significant error in temporal attribution.\n\n3) Reasoning and synthesis: The LLM correctly infers that NVIDIA maintains the notes at amortized cost rather than fair value on the balance sheet and interprets the strategy as locking in low-cost, long-term financing. This aligns with the ground truth’s conclusion about stability and management of liabilities despite market fluctuations. The multi-hop reasoning—linking fair value disclosures, carrying amounts, interest rates, and strategic implications—is sound and insightful.\n\n4) Despite the numerical and year-attribution errors, the core message about NVIDIA’s long-term debt strategy is accurately captured. The answer addresses both parts of the question: the evolution of valuation (with mostly correct numbers) and the strategic implication (very well explained). The contextual relevance is perfect, and the qualitative analysis exceeds expectations. However, due to the incorrect FY 2023 fair value and misattribution of the $851 million to FY 2024, the quantitative accuracy is reduced. Hence, a score of 8 is justified for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 580,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "- **2022:** Netflix began widening its membership‑plan portfolio by recently adding games to its entertainment video offering and signaled that it could adjust pricing or plan structures; it warned that if members did not value the new games or any pricing changes, the company could see slower acquisition of new members and higher cancellation rates.  \n\n- **2023:** The company continued the games rollout and introduced a lower‑priced, ad‑supported subscription tier, noting that a lack of member interest in games or a poor reception of the ad‑supported tier—or any other pricing tweaks—could negatively affect both new‑member growth and existing‑member retention.  \n\n- **2024:** Netflix further broadened its plans by adding live programming to the games offering and maintaining the ad‑supported tier while making periodic pricing adjustments, and it cautioned that mis‑steps in pricing, the ad‑supported or live‑content offerings, or other new product extensions could be poorly received and undermine its ability to attract and retain members.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: in 2022, Netflix introduced games and warned about member acquisition/retention risks if not valued; in 2023, the ad-supported tier was launched with similar risks noted; in 2024, live programming was added, and ongoing risks around pricing and features were emphasized. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes service expansions and associated risks across three years from Netflix’s evolving strategy, linking each new feature (games, ads, live) to stated business risks. (4) The only minor deviation is phrasing: the LLM says live programming was added 'to the games offering,' which slightly mischaracterizes the relationship—live programming was a separate expansion, not part of the games offering. However, this does not materially distort the core information. Overall, the answer is semantically equivalent, comprehensive, and contextually precise, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 338,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s equity‑security portfolio – which is dominated by venture‑type investments – rose from $3.7 billion at year‑end 2022 (up from $3.5 billion in 2021) to $4.9 billion in both 2023 and 2024, while its equity‑method stakes in health‑care operating businesses moved from $1.5 billion in 2022 (after $1.3 billion in 2021) to $1.4 billion in 2023 and then jumped to $3.8 billion in 2024. The steady increase in total equity holdings and the more than doubling of equity‑method health‑care investments signal that UnitedHealth is deepening its direct ownership exposure in the health‑care sector, positioning itself not just as a capital provider but as a strategic partner with sizable stakes in operating health‑care businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor quantitative inaccuracies. It states that equity-method investments were $1.5 billion in 2022, whereas the ground truth reports $1.3 billion. This is a significant deviation. Additionally, the LLM mentions $3.5 billion in equity securities for 2021, which is not part of the original question or ground truth and introduces extraneous data. However, the correct values for equity securities ($3.7B in 2022, $4.9B in 2023 and 2024) and the jump in equity-method investments to $3.8B in 2024 are accurately reported. (2) The calculation of the 'more than doubling' of equity-method investments is directionally correct (from $1.3B to $3.8B over two years), but the starting point is misrepresented due to the incorrect $1.5B figure for 2022. (3) The multi-hop reasoning is sound: the model correctly synthesizes trends over time and infers strategic intent from investment patterns, noting deeper engagement in operating businesses. The conclusion about strategic positioning aligns well with the ground truth. (4) Despite the incorrect 2022 equity-method investment figure, the overall trajectory and strategic interpretation are preserved, warranting a high qualitative and contextual score. The correctness score is reduced due to the factual error in a key number, though the core trend and message remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 384,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Nike’s financial tie to Sojitz America stayed the same – Sojitz America remained the sole owner of Nike’s $0.3 million of $1‑par redeemable preferred stock, which carries a $0.10‑per‑share cumulative dividend payable each May 31 and bars any common‑stock dividend until that preferred dividend is paid in full.  The preferred stock was fully issued, there were no changes or new issuances in any of the three years, and Sojitz America retained only limited voting rights on major corporate actions (sale of assets, merger, liquidation, etc.).  Strategically, Sojitz America – a large Japanese trading company – continued to provide import‑export financing services for Nike, underpinning Nike’s international supply‑chain and trade operations throughout the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in terms of quantitative details: it correctly states that Sojitz America held $0.3 million of redeemable preferred stock (par value), with a $0.10 per share cumulative dividend, and accurately describes the dividend payment date (May 31) and structural implications (blocking common dividends). These figures match the ground truth, and no numerical errors are present, warranting a perfect quantitative accuracy score. Entity accuracy is also strong—Sojitz America, Nike, the time frame (fiscal 2022–2024), and the nature of the preferred stock are all correctly identified. Contextual relevance is excellent, as the response directly addresses all components of the question: financial relationship (ownership, dividends), strategic role, and continuity over time. However, the qualitative accuracy is slightly lower because the LLM fails to capture a key evolution highlighted in the ground truth: while it notes Sojitz America’s ongoing import-export financing role, it does not reflect the *strategic shift emphasized in fiscal 2024*, where Nike explicitly underscored Sojitz’s importance amid rising trade risks and supply chain volatility—a nuance that marks a progression from purely financial to more operationally strategic framing. This missing evolution limits completeness in the multi-hop synthesis, particularly the change in narrative emphasis over time. Thus, while factually sound, the LLM answer lacks the full depth of strategic evolution described in the original answer, justifying a correctness score of 8 rather than 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 431,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "- In the 2022 Form 10‑K the 3.50 % Notes Due 2050 were carried at **$2,147 million** (Jan 30 2022); the 2023 Form 10‑K shows the same series at **$1,604 million** (Jan 28 2024); and the 2024 Form 10‑K lists the net carrying amount of the 3.50 % Notes Due 2050 at **$2,000 million** (Jan 28 2024, with the same $2,000 million shown for the 2025 balance).  \n\n- The balance fell sharply from FY 2022 to FY 2023, then rose again in FY 2024, indicating that NVIDIA reduced its exposure to this long‑dated note in 2023 (likely through repayments or discount amortization) but subsequently rebuilt the carrying amount in 2024.  \n\n- Overall, the series remains a sizable component of NVIDIA’s long‑term financing, showing that the company is actively managing its debt profile while still relying on low‑cost, long‑maturity debt to support its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all carrying values from fiscal 2022 to 2024: $2,147 million (2022), $1,604 million (2023), and $2,000 million (2024), matching the ground truth exactly. There is a minor typo in the date description—'Jan 28, 2024' is listed as the date for both 2023 and 2024 balances, but this does not affect the fiscal year alignment or the correctness of the numbers. (2) All numeric values are accurate and properly formatted; no calculation errors. The trend (decrease then increase) is correctly identified. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers a temporary reduction in debt exposure followed by strategic repositioning. It adds reasonable qualitative interpretation (e.g., possible repayments or amortization in 2023, rebuilding in 2024) that aligns with the trend. (4) The answer is semantically equivalent to the ground truth, with slightly more detailed interpretation but no factual deviation. The only minor flaw is the repeated date label, which doesn't impact the fiscal year correctness. Thus, high scores across all categories, with a 9 on correctness due to the date labeling imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 342,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s 2022 filing already stressed that its liquidity is sourced from a broad set of global markets—including a commercial‑paper program backed by an unsecured revolving credit facility that is reported in short‑term debt—and that this diversity “enhances our funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds.” The 2023 and 2024 10‑Ks repeat the same list of funding sources (preferred and common equity, short‑term debt/commercial paper, long‑term debt, collateral‑financing, PABs, credit facilities and shelf registration) and the same conclusion that a diversified funding mix continues to limit market dependence and reduce capital costs. Thus, from 2022 through 2024 MetLife’s reliance on short‑term debt such as commercial paper remained a core component of its liquidity strategy, and its overall dependence on global funding markets stayed stable by consistently using a diversified set of sources to keep funding costs low.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies MetLife's consistent funding strategy from 2022 to 2024, emphasizing diversified global funding sources to limit dependence on any single market and lower the cost of capital. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly noting the continuity in MetLife’s use of commercial paper, credit facilities, and other funding instruments. It accurately infers that reliance on short-term debt remained stable and that diversification was a consistent strategic goal. (4) The LLM includes all key elements from the original answer: the role of commercial paper backed by unsecured credit facilities, the list of funding sources, the strategic benefits (funding flexibility, lower cost of capital), and the absence of structural changes. Wording differs slightly but conveys the same meaning with high precision. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 343,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth Group’s parent disclosed that its service‑level‑guarantee accounting policy remained immaterial in every year covered – the amounts accrued, paid or charged to income for those guarantees were “not material” as of 12/31/2022, 12/31/2023 and 12/31/2024. At the same time, inter‑company debt to subsidiaries grew: $8.7 billion of notes payable in 2022, $9.9 billion in 2023, and in 2024 the company reported $2.0 billion of short‑term notes plus $14.4 billion of long‑term notes (total $16.4 billion), all with on‑demand features. The trend shows a rising liquidity commitment—especially a shift toward larger, longer‑dated financing in 2024—while the consistently immaterial service‑level guarantees indicate that contractual risk from those guarantees has remained low despite the expanding inter‑company debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures, particularly in the 2022 and 2024 notes payable amounts. The ground truth states notes payable were $8.1B in 2022, but the LLM reports $8.7B. More critically, the LLM claims total notes payable in 2024 were $16.4B ($2.0B short-term + $14.4B long-term), whereas the ground truth reports only $2.0B total—indicating a major overstatement. This error fundamentally misrepresents the trend (sharp drop vs. sharp rise). (2) The service level guarantee disclosures are correctly reported as immaterial across all years, which is factually accurate and consistent with the original answer. However, the inter-company debt figures are not. The claim of 'on-demand features' is not present in the ground truth and introduces unsupported detail. (3) The multi-hop reasoning is partially sound—linking service level guarantees to liquidity and risk exposure is appropriate—but the conclusion that liquidity commitments are rising in 2024 contradicts the ground truth, which shows a sharp decline in internal debt. This undermines the validity of the synthesis. (4) Contextual relevance is high because the answer addresses both service level guarantees and notes payable over time, and attempts to interpret liquidity and risk implications. However, due to major quantitative errors, the overall correctness score is low. The qualitative score is moderate because entity identification (UnitedHealth Group, subsidiaries, service level guarantees) and general reasoning structure are correct, but flawed data leads to incorrect conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 439,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From its 2022 filing (and reiterated in the 2023 filing) American Express described itself as the fourth‑largest general‑purpose card network in the world, competing directly with China UnionPay, Visa, Mastercard, JCB, Discover/Diners Club and a growing set of fintech platforms, while also facing intense pressure in the premium‑card and co‑brand space and from alternative‑payment innovators. By the 2024 filing the focus had shifted to a growing regulatory dependency: new and expanding rules on interchange fees, network‑routing practices, merchant pricing and network‑licensing have forced Amex to exit its EU and Australian licensing businesses, placed it in the U.S. Category III regulatory tier (subject to heightened supervisory expectations and higher compliance costs), and threaten the discount‑revenue model that relies on card‑network operations. In response, Amex is bolstering its compliance programs, emphasizing differentiated premium products and adjusting its network strategy (including exiting certain jurisdictions) to preserve its fourth‑place market position while navigating the intensified competitive and regulatory pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: American Express's position as the fourth-largest general-purpose card network (behind China UnionPay, Visa, Mastercard), the competitive pressures from traditional networks and fintech platforms like PayPal, Venmo, Alipay, and regional systems such as NPCI, and the strategic shifts due to regulatory changes are all accurately represented. (2) Quantitative and temporal details are precise: the 2022–2024 timeline is correctly used, with accurate reference to the 2024 shift to U.S. Category III regulatory status and the exit from EU and Australian licensing businesses—both explicitly mentioned in the original. There are no numerical inaccuracies, and all dates and regulatory classifications match. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive dynamics, regulatory developments, and strategic responses across years and jurisdictions, correctly inferring that Amex’s independence has been increasingly constrained by regulation. The mention of interchange fees, network routing, merchant pricing, and cobrand arrangements reflects accurate understanding of regulatory pressures. (4) The only minor shortcoming is that the LLM does not explicitly name the National Payments Corporation of India (NPCI) as a regional competitor, instead using the broader term 'fintech platforms' and 'alternative-payment innovators,' which slightly reduces specificity in entity identification. Also, while the 'discount-revenue model' is mentioned, the original emphasizes the broader impact on Amex’s strategic posture from market-driven competition to regulatory adaptation, a nuance slightly underdeveloped in the LLM version. However, these are minor omissions that do not detract from overall correctness. The answer is contextually excellent, directly addressing competitive positioning, regulatory dependency, and strategic responses across the three-year horizon.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1710,
        "completion_tokens": 533,
        "total_tokens": 2243
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "ConocoPhillips’ description of its cash‑settled performance‑share units (PSUs) is identical in the 2022, 2023 and 2024 Form 10‑K filings. In each year the company states that for PSUs whose three‑year performance period began **in 2018 or later**, the award does **not** provide a quarterly cash dividend‑equivalent. Instead, the award accrues a **reinvested dividend equivalent** that is charged to compensation expense and is paid only at the time the PSUs settle in cash (i.e., when the fair‑market value of a share is used to determine the cash payment). No change to this structure is noted across the three filings.\n\nThe unchanged treatment signals a deliberate, long‑term incentive design: by deferring dividend‑equivalent payments until settlement, ConocoPhillips aligns employee rewards with the ultimate cash value of the company’s stock and with shareholder returns over the full performance period, reinforcing a consistent, long‑term incentive‑alignment approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that ConocoPhillips maintained a consistent cash-settled PSU framework from 2022 to 2024, with no changes across the 10-K filings. The key evolution in dividend equivalent treatment—accrued reinvested dividends paid at settlement for performance periods beginning in 2018 or later—is accurately described. The LLM correctly notes that no quarterly dividend equivalents are paid during the performance period for these awards, which matches the ground truth's description of a shift from deferred payments (post-2018) to accrued reinvestment. (2) Quantitatively, all dates (2018 as the inflection point) and structural details (three-year performance period, cash settlement at fair market value) are correct. The LLM accurately reflects that dividend equivalents are accrued and reinvested, then paid at settlement, which is consistent with the ground truth. (3) The reasoning is sound: the LLM correctly infers that deferring dividend equivalents until settlement strengthens long-term incentive alignment by tying rewards to ultimate stock performance, which is a valid interpretation of the policy shift. The only minor shortcoming is that the ground truth mentions vesting tied to either five years or retirement eligibility, while the LLM refers to a three-year performance period—this discrepancy is notable but not critical, as the core evolution in dividend treatment and its strategic implication are correctly captured. (4) The answer is fully relevant, directly addressing the evolution of the dividend structure and its implications for long-term alignment. Overall, the LLM provides a factually correct, well-reasoned response with only a small omission regarding vesting duration, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Grants]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 496,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "NextEra Energy’s “Special Use Funds” – a pool of low‑risk, highly‑liquid securities – have risen steadily over the three‑year window.  The balance sheet shows the funds were $8.698 billion at 31 Dec 2023 and grew to $9.800 billion at 31 Dec 2024 (up from the 2022 level, which was lower than the 2023 amount).  At the same time, the company’s derivative‑related collateral that it actually posts has been falling: cash + letters‑of‑credit posted was about $4.6 billion in 2022 (≈ $1.813 bn cash + $2.806 bn LOCs) and dropped to roughly $2.3 billion in 2023 (≈ $0.691 bn cash + $1.595 bn LOCs).  Because the Special Use Funds now exceed the amount of collateral the firm must post – and the collateral requirement itself has been shrinking – the trend signals an increasingly comfortable liquidity position for NextEra Energy relative to its derivative‑related obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly states the Special Use Funds values for 2023 ($8.698 billion) and 2024 ($9.800 billion), it incorrectly claims the 2022 level was 'lower than the 2023 amount' without providing the actual 2022 figure, which is not in the ground truth and thus introduces uncertainty. More critically, the LLM fabricates collateral posting figures: it claims $4.6 billion total collateral posted in 2022 ($1.813B cash + $2.806B LOCs), but the ground truth states only $84 million in cash collateral was posted in 2022. Similarly, the LLM reports $2.3B total in 2023 ($0.691B cash + $1.595B LOCs), but the ground truth only confirms $691 million in cash—there is no mention of letters of credit or total collateral in the original answer. These fabricated numbers severely undermine quantitative accuracy. (2) The calculation of collateral totals is incorrect and unsupported by the ground truth. The original answer does not provide LOC data or total collateral figures, so summing cash and LOCs as done by the LLM is speculative and factually wrong. Additionally, the claim that 'collateral that it actually posts has been falling' contradicts the ground truth, which shows a sharp increase in actual cash collateral posted—from $84M to $691M—indicating more, not less, collateral posting. (3) The multi-hop reasoning is partially sound in linking Special Use Funds growth to improved liquidity positioning, and recognizing that declining potential collateral obligations (from $5.2B to $2.4B in downgrade scenarios) improves risk profile. However, the LLM misrepresents the direction of actual collateral trends and invents data points, breaking the logical chain. It also fails to mention the key 2022 disclosure about up to $2.7B in potential collateral due to downgrade risk, which is central to the original narrative. (4) Despite these issues, the LLM captures the general theme—growing Special Use Funds and reduced potential exposure—so the conclusion about improved liquidity positioning aligns qualitatively, albeit for incorrect reasons. Contextual relevance is high because it addresses the core question about liquidity and derivatives, but correctness is low due to major numerical and factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 621,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600 % senior notes were issued for $700 million (2022 10‑K) and have been amortized in small, declining tranches: $3.7 million was reduced in 2022, $2.6 million in 2023 (2023 10‑K) and $1.5 million in 2024 (2024 10‑K), leaving outstanding balances of roughly $696.3 million at end‑2022, $693.7 million at end‑2023 and $692.2 million at end‑2024. The pattern of modest, progressively smaller principal repayments signals a deliberate, cash‑preserving strategy that spreads the retirement of this low‑cost, long‑dated debt over its remaining life until the 2026 maturity rather than accelerating a large lump‑sum payoff.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that the outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across 2022, 2023, and 2024. However, the LLM claims the principal was amortized each year—$3.7M in 2022, $2.6M in 2023, $1.5M in 2024—leading to declining balances down to $692.2M by end-2024. This directly contradicts the ground truth of no principal reduction. (2) The numbers cited for 'reductions' do not match the ground truth: while the ground truth mentions adjustments to principal of (3.7) million in 2022 and (2.6) million in 2024, the LLM misinterprets these as principal amortizations and fabricates a $1.5M reduction for 2024 not present in the original. Moreover, the original does not report a 2023 adjustment, but the LLM inserts one. The calculations of remaining balances are therefore based on false premises. (3) The multi-hop reasoning is flawed: the LLM incorrectly synthesizes data across years, assuming amortization where none occurred. It also references 10-K filings for each year as sources, but the ground truth indicates no change in principal, suggesting the LLM misread or misrepresented the data. (4) While the LLM attempts to infer a debt management strategy (cash-preserving, gradual repayment), this conclusion is invalid because it is based on non-existent amortization. The actual pattern—stable principal with declining adjustments—suggests a different interpretation (e.g., declining accrued interest or other adjustments), which the LLM misses entirely. Scores reflect major factual and quantitative errors, though the response is contextually relevant in addressing the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 471,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth’s 10‑K filings show that its exposure to Medicare Advantage risk‑adjustment payment changes was a persistent, material risk throughout the 2022‑2024 period. In the 2022 filing the company first warned that “from time to time, CMS makes changes to the way it calculates Medicare Advantage risk‑adjustment payments” and noted that it had begun “adjusting members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management” to offset funding pressure. The 2023 filing repeated the same exposure—again emphasizing possible benchmark reductions and CMS‑driven risk‑adjustment changes—and reiterated those same mitigation steps, while the 2024 filing added that CMS now “adjusts monthly capitation payments … according to the predicted health status of each beneficiary” and confirmed that UnitedHealth continued to (1) selectively tweak benefits and premiums, (2) pull plans from low‑margin counties, and (3) deepen medical‑and‑operating cost‑management to blunt the impact of the regulatory shifts. Thus, the company’s exposure remained steady but grew more detailed over time, and its strategic response—benefit/premium adjustments, market‑exit of select plans, and intensified cost‑control—was applied consistently across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 is accurately described, with consistent mention of CMS methodology changes each year. The strategic responses—selective benefit and premium adjustments, exiting certain counties, and intensified cost management—are correctly reported for all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the continuity and evolution of both risk exposure and strategic response. It accurately notes that the 2024 filing added detail about CMS adjusting payments based on predicted health status, which reflects a deeper regulatory insight. (4) Semantic equivalence is strong—wording differs slightly but meaning is preserved. The only minor shortcoming is that the LLM slightly overemphasizes 'the same exposure' and 'same mitigation steps' without fully capturing the nuance of *evolution* in strategy (e.g., 'further refine' in 2024), but the core progression is still evident. Thus, the answer is excellent in completeness, entity accuracy, reasoning, and relevance, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 427,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Across the three filings Target’s employee‑discount benefit never changed its basic definition or mechanics. In the 2022 filing the benefits section lists “merchandise and other discounts” as part of the compensation package and notes that “eligibility for, and the level of, benefits vary depending on team members’ full‑time or part‑time status, work location, compensation level, and tenure.” The 2023 filing repeats the same language – “merchandise and other discounts” – with the identical eligibility qualifier, and the 2024 filing again describes the benefit as “merchandise and other discounts” with the same eligibility conditions. Thus, from 2022 through 2024 the scope (merchandise + other discounts) and structure (a tiered benefit tied to employment status, location, pay and tenure) remained consistent. This steady presence signals that Target treats employee discounts as a core pillar of its financial‑well‑being strategy, using a stable, broadly‑available savings tool to support team‑member purchasing power and reinforce its employer‑of‑choice positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that the scope and structure of merchandise discounts remained unchanged from 2022 to 2024, with the same phrasing used across filings and eligibility tied to employment status, location, compensation, and tenure. This aligns with the ground truth in terms of the stability of the discount benefit. Quantitatively, there are no numerical claims to verify, but the description of consistent language and conditions is accurate, earning full marks for quantitative accuracy. However, the LLM fails to capture the broader evolution in Target's employee financial well-being strategy emphasized in the original answer. While the discount mechanics did not change, the context around them expanded significantly: the increase in starting wages (from $15 to $15–$24), addition of sick pay, tuition-free education, free virtual healthcare, and mental health services in 2023–2024 are all omitted. The original answer highlights that merchandise discounts were increasingly framed within a holistic well-being strategy, which the LLM overlooks. This omission limits the qualitative accuracy, as it misses the multi-hop synthesis between stable benefits and evolving strategic framing. The answer is contextually relevant and directly addresses the question, but provides an incomplete picture by focusing narrowly on the discount mechanics rather than the strategic progression. Thus, while factually correct on the benefit's structure, it underrepresents the strategic evolution, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> FIN_INST <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 427,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express’s foreign‑government bond portfolio was almost entirely short‑dated in 2022, with $628 million (≈99 % of the $630 million holding) due within one year and only $1 million each in the 1‑5‑year and 5‑10‑year buckets; the company’s overall weighted‑average yield that year was 2.08% (1.74% for the <1‑year segment). In 2023 the weighted‑average yield on the foreign‑government segment was 6.45% for the <1‑year bucket and 4.48% for the 1‑5‑year bucket, and in 2024 it fell to 5.86% and 2.03% respectively, with no exposure beyond five years in any year. This three‑year pattern—persistent short‑term maturity focus and a gradual decline in yields—signals a conservative risk appetite that prioritizes liquidity and low interest‑rate risk, indicating an asset‑allocation strategy that keeps foreign sovereign exposure tightly bounded to short maturities despite modest yield opportunities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the 2022 maturity distribution and yield figures. The ground truth states that in 2022, American Express held $630 million in Foreign Government Bonds with a yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. However, the LLM claims an overall weighted average yield of 2.08% and breaks down the portfolio into $628 million in the <1-year bucket and $1 million each in 1-5 and 5-10 year buckets — none of which are supported by the original answer. These specific allocations and the 2.08% yield are fabricated or hallucinated, as the original answer does not provide maturity distribution data for 2022, only yields by maturity bucket. (2) The yield values for 2023 and 2024 are correctly reported: 6.45% and 4.48% in 2023, then 5.86% and 2.03% in 2024 for <1-year and 1-5-year buckets respectively. The dollar amount is slightly off ($628M vs $630M), which is minor and within acceptable rounding/formatting variance. However, the introduction of detailed maturity splits and a composite yield not present in the source constitutes a significant quantitative error. (3) The multi-hop reasoning is partially sound — the model correctly identifies the trend of rising yields in 2023 and a drop in 2024, especially the sharp decline in longer-term yields. However, the conclusion that this reflects a 'conservative risk appetite' and 'persistent short-term focus' contradicts the original interpretation, which sees the 2023 move as more aggressive and the 2024 pullback as a strategic retreat, suggesting dynamic rather than consistently conservative behavior. Thus, the qualitative inference is misaligned with the ground truth's strategic interpretation. (4) Despite incorrect details and flawed reasoning in parts, the answer remains contextually relevant, addressing yield evolution, maturity distribution, and strategic implications. It synthesizes across years and attempts to interpret risk appetite, fulfilling the question’s intent even if inaccurately. Hence, contextual relevance is high, but correctness is reduced due to key factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 591,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements – which is reflected in the “Other assets, including intangibles – net” line and is reported as collateral not offset against derivatives – fell sharply over the three‑year span: $1,494 million in 2022 ( disclosed in the 2023 filing), $800 million in 2023 (shown in both the 2023 and 2024 filings), and $491 million in 2024 (2024 filing). This steady decline suggests the company is reducing the amount of margin‑related collateral tied to its derivative positions, indicating tighter management of derivative exposure, more efficient netting of contracts, or a shift toward lower‑margin derivative activity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three values for collateral under master netting arrangements related to 'Other assets, including intangibles - net'—$1,494 million in 2022, $800 million in 2023, and $491 million in 2024—matching the ground truth exactly. Minor formatting differences (e.g., spacing, use of en-dash) are acceptable and do not affect meaning. (2) All numbers are accurate and correctly attributed to the respective years. The answer also correctly notes the source filings (e.g., 2023 filing for 2022 data), which aligns with standard SEC reporting practices and adds contextual precision. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers the trend of declining collateral. It logically connects this trend to derivative exposure management, offering plausible explanations such as tighter risk control, more efficient netting, or a shift to lower-margin derivatives—consistent with the ground truth’s interpretation of strategic reduction in exposure. (4) The answer fully addresses both parts of the question: the quantitative change over time and the implication for risk management. Semantic equivalence is maintained, with enhanced clarity and appropriate financial terminology. All scores are maximized due to complete factual accuracy, correct synthesis, and relevant, insightful interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 388,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "Across AMT’s 2022, 2023 and 2024 10‑K filings the company’s 2.700 % senior notes are shown as a single $700 million tranche that was issued on March 29 2021, carries a fixed 2.700 % coupon, pays interest semi‑annually on April 15 and October 15, and matures in early 2031 (par‑call January 15 2031). The 2023 and 2024 tables repeat the same principal amount, coupon and payment schedule, indicating no additional issuances, rate changes or amendments to this instrument after the original 2021 issuance. This stability reveals that AMT locked in low‑cost, medium‑term debt when rates were favorable and has chosen to retain that tranche rather than issue new 2.700 % notes as market conditions shifted to higher rates (evidenced by the many 5 %‑plus notes issued in later years).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $700.0 million principal amount, the 2.700% interest rate, semi-annual interest payments, and the original issuance date of March 29, 2021. However, there is a discrepancy in the maturity date: the ground truth states the maturity date was updated to January 15, 2031 by 2023 and 2024, while the LLM states 'early 2031 (par-call January 15 2031)', conflating par-call with maturity. While the par-call date is correctly cited as January 15, 2031, the original answer implies the maturity date was revised from April 15, 2031 (in 2022) to January 15, 2031 (in 2023 and 2024), which the LLM fails to acknowledge. This is a material change and omission. Additionally, the LLM does not mention the decrease in interest rate spread from (5.0) to (4.4) by 2024, a key quantitative detail indicating reduced borrowing costs. (2) The dollar amount ($700 million), interest rate (2.700%), and issuance date (March 29, 2021) are accurate. Interest payment months (April/October) are correct, though LLM specifies the 15th without noting variation across filings. The missing interest rate spread change (from 5.0 to 4.4) is a quantitative inaccuracy by omission. (3) The reasoning about AMT locking in favorable rates and not reissuing due to rising market rates is sound and contextually insightful, demonstrating good multi-hop synthesis between this issuance and broader financing trends. However, it misses the nuance that the terms themselves evolved slightly (maturity date adjustment, spread reduction), suggesting some post-issuance refinement rather than complete static stability. (4) The answer is highly relevant and interprets the strategic implications well, but loses points on quantitative precision and completeness due to omitted updates in maturity and spread. Correctness score is 7 due to accurate core facts but missing key evolving details; qualitative reasoning is strong (8), quantitative accuracy is moderate (7) due to omissions; contextual relevance is perfect (10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Financial_Instruments]-> FIN_INST <-[Discloses]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 547,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVDA disclosed that the 2.00 % Notes Due 2031 were recorded at a fair‑value liability of **$1.2 billion** in its 2022 filing (Jan 30 2022). The 2023 filing shows the fair‑value amount fell to **$1.044 billion** at Jan 29 2023 and then edged up to **$1.057 billion** by Jan 28 2024, while the 2024 filing reports a **net carrying amount of $1.250 billion** for the same series as of Jan 28 2024 (and projected for Jan 26 2025). This trajectory—initial reduction, modest rebound and a higher amortized‑cost figure—indicates NVIDIA is preserving a sizable, low‑cost, long‑dated debt tranche, using the 2.00 % notes as a cornerstone of a stable, long‑term financing strategy rather than aggressively retiring the debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key numerical and temporal details: the $1.2 billion fair value in 2022, the decrease to $1.044 billion at the beginning of 2023, the increase to $1.057 billion by end of 2023 (reported in Jan 2024), and the $1.25 billion carrying value in 2024—all match the ground truth. Minor formatting differences ($1.250 billion vs $1.25 billion) are acceptable and semantically equivalent. 2) Quantitative accuracy is perfect: all dollar amounts and dates align with the original answer. The LLM correctly distinguishes between fair value and carrying value, which is critical context. 3) The reasoning is sound: the LLM correctly infers that the stability and maintenance of this debt tranche reflect a strategic, long-term financing approach. It adds nuanced insight—'cornerstone of a stable, long-term financing strategy'—which is consistent with and expands upon the ground truth's 'strategic consistency.' 4) The answer fully addresses both parts of the question: the evolution of obligations (multi-hop across 2022–2024) and the implication for long-term debt strategy. The only minor limitation is that the original answer emphasizes 'no short-term portion,' which the LLM omits, but this does not undermine the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to excellent synthesis and minor contextual omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 387,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife discloses that reinsurance contracts that do not expose it to a reasonable possibility of a significant loss are recorded using the deposit method of accounting. In the 2022 filing the company reported deposit‑asset balances of $1.8 billion and deposit‑liability balances of $1.4 billion (the same amounts as the prior year), whereas the 2024 filing shows those balances rising to $5.1 billion of deposit assets and $1.3 billion of deposit liabilities at year‑end 2023 and then adjusting to $4.6 billion of assets and $1.2 billion of liabilities at year‑end 2024 after the large Global Atlantic risk‑transfer transaction. The sharp increase in deposit assets (and modest decline in deposit liabilities) signals that MetLife is increasingly using the deposit method to shift sizable blocks of risk to reinsurers while retaining relatively low liability exposure, reflecting a strategic move toward greater risk‑transfer and capital‑efficiency in its reinsurance program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timing, particularly regarding the 2024 figures and the sequence of events. According to the ground truth, deposit assets increased from $1.8B in 2022 to $5.1B in 2024, with no mention of a drop to $4.6B in 2024. However, the LLM claims assets were $5.1B in 2023 and then decreased to $4.6B in 2024, which contradicts the original answer. Similarly, the LLM states that liabilities were $1.3B in 2023 and $1.2B in 2024, but implies an increase from 2022 to 2023, while the original answer confirms liabilities declined slightly from $1.4B (2022) to $1.3B (2023) to $1.2B (2024), so this part is mostly correct. (2) The mention of a 'Global Atlantic risk-transfer transaction' aligning with the $10.3B reinsurance recoverables is consistent with the original answer’s reference to the Global Atlantic transaction, though the exact figure ($10.3B) is missing in the LLM response. However, the LLM incorrectly frames the asset increase as peaking in 2023 and then declining in 2024 due to the transaction, whereas the original answer shows a continued rise in assets to $5.1B by 2024. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that increasing deposit assets and stable/declining liabilities suggest a strategic shift toward risk transfer and capital efficiency using the deposit method. It correctly identifies the accounting policy and links the trend to strategic reinsurance behavior. However, the flawed numerical timeline undermines the accuracy of the synthesis. (4) The contextual relevance is high, as the LLM addresses both the evolution of deposit assets/liabilities and the strategic implications. The qualitative reasoning is strong but built on incorrect quantitative foundations, leading to a moderate correctness score. Minor formatting variations in dollar amounts are acceptable, but directional trends and year-specific values must match—these do not fully align.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 536,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s Debt Securities – Held‑to‑Maturity were reported at a total fair value of **$679 million** and a carrying value of **$696 million** on 12/31/2022; they fell to **$596 million** fair value and **$603 million** carrying value on 12/31/2023, and declined further to **$508 million** fair value and **$512 million** carrying value on 12/31/2024.  \n\nThe three‑year drop of roughly **$171 million** in fair value and **$184 million** in carrying amount, together with a narrowing discount (the gap shrank from about **$17 million** in 2022 to roughly **$4 million** in 2024), shows UNH is systematically reducing the size of its held‑to‑maturity portfolio while market‑driven valuation adjustments are aligning book values more closely with market values.  \n\nFor context, the 2022 filing showed the portfolio was relatively flat in prior years ($643 million fair value/$641 million carrying in 2021 and $647 million/$638 million in 2020), so the recent downward trajectory suggests a strategic shift—likely a reallocation of capital away from longer‑term debt holdings in response to rising rates or liquidity considerations, with modest valuation write‑downs reflecting current market conditions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values for fair value and carrying value across 2022, 2023, and 2024 are accurate: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024). The calculated declines of $171M in fair value and $184M in carrying value are correct. The narrowing discount from $17M to $4M is also accurately derived. (2) The answer is complete, addressing both the evolution of values over the three years and the strategic implications. It goes beyond the ground truth by adding context from 2020 and 2021, which supports the conclusion of a recent strategic shift. (3) Entity accuracy is perfect: UnitedHealth Group (UNH), 'Debt Securities - Held-to-Maturity', and correct fiscal years (2022–2024) are all properly identified. (4) The reasoning is sound and demonstrates strong multi-hop synthesis: it correctly infers a strategic reduction in the portfolio, links the narrowing fair-to-carrying value gap to market alignment, and plausibly attributes the trend to rising rates or liquidity needs. The added context from prior years strengthens the conclusion without contradicting the ground truth. (5) Semantically, the LLM conveys the same core information as the original answer and enhances it with relevant context, without introducing errors. All scores are maximized due to full factual accuracy, correct calculations, logical reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 399,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s RedCard (now Target Circle Card) penetration fell each year – it was 20.5 % for the fiscal year ended Jan 29 2022, 19.8 % for FY 2023 and 18.6 % for FY 2024. The company’s 2022 filing explains that the Target Credit Card (and related RedCards) are underwritten by TD, carry a 5 % purchase discount and generate profit‑sharing revenue, and that it monitors “RedCard Penetration” because card‑driven purchases are viewed as incremental sales. The steady decline in penetration therefore suggests the credit‑card program is becoming less effective at expanding the share of purchases made with the card and, by extension, at driving incremental sales for Target.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The fiscal year-end dates (e.g., Jan 29, 2022) are consistent with Target's reporting calendar and add precision without contradicting the original answer. (2) All numbers and percentages are accurate, and no calculations are required beyond correct year-over-year reporting. Format variations (e.g., 20.5% vs 20.5 %) are acceptable and do not affect meaning. (3) The reasoning correctly infers that declining penetration suggests reduced effectiveness in driving incremental sales, which aligns with the ground truth. It appropriately references Target’s own rationale (card-driven purchases = incremental sales) from the 2022 filing to support the interpretation. The only minor omission is that the original answer notes Target still sees 'ongoing strategic value' despite the decline, which the LLM answer downplays by concluding the program is 'becoming less effective' without acknowledging this nuance. (4) The answer is highly contextually relevant, addressing both the trend in penetration and its implication for Target's credit card strategy. The use of 'RedCard' and 'Target Circle Card' is accurate (the rebranding is correctly noted), and the reference to TD Bank underwriting and the 5% discount adds valuable context from the filings. Overall, the answer is factually excellent with only a slight softening of the original's balanced conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 418,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Across all three recent 10‑K filings Nike’s Laakdal, Belgium site was described in the same way:  \n\n* **FY 2022** – Nike listed Laakdal as one of its “most significant distribution facilities outside the United States” and explicitly said it was **owned** (the 2022 filing also noted the only other non‑owned overseas site was a leased, third‑party‑operated facility in Suzhou, China).  \n* **FY 2023** – The 2023 filing repeats that the Laakdal location is among the most significant overseas distribution centers and that **all of them, including Laakdal, are owned**.  \n* **FY 2024** – The 2024 filing again states the Laakdal facility is one of the key overseas distribution sites and that **Nike owns it**.\n\nThus, from FY 2022 through FY 2024 Nike’s ownership of the Laakdal distribution center did not change; the site remained an owned, core European logistics hub. This continuity signals Nike’s strategic emphasis on maintaining direct control of its European supply‑chain infrastructure rather than shifting to leased or third‑party operations, underscoring a long‑term focus on a proprietary logistics footprint to support growth in the EMEA market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: Nike maintained ownership of the Laakdal, Belgium distribution facility throughout fiscal years 2022–2024, and it was consistently described as one of the most significant international (or 'overseas') distribution centers. The LLM correctly notes that ownership and operational role did not change across the three years. (2) There are no numeric values requiring calculation, but the fiscal years (2022, 2023, 2024) are correctly referenced and consistent with the original answer. The additional detail about Suzhou, China being the only non-owned overseas facility adds contextual precision without contradicting the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three annual filings to confirm consistency in ownership and strategic role, correctly inferring that this reflects a stable, long-term strategy. (4) The conclusion about Nike’s strategic focus on direct control of European logistics infrastructure is semantically equivalent to the original answer’s interpretation. Wording differs slightly but meaning is preserved and enhanced with relevant detail. All aspects of the question—ownership evolution, operational footprint, and strategic implications—are thoroughly and accurately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 378,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Across NVIDIA’s FY 2022, FY 2023 and FY 2024 10‑K filings, Lumentum Holdings is repeatedly named as a competitor in the high‑performance interconnect and networking‑product space – first listed among “interconnect, switch and cable solutions” in 2022, then among “networking products (switches, network adapters and cable solutions)” in both 2023 and 2024 – indicating a stable competitive position in that segment. At the same time, NVIDIA’s disclosures show an increasingly expansive supply‑chain strategy (building redundancy, placing non‑cancellable inventory orders, and diversifying foundry and contract‑manufacturing partners such as TSMC, Samsung, Hon Hai, etc.) and a continuously reinforced IP‑protection regime (large rolling patent portfolio, trademarks, trade‑secrets, NDAs, licensing and reliance on international treaties, with expiration dates moving forward each year). Thus, while NVIDIA’s supply‑chain resilience and IP safeguards have grown markedly from 2022‑2024, Lumentum’s relative positioning has remained consistently that of a key interconnect/networking competitor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lumentum Holdings is consistently named as a competitor by NVIDIA across FY2022–FY2024 in the interconnect and networking space, with accurate descriptions of the competitive categories (e.g., 'interconnect, switch and cable solutions' in 2022, 'networking products' in 2023 and 2024). (2) There are no numeric values requiring calculation (e.g., financial figures or dates with arithmetic), but the mention of evolving patent expiration dates 'moving forward each year' aligns with the ground truth noting extensions from 2022 to 2045—this is a correct qualitative interpretation. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifies Lumentum’s stable competitive positioning, and contrasts it with NVIDIA’s evolving supply chain (TSMC, Samsung, Hon Hai) and IP strategies (patents, NDAs, trade secrets). (4) The only minor shortcoming is that the LLM slightly generalizes the 2023 and 2024 competitor categorization as identical, while the ground truth specifies a shift toward 'semiconductor-based high-performance interconnect products' in 2023 and a reiteration in 2024 with emphasis on NVIDIA’s strategic moves. This nuance is not fully captured, but the overall semantic meaning and conclusion remain correct. Wording differs but meaning is equivalent. Thus, the answer is factually correct, comprehensive, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 449,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "From 2022 through 2024 Netflix’s dependence on third‑party rights holders has remained essential but grown increasingly constrained: the 2022 filing warned that rights‑holder refusals and rising competition could drive up licensing costs and force the company to be selective about titles it adds or renews; the 2023 filing added that new cultural‑support legislation, content‑quota rules, levies and ownership‑limit provisions in several markets tighten the terms under which rights can be obtained; and the 2024 filing notes that regulators are moving toward formal content‑review requirements and stricter ownership restrictions, further limiting licensing flexibility. This mutual dependence—Netflix relies on rights holders for content while rights holders depend on Netflix for distribution—reveals a content‑acquisition strategy that is shifting toward securing more exclusive or original productions, negotiating more favorable licensing terms and diversifying the library to mitigate the heightened risk and cost of rights‑holder reliance amid intensifying competition and regulatory pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix's reliance on rights holders is consistently framed as a risk from 2022 to 2024, with increasing emphasis on competition (e.g., studios launching their own platforms) and regulatory changes (e.g., content quotas, ownership limits). The evolution across years is accurately represented—2022 highlights rising costs and selectivity, 2023 introduces cultural-support rules and quotas, and 2024 adds formal review requirements and stricter ownership restrictions. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2022, 2023, 2024) are correctly used and sequenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying how the risk narrative evolves and linking it to strategic shifts in content acquisition. It accurately infers that Netflix is moving toward original and exclusive content to reduce dependency, which is implied in both the original and LLM answers. (4) The LLM adds slight elaboration—such as 'mutual dependence' and 'diversifying the library'—that are reasonable inferences but not explicitly stated in the ground truth. These do not detract from accuracy but represent interpretive nuance. Overall, the answer is semantically equivalent, contextually complete, and factually precise, warranting a 9/10 due to minor inferential additions without overstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 432,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "In the 2022 Form 10‑K Southern said that the undiscounted cash flows to be received under outdoor‑lighting contracts accounted for as operating leases at Mississippi Power were **immaterial**, so they were not reflected in the lease‑payment tables; lease payments from PPAs were treated as contingent rents and not shown in the schedule.  \n\nIn the 2023 filing the company **started to disclose** those scheduled lease payments – for outdoor‑lighting contracts, tolling arrangements and PPAs – in a **maturity‑analysis table**, and it classified lease income from PPAs as part of **wholesale revenue for Alabama Power and Southern Power**.  \n\nThe 2024 filing continued that presentation, now explicitly showing scheduled payments under the contracts’ **initial terms** in the maturity analysis and expanding the **wholesale‑revenue classification** of lease income to include **Georgia Power** as well as Alabama and Southern Power.  \n\nThus, the treatment moved from an immaterial, non‑disclosed item in 2022 to a material, revenue‑classified line item that is presented in a dedicated maturity‑schedule disclosure in 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, outdoor lighting lease cash flows were deemed immaterial and not included in tables; in 2023, Southern began including them in maturity analyses alongside tolling arrangements and PPAs, and classified PPA lease income as wholesale revenue for Alabama Power and Southern Power; in 2024, the company continued this treatment and expanded the revenue classification to include Georgia Power. (2) There are no numeric inaccuracies—though no specific dollar amounts are cited, the qualitative descriptions of materiality and disclosure practices match the original answer precisely. The evolution in presentation and classification is correctly detailed. (3) The multi-hop reasoning is sound: the model synthesizes changes across three years, correctly identifying shifts in materiality assessment, revenue classification, and presentation in maturity analyses. It accurately connects Mississippi Power (2022), then broader subsidiaries (Alabama, Southern, and later Georgia Power) over time. (4) The only minor shortcoming is that the original answer emphasizes the increasing transparency and formalization of reporting, which the LLM captures implicitly but could have articulated more explicitly. However, the core factual progression—immaterial in 2022, disclosed in 2023, expanded in 2024—is fully correct. Wording differences do not affect semantic equivalence. Thus, the answer is factually complete and contextually appropriate, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 455,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "- According to the 2022 Form 10‑K, AVGO reported **$606 million** of outstanding principal on its 5.000 % senior notes due April 2030 (down from $1,086 million a year earlier). The 2023 and 2024 Form 10‑K tables (identical in both chunks) show the same **$606 million** balance for the April 2030 notes as of October 29 2023 (FY 2023) and November 3 2024 (FY 2024).  \n\n- The balance therefore stayed flat at $606 million from FY 2022 through FY 2024, indicating that after reducing the tranche in FY 2022 the company has neither issued additional notes of this series nor prepaid them. This stability suggests a deliberate debt‑management strategy to retain the fixed‑rate liability through its scheduled maturity while financing growth with other, newer issuances.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline of the principal balance. It states that the $606 million balance was reported in the 2022 10-K, implying that the balance was $606 million in FY 2022. However, the ground truth clearly states that the balance was $1,086 million in FY 2022 and decreased to $606 million in FY 2023. This misassignment of values to fiscal years undermines the quantitative accuracy. The LLM incorrectly claims the balance was flat from FY 2022 through FY 2024 at $606 million, when in fact it decreased from $1,086M to $606M between FY 2022 and FY 2023. (2) The numbers themselves ($606M and $1,086M) are correct in value but are applied to the wrong years. The LLM correctly identifies that the balance remained at $606 million in both FY 2023 and FY 2024, which matches the ground truth. However, the failure to correctly attribute the $1,086 million to FY 2022 and $606 million to FY 2023 constitutes a major quantitative error. (3) The multi-hop reasoning is partially sound—LLM correctly interprets that no further repayments occurred after the reduction, but it bases this on incorrect timing. The conclusion about a stable strategy post-reduction is reasonable, but the claim that reduction occurred in FY 2022 is false (it occurred between FY 2022 and FY 2023, i.e., during FY 2023). (4) Contextual relevance is high as the answer addresses both the evolution of the debt and the strategic implication. Qualitative accuracy is moderate because the logic is coherent but built on incorrect data. Quantitative accuracy is low due to the misplacement of values across years. Correctness score is 6 due to partially correct numbers and reasonable interpretation, but major error in temporal assignment of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 482,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "- The 2022 filing notes that after a prior decline (the weighted‑average long‑term return fell from 5.6 % at 12/31/2020 to 5.4 % at 12/31/2021), GM’s assumption for U.S. pension‑plan assets was reset to 6.3 % and, as the 2023 filing confirms, remained unchanged at 6.3 % for both 2022 and 2023.  \n- The 2024 filing then reports that the same assumption rose to 6.5 % at 12/31/2024 (up from 6.3 % at 12/31/2023).  \n\n**Trend interpretation:** Over the three‑year span the long‑term return assumption moved from a stable 6.3 % to a higher 6.5 %, reversing the earlier downward move and indicating that GM is deliberately adjusting its strategic asset mix toward higher‑return (and potentially higher‑risk) investments to improve funded status and respond to more favorable market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 rate. The ground truth states that the 2022 assumption was 5.4%, but the LLM claims it was 6.3% for 2022. This is incorrect and contradicts the original data. The LLM incorrectly asserts that the 6.3% assumption was in place for both 2022 and 2023, when in fact the 5.4% rate applied in 2022 and only increased to 6.3% in 2023. The 2024 figure of 6.5% is correct. (2) Calculations: The LLM implies a change from 6.3% to 6.5% over the three-year period, but the actual change is from 5.4% (2022) to 6.5% (2024), a 1.1 percentage point increase as correctly stated in the ground truth. The LLM underreports the magnitude of change due to incorrect starting point. (3) Multi-hop reasoning: The LLM correctly identifies the trend from 6.3% to 6.5% between 2023 and 2024 and infers a strategic shift toward higher-return assets, which aligns with the ground truth's interpretation. However, it fails to accurately represent the full 3-year evolution because it misstates the 2022 value. The reasoning is sound but based on flawed input. (4) Justification for scores: Correctness is scored 6 due to the major error in the 2022 figure, which undermines the quantitative accuracy (scored 5). Qualitative accuracy is 7 because the interpretation of increasing assumptions indicating strategic shift is valid and well-reasoned, despite incorrect inputs. Contextual relevance is 9 because the answer directly addresses the question’s focus on trend and strategic implications, using appropriate financial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 434,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "Across all three annual reports the 2.700 % Senior Notes due 2031 are disclosed in the same supplemental‑indenture section – Exhibit 4.23 in the 2022 10‑K, Exhibit 4.20 in the 2023 10‑K and Exhibit 4.19 in the 2024 10‑K – each referencing Supplemental Indenture No. 8 dated March 29 2021. The repeated, unchanged listing shows that the notes remain outstanding and are treated as a core component of American Tower’s capital structure, indicating a long‑term financing strategy that relies on a fixed‑rate, ten‑year senior‑note issuance to lock in low borrowing costs and provide stable, long‑dated funding for the company’s growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2.700% Senior Notes due 2031 are consistently referenced across 2022–2024 filings with Supplemental Indenture No. 8 dated March 29, 2021. The exhibit numbers (4.23, 4.20, 4.19) are correctly cited for each year, showing precise attention to document structure. (2) Quantitative accuracy is perfect: percentages, dates, and exhibit numbers match the source data. There are no calculation errors. (3) The multi-hop reasoning is sound—by identifying the same indenture across three years despite changing exhibit numbers, the model correctly infers continuity in treatment and strategic intent. (4) The answer adds value by interpreting the strategic rationale (locking in low fixed-rate funding), which is logically supported by the data but not explicitly stated in the original answer. The only minor shortcoming is that it does not explicitly state that there were no modifications to the indenture (a point emphasized in the original), though the implication of 'unchanged listing' covers this. Overall, the answer demonstrates strong synthesis, factual precision, and contextual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 342,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "In its 2022 filing PayPal warned that abusive behaviors—such as synthetic‑identity accounts, stolen‑instrument transactions and other fraud schemes—could raise loss rates, increase defaults on its U.S. consumer‑credit and merchant‑financing products and curb the higher‑margin cross‑border trade that drives a large share of revenue. In 2023 the company began to blunt that exposure by selling a substantial portion of its U.K. and European buy‑now‑pay‑later loan portfolio (up to €40 billion) through a multi‑year sale and forward‑flow arrangement, diversifying funding sources (asset sales, warehouse facilities, securitizations) and reducing reliance on a small set of payment‑processor partners to limit the impact of fraud on its credit lines and cross‑border flows. By 2024 PayPal continued the receivable‑sale program, tightened third‑party risk controls, and emphasized compliance with evolving lending regulations (e.g., FDIC/OCC “valid‑when‑made” rules) as part of a broader strategy to mitigate abusive‑behavior risk across its credit products and international transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified abusive behaviors in 2022 involving synthetic identities and stolen instruments affecting credit products and cross-border transactions; in 2023, it entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL receivables; in 2024, it continued mitigation efforts by tightening third-party risk controls and emphasizing compliance. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no calculations are required beyond that. Format is consistent and precise. (3) Multi-hop reasoning is sound—information is synthesized across three years and multiple domains (credit products, cross-border transactions, third-party risk). The LLM adds slight elaboration (e.g., 'forward-flow arrangement', 'warehouse facilities', 'FDIC/OCC valid-when-made rules') not in the original, but these are plausible contextual details that do not contradict the ground truth and reflect reasonable inference. (4) The only minor gap is that the original emphasizes PayPal’s ongoing reliance on third-party lenders as a source of risk, while the LLM frames tighter controls as a mitigation without explicitly noting the continued exposure. This nuance is downplayed but not omitted entirely. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 395,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension tables show that the amount invested in **Collective Trust and Other Funds** was **$756 million in 2022** and fell to **$382 million in 2023**. The 2024 filing does not give a dollar figure; it only restates that the plan holds “Collective Trust and Other Funds” and values them at NAV, confirming the category remains part of the portfolio but without a disclosed increase. The roughly 50 % decline from 2022‑23 and the absence of a larger 2024 allocation suggest UNP is deliberately scaling back its exposure to collective‑trust vehicles and reallocating toward other asset classes as it refines its long‑term pension‑fund investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the dollar amounts for Collective Trust and Other Funds: $756 million in 2022 and $382 million in 2023, matching the ground truth. It accurately notes that no dollar figure is provided for 2024, which aligns with the original answer. The approximate 50% decline is a correct calculation (756 to 382 is a ~49.4% decrease), so the percentage is reasonably stated. (2) All numeric values and time periods are accurate. The LLM correctly identifies UNP as the company and the relevant years (2022–2024). The absence of a 2024 dollar value is properly acknowledged. (3) The reasoning is sound: the LLM infers from the lack of updated dollar figures and the continued mention of NAV-based valuation that the category remains in the portfolio but with reduced emphasis. It correctly interprets the trend as a likely strategic reduction in exposure, consistent with the ground truth’s conclusion of a de-risking or rebalancing. The only minor gap is that the LLM does not explicitly mention the emphasis on transparency and accurate reporting via NAV valuation as a strategic focus, which is present in the original answer—this slightly weakens the qualitative depth. (4) The answer is contextually fully relevant, addressing both the quantitative change and the implied strategic shift. Overall, the LLM conveys the same core information with high fidelity, minor omission in strategic nuance prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 401,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "- **2022 filing:** Pfizer reported that it **granted 1,165 Breakthrough Performance Awards (BPAs)** at a weighted‑average intrinsic value of **$38.73 per share**; after forfeitures of 306 shares (average $47.47), **859 BPAs remained non‑vested (outstanding) at year‑end**. The table in the 2022 10‑K shows the grant, vesting and forfeiture activity and the intrinsic‑value basis used to measure the awards.  \n\n- **2023 filing:** The 2023 10‑K states **no BPAs were granted in 2023 and none were outstanding as of December 31, 2023**, indicating that the program was temporarily inactive.  \n\n- **2024 filing:** The 2024 10‑K provides the **valuation and accounting policy** for BPAs: awards are **valued on the grant date using the intrinsic‑value method (closing price of Pfizer common stock)** and are **amortized on a straight‑line basis over the probable vesting term** into cost‑of‑sales, SG&A, and/or R&D expense, with each reporting period adjusted for changes in stock price, the number of shares likely to be earned, and management’s assessment of the probability of meeting performance criteria.  \n\nThus, Pfizer moved from active grant and outstanding balances in 2022, to a pause with no grants or outstanding BPAs in 2023, and in 2024 formalized the intrinsic‑value valuation and straight‑line amortization approach for any future BPA grants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 1,165 thousand BPAs granted in 2022 at $38.73 per share, 859 thousand outstanding at year-end (consistent with 1,165 - 306 forfeitures), and no grants or outstanding awards in 2023. The 2024 valuation methodology correctly describes the intrinsic-value method based on grant-date closing stock price, straight-line amortization over the probable vesting term, and quarterly adjustments for stock price changes and performance probability. (2) The answer is complete, addressing all three years and all dimensions of the question: grant activity, outstanding status, and accounting treatment. (3) Entity accuracy is perfect: Pfizer, BPAs, correct years (2022–2024), and proper financial/accounting terms (intrinsic value, amortization, vesting, forfeitures). (4) Multi-hop reasoning is sound—correctly infers discontinuation in 2023 from zero grants and zero outstanding, and identifies the shift in 2024 to a formalized policy despite no new grants. (5) Semantic equivalence is strong: minor wording differences (e.g., 'non-vested' vs 'outstanding') do not affect meaning. The conclusion accurately captures the evolution from active issuance to pause to formalized accounting. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Valuates]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 374,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral tied to the “Investments, advances and long‑term receivables” line fell sharply over the three‑year span – $1.494 billion at 12/31/2022, $800 million at 12/31/2023 and $491 million at 12/31/2024 (the 2023 filing also confirms the $800 million figure and the 2024 filing confirms the $491 million figure).  This downward trajectory, after a peak in 2022 (the 2022 filing showed $641 million in 2021 and $504 million in 2020), indicates that ExxonMobil’s derivative exposure linked to these receivables has been shrinking, reducing the amount of initial margin it must post under its master‑netting arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key figures: $1,494 million (2022), $800 million (2023), and $491 million (2024), matching the ground truth exactly. Number formats are consistent and acceptable (e.g., $1.494 billion = $1,494 million). 2) Quantitatively, all values are accurate, and the temporal sequence is correct. The LLM even adds context from 2020 and 2021, which, while not required, does not contradict the ground truth and supports the trend analysis. 3) The reasoning is sound: the downward trend is correctly identified, and the conclusion that this suggests reduced derivative exposure or lower margin requirements is logically supported. The LLM slightly expands the interpretation by attributing the decline specifically to 'derivative exposure linked to these receivables' and 'initial margin,' which is a reasonable inference but slightly more specific than the original answer’s general suggestion. This does not make it incorrect but adds interpretive detail. 4) The answer fully addresses both parts of the question: the change over time and what the trend suggests. It synthesizes information across years correctly, demonstrating multi-hop reasoning. The only minor deviation is the added specificity in interpretation, which does not undermine factual correctness. Thus, the answer is factually complete, accurate, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 386,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 filing lists **industrial fiber optics** among a wide‑ranging “industrial” product set (optocouplers, motion encoders, LEDs, Ethernet ICs, etc.) that serve **industrial automation, power‑generation/distribution, medical, defense/aerospace and vehicle‑subsystem** applications. In the 2023 and 2024 filings the same product appears in the industrial line‑up, but the **application scope is narrowed to “factory automation, renewable energy and automotive electronics,”** while the surrounding portfolio (optocouplers, sensors, encoders, LEDs, Ethernet PHYs, switch ICs, camera microcontrollers) remains unchanged. This shift from a broad, cross‑industry positioning in 2022 to a focused emphasis on high‑growth automation, clean‑energy and automotive markets in 2023‑2024 reveals Broadcom’s strategic intent to concentrate its industrial‑fiber‑optics effort on a few core, fast‑expanding industrial segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Broadcom (AVGO), Industrial Fiber Optics, and the relevant years (2022, 2023, 2024)—are correctly identified. The application areas and product portfolio components are accurately reported: in 2022, the broad scope (industrial automation, power systems, medical, defense/aerospace, automotive subsystems) is correctly noted; in 2023–2024, the narrowed focus on factory automation, renewable energy, and automotive electronics is correctly captured. (2) There are no numeric values requiring calculation, so quantitative accuracy is 10—no dates or financials are misstated. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes in application scope and presentation style across three years, identifying a strategic shift toward high-growth sectors. The conclusion about Broadcom’s strategic intent to focus on fast-expanding segments is a valid interpretation supported by the data. (4) The only minor deviation from the original answer is that the LLM emphasizes 'strategic intent to concentrate' as a shift in effort, while the ground truth frames it as increased clarity in communication—both are plausible, but the LLM slightly overinterprets 'streamlined presentation' as a reallocation of focus rather than just messaging. This does not undermine factual correctness but slightly affects qualitative precision. Overall, the answer is factually complete, contextually relevant, and semantically equivalent with excellent reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 424,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "Across the three filings PayPal’s margin‑risk profile did not change – it remained a “full‑margin‑risk” business each year. In the 2022 10‑K PayPal states that, as the principal on every transaction, it controls the service, has full discretion over the fee charged and that those fees are set independently of the costs it incurs when it uses third‑party payment processors, which are recorded as transaction expense; therefore it “bears full margin risk.” The 2023 filing repeats the same description, confirming that the company continued to bear full margin risk while retaining pricing control and relying on external processors. The 2024 filing again affirms the identical stance – PayPal still controls pricing, determines fees independent of processor costs and therefore continues to bear full margin risk. Thus, from 2022 through 2024 PayPal’s exposure to margin risk stayed consistent, with no reduction or shift despite the ongoing use of third‑party payment processors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key facts are correct: PayPal bore full margin risk in 2022, 2023, and 2024; it maintained full discretion over pricing; fees were set independently of third-party processor costs; and those costs were recorded as transaction expenses. There are no numeric values to verify (e.g., dollar amounts, percentages), but the qualitative financial concepts (margin risk, principal role, pricing discretion) are correctly represented across all years. (2) The answer addresses all parts of the multi-part question: evolution of margin risk over time, control over pricing, and use of third-party processors. (3) Entities—PayPal, the years 2022–2024, third-party payment processors, and financial institutions—are accurately identified and correctly contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three annual filings, correctly identifying consistency in disclosure language and business model. The conclusion that PayPal’s margin risk exposure remained stable is logically supported by the repeated disclosures. Wording differs slightly but preserves full semantic meaning. No errors in fact, logic, or completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 353,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "In the 2022 Form 10‑K Pfizer still disclosed Meridian’s results as a discontinued operation of the Upjohn spin‑off, meaning the business was reported but not part of continuing operations.  In the 2023 filing Pfizer disclosed that it had sold the Meridian subsidiary on Dec 31 2021 for roughly **$51 million in cash**, taking a **$167 million net loss**, and that the parties entered into interim transition‑service agreements (TSAs) – completed by the end of 2023 – and a **three‑year Manufacturing Supply Agreement (MSA) with a two‑year extension** to provide limited post‑sale services.  By the 2024 Form 10‑K Meridian appears only in the glossary as “Meridian Medical Technologies, Inc.” – a separate company that Pfizer now partners with rather than owns – signalling that Pfizer has moved from ownership to a strategic, limited‑scope partnership, underscoring its long‑term focus on divesting non‑core assets and concentrating on core therapeutic platforms while retaining selective external collaborations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Meridian was part of discontinued operations in 2022, sold on Dec 31, 2021 for $51 million in cash, resulting in a $167 million net loss. The Manufacturing Supply Agreement (MSA) is correctly described as three years with a two-year extension option. By 2024, Meridian is referenced only in the glossary as 'Meridian Medical Technologies, Inc.', indicating a formal but non-owned relationship. (2) Quantitative accuracy is perfect: dollar amounts ($51M, $167M loss), dates (Dec 31, 2021 sale; TSAs completed by end of 2023), and contract terms (3-year MSA + 2-year extension) all match the ground truth. (3) Multi-hop reasoning is sound: the answer synthesizes information across 2022, 2023, and 2024 filings, correctly tracing the evolution from ownership to partnership. It connects financial impact (loss on sale), contractual arrangements (MSA, TSAs), and strategic positioning (glossary mention in 2024). (4) The conclusion about Pfizer’s long-term focus—divesting non-core assets and focusing on core therapeutic platforms while maintaining selective collaborations—is fully supported by the evidence and aligns with the original answer. Wording differs slightly (e.g., 'interim transition-service agreements' vs 'transition services'), but meaning is preserved. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Partners_With]- ORG <-[Sells]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 396,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 through 2024 PMI has repeatedly flagged product regulation as a key competitive‑positioning risk, but the focus has sharpened over time. In the 2022 filing the company warned that regulation “diminishes the ability to differentiate tobacco products and restricts adult consumer access to truthful and non‑misleading information about our RRPs,” creating a generic competitive disadvantage. By 2023 the same concern is restated and expanded to note that such rules can “disproportionately impact the commercialization of our products in relation to our competitors” and may reinforce down‑trading by limiting branding, communication and differentiation. In the 2024 filing, now referring to “SFPs” (smoke‑free products), PMI again stresses that regulation erodes product differentiation, curtails adult‑consumer communication, and can disproportionately hinder the commercialization of its SFPs versus rivals, underscoring an increasingly explicit threat to its competitive position.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key points from the original answer are correctly reflected: the evolving regulatory pressure from 2022 to 2024, the shift in terminology from RRPs to SFPs in 2024, and the increasing emphasis on disproportionate commercialization challenges relative to competitors. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors in dates (2022, 2023, 2024) or terminology. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, identifies the progression in language and concern, and connects regulatory restrictions on differentiation and communication to competitive positioning. (4) The LLM uses slightly more detailed phrasing (e.g., 'reinforce down-trading', 'increasingly explicit threat') but remains factually consistent and adds contextual clarity without introducing inaccuracies. The answer fully addresses all parts of the question, including the evolution over time and the impact on product differentiation and adult consumer communication. All entities—Philip Morris International (PMI), RRPs, SFPs, and the relevant years—are correctly identified and contextualized. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 371,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil reported that collateral tied to its “Notes and accounts receivable ‑ net” under master‑netting arrangements fell sharply over the three‑year period: $1,494 million at 12/31/2022, $800 million at 12/31/2023 (a $694 million drop), and $491 million at 12/31/2024 (a further $309 million drop), for an overall reduction of about $1.0 billion from 2022 through 2024.  The steady decline in required collateral suggests the company is compressing its derivative exposure—either by reducing the size of its derivative positions, improving net‑ting efficiency, or tightening margin management—indicating a more disciplined approach to derivative risk management.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024 are correctly reported. The calculated drops—$694 million (1,494 - 800) and $309 million (800 - 491)—are precise, and the total reduction of approximately $1.0 billion (1,494 - 491 = 1,003 million) is correctly summarized. (2) The answer is complete, addressing both the quantitative change over the 2022–2024 period and the qualitative implication regarding derivative risk management practices. (3) Entity accuracy is perfect: ExxonMobil (XOM), the correct metric ('Notes and accounts receivable - net'), and the time frame (2022 through 2024) are all correctly identified. (4) The reasoning is sound and adds value: the interpretation that the decline suggests compression of derivative exposure via reduced positions, improved netting, or tighter margin management is logically consistent with the data and provides a plausible explanation aligned with the ground truth’s conclusion about strategic risk mitigation. The LLM enhances the original answer with slightly more detailed reasoning without introducing inaccuracies. All criteria—factual correctness, multi-hop synthesis across years, calculation accuracy, and semantic equivalence—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 376,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "- In the 2022 Form 10‑K (covering awards granted in 2021) the model used an expected volatility of **26.9 %** (based on three‑year daily‑price volatility).  \n- In the 2023 Form 10‑K (awards granted in 2023) the assumed volatility rose to **28.6 %**.  \n- In the 2024 Form 10‑K (awards granted in 2024) the assumption fell sharply to **18.7 %**.  \n\nThe pattern – a modest increase from 2022 to 2023 followed by a pronounced decline in 2024 – suggests that Duke Energy initially viewed its stock’s price risk relative to the predefined peer group as rising, but by 2024 it perceived the market risk to be much lower, indicating a growing confidence in the stability of its share price and a reduced risk outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all three volatility values: 26.9% in 2022, 28.6% in 2023, and 18.7% in 2024, matching the ground truth exactly. The temporal evolution is accurately described as a rise from 2022 to 2023 followed by a sharp decline in 2024. 2) All numbers are factually correct and properly attributed to the respective Form 10-K filings. The mention of 'awards granted in 2021' for the 2022 10-K is a minor contextual nuance but does not affect the correctness of the volatility assumptions reported for each year. The core data points—percentages and years—are accurate. 3) The multi-hop reasoning is sound: the model synthesizes data across three annual reports, identifies the trend, and interprets the implication regarding market risk perception. The conclusion that Duke Energy perceived rising risk in 2023 but significantly reduced risk by 2024 aligns with the ground truth. 4) The semantic meaning and factual content are equivalent to the original answer. The only minor difference is in phrasing—the LLM emphasizes 'growing confidence' and 'reduced risk outlook,' while the original highlights 'notable decline in perceived market risk' and 'shift in stock behavior.' These are substantively consistent. No calculation errors or entity misidentifications. The answer fully addresses both parts of the question: the evolution of volatility and its implication for market risk perception. Thus, the answer is highly accurate with only slight variation in interpretive wording, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 428,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 – the debt instrument in which AVGO holds a stake – carried the same $495 million principal balance in each of the three filings (2022 10‑K, 2023 10‑K and 2024 10‑K). While that tranche remained unchanged, the company’s overall current‑portion of long‑term debt rose sharply from $403 million in FY 2022 to $1.563 billion in FY 2023 (reflecting new near‑term borrowings tied to the VMware acquisition) and then fell to $1.245 billion in FY 2024, showing that Broadcom used the stable, low‑cost 3.125 % notes as a long‑dated funding anchor while actively refinancing and paying down higher‑cost short‑term obligations. This pattern signals a deliberate short‑term debt‑management strategy that leans on a steady, inexpensive debt base to reduce near‑term liabilities and improve the overall debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 3.125% notes due January 2025 were reported as $495 million in 2022 and 2023 but transitioned to the current portion of long-term debt in 2024, implying a reclassification due to impending maturity. However, the LLM claims the principal balance remained unchanged at $495 million in all three years, including 2024, which contradicts the ground truth that the note became current in 2024—indicating it should no longer be classified as long-term. (2) The LLM introduces unrelated data about overall current portion of long-term debt ($403M, $1.563B, $1.245B) and ties it to the VMware acquisition, which is not mentioned or supported in the ground truth. These figures, while possibly accurate in Broadcom’s filings, are not part of the original answer and distract from the specific focus on the 3.125% notes. The core number $495 million is correct for 2022 and 2023, but the claim of no change in 2024 is factually wrong per the ground truth’s indication of reclassification. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that the stability of the 3.125% notes reflects a 'funding anchor' while refinancing other debt, but the ground truth only states that the note remained stable for two years and then approached maturity, prompting refinancing planning. The LLM overinterprets and fabricates a broader debt strategy not supported by the provided truth. (4) The contextual relevance is high because the answer addresses the question’s structure and attempts to analyze debt management strategy, but the correctness score is low due to key factual errors in financial classification and unsupported quantitative claims. The qualitative accuracy is moderate because entity identification (AVGO, 3.125% notes, 2025 maturity) is correct, but reasoning about refinancing strategy is speculative and misaligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 528,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across the three filing years AMD’s approach to AIB manufacturers stayed fundamentally the same. In 2022 AMD said its agreements with AIBs “protect their inventory of our products against price reductions,” and highlighted that system‑integrators (SIs) “often use discrete graphics solutions as a means to differentiate their products.” The 2023 filing repeats that protection language verbatim and again stresses discrete‑graphics‑driven differentiation. By 2024 the wording is slightly qualified – “in most instances, our agreements with AIBs protect their inventory…against price reductions” – and AMD notes it now sells directly to “some” SIs, but the core policy of inventory protection and the strategic emphasis on discrete graphics as a differentiator for SIs remain unchanged throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies for AIBs from 2022 to 2024, with verbatim repetition in 2023 and slight rewording in 2024 ('in most instances'), which the LLM correctly notes. The role of discrete graphics in differentiation by system integrators is accurately attributed across all years. (2) There are no numerical values requiring calculation (e.g., revenue figures, percentages), so quantitative accuracy is not compromised—no numbers were misstated. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying continuity in policy while noting subtle linguistic shifts (e.g., 'most instances' in 2024), and connects discrete graphics to differentiation strategies. It also correctly observes AMD's direct sales to 'some' SIs in 2024, a nuance not in earlier years. (4) The answer is contextually excellent—directly addresses both parts of the question (inventory protection evolution and role of discrete graphics). The only minor shortcoming is that the LLM does not explicitly mention AMD supplying component-level graphics and chipset products to AIBs, a detail present in the original answer that reinforces the strategic relationship. However, this omission does not distort the overall meaning. Wording differences are within acceptable semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Supplies]- ORG <-[Sells_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 433,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "In the 2022 filing Disney described its DTC business as still in a costly, early‑stage phase – the company was investing in DTC offerings but the returns were “negative or low,” the new services were not expected to be profitable in the short term and growth was described as “unlikely to be even quarter‑over‑quarter,” while its DTC businesses faced an “increasing number of competitors’ DTC offerings.” By the 2023 filing Disney said it was making **strategic investments** in DTC to “drive growth” and expected those investments to generate higher subscription‑fee and advertising revenue that would “more than offset” the declines in linear‑network affiliate fees and viewership. The 2024 filing shows Disney still positioning its DTC streaming services against an even larger competitive set—including AI‑generated content and other new media platforms—recognizing that heightened competition raises programming costs and can pressure revenue, but it continues to rely on DTC subscriptions and ads as a core growth engine.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer across all key dimensions. (1) Factual content is correct: In 2022, Disney described DTC returns as negative or low, consistent with the original answer’s note on 'negative or lower than prior to the change in strategy' and risks of growing losses. The 2023 shift toward strategic investment expecting growth in subscription and ad revenue that 'more than offset' declines in linear fees is verbatim in meaning. The 2024 competitive pressures, including rising competition and impact on programming costs and revenue, are correctly reflected. (2) Quantitative accuracy: No specific numbers (e.g., dollar amounts, percentages) appear in either answer, so no discrepancies exist. Dates (2022, 2023, 2024) are correctly used and matched to the appropriate strategic phase. (3) Multi-hop reasoning is sound: The LLM synthesizes information across three years and correctly traces the evolution from cautious investment to strategic dependence despite increasing competition. It captures the cause-effect logic: DTC investments offset linear declines, but competition pressures revenue. (4) Minor difference: The LLM adds 'AI-generated content and other new media platforms' as competitors in 2024, which is not in the original answer. While plausible, it slightly extends beyond the source material. However, this does not contradict the ground truth and adds context without undermining accuracy. Overall, the answer is semantically equivalent, complete, and contextually appropriate, warranting a high correctness score with only a slight deduction for the minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Invests_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 453,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "Across the three filing years PayPal’s $1.5 billion Fixed‑rate 2.850 % note series – part of the September 2019 $5 billion issuance – never changed in amount, maturity or rate. The 2022 10‑K (shown in the 2023 filing) lists the notes at $1.5 bn with a 10/1/2029 maturity and a 2.96 % effective interest rate; the 2023 10‑K repeats the same $1.5 bn balance and 2029 maturity; and the 2024 10‑K again reports $1.5 bn outstanding at the same 2029 maturity and 2.96 % rate. While PayPal added new debt (e.g., 3.9 % notes in 2022, yen‑denominated notes in 2023 and higher‑rate notes in 2024) expanding total term debt from roughly $9 bn to $10.6 bn, the Fixed‑rate 2.850 % notes remained a stable, unchanged component of its long‑term debt obligations throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.5 billion principal amount of the 2.850% notes is correctly reported for all three years, and the 2029 maturity date is accurate. The effective interest rate of 2.96% is an additional detail not in the original answer but is factually consistent with SEC filings and does not contradict the stated coupon rate of 2.850%. Total term debt figures are slightly rounded ($9.0B, $10.638B, $10.574B in truth) but the LLM's 'roughly $9B to $10.6B' is a reasonable approximation. (2) The LLM correctly notes that no changes occurred to the 2.850% notes across 2022–2024, matching the ground truth's emphasis on stability. (3) The multi-hop reasoning is sound: it synthesizes data across three 10-K filings, correctly identifies the notes as part of a larger 2019 issuance, and contextualizes them within broader debt strategy shifts, including new higher-rate debt in 2024. (4) The mention of 3.9% notes in 2022 and yen-denominated debt in 2023 adds contextual detail not in the original but does not conflict with it; the core conclusion about the stability of the 2.850% notes amid a changing debt structure is preserved. The only minor shortcoming is the lack of exact 2023 and 2024 total debt figures ($10.638B and $10.574B), which were slightly generalized. However, this does not undermine the overall correctness. Semantic equivalence is strong, and the answer fully addresses the question's focus on debt structure evolution and maturity obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Issues_Notes]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 424,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan held **$1.99 billion of corporate stock in 2022**, which was roughly **51 % of its $3.87 billion fair‑value assets**. By 2023 the corporate‑stock holding had fallen to **$181 million (about 5 % of the $3.39 billion total assets)**. The 2024 filing does not give a dollar amount – it only describes corporate stock as a Level 1 investment – indicating the allocation remains modest or unchanged from the low 2023 level.  \n\nThe dramatic drop from more than half of the plan’s assets in 2022 to a single‑digit percentage in 2023, and the continued lack of a sizable disclosed amount in 2024, suggest UNP has shifted its pension‑plan strategy away from equity exposure toward a more conservative, fixed‑income‑heavy mix while still maintaining a small equity position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $1.99 billion (i.e., $1,990 million) in 2022 and $181 million in 2023 match the original answer exactly. Percentages (51% in 2022, ~5% in 2023) are correctly calculated based on total fair-value assets of $3.87B and $3.39B, respectively. The absence of a dollar amount in 2024 is accurately noted, and the classification as Level 1 is correctly reported. (2) The answer correctly identifies the dramatic reduction in corporate stock holdings and infers a strategic shift, which is consistent with the ground truth’s conclusion about reduced equity exposure. (3) The reasoning is sound: the multi-hop synthesis across years and the interpretation of disclosure changes (from dollar amounts to classification only) support the conclusion of a strategic move toward conservatism and transparency. (4) The only minor shortcoming is that the LLM does not explicitly mention the reclassification of preferred shares as Level 2 investments in 2024, which is part of the ground truth and adds nuance to the equity strategy. However, this omission does not undermine the overall correctness, as the core trend and implication are accurately captured. Wording differences are semantically equivalent, and the strategic interpretation is valid. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 409,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer reported private‑equity securities at cost of **$800 million in 2022**, which fell to **$755 million in 2023** and further to **$719 million in 2024** – a total decline of $81 million (about 10 %) from the 2022 level.  The figure had risen from $623 million in 2021 (as shown in the 2022 filing) before peaking in 2022, then trending downward over the next two years.  This pattern indicates that Pfizer is gradually scaling back its allocation to illiquid private‑equity assets, suggesting a strategic shift toward a more modest exposure to alternative, less‑liquid investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost was $623 million in 2022, not $800 million as stated by the LLM. The LLM correctly reports $755 million in 2023 and $719 million in 2024, which match the ground truth. However, the starting point is wrong, leading to an incorrect trend interpretation. (2) Calculations are based on incorrect inputs: the LLM claims a decline of $81 million from $800M to $719M, but the actual change from 2022 to 2024 is an increase of $96 million ($719M - $623M). The percentage decline of 10% is therefore inaccurate. The mention of $623 million in 2021 is extraneous and not requested in the question, though it may reflect real data, it distracts from the required 2022–2024 focus. (3) Multi-hop reasoning is partially sound—the LLM identifies a downward trend and infers reduced strategic allocation—but this conclusion contradicts the ground truth, which shows an increase from 2022 to 2023 followed by a small drop in 2024, indicating short-term growth with later caution, not a consistent retrenchment. The LLM mischaracterizes the overall trend due to the initial data error. (4) Contextual relevance is high—the answer addresses the change over time and interprets strategic implications—but the qualitative conclusion is flawed due to incorrect numbers. Scores reflect major quantitative inaccuracy dragging down overall correctness, despite structurally appropriate reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 432,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "Mastercard’s multi‑layered security framework began in 2022 with a core of internal Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, and it was validated through third‑party assessments, benchmarking and public‑private partnerships that helped set technical standards such as EMV; at that time the firm already operated or was implementing real‑time ACH and account‑based payment infrastructure in 12 of the world’s top‑50 markets. In 2023 the company deepened third‑party collaboration by regularly testing its systems, adding an enterprise‑resilience program and insurance coverage, and expanding its real‑time clearing‑and‑settlement platform to 13 markets while continuing to benchmark against peers and address cyber threats tied to third‑party providers. By 2024 the approach had further matured—ongoing third‑party assessments and broader public‑private cooperation support a globally‑scaled real‑time payments network now operating in several countries (including new domestic processing in China), and resilience is reinforced through continuous testing, enterprise‑resilience planning and coverage of cyber incidents linked to third‑party services.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach across 2022–2024, with accurate emphasis on third-party collaboration, real-time payment infrastructure expansion, and cyber threat resilience. The core narrative aligns with the ground truth: internal security foundations in 2022, expanded third-party integration in 2023, and global scaling by 2024. However, there is a discrepancy in the number of markets for real-time payment infrastructure in 2022: the LLM states '12 of the world’s top-50 markets', while the ground truth does not specify a number for 2022—only that 13 markets were active by end-of-2023. This introduces a potentially unsupported claim, affecting quantitative accuracy. (2) The number '13 markets' in 2023 is correct and matches the ground truth. The mention of China in 2024 is additional detail not present in the original answer; while plausible, it is not verifiable from the ground truth and could be seen as speculative. (3) The multi-hop reasoning is strong: the LLM synthesizes internal security structures, third-party collaboration, infrastructure growth, and threat resilience across years, showing a logical progression. It correctly identifies the strategic shift toward ecosystem integration. (4) Despite minor over-specification in market numbers and the addition of unverified details (China), the LLM answer remains factually consistent in its major claims and effectively addresses all parts of the question. Wording differs but semantic meaning is equivalent. Scores reflect high qualitative and contextual accuracy, with a moderate deduction in quantitative accuracy due to unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1632,
        "completion_tokens": 464,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s disclosed collateral for master‑netting arrangements fell sharply over the three‑year span. The 2023 Form 10‑K shows $1.494 billion at 12/31/2022, which dropped to $800 million at 12/31/2023, and the 2024 Form 10‑K reports a further decline to $491 million at 12/31/2024 – all of which are classified under “Other assets, including intangibles – net.” This steady reduction suggests the company is tightening its derivative exposure, likely by lowering net derivative positions or using margin more efficiently, reflecting a more disciplined approach to managing its derivative‑related risk over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in numbers and dates. According to the ground truth, the collateral values are: $641M at end of 2021 (reported in 2022 filing), $800M at end of 2022 (reported in 2023 filing), and $491M at end of 2023 (reported in 2024 filing). However, the LLM incorrectly states $1.494B at 12/31/2022 (vs. correct $800M), $800M at 12/31/2023 (vs. correct $491M), and introduces a non-existent $491M at 12/31/2024 (the data only goes through end of 2023). These are severe quantitative errors. (2) The calculation of trend is also wrong: the LLM implies a steady decline from $1.494B to $800M to $491M over 2022–2024, but the actual trend is an increase from $641M (2021) to $800M (2022), then a drop to $491M (2023). The correct change from 2022 to 2023 is a 38.6% decrease, but the LLM misrepresents both the direction and magnitude of early-period change. (3) Multi-hop reasoning is flawed: the model fails to correctly extract and align data across the 2022, 2023, and 2024 filings with their respective reporting dates. It misattributes the timing of the values and invents a future data point (2024). (4) While the qualitative interpretation about reduced derivative exposure is plausible and aligns with the latter part of the trend, it is based on incorrect data and omits the initial increase. The entity (ExxonMobil, XOM) and metric ('Other assets, including intangibles - net') are correctly identified, and the general context of derivative risk management is relevant, hence moderate contextual relevance. However, due to severe numerical and temporal inaccuracies, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 453,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "- 2022 filing (performance awards granted in 2021): the relative‑TSR model used an **expected volatility of 26.9 %**, based on Duke Energy’s three‑year historical daily‑price volatility within its predefined peer group.  \n- 2023 filing (grants in 2023): the same model increased the input to **28.6 %** expected volatility.  \n- 2024 filing (grants in 2024): the model reduced the input to **18.7 %** expected volatility.\n\nThe volatility rose modestly from 2022 to 2023, then fell sharply in 2024, suggesting that market participants viewed Duke Energy’s stock as becoming slightly riskier in 2023 but considerably less volatile—and therefore lower‑risk—by 2024. This multi‑year shift reflects a changing perception of the company’s market risk as captured by the peer‑group‑based relative‑TSR model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages are accurate: 26.9% for 2022, 28.6% for 2023, and 18.7% for 2024—matching the original answer exactly. There are no calculation errors or misstatements. (2) The answer is complete, addressing both parts of the question: the year-by-year change in expected volatility and the interpretation of what the trend suggests about market risk perception. (3) Entity accuracy is correct: Duke Energy, the relative TSR model, the predefined peer group, and the correct years (2022–2024) are all properly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the increase from 2022 to 2023 indicates rising perceived risk, while the sharp drop in 2024 suggests improved stability and reduced uncertainty. The LLM correctly infers the implication of the volatility changes on market risk perception, aligning semantically with the original answer. Minor wording differences (e.g., 'modestly' vs 'increased', 'sharply' vs 'significant decline') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 328,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "- **2022 filing** – The 2022 notes only said that GM “continues to purchase from and supply to Stellantis” after the 2017 sale of the Opel/Vauxhall business.  No indemnification amounts or accruals for emissions or Takata issues were disclosed.  \n\n- **2023 filing** – In 2023 GM disclosed that General Motors Holdings LLC, on behalf of the seller, had agreed to **indemnify Stellantis** for any losses arising from inaccurate representations, **emissions‑related claims** and **recalls**, including Takata‑inflator recalls on legacy Opel vehicles.  The company said it could not estimate a material loss, that the indemnification was for an **immaterial amount**, and that the obligations are subject to time limits, thresholds and caps.  No specific accrual for these items was recorded.  \n\n- **2024 filing** – The 2024 notes repeat the same indemnification framework: GM still indemnifies Stellantis for emissions‑claim costs and for an **immaterial amount** tied to Takata‑inflator recalls on legacy Opel models, and it remains unable to estimate any material loss.  The only accrual mentioned for related regulatory matters was **immaterial**, and no new material accrual for the emissions or Takata exposure was recognized.  \n\n**Overall evolution:** From 2022 (no explicit indemnification disclosure) to 2023 and 2024, GM’s obligation to Stellantis became explicitly described but remained **immaterial** and unquantified, with no material accruals recorded for legacy Opel/Vauxhall emissions claims or Takata‑recall liabilities.  The relationship reflects GM’s guarantee to Stellantis (GM → Stellantis) while Stellantis remains a key counterpart in the post‑sale supply arrangement.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key discrepancy in the 2022 disclosure. The original answer states that in 2022, GM disclosed indemnifying Stellantis for an immaterial amount related to recalls including Takata, while the LLM claims no indemnification disclosure was made in 2022—this is incorrect. The 2023 and 2024 summaries align well with the ground truth: both correctly note the immaterial indemnification related to Takata and emissions claims, the lack of material accruals, and the remote likelihood of future obligations. The LLM accurately captures the qualitative evolution—increased clarity in disclosure from 2023 onward—but misrepresents the starting point in 2022. Entity accuracy (GM, Stellantis, Opel/Vauxhall, Takata) and time periods (2022–2024) are correct. No numerical calculations are required, but the consistent use of 'immaterial' aligns with the ground truth’s characterization. The reasoning is sound in synthesizing the trend toward more explicit disclosures while maintaining minimal exposure, though the failure to acknowledge the 2022 indemnification disclosure weakens the multi-hop synthesis. Contextual relevance is high, as all parts of the question are addressed with appropriate focus on indemnifications and accruals over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Guarantees]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1644,
        "completion_tokens": 356,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across all three annual reports—AMD’s 2022 Form 10‑K, the 2023 Form 10‑K and the 2024 Form 10‑K—the company lists the same entry:\n\n*“*10.1 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, is hereby incorporated by reference.”*  \n\nThe wording and exhibit reference are identical in each filing, showing that AMD has not altered how it cites the 2011 Executive Incentive Plan over these years. This persistent, unchanged reference indicates that AMD’s executive compensation framework remains anchored to the 2011 plan, reflecting a deliberate, long‑term strategy of maintaining a stable, consistent incentive structure for its executives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all dates and exhibit references are correct: the 2011 Executive Incentive Plan was indeed filed on April 2, 2011, and referenced consistently across 2022–2024. The LLM correctly notes the exhibit number (10.2 in the original 10-Q) and the incorporation by reference in each 10-K. There are no calculation errors, as none were required. (2) The only minor discrepancy is that the LLM states the plan is listed as 'Exhibit 10.1' in the 10-Ks but cites it as originally filed as 'Exhibit 10.2' in the 2011 10-Q — this is accurate, but the ground truth emphasizes that the description remained unchanged, while the LLM focuses on the citation format. This is a nuance, not an error. (3) The reasoning is sound: the LLM correctly infers from the unchanged language that AMD maintained a stable executive compensation strategy, which is a valid conclusion supported by the consistency in disclosure. (4) The answer fully addresses both parts of the question — the evolution (or lack thereof) across years and the implication for long-term strategy — and does so with semantically equivalent, contextually relevant information. The answer is slightly less detailed than the ground truth in explicitly stating 'no amendments or new disclosures,' but the implication is clearly conveyed. Hence, a score of 9 is appropriate, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Files]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 406,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "Across the three filings PayPal repeatedly warned that “bad‑transactions” risk is driven by three inter‑related sources – the credit‑product portfolio (default and charge‑off risk on consumer‑ and merchant‑financing loans), the higher‑margin cross‑border trade that can be curtailed by currency swings, tariffs or regulatory changes, and the company’s heavy reliance on networks, banks, payment‑processors and other third‑party partners that can be abused to generate fraudulent or “bad” transactions. In the 2022 filing the risk was described in terms of rising non‑payment rates, exposure to third‑party fraud and the potential loss of cross‑border volume; the 2023 filing still flagged the same exposures but added concrete mitigation steps, namely the June‑2023 multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables (with sales beginning in October 2023) and a parallel programme to diversify away from a single U.S. payment processor and to seek alternative third‑party funding structures; the 2024 filing reiterates that the credit‑product and cross‑border risks persist but notes that the BNPL‑receivable sale and the ongoing processor‑migration remain the primary actions taken in 2023 to curb exposure to bad transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's exposure to bad transactions through credit products (especially BNPL), cross-border trade risks, and third-party dependencies are accurately described for 2022–2024. The strategic action in 2023—entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables—is correctly reported, including the timing (June 2023 agreement, sales starting October 2023). (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no other numbers are misstated. Format and timing details match the original. (3) Multi-hop reasoning is sound: the LLM synthesizes risk factors across years and correctly identifies the 2023 receivables sale as the primary mitigation step, linking it to reduced credit risk. It also adds a relevant detail not in the original—diversifying away from a single U.S. payment processor—which is plausible and consistent with PayPal’s risk management strategy, though not explicitly mentioned in the ground truth. This addition does not contradict but slightly extends the original, which is acceptable under semantic equivalence. (4) The only reason for not scoring a 10 is that the original answer emphasizes regulatory uncertainty about loan sales post-transfer in 2024, a nuance slightly underemphasized in the LLM version. Otherwise, the answer is complete, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 410,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from 6,204 owned units in 2022 (average age 22.5 years) to 5,971 owned units in 2023 (average age 24.3 years) and then held essentially steady at 5,973 owned units in 2024 (average age 25.2 years), while leased units dropped from 1,038 in 2022 to 920 in 2024, reducing the total fleet from 7,242 to 6,893. The owned count declined sharply between 2022‑23 and then stabilized, but the average age rose about 2.7 years over the three‑year span, indicating that Union Pacific is retiring a portion of its older multiple‑purpose locomotives but is not replacing them quickly enough to keep the remaining fleet youthful. This pattern suggests a fleet‑right‑sizing strategy that emphasizes cost‑controlled retirements rather than aggressive modernization, with the company relying on a smaller, increasingly aged core of multiple‑purpose locomotives.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is highly accurate in conveying the evolution of Union Pacific's Multiple Purpose Locomotive fleet from 2022 to 2024. It correctly reports the decrease in owned units from 6,204 in 2022 to 5,973 in 2024 and the drop in leased units from 1,038 to 920. The average age increase from 22.5 to 25.2 years is accurately reflected. The only minor discrepancy is the mention of 5,971 owned units in 2023, which is not in the ground truth; however, since the 2024 number (5,973) matches and the overall trend is correct, this does not significantly impact accuracy. (2) Quantitatively, all key numbers align: owned units (6,204 → 5,973), leased (1,038 → 920), average age (22.5 → 25.2), and total fleet reduction (7,242 → 6,893) are correctly calculated. The 2.7-year age increase is approximately correct (25.2 - 22.5 = 2.7). (3) The multi-hop reasoning is sound: the model synthesizes changes in ownership, leasing, and aging trends to infer a cost-controlled, non-aggressive modernization strategy, which aligns with the ground truth's interpretation. (4) The answer is contextually excellent, addressing all parts of the question—ownership changes, aging profile, and strategic implications—with clear, logical flow and semantic equivalence to the original answer. The slight deviation in 2023 owned units prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Owns]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 386,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral that sits under master‑netting arrangements – the amount that is not offset against its derivatives and is tied to advances/receivables from equity companies – fell sharply from **$1.494 billion at 31 Dec 2022** to **$0.491 billion at 31 Dec 2024**, a reduction of roughly **$1.0 billion (about 67 %)**.  The decline follows earlier drops (e.g., $641 million in 2021 versus $504 million in 2020), showing a consistent downward trajectory.  This pattern suggests ExxonMobil is deliberately shrinking the collateral linked to its equity‑company receivables and initial‑margin requirements, indicating a tighter, more efficient approach to managing its derivative risk exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, $800 million in 2023, and $491 million in 2024. However, the LLM states it was $1.494 billion in 2022 and omits the 2023 value entirely, falsely implying a direct drop from 2022 to 2024. This misrepresents both the magnitude and the trend. The claimed 67% reduction is based on incorrect inputs and does not align with the actual data. Additionally, the LLM introduces unsupported data (e.g., $641 million in 2021, $504 million in 2020) not present in the original answer, further undermining accuracy. (2) Quantitative accuracy is severely compromised: the 2022 figure is more than double the correct amount ($1.494B vs $641M), and the 2023 increase to $800M is completely missing. The calculation of a $1B reduction and 67% decline is therefore invalid. (3) The reasoning is flawed due to incorrect data synthesis. The LLM incorrectly infers a 'consistent downward trajectory' when the actual trend shows an increase in 2023 before a drop in 2024. This misses the key nuance of a peak and reversal, which the ground truth identifies as potentially signaling a strategic shift. The conclusion about 'tighter, more efficient risk management' is plausible but not fully supported by the misrepresented data. (4) Contextual relevance is moderate—the answer addresses derivative risk management and collateral exposure, and correctly interprets the 2024 decline as potentially meaningful. However, due to major factual errors and omission of the intermediate 2023 increase, the overall correctness score is low. The answer fails the multi-hop requirement by not accurately synthesizing year-over-year changes across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 492,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Starbucks said its “Other” segment “primarily consists of packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, **serveware and ready‑to‑drink beverages**, among other items.” By contrast, the 2023 and 2024 filings describe “Other” as “primarily consists of packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, **and serveware**, among other items,” dropping the reference to ready‑to‑drink beverages. Thus, while the core components—including single‑serve coffee (which SBUX produces, per the KG relationship)—remain unchanged, the revenue composition of “Other” narrowed after 2022 by removing ready‑to‑drink beverages from the category.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in describing the composition of Starbucks' 'Other' category but introduces a significant factual inaccuracy by claiming that ready-to-drink beverages were dropped from the 2023 and 2024 10-K filings. The ground truth states that the composition remained 'largely unchanged' and 'consistent' across 2022–2024, with no explicit mention of removing ready-to-drink beverages. The LLM incorrectly infers a narrowing of the category based on a change in wording, but the original answer (from the knowledge graph) confirms that the structure remained stable and does not support the claim that ready-to-drink beverages were excluded post-2022. This misinterpretation undermines the core conclusion about revenue composition evolution. While the LLM correctly identifies the key components like single-serve coffees and royalty revenues, and the years and entities are accurate (Starbucks, 2022–2024, 'Other' category), the reasoning is flawed due to overinterpreting minor textual differences. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as the response directly addresses the question's focus on revenue composition changes. However, the qualitative accuracy is low because the multi-hop synthesis leads to an incorrect conclusion about a shift in category composition, contradicting the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 389,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "In 2022 Google’s filing described how it measured the monetization of inventory sold through Google Ad Manager on its Network properties (AdMob, AdSense and Google Ad Manager) by tracking **impressions** and calculating a **cost‑per‑impression** (impression‑based + click‑based revenues ÷ total impressions). Starting in the 2023 filing, the company clarified that for ads placed on those Network properties it generally acts as the **principal** – the amounts billed to advertisers through Google Ad Manager are recorded as **gross advertising revenue** (with partner payments shown as cost of revenue) and revenue is recognized **when the ad is displayed** for brand (impression‑based) ads and **when a user engages** for performance ads. The 2024 filing repeats the same policy, confirming that impression‑based (brand) revenue continues to be recognized at the point of display and that Network‑property inventory sold via Google Ad Manager is still reported on a gross‑basis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of monetization through Google Ad Manager from 2022 to 2024, accurately describing the impression-based revenue recognition model in 2022 using cost-per-impression (impression-based + click-based revenues ÷ impressions), which matches the original answer. (2) The quantitative elements are correct: no specific dollar amounts are involved, but the description of the calculation method for cost-per-impression is factually accurate and consistent with the knowledge graph. (3) The multi-hop reasoning is sound—LLM correctly synthesizes changes across years: in 2023, Google clarified its role as principal and began emphasizing gross revenue reporting, which continued in 2024. The LLM correctly notes that gross revenue means recording amounts billed to advertisers as revenue, with partner payments as cost of revenue. (4) The LLM adds slightly more detail than the original (e.g., naming AdMob and AdSense as Network properties, specifying that performance ads recognize revenue upon user engagement), which is factually consistent and enhances clarity without introducing error. The only minor gap is that the original emphasizes increasing 'transparency and accounting clarity' as a trend, a synthesizing point slightly underdeveloped in the LLM response, but the factual evolution is fully captured. All entities (Google Ad Manager, Network properties, 2022–2024 timeline, gross revenue, impression-based recognition) are correct. Wording differs but semantic meaning is equivalent or superior. No calculation errors. Thus, the answer earns a 9/10 for correctness—excellent, with only slight room for higher-level synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 473,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—Mondelēz notes that it remains subject to sales‑ and media‑marketing restrictions, most notably front‑of‑pack labeling rules that tie product promotion to nutrient‑profile or environmental‑claim standards. Each year the company also highlights that more than 25 European Union member states have adopted extended‑producer‑responsibility (EPR) packaging policies and that those EPR regimes are now being implemented or contemplated in additional jurisdictions such as India, Vietnam and certain U.S. states, indicating a steady exposure that is persisting and gradually widening in geographic scope.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but lacks key evolutionary details present in the ground truth, resulting in a moderate correctness score. (1) Quantitatively, the statement that 'more than 25 EU member states' have adopted EPR policies is accurate for all years and matches the original answer. The mention of India, Vietnam, and U.S. states as emerging jurisdictions aligns with the 2024 update in the ground truth. However, the LLM fails to distinguish how these developments evolved year-by-year. (2) The answer incorrectly implies that front-of-pack labeling rules were already in effect in 2022, while the original answer states that in 2022, advertising restrictions based on nutrient profiles were in place, but front-of-pack labeling was only emphasized in 2023. The LLM also omits the 2023 developments regarding single-use plastic bans in Indonesia and the Philippines and the 2024 adoption of the EU’s Packaging and Packaging Waste Directive. (3) The multi-hop reasoning is weak: while the LLM synthesizes EPR expansion and marketing restrictions, it collapses three years of nuanced regulatory progression into a static, repetitive trend, missing the shift from contemplation to enforcement and increasing specificity in 2024. (4) Contextual relevance is high because the answer addresses both EPR and marketing restrictions across the requested timeframe and correct entities (MDLZ, EU, India, Vietnam, U.S.), but the lack of temporal evolution and key policy milestones reduces qualitative accuracy. Minor wording flexibility is acceptable, but omission of critical year-specific developments constitutes significant informational gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 449,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across MA’s 2022, 2023 and 2024 Form 10‑K tables the A Class shares are described in exactly the same way: each share carries **one vote per share** and **dividend rights**. The wording “One vote per share Dividend rights” appears unchanged in the 2022 filing (Chunk 1), the 2023 filing (Chunk 3) and the 2024 filing (Chunk 2). This three‑year consistency shows that MA’s capital‑structure strategy is to keep the equity framework stable—preserving the voting power and dividend entitlement of its A Class shareholders and avoiding any re‑classification, dilution or alteration of those rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that A Class shares maintained one vote per share and dividend rights across 2022, 2023, and 2024, with no changes—matching the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and qualitative metrics (voting rights, dividend rights) are correctly cited and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of Form 10-K filings (referencing chunks for each year) and draws the logical conclusion that MA’s capital structure strategy emphasizes stability. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of rights and the strategic implication. Wording differs slightly but conveys identical meaning, with added detail (e.g., 'avoiding re-classification, dilution') that enhances rather than distorts the conclusion. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 308,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil reported that the collateral it posted under master‑netting arrangements (the amount that is not offset against its derivative positions) fell sharply over the three‑year span: **$1.494 billion at 12/31/2022**, **$800 million at 12/31/2023**, and **$491 million at 12/31/2024**. The 2022 level was markedly higher than the prior‑year amounts disclosed in the 2022 filing ($641 million in 2021 and $504 million in 2020), but then declined each subsequent year. This downward trajectory indicates that ExxonMobil’s exposure to derivatives – and the associated initial‑margin requirements tied to its “Investments, advances and long‑term receivables” line – has been decreasing, reflecting either a reduction in derivative positions, more efficient margin management, or a lower risk profile for those contracts.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 value: it reports $1.494 billion as the collateral amount, while the ground truth is $641 million. This is a major discrepancy (off by over $850 million), severely undermining quantitative accuracy. The 2023 ($800 million) and 2024 ($491 million) values are correct. (2) Calculations and comparisons based on the incorrect 2022 figure are therefore flawed. The claim of a 'sharp fall' from $1.494B to $491M is incorrect—the actual trend was an increase from 2022 to 2023, then a drop in 2024. The LLM mischaracterizes the trend due to the wrong starting point. (3) The multi-hop reasoning is partially sound: the model correctly identifies the need to track changes over time and links collateral to derivative exposure and margin requirements. It also correctly interprets the 2023–2024 decrease. However, it fails to capture the full dynamic profile (increase then decrease) due to the erroneous 2022 data. The mention of prior-year data (2021, 2020) adds context not requested and distracts from the 2022–2024 focus. (4) Despite strong contextual relevance and reasonable interpretation of what the trend might imply, the significant error in the 2022 number reduces the correctness score to 5—partially correct but with a major factual flaw affecting the overall narrative. Quantitative accuracy is low (4) due to the large dollar amount error. Qualitative accuracy is moderate (6) as reasoning is logical but based on incorrect input. Contextual relevance is high (9) as the answer addresses the right metric, time frame, and implications, just with flawed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 449,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "- **Fiscal 2022 filing:** Starbucks said that its total purchase commitments – together with existing inventory – were expected to provide an adequate supply of green coffee **through fiscal 2023**. It highlighted reliance on “fixed‑price and price‑to‑be‑fixed purchase commitments” and the use of forward contracts, futures and collars to hedge price exposure, and it noted that its relationships with coffee producers made the risk of non‑delivery remote.  \n\n- **Fiscal 2023 filing:** The outlook was extended, stating that the same mix of purchase commitments and inventory would now be sufficient **through fiscal 2025**. The language about dependence on coffee‑producer relationships and the hedging toolkit (fixed‑price, price‑to‑be‑fixed contracts, forwards, futures, collars) remained unchanged.  \n\n- **Fiscal 2024 filing:** The company reiterated the **through‑fiscal 2025** supply‑adequacy statement, again emphasizing its dependence on coffee producers and the continued use of the same hedging and contract mechanisms.  \n\n**What this progression shows:** Starbucks has moved from a near‑term (through FY 2023) to a longer‑term (through FY 2025) forward‑looking supply commitment, while consistently deepening its reliance on coffee‑producer relationships and financial hedges. This evolution signals a deliberate strategy to lock in supply and price over a longer horizon, thereby reducing exposure to coffee‑price volatility and supply‑risk by extending contracts, maintaining robust inventory buffers, and using forward‑contract and collar hedges.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates and timeframes are accurate: the progression from supply adequacy through fiscal 2023 (as stated in FY2022) to through fiscal 2025 (in FY2023 and FY2024) is correctly reported. There are no numerical or date discrepancies. (2) The answer is complete, addressing both parts of the question: the evolution of supply chain commitments across the three fiscal years and the strategic implications regarding price volatility and supply risk. (3) Entity accuracy is perfect—Starbucks is correctly identified, fiscal years are accurate, and financial instruments (forward contracts, futures, collars) are properly named and contextualized. (4) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three annual filings, identifies the extension of forward-looking commitments as a strategic shift, and links it to risk mitigation practices. The conclusion about a deliberate strategy to lock in supply and pricing over a longer horizon is semantically equivalent to the ground truth’s 'strategic shift toward longer-term stability in sourcing and price hedging.' Wording differs slightly but meaning is preserved. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 361,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "ACN’s asset‑allocation decisions—formalised as an accounting policy—set the target mix for its defined‑benefit pension plans. The 2022 10‑K disclosed the target allocation for fiscal 2023, and the 2023 and 2024 10‑Ks disclose a revised target allocation for fiscal 2025; the later mix shows a re‑balancing that raises the equity share and broadens diversification while preserving a core of fixed‑income to match liability duration. This multi‑year shift signals that ACN is deliberately tilting its pension portfolio toward higher‑return assets to improve risk‑adjusted returns and achieve an inflation‑beating long‑term return objective, while still using diversification and duration‑matching to manage overall portfolio risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of ACN's asset allocation shift and correctly identifies the long-term objective of exceeding inflation with risk-adjusted returns, which aligns with the ground truth. However, there are significant inaccuracies in the details that affect factual correctness. (1) The LLM claims the 2023 and 2024 10-Ks disclose a 'revised' target allocation for fiscal 2025 that 'raises the equity share'—this specific quantitative shift (increased equity) is not supported in the original answer, which emphasizes continuity, flexibility ranges, and liability matching rather than a strategic increase in equities. The ground truth does not mention any re-balancing toward higher equity exposure. (2) The LLM implies a formal revision and re-balancing occurred between 2023 and 2025, but the original answer states that the strategy showed 'continuity' with updated flexibility ranges, not a directional shift in asset mix. (3) While the LLM correctly references the 2022 10-K for fiscal 2023 targets and mentions later 10-Ks, it mischaracterizes the nature of the evolution—portraying it as a deliberate tilt toward higher-return assets, whereas the ground truth emphasizes adaptive management within a consistent framework. (4) No specific percentages, ranges, or numerical targets are provided in either answer, so the absence of numbers is not penalized, but the inference of a strategic equity increase is an unsupported addition. (5) The reasoning is partially sound in connecting diversification, duration matching, and risk-adjusted returns, but the multi-hop synthesis overstates change and strategic intent not present in the source. Thus, while contextually relevant and capturing the broad strategic themes, the answer introduces speculative details that reduce factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 491,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "In the 2022 Form 10‑K Amgen said that Olpasiran is an siRNA that lowers lipoprotein (a) and is in Phase 2 trials for atherosclerotic cardiovascular disease.  The 2023 filing added a strategic IP element – the company’s compound‑type patents for Olpasiran are projected to expire in 2036 in both the U.S. and Europe, giving the asset a long‑term exclusivity runway.  In the 2024 filing Olpasiran is still listed under Amgen’s cardiovascular‑disease portfolio, confirming that its therapeutic focus remains cardiovascular while its protection timeline has been positioned to run through 2036.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Olpasiran is an siRNA drug in Phase 2 trials for atherosclerotic cardiovascular disease in 2022; U.S. and European compound patent protection is projected to expire in 2036 (correctly reported in 2023); and in 2024, it remains in the cardiovascular disease portfolio, indicating sustained therapeutic focus. (2) Quantitative accuracy is perfect: the year 2036 is correctly cited for patent expiry, and no calculations are required. (3) Multi-hop reasoning is sound—information is synthesized across three years (2022–2024) from Amgen’s filings, correctly tracking the evolution of clinical development, IP strategy, and therapeutic positioning. (4) The answer addresses all parts of the question: therapeutic focus (cardiovascular disease, lipoprotein(a)) and IP timeline (2036 expiry). Wording differs slightly but meaning is preserved. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 283,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "- **2022:** American Express noted that it was dependent on aggregators (along with merchant acquirers and processors) to promote and support card acceptance, but warned that these third parties could have business interests, strategies or goals that conflict with Amex’s and could lead to surcharging, steering or other forms of discrimination that might reduce cards‑in‑force and transaction volumes.  \n\n- **2023:** The company said its reliance on aggregators had **increased** – it was “increasingly relying” on them to manage merchant relationships – and again stressed that misaligned interests could cause merchant discrimination, surcharging or steering and materially harm its business.  \n\n- **2024:** Aggregators were described as part of a broader set of third‑party service providers, and the risk focus shifted to operational and compliance concerns: possible service disruptions, failure to meet obligations, cybersecurity and data‑integrity incidents, fraudulent transactions, reputational damage and heightened regulatory scrutiny could all adversely affect American Express.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, American Express highlighted potential conflicts of interest with aggregators that could lead to surcharging and steering, impacting card usage; in 2023, the company explicitly stated increased reliance on aggregators and reiterated risks around merchant behavior; by 2024, the focus expanded to operational, compliance, and regulatory risks including service disruptions, cybersecurity, and reputational damage. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and reflects the evolving nature of risk disclosures. The only minor shortcoming is that the LLM answer does not explicitly mention 'litigation exposure' or 'changes in business practices due to regulatory actions' in 2024, which were part of the original answer, slightly reducing qualitative accuracy. (4) The response is fully contextually relevant, directly addressing both parts of the question: evolution of reliance and risk emphasis over time. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a minor omission in the 2024 risk details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 365,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks repeatedly notes that the volatility of green‑coffee prices – and the premium it pays for high‑altitude Arabica – is “impacted … by … hedge funds and commodity index funds” in each of its FY 2022, FY 2023 and FY 2024 filings. In all three years the company’s response is the same: it “utilizes forward contracts, futures contracts and collars” to hedge the ‘C’‑price exposure of its price‑to‑be‑fixed coffee purchases.  \n\nThe only evolution is in the forward‑supply outlook. In the FY 2022 filing the firm said its total purchase commitments and inventory should provide an adequate supply through **fiscal 2023**. By the FY 2023 filing (and reiterated in FY 2024) that horizon was extended, with commitments now expected to cover supply **through fiscal 2025**. Thus, exposure to commodity‑index‑fund‑driven price swings and the hedging toolkit stayed constant, while the forward supply commitment window was lengthened from FY 2023 to FY 2025 and then held steady.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Starbucks cited commodity index funds as influencing green coffee price volatility in FY 2022, 2023, and 2024; the company used forward contracts, futures, and collars for hedging across all years; and the forward supply commitment extended from covering through fiscal 2023 (in FY 2022 filing) to covering through fiscal 2025 (in FY 2023 and FY 2024 filings). (2) Quantitative elements—fiscal years (2022, 2023, 2025)—are correctly reported with no calculation errors. The extension of the supply outlook from FY 2023 to FY 2025 is accurately described. (3) Multi-hop reasoning is sound: the answer synthesizes information across three fiscal years and correctly identifies both the consistency in hedging strategy and the evolution in forward supply commitments. (4) The answer fully addresses both parts of the question: exposure to commodity index funds and changes in hedging/supply commitments. Wording differs slightly but meaning is preserved, including the strategic implication of a lengthened commitment window. No factual errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 332,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture’s publicly announced open‑market share‑purchase program was modest in FY 2022 – the board had authorized only **$3.13 million** of aggregate available authorization as of August 31 2022, with no specific repurchase amount disclosed for that year. By August 31 2024 the available authorization had grown to **$2.694 billion**, and a September 25 2024 board decision added **$4 billion** of extra authority, raising total outstanding authority to **$6.694 billion**. In the fourth quarter of FY 2024 the company put that capacity to work, buying **2,000,308 Class A shares for $605 million** under the open‑market program (plus 72,255 shares for employee‑related withholding), a level of buy‑back activity not evident in FY 2022. This steep rise in both authorized limits and executed repurchases signals that Accenture is intensifying its capital‑return strategy, using share buybacks as a primary tool to return cash to shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall trend and strategic implication correctly: Accenture significantly increased its share repurchase authorization and execution from FY2022 to FY2024, indicating a stronger capital return strategy. However, there is a critical numerical error in the FY2022 available authorization: the LLM states '$3.13 million' when the ground truth is '$3,129,296 thousand' (i.e., ~$3.13 billion), misrepresenting the scale by a factor of 1,000. This is a major quantitative inaccuracy. All other numbers are correct or acceptably rounded: $2.694 billion (correct), $4 billion added (correct), total $6.694 billion (correct), 2,000,308 shares for $605 million (correct). The repurchase activity in FY2023 (not FY2024 Q4 as implied) is correctly reported in amount but misattributed to the wrong fiscal year in the LLM answer. The original answer states the $605M repurchase occurred in fiscal 2023, not fiscal 2024. 2) Quantitative accuracy is compromised by the billion/million error and the misplacement of the $605M repurchase in time. The calculation of total authorization ($2.694B + $4B = $6.694B) is correct. 3) The reasoning is logically sound in interpreting the increasing authorizations and repurchases as a sign of intensified capital return strategy. Entity accuracy (Accenture, Class A shares, open-market program) is correct. The multi-hop synthesis across three fiscal years is attempted, but flawed due to incorrect year attribution of repurchase activity and the magnitude error in FY2022. 4) Despite these issues, the answer is contextually relevant and addresses all parts of the question: evolution over time and strategic implication. The conclusion about intensifying capital return is valid based on the correct later data points. The score is reduced primarily due to the severe magnitude error in FY2022 authorization and the misplacement of repurchase timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 513,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Alphabet’s filings show that the long‑term portion of marketable equity securities that are subject to lock‑up restrictions fell to **$803 million** as of December 31, 2022 (2023 10‑K) after having been **$1.4 billion** in the prior period (2022 10‑K).  By the next filing, the 2024 10‑K reports the same line item had risen back to **$1.4 billion** as of December 31, 2023.  This roughly **$600 million increase** after a dip indicates that Alphabet initially reduced its exposure to illiquid, lock‑up‑restricted equity positions in 2022 but then re‑expanded them, reflecting a strategic shift toward allocating more capital to long‑term, less‑liquid equity investments despite the associated liquidity constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the values of Google's (Alphabet's) marketable equity securities under long-term lock-up restrictions as $1.4 billion in 2022, $803 million in 2023, and $1.4 billion in 2024, matching the ground truth. However, there is a minor date mislabeling: the LLM states that $803 million is reported as of December 31, 2022 (in the 2023 10-K), which should correspond to the 2023 value (i.e., year-end 2023), not 2022. Similarly, the $1.4 billion rebound is stated as of December 31, 2023 (in the 2024 10-K), which correctly reflects the 2024 filing but corresponds to the 2023 fiscal year-end. This reflects a confusion in labeling the reporting year vs. the fiscal year, though the underlying data points are accurate. (2) The calculation of a ~$600 million increase from $803M to $1.4B is approximately correct ($597M increase), and the directionality of change is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three annual filings, identifies the dip and recovery, and infers a strategic shift in investment behavior regarding illiquid assets. (4) The qualitative interpretation aligns with the ground truth’s suggestion of strategic rebalancing, though it emphasizes re-expansion into long-term investments more than the neutral 'cyclical' interpretation. This is a reasonable alternative phrasing, not a factual error. The contextual relevance is perfect, addressing both the quantitative change and strategic implication. The correctness score is 9 due to the minor but notable misstatement of dates/fiscal years, despite correct underlying values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 449,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "In 2022 Electric Insurance Company (EIC) was still an operating captive property‑and‑casualty insurer that mainly provided coverage to GE and its employees, with net claim reserves of about $0.2 billion at year‑end.  In the fourth quarter of 2022 GE re‑positioned the business as a non‑core asset, classifying EIC as “held for sale”; by December 31 2023 the subsidiary carried $541 million of assets against $378 million of liabilities and GE booked a $109 million loss in other income to reflect a write‑down of its value.  The disposition was completed in the second quarter of 2024 when GE sold EIC to Riverstone International Holdings for cash proceeds of $120 million, generating a positive cash inflow that offset the prior‑year loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts from the ground truth: EIC's role in 2022 as a captive insurer with $0.2 billion in net claim reserves, its classification as held for sale, the 2023 asset ($541M) and liability ($378M) figures, the $109M loss, and the 2024 sale to Riverstone International Holdings Inc. for $120M in cash. All numeric values and entities match the original answer, with acceptable formatting variations (e.g., $0.2 billion = $200 million). (2) Quantitative accuracy is perfect: all dollar amounts, dates (including Q4 2022 repositioning and Q2 2024 sale), and the $109M loss are correctly reported. The calculation of the net asset value ($541M - $378M = $163M) is implied but not required; the loss recognition is properly attributed to the write-down. (3) The multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024, showing strategic evolution from operation to disposal. The only minor gap is that the original answer emphasizes GE’s strategic shift toward focused industrial operations, which the LLM mentions implicitly via 'non-core asset' but could have articulated more explicitly. (4) Contextual relevance is excellent—the response directly addresses strategic positioning, valuation, disposition, and financial impact across the three years. The mention of 'positive cash inflow that offset the prior-year loss' adds useful interpretation not in the original but is reasonable and does not distort facts. Overall, this is a highly accurate, well-reasoned answer with only slight room for deeper strategic context, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Classifies]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 447,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 pipeline expanded from the 13 programs it reported in February 2022 (after three regulatory approvals, four new Phase 3 initiations and one termination) to 18 programs by 31 January 2023, then to 24 programs by 31 January 2024 – a jump driven by the acquisition of five Horizon programs, three additional Phase 3 initiations, an FDA approval and the conclusion of one study – and finally to 25 programs as of 4 February 2025 after five new initiations, three FDA approvals and a Japanese approval. This near‑doubling of late‑stage candidates shows that Amgen is actively investing in and disclosing an expanding Phase 3 portfolio, using both internal development and strategic acquisitions to broaden its R&D pipeline and sharpen its focus on diversifying and accelerating its investigational product slate.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its description of Amgen's Phase 3 pipeline growth, capturing the expansion from 13 programs in 2022 to 25 by early 2025. However, there is a key discrepancy in timing: the ground truth states the portfolio reached 24 programs in 2024 and 25 by 2024 (with one additional program added after the Horizon acquisition), while the LLM claims 24 programs by January 31, 2024, and 25 as of February 4, 2025 — which misaligns with the original 2024 endpoint. The question asks about evolution through 2024, so projecting to 2025 introduces a factual error in timeframe. (2) Quantitatively, the starting point (13 in 2022) and intermediate step (18 in 2023) are accurate. The Horizon acquisition of five programs is correctly cited. However, the claim of reaching 25 programs 'as of February 4, 2025' contradicts the ground truth that the total was 25 by 2024. This overstates the timeline and implies growth beyond the evaluated period. Additionally, the ground truth specifies 24 programs in 2024 before rising to 25, which the LLM captures numerically but misdates. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes internal development (new initiations), external growth (Horizon acquisition), regulatory approvals (U.S. and Japan), and study conclusions to explain pipeline dynamics. It accurately links strategic focus to both internal R&D and acquisitions. (4) Despite the date misalignment, the core narrative — near-doubling of the pipeline, strategic expansion via acquisition and internal development, and increased diversification — aligns well with the ground truth. The answer is contextually excellent and semantically close, but the incorrect end date for the 25-program milestone reduces quantitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Discloses]- ORG <-[Increases]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 497,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "In its 2022 filing (and reiterated in 2023) American Express portrayed its global card network as the fourth‑largest general‑purpose network, competing head‑to‑head with Visa, Mastercard, China UnionPay, JCB, Discover and other networks on purchase volume, product features, pricing, rewards and partnerships. By the 2024 filing the company stressed that regulators worldwide were zeroing in on card‑network practices—interchange‑fee caps, network‑routing rules, “honor‑all‑cards” requirements and other payment‑legislation—and that, as a result, Amex had exited its network‑licensing businesses in the EU and Australia and was now subject to a stricter U.S. Category III regulatory framework. Thus, while Amex still competes with other card networks, its relationship has shifted from a broad, unfettered competitive stance to a more constrained, compliance‑driven one, with a reduced licensing footprint and heightened focus on fee‑structure and cobrand arrangements in response to the heightened regulatory and competitive pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the evolution of American Express's relationship with global card networks from 2022 to 2024, noting initial direct competition with Visa, Mastercard, China UnionPay, and others, and the shift by 2024 to a more constrained, regulation-driven posture. The key factual elements—Amex’s competitive positioning in 2022–2023, growing regulatory scrutiny, and the exit from network licensing in the EU and Australia by 2024—are all present and correct. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and regulatory jurisdictions, correctly linking regulatory pressures (interchange fees, routing rules) to strategic exits and shifts in business model. It accurately reflects the transition from competition to regulatory constraint, particularly in international markets. (4) The only minor shortcoming is that the LLM answer does not explicitly mention competitive dynamics from non-traditional players like Alipay and PayPal or the specific uncertainty around cobrand arrangements in the EU—details present in the original. However, it does reference 'cobrand arrangements' and 'heightened regulatory and competitive pressures,' which captures the essence. Thus, while slightly less detailed in competitive dynamics, the core evolution is accurately conveyed. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 454,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "In 2022 ConocoPhillips completed the monetization of its CVE common stock by selling the remaining **91 million CVE shares**, which generated roughly **$218 million** of proceeds (the amount reflected in the 2022 valuation‑allowance adjustment).  Those proceeds were fed into the company’s ongoing share‑repurchase program, which had already bought back **383 million shares for about $29 billion** by the end of 2023 and, after another year of buying, had repurchased **433 million shares for $34.3 billion** by the end of 2024 – an incremental **50 million shares and $5.3 billion** of repurchases in 2024.  Thus, the CVE disposition was a one‑time 2022 event that supplied cash for a repurchase program that continued to expand in share volume and dollar amount through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 91 million CVE shares sold in 2022 and the cumulative share repurchases of 383 million shares for $29 billion by the end of 2022 (as per ground truth). It also accurately reports the cumulative total of 433 million shares repurchased for $34.3 billion by 2024. However, it incorrectly states that the CVE share sale generated 'roughly $218 million' — this is factually wrong. The ground truth does not specify the proceeds from the CVE sale, but $218 million is implausibly low for 91 million shares (implying ~$2.40/share), especially given ConocoPhillips' subsequent $29 billion repurchase program. This figure appears to be a misinterpretation of a 'valuation-allowance adjustment' unrelated to the sale proceeds. Additionally, the LLM attributes the $29 billion repurchase total to 'end of 2023', while the ground truth states it was achieved by the end of 2022. This misalignment affects the timeline of repurchases. (2) The incremental repurchases in 2024 (50 million shares, $5.3 billion) are mathematically correct based on the difference between 383M and 433M shares and $29B vs $34.3B, but the error in timing (assigning $29B to 2023 instead of 2022) distorts the year-by-year evolution. (3) The multi-hop reasoning is otherwise sound: the model correctly links the monetization of CVE shares to funding share repurchases and traces the cumulative repurchase program through 2024. It captures the strategic evolution from asset sale to capital return. (4) Scores reflect mostly correct facts and calculations but significant errors in key dollar amounts (CVE proceeds) and timing of repurchase totals, which impact quantitative accuracy. Qualitative and contextual accuracy remain high due to correct entities, logical flow, and relevance to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 494,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "- 2022: The Home Depot’s 2005 Omnibus Stock Incentive Plan (the active Omnibus plan at that time) had **≈ 117 million shares** available for future grants as of January 30 2022.  \n- 2024: After the May 19 2022 amendment that created the current Omnibus Plan (capped at 80 million + up to 10 million underlying‑award shares), the filing for the 2023 fiscal year reported **≈ 77 million shares** available as of January 28 2024, and the 2024 filing shows the pool further reduced to **≈ 70 million shares** as of February 2 2025.  \n\n**Trend interpretation:** The share pool under The Home Depot’s Omnibus Stock Incentive Plans has been steadily shrinking—from 117 million in 2022 to about 70 million by early 2025—indicating that the company is actively issuing stock‑based awards and consuming a sizable portion of its authorized equity capacity, while still retaining a substantial (though declining) reserve for future compensation grants. The older 1997 Plan no longer contributes new awards (no issuances after 2005), so the observed changes reflect utilization of the newer Omnibus plans alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the available shares in 2022 (117 million), 2023 (~77 million), and 2024 (~70 million) match the ground truth. The dates (January 30, 2022; January 28, 2024; February 2, 2025) are consistent with fiscal year-ends and reporting timelines. The mention of the May 19, 2022 amendment aligning with the transition to the new Omnibus Plan is accurate. The interpretation of declining availability indicating active utilization of stock-based compensation is consistent with the original answer.\n\n2) Quantitative accuracy is high: all share numbers are correct within acceptable rounding (≈117M, ≈77M, ≈70M). The LLM correctly notes the 80 million cap plus potential 10 million from expired/forfeited awards, which provides context for the replenishment mechanism, even if not fully detailed in the original answer. The timeline is slightly adjusted (referring to '2024' filing showing data as of Feb 2, 2025, which corresponds to fiscal year 2024), which is accurate given Home Depot's fiscal calendar (fiscal year ends in January, so FY2024 ends Jan 28, 2024, and FY2025 ends Jan 26, 2025). The LLM’s use of 'as of January 28, 2024' for the 77 million figure is slightly misaligned—this should correspond to the end of FY2023, not FY2024—but this is a minor date labeling nuance rather than a factual error.\n\n3) Multi-hop reasoning is sound: the LLM correctly synthesizes data across years, identifies the plan transition from the 2005 Plan to the amended Omnibus Plan, excludes the inactive 1997 Plan, and infers ongoing utilization. It correctly attributes the decline to active issuance and notes the replenishment mechanism, which strengthens the qualitative analysis.\n\n4) Semantic equivalence is strong: while the LLM adds minor contextual details (e.g., plan cap structure), the core message—that available shares declined from 117M to 70M over the period, indicating steady use of equity compensation—is fully aligned with the ground truth. The conclusion about 'sizable portion consumed' and 'declining reserve' is a valid interpretation.\n\nMinor deduction in quantitative accuracy due to slight misstatement of reporting dates (e.g., attributing 77M to '2024' instead of 'end of FY2023'), but this does not affect the overall correctness of the trend or numbers. No major omissions or errors in entities, metrics, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 634,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "- 2022 10‑K: the Amended 2010 SIP authorized a maximum of **127 million** Accenture Class A ordinary shares for awards.  \n- 2023 10‑K (and reiterated in the 2024 10‑K): the authorized ceiling was increased to **141 million** shares, and it remained at **141 million** in the 2024 filing.  \n\nThe 14 million‑share increase from 2022 to 2023, held steady through 2024, shows Accenture deliberately expanded the pool of shares it can grant under its share‑based compensation plan, signaling a strategic emphasis on equity awards to attract, retain and align employees with shareholder interests.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in 2022 and 141 million shares in both 2023 and 2024. The increase of 14 million shares (141M - 127M) is correctly implied. Format variations (e.g., '127 million' vs '127,000,000') are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: the evolution of authorized shares from 2022 to 2024 and the strategic implication of the increase. (3) Entity accuracy is perfect: Accenture plc, Class A ordinary shares, Amended 2010 SIP, and correct fiscal years (via 10-K references) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across the 2022, 2023, and 2024 filings. The conclusion about strategic emphasis on equity compensation to align employee and shareholder interests is logically derived and consistent with the ground truth. (5) Semantic equivalence is maintained throughout, with slightly different but equally valid phrasing (e.g., 'strategic emphasis' vs 'growing emphasis'). No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 332,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "- In the 2022 Form 10‑K the weighted‑average yield on the “Foreign government bonds and obligations” line was about **2.08 %** (the total yield shown for the portfolio).  \n- By the 2023 filing the same line had risen to **6.45 %**, and the 2024 filing shows it at **5.85 %** (total weighted‑average yield for that category).  \n\n**Interpretation:** The yield on American Express’s foreign‑government‑bond holdings more than doubled between 2022 and 2024, after peaking in 2023. This upward swing indicates that the company’s investment exposure to foreign sovereign debt has become far more sensitive to rising international interest‑rate environments – delivering higher income potential but also increasing the portfolio’s interest‑rate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the 2022 weighted average yield was 5.86%, not 2.08% as stated in the LLM response. The 2023 figure (6.45%) is correct, and the 2024 figure is nearly correct at 5.85% vs. the true value of 5.86%—this minor rounding difference is acceptable. However, the incorrect 2022 value fundamentally distorts the trend analysis. (2) The dollar amount of $630 million in foreign government bonds is missing from the LLM answer, and the critical detail that these are instruments due within one year is omitted, affecting completeness and context. (3) The reasoning is partially sound: the LLM correctly identifies a rise and then a slight decline in yields, and infers increased sensitivity to international interest rates. However, because it starts from an incorrect baseline (2.08% vs. 5.86%), it falsely claims yields 'more than doubled'—in reality, they returned to their original level. The ground truth emphasizes a peak in 2023 followed by a reversion to 2022 levels, indicating volatility and possible stabilization; the LLM mischaracterizes this as a net increase. (4) Despite the flawed quantitative foundation, the answer addresses the core question about yield changes and exposure to international interest rate environments, showing relevant contextual understanding. The synthesis across years is attempted and mostly structured well, but the incorrect starting point undermines the conclusion. Thus, correctness and quantitative accuracy are penalized heavily, while qualitative reasoning and relevance retain moderate scores due to structural and interpretive efforts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 459,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s foreign‑government bond portfolio was almost entirely short‑term in 2022 – $628 million of the $630 million total was due within one year – and earned a modest 1.74 % yield in that bucket, pulling the overall portfolio weighted‑average yield to about 2.08 % (Chunk 1). In 2023 the company moved into higher‑yielding sovereigns, posting a 6.45 % weighted‑average yield on the foreign‑government segment (6.45 % for the one‑year bucket and 4.48 % for 1‑5‑year bonds) (Chunk 3), and in 2024 the yield slipped slightly to 5.85 % (5.86 % for the one‑year bucket and 2.03 % for 1‑5‑year bonds) (Chunk 2). The shift from a low‑yield, liquidity‑focused stance in 2022 to a higher‑yield position in 2023, followed by a modest pull‑back in 2024, indicates that American Express actively adjusted its foreign‑government bond allocation to capture rising global sovereign yields when market rates were high, then re‑balanced as yields eased or risk considerations tightened.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 yield data. The original answer states that the 2022 fair value distribution showed $630M in Foreign Government Bonds with $628M maturing within one year, but does not provide a yield for 2022. The LLM incorrectly introduces a 1.74% yield for 2022 and an overall portfolio weighted-average yield of 2.08%, which are not supported by the ground truth. These numbers appear fabricated or misattributed. (2) The 2023 and 2024 yields (6.45% and 5.85%) are correctly reported, and the breakdown into one-year and 1-5-year buckets (6.45% and 4.48% in 2023; 5.86% and 2.03% in 2024) are consistent with the provided data, but these details were not in the original answer and represent over-specificity not grounded in the truth. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift from low-yield to high-yield instruments and back, aligning with the original answer’s interpretation. However, the reasoning is built on incorrect 2022 yield data, undermining the validity of the progression narrative. (4) Contextually, the answer addresses the evolution of yield and investment strategy, matching the question's intent. However, the introduction of unsupported quantitative details and incorrect 2022 yields severely compromises factual correctness. The qualitative reasoning is plausible but based on flawed inputs, leading to a partial score. Quantitative accuracy is low due to the invented 2022 yields; qualitative accuracy is moderate due to correct directional interpretation; contextual relevance is high as the structure and focus match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 461,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "- **2022 10‑K** – The table lists a single line that reads **“Common Stock, $.01 Par Value 7% Debentures due 2029”** with the CUSIP 718507BK1 and the New York Stock Exchange shown twice. The debentures are therefore presented together with the common‑stock class.  \n\n- **2023 10‑K** – The filing separates the securities into two rows: one for **“Common Stock, $.01 Par Value”** (ticker COP) and a second, distinct row for **“7% Debentures due 2029”** (CUSIP 718507BK1, NYSE). The debentures are disclosed as a separate class.  \n\n- **2024 10‑K** – The table again combines the two items in a single title line **“Common Stock, $.01 Par Value 7% Debentures due 2029”**, with the ticker COP, the NYSE listing, and the CUSIP 718507BK1 provided.  \n\n**What the progression shows** – Across the three years ConocoPhillips consistently discloses the 7 % Debentures due 2029, but the formatting of that disclosure shifts. In 2022 and 2024 the company groups the debentures with the common‑stock line, while in 2023 it isolates the debentures as a separate class. This indicates a stable commitment to transparency about the debt instrument, coupled with a flexible presentation style that sometimes emphasizes granularity (2023) and other times streamlines the table (2022, 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the 2024 10-K description, which undermines the overall correctness. (1) Quantitatively, the percentages (7%), years (2029), and CUSIP (718507BK1) are accurate across all years, and the exchange (NYSE) is correctly identified—these match the ground truth. (2) However, the LLM incorrectly states that in the 2024 10-K, the debentures were 'combined' again with common stock in a single line. The ground truth confirms that in 2024, COP *maintained* the separated disclosure introduced in 2023, with the debentures listed as a distinct class. This reversal of the 2024 presentation is a major factual inaccuracy. (3) The multi-hop reasoning is sound in structure—comparing year-over-year changes in disclosure format—but fails due to incorrect input data for 2024. The conclusion that COP alternates between combined and separated formats is therefore invalid. In reality, the progression shows a one-time improvement in clarity (from combined in 2022 to separated in 2023) and consistency in 2024, indicating a move toward more transparent reporting. The LLM’s interpretation of 'flexible presentation style' contradicts the ground truth trend of increasing standardization. (4) Despite accurate entities and numbers, the core narrative is flawed, warranting a moderate correctness score. Contextual relevance is fair as the response addresses disclosure evolution, but the incorrect synthesis reduces its value.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 408,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVDA disclosed the 2.00 % Notes Due 2031 as a Level‑2 financial instrument, reporting a fair‑value of **$1.2 billion in FY 2022** (Chunk 1). The liability fell to **$1.044 billion in FY 2023** and was **$1.057 billion in FY 2024** (Chunk 3), while the **net carrying amount rose to $1.250 billion in FY 2024** (Chunk 2). This pattern—an early reduction followed by a modest rebound in the net carrying amount—shows NVIDIA first trimmed its exposure and then chose to retain a sizable, low‑cost, long‑dated debt tranche, reflecting a strategy of locking in cheap 2 % financing while preserving long‑term financial flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the reported values for the 2.00% Notes Due 2031. According to the ground truth, the exposure was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM states the fair value was $1.2B in 2022 (correct), but then reports $1.044B in 2023 (incorrect—should be $1.057B), and $1.057B in 2024 (incorrect—this repeats the 2023 value and contradicts the 2024 ground truth of $1.25B). It introduces a distinction between 'fair value' and 'net carrying amount' ($1.250B in 2024) not present in the original answer, which simply refers to exposure. This conflation of financial metrics (fair value vs. carrying amount) without clarification leads to confusion and misrepresentation. (2) The quantitative inaccuracies are significant: the 2023 value is off by $13 million, and the 2024 value is misrepresented entirely—reporting $1.057B instead of $1.25B is a material error. The claim of a 'modest rebound' based on fair value is unsupported, as the ground truth shows a consistent increase from $1.2B → $1.057B → $1.25B, which is not a drop-and-recovery pattern. (3) The multi-hop reasoning is partially sound—the LLM attempts to interpret the trend and link it to debt strategy, which aligns with the question. However, the flawed data leads to an incorrect characterization of the trend (reduction then rebound) versus the actual steady increase. The conclusion about 'locking in cheap financing' is plausible but not directly supported by the ground truth, which emphasizes stability rather than strategic retention. (4) Scores justified: Correctness is 6 due to partial factual accuracy—core instrument and direction of change (increase over time) is somewhat captured, but key values are wrong. Quantitative accuracy is 5 due to multiple incorrect dollar amounts. Qualitative accuracy is 7 because reasoning structure is logical and entity identification (NVIDIA, Notes Due 2031) is correct. Contextual relevance is 9—response directly addresses the question's focus on evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 562,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney’s treatment of Marvel has been consistent yet deepened over the three most recent fiscal years. In FY 2022 the 10‑K lists the Marvel trademark among Disney’s indefinite‑lived intangible assets (alongside ESPN and Pixar) 【Chunk 3】, and the same classification reappears in FY 2024 【Chunk 2】, confirming Marvel’s status as a protected, non‑amortizing brand. By FY 2023 Disney elevated Marvel to a marquee streaming brand – the Disney+ interface presents “Marvel” as one of the top‑level tiles (alongside Disney, Pixar, Star Wars and National Geographic) that drives subscriber engagement 【Chunk 1】, a positioning that continues into FY 2024. Together, the filings show Marvel evolving from a core intangible asset to a dual‑strategy pillar: a trademark‑protected asset and a flagship brand tile on Disney’s direct‑to‑consumer platforms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Marvel was listed as an indefinite-lived intangible asset in FY 2022 and FY 2024 alongside ESPN and Pixar, which reflects its long-term brand value. In FY 2023, Marvel was highlighted as a top-level branded tile on Disney+, a positioning that continued into FY 2024. These details match the original answer precisely. (2) There are no numerical values requiring calculation, but the fiscal years (2022, 2023, 2024) are correctly referenced and aligned with the appropriate strategic developments. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and two domains (financial assets and streaming strategy)—and the conclusion that Marvel serves as both a protected intangible asset and a flagship streaming brand is well-supported by the evidence. (4) The LLM adds slight elaboration (e.g., 'dual-strategy pillar') that enhances clarity without introducing inaccuracies. All components of the question—branding in streaming services and role in intangible assets across the three years—are fully addressed with correct entity and year mapping. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 344,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "From 2022, American Express recognized discount revenue at the moment a Card‑Member transaction occurred, deducting the merchant discount from the payment to the merchant and, when a third‑party acquirer (e.g., under the OptBlue program) was used, recording a separately negotiated network‑rate fee as discount revenue; contracts with small‑ and mid‑size merchants were open‑ended, while large‑merchant agreements were fixed‑term (typically three‑to‑seven years) with auto‑renewal features. In the 2023 filing the company added a distinct “processed revenue” line that captures royalties, fees and other amounts from network‑partnership agreements with third‑party merchant acquirers—still recognizing the individually negotiated network‑rate fee at transaction time and treating issuer rates as contra‑revenue—while reiterating that discount revenue is variable consideration and not projected. By 2024 the focus shifted to expanding merchant coverage globally, leveraging third‑party merchant acquirers, aggregators and processors to sign new merchants (especially low‑ and new‑to‑plastic businesses and B2B buyers), targeting priority international cities and industry verticals, and investing in digital network capabilities to support these expanded partnerships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the evolution of revenue recognition from 2022 to 2024, the role of third-party acquirers (e.g., OptBlue), the treatment of network rate fees as discount revenue, the introduction of 'processed revenue' in 2023, and the 2024 focus on global merchant coverage expansion through acquirers, aggregators, and digital integration. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes changes over time across revenue structure, contractual terms, and strategic direction, correctly identifying the shift from traditional discount revenue to a dual model including processed revenue and expanded partnerships. (4) The LLM adds slightly more detail than the original (e.g., contract durations for large merchants, auto-renewal, 'low- and new-to-plastic' segments), which is consistent with plausible 10-K disclosures and does not contradict the ground truth. The only minor gap is that the original emphasizes 'value propositions for merchants and acquirers' and 'scaling marketing efforts' in 2024, which the LLM does not explicitly mention, but it does reference targeting priority cities and verticals, which is semantically aligned. Overall, the answer is factually correct, comprehensive, and contextually precise—justifying a 9/10 due to slight omission of marketing/value proposition elements, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1655,
        "completion_tokens": 441,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "In Amgen’s 2022 10‑K the company only flagged that many of its products depend on drug‑delivery or companion‑diagnostic devices and that those devices carry separate regulatory, manufacturing and other risks, while reiterating that clinical trials must be completed before any product can be sold but giving no detail on post‑marketing or safety‑review obligations. By the 2023 filing the disclosure had expanded: the drug‑delivery devices used with Amgen’s products are now described as subject to ongoing regulatory oversight and safety‑malfunction reviews, with adverse‑event signals arising in clinical trials triggering continuous pharmacovigilance, inspections, warning letters, fines or even withdrawal, and post‑marketing commitments such as REMS, accelerated‑approval conditions and pediatric‑study requirements are explicitly tied to both the drug and its device. The 2024 filing reiterates and deepens this stance, emphasizing that drug‑delivery devices remain under regulatory scrutiny, that post‑marketing commitments—including risk‑management programs, recalls and additional safety assessments—are integral to compliance, and that non‑compliance can lead to enforcement actions, reflecting an evolution from a brief risk acknowledgment in 2022 to a comprehensive, enforcement‑focused disclosure by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Amgen acknowledged general regulatory risks related to drug delivery and companion diagnostic devices without detailing post-marketing obligations; in 2023, the company expanded disclosures to include increased regulatory scrutiny on confirmatory trials, referencing LUMAKRAS and accelerated approval requirements (though the LLM does not name LUMAKRAS explicitly, it accurately captures the broader context of accelerated approval and post-marketing commitments); by 2024, the focus shifted to ongoing safety reviews, pharmacovigilance, and enforcement risks. (2) There are no numeric values to verify, so quantitative accuracy is满分—dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the evolution from general risk statements to detailed compliance and enforcement language. It accurately links clinical trial dependencies, post-marketing requirements (e.g., REMS, pediatric studies), and device-related safety reviews across the timeline. (4) The only minor shortcoming is that the LLM omits the specific example of LUMAKRAS and the Complete Response Letter from the FDA, which is included in the ground truth as a concrete illustration in 2023. However, the LLM captures the essence of accelerated approval and confirmatory study requirements without naming the drug, so this is a slight omission rather than an error. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 457,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "In the 2022 10‑K ConocoPhillips said its HSE audit program “covers business units and staff groups,” with annual objectives, targets and deadlines, and that any improvement actions “are identified and tracked to completion” and that audit progress “is tracked and reported to our ELT and the Board of Directors.” The 2023 filing repeats exactly the same description – business‑unit and staff‑group audits, corrective actions tracked to completion, and reporting to the ELT and Board – showing no change from the prior year. By the 2024 filing the wording is refined to “Corporate HSE audits” (still applied to business units and staff groups), but the core mechanics remain: improvement actions, when identified, are “tracked to completion,” and audit results continue to be reported to the Executive Leadership Team and the Board of Directors. Thus, from 2022 to 2024 the program’s scope was clarified to a corporate‑level audit, while the tracking of corrective actions and the ELT/Board governance reporting structure stayed consistent.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, entities, and timeline. It accurately identifies the scope, tracking mechanisms, and governance reporting across 2022–2024. The quantitative and entity accuracy is perfect: years (2022–2024), company (ConocoPhillips), audit scope (business units and staff groups), tracking to completion, and reporting to ELT and Board are all correctly stated. The evolution from general HSE audits to 'Corporate HSE audits' in 2024 is correctly noted, reflecting a shift toward standardization. However, the LLM underrepresents the qualitative evolution between 2022 and 2023. While it claims the 2023 filing 'repeats exactly the same description,' the ground truth indicates a meaningful expansion in context—specifically the integration of Life Saving Rules, Process Safety Fundamentals, and a stop work policy within a broader human capital management framework. This represents a substantive enhancement in the program’s conceptual framing, even if the structural reporting and tracking remained consistent. The LLM overlooks this nuance, treating 2023 as static when in fact it reflects an important step in program maturation. This omission affects the depth of the multi-hop reasoning and slightly reduces qualitative accuracy. Nevertheless, the core facts and overall trajectory (increased centralization and institutionalization) are correctly conveyed, and the answer remains contextually precise and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Conducts]- ORG",
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 413,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Across the three filings Accenture’s pricing‑model strategy has broadened in step with emerging technology. In the 2022 10‑K the company warned that “cloud and as‑a‑service solutions” required new pricing or commercial models; the 2023 filing expanded that language to include “cloud, data and AI solutions,” and the 2024 filing further emphasized “AI‑based technologies, including generative AI,” indicating a shift from a primarily cloud‑focused pricing approach in 2022 to an increasingly AI‑centric framework by 2024. Nevertheless, each year the company repeatedly flagged the same set of risks: if it cannot roll out the new pricing/commercial models (or if client spending on the underlying technologies is delayed), results of operations could be materially harmed, and the adoption of AI‑driven models carries ongoing legal, reputational, regulatory and bias‑related uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Accenture's pricing model strategy from 2022 to 2024: starting with cloud and as-a-service in 2022, expanding to include data and AI in 2023, and emphasizing generative AI and AI-based technologies in 2024. The consistent risk of delayed client spending and failure to deploy new pricing models impacting operations is accurately highlighted each year. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are all correct. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, showing progression in focus and continuity in risk disclosure. The LLM correctly infers a shift from cloud-centric to AI-centric pricing models based on evolving language in the filings. (4) The only minor shortcoming is that the LLM adds a detail not present in the original answer—'legal, reputational, regulatory and bias-related uncertainties' associated with AI-driven models—while the ground truth emphasizes revenue shortfalls and competitive disadvantages due to slow adoption or deployment. This addition, while plausible, slightly deviates from the consistently highlighted risks in the original answer. Otherwise, the answer is factually correct, complete, and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 406,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "- **2022:** GE’s 2023 filing shows the AerCap note was **$900 million** at 12/31/2022.  \n- **2023:** The same filing (and the 2024 filing) reports the note rose to **$944 million** at 12/31/2023.  \n- **2024:** The 2024 filing lists the AerCap note at **$982 million** at 12/31/2024.  \n\n(For context, the 2022 filing disclosed a $993 million AerCap note at 12/31/2021, indicating the 2022 figure represented a dip before the subsequent rise.)\n\n**Interpretation:** After a reduction from the 2021 level, GE has been steadily increasing its holding of the AerCap note each year—$900 M → $944 M → $982 M. This upward trend suggests GE is deliberately rebuilding and expanding its exposure to AerCap, treating the note as a strategic Level‑3, available‑for‑sale investment rather than a one‑off position. The pattern reflects a growing confidence in, or a strategic partnership with, AerCap and an intent to deepen that relationship over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. According to the ground truth, GE's holdings in the AerCap note decreased from $993 million (end of 2021, reported in 2022 filing) to $944 million (end of 2023, reported in 2024 filing). However, the LLM claims that the holding was $900 million at the end of 2022, increased to $944 million at the end of 2023, and further rose to $982 million at the end of 2024—none of which aligns with the ground truth. The only correct number is $944 million at the end of 2023, which matches the ground truth. The $900 million figure for 2022 and $982 million for 2024 are unsupported and factually wrong. (2) The quantitative inaccuracies are severe: the LLM fabricates an upward trend ($900M → $944M → $982M), whereas the actual data shows a consistent decline from $993M to $944M over the period. There is no mention in the ground truth of a 2024 value, so asserting $982 million is speculative and incorrect. (3) The multi-hop reasoning is flawed. The question asks about the evolution from 2022 through 2024, but the ground truth only provides data up to the end of 2023 (reported in 2024). The LLM incorrectly assumes a 2024 value and misinterprets the direction of the trend. Instead of recognizing a strategic reduction, it infers a rebuilding of investment, which contradicts the evidence. (4) The contextual relevance is moderate because the answer addresses the right entities (GE, AerCap note) and attempts to interpret investment strategy, but the incorrect data leads to a completely reversed conclusion. The qualitative reasoning would be stronger if based on accurate data, but as it stands, the logic is sound only within a false framework. Thus, the correctness score is low due to major factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 489,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen launched Bemarituzumab into a pivotal phase‑3 trial for gastro‑esophageal junction adenocarcinoma in its 2022 Form 10‑K (Chunk 1). In the 2023 filing the company disclosed that the underlying polypeptide patents covering Bemarituzumab are slated to run out in 2029 in both the United States and Europe (Chunk 2). By the 2024 Form 10‑K, Bemarituzumab is still described among the candidates that have “advanced into human clinical trials” under the Phase 2/3 program description, and Amgen reiterates that the 2029 expiration dates are estimates based on issued patents that could be extended by regulatory exclusivities (Chunk 3).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key facts: Bemarituzumab entered a phase 3 trial in 2022 for gastro-esophageal junction adenocarcinoma, patent expiration is estimated at 2029 in the U.S. and Europe (disclosed in 2023), and the 2024 filing reiterates the 2029 estimate with a note on possible extension via regulatory exclusivities. These details align with the ground truth. However, the LLM answer omits the 2024 expansion of Bemarituzumab’s investigational scope to gastric cancer, gastroesophageal junction cancer, and advanced solid tumors beyond NSCLC—a key evolution in therapeutic positioning. Instead, it states the drug is still described among candidates in 'Phase 2/3 program,' which understates the progression and broader strategic shift noted in the original answer. (2) Quantitative accuracy is perfect: all dates (2022, 2023, 2024, 2029) and patent timelines are correct and consistent with the ground truth. Format variations (e.g., '2029' vs 'estimated at 2029') are acceptable. (3) Multi-hop reasoning is partially sound—information is correctly synthesized across years and filings, but the synthesis lacks completeness in capturing the full scope of Amgen’s evolving strategy in 2024. The LLM fails to highlight the shift from clinical development to broader therapeutic and IP positioning, which is central to the question. (4) Scores reflect high factual accuracy in numbers and entities, but a moderate deduction in qualitative accuracy due to missing key qualitative evolution in 2024. Contextual relevance remains high as the answer directly addresses the timeline and IP, though incompletely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 448,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "In its 2022 10‑K, American Express already warned that the “dynamic and rapid growth of alternative payment and financing mechanisms” – from digital wallets and BNPL to blockchain‑based solutions – was creating intense competitive pressure on its card‑issuing and network businesses. The 2023 filing repeats that view and adds that the **speed of innovation and investment in technology** is a decisive competitive factor, underscoring that alternative‑payment players are a growing threat. By the 2024 filing the company moves from acknowledgement to action: it states that “if we are not able to successfully invest in…open‑banking and alternative payment and financing mechanisms…our revenue and profitability could be materially adversely affected,” and it highlights substantial spending on AI, tokenization, real‑time settlement, and strategic acquisitions to both compete with and depend on these mechanisms. Together, the three filings show a clear evolution—from recognizing fintech rivals as a competitive risk to committing heavy technology investment and strategic partnerships—revealing that American Express is positioning itself for a long‑term, proactive response to fintech disruption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express identified alternative payment mechanisms (digital wallets, BNPL, blockchain) as competitive threats in 2022; expanded the scope in 2023 to include open banking and payment facilitators (implied through 'speed of innovation' and broader tech investment); and by 2024 shifted to a dependency posture emphasizing investment in open banking, tokenization, real-time settlement, and AI. The LLM correctly captures the evolution from threat recognition to proactive integration. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the strategic shift over time. It accurately reflects the increasing urgency and investment posture, citing a direct quote from the 2024 filing about material adverse effects on revenue. (4) The only minor gap is that the LLM does not explicitly name 'payment facilitators' as added in 2023 (though 'speed of innovation' and tech investment imply it), and slightly generalizes the 2023 expansion. Otherwise, semantic equivalence is strong, with accurate entity names (American Express, open banking, tokenization, real-time settlement), correct years (2022–2024), and correct interpretation of strategic evolution. The answer is fully relevant to the question about competitive pressure, technological investment, and long-term fintech response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1613,
        "completion_tokens": 454,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The 2021 filing only describes the cash‑settled PSU mechanics and gives no grant‑date fair‑value number; the 2023 filing reports a weighted‑average grant‑date fair value of **$91.58** for the 2022 cash‑settled PSU grants, and the 2024 filing shows that this rose to **$112.50** for the 2023 grants (the 2022 figure remains $91.58). The increase from $91.58 to $112.50 signals that ConocoPhillips is raising the monetary value of its cash‑settled performance‑share awards, indicating a more aggressive long‑term incentive compensation strategy aimed at better aligning employee rewards with future shareholder value.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers from the ground truth: $91.58 for 2022 and $112.50 for 2024 (though it refers to the $112.50 as being for 2023 grants, which is a misalignment in year labeling). However, the original answer states the value increased from $91.58 in 2022 to $112.50 in 2024, implying data for three years, but the LLM only provides two data points and incorrectly attributes the $112.50 to 2023 grants instead of 2024 grants. This misstatement of the year reduces quantitative accuracy. (2) The numbers themselves are accurate in value ($91.58 and $112.50), but the time period mapping is off—the LLM says the 2024 filing shows $112.50 for 2023 grants, while the ground truth indicates this value pertains to 2024. This affects both quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers an upward trend and links it to long-term incentive strategy, showing understanding of compensation alignment with performance. However, it fails to confirm the full 2022–2024 evolution due to missing or misattributed data for 2024. (4) Contextual relevance is strong—the answer addresses both parts of the question (trend and strategic implication), uses correct entities (ConocoPhillips, cash-settled PSUs), and draws a reasonable conclusion. The strategic interpretation aligns semantically with the ground truth. Minor wording differences are acceptable, but the misattribution of the $112.50 to 2023 instead of 2024 is a significant factual deviation, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 434,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "From 2022 through 2024 PayPal repeatedly flagged abusive‑behavior risk as a material threat to its credit portfolio. In the 2022 filing the company warned that third‑party actors were already creating fictitious PayPal accounts, using stolen or synthetic identities and that the controls needed to detect such fraud were complex and not always effective. In 2023 the discussion deepened, noting that its credit growth now depended on unaffiliated lenders and other third‑party funding (including a new €40 billion BNPL receivable‑sale programme) and that any inability to fund or purchase those receivables would curb credit‑product growth and raise loss rates, while it still expected continued abuse of its payment platform. By the 2024 filing the same exposure persisted—now coupled with regulatory uncertainty around the “valid‑when‑made” doctrine and ongoing reliance on third‑party processors—showing that abusive‑behavior risk has not diminished and that, although PayPal has taken steps such as diversifying processors and tightening third‑party oversight, its risk‑management framework has been only partially effective in containing the threat.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's concerns about fictitious accounts and synthetic identities in 2022, the €40 billion BNPL receivable-sale program in 2023 (correctly tied to U.K. and European credit products), and the ongoing risk from third-party fraud and regulatory uncertainty (specifically the 'valid-when-made' doctrine) in 2024. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, years (2022–2024) match, and no calculations are required. Format is consistent and precise. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, connects credit product growth to third-party funding and fraud exposure, and correctly infers that PayPal’s risk management—while improved through third-party oversight and receivable sales—remains only partially effective due to persistent threats. (4) The answer is contextually complete, addressing all parts of the question: evolution of abusive behaviors, link to credit products and third-party fraud, and implications for risk management. The only minor shortcoming is a slightly stronger emphasis in the original on the strategic intent behind the €40B agreement as a loss-mitigation tool, which the LLM implies but could have stated more explicitly. Otherwise, semantic equivalence is strong, and factual accuracy is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 390,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "In the 2022 10‑K Lilly listed Cyramza as a multi‑indication oncology drug – a second‑line monotherapy or combination for advanced/metastatic gastric or gastro‑esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and a first‑line option for EGFR‑mutated metastatic NSCLC. The 2023 filing adds a full IP schedule, showing compound patents that run to 2026 in the United States and Japan and to 2028 in major European countries, plus U.S. biologics data protection through 2026 and European data‑protection exclusivity through 2024 (Japan data protection expires 2023). The 2024 10‑K repeats the same therapeutic indications, indicating that Cyramza’s clinical positioning has stayed consistent while its exclusivity has been layered and extended across key territories, signalling that Eli Lilly is deliberately protecting Cyramza’s revenue stream and using it as a long‑term pillar of its oncology strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cyramza's therapeutic positioning in 2022 with accurate indications across gastric, lung, colorectal, and liver cancers, including both first-line and second-line uses. It accurately notes the patent and data protection timelines from the 2023 filing: U.S. and Japanese compound patents through 2026, European patents to 2028, U.S. biologics data protection through 2026, European exclusivity through 2024, and Japanese data protection expiring in 2023. However, the original answer states that Japan data protection expires 'as early as 2023'—the LLM presents this as a definitive 2023 expiry, which may be correct but lacks the cautious phrasing of the ground truth. The 2024 update correctly reflects no new indications, consistent with the ground truth. (2) Quantitatively, all dates and years are accurate, though the LLM adds European patent expiry in 2028, which was not mentioned in the original answer. This additional detail may be factually correct but introduces information not verified in the ground truth, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes therapeutic positioning (2022), IP landscape (2023), and continued positioning without expansion (2024), correctly inferring that Eli Lilly is protecting revenue and using Cyramza as a strategic pillar. However, the original answer suggests Lilly may be preparing next-generation products due to impending patent expiry, implying a transition strategy, while the LLM emphasizes long-term pillar status—this is a nuanced but important difference in strategic interpretation. (4) Scores reflect high factual accuracy and relevance, with minor deductions in quantitative and qualitative accuracy due to unverified European patent details and slightly divergent strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 503,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "Across the three filings the 3.875 % Notes due 2042 (PM42A) appear in every table – the 2022 filing lists it alongside a broad set of notes, the 2023 filing shows the same long‑term anchor still present, and the 2024 filing again includes the 3.875 % Notes due 2042 while adding newer, lower‑coupon, shorter‑dated issuances (e.g., 2.750 % Notes due 2025, 3.375 % Notes due 2025, 3.750 % Notes due 2031). This pattern shows Philip Morris using the 3.875 % Notes as a stable long‑term financing cornerstone while actively reshaping the remainder of its debt portfolio—issuing fresh notes and adjusting maturities—to manage liquidity, interest‑rate exposure and overall cost of capital.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the consistent presence of the 3.875% Notes due 2042 across all three years, which aligns with the ground truth and shows understanding of the core long-term anchor in Philip Morris's capital structure. However, it introduces significant factual inaccuracies regarding the newer debt instruments. The LLM claims that in 2024, Philip Morris issued 'newer, lower-coupon, shorter-dated issuances' such as 2.750% Notes due 2025, 3.375% Notes due 2025, and 3.750% Notes due 2031. This contradicts the ground truth, which states that by 2024, the 2043 and 2044 tranches were retired or refinanced and *no new long-dated notes beyond 2042 were introduced*. The cited short-term notes are not mentioned in the ground truth and represent a mischaracterization of the company's strategy. Additionally, the ground truth notes the presence of 4.125% Notes due 2043 and 4.875% Notes due 2043 in 2022 and their continuation into 2023 (with addition of 4.250% Notes due 2044), none of which are acknowledged by the LLM. Instead, the LLM incorrectly focuses on short-term instruments not referenced in the original data. While the overall reasoning framework—using the 3.875% Notes as a stable cornerstone while actively managing other debt—is conceptually aligned, the factual basis for the active management claim is flawed. The model fails to accurately reflect the specific instruments being retired or refinanced, undermining the quantitative and qualitative accuracy. The contextual relevance remains high because the answer addresses the evolution of capital structure and attempts multi-hop synthesis across years, but the incorrect debt instruments and maturities lead to a partially incorrect conclusion about the direction of the strategy (e.g., issuing new short-term debt vs. retiring long-term tranches).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 495,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "**Evolution of the exposure**\n\n- **2022:** PayPal warned that abusive behavior – synthetic‑identity accounts, stolen‑instrument transactions, and other fraud – was a material risk to its platform.  The company said that such fraud, together with defaults on its consumer‑credit, merchant‑financing and “PayPal Branded” credit products, could raise loss rates, trigger charge‑offs and constrain the growth of its credit portfolio.  Because many of these services are delivered through unaffiliated banks, payment processors, lenders and other service providers, PayPal noted that ineffective third‑party oversight could further amplify the abuse risk.\n\n- **2023:** To curb that exposure, PayPal began to **off‑load credit risk** and **reduce reliance on a single processor**.  It entered a multi‑year agreement to sell up to **€40 billion of U.K. and European “buy‑now‑pay‑later” (BNPL) loan receivables** and, in October 2023, started actually selling those receivables.  At the same time the company launched a program to **diversify its third‑party payment‑processor base**, working with its primary U.S. processor to migrate transactions to additional processors and exploring other third‑party funding structures (asset sales, securitizations, forward‑flow arrangements) to support its credit portfolio.\n\n- **2024:** PayPal continued the **BNPL‑receivable sale and forward‑flow arrangement** (the same multi‑year deal signed in June 2023) as a core mitigation tool, thereby further reducing the amount of credit exposure that could be affected by abusive behavior.  The filing again emphasized **enhanced third‑party risk‑management policies**—monitoring legal, regulatory, information‑security and operational risks of its network of banks, lenders, processors and other partners—to keep abusive schemes in check.  In addition, the company highlighted the FDIC/OCC “valid‑when‑made” rule, which clarifies loan‑sale treatment and helps protect its credit products from regulatory‑driven abuse.\n\n**Specific mitigation actions**\n\n- **2023:** Sale of up to €40 bn of U.K./European BNPL loan receivables (with the first sales in October 2023); diversification and migration away from a single U.S. payment processor; pursuit of alternative third‑party funding sources to lessen credit‑product concentration.  \n- **2024:** Continuation of the BNPL receivable sale and forward‑flow arrangement; reinforced third‑party oversight and risk‑management controls; reliance on the FDIC/OCC rule to safeguard the credit‑product portfolio from regulatory‑related abusive risk.  \n\nTogether, these steps show PayPal moving from a high‑exposure posture in 2022 to an active strategy of off‑loading credit risk and tightening third‑party governance in 2023‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) All key facts from the ground truth are present: PayPal's identification of abusive behaviors in 2022 (synthetic identities, stolen instruments), the 2023 €40 billion BNPL receivables sale agreement, and 2024's continued risk mitigation through enhanced fraud detection and third-party oversight. The LLM adds valuable detail not in the original (e.g., diversification of U.S. payment processors, forward-flow arrangements, FDIC/OCC 'valid-when-made' rule), which is consistent with plausible SEC filing content and enhances completeness without introducing inaccuracies. (2) Quantitative accuracy is perfect: the €40 billion figure, U.K./European BNPL focus, and October 2023 initiation of sales are correctly stated. The June 2023 agreement date is an addition but does not contradict the ground truth. (3) Multi-hop reasoning is sound: the answer synthesizes PayPal’s evolving strategy across years and connects credit products, third-party risk, and mitigation actions logically. The only minor gap is that the original emphasizes 'improving detection mechanisms' in 2024, which the LLM reframes as 'enhanced third-party risk-management policies'—a related but not identical focus. This slight shift in emphasis prevents a perfect 10. (4) Contextual relevance is excellent: every part of the question (evolution from 2022–2024, credit products, third-party risk, specific 2023/2024 actions) is addressed with precise, relevant information. Overall, the answer matches the ground truth in substance, adds contextually appropriate detail, and maintains factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1942,
        "completion_tokens": 443,
        "total_tokens": 2385
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 10‑K risk disclosures list “loss or modification of exemptions for taxes and tariffs” in every filing – 2022, 2023 and 2024 – showing that the company’s exposure to this regulatory risk has persisted unchanged across the three years. In the 2023 and 2024 reports the tax‑tariff risk is reiterated alongside new references to expanding sanctions and export‑control revisions (e.g., against Russia, Belarus and Ukraine), indicating that the threat of losing or altering tax‑tariff breaks is not diminishing but is being compounded by broader geopolitical and regulatory shifts. Together, the consistent mention and the added context of heightened sanctions suggest an escalating regulatory uncertainty for AMD’s worldwide operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately states that AMD consistently disclosed the risk of loss or modification of tax and tariff exemptions in its 10-K filings from 2022 to 2024, which matches the original answer. It also correctly notes the increasing context around geopolitical tensions and regulatory changes, particularly referencing sanctions and export controls related to Russia, Belarus, and Ukraine in 2023 and 2024. (2) There are no numerical values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the model synthesizes the persistence of the risk over time and the addition of new geopolitical context to infer increasing regulatory uncertainty, which is consistent with the original answer’s conclusion. However, the LLM slightly underemphasizes the progressive *elevation* of the risk—while it notes consistent mention and added context, it does not fully capture the nuance that AMD *increasingly emphasized* the risk each year, culminating in an explicit link to geopolitical conflicts in 2024. The original answer highlights a clear escalation in tone and priority, which the LLM acknowledges indirectly but does not explicitly state. (4) Despite this minor omission, the answer remains contextually rich and relevant, correctly interpreting the trend as indicative of growing regulatory uncertainty. Thus, the correctness and qualitative accuracy scores are high but not perfect due to the slightly less precise characterization of the evolving emphasis in risk disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 466,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s results for the “total‑return swaps‑deferred compensation” line show a clear swing from a loss in FY 2022 to growing gains in the next two years. Both the 2023 and 2024 Form 10‑K tables list a $(92) loss for the year ended July 30 2022, a $58 gain for the year ended July 29 2023, and a $91 gain for the year ended July 27 2024. The 2022 filing confirms the $(92) loss for FY 2022, reinforcing the baseline figure. This progression—from a negative result to increasingly positive outcomes—suggests Cisco’s exposure to deferred‑compensation‑linked swaps has turned favorable, reflecting either improved market conditions, more effective management of the contracts, or a strategic shift to use these derivatives to offset compensation costs rather than generate losses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: a $92 million loss in FY2022 (represented as $(92) in financial statements), a $58 million gain in FY2023, and a $91 million gain in FY2024. The fiscal year-end dates (July 30, 2022; July 29, 2023; July 27, 2024) are correctly cited, aligning with Cisco's fiscal calendar. (2) The answer is complete, addressing both parts of the question: the evolution of gains/losses over the three years and the interpretation of what this progression indicates. (3) Entity accuracy is perfect—Cisco is the correct company, the metric 'total return swaps tied to deferred compensation' is correctly identified, and the years are properly matched to the corresponding financial results. (4) The reasoning is sound and reflects proper multi-hop synthesis across multiple 10-K filings. The conclusion—that the shift from loss to gains suggests improved market conditions, better management, or a strategic shift—aligns semantically with the ground truth's interpretation about exposure or strategy changes. Minor wording differences (e.g., 'strategic shift to use these derivatives to offset compensation costs' vs. 'strategic shift in managing deferred compensation liabilities') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 380,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From FY 2022 Disney’s filings show that it was just beginning to pour capital into its DTC streaming platforms, warning that the “costs of our DTC strategy, and associated losses, may continue to grow or be reduced more slowly than anticipated” and that early‑stage investments were producing “negative or low” returns while the business faced “substantial competition” for talent, content and subscribers. In FY 2023 the company doubled down on those investments, stating it was “making strategic investments in our DTC offerings” and expecting higher subscription‑fee and advertising‑revenue growth to more than offset declines in linear‑network revenue, while emphasizing a strong cash position, access to $12.25 billion of bank facilities and covenant compliance that give it the liquidity to fund the scaling of the streaming unit. By FY 2024 the tone shifted to “increased competitive pressures” – a growing number of rival DTC services, AI‑driven low‑cost content, rising programming‑rights costs and renewal‑contract uncertainty – highlighting that the DTC business, though still a core investment of Disney, now carries heightened financial risk from cost inflation, contract‑renewal challenges and the need to sustain ample financing to support a streaming operation that remains dependent on Disney’s broader balance‑sheet strength.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney's acknowledgment of growing DTC costs and uncertain returns in FY2022, the strategic investment push in FY2023 despite losses, and the heightened competitive and financial pressures in FY2024. The LLM correctly captures the evolution of tone and strategy across the three fiscal years. (2) Quantitative accuracy is perfect: while no specific dollar figures for DTC losses are provided in the original answer, the LLM accurately references Disney’s $12.25 billion in bank facilities from FY2023 filings, which is a factual detail supporting liquidity — this number is correct and contextually appropriate. No calculations are required, and all dates (FY2022, FY2023, FY2024) are accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and correctly infers the strategic progression — from caution to doubling down to facing intensified pressures — demonstrating strong understanding of the evolving financial risks and market dynamics. (4) Semantic equivalence is high: though the LLM uses more detailed phrasing (e.g., 'AI-driven low-cost content', 'covenant compliance'), these are reasonable elaborations consistent with the original's emphasis on rising costs, competition, and financial risk. The only minor gap is that the original emphasizes the shift toward advertising and subscription revenue growth more explicitly as an offset strategy, while the LLM mentions it but integrates it slightly less centrally. This does not detract from factual correctness but slightly reduces qualitative precision. Overall, the answer is comprehensive, factually sound, and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Invests_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 474,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "Across all three fiscal years — 2022 (Chunk 3), 2023 (Chunk 1) and 2024 (Chunk 2) — PayPal repeatedly discloses that it “has full discretion in determining the fee charged to our customers, which is independent of the costs we incur when we use payment processors or other financial institutions.” Because the fee‑setting discretion is not offset by those processor costs, PayPal “therefore bears full margin risk when completing a payment transaction,” and the fees paid to processors are recorded as a separate transaction expense. The language is unchanged in each filing, indicating that PayPal’s exposure to margin risk remained consistent rather than increasing or decreasing from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual elements are accurately represented: PayPal bore full margin risk across 2022, 2023, and 2024; it maintained discretion in setting customer fees independent of processor costs; and processor fees were consistently recognized as transaction expenses. There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy pertains to correct handling of years and consistent reporting — which the LLM handles perfectly. (2) The answer addresses all parts of the multi-hop question: evolution over time (2022–2024), fee-setting discretion, treatment of processor costs, and accounting for transaction expenses. (3) Entity accuracy is flawless: 'PayPal' is correctly identified, years are accurate (2022, 2023, 2024), and financial concepts like 'margin risk', 'transaction expense', and 'payment processors' are used correctly. (4) The reasoning is sound and synthesizes information across the three years, correctly noting that the language and structure remained unchanged, indicating stable risk exposure. The mention of 'Chunk 3, Chunk 1, Chunk 2' appears to reference internal document chunks but does not affect factual correctness. The conclusion — that margin risk exposure remained consistent — matches the ground truth exactly. No material details are omitted, and no inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Bears]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 403,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell flagged the possibility that new aircraft orders could be delayed or cancelled in every three‑year risk‑factor series. In the 2022 10‑K the risk was tied to the COVID‑19‑driven downturn in global air‑travel demand; the 2023 filing repeated the same warning – now without an explicit pandemic reference but still emphasizing weak demand and order‑delay risk – and the 2024 filing again listed it under the renamed “Aerospace Technologies” segment. The fact that the concern has persisted, albeit with a shift from a pandemic‑specific to a broader demand‑uncertainty framing, indicates that commercial aviation is still in a recovery phase and that order‑cancellation risk remains a material, unresolved threat to the sector’s stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Honeywell consistently cited new aircraft order cancellations as a risk from 2022 to 2024. In 2022, the risk was tied to the pandemic's impact on air travel demand; by 2023 and 2024, the framing shifted to broader demand uncertainty and structural market changes. The LLM correctly notes the renaming of the segment to 'Aerospace Technologies' in 2024, which matches the ground truth context. (2) Quantitative accuracy is perfect: all years (2022, 2023, 2024) are correctly referenced, and there are no numerical claims that conflict with the original answer. (3) Multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers that the persistence of the risk—even as its framing evolved—indicates ongoing fragility in the commercial aviation recovery. The shift from pandemic-specific to broader macroeconomic concerns is accurately captured, though the LLM does not explicitly mention 'regional conflicts' or 'environmental issues' as noted in the 2023 risk expansion. This is a minor omission. (4) The answer is contextually relevant, directly addressing how the risk evolved and what it indicates about sector stability. The conclusion that order-cancellation risk remains a 'material, unresolved threat' effectively captures the ground truth's emphasis on continued fragility. The only reason for not scoring a 10 is the slight lack of specificity around the 2023 expansion of risk factors, which slightly reduces qualitative completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 434,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "PMI’s 10‑K risk disclosures from 2022‑2024 all flag product regulation as a key competitive risk. In 2022 the company warned that regulation curtails its ability to differentiate and to provide truthful, non‑misleading information about its Reduced‑Risk Products (RRPs); the 2023 filing repeats the same RRP‑focused concerns and adds that regulation can limit branding, communication and reinforce down‑trading, while the 2024 filing shifts the focus to Smoke‑Free Products (SFPs) but retains the identical constraints—diminished product differentiation, restricted adult‑consumer communication, and disproportionate impact on commercialization—showing that regulatory pressure has broadened and intensified, tightening PMI’s ability to leverage its reduced‑risk portfolio for competitive advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the evolution of regulatory concerns from 2022 to 2024 is accurately portrayed, with correct emphasis on RRPs in 2022–2023 and the shift to SFPs in 2024. The core constraints—limited product differentiation, restricted adult consumer communication, and disproportionate commercialization impact—are correctly identified across all years. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2022–2024) are correctly used and referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years and connects regulatory pressure to shifting product categories (RRPs to SFPs), demonstrating understanding of both timeline and strategic evolution. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'growing influence of digital media in spreading misleading information' in 2023, which is present in the original answer and adds nuance to the 2023 risk disclosure. This omission slightly affects completeness but does not undermine the overall correctness. Wording differs but maintains semantic equivalence. The answer is fully contextually relevant, directly addressing the evolution of regulatory impact on competitive positioning and product communication. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 437,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "Across the three filings PayPal’s margin‑risk profile has stayed essentially unchanged. In every year the company states that it acts as the **principal** on each payment, setting fees on a **fixed‑plus‑variable** basis (the variable portion is a percentage of the transaction value and is adjusted by volume‑based tiered pricing) and that the fees it charges are **independent of the costs it incurs to payment processors or other financial institutions**, which are recorded only as transaction expense – therefore the full margin risk remains on PayPal’s balance sheet. The **incentives** that reduce transaction revenue (discounts, rebates, rewards, coupons, and other promotional credits) are consistently treated as revenue reductions, with the 2023 filing adding more detail on performance‑based versus non‑performance‑based incentives, but the net effect on margin risk is the same. Thus, from 2022 through 2024 PayPal’s exposure to margin risk has remained high and unchanged, driven by its pricing model, its use of third‑party processors, and the ongoing practice of offering customer incentives that lower gross margins.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: PayPal bears full margin risk in 2022, 2023, and 2024; fees charged to customers are independent of processor costs; incentives reduce revenue and are treated consistently. The LLM correctly identifies that transaction expenses include fees paid to processors and that incentives are recognized as revenue reductions, with added detail in 2023 on performance-based versus amortized incentives. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the qualitative financial constructs (fixed-plus-variable pricing, tiered pricing, revenue reduction treatment) are accurately described and align with the original answer’s implications. (3) Multi-hop reasoning is sound: the LLM synthesizes information across all three years, correctly identifying consistency in margin risk exposure while noting increased disclosure detail over time, particularly around incentives. It connects pricing models, use of third-party processors, and customer incentives to the overall margin risk framework. (4) The answer is contextually fully relevant, addressing each component of the question—transaction pricing models, payment processor costs, and customer incentives—and their collective impact on margin risk evolution. Wording differs slightly (e.g., 'principal' role, 'fixed-plus-variable' pricing) but adds precision without deviating from the original meaning. No factual errors, omissions, or misinterpretations. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 442,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "Across the three filings AMD’s AIB strategy stayed essentially unchanged. In 2022 AMD said its agreements with AIB manufacturers “protect their inventory of our products against price reductions,” and noted that “SIs often use discrete graphics solutions as a means to differentiate their products.” The 2023 filing repeats the same language verbatim, and the 2024 filing adds only a modest qualifier—“in most instances, our agreements with AIBs protect their inventory…against price reductions”—while still emphasizing that SIs rely on discrete‑graphics solutions to add value and differentiate. Thus, from 2022‑2024 AMD consistently shielded AIB inventory from price cuts and continued to position discrete graphics as a key differentiator for system integrators, with only minor wording tweaks over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMD maintained inventory protection policies for AIB manufacturers from 2022 to 2024, accurately reflecting the consistent language in 2022 and 2023 and the slight rewording in 2024 ('in most instances') as noted in the original answer. It also correctly emphasizes the ongoing role of discrete graphics solutions as a differentiator for system integrators. (2) There are no numerical values requiring calculation, but all dates (2022, 2023, 2024) and references to filings are factually correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying both continuity and subtle evolution in language. However, it slightly underemphasizes the 2024 strategic shift toward deeper alignment with SIs who create differentiated offerings, which the original answer highlights as a nuanced but meaningful evolution in AMD's ecosystem strategy. (4) The answer is contextually fully relevant, addressing all parts of the question—inventory protection, role of discrete graphics, and the relationship with AIBs and SIs—over the specified time period. The only minor shortcoming is the lack of explicit mention of the growing emphasis on SIs leveraging regional or product-based strengths and faster technology adoption in 2024, which slightly reduces qualitative accuracy. Overall, the answer is factually correct with only minor omissions in nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Sells_To]- ORG <-[Sells_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 425,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney’s investment‑credit‑exposure framework has been unchanged from fiscal 2022 through fiscal 2024: the company transacts only with counterparties that have a credit rating of **A‑ or better** and **requires collateral** whenever a rating falls below A‑ or when aggregate exposures exceed the limits set in the contracts, and it **limits the amount of exposure to any one institution** in all three periods. In fiscal 2022 the company reported **no balances (excluding money‑market funds) with any single institution that exceeded 10 % of total cash and cash equivalents**, whereas by fiscal 2024 the same 10 % concentration threshold was breached – **balances above that level accounted for 24 % of total cash and cash equivalents**. Thus, while the rating‑and‑collateral policy and the 10 % concentration benchmark remained constant, the actual concentration of credit exposure grew from zero in FY 2022 to a material 24 % in FY 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and percentages are accurate: the 24% concentration in fiscal 2024 is correctly reported, and the absence of any >10% concentration in fiscal 2022 (i.e., 'no balances...exceeded 10%') aligns with the original answer's statement of 'no such concentration in fiscal 2022'. The 10% threshold is correctly referenced as a benchmark. (2) The answer addresses all parts of the multi-part question: counterparty credit ratings (A- or better), collateral requirements (triggered by rating drops or exposure limits), and concentration thresholds (10% benchmark and its breach in FY2024). (3) Entities are accurate: The Walt Disney Company, fiscal years 2022 and 2024, and financial terms like 'cash and cash equivalents' and 'concentration' are used correctly. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly identifies that while the risk management *policies* (ratings, collateral, exposure limits) remained unchanged, the *actual exposure concentration* increased significantly by FY2024, indicating a shift in liquidity strategy despite stable policy—this nuanced conclusion is consistent with the original answer. Wording differs slightly but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Limits]-> RISK_FACTOR <-[Depends_On]- ORG <-[Limits]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 377,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "- **2022:** The 2023 Form 10‑K shows $1.5 billion of the September 2019 Fixed‑rate 2.850 % notes (maturing 10/1/2029) on the balance sheet for the year‑ended December 31 2022.  \n- **2023:** The same 2023 Form 10‑K (2023 column) and the 2024 Form 10‑K (2023 column) both list $1.5 billion for this tranche, indicating no change from the prior year.  \n- **2024:** The 2024 Form 10‑K (2024 column) again reports $1.5 billion of the 2.850 % notes, showing the exposure remained unchanged.\n\n**Interpretation:** Across three consecutive years the amount of the 2029‑maturing Fixed‑rate 2.850 % notes stayed flat at $1.5 billion. This consistency—mirrored in the 2020‑2021 data from the 2022 10‑K—suggests PayPal has deliberately retained a stable, low‑cost medium‑term debt tranche rather than refinancing or retiring it. By locking in a relatively low fixed rate for a decade‑long horizon, the company is managing interest‑rate risk and preserving liquidity, reflecting a long‑term debt strategy focused on maintaining a predictable maturity profile and inexpensive financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $1.5 billion (equivalent to $1,500 million) is accurately reported for each year (2022, 2023, 2024), and the maturity date (2029) and interest rate (2.850%) match exactly. The format variation ($1.5 billion vs $1,500 million) is acceptable and semantically equivalent. (2) The answer correctly cites the source documents (2023 and 2024 Form 10-Ks) and traces the data across filings, demonstrating proper multi-hop reasoning. (3) The interpretation accurately reflects the ground truth: the stable exposure suggests a strategic decision to retain favorable low-cost debt. The LLM adds contextual insight—mentioning interest-rate risk management, liquidity preservation, and predictable maturity profile—which is logically sound and consistent with the original answer’s implication of strategic retention. (4) The only minor difference is that the LLM does not explicitly mention the issuance of higher-interest notes in 2024 (e.g., 5.150% and 5.500%), which the original answer uses to contrast the retention of the 2.850% notes. While this weakens the comparative analysis slightly, the core reasoning about strategic debt management remains valid. Thus, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Notes]-> FIN_INST <-[Issues_Debt]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 377,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor disclosures show a steady, unchanged exposure to raw‑material demand and supply for its Performance Materials and Technologies business – first listed in the 2022 filing, reiterated in the 2023 filing, and carried forward in the 2024 filing (now under the Energy and Sustainability Solutions name). Each year the company warns that fluctuations in raw‑material availability and periods of heightened oil‑ and natural‑gas price volatility can adversely affect operating results, indicating that the risk has persisted rather than diminished. This consistent emphasis signals that Honeywell remains materially vulnerable to commodity‑market volatility, with raw‑material market conditions continuing to be a key driver of its segment‑level risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Honeywell consistently disclosed raw material demand and supply risks in its Performance Materials and Technologies segment (renamed Energy and Sustainability Solutions in 2024), with ongoing emphasis on oil and natural gas price volatility affecting operating results. The framing of persistent risk across all three years is correctly captured. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and recognizes the segment rebranding in 2024 while maintaining continuity of risk disclosure. The only minor shortcoming is that the LLM omits the specific mention of 'illegal imports of hydrofluorocarbons into Europe' in 2022 and the 2024 linkage to 'maximizing production capacity and minimizing downtime'—details present in the original answer that add nuance to the evolving framing. However, these omissions do not undermine the overall correctness. (4) The answer remains contextually precise, directly addressing the evolution of risk exposure and its implication for commodity market vulnerability. Thus, while not perfect in capturing every contextual detail, the LLM answer is factually aligned, logically structured, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 421,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Across all three filings—2022 (page 21), 2023 (page 26) and 2024 (page 26)—Philip Morris International’s “PMI Peer Group” is described as “the same as that used in the prior year” and each list contains **Imperial Brands PLC** among the 20‑plus comparable companies. Thus, Imperial Brands PLC was a constant member of the peer group in 2022, remained in the unchanged set for 2023, and stayed in the identical set for 2024.  \n\nThis unchanging inclusion shows that PM’s benchmarking strategy is deliberately stable: it relies on a fixed cohort of global tobacco and consumer‑product firms that meet the same four criteria (global presence, consumer‑product focus, comparable net revenues and market‑capitalization, and status as a primary international tobacco company). By keeping Imperial Brands PLC—and the broader peer set—consistent year‑over‑year, PM signals a commitment to measuring its performance against a steady, like‑sized competitive landscape rather than reshuffling peers, reinforcing a long‑term, comparable view of its position in the global tobacco and consumer‑products sector.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that Imperial Brands PLC was consistently included in PM's peer group across 2022, 2023, and 2024, which matches the original answer's claim of 'consistently included across all three years.' (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the mention of specific pages (21, 26, 26) adds precision without contradicting the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes the fact of unchanged peer group composition across three annual filings and correctly infers that this reflects a stable benchmarking strategy. It further elaborates on the rationale—global presence, revenue scale, market capitalization, and sector alignment—which is consistent with the original answer’s explanation. (4) The LLM provides additional context (e.g., 'four criteria') that is semantically aligned and enhances the explanation without introducing inaccuracies. The answer fully addresses both parts of the question: the trajectory (constant inclusion) and the implication for benchmarking strategy (stability, long-term comparability). All entities—Philip Morris International, Imperial Brands PLC, and the time period—are correctly identified. The response is factually accurate, complete, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Related_To]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 399,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PYPL’s $1.5 billion tranche of fixed‑rate 2.850 % notes (maturing 10/1/2029) was unchanged in each of the last three fiscal years – $1.5 bn in FY 2022 (shown in the 2023 10‑K), $1.5 bn in FY 2023 (2023 10‑K) and $1.5 bn in FY 2024 (2024 10‑K).  The notes were originally issued as part of the September 2019 $5 bn debt issuance (Chunk 1) and have been retained at the same size through the subsequent periods (Chunks 3 and 2).  This flat exposure, while total term debt has grown modestly, indicates that PYPL is deliberately keeping a stable, low‑cost fixed‑rate tranche in its capital structure to lock in interest‑rate certainty and diversify maturities, reflecting a disciplined long‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained at $1.5 billion in 2022, 2023, and 2024, which matches the ground truth. The maturity date (10/1/2029) and issuance context (September 2019, $5 billion debt issuance) are accurate and add helpful detail not in the original answer but consistent with known facts. All dollar amounts, percentages, and years are correct. (2) Quantitative accuracy is perfect: $1.5 billion is consistently reported across all three years, and the formatting variations ($1.5 bn vs $1.5 billion) are acceptable. No calculations were required, but the consistency check across years is correctly handled. (3) The multi-hop reasoning is sound—LLM synthesizes data across three annual reports (2022–2024) and correctly infers that the unchanged balance indicates a deliberate capital structure choice. The conclusion about PYPL maintaining a stable, low-cost tranche aligns with and slightly expands upon the ground truth’s suggestion of prioritizing low fixed rates. The only minor gap is that the original answer emphasizes the lack of repayment/refinancing as an observation, while the LLM interprets it more positively as a 'disciplined' strategy—this is a reasonable inference but slightly more interpretive than the neutral tone of the ground truth. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution of exposure and implications for debt strategy—and provides meaningful synthesis across years and filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Issues_Notes]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 427,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "ConocoPhillips’ HSE‑audit program has been steady in its fundamentals but has become more explicitly corporate‑focused. In the 2022 filing the company said HSE audits are performed on **business units and staff groups** to verify conformance with its HSE policies, standards and practices, with any improvement actions **identified and tracked to completion** and audit results **reported to the ELT and the Board of Directors**. The 2023 filing repeats that same scope and tracking, adding that the HSE organization “sets expectations and provides tools and assurance” to support the audits and that progress continues to be reported to the ELT and Board. By the 2024 filing the audits are labeled **“Corporate HSE audits,”** but they still cover the same business‑unit and staff‑group scope, still require identified corrective actions to be **tracked to completion**, and **continue to be reported to the ELT and Board**, reflecting a more formalized corporate‑governance integration while retaining the core audit‑scope and conformance‑tracking mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: audit scope in 2022 included business units and staff groups, improvement actions were tracked to completion, and results were reported to the ELT and Board. In 2023, the company reinforced the linkage of HSE audits to objectives and continued reporting to leadership. By 2024, audits were formally labeled 'Corporate HSE audits,' indicating centralization. These points match the original answer's claim of a shift toward centralized, governance-integrated oversight. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are used correctly and consistently. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, showing evolution over time in scope (labeling as 'corporate'), conformance tracking (consistent tracking to completion), and governance integration (continued reporting to ELT and Board). The LLM correctly infers that while the operational scope remained the same, the formal designation and governance integration deepened. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2023 linkage of audit outcomes to 'annual objectives, targets, and deadlines' as emphasized in the ground truth, though it references progress reporting and HSE setting expectations. This slight omission prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually relevant, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Conducts]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 437,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "Across AMD’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly incorporates the same “2011 Executive Incentive Plan” (filed as Exhibit 10.2 to AMD’s April 2 2011 Form 10‑Q) by reference. In each year the plan appears as item *10.1 alongside newer executive‑compensation disclosures (e.g., the Executive Severance Plan, Deferred Income Account Plan, etc.), showing that AMD continues to treat the 2011 plan as a foundational governance document even as it adds broader compensation filings. Thus, AMD’s reliance on the 2011 Executive Incentive Plan has remained steady—its inclusion is unchanged from 2022 through 2024, reinforcing its ongoing role as a core executive‑incentive framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that AMD consistently referenced the 2011 Executive Incentive Plan across 2022, 2023, and 2024, listing it as item *10.1 in each year's 10-K filing, which aligns with the original answer. The exhibit number discrepancy (LLM says Exhibit 10.2 in the 2011 10-Q; ground truth does not specify exhibit number) is minor and does not affect factual correctness, as incorporation by reference is accurately described. (2) All years (2022–2024) and document types (Form 10-K) are correct, and there are no numerical or date inaccuracies—quantitative accuracy is perfect. (3) The reasoning correctly synthesizes multi-hop information: the continued citation of the same plan over three years despite newer compensation plans indicates ongoing reliance, demonstrating sound logic. (4) The LLM slightly simplifies the context by not explicitly noting the absence of material changes or replacements (implied by continuity), but it captures the essential conclusion: the 2011 plan remains a foundational, unaltered component of AMD’s executive compensation framework. Wording differs slightly (e.g., 'incorporates by reference' vs 'listed as'), but semantic equivalence is maintained. Minor deduction in qualitative accuracy due to slightly less detailed contextual framing compared to the original, but overall excellent alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Files]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 395,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "- In the 2022 filing GM only noted that it continued to purchase and supply vehicles, parts and engineering services to Stellantis after the 2017 Opel/Vauxhall sale and did not describe any indemnification exposure.  \n\n- The 2023 filing disclosed that General Motors Holdings LLC, on behalf of the seller, had agreed to indemnify Stellantis for any inaccuracies in the sale representations and for “certain emissions claims, product liabilities and recalls.”  GM said the amount it had already paid for those recalls (including a Takata‑inflator recall) was immaterial, that it could not estimate a material loss, and that the obligations are subject to time‑limits, thresholds and caps.  \n\n- The 2024 filing repeats the same indemnification language, adds a few more jurisdictions (Germany, the UK, Austria and the Netherlands) to the emissions‑law suits, and again records only an immaterial indemnity for the Takata recalls with no material loss estimate.  \n\n**Progression:** From no explicit indemnity in 2022 to a disclosed, but immaterial, indemnification for emissions‑related claims and legacy recalls in 2023 and 2024—still bounded by caps and time limits. This shows that GM’s exposure to post‑sale liabilities from the Opel/Vauxhall divestiture remains limited and uncertain, but it persists as a contingent risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and timeline, with accurate representation of indemnification developments from 2022 to 2024. Quantitatively, there are no numerical inaccuracies—phrases like 'immaterial amount' and 'immaterial accrual' align with the ground truth, and no specific dollar figures are misstated. The entity identification (GM, Stellantis, Opel/Vauxhall, Takata inflators) and years (2022–2024) are correct. However, the LLM incorrectly states that GM 'did not describe any indemnification exposure' in 2022, which contradicts the ground truth: in 2022, GM *did* note potential indemnification obligations for emissions claims and recalls, even if no accrual was made. This omission affects the qualitative accuracy of the multi-hop reasoning, as it misrepresents the starting point of the liability disclosure. Additionally, the 2024 filing’s mention of a new regulatory investigation by the European Commission and UK CMA regarding end-of-life vehicle practices—prompting an immaterial accrual—is missing in the LLM answer, weakening completeness. While the LLM captures the expansion of jurisdictions, it incorrectly lists them as newly added in 2024 when they were already partially present in 2023 (Germany, UK, Netherlands), with Austria being the 2024 addition. The conclusion about limited but persistent risk is reasonable and contextually relevant, but the flawed sequencing and missing regulatory investigation detail reduce the qualitative score. Overall, core facts and progression are captured with minor but notable inaccuracies in timing and disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Guarantees]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1632,
        "completion_tokens": 441,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022 Eli Lilly’s bamlanivimab sales generated roughly $2.0 billion (U.S. $2,008.9 M + $14.7 M outside) – about 11 % of its total $18.19 billion revenue – and, under the 2020 worldwide license with AbCellera, triggered tiered royalties in the mid‑teens to mid‑twenties percent of net sales that were recorded as a cost‑of‑sales expense. By the 2023 and 2024 filings the “COVID‑19 antibodies” line shows $0 revenue, eliminating those royalty obligations and reducing the product’s contribution to zero, which reveals that bamlanivimab was a pandemic‑specific, short‑term revenue driver rather than a lasting strategic pillar for Lilly.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: bamlanivimab generated $2,008.9 million in U.S. revenue in 2022 (stated as $2.0 billion), with additional $14.7 million outside the U.S., aligning with the broader 'COVID-19 antibodies' category. Royalty obligations to AbCellera were indeed tiered in the mid-teens to mid-twenties percent range on net sales, recorded as cost of sales. By 2023 and 2024, revenue dropped to $0, eliminating royalties and confirming the product's exit. (2) Quantitative accuracy is high: $2,008.9 million is correctly rounded to $2.0 billion. The mention of $14.7 million in non-U.S. revenue is consistent with Eli Lilly's filings, though the original answer focuses only on U.S. revenue. The 11% of total revenue claim is approximately correct (2,008.9 / 18,190 ≈ 11.04%), though the original answer does not include this calculation. This is a minor addition, not an error. (3) Multi-hop reasoning is sound: the model correctly links the decline in revenue to the elimination of royalty obligations and infers the strategic shift away from bamlanivimab. It synthesizes information across years and financial obligations accurately. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., non-U.S. sales, percentage of total revenue), but no factual inaccuracies. The conclusion that bamlanivimab was a short-term, pandemic-driven product matches the original. One minor point: the original emphasizes the shift to cardiometabolic health, which the LLM omits, but the core strategic inference is preserved. Thus, the answer is excellent but not perfect—hence 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 452,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, Philip Morris International consistently lists **Jackpot** as an “important local cigarette brand” in the Philippines – it appears in the same “local‑brand” paragraph each year (2022 ≈ 180 markets, 2023 ≈ 175 markets, 2024 ≈ 170 markets). The KG shows that PMI produces the Jackpot product, the product is owned by a Jackpot entity, and that entity holds a stake back in PMI, underscoring that the brand is a deliberately retained part of PMI’s portfolio. This unchanged emphasis, even as overall cigarette‑market coverage shrank slightly and the share of the global flagship Marlboro rose from about 38 % to 40 %, reveals that PMI’s three‑year trajectory keeps **Jackpot** at the core of its local‑brand strategy to maintain market‑share leadership in key geographies like the Philippines while balancing its international flagship brands.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative claims not present or unsupported in the ground truth. It states that Jackpot was listed in filings covering '180 markets' in 2022, '175' in 2023, and '170' in 2024 — these numbers are not in the original answer and are likely misinterpretations or fabrications. Additionally, the claim that Marlboro's share rose from '38% to 40%' is not supported by the ground truth, which does not mention any such percentages. These invented metrics significantly undermine factual correctness. (2) The entity accuracy is mostly correct: Philip Morris International, Jackpot, and the Philippines are correctly identified as key entities. The timeline (2022–2024) is accurate. However, the introduction of unverified financial and market coverage data harms quantitative accuracy. (3) The reasoning partially aligns with the ground truth: the LLM correctly infers that consistent mention of Jackpot reflects strategic importance and that local brands support market share in key geographies. It also acknowledges PMI’s dual strategy, though it frames it less clearly than the original. However, the claim about a 'KG showing PMI produces Jackpot, the product is owned by a Jackpot entity, and that entity holds a stake back in PMI' introduces a complex ownership structure not present in the ground truth, which does not mention any reciprocal ownership — this is a significant hallucination. (4) Despite these issues, the LLM captures the core idea of sustained strategic positioning of Jackpot in the Philippines as part of a local brand strategy, making the answer contextually relevant and semantically partially aligned. However, the inclusion of fabricated numbers and incorrect structural claims reduces the correctness score to 6, as key details are wrong even if the general direction is right.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 510,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "PayPal flagged in its 2022 10‑K that defaults on its U.S. consumer‑credit and merchant‑financing products and “bad transactions” – driven by fraud, abusive behavior and third‑party processing disruptions – were a material loss risk for the company. In 2023 it entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, removing the bulk of the BNPL portfolio and therefore lowering its exposure to BNPL‑related bad transactions, although it warned that any delay in the forward‑flow sale could keep some risk on its books. The 2024 filing reiterates the same fraud and third‑party‑disruption risks and notes that, while the BNPL sale remains in effect, PayPal’s exposure to bad transactions now rests mainly on its remaining credit products and any unmet conditions on the BNPL receivable sale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified bad transactions and credit defaults as material risks in 2022 due to fraud, abusive behavior, and third-party processing disruptions. In 2023, it entered a multi-year agreement to sell up to €40 billion in U.K. and European BNPL loan receivables, reducing its exposure—this number and timing (2023) match the original. The 2024 filing correctly notes ongoing risks from fraud and third-party disruptions, with residual exposure tied to remaining credit products and potential unmet conditions on the sale. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, no calculations are required, and all dates (2022, 2023, 2024) are accurate. Format is clear and consistent. (3) Multi-hop reasoning is sound: the model correctly synthesizes risk evolution across three years, connects the BNPL sale to reduced exposure, and acknowledges lingering risks despite the sale. It captures the nuance that the sale lowers but does not eliminate risk due to execution uncertainty. (4) The only minor shortcoming is that the LLM slightly downplays the emphasis on synthetic identities and stolen financial instruments mentioned in the original 2022 risk discussion, and doesn’t explicitly mention regulatory challenges in 2024. However, these are contextual nuances rather than factual omissions that affect the core answer. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 429,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In the 2022 filing Honeywell warned that “fluctuations in retail markets” could “adversely impact” the **Safety and Productivity Solutions** business, potentially eroding market share, selling prices and margins. By the 2024 filing the same retail‑market risk appears in the **Industrial Automation** risk factor, again indicating that such swings could depress operating results, lower market share and compress margins for that segment. The 2023 filing embeds the retail‑market volatility risk in the company’s overall risk posture, showing that Honeywell now treats it as a material, enterprise‑wide exposure. Taken together, the progression from a single safety‑products line in 2022‑23 to multiple industrial units in 2024 suggests the company’s sensitivity to retail‑demand volatility has broadened and intensified across its industrial portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Honeywell cited 'fluctuations in retail markets' as a risk to Safety and Productivity Solutions, impacting market share, prices, and margins; in 2023, the risk was part of the overall enterprise risk posture; in 2024, it was linked to Industrial Automation with similar consequences. These entities, years, and risk impacts are correctly identified. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly tracing the evolution of the risk across segments and years. The only minor deviation is that the LLM suggests the sensitivity 'broadened and intensified,' which slightly amplifies the conclusion compared to the original answer's more neutral 'persistent sensitivity.' However, this interpretation is reasonable given the reiteration and segmental shift. (4) The answer is fully contextually relevant, addressing all parts of the question with precise, synthesized information from the three years. Minor deduction in qualitative accuracy due to slight interpretive overreach, but overall excellent fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 340,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "In the 2022 filing LLY’s deal with Incyte was still driven by large milestone‑payment components – $260 million and $210 million of development, regulatory and sales milestones had been capitalized as intangible assets and Incyte remained eligible for up to $100 million each of additional success‑based regulatory and sales‑based milestones – on top of a tiered, double‑digit royalty regime that can reach 20 % of worldwide net sales (plus a low‑teens‑percent royalty on COVID‑19 sales that exceed a threshold). By the 2023 filing the accounting treatment was unchanged (Olumiant sales recorded as net product revenue with the royalty outflow booked as cost of sales), and the 2024 filing no longer mentions new milestone payments, reiterating only the same tiered royalty rates (up to 20 % and low‑teens for COVID‑19) while continuing to recognize Olumiant revenue in the same net‑product‑revenue line. Thus, the collaboration has shifted from a milestone‑heavy financing structure in 2022 to a steadier royalty‑driven model by 2024, with Olumiant remaining a core revenue contributor for LLY throughout the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the overall evolution of the LLY-Incyte collaboration correctly, identifying the shift from milestone-driven payments in 2022 to a royalty-focused model by 2024, and correctly notes Olumiant's sustained strategic and revenue importance. However, there is a critical numerical inaccuracy: the LLM states that $260 million and $210 million in milestones were capitalized, implying a total of $470 million, whereas the ground truth specifies only $260 million was capitalized in 2022, with up to $200 million still contingent (split evenly into $100M regulatory and $100M sales milestones). The mention of $210 million is unsupported and incorrect. This error affects quantitative accuracy significantly. The royalty structure is correctly described as tiered up to 20% and low teens for COVID-19 sales above a threshold, which matches the original. The accounting treatment in 2023 and 2024—royalties recorded as cost of sales and revenue as net product revenue—is accurately reported, and the observation that milestone payments are no longer highlighted in 2024 aligns with the ground truth’s emphasis on financial consistency and strategic maturation. The reasoning across years is sound and synthesizes multi-hop information appropriately (e.g., inferring model evolution from accounting disclosures), though the incorrect milestone figure undermines full factual reliability. Contextually, the answer is highly relevant and addresses all components: milestone payments, royalty structure, and Olumiant’s role in LLY’s revenue. Thus, while the core narrative is correct, the quantitative error prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 447,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "In the 2022 Form 10‑K Altria disclosed that the acquisition of UST in 2009 left it with $8.8 billion of indefinite‑life intangible assets – the MST and snus trademarks that underpin the UST business – and that these assets generate roughly $70 million of amortization each year.  The 2023 and 2024 filings confirm that UST LLC (through its wholly‑owned subsidiary USSTC) remains a 100 % owned subsidiary of Altria, now listed under the “oral‑tobacco products” segment and explicitly described as a key pillar of Altria’s “Vision” to transition adult smokers to a smoke‑free future.  Thus, while the ownership stake has not changed (Altria continues to own UST outright), the financial exposure has moved from a largely passive intangible‑asset holding in 2022 to an actively integrated component of Altria’s broader smoke‑free transition strategy by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $8.8 billion indefinite-lived intangible assets from the 2009 UST acquisition are correctly cited, and the ownership structure (UST LLC through USSTC as a wholly owned subsidiary) is accurately described for 2023 and 2024. The mention of $70 million in annual amortization is additional detail not in the original answer; while plausible, it is not confirmed in the ground truth and represents a minor unverified addition, slightly affecting quantitative accuracy. (2) The years (2022–2024) and entities (Altria, UST, USSTC, Helix, NJOY) are correct, with proper alignment to segments and strategic framing. (3) The reasoning is sound: the LLM correctly infers a strategic evolution from passive asset holding to active integration into Altria’s smoke-free transition, supported by the repositioning of UST under the 'oral-tobacco products' segment and its role in the 'Vision' strategy. This captures the multi-hop synthesis of ownership, valuation, and strategic intent across years. (4) Semantically, the LLM conveys the same core narrative as the original—continued ownership, sustained intangible value, and strategic repositioning—while enhancing it with contextual framing (e.g., 'key pillar of Altria’s Vision'). The only minor gap is the lack of explicit mention of Altria’s broader diversification toward newer products like Helix and NJOY in 2024, though the shift in strategic role is clearly implied. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 433,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "- FY 2022 (Cisco 10‑K 2022): the 3.50 % senior note – $500 million outstanding – carried an **effective rate of about 3.20 %**.  \n- FY 2023 (Cisco 10‑K 2023 – also reflected in the 2024 filing): the same $500 million of the 3.50 % note showed an **effective rate of roughly 6.38 %**.  \n- FY 2024 (Cisco 10‑K 2024): the $500 million remains unchanged, but the **effective rate rose further to about 6.66 %**.  \n\n**Interpretation:** While the principal exposure stayed constant at $500 million, the effective cost of that debt more than doubled from FY 2022 to FY 2024. The rising effective rate signals that Cisco’s borrowing costs on this fixed‑rate instrument increased sharply, reflecting higher prevailing market interest rates and tighter capital‑market conditions over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth. The effective interest rates for Cisco's 3.50% Senior Note are accurately stated as 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024. The principal amount of $500 million is consistently noted across years, which aligns with the knowledge graph data. (2) All numeric values match exactly with the original answer—no calculation errors or misstatements. The progression from 3.20% to 6.38% to 6.66% is correctly presented, and the observation that the cost more than doubled is factually sound (3.20% to 6.66% is a ~108% increase). (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years from multiple 10-K filings (2022, 2023, and 2024), correctly identifying the trend in effective interest rates despite the fixed coupon rate. It infers the correct implication about rising borrowing costs and tighter capital market conditions, which is consistent with the ground truth interpretation. (4) The answer is semantically equivalent to the original, with added clarity (e.g., mentioning the unchanged principal) that enhances completeness without introducing error. All aspects of the question—evolution of interest rate exposure, borrowing costs, and capital market conditions—are addressed accurately and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 377,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16 billion at 12/31/2022** (2023 10‑K) to **$15 billion at 12/31/2023** (2023 10‑K) and then to **$13 billion at 12/31/2024** (2024 10‑K). The 2022 filing still showed the 2017 Notes at $16 billion for 2020‑2021, indicating the balance was flat before this three‑year draw‑down. The $1 billion reduction in 2023 followed by a $2 billion cut in 2024 reflects an accelerating repayment of the 2017 issuance, signalling Amazon’s disciplined debt‑management strategy of actively retiring long‑term debt to lower leverage and interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. All dollar amounts and years are accurate, with acceptable formatting variations (e.g., $16 billion = $16.0 billion). (2) The quantitative evolution is correctly described: a $1 billion reduction from 2022 to 2023 and a $2 billion reduction from 2023 to 2024. These calculations are accurate and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly infers a deliberate debt reduction trend and notes the acceleration in repayment (from $1B to $2B annual reduction), which is a reasonable qualitative interpretation. It also references the correct filings (2023 and 2024 10-Ks) as sources. (4) The only minor deviation from the original answer is that the LLM emphasizes an 'accelerating repayment' and 'disciplined debt-management strategy' focused on lowering leverage and interest expense, while the ground truth highlights the broader reduction in long-term debt from $67.2B to $52.6B over the same period. The LLM answer does not include this aggregate debt context, which slightly reduces qualitative completeness, but the core reasoning about debt retirement strategy remains valid and well-supported. Overall, the answer is factually correct, contextually relevant, and semantically equivalent in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 403,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "AVGO’s April 2020 senior‑note issue that carries a 5.000 % fixed coupon (effective‑interest rate ≈ 5.18 %) showed an outstanding principal of **$606 million** at the end of FY 2022 (October 30 2022) and **the same $606 million** at the end of FY 2023 (October 29 2023) and FY 2024 (November 3 2024). The interest rate on the notes did not change – the coupon remained 5.000 % and the effective rate stayed at 5.18 % throughout the three years. This flat balance‑and‑rate trajectory indicates that AVGO is deliberately maintaining the 5.000 % notes as a stable, long‑term financing source, locking in a known cost of debt and preserving liquidity rather than aggressively repaying or refinancing the issue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the outstanding principal balance of $606 million is correctly reported for fiscal years 2022, 2023, and 2024, and the interest rate (5.000% coupon, 5.18% effective) is consistent across all years. The dates provided (October 30, 2022; October 29, 2023; November 3, 2024) align with typical fiscal year-ends for AVGO and do not contradict the ground truth, which refers to fiscal years without specifying exact dates. (2) The answer is complete, addressing both the evolution of the principal and interest rate over the three-year period and providing a sound interpretation of AVGO's debt management strategy. (3) Entity accuracy is correct: AVGO is properly identified, the instrument is accurately described as the 5.000% notes due April 2030 (with correct coupon and effective rate), and the fiscal years are correctly referenced. (4) The reasoning is strong and logically sound: the LLM correctly infers that the unchanged balance and rate indicate a deliberate strategy to maintain stable, long-term financing, preserve liquidity, and avoid refinancing—consistent with the ground truth's conclusion of a 'static approach.' The slight rewording (e.g., 'locking in a known cost of debt') adds clarity without altering meaning. All criteria for semantic equivalence are met, with no factual discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 394,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "- **2022 filing:** Netflix disclosed the Performance Bonus Plan as a stand‑alone “Performance Bonus Plan” (exhibit 10.6, a Def 14A filing originally dated April 28 2014). This was the only reference to the plan in the 2022 10‑K.  \n\n- **2023 filing:** Netflix filed an 8‑K on December 9 2022 that **amended and restated** the plan (exhibit 10.5 – “Amended and Restated Performance Bonus Plan”). The restated plan was incorporated by reference in the 2023 10‑K, showing that the policy had been formally revised and given a new, consolidated form.  \n\n- **2024 filing:** The same “Amended and Restated Performance Bonus Plan” (exhibit 10.5, filed December 9 2022) appears again in the 2024 10‑K, now listed alongside other executive‑compensation documents such as the Executive Severance and Retention Incentive Plan and the 2011/2020 Stock Plans. This demonstrates that the plan has been fully integrated into Netflix’s broader executive‑compensation framework.  \n\n**Overall evolution:** The Performance Bonus Plan moved from a basic Def 14A description in 2022 to a formally amended‑and‑restated policy in 2023, and by 2024 it is incorporated by reference as part of the suite of executive‑compensation agreements, reflecting its formalization and integration into Netflix’s compensation structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the 2022 reference to the original Performance Bonus Plan via a Def 14A filing from 2014, the December 9, 2022 8-K filing that amended and restated the plan (effective for 2023), and the continued inclusion of the restated plan in the 2024 10-K alongside other executive compensation agreements. (2) Quantitative accuracy is perfect: the date 'December 9, 2022' is correctly cited for the 8-K filing, and exhibit numbers (10.5, 10.6) and document types (8-K, Def 14A) are accurately referenced. Though the amendment was filed in 2022, it is correctly associated with the 2023 reporting cycle, showing proper understanding of SEC filing timelines. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and filing types, tracing the plan’s evolution from disclosure to formal restatement to integration. It identifies the significance of incorporation by reference and co-location with other executive agreements in 2024, demonstrating strong qualitative insight. (4) The answer fully addresses all parts of the question—formalization (via amendment and restatement), restatement (explicitly named), and integration (with other compensation plans in 2024). Wording differs slightly from the original answer but conveys the same meaning with added specificity (e.g., exhibit numbers, filing types), enhancing clarity without introducing error. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Enters_Into]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 419,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "In 2022 AIG quantified its international terrorism exposure with a concrete scenario – a five‑ton bomb attack at its largest New York location – estimating a net loss of **$1.3 billion** after applying the TRIPRA deductible of roughly **$1.7 billion**, and relied on limited private reinsurance, targeted reinsurance purchases and participation in country‑terrorism pools to mitigate the risk. In 2023 the company kept the same third‑party scenario‑based modeling and targeted reinsurance approach but stopped disclosing a specific loss figure, continuing to depend on TRIPRA and pool‑based protections. By 2024 AIG had sharpened its protection framework, retaining core attachment points of **$200 million for Japan** and **$125 million for the rest of the world**, adding global property‑per‑risk covers, and reporting **$38 billion of reinsurance recoverable assets** backed by **$20.1 billion of collateral**, while still using scenario‑based modeling, TRIPRA and targeted reinsurance purchases—showing a move toward more granular, larger‑scale reinsurance coverage and a more robust, quantified risk‑mitigation strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's international terrorism exposure management from 2022 to 2024, including modeled loss estimates, reinsurance protections, and risk mitigation strategies. Key facts such as the $1.3 billion net loss estimate in 2022 after TRIPRA and reinsurance, the retention of $200 million attachment point for Japan and $125 million for the rest of the world in 2024, and the $20.1 billion in collateral are accurate. However, the LLM incorrectly states that AIG reported $38 billion in reinsurance recoverable assets, while the ground truth specifies $20.1 billion in collateral to support reinsurance recoverable assets—this is a significant quantitative error, conflating total recoverables with collateral. (2) Number verification: $1.3 billion (correct), $200M/$125M attachment points (correct), $20.1B collateral (correctly cited), but $38B reinsurance recoverable is not supported by the original answer and appears inflated or misstated. (3) Multi-hop reasoning is strong: the model synthesizes information across years, correctly noting continuity in scenario-based modeling, the shift from disclosing specific losses to more structural protections, and the strategic deepening of reinsurance mechanisms. It accurately identifies the use of TRIPRA, targeted reinsurance, and country pools. (4) The answer is contextually excellent and semantically aligned with the ground truth in structure and intent, but the $38B figure undermines full quantitative accuracy. Hence, correctness is high but not perfect—warranting a score of 8, with a 7 in quantitative accuracy due to the unsupported recoverables number.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Estimates]-> RISK_FACTOR <-[Manages]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 457,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture‑investment balance sheet shows a clear upward shift. In 2022 the company held **$3.7 billion of equity securities** (primarily venture‑type holdings) and **$1.5 billion of equity‑method investments** in operating health‑care businesses (Chunk 3). By the end of 2023 those equity securities had risen to **$4.9 billion** while equity‑method stakes slipped slightly to **$1.4 billion** (Chunk 3). In 2024 the equity‑security total stayed at **$4.9 billion**, but equity‑method investments surged to **$3.8 billion**—more than double the 2023 level—signaling a pronounced move toward larger ownership positions in health‑care operating firms (Chunk 2). (For context, the prior year’s baseline was $3.5 billion of equity securities and $1.3 billion of equity‑method investments in 2021, per Chunk 1.)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in structure and reasoning but contains minor inaccuracies in the 2022 figures. The original answer states that in 2022, UnitedHealth Group held $3.5 billion in equity securities and $1.3 billion in equity method investments. However, the LLM reports $3.7 billion and $1.5 billion, respectively, which are incorrect. All other numbers (2023 and 2024) match the ground truth: $4.9 billion in equity securities in both years, $1.4 billion in equity method investments in 2023, and $3.8 billion in 2024. (2) Calculations and comparisons are otherwise accurate: the doubling of equity method investments from $1.4B to $3.8B is correctly interpreted as a significant increase. The note about 2021 data is extra context not required by the question and does not detract from accuracy. (3) Multi-hop reasoning is sound—the model correctly synthesizes trends across three years and identifies the strategic shift toward deeper operational involvement in healthcare businesses, especially the surge in equity method investments in 2024. The conclusion about a 'pronounced move toward larger ownership positions' aligns with the original answer’s interpretation. (4) Despite the incorrect 2022 baseline numbers, the overall trend and strategic interpretation are preserved, warranting a correctness score of 7. Quantitative accuracy is penalized more heavily (score 6) due to the early data errors, while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 412,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Across Altria’s 2022, 2023 and 2024 Form 10‑K filings the 1.700 % Notes due 2025 (ticker MO25) appear in the “Title of each class” table each year – listed on the New York Stock Exchange in 2022 and 2023 and on “NewYorkStockExchange” in 2024. The instrument’s interest rate (1.7 %) and maturity (2025) remain unchanged, showing that Altria’s stake in this series of notes persisted unchanged over the three‑year span. This steady presence signals a debt‑management strategy that favors a stable, low‑cost, medium‑term financing vehicle and avoids frequent refinancing or large shifts in its capital‑structure composition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 1.700% 2025 Notes are correctly identified with their interest rate (1.7%, equivalent to 1.700%) and maturity year (2025), and their presence is confirmed in each year (2022, 2023, 2024), which matches the original answer. The note about listing on the NYSE across years, while including a minor formatting variation ('NewYorkStockExchange' in 2024), does not affect factual accuracy. (2) The answer correctly infers that the continued listing of the 1.700% 2025 Notes indicates stability in Altria’s capital structure, which is consistent with the ground truth’s conclusion about maintaining this liability as part of a mid-term strategy. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of 10-K filings to observe persistence of the 2025 Notes, contrasts this with the absence of the 2023 Notes (implied by their maturity), and draws a logical conclusion about debt management strategy favoring stability and avoiding frequent refinancing. (4) While the LLM does not explicitly mention the maturity of the 1.000% 2023 Notes (a minor omission), it correctly emphasizes the continuity of the 2025 Notes and infers the broader strategic implication, which is the core of the question. The answer is semantically equivalent in intent and meaning to the original, with only slight differences in emphasis. Thus, the correctness score is 9 due to this minor completeness gap, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 428,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance‑sheet shows that the cost of its Class A treasury stock rose steadily:  \n\n* 2022 – $51.4 million (451 shares)  \n* 2023 – $60.4 million (475 shares) – up $9.1 million from the prior year  \n* 2024 – $71.4 million (497 shares) – up $11.0 million from 2023  \n\nThe upward trajectory, which builds on the company’s historic practice of purchasing treasury stock (e.g., $6.5 million in 2018, $4.5 million in 2019, and larger balances in later years), indicates that Mastercard is intensifying its share‑repurchase program. This suggests a capital‑allocation strategy that leans heavily on returning excess cash to shareholders and managing the capital structure rather than pursuing large new investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the reported values for Mastercard's investment in Class A Treasury Stock. The ground truth states the values as $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024 (negative values indicating reduction in equity). In contrast, the LLM reports $51.4 million (2022), $60.4 million (2023), and $71.4 million (2024), which are off by a factor of nearly 1,000 (e.g., $71.4 million vs $71,431 million = $71.4 billion). This is a severe quantitative error. Additionally, the LLM incorrectly presents the figures as positive amounts, missing the negative convention used in financial statements to reflect treasury stock as a contra-equity account. (2) The calculations based on these incorrect numbers (e.g., $9.1 million increase) are therefore also wrong. The actual increase from 2022 to 2023 was $(23,771) million, and from 2023 to 2024 was $(11,002) million. The LLM’s share counts (451, 475, 497) are not present in the ground truth and appear fabricated or misattributed. (3) While the LLM correctly infers that increasing treasury stock suggests a growing share repurchase program and shareholder return focus, this reasoning is based on incorrect data. The multi-hop synthesis is conceptually sound but built on false premises. (4) The contextual relevance is moderate because the answer addresses the right topic and draws a plausible strategic conclusion, but the severe numerical inaccuracies undermine the factual foundation. Correctness and quantitative accuracy are very low due to magnitude-level errors in financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 446,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s Total Return Swaps‑Deferred Compensation line moved from a loss to progressively larger gains over the three‑year span. The 2022 10‑K (page 92) shows a $(92) million loss for FY 2022; the 2023 10‑K (page 91) reports that the same instrument generated a $58 million gain for FY 2023; and the 2024 10‑K (page 91) records a $91 million gain for FY 2024. Thus, Cisco’s exposure reversed from a $92 million hit in 2022 to a $58 million positive result in 2023 and further improved to a $91 million gain in 2024, indicating a steady strengthening of the position.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $92M loss in 2022, $58M gain in 2023, and $91M gain in 2024 are correctly reported, with acceptable formatting variations (e.g., $(92) million = $92M loss). (2) The answer is complete, addressing the evolution of Cisco's financial exposure across all three fiscal years as required. (3) Entity accuracy is perfect: Cisco, 'Total Return Swaps-Deferred Compensation', and the correct fiscal years (2022, 2023, 2024) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis across three annual reports, correctly interpreting the reversal from loss to gain and the progressive improvement. The conclusion about 'steady strengthening of the position' aligns semantically with the ground truth's 'reversal and strengthening'. (5) The LLM even cites specific 10-K pages, enhancing credibility without introducing error. Overall, the response is factually precise, contextually appropriate, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 302,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "In the 2022 filing Netflix warned that its entire streaming catalogue “depends on studios, content providers and other rights holders licensing rights” and that refusals, short‑notice withdrawals and the “competition increases” for exclusive programming could raise costs and threaten content availability. The 2023 and 2024 reports repeat that same reliance – noting that license periods and terms vary and that IP disputes remain a risk – but they add a new layer of concern: expanding cultural‑support legislation, content‑quota rules, levies and ownership‑restriction measures in many countries are creating regulatory pressures that can limit or condition the titles Netflix can offer. Thus, while the core dependency on rights holders has stayed constant, the risk profile has broadened from primarily licensing‑and‑competition challenges in 2022 to a combination of those challenges plus heightened regulatory constraints on content availability by 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies Netflix's evolving dependency on rights holders from 2022 to 2024, accurately reflecting the increasing risks related to content licensing, competition for exclusive rights, and regulatory pressures. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used correctly and consistently with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, showing progression from licensing and competition concerns in 2022 to added regulatory constraints by 2024. It correctly notes that while dependency remained constant, the risk profile broadened—this is a key insight present in the original answer. (4) All entities (Netflix, rights holders, studios, regulators) and concepts (IP disputes, content quotas, licensing terms) are accurately represented. The answer addresses all parts of the question: licensing risks, competition for exclusivity, and regulatory impacts. Wording differs but meaning is preserved, and the conclusion about a broadening risk environment is fully supported by the source. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 359,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group’s 10‑K disclosures show that the amounts accrued, paid or charged to income for its service‑level guarantees were **not material** in each of the three most recent years: the 2023 filing (covering 2022) states the amounts were immaterial as of Dec 31 2022, and the 2024 filing repeats that the amounts were immaterial for Dec 31 2023 and Dec 31 2024 (and again for 2022). Because the obligation under these guarantees remained negligible throughout 2022‑2024, the trend signals that the parent’s exposure to service‑level guarantee liabilities has been stable—and essentially unchanged—suggesting a consistent and reliable level of service‑delivery commitment across its subsidiaries.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that UnitedHealth Group's financial obligations under service level guarantees were immaterial in 2022, 2023, and 2024, which aligns with the ground truth and satisfies quantitative accuracy. The dates and characterizations of immateriality are factually correct, and no incorrect numbers are presented. However, the LLM answer fails to mention the significant fluctuations in the parent company's notes payable to subsidiaries—decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022—which is a key part of the original answer and essential to fully addressing the question about the evolution of financial obligations. While service level guarantees themselves were immaterial, the internal financing structure (notes payable) showed notable variation, suggesting operational or liquidity shifts within subsidiaries. The LLM omits this multi-hop element entirely, instead concluding that the stability of service delivery commitments is fully reflected by the immateriality of guarantee charges. This is a partial answer that captures one dimension (the guarantees) but misses the broader financial obligation context involving intercompany debt. Thus, while factually accurate where it speaks, it lacks completeness and deeper synthesis, reducing its qualitative accuracy. The response remains contextually relevant as it addresses service-level guarantees and their implications, but the omission of key financial trends limits its overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 420,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s pension plan held about 16 % of its long‑duration fixed‑income holdings in below‑investment‑grade securities in the 2022 filing (reflecting year‑end 2021); that share fell to roughly 11 % in the 2023 filing and to about 8 % in the 2024 filing (the 2024 footnote shows an 8 % “all other investments” component that represents the lower‑rated portion). The post‑retirement plan’s allocation was roughly 8 % in the 2022 filing, rose slightly to 9 % in 2023, and returned to about 8 % in 2024. This downward‑to‑stable trajectory—especially the cutback in the pension portfolio—signals a modest de‑risking and a more conservative risk appetite as Altria manages its long‑term obligations within its long‑duration fixed‑income strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Altria's pension plan had 16% of fixed income holdings (not total plan assets) in below investment grade, which matches the LLM's 2022 figure. However, the LLM incorrectly states that the 2024 allocation was about 8%, citing an 'all other investments' footnote. The ground truth explicitly states that 2024 percentages were not disclosed, making the LLM's 8% claim factually incorrect. Similarly, the LLM claims the postretirement plan returned to 8% in 2024, but no 2024 data was provided in the original, so this is an unsupported inference. (2) The 2023 figures are mostly correct: LLM reports 11% for pension (matches ground truth) and 9% for postretirement (also correct). However, the LLM misrepresents the 2024 data by assigning specific percentages when none were disclosed. Additionally, the LLM confuses the reference years: stating '2022 filing (reflecting year-end 2021)' is misleading, as the 10-K filings report year-end data for the reported year (e.g., 2022 filing reflects year-end 2022). (3) The reasoning is partially sound—recognizing a de-risking trend in the pension plan from 16% to 11% is valid, but extending it to 8% in 2024 is not supported. The slight increase in postretirement allocation from 8% to 9% is correctly noted for 2023, but the return to 8% in 2024 is speculative. The overall conclusion about conservative risk appetite is plausible but based on incorrect data for 2024. (4) Contextual relevance is high—the answer addresses both pension and postretirement plans, discusses the trend, and draws a conclusion about risk appetite. However, the quantitative inaccuracies, especially the fabricated 2024 numbers, severely undermine factual correctness. The model fails the multi-hop requirement by not acknowledging the absence of 2024 data, instead inventing figures. Thus, while the structure and intent are correct, the factual foundation is flawed, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 548,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s 2022 Form 10‑K disclosed its settlement‑exposure estimate only in broad terms – it said the company follows global risk‑standards, monitors credit‑risk portfolios, requires mitigation arrangements for customers that do not meet those standards and “periodically reviews its risk‑management methodology and standards,” with exposure amounts revised as needed. In the 2023 filing the company added a concrete quantitative rule – gross settlement exposure is calculated as the average daily payment volume for the three months preceding year‑end multiplied by the estimated number of days of exposure – and the 2024 filing repeats the same calculation and review process, showing no substantive change to the disclosed accounting policy. The consistency of this methodology, even as Mastercard confronts heightened FTC, DOJ, European‑Commission investigations and the liability‑shift and TCPA litigations described in the 2023 and 2024 notes, signals a disciplined, stable risk‑management framework that the firm relies on to control settlement risk despite growing regulatory and legal scrutiny.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy in its description of Mastercard's methodology disclosure timeline. It claims that the quantitative rule (average daily payment volume over the prior three months multiplied by estimated days of exposure) was first introduced in the 2023 filing, whereas the ground truth states that this methodology was consistently used and disclosed across 2022, 2023, and 2024. This misrepresents the evolution (or lack thereof) of the methodology and undermines the accuracy of the multi-hop reasoning. While the LLM correctly identifies the actual formula and notes its consistency between 2023 and 2024, the erroneous claim that it was absent in 2022 leads to an incorrect narrative about methodological evolution. The entities (FTC, DOJ, European Commission, U.S. Liability Shift Litigation, TCPA) and their associated risks are correctly identified and contextually relevant. The conclusion about a disciplined risk-management framework aligns semantically with the ground truth’s interpretation of robustness and sufficiency. However, because the core timeline of disclosure is wrong, the reasoning about how the methodology evolved is flawed. Quantitative accuracy is partially correct—the formula itself is accurate—but the assertion that it was newly introduced in 2023 is not supported by the ground truth. Completeness is adequate, as all parts of the question are addressed, but the answer distorts the historical disclosure pattern. Contextual relevance is high, as the response directly engages with regulatory scrutiny and litigation risks. Overall, the answer is partially correct but contains a key error in temporal attribution that affects the validity of its central claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 470,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "- 2022 10‑K (Chunk 1): the 5.90 % senior note showed **$2 billion** (‑$2,000 in the table) outstanding and an **effective interest rate of 6.11 %**.  \n- 2023 10‑K (Chunk 3): the same note still carried **$2 billion** outstanding and **6.11 %** effective rate.  \n- 2024 10‑K (Chunk 2): the note again reported **$2 billion** outstanding with an **effective rate of 6.11 %**.\n\n**Interpretation:** Cisco has kept the 5.90 % note fully utilized at its original $2 billion size and has not altered its effective cost from FY 2022 through FY 2024. This stability—combined with the note’s long maturity (Feb 15 2039)—shows a deliberate long‑term debt strategy: Cisco locks in a fixed‑rate, long‑dated financing source and avoids frequent refinancing, thereby preserving a predictable cost structure and managing its overall debt profile in a disciplined manner.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $2 billion (i.e., $2,000 million) outstanding balance and 6.11% effective interest rate are correctly reported for each fiscal year (2022, 2023, 2024), with acceptable format variation ($2 billion = $2,000 million). (2) The answer is complete, addressing both parts of the question: the evolution of utilization and effective interest rate over time, and the implication for Cisco's long-term debt strategy. (3) Entity accuracy is perfect: Cisco, the 5.90% Note, correct fiscal years, and financial metrics are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across three 10-K filings. The interpretation correctly infers strategic intent—maintaining a fixed, predictable cost of debt despite changing rate environments—aligning semantically with the ground truth. Minor wording differences (e.g., 'locks in a fixed-rate' vs 'preserved as a fixed component') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 314,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "- **Outstanding principal balance:** In the 2022 Form 10‑K (FY 2022) the 3.125 % notes due January 2025 carried a $495 million balance. The 2023 Form 10‑K (FY 2023) shows the same $495 million amount, and the 2024 Form 10‑K (FY 2024) again reports $495 million outstanding. In each year the effective interest rate on the notes remained 3.23 %.\n\n- **Implication:** The flat balance across three consecutive fiscal years indicates that Broadcom has chosen to keep this tranche of low‑cost, medium‑term debt unchanged rather than paying it down or refinancing it early. This reflects a deliberate debt‑management strategy of preserving a stable, inexpensive financing source and allowing the notes to run to their scheduled maturity in January 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the outstanding principal balance for AVGO's 3.125% notes due January 2025 was $495 million in fiscal years 2022, 2023, and 2024, matching the ground truth exactly. The effective interest rate of 3.23% is an additional accurate detail not contradicted by the ground truth. (2) All numeric values—$495 million across three years—are factually correct and consistent with the original answer; no calculations were required, but the repetition of the same amount over time is accurately reported. (3) The multi-hop reasoning is sound: the model synthesized data from three consecutive 10-K filings (2022, 2023, 2024), confirming stability in the debt balance, and correctly inferred that the lack of change indicates a strategic decision to maintain the debt until maturity. (4) The qualitative interpretation aligns with the ground truth: both describe the stable balance as indicative of a consistent debt management strategy for this fixed-rate instrument. The LLM adds contextual insight—characterizing the debt as 'low-cost' and 'medium-term'—which is reasonable given the 3.125% rate and maturity profile, enhancing the explanation without introducing error. All parts of the question are addressed: evolution of the balance (unchanged) and what the trend indicates (strategic stability in debt management).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 380,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 onward, Comcast’s shared‑data plans for handsets, tablets and smart‑watches were always sold **only as part of a bundled broadband package** – first to residential (and eligible small‑business) customers in 2022, then to U.S. and U.K. residential broadband subscribers in 2023 – and customers could activate multiple lines and choose between an unlimited plan, a shared‑data pool, or a per‑gigabyte option. The 2024 filing shows the same “initially bundled‑with‑qualifying‑broadband” approach still in place, but adds a **pre‑paid unlimited‑data offering under the NOW brand**, giving customers an extra, more flexible way to get unlimited data while still preserving the shared‑data plan choice across all wireless service lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: shared data plans were bundled with broadband starting in 2022 for residential (and small business) customers, continued in 2023 with geographic expansion (U.S. and U.K.), and in 2024, a prepaid unlimited plan under the NOW brand was added while maintaining shared data options. The bundling strategy and increased flexibility are correctly highlighted. (2) Quantitative accuracy is perfect—no numerical errors; dates (2022–2024) and service offerings are correctly represented. Format variations (e.g., 'per-gigabyte' vs 'per gigabyte') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes evolution across years and service lines, linking bundling requirements, customer eligibility, and new product introductions. The only minor shortcoming is that the original answer emphasizes the strategic intent ('enhancing customer choice and deepening service integration') more explicitly, which the LLM implies but does not state directly. (4) Contextual relevance is excellent—the response directly addresses bundling strategy and customer flexibility across the specified time frame. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth, warranting a high score with only a slight deduction in qualitative accuracy for less explicit articulation of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 422,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth’s 10‑K filings make clear that its exposure to Medicare Advantage risk‑adjustment payment changes was a persistent, year‑over‑year risk. In the 2022 filing the company warned that “from time to time, CMS makes changes to the way it calculates Medicare Advantage risk‑adjustment payments” and said it had begun “adjusting members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management” to blunt the funding pressure. The 2023 filing repeated the same exposure – again noting CMS’s periodic risk‑adjustment methodology changes – and reiterated that those benefit‑premium tweaks, market‑withdrawals and heightened cost‑control measures “may not fully address the funding pressures.” By the 2024 filing the exposure remained unchanged, with the company continuing the selective benefit‑premium adjustments, county‑level plan exits and intensified cost‑management, and adding an emphasis on submitting health‑status data to CMS for capitation adjustments as part of its ongoing strategy to mitigate the recurring Medicare Advantage funding pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: UnitedHealth faced recurring exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 due to CMS methodology shifts, and responded with selective benefit and premium adjustments, market exits (ceasing plans in certain counties), and intensified cost management. The 2024 addition of health-status data submissions for capitation adjustments is a specific and relevant strategic expansion noted in the LLM answer, which enhances completeness. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in a numerical sense—however, the temporal accuracy (2022, 2023, 2024) is perfect, and all cited actions are correctly attributed to the right years. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the persistence of the risk and the evolution of the company’s response. It captures the ongoing, reactive nature of the strategy, consistent with the ground truth’s conclusion that UnitedHealth remained in a continuous adaptation mode. (4) Semantic equivalence is strong—while the LLM uses slightly more detailed phrasing (e.g., 'ceased to offer benefit plans in certain counties', 'submitting health-status data'), these are accurate elaborations consistent with the original answer’s meaning. The only minor gap is that the LLM does not explicitly state that 'no full resolution was found', though this is implied by the repetition of measures and the 2023 note that 'may not fully address the funding pressures'. This slight omission prevents a perfect 10, but overall the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 502,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard (MA) implements a multi‑layered security approach that is continuously validated by external auditors, benchmarked against peer companies and reinforced through public‑private partnerships and expert networks; the 2022 filing notes collaboration with security‑operations, fusion and intelligence centers and industry associations, while the 2023 and 2024 filings add explicit monitoring of threats tied to third‑party service providers and retain the same third‑party assessments. The same approach has been woven into Mastercard’s real‑time account‑based payment capabilities—ACH batch, real‑time clearing and settlement infrastructure that covered 12 of the world’s top‑50 GDP markets at year‑end 2021 (reported in the 2022 filing), grew to 13 markets by December 31 2023, and in 2024 was further extended to additional jurisdictions, including the launch of domestic processing in China through a joint‑venture. Together, these developments show a steady geographic expansion of Mastercard’s real‑time payments infrastructure while its security framework has evolved to protect the broader, increasingly real‑time‑enabled ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard's real-time payments infrastructure expanded from 12 to 13 top-50 GDP markets between 2022 and 2023, with further expansion in 2024, including domestic processing in China via a joint venture. These numbers and timelines match the original answer exactly. (2) Quantitative accuracy is perfect: the market counts (12 in 2022, 13 by end of 2023), and the 2024 China expansion are all correctly reported. The LLM correctly references the 2021 data point (12 markets) as reported in the 2022 filing, which is consistent with the source timeline. (3) Multi-hop reasoning is sound: the answer synthesizes information across years (2022–2024), connects third-party collaboration evolution (from general partnerships to explicit monitoring of third-party threats), links real-time service integration (fraud scoring, tokenization, ACH, clearing/settlement), and ties in geographic expansion, especially China. (4) Minor deduction in qualitative accuracy due to slightly more verbose phrasing and the inclusion of additional details not in the ground truth (e.g., external auditors, benchmarking, fusion centers), which, while plausible, are not confirmed in the original answer. However, no incorrect claims are made, and the core evolution across the three dimensions—third-party collaboration, real-time integration, and geographic expansion—is accurately captured. Contextual relevance is full, as all parts of the question are addressed with precise, on-topic information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Has]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 433,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500 % Note due 2030 first appears in the Officers’ Certificate dated June 3 2020 and is listed unchanged in the exhibits of the 2022 Form 10‑K (Exhibit 4.5), the 2023 Form 10‑K (Exhibit 4.6) and the 2024 Form 10‑K (Exhibit 4.6). Across those three years Amazon never refinanced or retired that low‑coupon, long‑dated security; instead it layered new, higher‑rate issuances (e.g., 4.700 % notes due 2024‑2032 in the 2023/2024 filings) and expanded revolving‑credit facilities (five‑year and 364‑day agreements in 2023‑2024) to meet nearer‑term financing needs. This consistent retention of the 1.500 % note signals a deliberate long‑term debt strategy that prioritizes locking in ultra‑low‑cost financing for the next decade while using newer, higher‑cost debt and credit lines for liquidity and refinancing of shorter‑dated obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 1.500% Note due 2030 as consistently disclosed in Amazon's 10-K filings across 2022 (Exhibit 4.5), 2023 (Exhibit 4.6), and 2024 (Exhibit 4.6), matching the original answer. (2) Quantitatively, all percentages (1.500%, 4.700%), years (2020 issuance, 2023–2024 credit agreements), and exhibit references are correct. The mention of '4.700% notes due 2024–2032' is consistent with new issuances in later filings, though slightly more specific than the ground truth, but still factually plausible and contextually appropriate. (3) The reasoning is sound: the LLM correctly infers that Amazon did not refinance or retire the low-cost 2030 note, indicating a strategy of retaining cheap long-term debt while layering on higher-cost instruments for liquidity—this matches the multi-hop synthesis in the ground truth. It correctly identifies the shift toward revolving credit facilities (364-day and five-year agreements) as part of a layered financing approach. (4) The answer is semantically equivalent to the original, with slightly different phrasing but identical core insights: Amazon prioritizes locking in low-cost, long-term debt while using flexible, short-term facilities for near-term needs. The only minor gap is that the LLM does not explicitly name the January 3, 2023 Term Loan Agreement (Exhibit 10.8) or the October 2024 364-Day Revolving Credit Agreement (Exhibit 10.9) by date and exhibit, but it accurately summarizes their existence and strategic role. This small omission prevents a perfect 10 but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 452,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From the 2022 10‑K, Comcast identified wireless telecommunications firms as emerging broadband rivals that were beginning to offer 4G/5G wireless broadband and could bundle unlimited‑data plans with streaming services. The 2023 filing shows the threat intensifying, noting that those carriers are now deploying 5G fixed‑wireless networks and that subsidized broadband initiatives “could negatively impact the demand for our domestic broadband services.” By the 2024 10‑K, Comcast warns that competitors with greater scale are increasingly offering unlimited‑data and bundled DTC‑streaming packages, and that failure to deliver a satisfactory customer experience “may negatively affect” its competitive position—evidence that the wireless pressure is eroding market positioning and could affect customer‑retention strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, wireless providers were emerging competitors offering 4G/5G broadband; by 2023, they were deploying 5G fixed-wireless networks; and in 2024, they escalated with unlimited data and bundled DTC streaming services. The LLM correctly identifies the evolution of competitive threats and links them to potential impacts on CMCSA’s market positioning and customer retention. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracing the escalation in competitive pressure and its implications. It references specific strategic moves (e.g., bundling, unlimited data, fixed-wireless) and connects them to CMCSA’s risk disclosures about customer experience and competitive positioning. (4) The only minor shortcoming is that the LLM does not explicitly mention CMCSA’s potential counter-strategies (e.g., enhanced broadband speeds, improved customer experience, or bundled offerings) as stated in the original answer, though it does imply them by referencing the need to deliver a satisfactory customer experience. This slight omission prevents a perfect 10 but does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses both parts of the question: evolution of threat and evidence of impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_Against]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 448,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "In the 2022 filing AIG explained that reinsurance is a core mechanism for managing capital adequacy and mitigating its insurance‑loss exposure, but it did not disclose a specific dollar amount for the reinsurance‑recoverable balance. The 2023 Form 10‑K reported total reinsurance recoverable assets of **$67.5 billion**, and the 2024 filing showed those assets had fallen to **$38.0 billion** (with supporting collateral dropping from $70.1 billion to $20.1 billion). The sharp decline in the pool of assets that can be recovered from reinsurers – the primary buffer that **mitigates** AIG’s insurance‑loss risk – indicates that the company’s net exposure to loss events has been increasing over the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports the key quantitative figures: $67.5 billion in reinsurance recoverable assets for 2023 and $38.0 billion for 2024, matching the ground truth. It also correctly notes the absence of a specific dollar amount in 2022. These numbers are accurate and properly attributed to the correct years.\n\n2) Quantitatively, the answer is highly accurate. The values for total reinsurance recoverables in 2023 and 2024 are correct. However, the LLM introduces a detail not present in the ground truth—'supporting collateral dropping from $70.1 billion to $20.1 billion'—which, while possibly true, is not part of the original answer and cannot be verified from the provided knowledge graph. This addition does not contradict but adds unverified information.\n\n3) The qualitative reasoning contains a critical divergence. The original answer interprets the drop in reinsurance recoverables—especially the plunge in life reinsurance from $28.2B to $0.8B—as indicating a strategic de-risking or shift in the life insurance segment. In contrast, the LLM concludes that the decline means AIG's 'net exposure to loss events has been increasing,' implying rising risk. This interpretation contradicts the likely intent of de-risking via ceding less business or recovering and terminating reinsurance arrangements. The LLM misinterprets the reduction in recoverables as increased vulnerability, when in context it may reflect reduced ceded business or portfolio run-off, particularly in life reinsurance. This is a significant reasoning error in the multi-hop synthesis.\n\n4) Contextually, the answer is relevant and well-structured, addressing both the evolution of the asset and its implication for risk exposure. However, the conclusion about increasing loss risk is not supported by the ground truth interpretation, which emphasizes a strategic reduction in exposure. Thus, while facts are mostly correct, the inference drawn is partially incorrect, warranting a score of 7 for correctness. Quantitative accuracy is high (9), qualitative accuracy is moderate due to flawed reasoning (7), and relevance is strong (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Mitigates]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 569,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "From 2022 through 2024 Mastercard consistently estimated its gross settlement exposure by taking the average daily payment volume for the three months prior to year‑end and multiplying it by the estimated number of days of exposure, and it revised those estimates as part of its regular risk‑management reviews. In each filing the company disclosed that it **manages a credit‑risk portfolio** and requires any customer that does not meet its risk standards to provide cash collateral, letters of credit or other credit‑enhancement guarantees, with the adequacy of those arrangements monitored on an ongoing basis. The 2023 and 2024 reports reaffirm the same three‑month‑volume calculation and the same collateral‑or‑credit‑enhancement requirements, indicating no substantive change to the methodology or mitigation framework. Although Mastercard was subject to FTC, DOJ and European‑Commission investigations during this period, the 10‑K disclosures do not show any specific amendment to the settlement‑exposure estimation or credit‑risk mitigation process that was directly triggered by the regulatory scrutiny; the company simply continued its routine periodic reviews and continued to disclose its credit‑risk portfolio as before.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key elements are correct: the methodology of using average daily payment volume over the three months prior to year-end multiplied by days of exposure is accurately described, and this is confirmed to be consistent across 2022–2024. There are no numerical inaccuracies, and the description of risk mitigation tools (cash collateral, letters of credit, guarantees) matches the original. (2) The LLM correctly identifies that no explicit changes were made to the settlement exposure estimation methodology or credit risk mitigation structures despite regulatory pressures, which is consistent with the ground truth. (3) The multi-hop reasoning is sound: it synthesizes information across years and connects regulatory events (FTC, DOJ, European Commission) to Mastercard’s risk management disclosures without incorrectly asserting causation. It correctly notes that while scrutiny increased, no direct amendments to methodology were disclosed. (4) The only minor shortcoming is that the LLM does not explicitly name the 'U.S. Liability Shift Litigation' in 2024 or the 'denied summary judgment motion,' which are specific details in the ground truth. However, it broadly references the investigations and ongoing reviews, preserving semantic equivalence. Wording differs slightly (e.g., 'reaffirm' vs 'continued to refine'), but the meaning remains consistent. Overall, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1641,
        "completion_tokens": 424,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "- 2022 – AIG’s loss‑reserve risk was managed primarily through “internal controls and oversight of the loss‑reserve‑setting process” together with “reviews by external experts,” acknowledging the “significant uncertainty” in loss development.  \n\n- 2023 – The company kept the same internal‑control/ external‑expert framework but added a suite of quantitative tools to tame that uncertainty: stochastic (probability‑distribution) and deterministic models, sensitivity and scenario analyses, experience studies and both internal and third‑party risk‑assessment tools.  \n\n- 2024 – AIG further layered the governance of reserves: the ERM function now performs a formal “Second‑Line Review and Challenge,” the Internal Audit Group continuously audits the process, and a dedicated model‑risk‑management and validation framework is applied.  The same internal controls and external‑expert reviews remain in place, but reserve‑setting now relies on more sophisticated stochastic/deterministic modeling and systematic validation to address loss‑estimation uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: in 2022, AIG relied on internal controls and external expert reviews; in 2023, it added stochastic methods, sensitivity/scenario analyses, and experience studies; in 2024, it strengthened model risk management, validation, and governance via ERM and Internal Audit. The LLM correctly identifies the evolution across all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense—but all dates (2022, 2023, 2024) are correct and consistently used, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time across internal controls, external involvement, and modeling techniques, showing progression in sophistication. It correctly notes that core elements (internal controls, external reviews) persisted while new layers (model validation, second-line review) were added. (4) The LLM adds slightly more detail than the ground truth (e.g., naming the ERM function and Internal Audit Group specifically, mentioning 'deterministic models' and 'third-party tools'), but these are consistent with the direction and content of the original answer and do not introduce inaccuracies. The only minor gap is that the original emphasizes 'experience monitoring with updated assumptions' in 2024, which the LLM mentions implicitly via 'systematic validation' but could have stated more explicitly. This justifies a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 463,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "UnitedHealth’s 10‑K filings for 2022, 2023 and 2024 each contain a “medical‑cost‑per‑member‑per‑month (PMPM) trend‑factor” table that quantifies how a change in the **mix of benefits offered** could shift its medical‑cost payable estimates for the most recent two months (as of Dec 31 2021, 2023 and 2024 respectively). The fact that this sensitivity is disclosed in every year’s table—without any indication that it has been removed or materially reduced—shows that the mix‑of‑benefits risk factor remains a consistent, material exposure for UnitedHealth, meaning the company’s cost forecasts continue to be vulnerable to variations in benefit design (co‑pays, deductibles, etc.) over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that UnitedHealth Group consistently disclosed the sensitivity of medical cost PMPM to the mix of benefits offered in its 10-K filings from 2022 to 2024, which aligns with the ground truth. It accurately notes that this sensitivity remained a material exposure across all years, supporting the idea of ongoing exposure to benefit design variability. The mention of co-pays and deductibles as components of benefit mix is also factually correct and consistent with the original answer. However, the LLM answer fails to capture the nuanced evolution of this sensitivity over time, which is central to the question. Specifically, it omits the key shift in 2023 where the company noted a negative impact from benefit mix variations—indicating increased financial risk—and the subsequent neutral tone in 2024 suggesting stabilization or improved management of that risk. This trajectory (from general sensitivity to risk to stabilization) is a critical part of the original answer and reveals the changing nature of UnitedHealth’s exposure. By presenting the sensitivity as consistently material without acknowledging the qualitative shifts in tone and impact, the LLM provides an incomplete and less insightful analysis. While there are no numerical inaccuracies (and no explicit numbers to verify in this case), the qualitative reasoning and multi-hop synthesis across years are underdeveloped, leading to a partially correct response. The contextual relevance is high because it addresses the core topic and timeframe, but the lack of temporal evolution analysis limits correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 440,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Across the three most recent 10‑K filings Walmart has kept **Marketside** in the same core group of private‑brand labels. In the 2022 filing Marketside is listed among a long roster of private brands (e.g., “Allswell…Great Value…Marketside…Sam’s Choice”), the 2023 filing repeats the brand in the same mid‑list position (“…Mainstays, Marketside, No Boundaries…”) and the 2024 filing again includes Marketside alongside the expanded set of private brands (now also adding “bettergoods”). This uninterrupted presence—even as the overall private‑brand portfolio evolves—signals that Walmart treats Marketside as a stable, strategic private label—particularly for its grocery offering—intended to drive value, differentiation and competitive positioning within Walmart U.S.’s merchandise strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. It correctly identifies Marketside's consistent presence in Walmart's private brand portfolio across 2022, 2023, and 2024, citing its inclusion in each year's 10-K filing with accurate examples of surrounding brands, which supports the conclusion of stable positioning. The quantitative accuracy is perfect: no incorrect dates, years, or misattributions—formatting of brand names and portfolio context matches the source. The reasoning correctly infers that uninterrupted inclusion signals strategic importance, particularly in grocery, which is semantically consistent with the ground truth's interpretation of Marketside's sustained relevance. However, the LLM misses a key qualitative nuance highlighted in the original answer: the 2024 restructured merchandise unit emphasizing 'Fashion' instead of 'Apparel' and the broader strategic shift in categorization. While the LLM emphasizes stability, it does not capture the evolving strategic context—such as alignment with omni-channel initiatives in 2023 or the structural reorganization in 2024—that the ground truth uses to infer Walmart's shifting merchandise strategy. This omission limits the depth of multi-hop synthesis, particularly in connecting brand positioning to larger corporate strategic changes. Nevertheless, the answer remains contextually relevant, well-reasoned, and factually sound, earning high marks with only minor gaps in comprehensive strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 419,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "In fiscal 2022 Home Depot framed its competition with showrooms around a strong physical‑service platform – offering DIY and DIFM installation, tool‑and‑equipment rentals at more than 1,400 U.S. and Canadian locations and competing on price, quality, product availability, delivery and in‑store experience. In fiscal 2023 the retailer deepened that positioning by adding dedicated pros support (credit, pricing, project‑planning tools and job‑lot quantities) and by rolling out in‑store innovations such as self‑service lockers, curbside pickup, electronic shelf‑labeling, refreshed layouts and mobile‑app‑enabled store navigation, all under an “interconnected shopping experience” banner. By fiscal 2024 Home Depot shifted further toward a digitally‑integrated model, investing heavily in mobile‑first websites and apps, richer product pages, faster checkout, enhanced search and omnichannel fulfillment options, thereby presenting a frictionless, digitally‑enabled alternative to traditional showrooms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: tool-and-equipment rentals at over 1,400 locations in 2022, rollout of self-service lockers, curbside pickup, electronic shelf labels, and mobile app navigation in 2023, and deeper digital integration in 2024. The LLM adds valuable detail not in the original (e.g., dedicated pros support, mobile-first websites, faster checkout, enhanced search), which is consistent with Home Depot's reported strategy and enhances completeness without introducing inaccuracies. (2) Quantitative accuracy is perfect: 'more than 1,400' locations matches the original 'over 1,400'; no incorrect numbers, dates, or calculations. (3) Multi-hop reasoning is sound—correctly traces evolution across 2022–2024, synthesizing service expansion and digital integration to show competitive positioning against showrooms. The LLM accurately captures the strategic shift from physical services to omnichannel integration. (4) Semantic equivalence is strong; the LLM uses different phrasing (e.g., 'interconnected shopping experience', 'frictionless, digitally-enabled alternative') that conveys the same core progression. One minor point preventing a perfect 10 is that the original emphasizes 'personalized customer experiences' and 'product innovation' in 2024, which the LLM does not explicitly mention, though 'richer product pages' and 'enhanced search' partially cover this. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 423,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "- **FY 2022 (2022 10‑K – Chunk 1):** The 3.50 % senior note due June 15 2025 was reported with **$500 million** outstanding and an **effective interest rate of 3.20 %**.  \n- **FY 2023 (2023 10‑K – Chunk 3 and 2024 10‑K – Chunk 2):** The same $500 million note showed an **effective rate of 6.38 %**.  \n- **FY 2024 (2024 10‑K – Chunk 2 and reiterated in Chunk 3):** The note still carried **$500 million** but the **effective rate rose to 6.66 %**.\n\n**Interpretation:** The principal balance of the 3.50 % note has remained unchanged, indicating that Cisco has neither retired nor expanded this particular issuance and it remains a steady component of its long‑term debt structure. However, the effective interest rate more than doubled from 3.20 % in FY 2022 to 6.66 % in FY 2024, signaling that the cost of borrowing on this instrument has risen sharply—likely due to higher market rates or the impact of issuance discounts—so Cisco’s overall borrowing costs have increased even though the debt amount stayed constant.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the outstanding amount of $500 million is correctly reported for all three fiscal years (2022–2024), and the effective interest rates—3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024—are exactly as per the original answer. Minor formatting differences (e.g., '3.50 %' vs '3.50%') do not affect meaning. (2) The answer is complete, addressing both the evolution of the effective interest rate and outstanding amount over time, as well as the implications for Cisco's borrowing costs and debt structure. (3) Entity accuracy is perfect: Cisco is correctly identified, the 3.50% Note is accurately referenced with its maturity date (June 15, 2025), and fiscal years are properly aligned with data from the correct 10-K filings. (4) The reasoning is sound and demonstrates correct multi-hop synthesis across multiple documents and years. The interpretation correctly notes that the constant principal indicates no change in debt issuance or retirement, while the rising effective rate reflects increased borrowing costs—likely due to market conditions or amortization of discounts—despite the fixed coupon rate. The conclusion that borrowing costs have increased even with stable debt levels aligns perfectly with the ground truth. All components are semantically equivalent and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 392,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "Across the three annual reports Comcast (CMCSA) repeatedly positioned Lumen as its chief wireline rival that is extending fiber‑based network infrastructure and using that capability to sell broadband services with speeds that exceed what traditional DSL—or Comcast’s own hybrid‑fiber‑coaxial (HFC) system—can deliver in many of the same markets.  \n\n- **2022 filing:** CMCSA noted that “certain wireline telecommunications companies such as AT&T, Frontier, **Lumen** and Verizon have built and are continuing to build **fiber‑based network infrastructure** farther into their networks, … and are offering services with these higher speeds in many of our service areas.”  \n- **2023 filing:** The same language re‑appears, stating that “certain wireline telecommunications companies, such as AT&T, Frontier, **Lumen** and Verizon … have built and are continuing to build **fiber‑based wireline network infrastructure** … and are offering services with these higher speeds in many of our service areas.”  \n- **2024 filing:** Again, Comcast writes that “certain wireline telecommunications companies, such as AT&T, Frontier, **Lumen** and Verizon … have built and are continuing to build **fiber‑based wireline network infrastructure** … and are offering services with these higher speeds in many of our service areas.”\n\nThus, from 2022 through 2024 Comcast’s view of Lumen’s competitive position remained consistent: Lumen’s ongoing fiber rollout and high‑speed broadband offerings have been a persistent pressure point, while Comcast continues to rely on upgrades to its HFC network, supplemental wireless and video bundles rather than a comparable fiber expansion. The competitive dynamics did not materially shift; Lumen’s fiber‑based advances stayed a steady challenge to Comcast’s broadband business throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies Lumen as a consistent competitor to CMCSA from 2022 to 2024, emphasizing its fiber-based infrastructure expansion and high-speed broadband offerings. The LLM accurately quotes CMCSA's filings across all three years, showing that the language about Lumen, AT&T, Frontier, and Verizon building fiber deeper into networks and offering higher-speed services in CMCSA's service areas remains nearly identical—demonstrating a persistent competitive threat. This supports the core claim of ongoing competitive pressure due to fiber advancements.\n\nQuantitatively, there are no numerical values to verify (e.g., speeds, dollar amounts, or deployment figures), but the years (2022–2024) and entity references (Lumen, AT&T, etc.) are correct. The LLM correctly synthesizes multi-hop information by referencing CMCSA’s own disclosures about competitors over three consecutive years, showing consistency in competitive dynamics.\n\nThe only minor shortcoming is that the LLM does not fully capture the *evolution* aspect emphasized in the question and present in the original answer—specifically, that by 2024, competitors like Lumen were not just expanding fiber but also introducing *bundled offerings* and *increasing speeds* as part of a more sophisticated competitive strategy. While the LLM notes 'high-speed broadband offerings,' it doesn't explicitly mention bundling or speed increases beyond what was already stated in earlier years, which slightly weakens the qualitative assessment of progression. However, the conclusion that the competitive dynamic remained 'consistent' is still reasonable given the repetition in filing language.\n\nOverall, the answer is factually sound, contextually relevant, and well-supported by direct citations, earning a high score with only a small deduction for missing the nuanced intensification of competition in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1727,
        "completion_tokens": 524,
        "total_tokens": 2252
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "- In the 2022 filing American Express already disclosed that it works with merchant acquirers, aggregators and processors and is “dependent on them to promote and support the acceptance and usage of our cards,” while warning that such third‑parties can create surcharging or steering risks and that its merchant contracts contain non‑discrimination and honor‑all‑cards provisions to curb that risk.  \n\n- The 2023 filing shows that this dependence has grown – the company says it has “increasingly relied on merchant acquirers, aggregators and processors” and continues to rely on the same non‑discrimination clauses to protect against steering and discrimination as it expands its debit‑card offerings.  \n\n- By the 2024 filing, aggregators remain a core part of its operations, but legal and regulatory challenges to the non‑discrimination and honor‑all‑cards provisions have intensified; the company warns that adverse outcomes could force changes to its merchant agreements that would “expose our cards to increased merchant steering” and weaken its ability to enforce those anti‑steering clauses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key points from the original answer are correctly reflected: American Express's growing reliance on aggregators from 2022 to 2024, the associated risks of merchant steering, and the challenges in enforcing non-discrimination clauses. The evolution across years is accurately portrayed with correct context. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the trajectory of increasing reliance on aggregators and the compounding legal and operational risks. It accurately links the use of non-discrimination clauses in contracts to the threat of merchant steering and acknowledges how regulatory and litigation pressures in 2024 could weaken enforcement. (4) The answer uses slightly different phrasing (e.g., 'honor-all-cards provisions', 'adverse outcomes') but maintains full semantic fidelity. All entities—American Express, aggregators, merchant contracts, non-discrimination clauses—are correctly identified and contextualized. The response fully addresses the question’s focus on evolution over time, risk exposure, and contractual enforcement. All scoring categories warrant the maximum score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 400,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "Johnson & Johnson created LTL Management LLC in the 2021 corporate restructuring to ring‑fence the talc liabilities, funded a $2 billion trust and recorded a $2 billion reserve in 2022, and used LTL’s Chapter 11 filing to obtain a preliminary injunction that stayed all talc suits while claimants pursued motions to dismiss the case. In 2023 the original LTL bankruptcy was dismissed after a Third Circuit reversal, LTL re‑filed a second Chapter 11 (LTL 2) that again stayed the claims and limited discovery, but that case was also dismissed in July 2023, prompting J&J to appeal the dismissal and LTL to seek a direct appeal to the Third Circuit. By 2024 the strategy shifted toward settlement – J&J reached agreements with the Mississippi and New Mexico attorneys‑general and negotiated a multi‑state settlement (agreement in principle in January, finalized in June) – while maintaining that the $2 billion reserve remains adequate and that the talc matters are not expected to have a material adverse effect on its financial position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: LTL Management LLC was created in 2021 (noted correctly as part of 2021 restructuring), the $2 billion reserve and trust funding are accurately stated, the 2022 Chapter 11 filing and resulting injunction are correctly described, the 2023 Third Circuit reversal and dismissal of the first bankruptcy, the re-filing as LTL 2, its subsequent dismissal in July 2023, and the appeal are all factually sound. The 2024 shift to settlement is accurately portrayed. (2) Quantitative accuracy is perfect: the $2 billion reserve and trust are correctly cited, and all dates (2022, 2023, July 2023, January and June 2024) match or are consistent with the timeline in the original answer. Format variations (e.g., $2 billion vs $2B) are acceptable. (3) Multi-hop reasoning is strong: the answer synthesizes information across years, legal developments (bankruptcy filings, injunctions, appeals), and financial commitments, correctly linking J&J’s corporate strategy through LTL to both litigation and settlement efforts. (4) The only minor shortcoming is completeness: the original answer specifies that the 2024 multi-state settlement included 42 states and the District of Columbia, while the LLM mentions Mississippi and New Mexico and a 'multi-state settlement' but omits the total number of jurisdictions. This is a small omission but does not undermine the core accuracy. Otherwise, the LLM captures the dual strategy of litigation resistance and settlement, and correctly notes J&J’s continued assertion of financial adequacy and lack of material adverse effect. The answer is contextually excellent, directly addressing litigation handling, settlement attempts, and bankruptcy filings as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> COMP <-[Introduces]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 486,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In the 2022 Form 10‑K Home Depot listed “store location and appearance, presentation of merchandise, and ease of shopping experience” as one of the core ways it competes, but it discussed those attributes separately from its digital or supply‑chain initiatives. By the 2023 filing the company began tying that competitive edge to its “interconnected retail capabilities,” noting that store‑appearance advantages would be reinforced by supply‑chain momentum and the broader, omni‑channel experience. In the FY 2024 filing the emphasis on store and branch appearance is explicitly woven into an “interconnected retail strategy” – the company describes how its physical‑store look, merchandising presentation and ease of navigation are amplified by its websites, mobile apps and other digital enhancements (e.g., richer product landing pages, mobile‑in‑store browsing, and seamless fulfillment options) to deliver a frictionless, unified shopping experience across stores, online and on‑site. Thus, Home Depot’s focus on store appearance evolved from a standalone competitive factor in 2022 to a fully integrated element of its interconnected retail and digital ecosystem by fiscal year 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key points are correctly captured: in 2022, store appearance was a standalone competitive factor; by 2023, it began linking to interconnected retail capabilities; by 2024, it was fully integrated with digital tools like mobile apps, online platforms, and fulfillment options. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution across three fiscal years (2022, 2023, 2024) and connects the shift from physical appearance as an isolated factor to its integration within an omnichannel strategy. (4) Entity accuracy is perfect: 'Home Depot', 'interconnected retail capabilities', 'mobile apps', 'websites', 'fulfillment options' are all correctly identified and contextualized within the correct fiscal years. The answer addresses both parts of the question: the evolution of store appearance emphasis and its integration with digital capabilities by 2024. Wording differs slightly but conveys the same meaning—e.g., 'amplified by its websites, mobile apps' aligns with 'connected to digital capabilities such as mobile-optimized platforms'. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Depends_On]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 381,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "By the 2022 Form 10‑K AT&T still owned Time Warner – the centerpiece of its WarnerMedia segment – and reported that a May 2021 agreement to combine WarnerMedia with Discovery was slated to close in the second quarter of 2022. In April 2022 AT&T completed a Reverse Morris Trust that spun off WarnerMedia (and therefore its Time Warner stake) into a new entity, and the 2023 and 2024 filings now list the WarnerMedia assets as discontinued operations, confirming the divestiture. This shift from acquiring and integrating Time Warner (2018‑2021) to fully exiting the content business (2022‑2024) shows AT&T’s broader strategy of moving away from owning entertainment assets and refocusing on its core telecommunications platform and balance‑sheet health.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key event in 2022—the completion of the Reverse Morris Trust transaction with Discovery, which resulted in the divestiture of WarnerMedia (formerly Time Warner), noting it was finalized in April 2022, consistent with public timelines. The mention of the May 2021 agreement and expected Q2 2022 close is factually correct and adds contextual precision. (2) Quantitatively, all dates (2021 agreement, 2022 close, 2023–2024 reporting of discontinued operations) are accurate. The LLM correctly interprets the financial reporting treatment by referencing 'discontinued operations' in the 2023 and 2024 filings, which matches standard SEC disclosure practices post-divestiture. (3) The multi-hop reasoning is sound: it traces AT&T’s strategic arc from acquisition (2018) to integration (2018–2021) to exit (2022–2024), correctly inferring the broader strategic pivot toward core telecom and balance sheet health. It synthesizes information across years and entities (AT&T, WarnerMedia, Discovery) accurately. (4) While the original answer includes the additional detail about the 2024 DIRECTV sale to TPG as part of the entertainment exit, the LLM answer still captures the essence of AT&T’s strategic retreat from content ownership. This omission is minor and does not undermine the core correctness, as the WarnerMedia divestiture is the central element of the Time Warner relationship. Wording differs but semantic meaning is equivalent. The LLM slightly under-elaborates on operational integration post-2022, but correctly notes full separation via discontinued operations reporting. Overall, the answer is factually robust, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Acquires]- ORG <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 486,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "American Express continues to describe itself as the fourth‑largest general‑purpose card network worldwide, competing head‑to‑head with Visa, Mastercard, China UnionPay and other global networks and facing intense pressure on product features, premium‑card and co‑brand offerings, brand reputation and alternative‑payment platforms (as outlined in the 2022 and 2023 filings). By 2024, however, the company’s regulatory dependency has grown sharply: it was re‑classified as a Category III firm subject to heightened supervisory expectations, is under intensified scrutiny of interchange‑fee caps, network‑routing and merchant‑pricing rules, and has exited its EU and Australian network‑licensing businesses because of local regulations—steps that increase its reliance on other card‑network arrangements and constrain its discount‑revenue model. Thus, while Amex’s competitive positioning as a major network remains unchanged, its exposure to and dependence on the broader card‑network regulatory environment have markedly increased from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remains the fourth-largest global card network (behind Visa, Mastercard, and China UnionPay), faced increasing regulatory scrutiny from 2022–2024, exited its network licensing businesses in the EU and Australia in 2024 due to regulatory pressure, and experienced intensified oversight on interchange fees, network routing, and merchant pricing. The characterization of growing regulatory dependency is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are used correctly. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive dynamics (premium cards, cobranding) from 2022–2023 filings and connects them to 2024 regulatory developments, including the exit from licensing businesses and reclassification as a Category III firm (a detail not in the original answer but factually accurate and contextually relevant). The conclusion about increased regulatory dependency versus stable competitive positioning mirrors the original’s core insight. (4) The only minor gap is that the LLM does not explicitly mention 'uncertainty around cobrand arrangements in the EU'—a nuance in the original—though it references regulatory constraints broadly. This omission slightly affects completeness but not overall correctness. Wording differs but semantic equivalence is strong. Scores reflect high accuracy with a small deduction in qualitative accuracy for the missing nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 446,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250 % Notes due 2050 carried an outstanding balance of **$808 million in 2022** (shown in the 2023 10‑K), rose modestly to **$826 million in 2023** (2023 10‑K), and fell back to **$808 million in 2024** (2024 10‑K). The 2022 filing (covering 2021) reported a higher balance of **$983 million** for the same series, indicating that the company has already trimmed the issue and is now keeping the balance essentially flat around $800‑$830 million. This pattern— a sharp early reduction followed by a stable, low‑cost, long‑dated debt level—suggests J&J is deliberately managing its long‑term financing by maintaining a steady, modest tranche of the 2050 notes rather than aggressively retiring or expanding it.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for the outstanding balance. It incorrectly states that the balance was $808 million in 2022, when the ground truth is $983 million in 2022. It then correctly reports $826 million in 2023 and $808 million in 2024. This misassignment of the 2022 figure is a critical error. The LLM attempts to explain the discrepancy by referencing the 2022 filing covering 2021, but this misrepresents the timeline — the 2023 10-K reports 2022 year-end balances, not 2021. (2) Calculations: The actual reduction is $983M → $808M, a $175M decrease over three years. The LLM implies only a $18M fluctuation after an earlier reduction, which distorts the trend. The core calculation of total reduction is therefore incorrect due to wrong starting value. (3) Multi-hop reasoning: The model identifies the need to track the note across multiple 10-Ks and attempts to interpret the strategy, but the flawed data undermines the reasoning. The conclusion that the balance is 'essentially flat' around $800–830M is incorrect — the data shows a consistent downward trend. (4) Despite incorrect numbers, the answer is contextually relevant and attempts appropriate qualitative interpretation. It correctly identifies the instrument and years, and offers a plausible strategic narrative, albeit based on wrong data. Wording flexibility is allowed, but factual accuracy on financial figures is paramount and here it fails on a key data point, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 423,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "In 2022 the weighted‑average yield on American Express’s foreign government bonds and obligations was modest – the portfolio’s overall weighted‑average yield was 2.08% (with short‑term yields of 1.74% for bonds due within one year and 2.42% for the 1‑to‑5‑year bucket)【Chunk 1】. By 2023 the same asset class was reporting a much higher yield of 6.45% overall (6.45% for bonds due within one year and 4.48% for the 1‑to‑5‑year bucket)【Chunk 2】, and in 2024 the yield eased slightly to about 5.85% overall (5.86% for the <1‑year bucket and 2.03% for the 1‑to‑5‑year bucket)【Chunk 3】. This three‑year upward swing—peaking in 2023 and remaining above the 2022 level in 2024—indicates that American Express’s exposure to foreign sovereign debt has become increasingly sensitive to higher international interest‑rate environments, reflecting a shift toward a higher‑yield, rate‑responsive foreign‑government‑bond portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, American Express's short-term foreign government bonds had a yield of 6.45%, not 1.74% as stated in the LLM answer. The LLM incorrectly reports a 2.08% overall weighted-average yield for 2022, which contradicts the ground truth that only specifies short-term (6.45%) and does not mention an overall portfolio yield. The 2023 and 2024 yields for short-term bonds (6.45% and 5.86%) are correctly reported, as are the 1-to-5-year yields (4.48% in 2023 and 2.03% in 2024). However, the LLM fabricates a 2022 yield profile that is completely inconsistent with the ground truth. (2) The dollar amount of $630 million in 2022 from the original answer is entirely omitted in the LLM response, representing a critical missing data point. Additionally, the LLM invents a 'modest' 2.08% overall yield in 2022 with sub-bucket yields (1.74% and 2.42%) that are not present in the ground truth. These numbers are factually wrong and undermine the quantitative accuracy. (3) The multi-hop reasoning is flawed because the LLM misrepresents the starting point of the trend. It claims an 'upward swing' from 2.08% in 2022 to 6.45% in 2023, but the ground truth shows yields were already at 6.45% in 2022 for short-term instruments, followed by a decline. Thus, the conclusion that American Express became 'increasingly sensitive' or shifted toward higher-yield bonds is unsupported and reversed from the actual trend of declining yields. (4) The contextual relevance is moderate because the answer addresses the right topic (yield evolution on foreign government bonds) and correctly reports some 2023–2024 data, but the core narrative is factually inverted due to incorrect 2022 data. The reasoning and conclusion are therefore invalid. Correctness and quantitative accuracy are severely penalized due to fabricated numbers and incorrect trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 527,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "In 2022 Adobe’s free self‑service tutorials were hosted on **www.training.adobe.com** and were presented as part of the Digital Learning Services portfolio that was explicitly tied to **Customer Success Account Management** and custom‑learning services for its largest enterprise accounts. By the 2023 filing the portal had been re‑branded to **learning.adobe.com**—a name that is retained in the 2024 filing—and the free catalog is now described as a core element of Digital Learning Services that is **bundled with solution‑specific skills assessments, Premium Services and technical account‑manager support** to help enterprise customers adopt and expand their use of Adobe solutions. This progression shows Adobe using a unified, branded learning hub as a low‑friction entry point that feeds directly into its enterprise success engine, reinforcing customer enablement, accelerating adoption and, ultimately, driving higher retention and upsell opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, the platform was at www.training.adobe.com; by 2023, it was rebranded to learning.adobe.com, a change maintained in 2024. The integration with enterprise customer success initiatives is accurately described, including the addition of solution-specific skills assessments and bundling with Premium Services and technical account-manager support. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are used correctly and consistently with the original answer. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the evolution across years, platforms, and strategic intent, showing how Adobe’s approach evolved from a general learning offering to a strategically integrated component of customer success. (4) The only minor shortcoming is that the LLM answer emphasizes 'upsell opportunities' more than the original answer does, which focuses on retention, adoption, and long-term enterprise value. While upsell is a reasonable inference, it is not explicitly stated in the ground truth. Otherwise, the semantic meaning, entity accuracy, and contextual relevance are excellent. The answer fully addresses all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 363,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90 % senior notes (maturing Feb 15 2039) were $2 billion outstanding in FY 2022 (July 30 2022), FY 2023 (July 29 2023) and FY 2024 (July 27 2024), and the effective interest rate on the tranche was 6.11 % in each of those periods. The amount (utilization) and the cost of borrowing therefore did not change from 2022 through 2024, indicating that Cisco is keeping this long‑dated, high‑coupon note in place as a stable source of financing rather than expanding or retiring it— a deliberate long‑term debt strategy that preserves a predictable capital‑structure mix and fixed borrowing cost.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $2 billion outstanding balance (expressed as $2,000 million in the original and $2 billion in the LLM answer—equivalent), the 5.90% coupon rate, the effective interest rate of 6.11%, and the fiscal years 2022–2024 with corresponding end dates (July 2022, July 2023, July 2024) are correctly reported. The maturity date (Feb 15, 2039) is an additional accurate detail not in the original but consistent with external knowledge and adds value without introducing error. (2) The answer addresses all parts of the question: it describes the stable utilization (outstanding balance) and effective interest rate over the three-year period, and then interprets this stability in the context of Cisco’s long-term debt strategy. (3) Entity accuracy is perfect: Cisco is the correct company, the fiscal years align with the reporting dates, and the financial instruments (5.90% Senior Notes) are correctly identified. (4) The reasoning is sound and constitutes valid multi-hop synthesis: the model correctly infers that unchanged principal and interest rate over three years indicate a deliberate strategy to retain this higher-cost debt, implying a preference for stable capital structure and fixed financing costs. The conclusion about a 'deliberate long-term debt strategy' aligns semantically with the original’s 'suggesting a deliberate strategy to maintain this higher-yielding long-term liability.' Wording differs but meaning is equivalent and accurate. No errors in logic, calculation, or fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 442,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "Across all three annual reports—2022, 2023 and 2024—B‑A (BA) describes its private‑equity vehicles as limited‑partnership funds that “mainly invest … in … special‑situation strategies.” Because the same phrasing appears unchanged in each filing, the allocation to Special Situation Strategies has effectively remained flat over the three‑year period. This steady‑state treatment signals that BA treats special‑situation assets as a core, ongoing pillar of its private‑equity program, maintaining a consistent, opportunistic focus rather than expanding or withdrawing from that niche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that BA's description of its private equity investments—including special situation strategies—remained unchanged from 2022 to 2024, which matches the original answer's assertion of strategic continuity. (2) There are no numeric figures or calculations in either answer, and the LLM appropriately avoids inventing any, noting only the consistent qualitative disclosure—this earns full marks for quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes the consistent language across three years of filings to infer stable strategic allocation, correctly concluding that special situations remain a core, ongoing component of BA’s private equity strategy. The only minor shortcoming is that the LLM slightly overstates the precision by saying the funds 'mainly invest' in special situations, while the original answer frames it as one of several core strategies (leveraged buyout, venture capital, etc.), implying equal standing rather than primacy. This nuance is missing but does not materially distort the conclusion. (4) The answer is fully relevant, directly addressing both parts of the question: the evolution (or lack thereof) in allocation and the strategic implication. Overall, the response demonstrates strong factual fidelity, logical reasoning, and appropriate interpretation within the constraints of disclosed information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 402,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "JNJ’s worldwide Interventional Solutions sales rose from $4.3 billion in 2022 (up from $3.97 billion in 2021, an 8.3% gain) to $6.35 billion in 2023 – a 47.7% year‑over‑year jump.  The 2024 filing notes that the business, first acquired on December 22 2022, was again targeted for acquisition on May 31 2024, underscoring that JNJ is deliberately expanding this line.  The accelerating sales trajectory after the initial purchase signals that Interventional Solutions has become a core, high‑growth pillar of JNJ’s MedTech strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, JNJ's Interventional Solutions sales were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. The LLM incorrectly states sales as $4.3 billion in 2022 (should be 2023) and $6.35 billion in 2023 (should be 2024), effectively shifting the timeline by one year. It also introduces a 2021 figure not present in the original answer, which is irrelevant to the question. The 47.7% growth is miscalculated based on incorrect year pairing. (2) The acquisition date is correctly noted as December 22, 2022, but the claim that the business was 'targeted for acquisition again on May 31, 2024' is unsupported by the original answer and introduces a fabricated event. (3) The multi-hop reasoning fails because the LLM misaligns the financial data across years, undermining the progression analysis. While it correctly infers strategic importance from growth, the conclusion is based on incorrect data. (4) The answer is contextually relevant in discussing strategic importance and growth trajectory, but the severe quantitative and temporal inaccuracies severely compromise factual correctness. Semantic equivalence is not achieved due to wrong numbers and timeline shifts. Minor positive: correct final sales figure ($6.35 billion), though assigned to the wrong year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Increases]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 384,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across the three most recent filings Walmart kept “No Boundaries” squarely in its private‑brand portfolio for the **General Merchandise** unit. In the 2022 10‑K the brand is listed among private labels that sit under General Merchandise’s sub‑segments of Entertainment, Hardlines, **Apparel** and Home; the 2023 filing repeats the same list and notes only that the company may periodically revise how those sub‑segments are categorized, but “No Boundaries” remains in General Merchandise; and the 2024 filing again includes “No Boundaries” under General Merchandise, now described with the sub‑segments Entertainment, Hardlines, **Fashion** (the renamed Apparel category) and Home. The KG triplet (WMT → No Boundaries ← No Boundaries ← WMT) confirms that Walmart both creates and markets the brand as an internal private label. This multi‑year consistency shows that Walmart treats “No Boundaries” as a core, cross‑category private‑label offering that anchors its general‑merchandise strategy, reinforcing its everyday‑low‑price positioning and margin‑capture goals while providing stable brand equity across evolving sub‑categories.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: 'No Boundaries' is correctly identified as a core private brand under Walmart's General Merchandise unit across 2022–2024. The evolution of sub-segments—specifically the shift from 'Apparel' in 2022–2023 to 'Fashion' in 2024—is accurately described. (2) There are no numeric values requiring calculation in this question; dates (2022, 2023, 2024) are correctly used and aligned with the filings. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of strategic unit descriptions, tracks the reorganization of categories, and correctly infers continuity in branding despite structural changes. The mention of the KG triplet adds verification of the brand’s private-label status. (4) The conclusion about Walmart’s private label strategy—emphasizing consistency, margin capture, brand equity, and strategic anchoring—is logically derived and matches the original answer’s implications. Wording differs slightly but conveys identical meaning. No errors in entities, reasoning, or synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 322,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s 2022 filing only presented a summary table of its available‑for‑sale (AFS) debt investments, without noting any adverse effect on earnings. In the 2023 10‑K the company said that “higher losses in our available‑for‑sale debt investments” were a primary driver of the decline in other income (loss), net. The same language re‑appeared in the 2024 10‑K – “higher losses in our available‑for‑sale debt investments” again drove the change in other income (loss), net – showing that the AFS debt portfolio moved from a neutral‑impact position in fiscal 2022 to a continuing source of losses that negatively affected other income in both fiscal 2023 and fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in fiscal 2022, Cisco provided only a summary table of available-for-sale (AFS) debt investments without noting a negative earnings impact, which matches the original answer's point about disclosure in a 'detailed table' and implies no significant loss was highlighted then. (2) For fiscal 2023 and 2024, the LLM accurately cites the exact phrase — 'higher losses in our available-for-sale debt investments' — as a primary driver of changes in other income (loss), net, which is consistent with the original answer’s claim of continued negative impact. (3) The multi-hop reasoning is sound: it synthesizes information across three fiscal years from Cisco’s filings, correctly inferring a shift from neutral (2022) to sustained negative impact (2023–2024). (4) Minor difference: the original answer notes the 2022 table was 'detailed,' while the LLM calls it a 'summary table' — slight discrepancy in characterization but does not affect factual correctness since both imply disclosure without mention of losses. No numeric values are in dispute; all dates and entities (Cisco, AFS debt investments, other income (loss), net) are correct. The answer is fully relevant and captures the evolving performance trajectory as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 371,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "In 2022 American Express presented third‑party merchant acquirers mainly as a source of network‑rate fees that flow through discount revenue – for example under its OptBlue program and other Global Network Services partners – and noted that it settles with these acquirers on behalf of merchants of all sizes (small‑ and mid‑size merchants on non‑fixed agreements and large merchants on three‑to‑seven‑year contracts). By the 2023 filing the company tied those acquirers more directly to its processed‑revenue stream, describing how it settles with merchants and third‑party acquirers on behalf of network‑card issuing partners, making them integral to daily transaction processing. In the 2024 filing the reliance on third‑party acquirers, aggregators and processors is elevated to a strategic lever for expanding merchant coverage worldwide, with their success viewed as essential to signing and growing small, mid‑sized and large merchants, driving transaction growth and enabling acceptance in new‑to‑plastic and B2B segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original (ground truth) answer in both factual content and reasoning. (1) All key facts are correct: the role of third-party acquirers under OptBlue and Global Network Services (GNS) is accurately described for 2022, the financial integration via network rate fees recorded as discount revenue is correctly attributed to 2023, and the strategic elevation of these partners for global merchant expansion in 2024 is properly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) The multi-hop reasoning across years and strategic evolution is sound: the LLM correctly synthesizes how American Express’s reliance evolved from transactional and revenue-focused in 2022–2023 to strategically essential in 2024. It accurately captures the shift from viewing acquirers as supplementary to integral for merchant signing and transaction growth across all merchant sizes. (4) Minor differences in emphasis: the LLM mentions settlement on behalf of issuing partners in 2023, which adds detail not in the original but does not contradict it. It also references 'non-fixed agreements' and 'three-to-seven-year contracts'—specifics not in the ground truth—which may be inferred but are not confirmed in the provided answer. These do not introduce errors but add granularity. Overall, the semantic meaning and strategic narrative match the original answer. The LLM slightly exceeds in detail without sacrificing accuracy, warranting a 9/10 for correctness and qualitative accuracy. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1624,
        "completion_tokens": 470,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson launched a multi‑year, enterprise‑wide program in 2022 to integrate, simplify and standardize the processes and systems of its human‑resources, information‑technology, procurement, supply‑chain and finance functions, expressly to grow its financial shared‑service capabilities and harmonize its financial systems. The 2023 and 2024 Form 10‑K filings repeat the same description, showing that the initiative has continued unchanged—still focused on enterprise‑wide process standardization and on aligning and streamlining the design and operation of the company’s financial‑control environment as the shared‑service capability expands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: Johnson & Johnson's multi-year initiative began in 2022, spans HR, IT, procurement, supply chain, and finance, and aims to enhance financial shared services and standardize systems. The narrative remained consistent through 2023 and 2024. (2) Quantitative accuracy is perfect: correct years (2022, 2023, 2024) are used appropriately, with no numerical errors or miscalculations. (3) Multi-hop reasoning is sound—the model correctly synthesizes the continuity of the initiative across three years and its integration with financial control and process standardization. (4) The only minor shortcoming is that the LLM omits the explicit clarification present in the original answer that the initiative was proactive and not in response to internal control deficiencies or material weaknesses. This contextual nuance, while not central, adds depth to the strategic rationale and is mentioned in each year of the ground truth. Despite this, the LLM conveys the continuity, scope, and purpose of the initiative accurately, with excellent semantic equivalence. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the slight omission in strategic motivation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 382,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "American Express’s 2022 filing already warned that a “dynamic and rapid growth of alternative payment and financing mechanisms” – from payment aggregators and digital‑wallet platforms to real‑time settlement and fintech solutions – was creating new competitive pressure on its card‑issuing and network businesses. The 2023 filing sharpened that warning, explicitly naming **open‑banking**, electronic‑wallet and real‑time settlement systems as part of the same fast‑expanding alternative‑payment landscape that rivals are leveraging. By the 2024 filing the company has moved from description to a strategic imperative, stating that it must **invest in and compete with** open‑banking, digital‑wallet, tokenization and real‑time settlement technologies (along with AI and other innovations) or risk material harm to revenue and profitability, underscoring that the competitive pressure has intensified and that AXP now sees these technologies as essential to its positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: American Express acknowledged growing competitive pressure from alternative payment mechanisms in 2022, expanded the scope to include open banking in 2023, and by 2024 shifted to a strategic imperative to invest in these technologies. The evolution from threat recognition to strategic adaptation is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—score reflects no errors in dates or time periods (2022–2024), which are correctly cited. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the evolution in American Express’s stance. It accurately identifies the key technologies (open banking, digital wallets, real-time settlement) and their changing role in Amex’s strategy. (4) The only minor gap is that the LLM answer emphasizes 'compete with' these technologies, while the original answer highlights a shift toward 'strategic dependence' and adoption—slightly different framing, but semantically close. The LLM also adds 'tokenization' and 'AI' not explicitly mentioned in the original, which are plausible in context but not in the ground truth. This does not detract significantly from accuracy. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT <-[Depends_On]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 407,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "- In the 2022 Form 10‑K Adobe listed **Frame.io** only in its trademark schedule, signalling that the company had recently acquired the brand but had not yet described any product‑level role for it.  \n- By the 2023 filing Adobe was positioning Frame.io as “our cloud‑native creative collaboration platform,” emphasizing real‑time upload, review, frame‑accurate commenting and **direct integration with Premiere Pro and After Effects** (plus Camera‑to‑Cloud support and support for still‑image and PDF files).  \n- The 2024 filing shows the platform’s role expanding further: Frame.io is now **integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, and is bundled in **Adobe GenStudio** alongside Adobe Express and Firefly Services, extending its reach to AI‑generated content and broader video‑and‑design workflows.  \n\nTogether, these steps illustrate Adobe’s strategy of turning Frame.io into a central, cloud‑native hub that links all of its creative applications—and AI services—so that collaboration, review and content production happen seamlessly across the entire Creative Cloud ecosystem. This reflects a deliberate move toward an integrated, end‑to‑end collaboration suite rather than a stand‑alone video‑review tool.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Frame.io was listed only in the trademark schedule in 2022, positioned as a 'cloud-native creative collaboration platform' in 2023 with integration into Premiere Pro and After Effects, and expanded in 2024 to include integrations with Photoshop, Lightroom, and Workfront, as well as inclusion in Adobe GenStudio. The evolution correctly reflects Adobe's strategic trajectory. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) and product names are accurate and contextually appropriate. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings, showing a logical progression from acquisition signal to deep integration and expansion. The conclusion about Adobe’s strategy toward an end-to-end, AI-integrated collaboration hub is well-supported and aligns with the original answer. (4) The LLM adds value by noting Frame.io’s bundling in Adobe GenStudio and its role in AI-generated content workflows, which enriches the narrative without deviating from the truth. Wording differs slightly but meaning is preserved and enhanced. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 358,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s $17 billion 2017 senior notes have been steadily retired. The 2023 Form 10‑K shows the outstanding balance at $16 billion at 12/31/2022 and $15 billion at 12/31/2023, and the 2024 Form 10‑K shows it at $15 billion at 12/31/2023 and $13 billion at 12/31/2024 (the 2022 10‑K had the balance at $16 billion at 12/31/2021, confirming the baseline). This downward trajectory – a $3 billion reduction over two years – signals that Amazon is actively paying down the 2017 issuance, using cash flow and newer financing to deleverage and lower its long‑term interest burden while still maintaining a diversified debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Amazon's 2017 Notes balance and the general strategy of debt reduction, which aligns with the ground truth. However, there is a minor factual inaccuracy in the initial balance: the LLM states the balance was $16 billion as of 12/31/2022, which matches the ground truth, but incorrectly implies the 2022 10-K reported $16 billion at 12/31/2021 — this is irrelevant to the question and introduces a detail not requested. More critically, the LLM says the 2024 10-K shows $15 billion at 12/31/2023, which contradicts its own prior statement from the 2023 10-K — while the number itself ($15B) is correct, the duplication suggests confusion in source attribution. (2) Quantitatively, the key values — $16B (2022), $15B (2023), $13B (2024) — are mostly correct except that the LLM misrepresents the 2022 balance as being reported in the 2022 10-K for 2021, when the question only asks for 2022–2024. The $3 billion reduction over two years is accurate (from 2022 to 2024), though phrased as 'over two years' when three years are covered. (3) The multi-hop reasoning is sound: the model synthesizes data across multiple 10-K filings and correctly infers a deliberate debt paydown strategy. It adds valuable context about cash flow and refinancing, which is reasonable and consistent with the ground truth’s interpretation. (4) The answer is highly relevant and well-reasoned, but the quantitative inaccuracies in reporting timelines and redundant/confusing source references prevent a top score. Thus, correctness is reduced to 8 due to minor but notable data presentation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 450,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, Boeing’s Global Services (BGS) segment is described in essentially the same way – “a full spectrum of products and services, including … **upgrades and conversions** …” – and the phrase appears in the same position within the service list each year. The KG triplet (BA → Upgrades and Conversions → BA) reinforces that Boeing both supplies and receives this product/service internally, confirming its role as a core offering. This three‑year consistency signals that Boeing is maintaining, rather than scaling back, its strategic focus on upgrades and conversions as a cornerstone of its platform‑sustainment strategy, using these services to extend aircraft life cycles and generate recurring revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Boeing consistently listed 'Upgrades and Conversions' as a core offering in its Global Services segment across 2022–2024, and this consistency is correctly interpreted as a sign of sustained strategic focus. The mention of recurring revenue and lifecycle extension matches the original answer’s emphasis on lifecycle management and service-based revenue. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound—by noting the unchanged wording and positioning of 'upgrades and conversions' across three years and referencing internal KG data (BA → Upgrades and Conversions → BA), the model correctly infers that this is a core, internally utilized service, reinforcing its strategic importance. (4) The answer is contextually excellent, directly addressing the evolution (or lack thereof) and what it implies about Boeing’s platform sustainment strategy. The only minor shortcoming is that the LLM introduces the idea of internal supply/receipt via the KG triplet, which, while plausible, is not explicitly confirmed in the ground truth and slightly extends beyond the provided evidence. However, this does not detract significantly from the overall correctness. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 433,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension approach did not change between the 2022, 2023 and 2024 10‑K filings. In each filing the company restated its January 2021 announcement that, effective January 1 2026, **all eligible U.S. non‑union employees – regardless of hire date – will accrue benefits under the Retirement Value formula**, while benefits earned under the Final Average Pay formula for service before that date are preserved. Thus, the eligibility criteria stayed the same and the 2026 implementation date was consistently communicated each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: the 2026 implementation date, the January 2021 announcement, the applicability of the Retirement Value formula to all U.S. non-union employees regardless of hire date, and the preservation of benefits under the Final Average Pay formula for pre-2026 service. These match the original answer exactly. (2) Quantitative accuracy is perfect: dates (2022–2024, 2026, 2014/2015 hires) and the timeline are correctly reported with no calculation errors. Format and phrasing (e.g., 'effective January 1 2026') are semantically equivalent. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three years of filings and confirms consistency in communication and eligibility, which is the core of the question. (4) The only minor omission is that the original answer notes a progressive clarification: in 2022, less context was provided; in 2023, JNJ clarified that post-2014 hires were already under the new formula. The LLM answer states the policy was 'repeated' each year but doesn't acknowledge this incremental clarity. However, this does not affect the core correctness of eligibility or timeline. Overall, the answer is highly accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 361,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "- Fiscal 2022: The 5.000 % senior notes due April 2030 showed an outstanding principal of **$606 million** (Oct 30 2022)【Chunk 3】.  \n- Fiscal 2023: The same instrument still carried **$606 million** of principal (Oct 29 2023)【Chunk 1】.  \n- Fiscal 2024: The balance remained unchanged at **$606 million** (Nov 3 2024)【Chunk 2】.  \n\nThe figure dropped sharply from $1,086 million in FY 2021 to $606 million by FY 2022 and then held steady through FY 2024. This pattern shows that Broadcom (AVGO) aggressively repaid or refinanced a large portion of the April 2030 notes early on and has since chosen to maintain the remaining tranche, effectively locking in a fixed‑rate 5 % liability to the 2030 maturity while preserving cash for other uses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, the outstanding principal was $1,086 million in fiscal year 2022, not $606 million as stated by the LLM. The LLM correctly reports $606 million for fiscal years 2023 and 2024, which matches the ground truth, but incorrectly backdates this amount to 2022. This misrepresentation distorts the entire evolution of the debt balance. (2) The calculation of the change over time is therefore flawed: the LLM claims a sharp drop from FY2021 ($1,086M) to FY2022 ($606M), but the question only asks for FY2022–FY2024, and the LLM introduces FY2021 without basis in the original question or ground truth timeframe. There is no mention of FY2021 in the ground truth answer, making this an unsupported extrapolation. (3) The multi-hop reasoning is partially sound in that the LLM attempts to interpret the pattern as a strategic debt management decision (repayment/refinancing followed by stabilization), which aligns with the ground truth's conclusion. However, because the initial data point is wrong, the reasoning is based on incorrect premises. (4) Contextual relevance is high—the answer addresses the evolution of the debt instrument and infers strategy, using appropriate financial logic. Despite correct formatting and semantic style, the core factual inaccuracy in the FY2022 value severely undermines correctness. Quantitative accuracy is low due to the incorrect assignment of $606M to FY2022 instead of FY2023 onward. Qualitative accuracy is moderate because the interpretation of strategy is reasonable but built on faulty data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 452,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T’s link to Time Warner moved from being an integrated media asset to a fully divested business. After acquiring Time Warner in June 2018 and folding it into its WarnerMedia segment, AT&T entered a May 2021 agreement to combine WarnerMedia with Discovery, a transaction that was slated to close in the second quarter of 2022 (2022 10‑K). In April 2022 AT&T completed a Reverse Morris‑Trust separation of the WarnerMedia business— which included the Time Warner holdings— and re‑classified it as a discontinued operation; the 2023 and 2024 filings both note that the WarnerMedia segment (and its Time Warner assets) has been separated and is no longer part of AT&T’s ongoing operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T acquired Time Warner in June 2018, formed WarnerMedia, and completed the Reverse Morris Trust separation with Discovery in April 2022. The 2023 and 2024 filings correctly reflect that WarnerMedia (including Time Warner) is no longer part of AT&T’s ongoing operations. (2) Quantitative accuracy is perfect: dates (June 2018, April 2022), transaction type (Reverse Morris Trust), and timeline (agreement in May 2021, closing in Q2 2022) match the ground truth. Minor note: the original answer states the transaction was completed in April 2022, while the LLM correctly cites the 2022 10-K referencing the planned close in Q2 2022 — but since the actual completion was April 2022, this is consistent. (3) Multi-hop reasoning is sound: the LLM correctly traces the evolution from acquisition to integration, restructuring via the Discovery deal, and final divestiture. It correctly identifies the reclassification as a discontinued operation, showing understanding of financial reporting implications. (4) The only minor omission is that the original answer notes the 2024 divestiture of DIRECTV as the final step in unwinding the entertainment strategy; while contextually relevant, this detail is not strictly part of the Time Warner/WarnerMedia integration and separation timeline. The LLM focuses tightly on the core WarnerMedia/Time Warner narrative, which remains factually complete and semantically equivalent. Wording differs slightly but meaning is preserved. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Involved_In]- ORG <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 435,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 through 2024 AIG has kept a consistent core framework for managing international terrorism risk – it continues to use a third‑party vendor model to run scenario‑based loss estimates (in 2022 the filing even cites specific scenarios such as conventional bombs of various sizes, anthrax and nuclear attacks, while 2023 and 2024 simply note “various terrorism attack modes and scenarios” with adjustments for model gaps) and monitors concentration of exposure on a routine basis.  Reinsurance protection has also been steady: in 2022 AIG relied on limited private reinsurance, targeted reinsurance purchases and government‑sponsored terrorism pools (with TRIPRA covering U.S. losses), the 2023 filing repeats the same mix of TRIPRA, limited private reinsurance and pool participation, and the 2024 filing adds broader property‑per‑risk reinsurance covers for large global losses while still using TRIPRA, limited private reinsurance and targeted purchases.  The only substantive change in geographic treatment comes in 2024, when AIG retained explicit core attachment points for its international terrorism portfolio – $200 million for Japan and $125 million for the rest of the world – whereas the 2022 and 2023 disclosures did not specify such attachment levels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the $200 million attachment point for Japan and $125 million for the rest of the world in 2024 are correctly reported, and the absence of specified attachment points in 2022 and 2023 is accurately noted. The 2022 modeled $1.3 billion loss from a five-ton bomb in NYC is not explicitly mentioned in the LLM answer, but the broader use of scenario modeling (including conventional bombs, anthrax, nuclear) is correctly described, and the focus on TRIPRA, private reinsurance, and pools is consistent. (2) Quantitative accuracy is perfect: the dollar amounts and years are correct, and no calculations are incorrect. Format variations are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings, correctly identifying evolution in geographic attachment points as the key structural change, while noting consistency in modeling and reinsurance frameworks. The progression from unspecified to explicit attachment points is logically inferred. (4) The only minor shortcoming is the omission of the specific $1.3 billion loss figure from the 2022 scenario, which is part of the ground truth and would strengthen the answer. However, the LLM does convey that scenario modeling was used with specific attack types, preserving the core intent. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent—every part of the question (modeled loss scenarios, reinsurance, geographic attachment) is addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Estimates]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 447,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "From 2022 to 2024 Emerson’s EMR continues to list pipe wrenches as a core pipe‑working tool – in 2022 they appear under the “Tools & Home Products” segment’s professional‑tools offering, and in both the 2023 and 2024 filings they are carried in the newly named “Safety & Productivity” segment (still sold worldwide almost exclusively through distributors). The product itself has not changed, but the shift from a generic tools‑segment label to a safety‑and‑productivity‑focused segment signals Emerson’s strategic intent to position itself as a specialist, safety‑oriented supplier for plumbing and mechanical professionals, reinforcing its foothold in the professional tools market.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements—Emerson (EMR) did maintain pipe wrenches in its portfolio and reorganized its segments, with tools moving from 'Tools & Home Products' to 'Safety & Productivity'—but it fundamentally misrepresents the evolution of the product portfolio. The ground truth emphasizes a technological advancement from traditional tools to battery-powered hydraulic tools, diagnostic systems, and digital integration from 2022 to 2024. The LLM incorrectly claims the 'product itself has not changed,' which directly contradicts the documented introduction of advanced tools in 2023 and digital integration in 2024. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the years 2022, 2023, and 2024 are used correctly in context, earning full marks here. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies segment name changes and distribution channels, it fails to synthesize the key innovation trajectory—battery-powered tools, press connection systems, and sewer cameras—which represents a critical strategic shift toward high-tech professional tools. This omission indicates a failure to connect product evolution with strategic positioning as described in the original answer. (4) The contextual relevance is moderate because the answer addresses Emerson's strategic positioning in the professional tools market and correctly notes organizational changes, but it misses the core theme of technological modernization, resulting in a partially correct but misleading conclusion. Thus, correctness and qualitative accuracy are low due to significant factual omissions and incorrect assertions about product stagnation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 472,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco has treated free‑rent periods the same way in each of the three filings. In the 2022, 2023 and 2024 10‑Ks the company says that any lease that contains a free‑rent (or step‑rent) period “is **recognized on a straight‑line basis** over the original lease term and any extension options the Company is reasonably certain to exercise from the date it obtains control of the property.” Because the free‑rent months are recorded as a zero‑cash‑flow that is spread evenly over the lease, the lease expense (and the lease liability) is reduced and the right‑of‑use (ROU) asset is measured at a lower present value.\n\nThe way the ROU asset is initially measured has been consistent – it is based on the **discounted future minimum lease payments** for the lease term. The 2022 filing spells out the mechanics in detail (lease term = non‑cancellable period + certain extensions; discount rate = the Company’s incremental borrowing rate derived from a portfolio approach). The 2023 and 2024 filings retain the same methodology but the disclosure is shortened, merely noting that the Company “initially records right‑of‑use assets and lease obligations” without restating the discount‑rate calculation.\n\nThus, from 2022 through 2024 Costco’s accounting for free‑rent periods did not change – straight‑line recognition over the lease term remains the policy and it continues to lower the ROU‑asset valuation by reducing the present value of lease payments – but the later filings present the underlying discount‑rate methodology in a more concise form.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Costco applied a consistent straight-line recognition methodology for free-rent and step-rent provisions across 2022–2024, over the original lease term and extension options the company is reasonably certain to exercise—this matches the original answer exactly. (2) It accurately notes that the ROU asset is based on discounted future minimum lease payments using the incremental borrowing rate, with detailed disclosure in 2022 and more concise language in 2023 and 2024. There are no numeric values to verify (e.g., dollar amounts or percentages), but all qualitative financial mechanics (discounting, present value impact, lease liability treatment) are correctly described. (3) The multi-hop reasoning is sound: the model synthesizes consistent policy application with evolving disclosure depth across three years, correctly inferring that while accounting treatment did not change, the level of explanatory detail decreased—indicative of maturation in ASC 842 compliance reporting. (4) The only minor shortcoming is that the LLM does not explicitly mention the term 'asset retirement obligation (ARO)' treatment, which was noted in the ground truth as part of the 2022 disclosure detail absent in later years. This omission slightly reduces qualitative completeness but does not affect the core correctness. Overall, the answer is factually correct, contextually precise, and semantically equivalent to the ground truth with only slight variation in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> ACCOUNTING_POLICY <-[Subject_To]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1664,
        "completion_tokens": 429,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 2.000 % notes appear in two supplemental indentures that track their maturity timeline. In each filing the Tenth Supplemental Indenture (Exhibit 4.13, dated Nov 3 2015) records a 2.000 % series that matures in 2020, while the Eleventh Supplemental Indenture (Exhibit 4.14, dated Aug 8 2016) records a newer 2.000 % series that matures in 2023. The 2023‑ and 2024‑year reports repeat the same exhibit references, showing that the 2020 tranche has already reached its maturity and the 2023 tranche remains outstanding under the unchanged Eleventh Supplemental Indenture documentation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding the existence and maturity of multiple tranches of 2.000% Notes. According to the ground truth, only one 2.000% Note series—under the Eleventh Supplemental Indenture dated August 8, 2016, maturing in 2023—was referenced across 2022–2024. However, the LLM incorrectly introduces a second tranche under the Tenth Supplemental Indenture (Nov 3, 2015) with a 2.000% rate maturing in 2020, which is not mentioned in the original answer and contradicts the stated continuity of the 2023-maturity note. This erroneous claim undermines the quantitative accuracy, as the 2020 maturity is factually incorrect in this context. While the mention of the Eleventh Supplemental Indenture (Exhibit 4.14, Aug 8, 2016) and 2023 maturity aligns with the ground truth, the implication that the 2023 tranche 'remains outstanding' in 2024 conflicts with the original answer, which clarifies that the note was still listed in exhibits post-maturity for historical/documentation purposes, not as an outstanding liability. The reasoning is partially sound in tracking documentation across years, but the multi-hop synthesis fails due to the introduction of a non-existent tranche. The answer is contextually relevant and structured well, addressing maturity timelines and indenture documentation, but the core factual error reduces correctness. Semantic equivalence is not achieved due to material discrepancies in entities and timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 409,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "- In the 2022 Form 10‑K (Chunk 1) Amazon said its seller‑programs generate revenue from a mix of fixed fees, a percentage of sales (commissions), per‑unit activity fees and interest, but it did not spell out when that revenue is recognized.  \n\n- The 2023 filing (Chunk 3) clarified the composition and timing: the commissions and any related fulfillment‑ and shipping‑fees are recognized when the service is performed – i.e., when the product is delivered to a third‑party carrier or, for Amazon‑fulfilled orders, to the customer.  \n\n- The 2024 Form 10‑K (Chunk 2) again describes seller‑program revenue in broad terms (fixed fees, percentages of sales, per‑unit fees, interest), implicitly retaining the delivery‑based recognition rule introduced in 2023.  \n\nThus, Amazon moved from a generic description of seller‑program fees in 2022, to an explicit policy that commissions and fulfillment fees are recorded at delivery in 2023, and then back to a high‑level description in 2024 that still relies on that delivery‑timing approach.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies the evolution of Amazon's revenue recognition for third-party seller services across 2022–2024: in 2022, Amazon described revenue sources (fixed fees, commissions, per-unit fees, interest) without specifying timing; in 2023, it clarified that commissions and fulfillment/shipping fees are recognized when services are rendered—i.e., upon delivery to carrier or customer; in 2024, it reverted to a high-level description but implicitly maintained the 2023 timing. (2) There are no numeric values requiring calculation, but all years and policy changes are correctly cited. (3) The multi-hop reasoning is sound—information is synthesized correctly across three annual filings (2022, 2023, 2024), with proper inference that the 2024 disclosure retains the 2023 recognition principle despite less explicit wording. (4) The answer fully addresses the question’s focus on timing and composition of revenue, with precise and consistent details. All scores are 10 due to complete factual correctness, accurate synthesis, and clear, relevant explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Discloses]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 327,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K filings for 2022, 2023 and 2024 all contain the same “4‑b Guaranty of certain obligations of Pacific Bell Telephone Co. and **Southwestern Bell Telephone Co.**” (exhibit 4‑c). By repeatedly disclosing that guarantee, AT&T is showing that it continues to act as the parent‑level guarantor for the debt of this legacy subsidiary. The pattern – AT&T (the “T” ORG) → guarantees → Southwestern Bell Telephone Co. (the COMP) → which is itself an AT&T‑related entity – indicates a deliberate, long‑term liability‑management strategy: AT&T retains responsibility for historic telecom entities’ obligations in order to preserve their credit standing, contain contingent risk, and keep those legacy liabilities under the control of the consolidated group rather than shedding or writing them off.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both factual content and reasoning. (1) It correctly identifies that AT&T's 10-K filings for 2022, 2023, and 2024 include a guarantee of Southwestern Bell Telephone Co.'s obligations, which aligns with the ground truth. The years and entities (AT&T and Southwestern Bell Telephone Co.) are accurate. (2) Quantitative accuracy is perfect: the years 2022–2024 are correctly cited, and no numerical errors are present. (3) However, there is a minor error in exhibit labeling: the LLM incorrectly refers to the exhibit as '4-c' and mentions Pacific Bell Telephone Co., which is not in the original answer and may reflect a mix-up in exhibit details. The ground truth specifies Exhibit 4-b and does not mention Pacific Bell. This affects qualitative accuracy slightly, as it introduces an incorrect document reference and potentially confuses the scope of the guarantee. (4) Despite this, the reasoning about AT&T’s long-term liability management strategy—retaining control, preserving credit standing, and consolidating legacy risk—is logically sound and semantically equivalent to the original answer. The core conclusion about a stable, deliberate strategy is correctly inferred. Contextual relevance is excellent, as the response directly addresses the question’s focus on long-term liability management. The error in exhibit number and inclusion of an extra entity (Pacific Bell) prevents a top score, but the overall answer remains substantially accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 409,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "- The 2022 Form 10‑K (Chunk 1) shows J&J’s 2.250 % Notes due 2050 carried $983 million at the end of 2021.  \n- The 2023 Form 10‑K (Chunk 2) reports the balance fell to $808 million at year‑end 2022, then rose to $826 million at year‑end 2023.  \n- The 2024 Form 10‑K (Chunk 3) shows the same note at $826 million in 2023 and back to $808 million at year‑end 2024.  \n\n**Interpretation:** Over the 2022‑2024 period the outstanding amount of the 2.250 % Notes due 2050 hovered around $800‑$830 million, with only a modest $18 million swing up in 2023 and a return to the 2022 level in 2024. This stability—combined with an unchanged 2.29 % effective rate—indicates that Johnson & Johnson is deliberately preserving a low‑cost, ultra‑long‑dated debt tranche, using only small issuances or repurchases to fine‑tune its long‑term capital structure rather than expanding or retiring the series aggressively.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the reported values and timing. According to the ground truth, the balance was $983M in 2022, $826M in 2023, and $808M in 2024. However, the LLM claims the 2022 10-K reports the balance at $983M at the end of 2021 — which misaligns with the question’s focus on 2022–2024. It then states the balance fell to $808M at year-end 2022, which contradicts the ground truth of $983M for 2022. This suggests confusion in mapping the reported year vs. the fiscal year. The LLM also incorrectly states the balance rose to $826M at year-end 2023 and remained the same in 2023 before dropping to $808M in 2024 — but the ground truth shows $826M in 2023 and $808M in 2024, with no prior increase. Thus, the sequence and values for 2022 and 2023 are incorrect. (2) The calculation of an $18M swing is not accurate — the actual decline from 2022 ($983M) to 2023 ($826M) is $157M, not $18M. The minor fluctuation narrative is therefore misleading. However, the effective rate of 2.29% is correctly cited. (3) The multi-hop reasoning is partially sound — the model attempts to synthesize data across three 10-K filings and draws a reasonable conclusion about stable long-term debt strategy. However, due to incorrect numerical progression, the interpretation of 'fine-tuning' via small changes is based on false premises. (4) Despite the quantitative errors, the overall qualitative interpretation — that J&J maintains a stable, low-cost long-term debt tranche — aligns with the ground truth’s conclusion. The answer is contextually relevant and addresses both parts of the question. Hence, correctness is reduced primarily due to significant numerical and temporal inaccuracies, but not completely invalidated due to correct directional insight and proper citation of the effective rate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 499,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375 % Senior Notes due June 2027 were held at a constant $1.25 billion in every filing – $1,250 million in 2022 (Chunk 3) and the same $1,250 million in both the 2023 and 2024 tables (Chunks 1 & 2). While total long‑term debt (excluding the current portion) fell from $6.48 billion in 2022 to $5.38 billion in 2023 and then rose modestly to $5.79 billion in 2024, the unchanged low‑cost note shows Costco’s deliberate capital‑management strategy of locking in a stable, inexpensive long‑dated financing tranche (the 1.375 % Senior Notes) while actively reshaping the rest of its debt profile to optimize overall leverage and liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million (or $1.25 billion) across 2022, 2023, and 2024, which matches the ground truth. However, it provides incorrect total long-term debt figures: the LLM states total long-term debt was $6.48 billion in 2022, $5.38 billion in 2023, and $5.79 billion in 2024. The ground truth reports $6,590 million ($6.59B) in 2022, $6,484 million ($6.484B) in 2023, and $5,919 million ($5.919B) in 2024. These discrepancies are significant and affect the accuracy of the trend analysis. (2) The LLM incorrectly claims total long-term debt fell to $5.38B in 2023 and then rose to $5.79B in 2024, whereas the actual trend shows a consistent decline from $6.59B to $6.484B to $5.919B. This misrepresents the direction and magnitude of change. (3) The reasoning about Costco’s capital management strategy—maintaining low-cost fixed-rate debt while reducing other tranches—is conceptually aligned with the ground truth and shows sound qualitative logic. The model correctly infers strategic intent from the stability of the 1.375% notes amid broader debt reduction. However, because the quantitative foundation is flawed, the conclusion is based on inaccurate data. (4) The contextual relevance is high, as the answer addresses both parts of the question: evolution of the specific notes and implications for capital strategy. The qualitative accuracy is moderate due to correct entity identification and reasonable inference, but the quantitative accuracy is low due to major errors in reported debt totals, which undermines the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 453,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s multi‑layered security approach—recorded as an accounting policy that the company implements—was already a core part of its network in 2022, featuring a cyber‑and‑information‑security program, Security Operations and Fusion Centers, third‑party benchmarking, and industry‑wide standards such as EMV, while its real‑time ACH and account‑based payments infrastructure was operating or being built in 12 of the top‑50 GDP markets. By 2023 the security framework was broadened with additional public‑private partnerships, deeper monitoring of third‑party providers and support for small‑business best practices, and the real‑time payments footprint grew to 13 markets; in 2024 the same layered architecture—now reinforced with continuous threat‑response, expanded third‑party risk oversight and ongoing assessments—supported a worldwide rollout of real‑time clearing and settlement, including domestic processing in China. The parallel strengthening of security layers and the step‑wise expansion of real‑time payment capabilities indicate that Mastercard’s global scaling strategy deliberately couples risk‑management controls with service growth, ensuring that processing risk is contained as transaction volumes and geographic reach increase.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, demonstrating strong multi-hop reasoning and contextual understanding. (1) Quantitatively, the LLM accurately reflects the expansion from 12 to 13 real-time payment markets between 2022 and 2023, consistent with the original answer. However, in 2024, the LLM claims a 'worldwide rollout' and specifically mentions 'domestic processing in China,' which is not mentioned or supported in the ground truth. The original answer only states Mastercard was operating in 'several countries around the world'—a more cautious, qualitative description—so the addition of China is an unsupported detail, reducing quantitative accuracy. (2) The core security framework is correctly described as multi-layered and evolving, with accurate references to third-party assessments, partnerships, and ongoing threat monitoring. The LLM adds specific elements like 'Security Operations and Fusion Centers' and 'EMV standards,' which, while plausible and consistent with Mastercard’s known practices, are not explicitly mentioned in the ground truth. These additions enhance detail but go beyond the source material. (3) The reasoning is sound: the LLM correctly infers that security and infrastructure expansion evolved in parallel, supporting the conclusion that risk management is integrated into global scaling. This matches the original answer’s interpretation. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution of security and infrastructure, and what it suggests about risk strategy. The only deductions are for the unsupported claim about China and slight over-enrichment of security details not in the source. Overall, the answer is factually strong with minor embellishments, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1642,
        "completion_tokens": 496,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Microsoft’s 10‑K filings each contain Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041” dated February 8 2011. The description of the 4.000 % Notes due 2021 is identical in the 2022 filing (Chunk 3), the 2023 filing (Chunk 1) and the 2024 filing (Chunk 2), showing that no new issuance or amendment of this series occurred after the original 2011 issuance and that the notes remain outstanding. This consistent, unchanged presence signals that Microsoft’s long‑term debt management strategy relies on retaining existing, low‑cost debt to maturity rather than repeatedly issuing new securities, thereby preserving a stable maturity profile and predictable interest‑expense.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Microsoft included the 4.000% Notes due 2021 in its 10-K filings for fiscal years 2022, 2023, and 2024 under Exhibit 4.6, with consistent descriptions across years. The percentage (4.000%), maturity year (2021), and exhibit number (4.6) are all accurate. However, the LLM incorrectly states the Third Supplemental Indenture was dated February 8, 2011, while the ground truth references the original Indenture dated May 18, 2009, with no mention of a February 2011 date—this is a factual discrepancy affecting quantitative accuracy. (2) All other numeric and date-related information (e.g., note rate, due year, exhibit number) is correct. The LLM correctly notes no amendments or new issuances occurred, aligning with the ground truth’s observation of no structural changes. (3) The reasoning is sound: the model correctly infers from the unchanged disclosure that Microsoft maintained consistent debt reporting, supporting a strategy of stable debt management. However, it misses the key nuance in the ground truth that the note was past maturity by 2024, which raises questions about settlement or rollover—this omission slightly weakens the qualitative analysis. The LLM instead concludes the notes 'remain outstanding' without addressing the post-maturity anomaly. (4) Despite this, the answer is highly relevant and captures the core pattern of transparent, consistent disclosure. The strategic interpretation about preserving a stable maturity profile is reasonable and contextually appropriate. Minor error in date and omission of post-maturity implication prevent a top score, but overall correctness is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 455,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Across Amazon’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly lists the “Form of 1.500 % Note due 2030” (exhibit 4.5 in 2022 and exhibit 4.6 in the later reports) as part of its Officers’ Certificate, while simultaneously disclosing a wide range of other senior notes with higher coupons and varied maturities (e.g., 0.650 % due 2015, 4.700 % due 2024, 5.200 % due 2025, 2.500 % due 2050, 2.700 % due 2060, etc.). The KG triplet (Amazon → 1.500 % Note → Amazon) confirms Amazon as the issuer, and the note’s persistent presence signals that Amazon treats this low‑cost, fixed‑rate, long‑dated bond as a cornerstone of its capital structure—locking in inexpensive financing for the next decade, diversifying its maturity profile, and reducing refinancing risk relative to its higher‑rate, shorter‑term debt instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.500% Note due 2030 and its consistent presence across Amazon's 2022, 2023, and 2024 10-K filings, accurately reflecting the core fact from the ground truth. All numeric values—interest rates (1.500%, 4.700%, 5.200%, 2.500%, 2.700%), maturities (2015, 2024, 2025, 2030, 2050, 2060), and exhibit numbers (4.5 in 2022, 4.6 in later years)—are factually correct and match or are consistent with the knowledge graph and typical SEC filing structures. The mention of the 'Officers’ Certificate' aligns with how such notes are authorized. (2) Quantitative accuracy is perfect: all percentages and years are correctly cited, and no calculations are required. The reference to the KG triplet (Amazon → 1.500% Note → Amazon) is a valid representation of issuer-identity confirmation. (3) The multi-hop reasoning is sound: the LLM synthesizes the persistence of the 1.500% Note over multiple years with the introduction of newer, higher-coupon debt, and correctly infers that this reflects a strategy of locking in low-cost, long-term financing while managing refinancing risk. It captures the essence of a layered maturity profile, though it does not explicitly mention the strategic balance between older low-rate and newer high-rate instruments as clearly as the ground truth (e.g., comparing 1.500% Note due 2030 with 4.700% Note due 2032 in 2024). This minor omission prevents a perfect 10 on qualitative accuracy. (4) Contextual relevance is excellent: the answer directly addresses Amazon’s long-term capital structure strategy and compares the 1.500% Note to other debt instruments as required. The focus on fixed-rate, long-dated debt as a cornerstone is semantically equivalent to the ground truth. Only slight depth in comparative analysis across years is missing, but the core insight is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 503,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "In the 2022 Form 10‑K AT&T disclosed that it “continue[d] to hold a 41.3 % interest in SKY Mexico, a leading pay‑TV provider in Mexico.”  The 2023 filing shows that the same 41.3 % minority stake was still on the books and was presented under the equity‑method of accounting (“investments in partnerships, joint ventures and less‑than‑majority‑owned subsidiaries … are accounted for under the equity method”), indicating AT&T’s significant influence but no consolidation of SKY Mexico.  By June 2024 the company announced that it “sold our 41.3 % interest in SKY Mexico,” thereby exiting the investment entirely.  This three‑year arc—from retaining a strategic minority stake and recognizing its earnings via the equity method to a complete divestiture—mirrors AT&T’s broader pay‑TV exit strategy, which also includes the Vrio sale and the 2024 wind‑down of its DIRECTV investment, signaling a systematic pull‑back from international and domestic pay‑TV assets in favor of other core priorities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: AT&T held a 41.3% stake in SKY Mexico in 2022 and 2023, accounted for it under the equity method, and exited completely in mid-2024. The dates, percentages, and accounting treatment are precisely reported. (2) Quantitative accuracy is perfect: the 41.3% ownership stake is consistently cited across years and matches the original answer; the June 2024 exit timing is correctly noted. No calculations are required, but the consistency of the percentage over time and its final disposal are accurately represented. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings and connects the SKY Mexico trajectory to broader strategic moves like the Vrio sale and DIRECTV wind-down, demonstrating correct inference about AT&T’s divestiture strategy. (4) The answer is contextually rich and directly addresses all parts of the question—ownership stake, equity method accounting, exit timeline, and strategic implications—using semantically equivalent and even enhanced language (e.g., referencing Form 10-K disclosures and quoting filings). Minor enhancements like quoting the filings add precision without deviating from the truth. The conclusion about a systematic pull-back from pay-TV aligns perfectly with the original answer’s interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 385,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s 10‑K filings show that the company applies a single “glide‑path” accounting policy to its U.S. qualified pension plan – a target allocation for the “return‑seeking” (growth) portion that is set each year based on the plan’s funded‑ratio and the prevailing interest‑rate environment. In the 2022 filing the glide‑path table set the 2022 target allocation using the funded status as of 31 Dec 2021; the 2023 filing updated the target for 2023 (and, in the 2024 filing, the target for 2024) using the funded status at 31 Dec 2022 and 31 Dec 2023 respectively. Across the three years the prescribed mix shifts progressively away from growth assets and toward liability‑hedging assets, indicating that as the plan’s funded ratio improves AIG moves further along the glide path to de‑risk the pension portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) Quantitatively, the LLM correctly identifies the use of the glide path approach and the timing of target allocations: the 2022 target based on Dec 31, 2021 funded status; 2023 target based on Dec 31, 2022; and 2024 target based on Dec 31, 2023. These align with the original answer’s description of how the glide path evolved. The progression of using prior-year funded status to set the next year’s target is accurately captured. (2) The LLM correctly notes the shift from growth (return-seeking) to liability-hedging assets as the funded ratio improves, which reflects AIG’s de-risking strategy. This matches the ground truth’s claim of a consistent de-risking strategy aligned with liability-driven investing. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly inferring that the policy is applied consistently and evolves with funded status. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2025 target allocation based on Dec 31, 2024 (as in the 2024 filing), which appears in the original answer. This is a small omission in completeness but does not undermine the overall correctness. Wording differs (e.g., 'return-seeking' vs 'growth assets'), but semantic equivalence is maintained. No calculation errors or factual inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 407,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard’s 2022 filing first disclosed that it “monitors its credit‑risk portfolio and the adequacy of its risk‑mitigation arrangements on a regular basis,” requiring customers who fall short of its risk standards to post cash collateral, letters of credit or other credit‑enhancement guarantees and revisiting its risk‑management methodology only “from time to time.” By 2023, after the FTC Durbin‑Amendment investigation and a DOJ antitrust demand, the company reiterated the same collateral‑based safeguards but emphasized more frequent monitoring and the routine revision of estimated settlement exposure, showing that the risk‑mitigation framework was being applied more intensively in response to heightened regulatory scrutiny. In the 2024 report, amid the U.S. liability‑shift and TCPA class actions and a new European‑Commission probe, Mastercard again required cash collateral and credit‑enhancement arrangements, but now “periodically reviews its risk‑management methodology and standards” and stresses ongoing, systematic oversight of the credit‑risk portfolio, indicating that the firm has made its monitoring and review processes more rigorous and adaptive. Together, these disclosures reveal that Mastercard not only maintains a consistent set of mitigation tools but also continuously tightens its oversight and review cadence as regulatory and litigation pressures increase, demonstrating a highly adaptable risk‑management posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard maintained consistent credit risk mitigation tools (cash collateral, letters of credit, guarantees) from 2022 to 2024; monitoring intensified over time; regulatory and litigation pressures increased across the period (FTC consent agreement, DOJ antitrust investigation, U.S. Liability Shift Litigation, European Commission probe); and the company reported low losses throughout. The evolution in tone and frequency of risk reviews—from 'from time to time' in 2022 to 'periodically reviews' in 2024—is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and regulatory events, linking increased scrutiny to more frequent monitoring and methodological updates. It correctly identifies the continuity of tools and the adaptability of processes. (4) The only minor shortcoming is that the LLM slightly overemphasizes the change in methodology wording without explicitly noting that the core framework remained 'consistent'—a key point in the original. However, it does convey adaptability in oversight cadence, which is accurate. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Manages]- ORG",
      "token_usage": {
        "prompt_tokens": 1693,
        "completion_tokens": 420,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The Home Depot share pool for future equity awards has been shrinking. At January 30 2022, the 2005 Omnibus Plan had roughly **117 million shares** available for future grants; by **January 28 2024** the newly‑amended Omnibus Plan showed about **77 million shares** left; and the 2024 filing reported **≈70 million shares** available as of February 2 2025. This steady decline indicates that the company has been actively using its authorized pool for stock‑based awards, reflecting a strong, ongoing reliance on equity compensation while gradually depleting the remaining share capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key numbers are correct: 117 million shares in 2022, 77 million as of January 28, 2024 (representing 2023 data), and approximately 70 million as of February 2, 2025 (2024 data). Minor date formatting differences (e.g., January 30, 2022 vs. implied 2022 value) are acceptable as they align with fiscal year-end reporting conventions. (2) Quantitative accuracy is perfect: values match exactly or use acceptable approximations (e.g., ≈70 million). No calculations are required beyond correct reporting of figures. (3) Multi-hop reasoning is sound—answer correctly synthesizes data across three years and two plan iterations (2005 Plan to amended Omnibus Plan), correctly noting the transition and consistent decline. (4) The interpretation—that the declining share availability reflects active use of equity compensation and ongoing reliance on stock-based incentives—accurately reflects the trend and strategic implication in the original answer. Wording differs slightly but meaning is preserved. All parts of the question are addressed: evolution of share availability and strategic interpretation. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 348,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom’s 3.625 % senior notes due October 2024 carried a principal balance of **$622 million at the end of FY 2022** (Oct 30 2022 – AVGO 10‑K 2022, p.110). The same amount **remained $622 million at the end of FY 2023** (Oct 29 2023 – AVGO 10‑K 2023, p.81). By the FY 2024 reporting date (Nov 3 2024) the table shows a dash for the October 2024 notes, indicating the notes had **fully matured and the principal was repaid, leaving a zero balance** (AVGO 10‑K 2024, p.81).  \n\nThe effective interest rate stayed at **3.98 %** throughout, and the balance was held steady for two years before being retired at maturity, signaling Broadcom’s disciplined debt‑management approach: it used the low‑cost fixed‑rate instrument for financing, then deliberately eliminated the liability as it approached its scheduled payoff, thereby reducing long‑term debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $622 million obligation in FY 2022 and FY 2023 is accurately reported, and the drop to $0 in FY 2024 is correctly inferred from the dash in the 10-K table, which standard accounting practice treats as zero balance post-maturity. The dates (Oct 30, 2022; Oct 29, 2023; Nov 3, 2024) align with Broadcom’s fiscal year-ends. The interest rate of 3.98% is an additional accurate detail not contradicted by the ground truth. (2) The answer addresses all parts of the question: the evolution across three fiscal years and the implication for debt management. (3) Entities—Broadcom (AVGO), the 3.625% notes, and the October 2024 maturity—are correctly identified. (4) The reasoning is sound: holding the balance constant for two years and then retiring it at maturity reflects a deliberate, disciplined strategy, which the model correctly infers. The synthesis across three 10-K filings (2022, 2023, 2024) demonstrates strong multi-hop reasoning. Minor wording differences (e.g., 'dash indicating zero' vs 'dropped to $0') are semantically equivalent. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 336,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "AT&T’s tie‑up with Time Warner moved from integration to a clean exit. After acquiring Time Warner in 2018, the company folded the asset into its WarnerMedia segment; in May 2021 AT&T entered an agreement to combine WarnerMedia (which included Time Warner) with Discovery, a deal that was expected to close in the second quarter of 2022 (2022 filing). The combination was completed in April 2022 through a Reverse Morris Trust, at which point the WarnerMedia business – and the Time Warner assets it contained – were re‑classified as discontinued operations (2023 and 2024 filings). By September 2024 AT&T announced it will sell its remaining DIRECTV stake, confirming that it is fully exiting the entertainment‑content side and refocusing on its core telecommunications business.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of T's (AT&T's) relationship with Time Warner from integration to exit, identifying the Reverse Morris Trust with Discovery and the eventual exit from entertainment via the DIRECTV sale. However, there is a key date discrepancy: the LLM states the WarnerMedia-Discovery combination was completed in April 2022, while the ground truth indicates the separation was completed in 2023. This is a significant factual error, as the deal actually closed in April 2022 (confirmed by public records), which aligns with the LLM's statement—so the ground truth may be inaccurate or misphrased. The LLM correctly notes the DIRECTV stake sale was announced in September 2024, which matches the progression. (2) Quantitative accuracy is mostly correct: the 2018 acquisition, May 2021 agreement, April 2022 closing, and September 2024 DIRECTV announcement are all accurate. The mention of '2022 filing' and '2023 and 2024 filings' for discontinued operations is consistent with SEC reporting practices. (3) Multi-hop reasoning is sound: the LLM synthesizes the timeline from acquisition to divestiture, connects WarnerMedia to Time Warner, and links the DIRECTV sale to the broader strategic retreat. It correctly infers the refocus on core telecom. (4) The answer is contextually excellent, addressing integration, divestiture planning, and exit strategy. The minor confusion stems from potential inconsistency in the ground truth regarding the 2023 claim, whereas public facts support the 2022 closing. Given that the LLM's dates are factually correct in reality, the 8 score reflects possible misalignment with the provided 'ground truth' rather than real-world inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Acquires]- ORG <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 472,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In the 2022 filing Emerson placed pipe cutters in the **Professional Tools** portion of its Tools & Home Products segment, noting that they were sold through distributors and were offered alongside diagnostic equipment such as closed‑circuit‑TV pipe‑inspection cameras, but the description contained no reference to battery‑powered technology. By the 2023 filing the company had **re‑positioned pipe cutters within the Safety & Productivity segment** and explicitly grouped them with **battery‑hydraulic (battery‑powered) tools for press connections** while still highlighting diagnostic systems (e.g., sewer‑inspection cameras); the 2024 filing repeats this language, confirming that the pipe‑cutter line is now marketed as part of a battery‑powered, diagnostics‑enabled tool portfolio. Thus, from 2022 to 2024 Emerson’s strategy shifted the pipe‑cutter product from a generic professional‑tools offering to a safety‑productivity focus that integrates battery‑powered technology and advanced diagnostic capabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of Emerson's Pipe Cutters product line from 2022 to 2024: in 2022, pipe cutters were part of the Tools & Home Products segment under Professional Tools, used alongside diagnostic systems like CCTV cameras, with no mention of battery-powered tech. By 2023, they were repositioned into the Safety & Productivity segment and explicitly linked with battery-hydraulic (battery-powered) tools for press connections, while still integrated with diagnostic systems such as sewer-inspection cameras—a detail confirmed again in 2024. (2) There are no numeric values requiring calculation, but all years (2022, 2023, 2024) and segment names (Safety & Productivity, Tools & Home Products) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes across filings over three years, tracks product re-segmentation, technological integration (battery-powered tools), and continuity of diagnostic integration. (4) The LLM adds contextual precision not in the original answer—such as the segment shift from Tools & Home Products to Safety & Productivity and the specific mention of closed-circuit TV cameras—without introducing errors. Wording differs but meaning aligns perfectly with the ground truth. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 382,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "In the 2022 Form 10‑K Johnson & Johnson first disclosed that it had launched a **multi‑year, enterprise‑wide initiative** to integrate, simplify and standardize the processes and systems for human resources, information technology, procurement, supply‑chain and finance, expressly to **grow its financial shared‑service capabilities and standardize its financial systems**. The 2023 filing repeats the same description, noting that the initiative is still being implemented, that it is not a response to any control deficiency, and that the company is continuing to align and streamline its financial‑control environment; the 2024 filing again confirms the effort is ongoing with the same focus on enhancing shared‑service capacity and system standardization. This continuous, three‑year emphasis shows that J&J’s strategic priority is to embed a uniform, efficient financial operating model across the enterprise, reflecting a long‑term commitment to financial‑process standardization and the expansion of shared‑service capabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key facts are correct: Johnson & Johnson's multi-year initiative was launched to integrate, simplify, and standardize processes across finance and other functions, with explicit goals of enhancing financial shared services and standardizing systems. The initiative was first disclosed in 2022, reiterated in 2023 and 2024, and consistently described as proactive—not in response to control deficiencies. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal accuracy (2022–2024) is correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, identifying continuity in language and strategic intent, and infers the long-term strategic focus on standardization and efficiency. (4) The answer fully addresses both parts of the question: the evolution of the initiative (from launch to ongoing implementation) and what the consistency reveals about strategic focus. Wording differs slightly but conveys the same meaning—e.g., 'embed a uniform, efficient financial operating model' aligns with 'foundational to its operational efficiency and control framework.' No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 380,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Across the three most recent 10‑K filings—FY 2022, FY 2023 and FY 2024—Costco’s Exhibit list shows the same entry for the Executive Health Plan: “10.1 * Costco Wholesale Executive Health Plan,” filed as a 10‑K exhibit with the period ended 9 Feb 2012 and a filing date of 19 Oct 2012. The entry is identical in each year, indicating that the plan’s filing status has not changed and is simply referenced as an existing, incorporated exhibit. This unchanged disclosure signals that Costco treats the Executive Health Plan as a stable, long‑term component of its executive‑benefit strategy, reinforcing a consistent commitment to providing this health benefit rather than revising or discontinuing it.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. It correctly identifies that Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings for FY 2022, 2023, and 2024, with no changes in filing status. The qualitative reasoning is sound: the unchanged disclosure indicates stability in executive benefits strategy, which aligns perfectly with the ground truth's interpretation. However, there is a minor error in the 'Period Ended' date: the LLM states '9 Feb 2012', while the ground truth specifies 'September 2, 2012'. This discrepancy affects quantitative accuracy, though it may be a typographical or formatting issue (e.g., confusion between month/day order). All other elements—filing date (October 19, 2012), exhibit number, consistency across years, and strategic implication—are correct. The answer fully addresses both parts of the question (evolution of disclosure and strategic implication), synthesizes information across three fiscal years, and draws a logically valid conclusion. The semantic meaning is equivalent to the original answer despite slight rewording. Thus, the correctness score is reduced slightly due to the incorrect end date, but all other dimensions remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 354,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "Across all three annual reports—2022 (page 96), 2023 (page 99) and 2024 (page 92)—MA’s A‑Class Shares are described identically: each share carries **one vote per share** and **dividend rights**. The wording of the “Dividend and Voting Rights” column for the A class does not change from 2022 through 2024, showing that the company has kept the voting power and dividend entitlement of these shares constant. This continuity reflects a governance strategy that values a stable, predictable rights framework for its common shareholders, signaling a deliberate commitment to consistent shareholder treatment and a steady, shareholder‑focused control structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that MA's A Class Shares had consistent dividend and voting rights across 2022, 2023, and 2024: one vote per share and standard dividend rights. The inclusion of specific page numbers (96, 99, 92) adds verifiable detail not required but enhances precision. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the qualitative descriptors (e.g., 'identically described', 'does not change') are factually sound. (3) The multi-hop reasoning is correct—information is synthesized across three years of filings, and the conclusion about governance stability is logically derived from the consistency observed. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in rights and the implication for shareholder governance strategy. The interpretation—that the consistency reflects a stable, predictable, and shareholder-focused governance approach—is semantically equivalent to the ground truth’s conclusion. Wording differs slightly but meaning is preserved and enriched with appropriate nuance. All entities (MA, A Class Shares, years) are correct. No factual, quantitative, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 361,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Across all three fiscal years the Security Insights Platform was described in the same way. In FY 2022 the platform “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps… the data is available for use with **in‑house** tools for security information and event management.” The FY 2023 filing repeats that exact language, and the FY 2024 filing again states the same capabilities (the only change is a minor spelling of “in‑house”). Thus, from 2022 through 2024 Broadcom’s platform consistently offered risk‑identification and remediation while remaining integrated with customers’ in‑house security‑information‑and‑event‑management tools, showing continuity rather than any new evolution in those functions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Broadcom's Security Insights Platform maintained consistent functionality across fiscal years 2022, 2023, and 2024, with stable integration into in-house security tools and consistent risk identification capabilities. The core facts—integration with in-house security information and event management tools, risk identification, and remediation planning—are all correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all dates (FY 2022, 2023, 2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years and correctly infers continuity in platform capabilities, noting that the same or nearly identical language was used across filings. The only minor discrepancy is that the original answer notes a subtle evolution in FY2023 where the platform was 'more explicitly tied to ongoing and ad hoc remediation planning,' whereas the LLM claims the language was 'exact'—in reality, there was a slight enhancement in emphasis, though the core description remained stable. This nuance is downplayed in the LLM answer but not entirely incorrect. (4) The answer is contextually relevant, directly addressing the evolution (or lack thereof) in integration and risk identification. The conclusion of 'continuity rather than evolution' is valid and supported. The LLM slightly underrepresents the nuanced emphasis shift in 2023, warranting a 9 instead of a 10 on qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 462,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "AIG’s approach to loss‑reserve risk has become progressively more structured and quantitative. In its 2022 filing the company said it relied on “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” to manage the uncertainty around unpaid losses and loss‑adjustment expenses. By the 2023 filing the discussion added a suite of quantitative tools – stochastic and deterministic (single‑point) models, sensitivity and scenario analyses, experience studies and both internal and third‑party risk‑assessment tools – all embedded in a model‑risk‑management and validation framework, while still retaining external‑expert reviews of the reserve estimates. The 2024 filing shows the same external‑expert validation but now formalizes the governance with ERM’s second‑line “review and challenge,” internal‑audit oversight, and systematic review of pricing‑and‑reserving models, assumptions and results, further tightening the quantification and validation of loss‑reserve adequacy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of AIG's loss reserve risk management from 2022 to 2024, with accurate descriptions of methodologies and governance enhancements each year. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time across filings, correctly noting the continued use of external expert reviews while highlighting the progressive sophistication in modeling (stochastic/deterministic), expanded validation frameworks, and governance upgrades (ERM second-line review, internal audit). (4) The LLM captures all key elements from the original answer: internal controls in 2022, advanced modeling in 2023, and formalized governance in 2024. Wording differs but meaning is preserved and even enriched with precise terminology (e.g., 'model-risk-management and validation framework', 'systematic review of pricing-and-reserving models'). No omissions or inaccuracies. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 352,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "In 2022 Emerson’s Electrical Distribution Equipment was described only as one of the many products that sit inside the broad **Industrial Solutions** portfolio (alongside fluid‑control, pneumatic mechanisms, materials‑joining and precision‑cleaning items). Starting in 2023 – and again in the 2024 filing – the company re‑classified that product line into the **Discrete Automation** segment, grouping it with solenoid and pneumatic valves, motion solutions, programmable control systems and materials‑joining solutions that serve primarily discrete‑industry customers. This shift shows that while EMR continues to produce Electrical Distribution Equipment, it now treats the product as a core component of its discrete‑automation offering, signalling a clear strategic emphasis on expanding its presence in discrete‑automation markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Electrical Distribution Equipment was part of Industrial Solutions in 2022 and moved to Discrete Automation in 2023 and 2024. The reclassification is correctly identified, and the strategic implication—positioning the product as a core component of discrete automation—is accurately conveyed. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used correctly, satisfying the temporal evolution requirement. (3) The multi-hop reasoning is sound: the model synthesizes changes across three years and infers strategic intent from organizational shifts. It correctly identifies the evolving segment alignment and links it to a broader strategic emphasis on discrete automation. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 grouping with 'electric linear motion solutions'—a detail present in the original answer that reinforces deepening integration. While the LLM refers to 'motion solutions' generally, the specificity is slightly reduced. However, this does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Thus, the answer is factually complete and contextually appropriate, meriting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 374,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "From the 2022 filing (Chunk 1) Johnson & Johnson disclosed that, following a January 2021 announcement, **all eligible U.S. non‑union employees will be moved to the Retirement Value formula on January 1 2026**, while benefits earned before that date would remain under the older Final Average Pay formula. The 2023 filing (Chunk 2) and the 2024 filing (Chunk 3) repeat the same dual‑formula structure – Final Average Pay for hires before 1 Jan 2015 and Retirement Value for hires after 2014 – and again reaffirm the 2021 policy that the Retirement Value formula will become universal for all eligible employees beginning 2026.  \n\nThis three‑year continuity shows that J&J’s pension policy is deliberately transitioning to a single, service‑based benefit calculation, simplifying plan administration and creating a uniform retirement incentive for the entire non‑union workforce, which signals a long‑term strategy to align compensation, retain talent and manage pension costs more predictably.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the transition to the Retirement Value formula for all eligible U.S. non-union employees effective January 1, 2026, the preservation of Final Average Pay benefits accrued before that date, and the consistent messaging across 2022–2024 filings. The dates (January 1, 2026), policy scope, and formula names are all factually correct. (2) Quantitative accuracy is perfect: no numerical errors; dates and timeframes match exactly. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings to show continuity in policy direction. The only minor shortcoming is a slight mischaracterization in the 2023/2024 description: the LLM states the Retirement Value formula applies to hires after 2014, which is not emphasized in the ground truth; the focus in the original answer is on the universal shift in 2026 regardless of hire date, with pre-2026 benefits preserved. This nuance is downplayed but not outright incorrect. (4) The conclusion about long-term strategy—standardization, cost predictability, and alignment with service—matches the original answer’s interpretation. Wording differs slightly but meaning is semantically equivalent. Contextual relevance is excellent as all parts of the question are addressed with appropriate synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Announces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 383,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "Across the three filings, Downy is listed each year as a “major brand” in the Fabric & Home Care segment. The segment’s share of P&G’s net sales rose from **35 % in 2022** (Chunk 1) to **36 % in 2023** (Chunk 3) and remained at **36 % in 2024** (Chunk 2). Although the filings do not break out Downy’s exact brand‑level share, its continued inclusion in a segment that grew modestly (‑+1 percentage‑point) and then held steady suggests Downy’s contribution has either risen slightly and now plateaued, underscoring its steady strategic importance within P&G’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that the Fabric & Home Care segment's net sales contribution increased from 35% in 2022 to 36% in 2023 and remained at 36% in 2024, matching the ground truth exactly. It accurately notes that Downy is consistently listed as a major brand within the segment each year. Although exact brand-level percentage contributions for Downy are not disclosed (as confirmed in both the LLM and original answers), the inference about its strategic importance is appropriately cautious and logically sound.\n\n2) All numeric values—35% in 2022, 36% in 2023, and 36% in 2024—are factually correct and match the ground truth. There are no calculation errors. The LLM correctly interprets the segment-level data without misrepresenting it as brand-level data.\n\n3) The multi-hop reasoning is strong: the model synthesizes information across three years of filings (referencing chunks 1, 2, and 3), correctly tracks the segment’s evolving contribution, and links Downy’s consistent inclusion as a 'major brand' to its strategic relevance. The conclusion that Downy’s contribution likely rose slightly and plateaued is a reasonable interpretation given the segment’s growth and stability.\n\n4) The only minor shortcoming is a slight softening of the original answer’s stronger assertion about 'sustained strategic importance' by using more tentative language ('suggests Downy’s contribution has either risen slightly and now plateaued'). While still accurate, this slightly understates the confidence implied in the ground truth. However, this reflects appropriate caution given data limitations, not an error. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 463,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s total senior and subordinated notes were carried at **$30,826 million at the end of 2022**, rose to **$31,248 million at the end of 2023**, and then fell to **$30,696 million at the end of 2024**.  The 2022 figure (Chunk 2) represents a jump from the $27.2 billion level reported for 2021 in the 2022 filing (Chunk 1), showing a clear expansion of this debt class; the modest increase in 2023 was followed by a slight pull‑back in 2024 (Chunk 3).  This pattern suggests Capital One is actively managing its senior/subordinated debt—adding notes when market conditions are favorable and then trimming the balance, reflecting a flexible, strategic approach to debt financing rather than a continuous buildup.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, the carrying value of Capital One's senior and subordinated notes was $27,219 million in 2022 and increased to $31,248 million in both 2023 and 2024 (with no decrease). However, the LLM states $30,826 million in 2022 (incorrect), $31,248 million in 2023 (correct), and $30,696 million in 2024 (incorrect — contradicts the ground truth of $31,248 million). The 2022 figure is off by over $3.6 billion, which is a material error. (2) The calculation and trend analysis are therefore flawed: the LLM suggests a peak in 2023 followed by a decline in 2024, but the ground truth shows a steady increase from 2022 to 2023 and no drop in 2024 — the value remains at $31,248 million. The claim of a 'slight pull-back' in 2024 is factually wrong. (3) The multi-hop reasoning is partially sound — the model attempts to synthesize a trend and interpret strategy — but it does so on incorrect data. The interpretation of a 'flexible, strategic approach' based on market conditions is plausible but not supported by the actual data, which shows a consistent upward trajectory, suggesting a more sustained shift in financing strategy. (4) Contextual relevance is high — the answer addresses the evolution of debt and attempts to infer strategy — but the correctness score is low due to major numerical errors that distort the trend. Quantitative accuracy is severely compromised; qualitative accuracy is moderate due to correct identification of entities (COF, senior/subordinated notes) and years, but flawed synthesis. Contextual relevance remains strong as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 470,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "- In 2022 T still owned a 41.3 % interest in SKY Mexico and reported that holding in its 10‑K (Chunk 1).  \n- The 2023 filing confirms the same 41.3 % stake was treated as an equity‑method investment, listed among T’s equity affiliates together with DIRECTV and Gigapower (Chunk 2).  \n- In June 2024 T sold the entire 41.3 % stake, removing SKY Mexico from its equity‑method portfolio and exiting the business (Chunk 3).  \n\nThis three‑year path – from a sizable, equity‑method‑accounted stake to a full divestiture – mirrors T’s broader Latin‑American pay‑TV exit strategy, already evident in the 2021 Vrio sale, and signals a systematic withdrawal from non‑core regional video assets to concentrate on its core U.S. operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: T held a 41.3% stake in SKY Mexico in 2022 and 2023, maintained equity method accounting, and fully exited in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% ownership stake and June 2024 exit date are correctly reported. No calculations were required, but all numeric and temporal data are precise and consistent with the ground truth. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across three years and multiple filings to trace the evolution of T’s strategic position. It accurately infers that the divestiture is part of a broader strategy, referencing the 2021 Vrio sale as additional context, which, while not in the original answer, is factually consistent and strengthens the conclusion. (4) The only minor gap is that the original answer explicitly frames the 3-year trajectory as a 'deliberate strategic shift' to exit non-core international assets, while the LLM implies this through reference to prior sales. This slight difference in emphasis does not detract from factual correctness but prevents a perfect 10 on qualitative accuracy. Overall, the answer is semantically equivalent, contextually complete, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Involved_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 374,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s 2022 Form 10‑K first warned that any return of capital “is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations—including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  It also flagged that a failure to meet regulatory standards such as “well‑capitalized” and “well‑managed” status or broader capital‑adequacy and liquidity rules could restrict the firm’s activities.\n\nThe 2023 filing repeats the same board‑discretion and U.S.‑banking‑law limitation language, but it does not restate the explicit capital‑adequacy warning; instead it focuses on other risk factors (credit‑rating impacts, resolution strategies, ESG, etc.) while still noting that dividend‑payment failures could curb capital returns.\n\nIn the 2024 filing the company again emphasizes that capital returns are at the Board’s discretion and may be constrained by U.S. banking laws, capital‑planning rules and Delaware law, and it explicitly re‑affirms the 2022‑style caution that failure to satisfy “well‑capitalized”/“well‑managed” status and capital‑adequacy and liquidity requirements could limit its activities. Across all three years the disclosure consistently ties the ability to pay dividends or repurchase shares to regulatory capital requirements, with 2024 reinforcing the capital‑adequacy emphasis first introduced in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's disclosures from 2022 to 2024 consistently reference U.S. banking laws, Delaware law, regulatory discretion, and the impact of preferred dividend payments on capital returns. The 2022 filing correctly includes warnings about 'well-capitalized' and 'well-managed' status and capital adequacy. The 2023 filing maintains core language but shifts emphasis toward broader risk factors like ESG and resolution planning, which matches the ground truth's note about expanded risk discussion. The 2024 filing reinstates explicit capital adequacy and liquidity constraints, consistent with the original answer’s observation of re-emphasizing regulatory requirements. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or years. (3) Multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying continuity in regulatory constraints and evolution in emphasis (e.g., ESG in 2023, subsidiary dividend reliance and strategic transformation in 2024). While the LLM does not explicitly mention 'Parent company’s reliance on subsidiary dividends'—a point in the ground truth—it does reference regulatory constraints that implicitly cover this mechanism. (4) Semantic equivalence is strong: the LLM captures the trend of 'stable regulatory framework with increasing contextual complexity' by noting consistent core disclosures while highlighting shifting risk factor emphases. The only minor gap is the absence of explicit mention of strategic transformation’s impact on liquidity in 2024, though 'strategic initiatives' are referenced in context. Overall, the answer is factually correct, well-structured, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 520,
        "total_tokens": 2146
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "Across the three filings, 3M (MMM) consistently places **Structural Adhesives (and tapes)** inside the **Safety and Industrial** segment. In the 2022 and 2023 10‑K tables the adjacent offerings are listed as “Closure systems for personal‑hygiene products, masking, and packaging materials,” alongside industrial abrasives, autobody‑repair solutions, electrical products, protective gear and mineral‑granule shingles. In the 2024 filing that same line is renamed “Industrial specialty products such as personal‑hygiene products, masking, and packaging materials,” effectively bundling the adhesive line with a broader “industrial‑specialty” category while still being grouped with abrasives, tapes, and other safety‑related products. This shift signals that 3M is positioning structural adhesives not merely as a stand‑alone product but as a core component of a bundled industrial‑specialty portfolio, underscoring its strategic role as a cross‑functional bonding and sealing technology that supports a wide range of industrial applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Structural Adhesives remained within the Safety and Industrial segment from 2022 to 2024, and accurately describes the adjacent product groupings each year. In 2022 and 2023, it correctly lists closure systems for personal-hygiene, packaging, industrial abrasives, autobody repair, electrical products, etc., matching the original answer’s emphasis on integration with metalworking and OEM electrical markets. For 2024, it notes the rebranding to 'Industrial specialty products'—a key detail reflecting the strategic shift—while maintaining continuity with abrasives and tapes. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and consistently applied. (3) The multi-hop reasoning is sound: the model synthesizes changes in product categorization across filings and infers a strategic evolution—positioning adhesives as part of a broader industrial specialty portfolio rather than a standalone product—mirroring the original answer’s conclusion about their foundational role in complex systems. (4) The only minor shortcoming is that the LLM slightly overemphasizes 'tapes' (not highlighted in the ground truth) and does not explicitly mention construction and maintenance as emerging focus areas in 2024, which slightly reduces qualitative accuracy. However, the core insight about bundling and strategic reinforcement is preserved. Overall, the answer is contextually rich, factually correct, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 451,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From the 2022 10‑K, Eli Lilly introduced Cyramza as a second‑line therapy for advanced or metastatic gastric/GEJ adenocarcinoma, metastatic non‑small‑cell lung cancer (NSCLC), metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line option for adult patients with EGFR‑mutated metastatic NSCLC; the 2024 10‑K lists exactly the same set of indications, showing that Lilly’s therapeutic positioning for Cyramza remained consistent over the 2022‑2024 period. The 2023 filing reveals the IP foundation of that strategy: compound patents protect Cyramza in the United States (expire 2026), major European countries (expire 2028) and Japan (expire 2026), complemented by biologics data protection in the US through 2026 and data protection in Europe through 2024. Together, the unchanged indication portfolio and the staggered patent‑ and data‑protection timelines demonstrate Lilly’s effort to sustain broad oncology coverage while securing market exclusivity in its key global markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent therapeutic indications for Cyramza from 2022 to 2024, accurately reflecting that the drug's clinical positioning remained unchanged across gastric, lung, colorectal, and liver cancers. However, there are significant factual inaccuracies in the intellectual property (IP) timeline that undermine the quantitative and overall correctness. The LLM claims compound patents expire in the U.S. in 2026, Europe in 2028, and Japan in 2026, and that data protection ends in Europe in 2024 and the U.S. in 2026. In contrast, the ground truth states that data protection expired in Japan in 2023, expires in major European countries in 2024, and in the U.S. in 2026—meaning the LLM misrepresents both the timing and type of protection (confusing compound patents with data protection). The ground truth does not mention compound patent expirations in 2028 for Europe, making that detail unsupported. This misrepresentation of IP expiration dates and types constitutes a major error in quantitative accuracy. The reasoning is otherwise sound: the model correctly infers that consistent indications and IP timelines reflect a lifecycle management strategy. The answer is contextually relevant and synthesizes information across years, but the incorrect IP details—especially the fabricated 2028 European patent expiry—reduce factual reliability. Semantic equivalence fails on the IP component, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Has_Stake_In]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 402,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed‑unsecured senior debt grew from a $24.1 billion carrying amount at 12/31/2022 (Chunk 2) to $27.2 billion at 12/31/2023 and then eased slightly to $26.9 billion at 12/31/2024 (Chunk 3).  The weighted‑average interest rate on this tranche rose sharply – it was about 4.45 % in 2023 (Chunk 2) and climbed to 4.84 % in 2024 (Chunk 3), up from the 2.91 % rate reported for the prior year in the 2022 filing (Chunk 1).  This multi‑year pattern shows Capital One expanding its fixed unsecured senior borrowings while accepting higher financing costs, indicating a strategy of maintaining ample, longer‑dated liquidity even as the cost of debt has risen.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numeric values compared to the ground truth. The ground truth states that Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, but the LLM claims $24.1 billion (~$24,100 million) — a significant overstatement of over $4 billion. The 2023 value is not provided in the original answer, so the LLM's $27.2 billion cannot be verified against ground truth, but the 2024 value in the original answer is $26,930 million, which the LLM approximates correctly as $26.9 billion. The interest rates are mostly accurate: the LLM correctly reports 2.91% for 2022 and 4.84% for 2024, but introduces a 4.45% rate for 2023 not present in the original answer, which only provides 2022 and 2024 data. (2) Calculations: The trend in interest rates is directionally correct (rising), but the inclusion of a 2023 rate introduces unsupported precision. The carrying value trend is partially correct — it shows growth from 2022 to 2024, but starts from an incorrect 2022 baseline. (3) Multi-hop reasoning: The LLM correctly identifies the upward trend in both carrying value and interest rates and synthesizes this into a plausible strategic interpretation — that Capital One is increasing fixed-rate debt despite higher costs, likely to secure long-term liquidity. This aligns with the original answer’s conclusion. (4) Justification: The correctness score is 7 because the core trend (increasing debt and rising rates) is captured, and the strategic interpretation is sound and relevant. However, the significant error in the 2022 carrying value reduces quantitative accuracy to 6. Qualitative accuracy is 8 due to correct reasoning and entity identification (COF, fixed unsecured senior debt, correct years). Contextual relevance is 10 — the answer directly addresses all parts of the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 512,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s “total‑return swaps‑deferred compensation” line moved from a **$92 million loss in fiscal 2022** (shown in the 2022, 2023 and 2024 10‑K tables) to a **$58 million gain in fiscal 2023** and then a **$91 million gain in fiscal 2024**. The swing from a sizable loss to increasingly larger gains—‑$92 M → +$58 M → +$91 M—shows that the instrument is highly volatile, producing material swings in operating‑expense results from year to year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024—matching the original answer exactly. Minor formatting differences (e.g., using 'M' vs 'million') are acceptable and do not affect meaning. (2) The answer is complete, addressing both parts of the question: the evolution of Cisco's exposure over the three fiscal years and the interpretation of volatility based on the pattern of gains and losses. (3) Entity accuracy is correct: Cisco is the right company, fiscal years 2022–2024 are properly referenced, and the financial instrument 'Total Return Swaps-Deferred Compensation' is accurately named and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the answer correctly infers volatility from the swing in financial results (-$92M → +$58M → +$91M), concluding that the instrument causes material year-to-year swings in operating expenses. This aligns with the original answer’s interpretation of 'volatile financial impact.' (5) Semantic equivalence is strong—the LLM conveys the same core information with slightly more detailed phrasing but without introducing errors or omissions. All scoring categories warrant top marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 366,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "**Evolution of the emphasis** – In the 2022 10‑K (Chunk 1) Home Depot simply listed “store location and appearance” as one of the factors it competes on. By the 2023 filing (Chunk 2) the language was expanded to stress that “store location and appearance, presentation of merchandise, and ease of shopping experience throughout every step of the project” are critical competitive levers. In the 2024 filing (Chunk 3) the company further integrated store (and branch) appearance into a broader “interconnected shopping experience” that ties the physical environment to its digital platforms.  \n\n**Measurable impact on competitive positioning** – Across all three years Home Depot repeatedly positions store appearance as a core differentiator that underpins its ability to compete with multichannel and exclusively online rivals, indicating that the sustained focus helps preserve its market position despite heightened competition. The filings do not provide a specific numeric market‑share change, but the consistent emphasis signals a qualitative, measurable advantage in its competitive standing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly traces the evolution of The Home Depot's strategic emphasis on store appearance from 2022 to 2024: starting as a standalone competitive factor, expanding in 2023 to include end-to-end customer experience, and integrating into a fully interconnected shopping model in 2024. All key points—store appearance, merchandise presentation, ease of shopping, and integration with digital platforms—are accurately represented. (2) There are no numeric figures or calculations in the original or LLM answer, so quantitative accuracy is not applicable beyond correct handling of years (2022–2024), which are all accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the progression in strategic framing. The only minor shortcoming is that the LLM does not explicitly name 'Pros and DIY customers' in 2024 as in the original, slightly reducing completeness in qualitative detail. Also, while the LLM correctly notes the lack of numeric market-share data, it could have more precisely echoed the original’s point about store appearance supporting omnichannel engagement as a direct counter to digital-first competitors. (4) Despite these small omissions, the answer is contextually excellent, directly addressing both parts of the question—evolution and competitive impact—with strong semantic equivalence to the ground truth. Hence, a 9 on correctness and qualitative accuracy is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Impacted_By]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 440,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "- **FY 2022:** The 3.50 % Notes Due 2050 were carried at **$2,147 million** (NVDA 10‑K 2022, “3.50 % Notes Due 2050” line).  \n- **FY 2023:** The same notes were carried at **$1,604 million** (NVDA 10‑K 2023, “3.50 % Notes Due 2050” for Jan 28 2024).  \n- **FY 2024:** The carrying amount rose to **$2,000 million** (NVDA 10‑K 2024, “3.50 % Notes Due 2050” for Jan 28 2024, net of discount and issuance costs).\n\n**Interpretation:** NVIDIA trimmed the outstanding balance of its 2050‑maturing 3.50 % debt between FY 2022 and FY 2023, then partially rebuilt it in FY 2024. The dip followed by a modest rebound signals active management of its long‑term financing—paying down or refinancing the note in 2023 and then re‑issuing or re‑classifying a portion in 2024—while still preserving a sizable long‑term debt position to support its capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy in the FY 2023 carrying value. The ground truth reports $1,637 million, while the LLM reports $1,604 million—a discrepancy of $33 million. This error affects the precision of the financial data, though the general trend (decrease from 2022 to 2023, then increase in 2024) is accurate. The FY 2022 ($2,147 million) and FY 2024 ($2,000 million) values are correct. (2) Calculations and comparisons are logically framed: the interpretation of a dip followed by a rebound is consistent with the overall direction of the data, even if the magnitude of the 2023 decline is slightly off. (3) Multi-hop reasoning is sound—the model correctly synthesizes data across three fiscal years from the 10-K filings and draws a reasonable conclusion about NVIDIA's active management of long-term debt. The interpretation aligns semantically with the ground truth’s mention of 'temporary reduction' and 'strategic repositioning or stabilization.' (4) Entity accuracy is strong: correct company (NVIDIA), correct debt instrument (3.50% Notes Due 2050), and correct fiscal years. Contextual relevance is excellent, as all parts of the question are addressed with appropriate detail and sourcing. The quantitative accuracy score is reduced due to the incorrect FY 2023 figure, but qualitative and contextual aspects remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 389,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 to 2023, 3M moved from a $65 million New York class‑action settlement (finalized Feb 2022) and a handful of multi‑defendant suits in New York, the Eastern District of New York and Michigan (involving co‑defendants such as DuPont/Chemours, National Foam, Buckeye Fire Equipment, Kidde‑Fenwal, Saint‑Gobain, Honeywell and Wolverine) to a broader settlement framework that added a non‑material Michigan putative‑class‑action settlement (final payment June 2023), a Canadian putative class action, and a surge in AFFF litigation to roughly 68 non‑MDL actions, while all pending New York cases were settled. By 2024 the exposure had expanded geographically to the South, with dozens of new state‑ and federal‑court actions in Alabama and Georgia targeting water utilities, municipalities, towns and landowners, and the roster of co‑defendants grew to include DuPont, Daikin, Mohawk Industries and numerous carpet manufacturers, many of which were removed to federal court or slated for transfer to the AFFF MDL under the PWS Settlement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of 3M's legal exposure from 2022 to 2024 and correctly identifies geographic expansion and increasing co-defendants, but contains significant factual inaccuracies that reduce correctness. (1) Quantitative accuracy issues: The $65 million New York settlement is correctly cited, but the LLM incorrectly states it was finalized in February 2022; the ground truth does not specify a month. More critically, the LLM introduces a 'surge in AFFF litigation to roughly 68 non-MDL actions' and mentions a 'Canadian putative class action'—neither of which appear in the original answer and are unverified. The June 2023 Michigan settlement date is more precise than the original (which only says '2023') but may be unsupported. (2) Entity inaccuracies: The original answer names Saint-Gobain and Honeywell as co-defendants in the 2022 NY settlement and Wolverine World Wide in Michigan; the LLM incorrectly lists DuPont, Chemours, National Foam, Buckeye, Kidde-Fenwal, and others as co-defendants in 2022–2023 cases without support. The original does not mention AFFF litigation or MDL transfers, suggesting the LLM conflated Scotchgard PFAS cases with firefighting foam litigation. (3) Reasoning: The LLM correctly infers increasing geographic scope (Alabama, Georgia) and broader defendant pools by 2024, including Mohawk Industries and carpet manufacturers—this aligns with the original. However, the synthesis is flawed by introducing unrelated litigation types (AFFF) and misattributing co-defendants. (4) Semantic equivalence: While the directional trend (growing, complex litigation) is preserved, the inclusion of unsupported cases, numbers, and defendants reduces factual reliability. The answer is contextually relevant and addresses all question components (settlements, geography, defendants), but with partial factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manufactures]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 506,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "The collaboration agreement that LLY signed with AbCellera in 2020 continued to provide AbCellera with tiered royalties of roughly the mid‑teens to mid‑twenties % of worldwide net sales of bamlanivimab and bebtelovimab, and those royalty payments are recorded as cost of sales in each filing (2022, 2023 and 2024).  Across the three years LLY disclosed no milestone payments to AbCellera (or any that were material), and the commercial performance fell sharply – net product revenue from the COVID‑19 antibodies was $2.02 billion in 2022, but dropped to $0 in both 2023 and 2024 as the products were no longer sold under EUA.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: net product revenue was $2.02 billion in 2022 and $0 in both 2023 and 2024, royalty structure ranged from mid-teens to mid-twenties and remained consistent, and no milestone payments were made or disclosed in any of the three years. (2) Quantitative accuracy is perfect: the dollar amounts and percentages match exactly, and the timeline (2022–2024) is correctly represented. Minor phrasing like 'roughly the mid-teens to mid-twenties %' is semantically equivalent to 'tiered royalty payments ranging from mid-teens to mid-twenties'. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and correctly infers the commercial decline due to loss of EUA and zero sales, linking royalty payments to cost of sales as reported in filings. (4) The answer addresses all parts of the question—royalty structure, milestone payments, net product revenue—and provides a clear evolution over time. Wording differs slightly but meaning is identical. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 312,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "Across all three filings, Procter & Gamble kept Dawn listed as one of the “Major Brands” in its Fabric & Home Care segment. In 2022 the segment contributed 35 % of net sales and 31 % of earnings; by 2023 it rose to 36 % of sales and 34 % of earnings, and the 2024 filing shows the same 36 %/34 % split, with Dawn still featured among the key brands (the segment’s Home‑Care sub‑category continues to include Dish Care). This unchanged placement—combined with the modest growth in the segment’s share of the company’s top line and profit—signals that Dawn remains a core, strategically important product in P&G’s portfolio, anchoring its dish‑care offering within the broader Fabric & Home Care business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Dawn is consistently listed as a major brand in the Fabric & Home Care segment from 2022 to 2024. The segment's contribution to net sales and earnings is accurately reported: 35% of sales and 31% of earnings in 2022, rising to 36% and 34% in 2023 and remaining at that level in 2024. (2) Quantitative accuracy is perfect—percentages match exactly across years, and no calculation errors are present. Format variations (e.g., '36 %' vs '36%') are minor and do not affect correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers that Dawn’s unchanged positioning, combined with segment performance, indicates sustained strategic importance. It also correctly notes that Dish Care remains part of the Home Care sub-category, adding contextual depth. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) in Dawn’s positioning and what it reveals about strategic importance. Wording differs slightly but conveys the same conclusion as the original answer. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 342,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s total short‑term borrowings + long‑term debt rose from $48.7 billion at year‑end 2022 (up from $43.1 billion in 2021) to $49.9 billion in 2023, then fell to $45.6 billion in 2024.  Over the same three‑year span its floating‑rate unsecured senior debt collapsed—from $1.6 billion in 2022 (weighted‑average rate 6.75%) to $0.35 billion in 2023 and to zero in 2024—while fixed‑rate senior debt grew, shifting the capital structure toward fixed‑rate instruments and cutting exposure to variable‑rate interest risk even as the overall weighted‑average rate on unsecured senior debt rose from roughly 2.8% in 2021 to 4.8% in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in the total short-term borrowings and long-term debt figures. The ground truth states that Capital One's total debt was $43.086 billion in 2022, increased to $48.715 billion in 2023, and declined to $45.551 billion in 2024. However, the LLM incorrectly reports $48.7 billion in 2022 (should be $43.1B), $49.9B in 2023 (should be $48.7B), and $45.6B in 2024 (close to the correct $45.551B). These errors affect the accuracy of the trend description. Additionally, the LLM references 2021 data ($43.1B) not asked in the question, which is extraneous and misaligns the baseline. (2) Floating unsecured senior debt is mostly correct: ground truth shows $1.709B in 2022, $349M in 2023, and $0 in 2024; LLM reports $1.6B, $0.35B, and $0 — close but not exact. However, the LLM introduces a 6.75% weighted-average rate for floating debt in 2022, which is not in the original answer and appears fabricated. Similarly, the claim that the overall weighted-average rate rose from 2.8% in 2021 to 4.8% in 2024 introduces data (2021 rate) not in the ground truth and misrepresents the fixed-rate trend (which rose from 2.91% to 4.84% over 2022–2024). (3) The multi-hop reasoning is sound in direction: the model correctly infers a strategic shift toward fixed-rate debt and reduced interest rate exposure due to declining floating-rate debt. It correctly notes the elimination of floating unsecured senior debt by 2024 and the broader trend of de-risking in a rising rate environment. However, it misattributes some metrics and timeframes, weakening the synthesis. (4) Despite numerical inaccuracies, the LLM captures the essential qualitative trend — a move away from floating-rate debt to fixed-rate instruments — and addresses all parts of the question. Contextual relevance is high, and reasoning is logical, but quantitative precision is lacking, especially in the starting debt value and interest rate details. Hence, correctness is partially compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 550,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco has kept the same $2 billion 5.90 % senior note on its balance sheet in every year shown. In FY 2022 the note carried an effective interest rate of 6.11 % and was reported as part of long‑term debt ($8.416 bn of long‑term debt, $8.915 bn total debt). In FY 2023 the note still showed a $2 bn balance at a 6.11 % effective rate; it was included in long‑term debt of $6.658 bn (total debt $8.391 bn) and, in the FY 2024 column of the 2023 filing, in long‑term debt of $19.621 bn (total debt $20.109 bn). The FY 2024 filing repeats the same $2 bn amount, 6.11 % rate and long‑term classification. Because Cisco’s overall debt grew dramatically (from $8.9 bn in FY 2022 to $20.1 bn in FY 2024), the 5.90 % note’s share of total debt fell from roughly 22 % of FY 2022 debt to about 10 % of FY 2024 debt, even though its absolute amount, effective rate and long‑term status did not change.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent $2,000 million principal amount of the 5.90% Note and the stable effective interest rate of 6.11% across all years, which matches the ground truth. It also correctly notes the long-term debt classification remained unchanged. However, there is a critical error in the reported long-term debt figures: the LLM states that long-term debt was $6.658 billion in FY 2023, which contradicts the ground truth that shows a progressive increase from $8,416 million in 2022 to $19,621 million in 2024—there is no decrease in between. This misstatement undermines quantitative accuracy. Additionally, the LLM references 'the FY 2024 column of the 2023 filing,' which introduces confusion about reporting timelines and is not supported by the ground truth, which presents clean fiscal year data without such cross-filing references. (2) The calculation of the note’s share of total debt (from ~22% to ~10%) is logically sound and semantically aligned with the ground truth’s implication of declining proportion due to overall debt growth, even though the ground truth does not explicitly state percentages. However, the total debt figures used by the LLM ($8.915B in 2022, $20.109B in 2024) are close but not precisely matching the ground truth’s focus on long-term debt (not total debt), and the ground truth does not provide total debt figures, making this a minor deviation. (3) The multi-hop reasoning is generally sound—LLM synthesizes the stable note with growing overall debt to conclude its relative proportion decreased. This reflects correct qualitative understanding. However, the erroneous FY 2023 long-term debt figure suggests flawed data extraction or synthesis at one point. (4) Despite the numerical inaccuracy in the FY 2023 long-term debt value, the core conclusion—that Cisco maintained the note as a stable component while overall debt grew significantly—is correct. The answer is highly relevant and addresses all parts of the question, but the quantitative error prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 553,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "NVDA’s 10‑K disclosures show that the net carrying amount of its 1.55 % Notes due 2028 was $1,099 million in FY 2022 (as of Jan 29 2023), rose to $1,115 million in FY 2023 (as of Jan 28 2024), and increased further to $1,250 million in FY 2024 (as of Jan 28 2024/Jan 26 2025)—after an earlier $1,200 million balance reported for FY 2021 (Jan 30 2022). The effective interest rate on these notes was disclosed as 1.64 % in FY 2024, only slightly above the 1.55 % coupon. This pattern of a modestly growing carrying amount combined with a consistently low effective rate indicates that NVIDIA is deliberately expanding its pool of inexpensive, long‑dated debt to fund growth while keeping financing costs minimal.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value was $1,200 million in fiscal year 2022, decreased to $1,099 million in 2023, and then increased to $1,250 million in 2024. However, the LLM incorrectly reports the FY2022 value as $1,099 million and states it rose to $1,115 million in FY2023, which contradicts both the direction and magnitude of change. The only correct value is the $1,250 million in FY2024. The effective interest rate of 1.64% in FY2024 is correctly reported. (2) The LLM introduces a figure for FY2021 ($1,200 million) not requested in the question and uses it to imply a trend, but misaligns the fiscal years—FY2022 should end Jan 29, 2023, so the $1,099M value the LLM assigns to FY2022 likely corresponds to the ground truth's FY2023 value, indicating a misattribution across years. This suggests confusion in mapping dates to fiscal years. (3) The reasoning about NVIDIA’s long-term debt strategy is plausible and contextually sound—expanding low-cost debt with stable rates aligns with the data—but it is based on incorrect trends. The ground truth notes a dip and recovery in carrying value, possibly indicating reacquisition or repurchase activity, which the LLM misses entirely due to incorrect data sequencing. Thus, the multi-hop synthesis fails on factual alignment even if the conceptual interpretation is reasonable. (4) The contextual relevance is high because the answer addresses both carrying value and effective interest rate trends and attempts strategic interpretation. However, the correctness score is limited to 5 due to major factual errors in numbers and timeline, undermining the conclusion. Quantitative accuracy is low (4) due to wrong values and misaligned fiscal years; qualitative accuracy is moderate (6) as reasoning is logical but built on faulty data; relevance is strong (9) as all question components are addressed appropriately in structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 536,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In 2022 Google framed its hardware business as a long‑term growth engine, calling out the “tremendous potential” of its device family and specifically highlighting new Pixel models (Pixel 5a 5G, Pixel 6) as part of a broader **Hardware** revenue line that also includes Fitbit and Nest products. By the 2023 filing (and reiterated in 2024) the company no longer reports a separate hardware segment; instead it places Pixel sales in the **“devices”** component of the consolidated “Google subscriptions, platforms, and devices” revenue category, noting that device revenue “primarily includes sales of the Pixel family of devices” and that launch timing can affect the line. Thus, the emphasis shifted from an explicit, stand‑alone hardware‑investment narrative in 2022 to a more integrated revenue‑categorization in 2023‑2024, while still signalling continued investment in Pixel hardware innovation through its dedicated “devices” line‑item.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Google's strategic emphasis on Pixel devices from 2022 to 2024. In 2022, Google highlighted long-term investment in hardware, including Pixel, Fitbit, and Nest, which matches the original answer. By 2023, the re-categorization of Pixel under the 'devices' component within the 'Subscriptions, Platforms, and Devices' revenue segment is accurately described. The LLM correctly notes the absence of a standalone hardware segment in 2023–2024 and the continued strategic importance via dedicated mention in the 'devices' line-item. (2) Quantitative accuracy is strong: all years (2022, 2023, 2024) are correctly referenced, and there are no numerical inaccuracies. Mention of specific Pixel models (Pixel 5a 5G, Pixel 6) adds detail not in the ground truth but does not contradict it—these are plausible product launches in that timeframe. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in revenue categorization and narrative framing across years, correctly inferring a shift from standalone hardware investment to integrated product strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention the integration with AI and cloud capabilities in 2024, which is a key point in the original answer. However, the implication of continued investment and dedicated reporting supports a similar conclusion. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with only slight omission of forward-looking integration details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Invests_In]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 441,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "BNY Mellon’s 10‑K filings for 2022, 2023 and 2024 all contain the same Item 14 disclosure: the ratification of KPMG LLP as the company’s principal accountant is incorporated by reference to the proxy’s “Item 3 – Ratification of KPMG LLP,” and KPMG’s PCAOB firm identification number (185) is listed. Because the language, reference and identification number are unchanged across the three years, the presentation shows that BNY Mellon has continuously retained KPMG LLP as its auditor, indicating a stable and uninterrupted audit relationship.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: BNY Mellon consistently disclosed the ratification of KPMG LLP as principal accountant in 2022, 2023, and 2024; the disclosure was incorporated by reference to the Proxy's 'Item 3'; and KPMG’s PCAOB identification number (185) was consistently listed. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly cited across all years, and no incorrect figures are introduced. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three years and two document types (10-K and Proxy), identifying both the structural consistency (same Item 14 language, same reference) and its implication for audit stability. (4) The conclusion about a stable and uninterrupted audit relationship is logically derived from the unchanged presentation, matching the original answer’s interpretation. Wording differs slightly but conveys identical meaning, satisfying semantic equivalence. All parts of the question—evolution over time and implications for audit stability—are fully addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 320,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "LLY disclosed that its private‑alternative‑investment holdings rose from roughly **$8.58 billion in 2022** (about $7.94 bn in defined‑benefit pension plans + $0.64 bn in retiree‑health plans) to **about $9.64 billion in 2023** (≈ $8.87 bn + $0.76 bn) and then slipped slightly to **≈ $9.35 billion in 2024** (≈ $8.61 bn + $0.74 bn).  \n\nThe three‑year trend—overall growth with only a modest 2024 pull‑back—shows LLY’s consistent, expanding commitment to illiquid private‑alternative assets (hedge funds, equity‑like funds, real‑estate and other) as a strategic, long‑term component of its pension and retiree‑health portfolios.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for LLY's private alternative investment allocations. According to the ground truth, the allocation was $10,542.5 million in 2022, decreased to $10,335.2 million in 2023, and further declined to $10,051.0 million in 2024. However, the LLM reports $8.58 billion in 2022, $9.64 billion in 2023, and $9.35 billion in 2024—values that are both numerically incorrect and show an increasing trend in 2023 contrary to the actual downward trajectory. These discrepancies are substantial and affect the core of the question. (2) The LLM appears to have incorrectly summed component values (e.g., pension + retiree-health plans), which are not provided in the original context and seem fabricated. There is no mention in the ground truth of $7.94B/$0.64B splits or similar breakdowns, indicating a potential hallucination of sub-components. Additionally, the reported 'slight dip' in 2024 contradicts the actual consistent decline from 2022 to 2024. (3) While the LLM attempts multi-hop reasoning by analyzing a three-year trend and inferring strategic intent, the flawed data leads to an incorrect conclusion about 'overall growth' when the true trend is a steady decrease. The qualitative interpretation of LLY’s long-term strategy is therefore based on false premises. (4) Despite the factual errors, the answer is contextually relevant—addressing the right company (LLY), time frame (2022–2024), and asset class (private alternatives)—and attempts to synthesize a strategic narrative, which supports a moderate score in contextual relevance. However, the quantitative inaccuracy severely undermines correctness and reasoning, warranting low scores in those areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 476,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "**2022 – Broad “Feminine Care” grouping**  \nIn the 2022 filing, Tampax appears under the combined “Baby, Feminine & Family Care” segment. The segment’s sub‑categories list “Feminine Care (Adult Incontinence, Feminine Care)” – a generic feminine‑care bucket – and Tampax Bounty is named among the major brands.\n\n**2023 – Introduction of a specific “Menstrual Care” label**  \nThe 2023 filing still places Tampax in the same “Baby, Feminine & Family Care” segment, but the sub‑category is revised to “Feminine Care (Adult Incontinence, Menstrual Care).” This change explicitly highlights menstrual‑care products, positioning Tampax Bounty as the flagship menstrual‑care brand alongside Always and Always Discreet.\n\n**2024 – Consistent focus on Menstrual Care**  \nThe 2024 filing retains the same segment name and the same sub‑category wording (“Feminine Care (Adult Incontinence, Menstrual Care)”), with Tampax Bounty again listed as a major brand. Thus, the classification and product‑line emphasis introduced in 2023 remain unchanged in 2024.\n\n**Overall evolution** – Across the three years, P&G moved Tampax from a broad, generic feminine‑care classification in 2022 to a clearly defined “Menstrual Care” focus in 2023, and it kept that targeted positioning in 2024, while continuously listing Tampax Bounty as a flagship brand within the segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Tampax's reclassification from a broad 'Feminine Care' category to a more specific 'Menstrual Care' focus starting in 2023, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. First, the LLM repeatedly refers to 'Tampax Bounty'—this is incorrect; 'Bounty' is a separate P&G brand (paper towels), and there is no product called 'Tampax Bounty.' This error suggests confusion between brands and undermines entity accuracy. Second, the ground truth states that in 2024, the 'Baby Care' category was removed from the segment, signaling a strategic shift, but the LLM fails to mention this key structural change. Instead, it claims the 2024 classification is unchanged from 2023, which is partially true for the sub-category wording but misses the broader segment-level streamlining. Additionally, the LLM omits the sales contribution percentages (25% in 2022, 24% in 2023 and 2024), which are important quantitative indicators of the segment’s performance and strategic weight. While the qualitative shift toward 'Menstrual Care' is correctly identified, the reasoning is incomplete as it does not connect the reclassification to the broader strategic pivot away from infant-related products. The contextual relevance is high because the answer addresses the core question about classification evolution, but the factual and quantitative errors—especially the invented brand name and missing sales data—prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 419,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "- **2022 filing** – Capital One reported net derivative assets (liabilities) as Level 3 fair‑value items with a balance of **$31 million at the start of the year and $19 million at year‑end**. The 2022 table shows the balances and gains/losses but does **not disclose the valuation technique or the specific unobservable inputs** used to price these assets.  \n\n- **2023 filing** – The company began disclosing the **valuation methodology**: net derivative assets are measured using **discounted‑cash‑flow (DCF) models**. The key unobservable inputs cited were **default rates** (range 53‑163 %, weighted‑average 4 %) and **swap rates** (range 3‑5 %). No fair‑value amount was shown in the table, but the DCF approach and those inputs were explicitly described.  \n\n- **2024 filing** – Capital One continued to value the net derivative assets with **discounted‑cash‑flow models**, but the **primary unobservable input shifted to swap rates** (range 3‑5 %, weighted‑average 4 %). The fair‑value of the net derivative assets is now **reported as $58 million**.  \n\n**Overall evolution:** From 2022 to 2024 Capital One moved from a Level‑3 fair‑value disclosure with no detailed methodology to a transparent DCF‑based valuation. In 2023 the model emphasized default‑rate assumptions; by 2024 the focus had shifted to swap‑rate assumptions while retaining the DCF framework and a roughly 4 % weighted‑average input.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant factual inaccuracies that impact the overall correctness. (1) Quantitative Accuracy: The 2022 year-end fair value of $19 million is correct, but the LLM incorrectly adds a $31 million starting balance not present in the ground truth. The ground truth does not mention Level 3 classification or beginning balances, so this is an unsupported addition. The 2023 and 2024 fair values are partially correct: while the ground truth states $58 million for both 2023 and 2024, the LLM claims no fair value was shown in 2023 (contradicting the ground truth), and only reports $58 million in 2024. This misrepresents the availability of data. Additionally, the LLM introduces a 'weighted-average 4%' for default and swap rates, which is not mentioned in the ground truth—only ranges (53–163%, 3–5%) are provided. (2) Completeness: The answer addresses the evolution of valuation methods and inputs across years, satisfying the multi-part nature of the question. However, it omits the 2023 fair value figure ($58 million) that should have been included per the ground truth. (3) Entity Accuracy: The company (Capital One), metric (net derivative assets/liabilities), and years (2022–2024) are correctly identified. (4) Reasoning: The LLM correctly identifies the shift from no disclosed methodology in 2022 to DCF use in 2023–2024, which aligns with the ground truth. However, the claim that 'focus shifted' from default rates in 2023 to swap rates in 2024 is speculative—the ground truth states both inputs were used and maintained, with no indication of a shift in emphasis. (5) Semantic Equivalence: While the general trend of increasing transparency is captured, the specific details about inputs and values are distorted by unsupported numbers and attributions. Overall, the answer gets the broad narrative right but fails on key quantitative details and introduces unverified specifics, warranting a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 530,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s 2022 Form 10‑K simply disclosed the size of its available‑for‑sale (AFS) debt portfolio (see the “Summary of Available‑for‑Sale Debt Investments” table in Chunk 1) but did not call out any material effect on the “other income (loss), net” line. By fiscal 2023, Cisco told investors that “the change in our other income (loss), net was primarily driven by higher losses in our available‑for‑sale debt investments” (Chunk 2), and the 2024 filing repeats the same explanation (Chunk 3). The shift from a neutral disclosure in 2022 to a recurring, primary source of loss in 2023‑2024 reveals that the AFS debt holdings have moved from a non‑impactful asset to a deteriorating, risk‑laden investment that is eroding Cisco’s other‑income performance over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that in fiscal 2022, Cisco only disclosed the existence of AFS debt investments without indicating a material impact on 'other income (loss), net,' matching the original answer. In 2023 and 2024, it accurately states that higher losses in AFS debt investments were a primary driver of declines in 'other income (loss), net,' with direct quotes supporting the claim. (2) There are no numerical inaccuracies—while exact dollar amounts are not provided in either answer, the qualitative characterization of impact (neutral in 2022, negative in 2023–2024) is consistent and correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years and correctly infers a trend from disclosure to material negative impact, concluding that the risk profile of these investments has deteriorated over time. (4) The answer fully addresses both parts of the question—impact on 'other income (loss), net' over time and what this reveals about financial performance and risk—making it contextually excellent. Minor wording differences (e.g., 'non-impactful asset' vs 'no immediate material impact') do not affect factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 360,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "- **Fiscal‑2022 filing:** Starbucks said that its total purchase commitments + inventory would be sufficient to provide an **adequate supply of green coffee through fiscal 2023**.  \n- **Fiscal‑2023 filing:** The outlook was extended, stating that those commitments and inventory are expected to provide an **adequate supply through fiscal 2025**.  \n- **Fiscal‑2024 filing:** The company reiterated the same forward‑looking view, again projecting **adequate supply through fiscal 2025**.\n\n**What this progression shows:**  \nStarbucks moved from a near‑term (one‑year) supply assurance in 2022 to a longer‑term (two‑year) assurance in 2023 and maintained that horizon in 2024. By locking in fixed‑price and price‑to‑be‑fixed contracts, using forward/futures hedges, and relying on strong, established relationships with coffee producers (the entities on which Starbucks depends, per the KG links), the firm is deliberately broadening its sourcing horizon to mitigate risks from weather, crop disease, price volatility and other supply‑chain disruptions. This multi‑year evolution reflects a proactive, risk‑mitigation‑focused sourcing strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the fiscal year projections are accurate: in fiscal 2022, Starbucks projected adequacy through fiscal 2023; by fiscal 2023 and continuing in fiscal 2024, the projection extended through fiscal 2025. These timeframes are correctly reported. (2) The answer is complete, addressing both the evolution of supply adequacy across the three fiscal years and the strategic implications. (3) Entity accuracy is perfect—Starbucks is the correct company, and the fiscal years (2022, 2023, 2024) and projected coverage periods (through 2023, then through 2025) are correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the extension from one-year to two-year visibility indicates a strategic shift toward longer-term contracts, hedging, and stronger producer relationships, which the model correctly infers as risk mitigation against supply chain disruptions. The explanation of fixed-price contracts, futures hedges, and reliance on established producers aligns with the sourcing strategy described in the ground truth. (5) The semantic meaning is equivalent to the original answer, with slightly more detail on mechanisms (e.g., hedging) but without introducing inaccuracies. Minor wording differences do not affect factual correctness. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 383,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVDA’s 10‑K filings show that the 2.00 % Notes due 2031 were reported at **$1.2 billion in FY 2022**, fell to **$1.04 billion in FY 2023**, and then rose modestly to **$1.06 billion in FY 2024** (fair‑value) – the 2024 filing also lists a **net‑carrying amount of $1.25 billion** for the same series. The dip after FY 2022 followed by a small re‑increase indicates that NVIDIA trimmed its exposure to this low‑cost, long‑dated debt but is now rebuilding a modest amount of it, reflecting a strategy of maintaining a stable, inexpensive long‑term financing base to fund growth while keeping overall leverage under control.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1,200 million in 2022, $1,044 million in 2023, and $1,250 million in 2024. The LLM correctly reports $1.2 billion (i.e., $1,200 million) for 2022 and $1.04 billion ($1,044 million) for 2023, which is acceptable within rounding. However, it incorrectly states the 2024 value as $1.06 billion in fair value while noting a carrying amount of $1.25 billion, creating confusion. The ground truth reports only $1,250 million (i.e., $1.25 billion) for 2024—there is no indication that fair value was the primary metric in prior years or that there was a discrepancy between fair value and carrying amount in the trend. The LLM introduces a nuance (fair value vs. carrying amount) not present in the original answer and uses the lower fair value figure ($1.06B) as the main 2024 data point, contradicting the ground truth's $1.25B. (2) Calculations: The trend described—down then up slightly—is incorrect because the 2024 figure should show a rise back above the 2022 level ($1,250M > $1,200M), not a modest increase from a dip. The LLM underreports the 2024 exposure and misrepresents the magnitude of recovery. (3) Multi-hop reasoning: The LLM correctly identifies the multi-year trend and attempts to interpret strategic intent, which aligns with the question’s requirement. It synthesizes across fiscal years and draws a reasonable conclusion about debt strategy, albeit based on flawed numbers. (4) Despite the incorrect 2024 figure, the qualitative interpretation of a 'dynamic' or 'stable but managed' long-term debt strategy is plausible and contextually relevant. The mention of low-cost, long-dated debt and leverage control adds useful context not in the original but does not contradict it. However, the core factual error in the 2024 number—especially presenting $1.06B instead of $1.25B—undermines the correctness score. The answer is partially correct but fails on key quantitative precision, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 553,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "Across the three filings, MMM consistently lists Fall Protection Solutions together with its other personal‑protective‑equipment offerings. In the 2022 filing the Safety & Industrial segment notes “Respiratory, hearing, eye **and fall protection solutions**”; the 2023 filing repeats the same phrasing, and the 2024 filing again groups “Respiratory, hearing, eye **and fall protection solutions**” in the same bullet. Thus, from 2022 through 2024 the product remained categorized as a core PPE line within the Safety & Industrial segment, with no change in emphasis relative to the other industrial safety products.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in noting that Fall Protection Solutions were grouped with respiratory, hearing, and eye protection across 2022–2024 filings, which aligns with the ground truth on surface-level categorization. However, it fails to capture the nuanced evolution described in the original answer—specifically, the subtle but meaningful shift in 2024 where Fall Protection Solutions were presented within a revised grouping that emphasized industrial specialty products and integration into broader safety systems, indicating a change in strategic framing. The LLM incorrectly concludes there was 'no change in emphasis,' directly contradicting the ground truth’s assertion of a 'subtle shift' in positioning. While entity accuracy (MMM, Safety & Industrial segment, years 2022–2024) and qualitative details like product categories are correctly identified, the reasoning is flawed in dismissing any evolution due to identical phrasing. This reflects a failure in multi-hop synthesis: the model does not infer or acknowledge that consistent wording can coexist with strategic repositioning in presentation and context. Quantitative accuracy is not applicable here (no numbers), but all referenced years and product groupings are factually correct. Contextual relevance is high as the response addresses the core question about categorization and emphasis over time, but the conclusion is misleading due to incomplete interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 399,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s COVID‑19 antibody line—led by bamlanivimab—generated about **$2.0 billion in 2022** (U.S. $2,008.9 M + outside‑U.S. $14.7 M).  The 2023 and 2024 10‑K tables list “‑” for COVID‑19 antibodies, meaning **revenue fell to zero** in both years.  After a multi‑billion‑dollar peak in 2021 ($2.24 billion, per the 2022 filing) the product’s sales collapsed, indicating that Eli Lilly has essentially moved away from, and no longer relies on, its bamlanivimab/COVID‑19 antibody portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Eli Lilly's revenue from bamlanivimab was approximately $2.01 billion in 2022 (reported as $2,008.9M + $14.7M = $2,023.6M, which rounds to ~$2.02B; minor discrepancy likely due to rounding or subset reporting, but within acceptable tolerance). It accurately notes that revenue fell to $0 in 2023 and 2024, consistent with the '–' notation in the 10-K filings indicating no revenue. (2) Quantitatively, all figures align with the ground truth within reasonable reporting variance. The mention of $2.24 billion in 2021 (from prior-year context in 2022 filing) is accurate and adds useful background, even though not required. (3) The multi-hop reasoning is sound: the model synthesizes data across multiple years and filings, correctly interprets '–' as $0 revenue, and infers the trend indicating reduced reliance on the COVID-19 antibody portfolio. (4) The conclusion that Eli Lilly has 'moved away from' and 'no longer relies on' the portfolio is semantically equivalent to the ground truth's statement about declining reliance. The only minor shortcoming is the slightly imprecise aggregation of $2.0236B vs. the exact $2.01B in the original answer, possibly due to different line-item inclusions, but this does not materially affect correctness. All parts of the question are addressed: revenue evolution (2022–2024) and interpretation of trend. Entity names (Eli Lilly, bamlanivimab), years, and metrics are accurate. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 426,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks repeatedly acknowledges in its 2022, 2023 and 2024 10‑K filings that coffee prices are “impacted by trading activities in the Arabica coffee futures market, including hedge funds and commodity index funds,” confirming a steady exposure to commodity‑index‑fund price swings. In 2022 the company said its fixed‑price, price‑to‑be‑fixed contracts and hedging tools (forward contracts, futures and collars) would secure green‑coffee supply only through fiscal 2023, but by the 2023 filing (and reiterated in 2024) those same hedging mechanisms were tied to purchase commitments that now extend through fiscal 2025. This evolution—from a short‑term coverage horizon to a multi‑year commitment—shows Starbucks’ risk‑management strategy has become more proactive, using long‑dated contracts and derivatives to lock in supply and blunt the volatility generated by commodity index funds.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Starbucks acknowledged commodity index fund impact on coffee prices in 2022, 2023, and 2024; the company's hedging and supply visibility extended from fiscal 2023 in the 2022 filing to fiscal 2025 in the 2023 and 2024 filings. (2) Quantitative elements—fiscal years (2022–2025), use of forward contracts, futures, and collars—are correctly reported with no calculation errors. Format variations (e.g., 'fiscal 2025' vs 'through fiscal 2025') are acceptable and preserve meaning. (3) Multi-hop reasoning is sound: the answer synthesizes disclosures across three years of 10-Ks, correctly inferring a strategic shift toward longer-term risk mitigation. It connects exposure to index funds with evolving hedging practices, showing how Starbucks improved supply chain resilience. (4) The answer fully addresses both parts of the question: evolution of exposure (ongoing) and what the trend reveals (more proactive, extended risk management). Wording differs slightly but conveys identical meaning, including the use of hedging tools and the extension of supply commitments. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 341,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In 2022 Alphabet’s filing explained that the bulk of its impression‑based revenue came from Google Network properties that “participate primarily in AdMob, AdSense, and Google Ad Manager,” and that cost‑per‑impression was the key metric used to price those ads — showing that Google Ad Manager was already the core platform through which the company monetized impressions. The 2024 filing repeats this description, confirming that Google Ad Manager remains the primary vehicle for selling impression inventory on the Network and that advertisers continue to purchase that inventory through the Google Ad Manager product (which Alphabet (GOOGL) produces and the Google Ad Manager business unit depends on). The 2023 accounting change that extended the useful life of servers from four to six years cut depreciation expense by $3.9 billion and lifted net income by $3.0 billion, thereby strengthening profitability and giving Alphabet more financial headroom to invest in the infrastructure that supports its impression‑based ad business, which bolsters long‑term profit outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the role of Google Ad Manager in impression-based monetization in 2022 and 2024, aligning with the ground truth. It accurately notes the 2023 change in server depreciation schedules (from 4 to 6 years for servers and network equipment), the $3.9 billion reduction in depreciation expense, and the $3.0 billion increase in net income. These figures match the original answer exactly, and format variations (e.g., $3.9 billion vs $3.9B) are acceptable. (2) Quantitative accuracy is perfect: all dollar amounts, years, and metrics are correct and consistent with the ground truth. The calculation implications (lower depreciation → higher net income) are correctly interpreted. (3) The reasoning is sound and reflects multi-hop synthesis: connecting the accounting change in 2023 to infrastructure costs, linking it to Ad Manager’s cost structure, and inferring improved long-term profitability. The only minor gap is that the LLM answer does not explicitly mention the continuation of gross reporting of advertising revenue in 2024, which is a small omission in completeness. However, it does convey the ongoing strategic importance of Ad Manager. (4) The answer is semantically equivalent to the original in intent and factual content, with slightly different phrasing. Contextual relevance is excellent, addressing all core aspects of the question: evolution over time, the 2023 adjustment, and implications for profitability. The qualitative score is 9 due to the minor omission of gross revenue reporting, but all key financial and strategic points are covered.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 442,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "In the 2022 Form 10‑K the Bank of New York Mellon Corporation attached the 2019 Long‑Term Incentive Plan (Exhibit 10.38) and the most recent Performance Share Unit Agreement was the 2021 version (Exhibit 10.45). The 2023 Form 10‑K again referenced the same 2019 Long‑Term Incentive Plan (Exhibit 10.14) but filed the 2020 Performance Share Unit Agreement (Exhibit 10.16) as the latest version, and the 2024 Form 10‑K continued to cite the 2019 Long‑Term Incentive Plan (Exhibit 10.13) while including the 2022 Performance Share Unit Agreement (Exhibit 10.18). This pattern of filing progressively newer PSUAs under an unchanged 2019 LTI framework shows that BK is continually updating its performance‑share component, signalling a compensation strategy that emphasizes regularly refreshed, performance‑based equity awards to keep executive pay aligned with current performance goals and market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in structure and interpretation but contains a key factual error in the 2023 filing — it states that the 2020 Performance Share Unit Agreement (Exhibit 10.16) was filed, while the ground truth indicates that 2023 re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14) without introducing a new PSUA; the next update was in 2024 with the 2022 agreement. This misstatement of the 2020 agreement in 2023 undermines quantitative accuracy. (2) The dates and exhibits are mostly accurate: 2022 correctly references the 2021 PSUA (Exhibit 10.45), and 2024 correctly includes the 2022 PSUA (Exhibit 10.18). However, the claim that 2023 filed the 2020 PSUA (Exhibit 10.16) is incorrect per ground truth — no new PSUA was filed in 2023. The 2019 LTI plan was re-filed (Exhibit 10.14), but the LLM misattributes the PSUA version. (3) The multi-hop reasoning is sound: the model correctly infers a pattern of maintaining the 2019 LTI plan while periodically updating the PSUA, indicating a strategy of stability with iterative updates. The conclusion about aligning executive pay with current performance goals is semantically equivalent to the ground truth’s 'adaptive approach' and 'refining incentive mechanisms.' (4) Despite the error in the 2023 PSUA version, the overall trend and strategic interpretation are valid, warranting a correctness score of 7. Quantitative accuracy is penalized due to the incorrect year (2020 vs. no new agreement in 2023), but qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 435,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across the three filings the Safety & Industrial segment always listed the same line of business – “Electrical products and materials for construction and maintenance, power distribution and electrical OEMs.” In the 2023 report the abbreviation was expanded to “electrical original equipment manufacturers (OEMs),” and the 2024 filing kept that fuller wording (the only change being the added clarification of “original equipment manufacturers”). The consistent placement of this line within the Safety & Industrial segment, together with the move toward a more explicit OEM description, signals that 3M is maintaining—and modestly sharpening—its strategic emphasis on supplying electrical‑OEM customers rather than shifting away from that market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the consistency of the product description across years. The original answer states that in 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs'—but the LLM incorrectly claims the *exact same line* was used across all three years. In reality, the phrasing evolved: 2022 used 'electrical OEMs', 2023 expanded it to 'electrical original equipment manufacturers (OEMs)', and 2024 restructured it to 'power distribution and electrical original equipment manufacturers (OEMs)', indicating a shift in emphasis and specificity. The LLM correctly identifies the expansion of the abbreviation in 2023 and the retention of fuller wording in 2024, which supports the conclusion about increasing clarity and strategic focus. However, by asserting that the 'same line of business' was listed throughout, it overlooks the meaningful reordering and refinement in 2024 that adds continuity with power systems. This omission slightly weakens the qualitative accuracy, though the core insight—that 3M is sharpening its focus on electrical OEMs—remains valid and well-supported. There are no numerical errors (quantitative accuracy is perfect), and the response is fully contextually relevant, addressing both the evolution in language and the implied strategic focus. The reasoning is sound but not fully precise in capturing the multi-hop nuance of how the categorization changed over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 426,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed‑unsecured senior debt rose from $19.975 billion at a weighted‑average rate of 2.91% in 2021 (as shown in the 2022 filing) to $24.134 billion at 4.45% in 2022, then to $27.168 billion at the same 4.45% rate in 2023, before easing slightly to $26.930 billion in 2024 as the weighted‑average rate climbed to 4.84% (2024 filing). This trajectory—expanding the principal balance, extending maturities and accepting a higher average cost of debt—signals a deliberate long‑term strategy to maintain a sizable, long‑dated fixed‑rate senior debt base to fund growth while managing leverage and interest‑rate risk in a rising‑rate environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It incorrectly states that the 2022 carrying value was $24.134 billion at 4.45%, but the ground truth is $19,975 million (i.e., $19.975 billion) at 2.91%. It also mislabels the 2021 data as 'in 2022 (as shown in the 2022 filing)', which confuses the reporting year with the fiscal year. The correct progression is 2022: $19.975B at 2.91%, 2023: $27.168B at 4.45%, 2024: $26.930B at 4.84%. The LLM incorrectly claims the rate was 4.45% in both 2022 and 2023, when in fact it rose from 2.91% to 4.45% between those years. (2) Number verification: Carrying values for 2023 ($27.168B) and 2024 ($26.930B) are correct, and the final 2024 rate (4.84%) is accurate. However, the 2022 rate is wrong (states 4.45% instead of 2.91%), and the 2022 carrying value is misstated as $24.134B (possibly a mix-up with another debt category or year). (3) Multi-hop reasoning is partially sound: the LLM correctly infers a strategic intent to lock in long-term fixed-rate debt despite rising costs, which aligns with the ground truth interpretation. It recognizes the trend of increasing debt balances and rising rates as a deliberate risk management strategy. However, due to incorrect data inputs, the reasoning is based on flawed premises. (4) Scores justified: Correctness is 5 due to major factual errors in key numbers, especially the 2022 interest rate and value. Quantitative accuracy is low (4) because two of three years' data are incorrect. Qualitative accuracy is moderate (6) because the strategic interpretation is reasonable and contextually appropriate. Contextual relevance is high (9) as the answer addresses all aspects of the question and provides a coherent narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 475,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA disclosed its 3.50 % Notes Due 2040 as a Level‑2 liability in each filing.  In FY 2022 the fair‑value of the notes was $1,066 million (down from $1,152 million a year earlier) and in FY 2023 the fair‑value fell further to $851 million (versus $870 million in FY 2022).  By FY 2024 the company also presented the same notes on a debt‑schedule at a net carrying amount of $1,000 million (amortized cost) with a 15.2‑year remaining term and a 3.54 % effective interest rate, indicating a hold‑to‑maturity treatment rather than ongoing fair‑value re‑measurement.  \n\nThis multi‑year trend—declining market‑based fair values alongside a stable amortized‑cost balance—shows NVIDIA’s strategy of locking in low‑coupon, long‑dated financing and managing interest‑rate risk by keeping the debt on its books at cost, thereby preserving a predictable long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, correct evolution of NVIDIA's 3.50% Notes Due 2040 from fiscal years 2022 to 2024. (1) Quantitatively, the fair values for FY2022 ($1,066 million) and FY2023 ($851 million) match the ground truth exactly. The FY2024 carrying amount of $1,000 million is also correct. The LLM adds extra details not in the original—such as the prior-year comparisons ($1,152M in FY2021, $870M in FY2022), effective interest rate (3.54%), and remaining term (15.2 years)—which are plausible and consistent with typical 10-K disclosures, but cannot be verified against the provided ground truth; however, they do not contradict it. (2) The core numbers required by the question are fully accurate, with only minor, non-essential additions. (3) The reasoning is excellent: the LLM correctly infers a shift from fair-value reporting to amortized cost (carrying amount), identifies this as indicative of hold-to-maturity accounting, and draws a logical conclusion about NVIDIA’s long-term debt strategy—locking in low-cost financing and managing interest rate risk. This goes beyond restating facts and provides insightful synthesis. (4) The answer fully addresses both parts of the question: the multi-year valuation progression and the strategic implications. The entities (NVIDIA, 3.50% Notes Due 2040, fiscal years 2022–2024) are correct, and the multi-hop reasoning—linking accounting treatment changes to strategic intent—is sound. The only reason for not scoring a 10 is the inclusion of unverifiable prior-year values and technical details not present in the ground truth, which, while reasonable, slightly exceed the confirmed data. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 477,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 Notes – a $17 billion senior unsecured issuance – were reported at a $16 billion outstanding balance through 2021 (2022 10‑K, Chunk 3) and remained $16 billion at year‑end 2022 (2023 10‑K, Chunk 1). The balance then fell to $15 billion at year‑end 2023 (both the 2023 10‑K and the 2024 10‑K, Chunk 1 & 2) and further to $13 billion at year‑end 2024 (2024 10‑K, Chunk 2). This $3 billion reduction over two years signals a deliberate pay‑down or refinancing of the 2017 issuance, reflecting Amazon’s proactive debt‑management strategy to lower leverage and interest expense while preserving liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. All numeric values are accurate, with acceptable formatting variations (e.g., $16 billion = $16.0 billion). The $3 billion total reduction over two years is correctly calculated (16→13), and the year-by-year reductions (16→15→13) are consistent with the ground truth. (2) Quantitative accuracy is perfect: all dollar amounts and time periods align with the original answer. The LLM even provides additional context (e.g., initial $17 billion issuance) that is consistent with typical financial reporting and does not contradict the ground truth. (3) The multi-hop reasoning is sound—information is synthesized across multiple 10-K filings (2022, 2023, 2024) and document chunks, demonstrating correct cross-document tracking of the debt balance over time. The conclusion about Amazon’s proactive debt management strategy is logically supported by the observed reduction pattern and aligns with the ground truth’s interpretation of a 'deliberate' strategy. The only minor gap is that the original answer emphasizes 'gradual retirement' while the LLM mentions 'pay-down or refinancing'—slightly broader, but still reasonable given the data. (4) Scores reflect near-perfect factual accuracy, complete coverage of the question, and strong reasoning. The 9 (instead of 10) on qualitative accuracy reflects the slight expansion into 'refinancing' without explicit evidence from the ground truth, though it remains plausible. Contextual relevance is full—every part of the question is addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 470,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 2022 (Exhibit 4.4), 2023 (Exhibit 4.4) and 2024 (Exhibit 4.4) 10‑K filings all contain an Officer’s Certificate that lists “Floating Rate Notes due 2019” as part of the securities it has issued. The fact that this series of floating‑rate notes is disclosed in three consecutive filings indicates that Apple still has exposure to a short‑term, variable‑rate debt tranche that will reset (or be refinanced) as market rates move. Consequently, if benchmark rates rise, the interest on those floating‑rate notes will increase on each reset, making Apple’s overall interest‑expense more sensitive to a higher‑rate environment, even though the short maturity limits the duration of that exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all references to years (2019 maturity, 2022–2024 filings), exhibit numbers (4.4), and the Officer’s Certificate are correct. The description of the Floating Rate Notes due 2019 being included in three consecutive filings is factually sound. (2) The reasoning correctly identifies that the continued disclosure suggests ongoing exposure or obligation, even post-maturity, and accurately links floating rate notes to variable interest expense that resets with benchmark rates. (3) The multi-hop synthesis—connecting repeated disclosure across years to implications for interest rate sensitivity and short-term debt exposure—is logically sound. The only minor shortcoming is that the LLM does not explicitly mention the May 6, 2014 Officer’s Certificate date or clarify that the notes are incorporated by reference, which slightly weakens the precision of the disclosure mechanism. It also doesn’t address potential rollover obligations or continuing commitments as directly as the original answer, which slightly reduces completeness in qualitative depth. However, the core financial logic and implications are correctly conveyed. (4) The answer is fully contextually relevant, directly addressing both parts of the question: Apple’s exposure to short-term debt instruments and the impact on interest expense sensitivity in a rising rate environment. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions in procedural detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 436,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "In the 2022 filing Google framed its hardware business as a long‑run investment, saying it was “investing … for the long run” in a growing family of devices and pointing to the then‑latest Pixel 5a 5G and Pixel 6 as examples of the AI‑enabled, privacy‑focused products it was building. By the 2023 filing the Pixel line had been promoted to a distinct “devices” revenue segment – the filing explicitly calls out “sales of the Pixel family of devices” and notes that Pixel revenue now fluctuates with launch timing, showing that the phones had moved from a pure investment focus to a measurable revenue contributor. The 2024 filing still lists “devices, which primarily include sales of the Pixel family of devices,” treating Pixel sales as a stable, integrated part of Google’s overall revenue mix, which signals that the product line has matured and that Google is positioning itself for a sustained, long‑term presence in the hardware market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Google described hardware as a long-term investment with specific mention of Pixel 5a 5G and Pixel 6; in 2023, Pixel sales were explicitly categorized under a distinct 'devices' revenue segment, indicating measurable financial contribution; in 2024, the Pixel family remained a core part of the 'devices' revenue line, signaling maturity and stability. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) and entity references (Pixel family, devices revenue segment) are accurate and consistent with the original. (3) The multi-hop reasoning is sound—correctly tracing the evolution from investment focus to revenue contribution to product maturity across three years, synthesizing changes in disclosure and categorization as indicators of strategic progression. (4) The answer fully addresses all parts of the question: investment focus (2022), revenue contribution (2023), product maturity (2024), and long-term positioning (conclusion). Wording differs slightly but meaning is preserved, and the LLM even adds relevant detail (e.g., revenue fluctuating with launch timing) that enriches the response without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 378,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "- **2022:** Schwab disclosed the fair‑value of all client‑owned securities that were eligible to be used as collateral for its margin‑lending program and, separately, the amount of those securities that it had already pledged to third parties in securities‑borrowing transactions. The table in the 2022 note showed both the “available” pool and the “pledged” pool of client securities.\n\n- **2023:** The 2023 filing reiterated that margin loans remain fully collateralized by client securities and that Schwab may pledge those securities to third parties under federal regulations. The pledged securities are treated as off‑balance‑sheet collateral – they are not reflected on the consolidated statements – and the firm continues to hold the securities in segregated reserve accounts for the exclusive benefit of clients.\n\n- **2024:** The 2024 filing shows a shift in the securities‑lending side of the business: instead of pledging client securities to meet its borrowing obligations, Schwab now satisfies securities‑lending collateral requirements with cash. For margin‑related obligations (e.g., options cleared by the OCC) it still pledges client securities, but for securities‑lending it provides cash collateral and sweeps uninvested client cash off‑balance‑sheet to a TD Depository.\n\n**Trend/Implication:** Over the three‑year period Schwab has kept client securities as the primary collateral source for margin lending, but has moved away from using those same securities for its securities‑lending activities, substituting cash instead. This evolution signals a more conservative collateral‑management strategy that preserves client‑owned securities, reduces off‑balance‑sheet exposure, and enhances liquidity by relying on cash for external lending obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite being contextually relevant and well-structured. (1) On quantitative and factual accuracy: The LLM incorrectly claims that in 2022, Schwab disclosed the fair value of client securities eligible for use as collateral and provided a table showing 'available' and 'pledged' pools. The ground truth states that no specific dollar value was provided in 2022, making this a major factual error. Similarly, the LLM asserts that in 2024, Schwab shifted to using cash instead of client securities for securities-lending collateral, citing a 'shift in the securities-lending side' and sweeping uninvested cash to a 'TD Depository'—none of which appears in the ground truth. The mention of 'TD Depository' introduces an incorrect entity (TD is not mentioned in the original answer and is factually suspect in this context). (2) The original answer states that in 2024, Schwab was *actively pledging* client securities for margin-related obligations (e.g., OCC-clearing) *and* providing cash as collateral in securities lending—this partial alignment gives some credit—but the LLM overstates and misrepresents this as a strategic substitution, which is not supported by the ground truth. (3) On reasoning: The LLM constructs a narrative of a 'more conservative strategy' and 'reduced off-balance-sheet exposure', but the ground truth describes a broader, more integrated use of client securities, indicating *increased* reliance for operational needs—not a pullback. This misreads the trend direction. (4) Contextual relevance is high because the answer addresses the right themes (margin lending, securities lending, collateral use over time) and attempts multi-hop synthesis across years. However, the core factual misstatements—especially the fabricated 2022 data table and the erroneous 2024 shift narrative—severely compromise correctness. Minor format flexibility is allowed, but invented details are not. Thus, the answer is partially aligned but fundamentally flawed in key assertions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Holds]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1714,
        "completion_tokens": 555,
        "total_tokens": 2269
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "- In the 2022 10‑K GE disclosed that, as a reinsurer, it “has no direct ability to seek or to institute” long‑term‑care (LTC) premium hikes but “often collaborates with the primary insurers … to file proposed premium rate increases,” using recent ceding‑company filing experience and state‑regulator precedents to shape its expectations.  \n\n- The 2023 and 2024 filings repeat the same collaborative framework, adding the clarification that “substantially all” premium‑paying LTC policies permit the issuing insurer to raise premiums (or reduce benefits) with regulator approval, but still emphasize that GE relies on the primary insurers to submit the rate‑increase proposals and that the frequency of filings varies by ceding company.  \n\n- This unchanged, progressively more detailed reliance on primary insurers shows that GE’s run‑off reinsurance risk‑management strategy is built on a stable partnership model: GE manages LTC premium‑rate risk indirectly through contractual collaboration with primary insurers and monitoring of regulatory filing trends, rather than by exercising direct premium‑adjustment authority.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of GE's role as a reinsurer and correctly states that GE cannot directly institute premium increases, relying instead on primary insurers to file rate hikes with regulators. It accurately notes the collaborative framework and references to regulatory precedents and ceding company experience, which are consistent across 2022–2024. The quantitative accuracy is perfect: no numerical errors, and all dates (2022, 2023, 2024) and terms (e.g., 'substantially all') are correctly cited. However, the LLM underrepresents the evolution in GE's strategy. While it correctly observes that the collaborative framework is repeated in 2023 and 2024, it fails to capture the key progression highlighted in the ground truth: the formalization of collaboration under reinsurance contractual terms in 2023 and the more active participation in filing proposed increases. Instead, the LLM characterizes the approach as 'unchanged' and 'progressively more detailed,' which downplays the strategic shift toward a more structured and proactive risk management model. This misjudges the qualitative evolution—GE did not just add clarifications but enhanced its contractual and operational integration with ceding companies. The reasoning is sound in parts but lacks full multi-hop synthesis of the strategic progression across years. Contextual relevance is high, as the answer directly addresses GE’s reinsurance risk management in run-off operations and ties collaboration to risk mitigation. The omission of the strategic deepening in 2023–2024 prevents a higher score on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 448,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS disclosed that its residential mortgage‑backed securities (RMBS) were valued at **$629 million in 2022** (with a $10 million unrealized loss) [Chunk 1], **$614 million in 2023** (with a $60 million unrealized loss) [Chunk 3], and fell sharply to **$71 million in 2024** [Chunk 2]. The three‑year pattern shows a modest decline from 2022 to 2023 and a dramatic cut‑back in 2024, signalling that CVS has been actively de‑risking its structured‑credit holdings and positioning itself with far lower exposure to RMBS‑related market risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, CVS's RMBS exposure was $721 million in 2022, not $629 million as stated in the LLM answer. The 2023 value ($614 million) is correct, and the 2024 value is misinterpreted: the ground truth states exposure increased to $71 million in 2024 from $614 million in 2023, which implies a decrease, but the LLM incorrectly frames it as a 'sharp fall' to $71 million, missing that this is a rebound from a lower base (the phrasing suggests a decline when the trend from 2023–2024 is actually an increase from $614M to $71M only if the original were lower, but $71M < $614M, so it is a decrease — however, the original answer says 'increased to $71 million', which contradicts the numerical logic and suggests a possible error in the ground truth or misinterpretation). However, given the ground truth explicitly states: 'decreased from $721M in 2022 to $614M in 2023, then increased to $71M in 2024', this implies $71M is greater than $614M — which is numerically impossible. This suggests a likely typo in the ground truth (possibly meant $710M or $171M). Assuming the ground truth intended $71M as a decrease (since $71M < $614M), then the correct trend is decrease from $721M → $614M → $71M. In that case, the LLM correctly identifies the direction of change but is wrong on the 2022 figure. But since the ground truth explicitly says 'increased to $71 million in 2024', we must treat that as the correct interpretation — meaning either the number is wrong or the word 'increased' is wrong. Given this ambiguity, the LLM’s use of $71M in 2024 aligns with the number but contradicts the direction stated in the ground truth. This creates a conflicting evaluation environment. However, per strict reading, the LLM reports $629M (wrong), $614M (correct), $71M (correct number but implies continued decrease, while ground truth says 'increased' — so reasoning conflict). (2) Quantitative accuracy fails on 2022 value: $629M vs $721M is a $92M error — significant. 2023 is correct. 2024 number matches but direction of change misaligned with ground truth narrative. (3) Multi-hop reasoning is partially sound — the LLM identifies year-over-year changes and infers de-risking, which is plausible, but misses the nuanced 'strategic rebalancing' interpretation due to incorrect starting value and misreading of trend. It fails to note rising unrealized losses as context. (4) Contextual relevance is high — addresses evolution over three years and interprets risk positioning. However, due to key numerical inaccuracies and flawed trend interpretation, the correctness score is low. Final scores reflect partial credit for correct 2023/2024 numbers and relevant reasoning, but major deduction for 2022 inaccuracy and misrepresentation of trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 752,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "- 2022: COF reported **total short‑term borrowings + long‑term debt of $48.7 billion** and **long‑term debt of $47.8 billion** (the 2022 filing shows this as a rise from $43.1 billion total in 2021).  \n- 2023: The figures increased to **$49.9 billion total** and **$49.3 billion long‑term debt**.  \n- 2024: Both metrics fell to **$45.6 billion total** and **$45.0 billion long‑term debt**.\n\n**What this reveals:** COF’s leverage grew modestly from 2022‑23, suggesting the bank used additional borrowing—likely to fund growth or refinance existing obligations. The sharp drop in 2024 indicates a deliberate deleveraging move, cutting both short‑term and long‑term liabilities, which reduces liquidity risk, improves its capital‑structure ratios and reflects a strategy to manage debt cost and exposure in a higher‑interest‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 total debt figure. The ground truth states COF's total short-term borrowings and long-term debt was $43.086 billion in 2022, but the LLM reports $48.7 billion, which is off by over $5.6 billion. The 2023 value ($49.856B) is correctly approximated as $49.9B. The 2024 value ($45.551B) is reasonably close at $45.6B. However, the LLM introduces a breakdown between 'total' and 'long-term debt' not present in the original answer, and these sub-components (e.g., $47.8B long-term in 2022) are unsupported by the ground truth and appear fabricated. 2) The original answer does not provide a split between short-term and long-term debt individually, only their sum. Therefore, the LLM's inclusion of long-term debt figures for each year introduces false precision and misrepresents the data. Additionally, the mention of 2021 ($43.1B) is extraneous and not requested. 3) The qualitative reasoning about deleveraging in 2024 and strategic debt management is sound and aligns with the ground truth's interpretation. The explanation of reducing risk in a higher interest rate environment is consistent with the rising weighted-average interest rates (2.76% → 4.84%) mentioned in the original, though the LLM fails to include this specific data point. The elimination of floating unsecured senior debt from $1,709M to $0 is also omitted, weakening the completeness of the analysis. 4) Despite missing key details and introducing incorrect numbers, the LLM captures the overall trend (increase then decrease) and infers a plausible strategy, earning moderate scores for qualitative accuracy and high relevance. However, the major error in the 2022 figure and unsupported breakdowns severely undermine quantitative accuracy, justifying a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 496,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s liability for its 3.50 % Notes due 2050 fell sharply over the three most recent fiscal years. The 2022 10‑K shows a fair‑value liability of **$2.147 billion** (Jan 30 2022); the 2023 10‑K reports **$1.637 billion** (Jan 29 2023) and the 2024 10‑K shows **$1.604 billion** (Jan 28 2024) for the same instrument. At the same time, the FY 2024 filing’s balance‑sheet schedule lists the **net carrying amount (long‑term portion) of the 3.50 % Notes due 2050 at $2.0 billion**, essentially unchanged from the prior period.\n\nThe decline in fair‑value liability—while the book amount stays roughly constant—suggests NVIDIA is actively reducing the market‑value exposure of this ultra‑long‑dated debt (through repayments, refinancing or amortization of discounts) but is retaining a modest, fixed‑rate financing base. Together, the trend points to a capital‑structure strategy that is gradually lowering leverage and interest‑cost risk while preserving a stable long‑term funding source to support growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains both correct and incorrect information. The fair value figures of $2.147 billion (FY2022), $1.637 billion (FY2023), and $1.604 billion (FY2024) match the ground truth and are accurately reported. However, the LLM introduces a conflicting figure — a 'net carrying amount' of $2.0 billion in FY2024 — which contradicts the ground truth that the liability decreased to $1,604 million. This creates factual inaccuracy, as the answer suggests the book amount is 'essentially unchanged,' which is not supported by the ground truth. (2) The quantitative values for fair value are correct and align with the original answer ($2,147M → $1,637M → $1,604M), but the introduction of a higher 'net carrying amount' of $2.0 billion is not present in the ground truth and misrepresents the trend. There is no indication in the original answer of a discrepancy between fair value and carrying amount; thus, this addition appears to be an unsupported inference. (3) The multi-hop reasoning is partially sound — the model correctly identifies the decreasing fair value trend across three fiscal years from 10-K filings. However, it fails to maintain consistency by introducing a conflicting metric that undermines the conclusion. The original answer draws a clear, correct inference about strategic debt reduction, while the LLM overcomplicates the interpretation with unverified distinctions between fair value and carrying amount. (4) The contextual relevance is high — the answer addresses the evolution of the liability and attempts to interpret capital structure strategy. However, due to the inclusion of an incorrect and contradictory data point, the overall correctness score is reduced significantly. The qualitative reasoning is plausible but based on a mix of correct and unsupported data, leading to a partially incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 499,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Across Apple’s three most recent Form 10‑K filings the 0.45 % Notes due 2016 are presented in exactly the same way. In the 2022 filing (Exhibit 4.3 – Officer’s Certificate dated May 3 2013) the notes are listed alongside other securities; the 2023 filing repeats the identical Exhibit 4.3 description, and the 2024 filing again incorporates the same Exhibit 4.3 with the 0.45 % Notes due 2016. The lack of any new issuance or amendment and the repeated use of the same officer’s certificate shows that Apple relies on incorporation‑by‑reference to disclose this historic debt instrument consistently, indicating a stable, transparent long‑term‑debt reporting strategy rather than a pattern of new issuances or changing disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple consistently disclosed the 0.45% Notes due 2016 in its 2022, 2023, and 2024 10-K filings through repeated inclusion of Exhibit 4.3, originally dated May 3, 2013. This aligns with the ground truth, which confirms the notes were issued in 2013 and matured in 2016 but continued to appear in disclosures. All entities—Apple, the 0.45% Notes due 2016, Exhibit 4.3, and the 2013 issuance date—are accurately referenced. (2) Quantitative accuracy is perfect: the interest rate (0.45%), maturity year (2016), exhibit number (4.3), and issuance date (May 3, 2013) are all factually correct and match the ground truth. No calculations are required, but the temporal consistency across 2022–2024 is correctly observed. (3) The multi-hop reasoning is sound: the model infers from repeated unchanged disclosure that Apple uses incorporation-by-reference to maintain transparency and legal continuity, which is a valid interpretation of the pattern. It correctly distinguishes between new issuance and legacy disclosure, concluding that no new activity occurred—consistent with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that the notes *matured* in 2016, which would strengthen the point about post-maturity disclosure. However, the implication is clear from context. Overall, the answer is factually correct, well-reasoned, and fully relevant, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 405,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One disclosed that its net derivative assets (liabilities) were a modest $19 million at year‑end 2022 (the balance shown in the 2022 10‑K) and the filing did not detail any Level‑3 unobservable inputs for that line‑item. By the 2023 filing the fair‑value had risen to $58 million, still valued with discounted‑cash‑flow models but now driven by a credit‑default input (range 53‑163 %, weighted‑average 4 %) together with swap‑rate assumptions (3‑5 %). The 2024 filing reports the same $58 million amount, but the disclosed unobservable input is limited to swap rates (3‑5 % range, weighted‑average 4 %), indicating that the derivative exposure grew roughly three‑fold and the company’s valuation model shifted its emphasis from default risk to interest‑rate (swap) risk while keeping the overall risk‑weighting assumption stable.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative values. The ground truth states that Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, but the LLM claims $19 million — this is a material discrepancy. Additionally, the ground truth notes a net unrealized loss of $20 million still held in 2022 and a realized loss of $43 million in 2022, which the LLM omits entirely. The LLM incorrectly states that no Level-3 unobservable inputs were disclosed in 2022, while the ground truth implies risk inputs became more explicitly defined in 2023 and 2024, though not necessarily absent in 2022. (2) The 2023 and 2024 fair values of $58 million are correctly reported, and the shift from 'default' to 'swap rates' as the significant unobservable input with a 4% weighted average is mostly accurate, though the LLM adds a range of 3-5% and mentions both inputs being used in 2023, which is not in the original answer. The original specifies 'default' as the significant input in 2023 and 'swap rates' in 2024, not a combination. (3) The multi-hop reasoning is partially sound — the LLM correctly infers a shift in risk emphasis from credit default to interest rate (swap) risk and notes stable valuation, which aligns with the ground truth. However, it misses the key point about reduction in realized losses from $43M in 2022 to stability in later years, which is critical for assessing risk management improvement. (4) The contextual relevance is high as the answer addresses the evolution of valuation and risk inputs over time and draws a reasonable conclusion about shifting risk drivers. However, due to incorrect 2022 figures, omission of loss data, and overcomplication of input disclosures, the quantitative accuracy is low, pulling down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Impacts]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 501,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA disclosed that the 1.55 % Notes due 2028 were carried at a fair‑value of **$1.2 billion in FY 2022** (as of Jan 30 2022) 【Chunk 1】, **$1.115 billion in FY 2023** (as of Jan 28 2024) after a prior‑year level of $1.099 billion 【Chunk 2】, and the **net carrying amount rose to $1.25 billion in FY 2024** (as of Jan 28 2024) with an effective interest rate of 1.64 % 【Chunk 3】.  \n\nThis modest dip in 2023 followed by a rebound in 2024 shows NVIDIA is actively managing its debt mix—maintaining a core low‑coupon, medium‑term issuance while adjusting the overall exposure to match cash‑flow needs and to lock in inexpensive, longer‑dated financing.  \n\nThe consistent disclosure of the 1.55 % Notes (the FIN_INST) across the three filings underscores a long‑term debt strategy focused on extending maturity, minimizing interest cost, and preserving a stable, low‑rate liability base.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the exposure amounts for the 1.55% Notes Due 2028 across the three fiscal years: $1.2 billion in FY2022, $1.115 billion in FY2023 (ground truth states $1.1 billion — the LLM provides a more precise figure, which is consistent with a minor rounding difference), and $1.25 billion in FY2024, which matches the ground truth exactly. The slight discrepancy in FY2023 ($1.115B vs $1.1B) is within acceptable rounding tolerance and does not constitute a factual error, especially given that the ground truth may have rounded to the nearest hundred million. (2) All dates and interest rates (e.g., 1.64% effective rate) are correctly cited from the source chunks and do not contradict the ground truth, which focuses only on carrying amounts. The LLM adds contextual detail (fair value vs. carrying amount, effective rate) that enriches the answer without introducing inaccuracies. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three fiscal years and correctly infers a strategic pattern — a temporary dip followed by an increase — aligning with the ground truth’s interpretation of 'strategic maintenance' of the debt instrument. The conclusion about NVIDIA managing its debt mix to preserve low-cost, long-term financing is logically supported and semantically equivalent to the original answer’s claim about maintaining a stable liability base. (4) The answer fully addresses both parts of the question: the evolution of exposure and the implication for long-term debt strategy. The reasoning is slightly more detailed than the ground truth but remains factually aligned. Scores reflect high accuracy with a minor deduction in quantitative accuracy due to the more precise $1.115B vs. the rounded $1.1B in the ground truth, though this is not an error per se.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 495,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "Across the three most recent 10‑K filings GE repeatedly flags “trailing legal liabilities” that stem from two distinct sources – legacy claims tied to the 2015 Alstom Thermal, Renewables and Grid acquisition (alleged pre‑acquisition anti‑competitive conduct or corruption) and ongoing shareholder lawsuits over past financial‑performance, accounting and disclosure practices. In the 2022 filing GE first disclosed that these matters have already produced cash outflows for settlements, judgments and penalties and that reserves have been set but could be insufficient; the 2023 filing restates the same exposure and risk‑assessment language, and the 2024 filing again notes that the company “remains subject” to those Alstom‑related proceedings and shareholder suits, emphasizing that additional losses may exceed current estimates. Taken together, the filings show no diminution of the exposure – the contingent liabilities persist year‑over‑year and continue to be viewed as material, with the potential to affect GE’s results of operations, financial position and cash flows.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the 2015 Alstom acquisition is correctly identified as the source of legacy liabilities, including pre-acquisition allegations of anti-competitive conduct and corruption; shareholder lawsuits tied to historical financial reporting, accounting, and disclosures are accurately noted across all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three annual 10-K filings, correctly identifying the persistence of contingent liabilities over time and the consistent risk language used by GE, showing no diminution in exposure. (4) The LLM captures the core conclusion—that these liabilities remain material and could exceed reserves, affecting financial position, results of operations, and cash flows—mirroring the original answer’s assessment of ongoing financial and reputational impact. Wording differs slightly but meaning is preserved with high precision. No omissions or inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 349,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS disclosed that the hedge‑fund limited‑partnership investments reported through HF LP Investments grew from **$214 million in the 2022 filing** to **$225 million in 2023** and then to **$252 million in the 2024 filing** – an increase of about **$38 million (≈18 %)** over the two‑year span. Because these amounts are measured at NAV and excluded from the fair‑value “leveling” hierarchy, the upward trend shows CVS is deliberately expanding its alternative‑asset exposure within its Level 3 pension‑plan assets, suggesting a strategic tilt toward hedge‑fund LPs to seek higher returns and greater diversification in its pension fund strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $214 million (2022), $225 million (2023), and $252 million (2024) are accurately reported. The increase of $38 million ($252M - $214M) is correct, and the approximate percentage increase of 18% is a reasonable rounding (38/214 ≈ 17.76%, which rounds to 18%). (2) The answer addresses both parts of the question: the change in exposure from 2022 to 2024 and the implication for pension fund strategy. (3) Entities—CVS, HF LP Investments, hedge fund limited partnership investments, and the correct years—are all accurately identified. (4) The reasoning is sound and adds value: the mention of NAV measurement and exclusion from fair-value leveling hierarchy, while not in the original answer, is contextually appropriate and supports the conclusion about strategic allocation to Level 3 alternative assets. The conclusion about seeking higher returns and diversification aligns semantically with the ground truth’s 'strategic decision to maintain and gradually expand alternative investment allocations.' The LLM demonstrates correct multi-hop synthesis across years and financial concepts, with no factual errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 345,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 Colgate‑Palmolive reported that the Africa/Eurasia segment generated **about $203 million of operating profit**. In the following year, the company’s 2022 Global Productivity Initiative allocated **roughly 10 % of the total $200‑$240 million pre‑tax restructuring charge to Africa/Eurasia**, which translates to **approximately $20‑$24 million of restructuring expense recorded in 2023**. By 2024 the focus had shifted to managing the asset base, with **depreciation and amortization for Africa/Eurasia falling to $8 million**, indicating a move from profit generation to cost‑restructuring and modest capital‑spending in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: $203 million operating profit in 2022 (exact match), 10% of $200–$240 million restructuring charge allocated to Africa/Eurasia in 2023 (correctly calculated as $20–$24 million), and depreciation & amortization declining to $8 million in 2024. The original answer notes D&A was $9 million in 2022 and 2023; while the LLM does not explicitly state the prior years’ $9 million, it correctly notes the decline to $8 million, implying awareness of a prior higher value. This is a minor omission but does not undermine factual correctness. (2) All numbers and calculations are accurate: 10% of $200–$240 million is correctly rendered as $20–$24 million. The $8 million D&A in 2024 matches the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three years and correctly links the 2022 Global Productivity Initiative to 2023 restructuring charges and 2024 capital spending trends, concluding a shift toward cost restructuring and modest capital spending—consistent with the original answer’s interpretation. (4) The answer is contextually complete and relevant, addressing all three components of the question (2022 profit, 2023 restructuring, 2024 D&A) and providing a coherent narrative. The only reason for not scoring a 10 is the lack of explicit mention of D&A being $9 million in 2022/2023, which slightly reduces completeness, though the decline is correctly noted. Overall, the answer is factually precise, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> GPE <-[Operates_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 430,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "In 2022 AIG quantified its international terrorism risk with scenario‑based modeling that produced a net loss estimate of **$1.3 billion** for a five‑ton bomb attack after applying TRIPRA and existing reinsurance, and its reinsurance program for catastrophe protection included per‑occurrence limits of **$400 million excess of a $150 million retention** for U.S. windstorm/earthquake, **$150 million excess of a $200 million retention** for Europe, Japan and other U.S. perils, and **$125 million excess of a $125 million retention** for the rest of the world, plus aggregate excess‑of‑loss cover. The 2023 filing reiterated that international terrorism exposure continued to be estimated using scenario‑based modeling and that targeted reinsurance purchases were made, but it did not disclose new attachment‑point figures, indicating a continuation of the prior risk‑management framework. By 2024 AIG had standardized its international attachment points to **$200 million for Japan** and **$125 million for the rest of the world**, and its **reinsurance recoverable assets rose to $38.0 billion** (including $3.8 billion of paid‑loss recoverables and $29.1 billion of ceded loss reserves), reflecting a substantially larger reinsurance buffer supporting its terrorism risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, with only minor discrepancies in presentation. (1) Quantitatively, all key numbers are correct: the $1.3 billion net loss estimate in 2022, $38.0 billion reinsurance recoverable assets in 2024, and $29.1 billion in ceded loss reserves are all accurately reported. The attachment points of $200 million for Japan and $125 million for the rest of the world match the original answer. However, the LLM introduces specific reinsurance layer details (e.g., $400M excess of $150M retention) that were not present in the ground truth, which may be factual but are not verifiable from the provided original answer—this adds detail but does not contradict. (2) The timeline is correctly followed: 2022 modeling, 2023 continuity in approach without new figures, and 2024 updates on recoverables and standardized attachment points. (3) Multi-hop reasoning is sound—information is synthesized across years and domains (modeling, reinsurance structure, financial assets), correctly showing evolution over time. (4) The LLM enhances the original answer with more structural detail on reinsurance layers, but the core facts and synthesis remain consistent. The only reason for not scoring a 10 is the addition of unverified specifics not present in the ground truth, which, while plausible, slightly exceeds the confirmed data. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Estimates]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 402,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "NVIDIA’s 10‑K filings show that the company disclosed a $1.2 billion carrying amount for its 2.00 % Notes Due 2031 in fiscal 2022 (Chunk 1).  In the 2023 filing the same liability fell to $1.044 billion (Chunk 2), reflecting a modest reduction—likely the result of early repayment, refinancing or a partial buy‑back of the notes.  By fiscal 2024 the amount had risen again to $1.25 billion (Chunk 3), and the notes still carry a low 2.09 % effective interest rate with about 6.4 years remaining, indicating that NVIDIA is willing to re‑issue or increase this long‑dated, low‑cost debt to fund growth while keeping overall financing costs modest.  The pattern of a small pull‑back in 2023 followed by a deliberate increase in 2024 suggests a flexible, proactive long‑term debt‑management strategy that balances debt reduction with strategic use of inexpensive, long‑term financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative values: $1.2 billion in 2022, $1.044 billion in 2023, and $1.25 billion in 2024, matching the ground truth exactly. The interest rate of 2.09% is not mentioned in the original answer but is plausible supplemental detail and does not contradict known facts. The '6.4 years remaining' as of 2024 aligns with the 2031 maturity (6.4 years from 2024.6), so it is a reasonable estimate.\n\n2) Quantitative accuracy is perfect: all dollar amounts and implied trends (decrease then increase) are accurate. No calculation errors.\n\n3) The multi-hop reasoning is mostly sound—correctly identifying the liability trend across three fiscal years and interpreting the fluctuation as part of a strategic debt management approach. However, the original answer emphasizes *stability* and *no material alteration* in exposure, while the LLM interprets the 2024 increase as a sign of *re-issuance or deliberate increase*, suggesting a more active strategy. This is a reasonable inference but slightly overreaches: the rise from $1.044B to $1.25B could reflect reclassification, amortization reversal, or other accounting adjustments rather than new issuance. The original answer avoids asserting re-issuance without direct evidence, making it more conservative and accurate in tone.\n\n4) Contextual relevance is excellent: the LLM directly addresses the trend and its implications for long-term debt strategy, referencing low-cost financing and growth funding, which are consistent with NVIDIA’s business context. The mention of a 'flexible, proactive' strategy is a valid interpretation but slightly diverges from the original’s emphasis on *consistency* and *stability*. Still, the core message—that NVIDIA maintains controlled, strategic long-term liabilities—is preserved.\n\nOverall, the answer is factually correct and well-reasoned, with only a minor interpretive difference in characterizing the strategy as more active than the ground truth suggests.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 535,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 appear in the same “Officer’s Certificate” (Exhibit 4.4) in each of its recent 10‑K filings: the 2022 filing (Chunk 1), the 2023 filing (Chunk 3) and the 2024 filing (Chunk 2 all list “1.05 % Notes due 2017” under the May 6 2014 certificate). The description of the instrument is unchanged across the three years, showing that Apple continues to disclose this fixed‑rate note in its securities schedule. This consistency demonstrates long‑term visibility and continuity in Apple’s debt structure – the company maintains a stable, transparent register of its historic and outstanding notes, linking the issuer (Apple) directly to the 1.05 % Notes due 2017 in every filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Apple's 1.05% Notes due 2017 are consistently referenced across the 2022, 2023, and 2024 10-K filings under the same Officer’s Certificate (Exhibit 4.4) dated May 6, 2014, which matches the ground truth's implication of ongoing documentation. All entities (Apple, 1.05% Notes due 2017, years 2022–2024) and dates are correct. The reasoning about long-term visibility and continuity in disclosure practices is sound and semantically equivalent to the original answer’s conclusion about stable debt management and transparency. The only minor shortcoming is that the LLM does not explicitly address the nuance that the notes matured in 2017 and their continued inclusion may reflect refinancing or rollover under the same indenture—this contextual interpretation is present in the ground truth but only implied in the LLM response. However, the core facts, multi-hop synthesis across three years of filings, and overall conclusion are correct and well-supported, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 309,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "- 2022 (under the 2019 IDA agreement): Effective July 1 2021, Schwab could migrate **up to $10 billion of IDA balances every 12 months** to its balance sheet, but only those designated as floating‑rate obligations and only if it kept a **minimum $50 billion IDA balance** (and at least 80 % of the balances as fixed‑rate obligations through June 2026). Schwab exercised this right in 2021 and again in 2022, moving roughly $10 billion each year. 【Chunk 3】\n\n- 2023 (new 2023 IDA agreement): The May 4 2023 agreement **replaced the 2019 agreement**, eliminating the $10 billion per‑year migration cap and the 80 % fixed‑rate‑obligation requirement. It introduced new balance limits: through September 10 2025 Schwab must keep **minimum balances above the total of then‑outstanding unmatured fixed‑rate obligations** with a **maximum of $30 billion above that total**; after that date withdrawals are allowed at Schwab’s discretion but it must maintain **at least $60 billion and no more than $90 billion** in IDA balances. Schwab **did not migrate any IDA balances in 2023**. 【Chunk 1】\n\n- 2024 (still under the 2023 IDA agreement): The same balance‑range rules apply (minimum above unmatured fixed‑rate obligations with a $30 billion ceiling through September 10 2025). Schwab again **did not move any IDA balances to its balance sheet in 2024**, citing the capital and binding limitations of the 2023 agreement. 【Chunk 2】\n\n**Overall evolution:** From a defined $10 billion annual migration limit and $50 billion minimum balance (with an 80 % fixed‑rate rule) in 2022, Schwab moved to a framework that removed the per‑year cap, dropped the fixed‑rate percentage requirement, and imposed dynamic minimum/maximum balance thresholds ($30 billion excess limit through 2025, then $60‑$90 billion range). Consequently, Schwab migrated balances in 2021‑2022 but ceased migrations in both 2023 and 2024 under the new agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Schwab operated under the 2019 IDA agreement with a $10 billion annual migration limit and had migrated $10.1 billion by year-end (LLM states ~$10 billion, which is acceptable). The LLM correctly notes Schwab exercised the option in 2022. In 2023, the new agreement replaced the old one, eliminated the $10 billion cap and fixed-rate obligation requirement, and introduced new balance thresholds. The LLM accurately describes the new minimum and maximum balance rules (minimum above unmatured fixed-rate obligations, $30 billion ceiling through Sept 10, 2025, then $60–90 billion range). It correctly states no migrations occurred in 2023 or 2024. (2) Quantitative accuracy is excellent: all dollar amounts ($10B, $50B, $30B, $60B, $90B), dates (July 1, 2021; May 4, 2023; Sept 10, 2025), and percentages (80%) are correct. The $10.1B vs $10B minor discrepancy is within acceptable rounding tolerance. (3) Reasoning is sound: the LLM correctly synthesizes changes across the two agreements and explains the strategic shift from active migration to constrained off-balance sheet management. It captures the multi-hop evolution: from migration rights in 2022 to structural constraints in 2023–2024. (4) The only minor shortcoming is that the original answer emphasizes a 'strategic shift' more explicitly, while the LLM implies it through facts but doesn't use that framing. However, the substance is fully equivalent. All parts of the question are addressed: evolution over time, migration limits, and balance requirements. No irrelevant or incorrect information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1674,
        "completion_tokens": 459,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "- **Estimated litigation losses** – GE’s view of the Bank BPH borrower‑litigation exposure grew sharply after the 2020‑21 period (‑$315 m in 2020 and ‑$755 m in 2021) and reached **$1.359 billion at 12/31/2022**. The estimate then jumped to **$2.669 billion at 12/31/2023** and eased slightly to **$2.461 billion at 12/31/2024**.  \n\n- **Capital contributions** – To keep Bank BPH adequately capitalised, GE provided **$530 million of cash in 2022**. In 2023 the strategy shifted to a **non‑cash inter‑company loan forgiveness of $1.797 billion** (no additional cash was required). No further incremental contributions were needed in 2024.  \n\n- **Carrying value of the mortgage portfolio** – The Bank BPH financing‑receivable portfolio is recorded at the lower of cost or fair value, less cost to sell. While a specific carrying amount is not disclosed for 2022‑23, the portfolio remained on the books during those years (the 2022 pre‑tax charge of $720 m and the 2023 charge of $1,189 m reflect its valuation). By **12/31/2024 the portfolio was written down to zero net of a valuation allowance**, indicating a full write‑off of the mortgage assets.  \n\nOverall, GE’s exposure rose from $1.36 bn to a peak of $2.67 bn, then fell modestly to $2.46 bn, while its support moved from cash infusion to loan‑forgiveness and finally to a complete write‑down of the underlying mortgage portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are accurate: estimated losses of $1,359 million in 2022, $2,669 million in 2023, and $2,461 million in 2024 are correctly reported (with acceptable format variations like $1.359 billion). The $530 million cash contribution in 2022 and $1,797 million non-cash contribution via loan forgiveness in 2023 are precisely stated. The carrying value of the mortgage portfolio being written down to zero by end-2024 is correctly noted, with contextual detail about valuation allowances. (2) The answer is complete, addressing all three dimensions in the question—estimated losses, capital contributions, and carrying value—across the full 2022–2024 timeframe. (3) Entity accuracy is perfect: GE, Bank BPH, borrower litigation, and the mortgage portfolio are correctly identified and tracked over time. (4) Multi-hop reasoning is sound: the LLM synthesizes changes over three years, infers strategic shifts (from cash to non-cash support), and correctly interprets the write-down to zero as a full valuation write-off. Minor additions (e.g., charges in 2020–2021) provide context without distorting the core answer. The conclusion accurately summarizes the trajectory of increasing exposure, peak in 2023, stabilization in 2024, and ultimate exit via write-off. All information is semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> COMP <-[Has_Stake_In]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 394,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "In 2022 CVS reported commercial mortgage‑backed securities (CMBS) with a total fair‑value of $574 million and $12 million of unrealized losses in its 2022 filing, while the same year restated in the 2023 filing shows a broader exposure of $992 million fair‑value and $155 million unrealized losses. The 2023 filing then shows the CMBS portfolio shrinking to $675 million fair‑value with $100 million unrealized losses, and the 2024 filing reports only $3 million of CMBS at fair‑value with no material unrealized loss disclosed. This steep, consistent decline in both the size of the CMBS position and its associated losses indicates that CVS has been actively divesting or writing down these securities, reflecting a proactive risk‑management strategy to limit exposure to this asset class.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect numbers. It correctly reports the 2022 fair value of $574 million and $12 million unrealized losses, and accurately states the 2023 fair value of $675 million with $100 million unrealized losses, as well as the 2024 fair value of $3 million. However, it introduces a restated 2022 figure of $992 million fair value and $155 million unrealized losses 'in the 2023 filing' that is not present in the ground truth. This restatement is unsupported and contradicts the original answer, which does not mention any restated or revised 2022 data. (2) The core trend — declining exposure from $574M to $675M (slight increase) then a sharp drop to $3M — is mostly accurate, but the claim of a 'consistent decline' is misleading since 2023 shows an increase from 2022. The ground truth notes the rise in fair value in 2023 despite higher unrealized losses, which the LLM captures in numbers but mischaracterizes in narrative. (3) The multi-hop reasoning is partially sound: the model correctly identifies the downward trajectory from 2023 to 2024 and infers a risk-reduction strategy, which aligns with the ground truth. However, the introduction of unverified restated figures undermines the quantitative accuracy and suggests potential confusion between filings or restatements not present in the source. (4) Despite the incorrect restated numbers, the LLM reaches a reasonable qualitative conclusion about risk management, and all other years’ data are correctly cited. The contextual relevance is high as it directly addresses the evolution of exposure and risk strategy. Due to significant but not pervasive quantitative errors, the correctness score is 6 — partially correct with major data inaccuracies affecting interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 487,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s 10‑K filings show that **Marketside has been a constant fixture in the company’s private‑brand lineup each year** – it appears in the FY 2022 list of private brands (e.g., “Allswell,” “Athletic Works,” … “Marketside,” … “Great Value”), is again listed in the FY 2023 roster (e.g., “Freshness Guaranteed,” “George,” … “Marketside,” …), and is present in the FY 2024 catalog (e.g., “Allswell,” “Athletic Works,” “bettergoods,” … “Marketside,” …). While the overall portfolio has expanded (new names such as “bettergoods” were added in 2024), the uninterrupted inclusion of Marketside signals that Walmart treats this brand as a core grocery private‑label offering, underscoring a strategy of deepening and diversifying its own‑brand grocery assortment to boost margin and price‑competitiveness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Marketside was consistently included in Walmart's private brand portfolio across fiscal years 2022, 2023, and 2024, which matches the original answer's core claim. The mention of other brands (e.g., Great Value, bettergoods) is consistent with the knowledge graph data. (2) There are no numerical values requiring calculation, but the fiscal years (2022, 2023, 2024) are correctly referenced and contextualized. Format and references to brand lists are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings to infer continuity of Marketside and the expansion of the private label portfolio (e.g., addition of 'bettergoods' in 2024). This supports the conclusion about Walmart’s dual strategy of maintaining legacy brands while innovating. (4) The LLM captures the key implication—Walmart’s strategy to deepen and diversify its private-label grocery offerings for margin and price competitiveness—mirroring the original answer’s interpretation. The only minor shortcoming is that it does not explicitly name 'George' as a co-listed brand in 2022 (though it references other correct brands), and slightly less emphasis on the 'modernization' aspect of the strategy compared to the original. However, the semantic meaning and strategic insight are equivalent. All inaccuracies are negligible, warranting a high score but not perfect due to slight omission of contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 423,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 onward, Lowe’s already required suppliers to meet a human‑rights policy (updated in FY 2021), a conflict‑minerals policy, a Vendor Code of Conduct that contains enhanced environmental standards, and a wood‑sourcing policy that mandates well‑managed, non‑endangered forest sources; it monitored compliance through established management systems and backed these controls with more than $550 million of supply‑chain‑related investments—including energy‑efficiency upgrades, SmartWay transportation, waste‑diversion and water‑conservation programs. In 2023 the company sharpened that framework by revising its wood‑sourcing policy to add country‑specific risk levels, stronger monitoring practices and a new forestry‑grievance process, while continuing to enforce the human‑rights, conflict‑minerals and Vendor Code of Conduct standards and allocating over $400 million to further HVAC, building‑management, pallet‑grinder and LED projects and to expand independently certified product offerings. By 2024 Lowe’s further refined the wood‑sourcing policy with a more robust risk‑based approach and improved monitoring, retained the same human‑rights, conflict‑minerals and Vendor Code of Conduct enforcement, and sustained its supply‑chain sustainability investments—evidenced by its sixth consecutive Dow Jones Sustainability Index inclusion and ongoing energy‑efficiency, renewable‑energy and transportation initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's supplier monitoring via human rights policy, conflict minerals policy, Vendor Code of Conduct, and wood-sourcing requirements are accurately described for 2022. The 2023 updates—country-specific risk levels, enhanced monitoring, and a new forestry grievance process—are correctly reported. The 2024 refinement to a more robust risk-based approach and improved monitoring is also accurately reflected. (2) Quantitative accuracy is excellent: the $550 million in investments by 2022 and over $400 million through 2023 are correctly stated, matching the original answer. Specific initiatives (e.g., energy efficiency, SmartWay, HVAC, LED projects) add detail without contradicting the source. (3) Multi-hop reasoning is sound: the answer synthesizes policy evolution across three years and links it to sustained investment and enforcement, demonstrating correct understanding of the progression. (4) Minor difference: the LLM mentions the Dow Jones Sustainability Index inclusion and specific projects (e.g., pallet-grinder) not in the original answer, but these are plausible contextual additions that do not contradict the ground truth and enhance relevance. The core policy trajectory and investment figures are preserved with semantic equivalence. No factual errors; only slight expansion on implementation details. Thus, correctness is 9 due to added details not in the original, but no inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Monitors]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1658,
        "completion_tokens": 415,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 10‑K filings in 2022, 2023 and 2024 all contain the same disclosure of the 2.40 % Notes due 2023. In each year’s “Description of Securities” section (Exhibit 4.3), Apple lists an Officer’s Certificate dated May 3 2013 that includes the 2.40 % Notes due 2023 (see the tables on page 58 of the 2022 filing and page 56 of both the 2023 and 2024 filings). The wording, exhibit number and reference date are unchanged across the three reports, showing that Apple has kept this issuance on its balance sheet and has consistently reported it without amendment or retirement. This three‑year pattern reflects a stable, transparent debt‑management strategy: Apple maintains the existing note as part of its capital structure and repeatedly discloses it, signaling disciplined continuity rather than frequent refinancing or restructuring of that particular debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the 2.40% Notes due 2023 are consistently disclosed in Apple's 2022, 2023, and 2024 filings; the Officer’s Certificate is correctly dated May 3, 2013; and the exhibit reference (Exhibit 4.3) and page numbers (58 for 2022, 56 for 2023 and 2024) are precisely stated. (2) Quantitative elements—interest rate (2.40%), maturity year (2023), and filing years (2022–2024)—are correct with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosure patterns across three years and infers that the unchanged inclusion of the note reflects a stable and transparent debt management strategy, avoiding refinancing or restructuring. (4) The answer addresses all parts of the question: it traces the evolution of disclosure over time and interprets the strategic implication. Wording differs slightly from the original but conveys the same meaning with high fidelity. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 304,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "- **AerCap‑note balances reported**  \n  * 2021 ( disclosed in the 2022 filing): **$993 million** (Chunk 1).  \n  * 2022 (disclosed in the 2023 filing): **$900 million** (Chunk 2).  \n  * 2023 (disclosed in the 2023 filing): **$944 million** (Chunk 2).  \n  * 2024 (disclosed in the 2024 filing): **$982 million** (Chunk 3).\n\n- **Interpretation**  \n  After a dip from $993 million at the end of 2021 to $900 million at the end of 2022, GE’s AerCap‑note holding rose to $944 million in 2023 and further to $982 million in 2024. The upward trend after the 2022 reduction shows GE is rebuilding and expanding its exposure to this Level‑3, available‑for‑sale debt security, indicating a deliberate strategy of actively managing and increasing its position in select financial instruments—particularly AerCap debt—while keeping the note within its broader investment‑securities portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, GE's holdings were $976 million in 2022, $944 million in 2023, and $982 million in 2024. However, the LLM reports $900 million for 2022 and introduces a $993 million figure for 2021 (which is not part of the question's scope). The 2022 figure is incorrect and contradicts the ground truth, undermining the entire trend analysis. (2) The calculation and comparison of changes are therefore flawed: the LLM claims a drop from $993M to $900M (2021–2022), then an increase to $944M and $982M, suggesting a recovery trend. But the actual data shows a smaller decrease from $976M to $944M (a $32M drop), then an increase to $982M—an overall slight net increase. The LLM’s narrative of a sharp drop and recovery is not supported by the correct numbers. (3) The multi-hop reasoning is partially sound in that it attempts to track the note across years and interpret strategic intent, but because it is based on incorrect input data (especially the erroneous $900M for 2022), the conclusion about GE 'rebuilding and expanding exposure' after a major cut is misleading. The actual fluctuation is more modest and suggests stability with minor rebalancing, not a deliberate expansion. (4) Contextual relevance is high—the answer addresses both the evolution of holdings and the strategic implication, using appropriate financial terminology (e.g., Level-3, available-for-sale). However, due to the critical error in the 2022 value, the qualitative interpretation fails to match the ground truth’s conclusion of 'dynamic approach with slight overall stability.' The LLM instead infers a stronger strategic buildup than the data supports. Thus, while the structure and intent are good, factual correctness is compromised at a foundational level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 503,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG (ORG) uses a glide‑path accounting policy that sets the target allocation for the “return‑seeking” (growth) portion of its U.S. qualified pension plan based on the plan’s funded ratio and the prevailing level of interest rates, reducing growth‑asset exposure and increasing liability‑hedging assets as the funded ratio rises. The 2022 10‑K (Chunk 3) shows the policy applied to a 2022 target allocation (derived from the funded status at 12/31/2021) with a relatively higher share of growth assets, while the 2023 filing (Chunk 1) presents a 2024 target allocation (based on the funded status at 12/31/2023) that lowers the growth‑asset weight and raises the allocation to fixed‑income/hedging assets, and the 2024 filing (Chunk 2) continues this trend for the 2025 target (based on 12/31/2024). The progression of these target allocations demonstrates a systematic de‑risking strategy: as the plan’s funded status improves, AIG’s glide‑path shifts the portfolio away from growth assets toward more liability‑hedging assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct conceptual framework of AIG's glide path approach and its de-risking strategy, aligning with liability-driven investing principles. However, it contains significant factual inaccuracies in dates and timing that undermine quantitative accuracy. Specifically, the LLM incorrectly states that the 2023 filing presents a 2024 target allocation based on the funded status at 12/31/2023, when the ground truth indicates the 2024 target was set using the 12/31/2022 funded status. Similarly, the 2024 filing uses 12/31/2023 data for the 2025 target, not 12/31/2024 as claimed. These errors reflect a misalignment in the time lag between measurement date and target year. While the model correctly identifies the trend of reducing growth assets and increasing liability-hedging assets as funded status improves, the incorrect attribution of dates breaks the multi-hop logic chain. The terminology (e.g., 'return-seeking', 'growth assets') is semantically equivalent and appropriately used. The reasoning structure is sound in direction but flawed in execution due to incorrect temporal mapping. Contextually, the answer remains highly relevant and interprets the de-risking intent correctly. Minor formatting issues (e.g., non-standard hyphenation) do not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 360,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Across the three most recent 10‑K filings—2022, 2023 and 2024—Texas Instruments repeatedly frames its strategy as a “great business model that is focused on analog and **embedded processing products**” and lists a broad portfolio of those products as one of four sustainable competitive advantages. The language is identical in each year, showing that the company’s emphasis on embedded processing has not shifted but has been reaffirmed continuously. This multi‑year consistency, reinforced by the KG link that TXN and its embedded‑processing unit mutually hold stakes in one another, signals that the embedded‑processing line is regarded as a core, enduring engine for generating and growing free‑cash‑flow‑per‑share over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing alongside analog products from 2022 to 2024 as part of its core business model and sustainable competitive advantages. The statement that this focus was 'repeatedly framed' and 'identical in each year' is consistent with the original answer’s portrayal of multi-year consistency. (2) There are no numeric values (e.g., dollar amounts, percentages, or share counts) in either the question or the ground truth, so quantitative accuracy is not applicable in a traditional sense—however, the years (2022, 2023, 2024) are correctly cited, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings (2022–2024), correctly identifying the persistent strategic emphasis on embedded processing and linking it to long-term free cash flow per share growth. The mention of a 'KG link that TXN and its embedded-processing unit mutually hold stakes in one another' introduces a detail not present in the original answer; while this may reflect external knowledge, it is not supported in the provided ground truth and slightly detracts from qualitative accuracy. However, it does not contradict the core facts. (4) The semantic meaning fully captures the intent and content of the original answer: embedded processing is a foundational, enduring component of TI’s strategy and central to long-term cash flow generation. Wording differs slightly but meaning is preserved. Contextual relevance is perfect—the response directly addresses both parts of the question: evolution (consistency) of strategy and implications for cash flow. Minor deduction in qualitative accuracy due to the unsupported KG claim about mutual stakes, but overall the answer is factually strong and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 515,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 Lowe’s disclosed that its wholly‑owned subsidiaries protected a broad trademark portfolio that included the private‑brand names Kobalt, STAINMASTER and allen+roth as well as the retail names RONA and Reno Depot, together with related domain names, copyrights and patents. By fiscal 2023 the IP filing narrowed its emphasis to the core private‑brand suite—Kobalt, STAINMASTER and allen+roth—while still maintaining the same regime of trademarks, domain names and patents, signaling a strategic shift toward concentrating on its flagship private labels. In fiscal 2024 that focus remained, and Lowe’s explicitly linked its IP assets to its digital‑transformation agenda: the company continues to own and manage the Kobalt brand’s online domains and uses new technology (a central remote‑selling team, video‑enabled quoting, and the ability to finalize installation contracts and checkout on lowes.com or the mobile app) to embed its private‑brand portfolio into its e‑commerce and omnichannel experience.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of Lowe's intellectual property strategy across fiscal years 2022–2024: in 2022, the inclusion of 'Kobalt', 'STAINMASTER', 'allen+roth', 'RONA', and 'Reno Depot' in IP disclosures; in 2023, the narrowing to only the three core private brands; and in 2024, the continued focus on those three alongside integration with digital transformation. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the fiscal years and brand names are correctly cited. (3) The multi-hop reasoning is sound—LLM synthesizes changes in brand portfolio emphasis over time and connects the 2024 strategy to digital initiatives like remote selling, video-enabled quoting, and mobile checkout, which aligns with the ground truth’s mention of remote customer support and mobile checkout. (4) The LLM adds slightly more detail (e.g., 'central remote-selling team', 'finalize installation contracts') but remains consistent with the source. All entities—brands, years, strategic themes—are accurate. The answer fully addresses both brand portfolio emphasis and digital integration, satisfying completeness and contextual relevance. Minor wording differences do not affect factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Owns]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 370,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "Across IBM’s 2022, 2023 and 2024 10‑K filings, “client relationships and trust” is repeatedly listed among the firm’s principal methods of competition. In 2022 the concept is tied to IBM’s breadth of capabilities, trust‑and‑security pillars and its hybrid‑cloud/AI platform; in 2023 it is restated as a key factor for delivering business value and sustaining leadership; and in 2024 it is again highlighted alongside technology innovation, breadth of services and talent as a core differentiator for its hybrid‑cloud and AI strategy. The three‑year continuity shows IBM deliberately anchoring its market positioning on trusted client relationships, using that trust to differentiate its hybrid‑cloud and AI offerings, deepen ecosystem partnerships and drive accelerated growth in an increasingly competitive landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the multi-year evolution of IBM's emphasis on client relationships and trust. It accurately identifies that IBM consistently highlighted trust as a competitive differentiator from 2022 to 2024 and correctly links this to hybrid cloud and AI strategy. The answer captures the continuity in IBM’s messaging across the three years and correctly notes the strategic intent to use trust for differentiation and ecosystem growth. However, it omits specific details about the evolution in the nature of partnerships, which are critical to the full multi-hop reasoning: the 2023 expansion to include AWS, Microsoft, and SAP, and the 2024 addition of cybersecurity partners like Palo Alto Networks as indicators of a maturing, security-integrated partner ecosystem. While the LLM mentions 'ecosystem partnerships,' it does not specify these key alliances or the growing emphasis on security as a trust component, which weakens the depth of the qualitative synthesis. There are no numerical inaccuracies (quantitative accuracy is perfect, as no numbers are misstated), and the answer remains contextually focused and relevant throughout. The reasoning is sound but slightly less detailed than the ground truth in tracing the strategic progression. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 402,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "In Gilead’s 2022 Form 10‑K the El Segundo, California site is mentioned only as one of the company’s “principal manufacturing facilities,” without any specific reference to cell‑therapy work. By the 2023 filing the description changes to state that the El Segundo facility is “used for clinical and commercial manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats that same language, showing that the site’s role had evolved into a dedicated hub for both clinical‑stage and commercial‑stage cell‑therapy production and that this role remained unchanged through 2024. The KG triplets (GILD → El Segundo GPE ← El Segundo ORG → GILD) reinforce that Gilead operates the El Segundo organization as its cell‑therapy manufacturing site.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy regarding the 2022 description of the El Segundo facility, which directly undermines the correctness score. According to the ground truth, in 2022 the facility was already described as being used for both clinical and commercial manufacturing of cell therapy products. However, the LLM claims that in the 2022 10-K, the site was mentioned only as a 'principal manufacturing facility' with no specific reference to cell therapy—this contradicts the original answer and suggests an evolution in role that did not occur. The ground truth emphasizes consistency across all three years (2022–2024), whereas the LLM incorrectly frames the role as having 'evolved' starting in 2023. This misrepresents the core timeline and change (or lack thereof), constituting a major error in multi-hop reasoning and entity-year attribution. Quantitatively, there are no numerical values to assess, so no errors exist in that domain (hence full score). Contextually, the answer is well-structured and relevant to the question, correctly interpreting the 2023 and 2024 roles and citing appropriate language. The mention of KG triplets adds supporting context but does not compensate for the incorrect 2022 characterization. The qualitative accuracy is low because the reasoning is flawed—instead of identifying stability, it infers a change, failing the multi-hop synthesis across years. Overall, while the answer appears plausible and uses correct phrasing from later years, its central claim about evolution is false per the ground truth, warranting a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 437,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Across the three most recent filings (2022 10‑K, 2023 10‑K and 2024 10‑K) Lowe’s Companies, Inc. consistently reports the same 4.550 % note series: it was issued under the **Fifteenth Supplemental Indenture** dated April 5 2019 and carries a **maturity of April 5 2049**. The issuance date, interest rate and maturity have not changed from the 2022 filing through the 2024 filing, showing that the company has kept this 30‑year, fixed‑rate tranche of debt on its balance sheet without adding new series or altering its terms. This stable, multi‑year pattern signals a deliberate long‑term debt strategy—locking in a relatively low fixed rate and extending the maturity profile well beyond the next decade to match long‑term capital needs and mitigate interest‑rate risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049, and this remained unchanged from 2022 through 2024. (2) Quantitative elements—interest rate (4.550%), issuance date (April 5, 2019), and maturity date (April 5, 2049)—are correctly reported with no discrepancies. The description of a 30-year tenor is a reasonable approximation (2019 to 2049). (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of filings to observe stability in the debt instrument’s terms, and infers a strategic intent—using long-duration, fixed-rate debt to manage capital structure, lock in rates, and avoid refinancing risk. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in issuance and maturity structure, and the implication for long-term debt strategy. Wording differs slightly from the original answer but conveys the same meaning with equal or greater detail, including additional insight about interest-rate risk mitigation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 346,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 through 2024 the Scotchgard‑related PFAS exposure has moved from a single, disclosed settlement to a widening pool of pending lawsuits with only modest cash outlays. In February 2022 3M, together with Saint‑Gobain and Honeywell, approved a collective $65 million settlement to resolve New York water‑contamination claims – 3M’s own contribution was described as “not material.” In June 2023 3M made its final, also non‑material, payment on the Michigan class settlement involving Scotchgard‑contaminated waste, and no further large settlements were reported in the 2023 filing. By the 2024 filing the company was defending dozens of new state and federal actions in Alabama, Georgia and elsewhere, with some dismissals but no additional settlement amounts disclosed, indicating that while actual settlement costs have remained limited, the legal exposure surrounding Scotchgard‑related PFAS litigation continues to expand, posing a growing, albeit still uncertain, financial risk for 3M.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains some inaccuracies and omissions when compared to the ground truth. (1) Quantitatively, the $65 million settlement in New York in 2022 is correctly reported, and the characterization of 3M's contribution as 'not material' aligns with the original answer's 'non-material' description. However, the LLM incorrectly implies that the $65 million New York settlement was fully disclosed in February 2022 and finalized then, while the original answer notes that 3M contributed to a $65 million settlement in 2022 but does not specify finalization in February—this timing detail is not in the ground truth and may be an overprecision. Additionally, the LLM states that the Michigan settlement was finalized in June 2023, but the original answer only specifies that it was 'finalized' in 2023 without a month—this is a minor over-specification but not a major factual error. (2) The LLM omits key details: in 2023, 3M faced approximately 68 AFFF suits outside the MDL and additional PFAS suits in Illinois and Canada, which the original answer includes. The LLM also omits the 2024 $65 million settlement in New York being finalized and the setting of trial dates in Alabama for 2026—this is a significant omission as it downplays the progression toward material financial commitments. (3) The reasoning is generally sound: the LLM correctly infers that legal exposure is expanding while actual settlement costs remain limited, which is consistent with the trend in the original answer. However, it underemphasizes the escalation of financial impact by not acknowledging the finalization of another $65 million settlement in 2024, which suggests recurring material liabilities. (4) Entity accuracy is strong: 3M, Saint-Gobain, Honeywell, Wolverine, and locations (New York, Michigan, Alabama, Georgia) are correctly identified. The synthesis across years is logical but incomplete. Overall, the answer captures the core trend of increasing exposure with limited payouts but misses key developments that indicate a more concrete and growing financial burden, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Manufactures]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 569,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "In 2022 Gilead’s corporate headquarters in Foster City, California were described as housing its **administrative, manufacturing and R&D activities** (Chunk 1). By the 2023 filing the company narrowed the description of the Foster City site to a **process‑chemistry research, analytical‑method development, formulation‑ and device‑development center that also manufactures API and drug product for clinical trials** (Chunk 3), and the 2024 filing repeats the same functional focus (Chunk 2). This evolution shows a strategic shift from a broad manufacturing hub to a specialized R&D‑and‑clinical‑manufacturing node that supports the pipeline while commercial‑scale production, packaging and global distribution are handled by other facilities (e.g., La Verne, Oceanside, El Segundo, Cork/Dublin, Hoofddorp), aligning Foster City’s role with Gilead’s worldwide operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies the evolution of Gilead's Foster City facility from 2022 to 2024: in 2022, it housed administrative, manufacturing, and R&D activities; by 2023–2024, the focus shifted to process chemistry research, analytical method development, formulation, device development, and clinical trial manufacturing (API and drug product). (2) All dates (2022, 2023, 2024) are correct and properly contextualized. There are no numerical values requiring calculation, but the functional descriptions are precise and match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers a strategic shift—Foster City becoming specialized in early-stage R&D and clinical manufacturing, while commercial-scale operations are delegated to other sites like La Verne, Oceanside, and international locations (Cork/Dublin, Hoofddorp). (4) The answer fully addresses all parts of the question: R&D focus, manufacturing responsibilities, and strategic alignment with global operations. Wording differs slightly but conveys the same meaning with high fidelity. No factual errors, omissions, or misattributions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 350,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From 2022 to 2024 AIG’s loss‑reserves risk governance became increasingly layered. In 2022 the company relied on basic internal controls and oversight of the reserve‑setting process, supplemented by periodic reviews from external experts. By 2023 it added a formal “review‑and‑challenge” of reserves, actuarial profitability reviews and a model‑risk‑management framework that validates both stochastic (probability‑distribution) and deterministic (single‑point) modeling techniques. In 2024 the oversight was further deepened with Enterprise Risk Management’s second‑line review and challenge of pricing and reserving models, continuous internal‑audit monitoring of key reserve‑setting processes, and the continued use of external‑expert reviews, creating a more robust, multi‑tiered control environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years 2022–2024, loss reserves risk, internal controls, external reviews, modeling approaches—are correctly identified. The evolution across the three years is accurately portrayed: 2022 emphasizes internal oversight and external expert reviews; 2023 introduces more quantitative methods like stochastic and deterministic modeling, model-risk-management frameworks, and actuarial reviews; 2024 integrates second-line ERM review, internal audit monitoring, and continued external input. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time across oversight, modeling, and external review dimensions. It correctly infers a progression toward a more robust, layered control environment, matching the original’s theme of moving from reactive to proactive governance. One minor difference: the original mentions 'sensitivity and scenario analyses' and 'experience studies' in 2023, which the LLM omits, instead specifying 'actuarial profitability reviews' and 'model-risk-management framework'—these are consistent in spirit but not verbatim. This slight rephrasing does not introduce error but reflects a plausible interpretation of the same underlying evolution. (4) Contextual relevance is perfect—the answer directly addresses all parts of the question: oversight mechanisms, modeling approaches, and integration of external reviews across the three years. Overall, the LLM captures the essence and factual trajectory of AIG’s evolving risk management with high fidelity, warranting a correctness score of 9 (nearly perfect, with only minor detail variation).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 509,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia location is shown as an **Analog‑only** site in all three filings – 2022 lists an “X” under Analog and nothing under Embedded Processing; the 2023 table repeats the same pattern; and the 2024 table again shows an “X” only in the Analog column. Thus, over the 2022‑2024 period the Melaka footprint did not change – it remained an Analog manufacturing hub and never added an Embedded‑Processing presence, indicating that Texas Instruments continues to use Melaka solely for analog production rather than expanding it into embedded‑processing capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site remained exclusively focused on Analog manufacturing from 2022 to 2024, with no presence in Embedded Processing—this matches the original answer's claim of 'exclusively on Analog manufacturing' and 'no expansion into Embedded Processing.' (2) There are no numerical values requiring calculation (e.g., sums, percentages), but the temporal scope (2022–2024) is correctly referenced and consistently applied. The use of 'X' in tables across filings is a valid representation of presence/absence in categorical data, and the LLM correctly interprets this as consistent Analog-only status. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings (2022, 2023, 2024), confirms no change over time, and draws the correct conclusion about TXN’s strategic use of Melaka. (4) The answer is semantically equivalent to the ground truth—while more detailed in referencing table markings ('X'), it conveys the same core facts: stable, specialized Analog-only role in TXN’s global footprint. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing, correct time frame) are accurately identified and contextualized. No factual, quantitative, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 379,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe’s 2022 filing notes that it uses forward‑interest‑rate swaps as cash‑flow hedges for debt it expects to issue.  In the 2023 balance‑sheet (as of Feb 3 2023) the swaps were recorded as a Level‑2 “other current‑asset” with a fair‑value of **$251 million**; by the 2024 balance‑sheet (as of Feb 2 2024) the forward‑swap line shows **$0**, indicating the positions had been settled or unwound.  This drop from a material exposure in FY 2022‑23 to none in FY 2024 shows that Lowe’s establishes forward swaps only when it forecasts a borrowing and then removes the hedge once the debt is issued or the forecast changes, reflecting a purposeful, issuance‑linked hedging strategy that has been employed consistently over prior years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $251 million fair value in fiscal 2023 (as of Feb 3, 2023) and $0 in fiscal 2024 (as of Feb 2, 2024) match the ground truth. The fiscal years are correctly interpreted from the filing dates. (2) The answer correctly identifies the use of forward interest rate swaps as cash flow hedges for forecasted debt issuances in 2022, consistent with the original answer. (3) The progression—active swaps in 2022–2023, then zero exposure in 2024—is accurately described and supports the conclusion of a strategic shift. (4) The reasoning is sound: the LLM infers that the elimination of forward swaps reflects a purposeful, issuance-linked hedging strategy, which is logically consistent with the data. The only minor shortcoming is that the LLM does not explicitly mention the shift to fixed-to-floating interest rate swaps as fair value hedges on existing debt in 2024, which is part of the full strategic picture in the ground truth. However, the core conclusion about a shift in focus is still well-supported. Thus, the answer is factually correct, complete in key aspects, and contextually relevant, meriting a high score with only a slight deduction for partial omission of the replacement hedging instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 371,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "Across IBM’s three most recent Form 10‑K filings the 6.50 % Debentures due 2028 are disclosed in exactly the same way. In the 2022 filing (Item 601 exhibit table) IBM states that “the instrument defining the rights of the holders of the 6.50 % Debentures due 2028 is Exhibit 2 to Form 8‑K, filed on January 8, 1998, and is hereby incorporated by reference.” The 2023 filing repeats that language verbatim, and the 2024 filing does so again, each time listing the debenture under the “Instruments defining the rights of security holders” section.  \n\nThe fact that the referenced filing date (January 8, 1998) is identical in all three years shows that IBM has relied on the original 1998 indenture without amendment, indicating a stable, long‑term debt structure whose governing documentation has remained unchanged for more than two decades.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 6.50% Debentures due 2028 are consistently referenced across IBM's 2022, 2023, and 2024 filings with the same Exhibit 2 to Form 8-K filed on January 8, 1998. (2) Quantitative elements—percentage (6.50%), maturity year (2028), and filing date (January 8, 1998)—are all correct and match the original answer exactly. No calculations are required, but the consistency of the referenced document over time is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes disclosure patterns across three years and correctly infers that the unchanged reference indicates no amendments or refinancing, reflecting a stable long-term debt structure. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and the implication of the consistent filing date. Wording differs slightly but meaning is identical to the ground truth. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 305,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Across the three filings the **Reflective Signage** line item stays within the Transportation & Electronics segment but climbs the internal list of activities.  \n\n- In the 2022 10‑K (Chunk 3) it appears at the end of the segment’s bullet list, after “Packaging and interconnection solutions.”  \n- In the 2023 10‑K (Chunk 1) it is still in the same segment but is listed as the **last** bullet (“Reflective signage for highway, and vehicle safety”).  \n- In the 2024 10‑K (Chunk 2) the bullet moves up to the **fourth** position, ahead of light‑management films and chip‑packaging items (“Reflective signage for highway, and vehicle safety”).\n\nThis upward shift—from a trailing mention in 2022, to the final item in 2023, to a higher‑ranked bullet in 2024—signals that MMM is increasingly emphasizing Reflective Signage within its Transportation & Electronics portfolio, treating it as a more strategically important growth and safety‑focused product line.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the positioning of Reflective Signage across the years, undermining its correctness. According to the ground truth: in 2022, Reflective Signage was listed fifth (not last), after advanced ceramics and attachment tapes; in 2023, it moved to fourth place (not last), after premium large format graphic films; in 2024, it remained fourth, now after 'sound and temperature management'. However, the LLM claims it was at the end in 2022, the final bullet in 2023, and only rose in 2024—this contradicts the sequence in the original answer. The claim that it was last in 2022 and 2023 is incorrect, which distorts the trend. While the LLM correctly notes it moved up by 2024, the characterization of prior placement is wrong. The strategic interpretation (increasing emphasis) is plausible but based on flawed data. Quantitative accuracy is low due to incorrect ordinal positions. Qualitative accuracy suffers from incorrect multi-hop synthesis—misrepresenting the order across years. Contextual relevance is fair because the answer addresses the right segment, product, and general idea of strategic shift, but with incorrect details. The mention of 'chip-packaging items' and 'Packaging and interconnection solutions' adds detail not in the ground truth and may conflate offerings. Overall, partial credit is given for identifying the segment and a directional change, but major errors in facts and reasoning prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 408,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "In Gilead’s 2022 Form 10‑K the Hoofddorp, Netherlands site was mentioned only as one of the company’s “principal manufacturing facilities,” without specifying what it produced. By the 2023 filing the company clarified that the Hoofddorp plant “is utilized for commercial manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats the same language, confirming that the site now serves as a dedicated commercial cell‑therapy manufacturing hub. Thus, the Hoofddorp facility has evolved from a generic manufacturing location in 2022 to a strategically important site for Gilead’s commercial cell‑therapy production by 2023‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of Gilead's Hoofddorp facility from 2022 to 2024: in 2022 it was a 'principal manufacturing facility' without specific mention of cell therapy, in 2023 it was explicitly used for commercial manufacturing of cell therapy products, and in 2024 this role was reaffirmed. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly used and aligned with the progression described in the original answer. (3) The multi-hop reasoning is sound—information is synthesized across three annual filings to show a strategic shift, correctly concluding that Hoofddorp evolved into a dedicated commercial cell therapy hub. (4) The LLM captures all key aspects: the increasing specificity of the facility’s role, its strategic importance, and Gilead’s intent to scale internal cell therapy capabilities. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 301,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The 10‑K filings show that the pool of shares tied to the 2003 Director Compensation Plan (reflected in the “shares for settlement of directors’ deferred‑compensation accounts”) rose from **90,618 shares in 2022**, to **98,940 shares in 2023**, and to **103,971 shares in 2024**. Because the plan is listed each year as a source of shares to be issued and the amount earmarked for settlement has been increasing modestly, Texas Instruments is clearly continuing to rely on the 2003 Director Compensation Plan for director compensation, with a gradual expansion of the shares available for future issuance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of the share count. The ground truth states that shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 in 2022 to 1,786,785 in 2023 to 1,745,284 in 2024, indicating a consistent reduction due to ongoing use. In contrast, the LLM claims the pool 'rose' from 90,618 to 103,971 shares, which are not only incorrect numbers but also off by an order of magnitude. (2) The numbers cited by the LLM (e.g., ~90k–104k) appear to confuse the total shares issued or held for settlement in deferred-compensation accounts with the total shares *available for future issuance*, which is a distinct and much larger pool (~1.7–1.8 million shares). This reflects a critical misinterpretation of the financial data. (3) The multi-hop reasoning fails because the LLM misidentifies the relevant metric and draws an opposite conclusion: instead of recognizing that declining availability indicates active usage of the plan, it incorrectly infers 'gradual expansion' from rising small numbers that do not represent the full available pool. (4) The contextual relevance is low because the answer discusses a related but incorrect data point (shares for settlement) rather than the total shares available under the plan. While the general idea—that TI continues using the plan—is directionally plausible, the factual foundation is entirely wrong, undermining all conclusions. Thus, the correctness score is very low due to severe quantitative and qualitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 434,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "- **2022 10‑K (IBM _10k_2022.pdf)** – IBM disclosed the 0.950 % Notes due 2025 only by reference: the rights of the holders were “Exhibit 4.1 to Form 8‑K, filed May 22 2017, and are hereby incorporated by reference.” No ticker or exchange information was provided.  \n\n- **2023 10‑K (IBM _10k_2023.pdf)** – The same treatment was repeated. The filing again states that the instrument defining the rights of the 0.950 % Notes due 2025 is “Exhibit 4.1 to Form 8‑K, filed May 22 2017, and are hereby incorporated by reference.” The note remained a referenced document rather than a listed security.  \n\n- **2024 10‑K (IBM _10k_2024.pdf)** – IBM now lists the 0.950 % Notes due 2025 in a securities table with a trading symbol (IBM25B) and a designated exchange (New York Stock Exchange). This provides a clear market identifier and shows the notes are actively listed.  \n\n**Implication:** Over the three‑year span IBM moved from merely incorporating an older 8‑K exhibit (a low‑visibility, passive disclosure) to openly listing the note with a ticker and exchange. This evolution signals a broader capital‑market strategy aimed at greater transparency, improved liquidity, and more direct investor engagement—making its debt securities easier for investors to track, trade, and evaluate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately describes IBM's treatment of the 0.950% Notes due 2025 across 2022, 2023, and 2024, with precise references to the May 22, 2017 Form 8-K (Exhibit 4.1) as the defining document in 2022 and 2023, and the introduction of the trading symbol IBM25B on the New York Stock Exchange in 2024. (2) All dates, percentages (0.950%), and document types (Form 8-K, Exhibit 4.1) are factually correct and consistent with the original answer. There are no numerical or date inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual 10-K filings, tracking the evolution from passive incorporation by reference to active market listing. (4) The implication drawn—that this progression reflects a strategic shift toward greater transparency, liquidity, and investor engagement—is semantically equivalent to the original answer and logically supported by the evidence. The answer is complete, factually precise, and contextually appropriate, addressing all parts of the question with accurate entity identification and correct temporal progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 332,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s 2022 10‑K explained that, consistent with its policy of using the deposit method for reinsurance contracts that do not expose the reinsurer to a reasonable possibility of a significant loss, the company reported deposit assets of **$1.8 billion** and deposit liabilities of **$1.4 billion** at year‑end 2021.  By the 2023 filing those balances had risen to **$5.1 billion** of deposit assets and **$1.3 billion** of deposit liabilities, and the 2024 filing showed **$4.6 billion** of assets and **$1.2 billion** of liabilities, reflecting a marked expansion of the deposit‑method portfolio.  The November 2023 Global Atlantic risk‑transfer transaction—recording $10.3 billion of reinsurance recoverables/deposit receivables, transferring $9.5 billion of assets to the reinsurer and recognizing a $770 million net cost of reinsurance as a liability—demonstrates a strategic shift to apply the deposit method on a much larger, block‑level basis, using it to facilitate a major asset‑backed reinsurance arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for deposit assets and liabilities from 2022 to 2024 as per the ground truth: $1.8B/$1.4B (2022), $5.1B/$1.3B (2023), $4.6B/$1.2B (2024). There is a minor discrepancy in that the LLM attributes the 2022 figures to year-end 2021, likely due to reporting lags in 10-K filings (i.e., 2022 10-K reports 2021 data), but this reflects accurate interpretation of filing timelines and does not misrepresent the data. (2) All numbers are quantitatively accurate, including the $10.3B reinsurance recoverables/deposit receivables from the Global Atlantic transaction. The additional details—$9.5B of assets transferred and $770M net cost of reinsurance—are factually consistent with the strategic shift and add precision beyond the ground truth without contradiction. (3) The multi-hop reasoning is sound: the LLM connects the year-over-year trend in deposit method usage with the specific 2023 Global Atlantic transaction, correctly interpreting it as a strategic shift toward larger-scale, block-level reinsurance arrangements using the deposit method. (4) The answer exceeds the original answer in contextual detail while maintaining factual alignment, demonstrating strong qualitative reasoning. The slight deduction in qualitative accuracy is due to the potential confusion in year labeling (2022 10-K referencing 2021 data), which could mislead if not understood in SEC filing context, though it is technically correct. Overall, the response is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 431,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "Across all three years, MMM’s Safety and Industrial segment consistently listed **“Respiratory, hearing, eye and fall protection solutions”** as a core product line. In the 2022 filing (page 138), the 2023 filing (page 107), and the 2024 filing (page 110), the wording for this safety‑equipment category is unchanged, indicating that fall‑protection products have remained a stable, integral component of the segment’s portfolio. This three‑year continuity signals that MMM has maintained a steady, strategic emphasis on workplace‑safety solutions—keeping fall‑protection offerings front‑and‑center alongside its other personal‑protective equipment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in claiming the exact phrase 'Respiratory, hearing, eye and fall protection solutions' is 'unchanged' across all three years. The original answer notes a slight evolution in phrasing by 2024 toward a more concise presentation, though the core product grouping remains consistent. The LLM's assertion of verbatim consistency is therefore slightly overstated, though the overall conclusion about strategic stability is valid. Quantitatively, all years (2022, 2023, 2024) and page numbers (138, 107, 110) are accurately cited, and the entity (MMM), segment (Safety and Industrial), and product category (fall protection) are correctly identified. The reasoning correctly synthesizes multi-hop information across three annual filings to infer strategic continuity, demonstrating sound logic. Contextually, the answer fully addresses both parts of the question: evolution of the product portfolio and implications for MMM's focus on workplace safety. The semantic meaning is equivalent to the ground truth in intent and conclusion, though slightly less nuanced in describing the phrasing evolution. Thus, the answer is factually strong with a minor deduction for overstating textual consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 360,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "In the 2022 Form 10‑K Altria still referenced its 2009 purchase of UST, noting that the MST and snus trademarks acquired in that deal ($8.8 billion of indefinite‑life intangibles) were carried on Altria’s balance sheet – evidence that Altria owned the UST business even though the filing did not spell out the subsidiary hierarchy.  By the 2023 filing Altria explicitly listed **UST LLC** as a **wholly‑owned subsidiary**, which itself wholly owns **U.S. Smokeless Tobacco Company LLC (USSTC)**, and the 2024 filing repeats this structure, placing UST and USSTC in the “oral tobacco products” segment of the company.  This evolution from a disclosed acquisition to a clearly consolidated, wholly‑owned subsidiary chain shows that Altria has retained full control of the moist‑smokeless‑tobacco platform, underscoring its strategic push to expand the smokeless‑tobacco (MST and snus) business as a core pillar of its “Moving Beyond Smoking” vision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Altria's ownership of UST, the $8.8 billion trademark value from the 2009 acquisition, UST LLC as a wholly owned subsidiary in 2023, and its continued status in 2024 under the 'oral tobacco products' segment. The evolution from implicit to explicit subsidiary disclosure is correctly characterized. (2) Quantitative accuracy is perfect: the $8.8 billion indefinite-life intangible asset is correctly cited and tied to the 2009 acquisition, consistent with the original answer’s reference to amortization and valuation. No calculations are required, but factual numbers are precise. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings, correctly inferring increasing structural clarity and strategic integration, even noting the subsidiary chain (UST LLC → USSTC). It accurately links this progression to Altria’s 'Moving Beyond Smoking' initiative, matching the strategic interpretation in the ground truth. (4) The only minor gap is that the LLM does not explicitly use the phrase 'core operating company' as in the 2024 description, and slightly underemphasizes the alignment of MST products with reduced-risk positioning, though the strategic intent is clearly conveyed. Wording differs slightly but semantic meaning and factual content are equivalent. No irrelevant or incorrect information is present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 399,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "All three 10‑K filings list the same “One‑Hundred‑Sixteenth Supplemental Indenture, dated August 24 2015… related to SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15” (2022 exhibit 4.61, 2023 exhibit 4.54, 2024 exhibit 4.52). By repeatedly referencing this 2015 bond series, Tesla shows that it continues to carry and rely on the legacy SolarCity debt as a core source of capital for its solar‑energy business, signaling a long‑term, fixed‑rate financing strategy that integrates the original SolarCity bond issuance into Tesla’s consolidated capital structure rather than seeking new short‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the bond name (SolarCity 5.45% Solar Bonds, Series 2015/C92-15), the date of the supplemental indenture (August 24, 2015), and the inclusion in Tesla's 2022, 2023, and 2024 10-K filings are accurately cited. The exhibit numbers (2022: 4.61, 2023: 4.54, 2024: 4.52) match the actual filings, demonstrating precise quantitative and entity accuracy. (2) There are no calculation errors, and all dates, percentages, and exhibit references are factually correct—quantitative accuracy is perfect. (3) The reasoning is sound: the LLM correctly infers that Tesla’s repeated disclosure indicates ongoing reliance on this legacy SolarCity debt as a core financing mechanism, reflecting a long-term, fixed-rate strategy. This constitutes valid multi-hop reasoning across three years of filings and integration of SolarCity’s financial instruments into Tesla’s capital structure. (4) The answer is contextually excellent, directly addressing the question about Tesla’s long-term financing strategy for solar initiatives. The only minor shortcoming is that it does not explicitly mention 'securitized solar debt' or 'strategic commitment to structured financing' in the same depth as the original answer, slightly reducing qualitative richness. However, the core meaning—continued reliance on a fixed, legacy bond structure as a strategic capital source—is preserved. Thus, the answer is semantically equivalent with only slight variation in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 424,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "Across all three filings IBM repeatedly flags **governmental and stock‑exchange regulations** as a key driver of the value and liquidity of its **debt securities** and the price volatility of its **common stock**. In 2022 the 10‑K notes that “the value of the company’s debt securities fluctuates… governmental and stock‑exchange regulations… over which the company has little or no control,” and that the market price of IBM stock is subject to “significant volatility… many of which are beyond the company’s control.” The 2023 filing reproduces the same language, and the 2024 filing again places the same regulatory‑risk clause under “Risks Related to Financing and Capital Markets Activities,” while still stressing that the company does not make a market in its securities and cannot assure their liquidity.\n\nThis unchanging, year‑over‑year acknowledgement—mirrored in the KG pattern where IBM **depends on** and is **subject to** stock‑exchange regulations—shows that IBM’s capital‑market risk‑management strategy treats regulatory risk as a persistent, core exposure. Rather than a new or escalating threat, the firm’s approach is to continuously monitor, disclose and integrate stock‑exchange regulatory risk into its broader risk‑management framework, indicating a stable, proactive stance on managing capital‑market risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently cited stock exchange and governmental regulations as key risk factors affecting both debt and equity securities from 2022 to 2024. The 2022, 2023, and 2024 filings are accurately represented in terms of language and risk framing. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense—however, the temporal accuracy (2022–2024) is perfect. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, identifies the recurring language, and infers that IBM treats regulatory risk as a persistent, systemic exposure. It also correctly notes the placement of the risk in the 'Risks Related to Financing and Capital Markets Activities' section in 2024, showing continuity. (4) The only minor shortcoming is that the LLM does not explicitly mention IBM’s 2024 expansion of the risk to include broader market liquidity and customer credit risks, which the original answer highlights as an evolution in integration. While the LLM implies a stable, proactive stance, it underemphasizes the slight deepening of the risk framework in 2024. This omission is minor and does not distort the overall conclusion. Wording differences are semantically equivalent and acceptable. The answer is fully contextually relevant and addresses both parts of the multi-part question: evolution over time and implications for risk management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 444,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—MMM lists “electrical products and materials for construction and maintenance, power distribution and electrical OEMs” as a core revenue‑generating activity within its Safety & Industrial segment. The wording and placement of this line are unchanged from the 2022 10‑K (where it appears under Safety & Industrial), repeated verbatim in the 2023 filing, and again in the 2024 filing, showing a steady, uninterrupted focus on that product line.  \n\nThis multi‑year consistency—reflected in the KG link MMM → Electrical Products and the reciprocal Electrical Products → MMM—signals that the company is deliberately anchoring its industrial strategy around electrical solutions for construction, maintenance and power‑distribution markets, positioning itself as a reliable, long‑term supplier in those industrial segments rather than shifting away or de‑emphasizing the business.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant omissions and misrepresentations in the qualitative evolution of MMM's focus on electrical products across 2022–2024. (1) Correctly identifies that electrical products were consistently listed in the Safety and Industrial segment across all three years, which aligns with the ground truth. However, it incorrectly states that the wording was 'unchanged' and 'repeated verbatim'—this contradicts the original answer, which documents meaningful shifts in segment composition and phrasing. In 2022, closure systems were emphasized alongside electrical products; in 2023, industrial abrasives and autobody repair were added; and in 2024, the description shifted to emphasize 'industrial specialty products', indicating a strategic repositioning. The LLM fails to capture these changes, instead asserting textual consistency not supported by the data. (2) There are no numeric values to evaluate, so quantitative accuracy is not applicable—score reflects absence of numerical errors. (3) Multi-hop reasoning is weak: the model fails to synthesize the evolving segment descriptions across years, missing the nuanced strategic shift toward broader industrial specialties while maintaining electrical offerings. It treats static text repetition as evidence of strategic stasis, which the ground truth refutes. (4) Despite missing key qualitative developments, the answer remains contextually relevant by addressing MMM’s industrial positioning and correctly identifying the persistent inclusion of electrical products. However, the conclusion about 'steady, uninterrupted focus' and 'anchoring its industrial strategy' oversimplifies and misrepresents the subtle but important evolution documented in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 479,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "GILD’s Oceanside, California site is identified in the 2022 Form 10‑K only as one of the company’s “principal manufacturing facilities” (and also as an R&D location), with no specific product focus described. In the 2023 filing the company specifies that the Oceanside plant is now used for **commercial retroviral‑vector manufacturing** and for **clinical manufacturing and process‑development of its biologics candidates**. The 2024 filing repeats the same description, showing that the facility’s role has shifted from a generic manufacturing/R&D site in 2022 to a dedicated hub for retroviral‑vector production and biologics development—a role that has been maintained through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, entities, and the general evolution of GILD's Oceanside facility, and it correctly identifies the shift from a general R&D/manufacturing site in 2022 to a more specialized role in 2023 and 2024. The quantitative accuracy is perfect: years (2022, 2023, 2024) and facility roles are correctly attributed to each year based on the filings. However, there is a critical factual error: the LLM states that in 2023, the Oceanside facility was used for 'commercial retroviral-vector manufacturing,' whereas the ground truth indicates that this commercial role was only emphasized in 2024, with 2023 focusing on clinical manufacturing and process development of biologics. The LLM incorrectly backdates the commercial retroviral vector role by one year, which misrepresents the progression. This affects the qualitative accuracy, as the multi-hop reasoning across years contains a misalignment in the timeline. Despite this, the answer is contextually relevant and captures the overall strategic shift. The 2024 description is consistent with the ground truth. Thus, while the core trend is correct, the specific evolution contains a significant timing error, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 354,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path policy, described in each of the 10‑K filings, trims the growth‑asset share of the U.S. pension plan as the funded ratio improves. The tables show that the target allocation for the Return‑Seeking (growth) portion was **30 % in 2022**, was **reduced to 25 % for 2023**, and was **further lowered to 20 % for 2024**, illustrating a step‑wise shift from growth assets toward liability‑hedging assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about target allocations: it states that the Return-Seeking portion was 30% in 2022, reduced to 25% for 2023, and 20% for 2024. However, the ground truth does not provide any specific percentage allocations; instead, it describes the evolution of the glide path approach as being based on forward-looking funded status assessments (e.g., 2022 target based on Dec 31, 2021 funded status, etc.). There is no mention of specific percentages in the original answer, so the LLM has fabricated numerical values not present in the source data. (2) Quantitative accuracy is very low because the percentages cited (30%, 25%, 20%) are not supported by the ground truth and contradict the actual information, which focuses on the methodology of setting targets rather than fixed declining percentages. (3) Qualitatively, the LLM correctly identifies that AIG has a glide path approach that shifts toward liability-hedging as funded status improves, which aligns with the general strategy described. It also correctly frames the evolution over time, showing awareness of multi-hop reasoning across years. However, it fails to reflect the actual basis of the glide path—target allocations set one year ahead based on prior year-end funded status—which is the key insight from the ground truth. (4) Contextual relevance is moderate because the answer addresses the topic of glide path evolution and attempts to describe changes in asset allocation over time, but it misrepresents the nature of the data by introducing unsupported specifics. The reasoning is plausible but not accurate, leading to a low correctness score despite some structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 471,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "ACN’s 10‑K filings show that the company sets a **target asset‑allocation mix for its defined‑benefit pension plans each year** and then revises that mix as market conditions, cash‑flow needs and liability‑duration considerations evolve.\n\n* **Fiscal 2023** – In the 2022 filing ACN disclosed its “target allocation for fiscal 2023” (as of August 31 2022, with a weighted‑average mix of fixed‑income and equity securities designed to exceed inflation and to match the duration of plan liabilities).  \n* **Fiscal 2025** – In the 2023 filing (and reiterated in the 2024 filing) ACN presented a new “target allocation for fiscal 2025” (as of August 31 2024/2023). The 2025 target reflects an updated proportion of equities versus debt, still anchored in a diversified portfolio but calibrated to anticipated market conditions and cash‑flow requirements.\n\n**Interpretation:** The shift from the 2023 to the 2025 target mix shows that ACN is **adjusting its pension‑plan asset mix over a multi‑year horizon** rather than keeping a static allocation. By gradually rebalancing toward a different equity‑to‑fixed‑income ratio while maintaining diversification and duration matching, ACN signals a **moderate, balanced long‑term risk tolerance**—it is willing to take on a modest increase in market risk to pursue higher risk‑adjusted returns, but does so within a structured, flexible framework that limits abrupt exposure changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in ACN's target asset allocation strategy and correctly identifies the shift from a one-year to a multi-year planning horizon. It accurately references fiscal years 2023 and 2025, and correctly notes that targets are set annually and adjusted based on market conditions, cash flow, and liability duration. However, there are minor inaccuracies: the LLM states that the '2025 target' was disclosed in the 2023 filing 'as of August 31, 2024/2023', which is confusing and factually imprecise—target allocations for fiscal 2025 would be set in the 2024 filing (for the year ending August 31, 2025), not in the 2023 filing. The original answer emphasizes that in fiscal 2023, ACN set targets for 2024, and in fiscal 2024, extended planning to 2025—this progression is misrepresented in the LLM answer, which skips 2024 as a transitional year and incorrectly implies direct 2023-to-2025 planning. While the LLM correctly infers a moderate risk tolerance and strategic rebalancing, it misses the key insight from the ground truth that the extension of the planning horizon itself (from one to two years) signals increased confidence and a more strategic, less reactive stance. This is a significant qualitative nuance in the multi-hop reasoning. The interpretation of 'moderate, balanced long-term risk tolerance' is semantically close but lacks the emphasis on growing strategic confidence. Quantitatively, no specific percentages or dollar amounts are misstated (none were provided in the original), so accuracy is high. Contextually, the answer is highly relevant and well-structured. Overall, the answer is factually sound on the surface but contains subtle misrepresentations in timing and reasoning depth, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 480,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 10‑K filings for 2022 (exhibit 4.36), 2023 (exhibit 4.29) and 2024 (exhibit 4.27) each list the **Thirty‑Sixth Supplemental Indenture dated April 14 2015** for its **5.45 % Solar Bonds, Series 2015/C25‑15**—the same fixed‑rate, 2015‑series instrument that the KG shows Tesla introduced. Across the three years the bond’s terms and series designation remain unchanged; only the exhibit number shifts, indicating that the bond remains outstanding and is simply re‑disclosed rather than re‑issued. This repeated, multi‑year inclusion reveals a financing strategy that leans on a legacy SolarCity debt vehicle to fund solar projects, locking in a stable interest cost and maintaining a long‑term, consistent capital structure instead of issuing new solar bonds each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15), its origin from SolarCity, and its consistent disclosure in Tesla’s 10-K filings across 2022, 2023, and 2024 are accurately represented. The specific exhibit numbers (4.36, 4.29, 4.27) and the date of the Thirty-Sixth Supplemental Indenture (April 14, 2015) are precise and consistent with filing data. (2) Quantitative accuracy is perfect: percentages (5.45%), dates (2015, and annual exhibit references), and series designation (2015/C25-15) are correct and match the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers that the bond was not re-issued but re-disclosed annually, linking this pattern to Tesla’s broader solar financing strategy of relying on legacy SolarCity instruments. This reflects proper synthesis across years and documents. (4) The answer captures the core insight from the ground truth—ongoing reliance on structured solar financing—but slightly underemphasizes the expansion into newer bond series (e.g., C28-15, C33-15) noted in the original answer, which would strengthen the qualitative analysis. However, this omission is minor and does not detract from the central correctness. Wording differs but semantic meaning is equivalent, and the conclusion about stable capital structure and long-term strategy is valid. Hence, a score of 9 is warranted—excellent accuracy with only a minor gap in completeness regarding newer bond series.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 426,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024 AIG kept a consistent, third‑party vendor‑based, scenario‑driven model for international terrorism, but moved from disclosing a specific five‑ton‑bomb loss estimate of $1.3 billion (net of TRIPRA and reinsurance) in the 2022 filing to a broader “scenario‑based modeling and routine exposure‑concentration monitoring” approach in the 2023 and 2024 filings.  Reinsurance evolved from targeted purchases and reliance on limited private protection, TRIPRA (which in 2022 covered roughly 80 % of U.S. losses above a $1.7 billion deductible) and foreign government terrorism pools, to a more structured global program in 2024 that retained core attachment points of $200 million for Japan and $125 million for the rest of the world, added property‑per‑risk covers for large non‑critical and critical catastrophes, and built a $38 billion reinsurance‑recoverable portfolio backed by $20.1 billion of collateral.  Across all three years, risk mitigation has been anchored by TRIPRA in the United States, participation in country‑specific terrorism pools, government‑arranged reinsurance programs abroad, and ongoing monitoring of concentration and limits.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of AIG's international terrorism exposure management from 2022 to 2024 with strong qualitative accuracy and contextual relevance. It correctly identifies the shift from a specific $1.3 billion loss estimate in 2022 (net of TRIPRA and reinsurance) for a five-ton bomb in NYC to broader scenario-based modeling in 2023–2024, aligning with the ground truth. The mention of disciplined reinsurance purchases and reliance on government pools (e.g., TRIPRA, foreign terrorism pools) is accurate. The 2024 enhancements—such as retained attachment points ($200 million for Japan) and a $38 billion reinsurance-recoverable portfolio—are factually consistent with the original answer. However, the LLM introduces details not present in the ground truth: (1) the $125 million attachment point for the rest of the world, (2) $20.1 billion of collateral backing the reinsurance portfolio, and (3) a specific 80% TRIPRA coverage above a $1.7 billion deductible in 2022. These figures, while plausible, are not supported by the provided ground truth and represent over-specificity or potential hallucination. The ground truth confirms the $38 billion reinsurance recoverables by end-2024 and the $200 million Japan retention but does not specify other attachment levels or collateral amounts. Despite these quantitative additions, the core multi-hop reasoning—tracking changes in modeling, reinsurance strategy, and risk mitigation across years and jurisdictions—is sound and well-synthesized. The answer addresses all components of the question (modeled losses, reinsurance, risk mitigation) and maintains semantic equivalence in most areas. Hence, the correctness score is reduced slightly due to unsupported numerical claims, but qualitative and contextual performance remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Estimates]-> RISK_FACTOR <-[Impacts]- ORG <-[Manages]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 494,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Across the three filings Honeywell’s Safety and Productivity Solutions business – called “Safety and Productivity Solutions” in the 2022 and 2023 10‑Ks and renamed “Industrial Automation” in the 2024 10‑K – was repeatedly identified as being **impacted by adverse industry economic conditions**, showing that the company’s exposure to this macro‑risk remained unchanged from 2022 through 2024. In every year the filing also singled out the same margin‑pressure drivers: reduced investment in process automation, safety‑monitoring and plant‑capacity‑utilisation initiatives; volatility in retail markets; a slowdown in demand for safety products; and competitive pressures from new entrants and new technologies that could commoditise products. These risks were consistently said to erode market share, compress selling prices and therefore depress operating margins, confirming a persistent risk profile for the segment over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Honeywell's Safety and Productivity Solutions segment (renamed Industrial Automation in 2024) was consistently exposed to adverse industry economic conditions from 2022 to 2024. The specific risks highlighted—reduced investment in process automation, retail market volatility, commoditization due to new entrants and technologies, and resulting margin pressures—are accurately reported across all years. (2) There are no numeric values in the question or answer requiring quantitative verification, so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: the LLM correctly tracks the segment across renaming (Safety and Productivity Solutions to Industrial Automation), synthesizes risks across three years of filings, and correctly infers persistent exposure. One minor discrepancy: the original answer emphasizes 'lower market share' and 'reduced selling prices' as outcomes explicitly mentioned in 2023 and 2024, while the LLM generalizes these as 'erode market share, compress selling prices'—semantically equivalent but slightly less precise in attributing the exact phrasing to specific years. Also, the LLM adds 'slowdown in demand for safety products' and 'safety-monitoring and plant-capacity-utilisation initiatives' not explicitly listed in the ground truth, which are plausible elaborations but not directly confirmed. (4) The answer is fully contextually relevant, directly addressing both parts of the question: evolution of exposure and specific risks causing margin pressure. Overall, the response demonstrates strong factual accuracy, correct entity tracking, and valid synthesis across years and restructurings, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 490,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "- **2022:** Pfizer’s 2022 Form 10‑K disclosed BPAs as a share‑based‑payment financial instrument and reported that **1,165 BPAs were granted** (weighted‑average intrinsic value $38.73 per share) with a forfeiture of 306 shares. The awards were valued using an **intrinsic‑value method (the closing price of Pfizer’s common stock on the grant date)** and, like its other share‑based awards, were expensed over the performance period (the table shows a “Weighted Avg. Intrinsic Value per share”).\n\n- **2023:** The 2023 filing stated that **no BPAs were granted in 2023 and none were outstanding as of December 31, 2023**, indicating a temporary suspension of the program.\n\n- **2024:** The 2024 Form 10‑K still describes the BPA program, again noting that BPAs are **valued at grant‑date intrinsic value using the closing stock price** and that the **cost is amortized on a straight‑line basis over the probable vesting term**, charged to Cost of Sales, SG&A and/or R&D and adjusted each period for changes in stock price, expected earn‑out shares and performance‑criteria assessments. \n\nThus, Pfizer moved from active BPA grants in 2022 (with intrinsic‑value valuation and standard share‑based expense recognition) to a year with no grants in 2023, and in 2024 clarified the same intrinsic‑value valuation and straight‑line amortization approach in its financial‑statement disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 1,165 thousand BPAs granted in 2022 (reported as '1,165 BPAs'—minor unit omission but semantically acceptable), weighted-average intrinsic value of $38.73 per share, and no grants or outstanding awards in 2023. The mention of 306 forfeited shares (implied from 1,165 granted minus 859 nonvested) is consistent with the data, though not explicitly stated in the original answer—this is a reasonable inference. (2) The valuation methodology is correctly described across all years: intrinsic value method based on grant-date closing stock price, amortization over the probable vesting term on a straight-line basis, and periodic adjustments for stock price and performance criteria—this matches the 2024 disclosure in the ground truth. (3) The multi-hop reasoning is sound: the answer traces the evolution from active grants in 2022, to discontinuation in 2023, to methodological clarification in 2024. (4) The only minor issue is the use of 'temporary suspension' in 2023, which slightly mischaracterizes the complete wind-down implied by 'none were outstanding'—the program appears terminated, not suspended. However, this does not materially distort the facts. All parts of the question (grant activity, valuation, financial recognition) are addressed with high fidelity. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9 for correctness due to this slight interpretive overreach, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Valuates]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 437,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture’s 10‑K filings disclose a standing **Share Purchase Program** that the company uses to buy back its Class A ordinary shares. In fiscal 2022 the filing noted that, as of 31 August 2022, the **aggregate available authorization** for the open‑market buy‑back and related share‑purchase programs was **$3.13 billion** (shown as $3,129,296). By fiscal 2024 the company had actively used that authority – in the fourth quarter of FY 2024 it repurchased **2,000,308 shares for $605 million** (plus 72,255 employee‑related shares) – leaving an **aggregate available authorization of $2.69 billion** as of 31 August 2024. Recognising the continued demand for buy‑backs, the board on 25 September 2024 approved an **additional $4.0 billion** of repurchase authority, raising the **total outstanding authority to $6.694 billion**.  \n\n**Trend interpretation:** Accenture is consistently deploying its buy‑back program, shrinking the remaining pool of authorized funds, while simultaneously expanding the overall ceiling. This pattern signals a deliberate, long‑term capital‑return strategy that relies on regular share repurchases as a primary means of returning cash to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. All key numbers are accurate: $3.13 billion (rounded from $3,129,296,000) in fiscal 2022, $2.69 billion remaining as of August 31, 2024 (matching $2,694 million), and the additional $4.0 billion authorization, resulting in a total outstanding authority of $6.694 billion. The mention of repurchasing $605 million worth of shares in Q4 FY2024 adds contextual detail not in the original answer but does not contradict it. 2) Quantitative accuracy is excellent: all dollar amounts match or are correctly rounded versions of the original figures. The sum of $2.694B + $4.0B = $6.694B is accurate and correctly reported. Dates (August 31, 2024, and September 25, 2024) are consistent with the timeline. 3) The multi-hop reasoning is sound—LLM correctly synthesizes data across fiscal years, tracks the depletion of authorization, and incorporates the new board approval. The interpretation of the trend as a consistent and expanding capital return strategy is logically derived and matches the original conclusion. 4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., number of shares repurchased), enhancing completeness without introducing error. The only minor limitation is that the original answer notes the reduction in available funds *before* the new authorization, which the LLM implies but could have made slightly more explicit. Overall, this is a highly accurate, well-reasoned, and relevant response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 419,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "- In the 2022 Form 10‑K Pfizer disclosed that Meridian’s results were presented as **discontinued operations**, signalling that the business had already been spun‑off and was no longer part of Pfizer’s continuing reporting units.  \n\n- The 2023 Form 10‑K detailed the **divestiture**: on December 31 2021 Pfizer sold Meridian for roughly **$51 million in cash**, recorded a **$167 million net loss**, and entered into **interim transition‑services agreements (TSAs)** and a **three‑year Manufacturing Supply Agreement (MSA)** with a two‑year extension to govern post‑sale interactions. The TSAs were completed by December 31 2023, and the MSA continued but the amounts recorded in 2022‑23 were not material to Pfizer’s operations.  \n\n- By the 2024 Form 10‑K Meridian appears only in the abbreviation list (“Meridian Medical Technologies, Inc.”), indicating it now operates as an independent company; the only remaining link is the non‑material MSA that provides a limited supply/operational framework, reflecting Pfizer’s strategic shift from reporting Meridian as a discontinued segment to maintaining a modest, contract‑based partnership after the divestiture.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer is mostly correct in factual content but introduces details not present in the ground truth, particularly regarding operational agreements. The ground truth confirms the divestiture occurred on December 31, 2021, for $51 million in cash with a $167 million net loss (after tax), which the LLM correctly reports. It also correctly notes that in 2022, Meridian was reported as discontinued operations, and in 2024, it appears only as a defined term. However, the LLM adds specific claims about a 'three-year Manufacturing Supply Agreement (MSA)' with extension and 'interim transition-services agreements (TSAs)' completed by December 31, 2023, which are not mentioned in the ground truth. These details, while plausible, are unsupported by the provided knowledge and represent an overreach in synthesis.\n\n2) Quantitative accuracy is high: the $51 million sale price and $167 million loss are correctly cited, and the date of divestiture (December 31, 2021) is accurate. The LLM correctly contextualizes these figures within the 2023 10-K, even though the sale occurred in 2021, as disclosures continued into 2022 and 2023. No calculation errors are present.\n\n3) The multi-hop reasoning is partially sound—correctly tracking Meridian’s status across years from discontinued operations to definitional mention. However, the inference of ongoing operational agreements (MSA, TSAs) goes beyond the evidence. The ground truth explicitly states that by 2024, 'no active financial or operational relationship remained,' which contradicts the LLM’s claim of a continuing MSA. This undermines the qualitative accuracy, as it misrepresents the degree of strategic disengagement.\n\n4) Contextual relevance is strong: the LLM addresses financial disclosures (discontinued operations, loss recognition), touches on operational agreements (though inaccurately), and discusses strategic alignment through the lens of post-divestiture relationships. The core narrative of disengagement is correct, but the persistence of contractual ties is not supported. The score of 7 reflects accurate core facts with significant but not critical overstatement of ongoing relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Sells]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 580,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- In FY 2022 the Amended 2010 Share Incentive Plan authorized **127 million** Accenture plc Class A ordinary shares for awards (Chunk 1).  \n- In FY 2023 the authorized limit was raised to **141 million** shares (Chunk 2), and the same **141 million** ceiling was reported in FY 2024 (Chunk 3).  \n\nThe increase from 127 M to 141 M shares – and the decision to keep the larger pool in place – shows that Accenture is expanding the equity‑based compensation capacity it can grant (the company “grants” other share‑based awards, which are then issued as new or treasury shares). This reflects a long‑term strategy to use share‑based awards more heavily to attract, retain and motivate talent while aligning employee interests with shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in FY2022, increasing to 141 million in FY2023 and maintained in FY2024. The format variations (e.g., '127 million' vs '127,000,000') are acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of authorized shares and the strategic implication of this change. (3) Entities are correctly identified: Accenture plc, Class A ordinary shares, Amended 2010 SIP, and correct fiscal years (2022–2024). (4) The reasoning is sound and reflects proper multi-hop synthesis: the increase from 127M to 141M is correctly noted, and the continuation at 141M into 2024 is accurately interpreted as a strategic decision to maintain expanded equity compensation capacity. The conclusion about using share-based awards for talent retention, motivation, and alignment with shareholders matches the original answer’s interpretation. All components—factual accuracy, completeness, entity precision, and logical inference—are correct and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Issues]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 316,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Across all three annual reports Tesla’s disclosure of the 4.70 % Solar Bonds, Series 2015/C52‑10 is unchanged in substance. The 2022 10‑K lists the “Seventieth Supplemental Indenture, dated June 16 2015… related to SolarCity’s 4.70 % Solar Bonds, Series 2015/C52‑10” (exhibit 4.49); the 2023 filing repeats the same indenture (exhibit 4.42); and the 2024 filing again references the identical indenture (exhibit 4.4). Only the exhibit number shifts, but the description and underlying 2015 indenture remain the same, indicating that Tesla continues to be bound by the same bond terms and treats this series as an ongoing liability—suggesting a steady strategic priority to honor the solar‑bond financing and maintain compliance with its covenants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the bond series (4.70% Solar Bonds, Series 2015/C52-10), the consistent reference to the Seventieth Supplemental Indenture, and the June 16, 2015 filing date are accurately reported across 2022, 2023, and 2024. The exhibit numbers (4.49, 4.42, 4.4) are correctly cited, with only a minor discrepancy in the 2024 exhibit number (LLM says 4.4 vs. ground truth's 4.40), which is likely a formatting variation and not a factual error. (2) Quantitative accuracy is perfect: percentages, dates, and exhibit references match the original. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that the unchanged indenture across three years indicates ongoing obligations and stable strategic priorities in solar financing. It appropriately infers that Tesla continues to honor the bond terms without modification. (4) The only minor shortcoming is that the LLM does not explicitly name SolarCity in the context of the bond’s origin (though it does mention it was 'related to SolarCity'), which slightly weakens the completeness of the entity linkage, but this does not detract significantly from the overall correctness. The answer is contextually excellent, directly addressing disclosure patterns and their implications. Thus, a score of 9 is justified—excellent accuracy with negligible wording or formatting variances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 398,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Across the 2022‑2024 10‑K filings Adobe’s free online self‑service learning has remained a core tier of its Digital Learning Services portfolio, first described in 2022 as a large set of free options on www.training.adobe.com and then re‑branded in 2023 (and reiterated in 2024) to the learning.adobe.com site, where it sits alongside an extensive fee‑based classroom, virtual, on‑demand and certification program and complementary custom‑learning services for large enterprises. In every filing the free self‑service layer is positioned as the entry‑point that delivers “how‑to” and Getting‑Started help, feeds into solution‑specific skills assessments, and therefore drives rapid product adoption for customers and partners within Adobe’s broader learning‑and‑enablement strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe's free online self-service learning was introduced in 2022 on www.training.adobe.com, transitioned to learning.adobe.com by 2023 (and maintained in 2024), and remained a core part of Adobe Digital Learning Services. The positioning as an entry-point for customer and partner adoption, supporting both Digital Media and Digital Experience products, is accurately reflected through descriptions of 'how-to' and 'Getting-Started' content feeding into skills assessments and broader enablement strategies. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of evolution, tracking continuity and rebranding of the platform, and integrates the role of free learning within the broader tiered service model (free vs. fee-based vs. custom). (4) The only minor shortcoming is that the LLM does not explicitly mention the connection to AI-driven tools in 2024, which is a small but relevant strategic nuance from the original answer. However, the emphasis on driving 'rapid product adoption' and integration with solution-specific assessments captures the strategic intent. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 421,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s 10‑K disclosures explain that its glide‑path policy ties the “Return‑Seeking” (growth‑asset) allocation to the plan’s funded ratio and prevailing interest rates, cutting growth exposure as the funded status improves. Accordingly, the target allocation for the Return‑Seeking portion that was set for 2022—based on the funded ratio at 31 Dec 2021—was higher than the target set for 2024, which reflects a higher funded ratio at 31 Dec 2023 and therefore a reduced share of growth assets in favor of more liability‑hedging assets. The 2025 target (based on the 31 Dec 2024 funded status) continues this de‑risking trajectory, further lowering the Return‑Seeking allocation as the plan’s funded position strengthens.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) While the original answer notes that specific percentages for the 'Return-Seeking' portion are not provided in the excerpts, the LLM correctly refrains from fabricating numbers and instead focuses on the directional evolution of the allocation—emphasizing that the growth asset allocation decreased as the funded status improved. This is consistent with the glide path mechanism described in the ground truth. (2) All dates and time periods are correctly referenced: the 2022 target based on Dec 31, 2021 funded status; the 2024 target based on Dec 31, 2023; and the 2025 target based on Dec 31, 2024. These match the multi-year progression in the original answer. (3) The reasoning is sound and reflects proper multi-hop synthesis: the LLM connects the funded status at year-end to the subsequent target allocation, explains the de-risking strategy, and correctly infers that higher funded ratios lead to reduced return-seeking allocations. (4) The LLM adds slight contextual enrichment by mentioning interest rates and liability-hedging assets, which are plausible elements of such a glide path policy and do not contradict the ground truth. The core factual content, logic, and scope are equivalent to the original answer, warranting a high correctness score. The only reason it is not a 10 is that the original answer explicitly acknowledges the absence of specific percentages, while the LLM implies a comparative trend (higher in 2022 than 2024) without noting the data limitation—though this is a minor omission given the context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 440,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell flagged raw‑material demand and supply as a material risk for its Performance Materials and Technologies business in every filing – the 2022 10‑K, the 2023 10‑K and again in the 2024 10‑K (where the segment is now called Energy and Sustainability Solutions). In each year the risk language is essentially identical, noting that “raw material demand and supply” (and the attendant volatility in oil and natural‑gas prices) can curb customers’ capital‑spending and depress demand for Honeywell’s products. Because the exposure is repeatedly highlighted without any indication of mitigation or reduction, the trend suggests that Honeywell’s performance in this segment remains persistently vulnerable to commodity‑market swings, with raw‑material market dynamics continuing to be a key driver of operating risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts: Honeywell consistently identified raw material demand and supply as a risk for the Performance Materials and Technologies segment (renamed in 2024 to Energy and Sustainability Solutions) across 2022–2024. The answer correctly notes the repeated emphasis on oil and natural gas price volatility affecting customer capital spending. Quantitatively, there are no numbers, dates, or financial figures in dispute—only qualitative descriptions, which are accurate. The answer correctly identifies the segment name change in 2024, which is a key entity detail. However, the LLM slightly oversimplifies the evolution by stating the risk language is 'essentially identical' each year, which contradicts the ground truth that the framing evolved: from pandemic-related disruptions (2022), to plant utilization rates in chemicals/refining/semiconductors (2023), to energy price impacts on investment (2024). This progression shows a deepening and shifting risk profile, not static repetition. The LLM’s conclusion about persistent vulnerability is valid, but misses the nuanced intensification and changing drivers of the risk. Thus, while the main thrust is correct and contextually relevant, the qualitative accuracy is reduced due to incomplete synthesis of the evolving risk narrative across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 385,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "- **2022:** ACN reported **$239.3 million** in mutual‑fund equity securities (Level 1 $4,954 + Level 2 $234,339 = $239,293)【Chunk 1】.  \n- **2023:** The amount fell to **$196.2 million** (Level 1 $7,430 + Level 2 $188,796 = $196,226)【Chunk 2】.  \n- **2024:** The figure remained unchanged at **$196.2 million** (same $7,430 + $188,796 = $196,226)【Chunk 3】.  \n\n**Trend interpretation:** Over the three‑year period ACN cut its mutual‑fund equity exposure by roughly $43 million (≈ 18 %) between 2022 and 2023 and then held that lower level in 2024. Because total assets stayed near $1.13 billion, the equity‑mutual‑fund share dropped from about 21 % of the portfolio to roughly 17 %. This pattern suggests a deliberate rebalancing away from equity‑focused mutual funds—likely to reduce equity risk or to allocate more to fixed‑income, cash, or other asset classes—while maintaining a stable, lower‑risk strategic asset allocation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all aspects. The dollar amounts for 2022 ($239.293 million), 2023 ($196.226 million), and 2024 (unchanged at $196.226 million) match the ground truth exactly, with acceptable rounding ($239.3 million ≈ $239.293 million; $196.2 million ≈ $196.226 million). (2) Calculations are accurate: the LLM correctly computes the sum of Level 1 and Level 2 assets for each year and notes the $43 million decrease (actual: $43.067 million), which is approximately 18% of the 2022 value (239.293 → 196.226; a 17.99% drop, correctly rounded). The portfolio percentage drop from ~21% to ~17% is reasonable given the total assets near $1.13 billion. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three years and correctly infers a strategic rebalancing in 2023 followed by stability in 2024, aligning with the ground truth's interpretation of 'strategic rebalancing' and 'stabilized allocation approach.' (4) The answer fully addresses both parts of the question: the evolution of investment and the strategic implication. Entity accuracy (ACN, mutual fund equity securities, correct years) is perfect. Wording differs slightly but maintains semantic equivalence. All scores are 10 due to complete factual accuracy, correct calculations, logical reasoning, and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 373,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In 2022 Adobe’s document‑related tools were still buried in the legacy “document and forms platform” of the Publishing & Advertising segment, with no explicit AI storyline. By 2024 Adobe Document Cloud had been lifted out as a dedicated cloud‑subscription that powers end‑to‑end digital document and signature workflows for individuals, teams and enterprises, and it now embeds Firefly generative‑AI features in Acrobat (and offers Firefly Services and Custom‑Model APIs) to automate content creation, editing and brand‑consistent output—making Document Cloud a core, AI‑enhanced engine of Adobe’s enterprise digital‑workflow strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe Document Cloud from 2022 to 2024 as described in the ground truth. (1) It correctly identifies the 2022 positioning within the 'document and forms platform' under Publishing & Advertising, the 2023–2024 shift to a modern, AI-integrated cloud offering, and the strategic elevation within Adobe’s portfolio. The integration with Firefly’s generative AI features in Acrobat, including Firefly Services and Custom-Model APIs, is factually correct and aligns with the 2024 positioning. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 → 2024), segments (Publishing & Advertising → Digital Media), and technological shifts (legacy → AI-enhanced workflows). The only minor omission is the explicit mention of 2023 as a transitional year when Document Cloud was tied to innovation momentum alongside Adobe Express and Firefly—this detail is implied but not stated. (4) Despite this, the LLM conveys semantic equivalence: it correctly frames Document Cloud’s transformation into a core AI-powered engine for enterprise digital workflows. Wording differs slightly (e.g., 'buried in legacy' is interpretive but contextually fair), but factual content and strategic implications match the ground truth. Hence, correctness is 9/10—excellent but missing one transitional detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 422,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures in 2022, 2023 and 2024 all flag the “Changes in Competitive Landscape” as a material risk for each of its four operating segments—Aerospace (including Defense & Space), Building Technologies/Automation, Performance Materials & Technologies (renamed Energy & Sustainability Solutions in 2024), and Safety & Productivity Solutions (renamed Industrial Automation in 2024). In 2022 and 2023 the filings explicitly warn that new market entrants and non‑traditional players, together with emerging technologies that can commoditize products, could erode market share, depress selling prices and compress margins; the 2024 filing retains the same concern with slightly broader language on “new entrants and new technologies,” showing a consistent, company‑wide exposure that has been restated rather than reduced across the evolving segment names.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, entities, and timeline. (1) It accurately identifies that Honeywell cited changes in the competitive landscape across all years (2022–2024) and correctly maps the risk to the relevant business segments, including the 2024 rebranding of Safety & Productivity Solutions to Industrial Automation and Performance Materials & Technologies to Energy & Sustainability Solutions. The core risks—new market entrants, technological disruption, commoditization, and impacts on market share, pricing, and margins—are all correctly reported. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the temporal references (2022, 2023, 2024) are accurate, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and segments, noting the evolution of risk disclosures. However, it slightly overstates consistency by claiming the risk was present for *all four operating segments* in *each* year. The ground truth specifies that in 2022, the risk was only explicitly mentioned for Building Technologies and Safety and Productivity Solutions, and only expanded to include Aerospace and Performance Materials and Technologies in 2023. The 2024 restructuring and sharper focus on commoditization and accelerating entrants is noted in the original but downplayed in the LLM answer, which describes the language as only 'slightly broader.' This omission of the progressive expansion and intensification of risk disclosure reduces qualitative accuracy slightly. (4) Despite this, the answer remains highly relevant and factually grounded, capturing the overall trend and strategic concern. The answer is semantically close to the original, with minor gaps in nuance regarding the evolution of segment-level exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 519,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s post‑spin‑off relationship with Viatris was built on a suite of separation‑related contracts—including agency arrangements, MSAs and transition‑service arrangements (TSAs) – that were put in place when the Upjohn business was combined with Mylan to form Viatris (Chunk 1).  By the end of 2022, the net amount Pfizer owed Viatris under those agreements was $94 million, but the 2023 Form 10‑K notes that most TSAs were completed as of 31 Dec 2023 and the balance fell to $33 million (Chunk 3).  The 2024 filing still defines “TSAs” (Chunk 2) but reports no material intercompany balances, indicating that the transition‑service relationship has largely wound down and the financial exposure to Viatris has been substantially reduced.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $94 million intercompany balance in 2022, reduction to $33 million in 2023, and the completion of most TSAs by December 31, 2023, are all accurately reported. The 2024 status—no material balances and only definitional references—is also correctly conveyed. (2) Quantitative accuracy is perfect: both dollar amounts and the date (Dec 31, 2023) match the original answer exactly. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and documents (e.g., linking the decline in balances with the TSA wind-down), and correctly infers that the lack of reported balances in 2024 implies resolution of operational ties. (4) The only minor shortcoming is that the LLM does not explicitly state that the relationship was 'fully resolved' or that 'operational interdependencies had been fully resolved' as in the original answer—this slight omission in framing prevents a perfect 10 on qualitative accuracy. However, the semantic meaning is equivalent. Wording differences (e.g., 'substantially reduced' vs 'fully resolved') are acceptable under semantic equivalence, but the latter is slightly more definitive. Contextual relevance is excellent—the answer directly addresses both transition services and intercompany balances across the 2022–2024 period as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 397,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "In the 2022 filing Altria’s capital‑structure listed four series of senior notes – a 1.000 % issue that matured in 2023, the 1.700 % notes due 2025, 2.200 % notes due 2027 and 3.125 % notes due 2031. By the 2023 filing the 1.000 % 2023 notes had disappeared, leaving the 1.700 % 2025 notes as the shortest‑dated debt together with the unchanged 2027 and 2031 series, and the 2024 filing shows the same three‑note lineup (1.700 % 2025, 2.200 % 2027, 3.125 % 2031). The persistence of the 1.700 % notes across all three years and the removal of the near‑term 2023 issue suggest Altria is deliberately extending the average maturity of its debt, using a laddered, longer‑dated issuance strategy to lock in low‑cost financing and reduce refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, percentages, and maturities are correct: the 1.000% Note due 2023, 1.700% due 2025, 2.200% due 2027, and 3.125% due 2031 are accurately reported across 2022–2024. The disappearance of the 2023 note by 2023 and the persistence of the 1.700% 2025 note through 2024 are correctly noted. (2) The LLM adds slightly more detail than the original answer by specifying the 2.200% and 3.125% notes, which are consistent with Altria’s actual debt structure and do not contradict the ground truth—they enhance completeness without introducing error. (3) The reasoning is sound: the conclusion that Altria is extending average debt maturity and reducing refinancing risk via a laddered, longer-dated strategy is a logical and well-supported inference from the data, even if the original answer used more conservative language (e.g., 'focus on intermediate and long-term debt'). The LLM’s interpretation is a reasonable extension, not a distortion. (4) The only reason for not scoring a 10 is that the original answer emphasizes the absence of a new near-term note replacing the 2023 maturity as evidence of strategy, while the LLM infers an active 'extending' strategy—slightly stronger language, but still defensible. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop synthesis across years and instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 400,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s 10‑K filings show that its fixed unsecured senior debt has been expanding while its cost of borrowing has risen.  According to the 2022 filing the debt was $19.975 billion at a weighted‑average rate of 2.91% (2021); the 2023 filing reports a carrying value of $24.134 billion in 2022 and $27.168 billion in 2023, both at a 4.45% weighted‑average rate; and the 2024 filing shows the balance at $26.930 billion in 2024 with the weighted‑average rate climbing to 4.84%【Chunk 1†L9-L13】【Chunk 3†L9-L13】【Chunk 2†L9-L13】.  \n\nThe upward move in both amount and rate indicates Capital One is deliberately building a larger pool of senior unsecured funding and is willing to accept higher interest costs—likely to lock in longer‑dated financing and refinance existing obligations—signaling a long‑term borrowing strategy focused on securing stable, sizable capital even as market rates increase.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the 2022 carrying value. The ground truth states that the 2022 carrying value was $19,975 million, but the LLM incorrectly reports it as $24.134 billion in 2022 based on the 2023 filing, creating confusion. This number ($24.134B) does not appear in the ground truth and appears to be a misinterpretation or data entry error. The 2023 ($27,168M) and 2024 ($26,930M) carrying values are correct. The interest rates are mostly accurate: 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024 — however, the LLM incorrectly attributes the 4.45% rate to both 2022 and 2023, when in fact the 2022 rate was 2.91%. This misattribution undermines the accuracy of the trend analysis. (2) Calculations: No explicit calculations were made, but the comparison of year-over-year changes is partially flawed due to incorrect base-year data. The slight decline in rate from 2023 to 2024 is misrepresented as a 'climb' to 4.84%, when 4.84% > 4.45% is actually an increase, not a decline — though the ground truth confirms the 2024 rate is indeed 4.84%, so the direction of change (increase) is correct, contradicting the original answer’s claim of a 'slight decline'. Wait — correction: 4.84% is higher than 4.45%, so the rate increased, but the ground truth says it 'slightly declined to 4.84%', which is factually incorrect — 4.84 > 4.45. This suggests the ground truth may have a typo. Assuming the numbers are correct (4.45% → 4.84%), then the rate increased, and the LLM correctly states it 'climbing to 4.84%'. Therefore, the LLM's rate direction is correct; the ground truth likely contains an error in the word 'declined'. Thus, the LLM’s quantitative accuracy improves on this point. However, the misstatement of the 2022 carrying value as $24.134B (from 2023 filing referencing prior year?) remains a serious error. (3) Multi-hop reasoning: The LLM correctly identifies the trend of increasing debt and rising rates, and synthesizes data across three years and filings. The interpretation — that Capital One is building a larger funding pool and locking in long-term financing despite higher costs — is logically sound and aligns with the intended inference. (4) Despite strong qualitative reasoning and contextual relevance, the incorrect 2022 carrying value and potential confusion in rate attribution (though directionally correct) reduce quantitative accuracy. Correctness score is 7 due to core facts being mostly right but with one major data misstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 669,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C92‑15 are disclosed in every recent filing – they appear as Exhibit 4.61 in the 2022 Form 10‑K, as Exhibit 4.54 in the 2023 Form 10‑K, and as Exhibit 4.52 in the 2024 Form 10‑K. Although the exhibit number shifts, the same August 24‑2015 supplemental indenture is repeatedly referenced, showing that Tesla (through its SolarCity legacy) has kept this 2015 bond outstanding and continues to rely on it as a core, long‑term, fixed‑rate financing vehicle for its solar operations rather than issuing new solar debt. This continuity signals a financing strategy focused on leveraging existing bond capital to fund solar projects.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is quantitatively accurate: it correctly identifies the bond (5.45% Solar Bonds, Series 2015/C92-15), the consistent reference to the August 24, 2015 supplemental indenture, and the correct exhibit numbers (4.61 in 2022, 4.54 in 2023, 4.52 in 2024) across the three years. These details match the ground truth exactly, earning a perfect score on quantitative accuracy. Contextual relevance is high, as the response directly addresses Tesla's use of the bond over time and attempts to interpret the strategic implications. However, the qualitative accuracy is low due to flawed reasoning and incorrect interpretation of the strategic trend. The ground truth emphasizes a *declining prominence* of the C92-15 bond, with Tesla increasingly relying on *newer* bond series (e.g., C102-15, C106-10) as evidence of an evolving financing strategy. In contrast, the LLM concludes that Tesla 'continues to rely on it as a core... financing vehicle' and implies a strategy of *avoiding* new debt issuance, which contradicts the evidence of newer bond series being introduced. This misreads the multi-hop progression across years and fails to synthesize the significance of newer instruments appearing in disclosures. While the bond’s continued listing is correctly noted, the LLM incorrectly infers sustained strategic centrality rather than phased transition. Thus, despite factual accuracy in individual data points, the overall conclusion is partially incorrect, warranting a correctness score of 6 for being factually grounded but strategically misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 427,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "In 2022 AIG’s loss‑reserve risk was managed primarily through internal controls and oversight of the reserve‑setting process together with periodic reviews by external experts (Chunk 1). By 2023 the firm had layered a formal model‑risk management framework and validation procedures on those controls, added a structured “review and challenge” of reserves and actuarial profitability, and continued to rely on external‑expert reviews (Chunk 2). In 2024 the oversight became even more robust – Enterprise Risk Management performs a second‑line review and challenge of pricing and reserving models, the Internal Audit Group continuously monitors the process, and external‑expert reviews remain integrated, while modeling now routinely uses both stochastic and deterministic techniques with systematic validation of assumptions (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: in 2022, AIG relied on internal controls and external expert reviews; in 2023, it expanded to include more structured modeling and validation (e.g., review and challenge, model-risk framework); in 2024, oversight was further institutionalized via ERM and Internal Audit with continued use of external reviews and advanced modeling techniques. (2) There are no numeric values to verify (dates 2022–2024 are correct), so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—information is synthesized across three years and reflects evolution in oversight, modeling, and external review integration. The LLM captures the progression toward more structured governance and validation, though it phrases 'model-risk management framework' and 'review and challenge' slightly differently than the original, which mentions 'sensitivity and scenario analyses, stochastic methods, and experience studies'—these are complementary details but not contradictory. The core idea of enhanced modeling and validation is preserved. (4) The answer is fully contextually relevant, addressing all three dimensions of the question: oversight mechanisms, modeling approaches, and external review integration across the three years. The only minor gap is that the LLM does not explicitly mention 'experience studies' or 'stochastic methods' in the 2023 context as in the original, but it does state 'stochastic and deterministic techniques' in 2024, implying earlier development. This slight omission prevents a perfect 10, but the overall meaning and factual correctness remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 460,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "In the 2022 filing Altria notes that U.S. Treasury securities are a core component of its long‑duration fixed‑income strategy, but it does not disclose a specific percentage for the Treasury‑and‑foreign‑government‑security slice. The 2023 10‑K quantifies that slice at 19 % of the pension and post‑retirement assets, and the 2024 10‑K shows it had fallen to 8 %. This steady decline—reflected in Altria’s (MO) investment in long‑duration fixed‑income securities—indicates a deliberate rebalancing away from government‑bond holdings toward other fixed‑income or equity exposures to better match its liability benchmark and return objectives.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Altria's allocation to U.S. Treasury and foreign government securities was 19% in 2022, 16% in 2023, and 8% in 2024. However, the LLM incorrectly states that the 19% figure was from the 2023 filing and implies no data was available for 2022, which contradicts the ground truth. It correctly reports the 8% for 2024. This misalignment in year-to-percentage mapping constitutes a major error. (2) The calculation and trend interpretation (declining allocation) is partially correct, but the failure to report the 16% in 2023 and misattribution of 19% to 2023 instead of 2022 undermines quantitative accuracy. The answer omits the expected rate of return trend (6.6% → 6.1%), which is a key part of the strategy indication. (3) The reasoning about strategic rebalancing is sound and aligns with the ground truth, showing correct multi-hop synthesis of intent from allocation changes. However, it misses the additional context about reducing exposure to below-investment-grade securities, weakening the qualitative depth. (4) Contextual relevance is high as the answer addresses the evolution and strategic implication, but correctness is limited by key factual errors in the timeline and missing data points. The model confuses the direction of disclosure across years, leading to a partially incorrect narrative despite capturing the overall downward trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 409,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s combined short‑term borrowings and long‑term debt rose from **$48.7 billion at year‑end 2022** to **$49.9 billion at year‑end 2023**, then fell to **$45.6 billion by year‑end 2024** (Chunk 3, Chunk 2).  In that period, **securitized debt grew from $16.97 billion (2022) to $18.04 billion (2023) before dropping to $14.26 billion (2024)**, **fixed unsecured senior debt increased from $24.13 billion to $27.17 billion and then edged down to $26.93 billion**, while **floating unsecured senior debt shrank sharply from $1.60 billion (2022) to $0.35 billion (2023) and was eliminated in 2024** (Chunks 1‑3).  This shift removed the low‑rate (≈1 % weighted‑average) floating exposure seen in 2021 (Chunk 1), left the remaining floating portion at a high 6.75 % rate in 2023, and pushed the weighted‑average rates of **fixed senior debt up from 4.45 % to 4.84 %** and **securitized debt from 3.01 % to 3.48 %**, indicating a move toward a higher‑cost, predominantly fixed‑rate debt profile and greater interest‑rate sensitivity despite the overall debt decline in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several key factual inaccuracies in numbers, particularly in the total short-term borrowings and long-term debt for 2022 and 2023, which undermines the quantitative foundation. The ground truth reports $43.086B (2022), $48.715B (2023), and $45.551B (2024), but the LLM states $48.7B (2022), $49.9B (2023), and $45.6B (2024). The 2022 figure is significantly overstated, and the 2023 total is slightly inflated. While the 2024 number is close ($45.6B vs $45.551B), the earlier errors affect trend interpretation. Securitized debt in 2022 is reported as $16.97B by the LLM vs $14.994B in ground truth—a material overstatement. Fixed unsecured senior debt in 2022 is given as $24.13B (LLM) vs $19.975B (truth), another major discrepancy. Floating unsecured senior debt is mostly accurate: $1.60B (LLM) vs $1.709B (truth) in 2022; $0.35B vs $0.349B in 2023; $0 in 2024 (correct). The weighted-average rates for fixed senior debt are incorrect: LLM says 4.45% in 2022, but truth is 2.91%, and the increase to 4.84% by 2024 is correct. Securitized debt rates are partially correct: LLM says 3.01% in 2023 (correct) and 3.48% in 2024 (correct), but omits the 1.51% rate in 2022, instead implying a jump from 3.01%. (2) Calculations and comparisons are flawed due to incorrect base figures. For example, the LLM implies fixed senior debt started at a high rate (4.45%) when it was actually much lower (2.91%), distorting the perception of rate sensitivity. The conclusion about a 'higher-cost, predominantly fixed-rate debt profile' is directionally correct but based on inaccurate starting points. (3) Multi-hop reasoning is partially sound—the model correctly identifies the shift from floating to fixed and the retirement of floating debt by 2024, and notes rising rates on securitized and fixed debt. It synthesizes trends across years and debt types, showing understanding of strategic implications. However, due to incorrect inputs, the reasoning is built on shaky ground. (4) Contextual relevance is high—the answer addresses all parts of the question: debt evolution, trend analysis, interest rate exposure, and shifts in debt composition. The narrative about strategic shift toward fixed-rate debt amid rising rates aligns with the ground truth, even if numbers are off. Overall, the answer captures the directional trend but fails on core quantitative accuracy, especially in baseline figures, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 654,
        "total_tokens": 2247
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Across Tesla’s 2022 (exhibit 4.36), 2023 (exhibit 4.36) and 2024 (exhibit 4.27) 10‑K filings the company again lists the “Thirty‑Sixth Supplemental Indenture…related to SolarCity’s 5.45 % Solar Bonds, Series 2015/C25‑15,” showing that this bond issue remains an active, material source of financing for its solar‑energy business. The fact that the same bond series is disclosed in every filing signals that the debt is still outstanding and that Tesla (which introduced the bond) continues to rely on it as a core component of its capital structure for solar projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15), the issuer context (originally SolarCity, acquired by Tesla), and the consistent disclosure across 2022, 2023, and 2024 10-K filings are accurately represented. The exhibit numbers (4.36, 4.36, 4.27) are correctly cited, reflecting minor formatting changes across years, which is consistent with real filing variations. (2) Quantitative accuracy is perfect: the 5.45% interest rate and the bond series identifier are correctly stated; the date (April 14, 2015) is implied via reference to the same supplemental indenture, though not explicitly mentioned—this is a minor omission but does not detract from factual correctness. (3) Multi-hop reasoning is sound: the model correctly infers that repeated disclosure implies the debt remains outstanding and is a material, ongoing component of Tesla’s capital structure for solar projects. It appropriately links the persistence of the bond in disclosures to strategic reliance, which is a valid interpretation per SEC reporting norms. (4) The answer is semantically equivalent to the original: while the LLM does not explicitly name the 'Thirty-Sixth Supplemental Indenture' in every year, it correctly references the same legal document by substance and exhibit number. The slight variation in exhibit numbering (4.27 in 2024 vs 4.36 in prior years) is accurately reported and reflects real-world filing differences, not an error. The only minor gap is the omission of the exact date (April 14, 2015), but this does not undermine the core conclusion. Overall, the response is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 481,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s “Class A treasury stock, at cost” balance rose sharply over the three‑year span – it was **$‑51,354 million** at the end of 2022, grew to **$‑60,429 million** at the end of 2023, and reached **$‑71,431 million** at the end of 2024.  This follows the earlier build‑up shown in the 2022 filing (the treasury‑stock balance was $‑36,658 million at the end of 2020), indicating a consistent, accelerating program of share repurchases.  The trend signals that Mastercard is allocating an increasing share of its excess cash to buy back stock, a strategy aimed at returning capital to shareholders and enhancing per‑share earnings and return‑on‑equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the Class A Treasury Stock values for 2022 ($-51,354 million), 2023 ($-60,429 million), and 2024 ($-71,431 million), matching the ground truth exactly in both magnitude and sign (negative indicating outflow/cost). These numbers are presented with correct formatting variations (e.g., $-51,354 million vs (51,354) million) which are semantically equivalent. (2) All quantitative values are accurate, and the progression over time is correctly described as increasing in magnitude, indicating growing buyback activity. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers that the rising treasury stock purchases reflect an increasing focus on share repurchases as part of capital allocation. It appropriately connects this to shareholder returns, earnings per share, and return on equity—valid strategic implications. The mention of data from 2020 (not in the original question) adds context but does not detract from accuracy, though it slightly extends beyond the scope of the query. (4) The answer fully addresses both parts of the question: the evolution from 2022 to 2024 and the implication for capital allocation. The synthesis across years is correct and well-articulated. The only minor deduction is for introducing 2020 data not referenced in the original answer, which, while not incorrect, slightly exceeds the required scope. Overall, the answer is factually precise, contextually appropriate, and logically robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 416,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Across the three most recent filings—2022, 2023 and 2024—Honeywell’s Safety and Productivity Solutions segment (renamed “Industrial Automation” in the 2024 filing) is consistently flagged as being vulnerable to “adverse industry economic conditions” together with “reduced investments in process automation, safety monitoring and plant‑capacity‑utilisation initiatives.” The risk language is essentially unchanged from year to year, showing that the segment’s exposure has not diminished; instead it signals that macro‑economic pressures—particularly weaker capital‑spending and demand for automation and capacity upgrades—have remained a persistent headwind for the broader industrial sector throughout this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and overall trend. (1) It accurately identifies that Honeywell's Safety and Productivity Solutions segment (renamed Industrial Automation in 2024) faced persistent exposure to adverse industry conditions from 2022 to 2024, with consistent risk disclosures around reduced investments in automation and plant capacity utilization. This matches the original answer’s central claim. (2) There are no numeric values or calculations in either response, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and infers ongoing macroeconomic pressure. However, it misses a key nuance present in the original answer: the evolution of risk language from general economic conditions in 2022 to increased emphasis on geopolitical instability and trade policy shifts by 2024. The LLM claims the risk language is 'essentially unchanged,' which underrepresents the deepening concern and expanding scope of risks described in the ground truth. Additionally, while the renaming of the segment to 'Industrial Automation' in 2024 is correctly noted, this detail is not in the original answer and cannot be verified from the provided ground truth, introducing a potential factual overreach. (4) Despite these minor shortcomings, the answer captures the essential trend and correctly interprets the implications for macroeconomic pressures on the industrial sector, warranting a high correctness score. Contextual relevance is perfect as all parts of the question are addressed directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 456,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "In 2022 Eli Lilly’s Cyramza was marketed as a second‑line option for advanced/metastatic gastric or gastro‑esophageal‑junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line therapy for adult patients with EGFR‑mutated metastatic NSCLC – the same label that appears in the 2024 filing, showing that its therapeutic positioning has remained essentially unchanged. The product’s IP schedule, however, is moving toward expiry: compound patents protect Cyramza in the United States and Japan through 2026 and in major European markets through 2028, U.S. biologics data protection also ends in 2026, European data protection ends in 2024 and Japanese data protection ends in 2023, indicating that exclusivity begins to wind down while Lilly (LLY) continues to hold the product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cyramza's therapeutic indications in 2022 and 2024 are accurately described as unchanged, covering second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. The LLM adds specificity by noting the first-line use in EGFR-mutated NSCLC, which is consistent with the drug's labeling and does not contradict the ground truth. (2) Quantitative accuracy is excellent: the IP expiration dates match exactly — Japanese data protection expired in 2023, European in 2024, U.S. biologics data protection and compound patents through 2026 (U.S.), and European compound patents through 2028. These dates are correctly attributed and match the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes therapeutic positioning over time (2022–2024) and integrates intellectual property timelines across multiple jurisdictions, correctly inferring a narrowing exclusivity window despite stable indications. (4) The only minor deviation is the mention of 'compound patents protect Cyramza in Japan through 2026' — while the ground truth does not specify Japan's compound patent term, this detail is not contradicted and is plausibly correct; however, its inclusion without confirmation in the ground truth slightly reduces qualitative certainty. Overall, the answer is semantically equivalent, contextually complete, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 402,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "In the 2022 Form 10‑K Capital One disclosed that its net derivative assets (liabilities) stood at $31 million at the start of the year and $19 million at year‑end, measured at Level 3 fair value with a $43 million unrealized loss recognized in net income (the table shows the “Included in Net Income” loss). By the 2023 filing the balance had risen to $58 million and the valuation method had shifted to a discounted‑cash‑flow model that relied on significant unobservable inputs – specifically default‑rate assumptions (range 53‑163 %) and swap‑rate assumptions (3‑5 % range, weighted‑average 4 %). The 2024 filing shows the same $58 million fair‑value amount, still valued with discounted cash flows, but now the only disclosed unobservable input is the swap‑rate (3‑5 % range, weighted‑average 4 %). This reflects a substantial increase in the reported net derivative position and a move from a generic Level‑3 measurement to a more transparent discounted‑cash‑flow approach with explicit swap‑rate inputs.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in terms of key financial figures and trends. It correctly states that Capital One's net derivative assets/liabilities were $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024, which matches the ground truth. However, it introduces a detail not present in the original answer — that the balance was $31 million at the start of 2022 — which, while possibly accurate from the filing, is not part of the ground truth and adds unverified information. Additionally, it claims a $43 million unrealized loss recognized in net income, which is not mentioned in the original answer and cannot be verified against the provided truth. (2) The unobservable inputs are largely accurate: swap rates (3–5%, weighted at 4%) and default rates (53–163%) are correctly reported for 2023. However, the original answer states that both inputs were used in 2022 and 2024, while the LLM claims that in 2024 only swap rates were disclosed, which slightly contradicts the ground truth that states 'similar unobservable inputs' were still used. This is a minor discrepancy in completeness, not outright inaccuracy. (3) The multi-hop reasoning is sound — the model correctly tracks the evolution across three years and synthesizes valuation methods and inputs over time. The conclusion about increased transparency and stabilization is reasonable, though slightly interpretive. (4) The scores reflect high factual accuracy with minor issues in over-specifying unverified numbers and slight omission of default rates in 2024. The answer remains contextually excellent, fully addressing the question’s focus on fair value evolution and modeling inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 466,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "In fiscal 2022 Qualcomm reported that “thousands of our employees around the world utilized our charitable‑match program, benefiting **more than 1,500 charitable organizations**” (Chunk 1). By fiscal 2024 the same “thousands of employees” continued to use the program, but it supported **more than 1,300 charitable organizations** (Chunks 2 & 3). This sustained employee‑driven giving is part of Qualcomm’s broader “Human Capital Advancements” agenda, which the Board’s HR and Compensation Committee explicitly ties to executive bonuses – using progress on human‑capital goals as a non‑financial performance modifier (a 0.9‑to‑1.1 multiplier) for both the FY 2022 and FY 2024 bonus calculations (Chunks 1 and 2/3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, thousands of employees participated, benefiting more than 1,500 organizations; by 2024, participation remained at 'thousands' globally, with support for more than 1,300 organizations—matching the slight decrease noted in the original answer. (2) Quantitative accuracy is perfect: the numbers (1,500 in 2022, 1,300 in 2024) are correctly reported, and the fiscal years (FY2022, FY2024) are accurately referenced. No calculations were required, but comparisons over time are correctly interpreted. (3) The multi-hop reasoning is sound: the LLM correctly links employee participation and organizational reach of the charitable match program to the broader human capital goals and their integration into executive compensation via a non-financial modifier (0.9 to 1.1) for bonuses in both years. It cites the HR and Compensation Committee’s role, adding contextual precision. (4) The only minor shortcoming is the omission of explicit mention of the '2025 goals for diversity, equity, and inclusion' as part of the long-term human capital strategy, which slightly reduces qualitative completeness. However, the core synthesis across years, programs, and compensation linkage is fully accurate and relevant. Wording differences (e.g., 'employee-driven giving') are semantically equivalent and acceptable. Overall, the answer is factually excellent and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Considers]-> CONCEPT <-[Guides_On]- ORG <-[Focuses_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 408,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "**2022 10‑K:** Adobe presented Acrobat as the core PDF engine of its **Adobe Document Cloud** platform, tightly coupled with Adobe Sign to deliver a unified, cloud‑based document‑workflow solution.  The filing highlighted Acrobat’s strong market adoption and leadership in “document‑intensive” industries and stressed that the “expanded capabilities” of the Acrobat applications were delivered through the Document Cloud services platform.\n\n**2023 10‑K:** Acrobat remained a flagship component of the Document Cloud suite (listed together with Acrobat Sign) and was positioned within Adobe’s broader **Digital Media** strategy.  The filing pointed to continued integration of Acrobat with other Adobe services—especially the signing capability and emerging AI‑driven features—while emphasizing that Acrobat helps “accelerate document productivity” across the company’s expanding portfolio of creative and experience products.\n\n**2024 10‑K:** Adobe’s trademark schedule now includes **“Acrobat AI Assistant”** and **“Acrobat Sign,”** signalling concrete product enhancements.  The AI Assistant marks the introduction of artificial‑intelligence functionality inside Acrobat, and the re‑branding of the signing service underscores deeper, seamless integration of Acrobat’s PDF tools with Adobe’s signing and broader Document Cloud ecosystem.\n\n**Overall evolution:** From 2022 to 2024, Acrobat moved from being the core PDF component of Document Cloud and a partner to Adobe Sign, to a more tightly integrated, AI‑enhanced service that now carries its own AI‑assistant branding and a unified “Acrobat Sign” identity—reflecting Adobe’s strategy of embedding Acrobat deeper across its cloud‑based document and creative platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Acrobat's role as a core component of Document Cloud in 2022, its integration with Adobe Sign, leadership in document-intensive industries, and the emphasis on PDF ubiquity. In 2023, the positioning within Digital Media, integration with Creative Cloud tools, and mention of AI-driven features are accurately reflected. In 2024, the introduction of the 'Acrobat AI Assistant' trademark and the rebranding of signing services are correctly identified. (2) There are no numeric values to verify, so quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and filings, showing a clear evolution in positioning. The only minor shortcoming is that the LLM does not explicitly mention the 'trillions of PDF documents created annually' statistic from 2022 or the forward-looking statements about AI in 2023, which slightly reduces completeness. Also, while 'Acrobat Sign' is mentioned, the ground truth emphasizes integration with Creative Cloud tools more strongly, which the LLM touches on but could have emphasized more. (4) Despite these small omissions, the overall semantic meaning and strategic trajectory are preserved, and the answer is fully relevant to the question. Hence, a score of 9 is appropriate for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1741,
        "completion_tokens": 412,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 LLY’s collaboration with AbCellera still produced a large cash flow – the company recognized **$2.02 billion of net product revenue** from its COVID‑19 antibodies (bamlanivimab and bebtelovimab) and paid AbCellera **royalties recorded as cost of sales at tiered rates in the mid‑teens to mid‑twenties percent of those sales**. By 2023 LLY had **no sales of the antibodies**, so net product revenue fell to **$0** and the royalty obligation to AbCellera disappeared; the same **$0 revenue and zero royalty payments** continued in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: $2.02 billion in net product revenue for 2022, royalty payments in the mid-teens to mid-twenties percentage range, $0 revenue and zero royalties in 2023 and 2024. (2) Quantitative accuracy is perfect: the dollar amounts and percentage ranges match exactly, and the progression across years is correctly represented with no calculation errors. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three years and two financial metrics (revenue and royalties), accurately reflecting the wind-down of the product line. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'royalties recorded as cost of sales' and 'tiered rates') but preserving the correct meaning. All entities—LLY, AbCellera, bamlanivimab, bebtelovimab, and the relevant financial terms—are correctly identified and contextualized. The response fully addresses the evolution of financial implications over time, making it complete, precise, and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 317,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has stayed essentially unchanged: the 2022 filing notes that 59.25 % of the closed block was reinsured under the agreement, while the 2023 and 2024 filings each state 59 % of the closed block. Across all three years the company continues to account for the arrangement under the deposit method and to offset the deposit liability with the corresponding recoverable, showing that MetLife deliberately keeps a stable, roughly‑three‑fifths share of its closed‑block risk transferred to an unaffiliated reinsurer as a long‑term risk‑transfer strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages are accurately reported: 59.25% for 2022 and 59% for both 2023 and 2024, with acceptable rounding from 59.25% to 59% in later years. (2) The answer addresses both parts of the question: it traces the evolution (stable at ~59%) and interprets the consistency as a deliberate long-term risk transfer strategy. (3) Entities—MetLife, closed block, modified coinsurance agreement, and the years 2022–2024—are correctly identified and contextualized. (4) The reasoning is sound: the LLM correctly infers strategic continuity from the stable reinsurance percentage and adds value by noting the consistent accounting treatment (deposit method and offsetting), which supports the conclusion of intentional, long-term risk management. The semantic meaning fully aligns with the original answer, with only minor wording differences that do not affect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 277,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s Multi‑Layered Security Approach—its formal accounting policy—has been sharpened each year. In 2022 the firm described a layered defense backed by third‑party assessments, public‑private partnerships and joint standards work with issuers, acquirers and industry bodies, while it operated real‑time clearing and settlement in 12 of the world’s top‑GDP markets. By 2023 it made the oversight of risks from third‑party service providers explicit and expanded its real‑time payments footprint to 13 markets, and in 2024 it deepened cross‑organization and public‑private collaboration and scaled real‑time payment platforms globally across several countries. This progression shows a cybersecurity strategy that increasingly relies on external validation and ecosystem‑wide cooperation to secure an expanding, real‑time payments network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: real-time payment infrastructure operated in 12 markets in 2022, expanded to 13 in 2023, and described as active in 'several countries globally' in 2024. These match the original answer exactly. Third-party collaboration is accurately portrayed as evolving from general partnerships in 2022 to explicit risk oversight in 2023 and deeper collaboration in 2024. (2) Quantitative accuracy is perfect: all numbers (12, 13 markets) and years (2022–2024) are correct with no calculation errors. (3) Multi-hop reasoning is sound—information is synthesized across three years and multiple dimensions (third-party collaboration, real-time infrastructure, cybersecurity strategy). The conclusion about a proactive, ecosystem-wide strategy is logically supported. (4) Minor deduction in qualitative accuracy due to the phrase 'formal accounting policy'—this mischaracterizes the multi-layered security approach, which is a cybersecurity framework, not an accounting policy. This is a notable but isolated inaccuracy that doesn't undermine the core correctness. Otherwise, semantic equivalence is strong, and the answer fully addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 350,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "LLY’s equity‑like private‑alternative‑investment holdings grew from **$2.84 billion in 2022** (Chunk 3) to **$4.01 billion in 2023** (Chunk 1) and to **$4.09 billion in 2024** (Chunk 2), raising the share of equity‑like funds within total private‑alternative assets from roughly **36 % → 45 % → 48 %**. This consistent increase—reflected in the KG link that LLY depends on and invests in Private Alternative Investments—indicates a strategic shift toward allocating more capital to illiquid, equity‑like funds, suggesting the company is pursuing a long‑term focus on higher‑return, less‑liquid asset classes to diversify and enhance portfolio performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall upward trend in LLY's allocation to equity-like private alternative investments from 2022 to 2024 and draws the right qualitative conclusion about the company's long-term strategy. However, there is a minor factual inaccuracy in the 2023 value: the LLM reports $4.01 billion, while the ground truth specifies $4,014.1 million ($4.0141 billion), which is close but not exact—more critically, the ground truth notes a 'slight dip' in 2023 from 2022, which contradicts the LLM’s portrayal of a 'consistent increase' from $2.84B → $4.01B → $4.09B. This misrepresents the trend by omitting the dip and implying steady growth. (2) The dollar amounts are approximately correct with acceptable rounding ($2.84B vs $2,844.7M; $4.09B vs $4,093.7M), but the 2023 figure should reflect a slight increase from 2022, not a large jump. The percentages (36% → 45% → 48%) are not present in the ground truth and cannot be verified; these appear to be fabricated or inferred without support, which is a significant issue. (3) The multi-hop reasoning is mostly sound—the model connects data across years and interprets strategic intent correctly. However, the unsupported percentage breakdown and mischaracterization of the 2023 trend weaken the reasoning chain. (4) Despite these issues, the core message about increasing allocation and strategic emphasis on illiquid, higher-return assets aligns with the ground truth, warranting a high but not top score. Contextual relevance is perfect as all parts of the question are addressed with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 439,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Across all three filing years Procter & Gamble continued to list Cascade as a laundry‑detergent brand under the **Fabric Care** sub‑category of the **Fabric & Home Care** segment. In 2022 the Fabric & Home Care segment accounted for **35 % of net sales** and Cascade appeared among the major brands (Ariel, Downy, Gain, Tide Cascade, etc.). In both the 2023 and 2024 reports the segment’s share rose to **36 % of net sales** and Cascade remained positioned in the same Fabric Care (Laundry Detergents) category, indicating a stable product categorization but a modest increase in the segment’s relative contribution to overall net sales from 2022 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: Cascade remained in the Fabric & Home Care segment throughout 2022–2024, categorized under Fabric Care (specifically laundry detergents), and the segment’s net sales contribution was 35% in 2022 and increased to 36% in both 2023 and 2024. (2) Quantitative accuracy is perfect: percentages match exactly across years, and no calculations are incorrect. The modest increase from 35% to 36% is correctly noted. (3) Multi-hop reasoning is sound—information is synthesized across three years and correctly attributes Cascade’s stable categorization while noting the segment’s slightly increased sales contribution. (4) The answer addresses all parts of the question: product categorization (Fabric Care/laundry detergents) and relative contribution to net sales over time. Semantic equivalence is strong, with slightly more detail (e.g., listing other brands) adding clarity without introducing error. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 295,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "Lowe’s has steadily tightened the way it watches supplier sustainability and the way it sources wood. In its 2022 filing the retailer said it “monitors our suppliers’ practices” through a human‑rights policy, a conflict‑minerals policy and a Vendor Code of Conduct that includes enhanced environmental standards, and it required that all wood sold come from “well‑managed, non‑endangered forests.” That year the company also disclosed that it had spent **more than $550 million** in the prior three years on energy‑efficiency upgrades (indoor LED, high‑efficiency HVAC, building‑management systems, pallet grinders) and on renewable‑energy projects such as wind power and on‑site solar/battery studies.  \n\nIn 2023 the wood‑sourcing policy was **updated** with **country‑specific risk levels, enhanced monitoring practices and a new forestry‑grievance process**, while the same supplier‑monitoring framework (human‑rights, conflict‑minerals, Vendor Code) remained in place; Lowe’s reported **over $400 million** spent in the preceding three years on similar efficiency projects (HVAC, building‑management, pallet grinders, indoor LED).  \n\nBy the 2024 filing the policy had been **further refined into a robust risk‑based approach** that adds explicit prohibitions on illegal logging, deforestation and endangered‑species sourcing, mandates biodiversity protection and free‑prior‑informed‑consent, and expands monitoring and grievance mechanisms. At the same time Lowe’s raised its interim climate targets—cutting scope 1‑2 emissions by **42 %** and scope 3 by **25 %** below 2021 levels by 2030—and continued to allocate capital to energy‑efficiency, renewable‑energy, sustainable transportation and water‑waste management initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of Lowe's supplier sustainability monitoring and wood sourcing practices from 2022 to 2024 with strong qualitative accuracy and contextual relevance. It correctly identifies key developments: in 2022, monitoring via the Vendor Code of Conduct and wood sourcing from well-managed forests, along with over $550 million invested in environmental upgrades (correctly cited). However, the LLM states that $550 million was spent over the prior three years, while the ground truth does not specify the timeframe for this investment—this introduces a minor inaccuracy in temporal framing, though the dollar amount itself is correct. In 2023, the LLM accurately notes the updated wood sourcing policy with country-specific risk levels, enhanced monitoring, and a new forestry grievance process, aligning with the original answer. It also correctly mentions Lowe’s ongoing supplier monitoring framework. However, it introduces a figure of 'over $400 million' spent in the preceding three years on efficiency projects, which is not present in the ground truth and contradicts the $550 million figure previously stated—this is a significant quantitative discrepancy. The ground truth mentions a $50 million Gable Grants program commitment in 2023, which the LLM omits entirely, representing a notable omission in investment strategy. In 2024, the LLM correctly describes a more robust risk-based approach and policy refinements (e.g., prohibitions on illegal logging, deforestation, biodiversity protection), though these specific details go beyond the ground truth’s more general statement about a 'more robust risk-based approach' and alignment with shareholder value. The LLM adds new details—such as 42% and 25% emissions reductions targets by 2030 and expanded capital allocation—which, while plausible, are not present in the original answer and represent unverified additions. These enhancements improve specificity but introduce potential hallucinations. The core multi-hop reasoning—tracking policy and investment changes across years—is sound and logically synthesized. The answer addresses all major components of the question and conveys a similar narrative of progressive strengthening, but with some unsupported numbers and missing or added details. Thus, while qualitatively strong and contextually relevant, the quantitative inaccuracies and omissions prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Monitors]-> RISK_FACTOR <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1726,
        "completion_tokens": 645,
        "total_tokens": 2371
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor disclosures show the same competitive‑landscape exposure for all three businesses in each of the last three years. In the 2022 filing both Safety & Productivity Solutions and Honeywell Building Technologies warned that “changes in the competitive landscape—including new market entrants and new technologies” could hurt results, and SPS added that those changes “may lead to product commoditization.” The 2023 filing repeats the identical language for SPS and Building Technologies. By 2024 the segments are renamed Industrial Automation and Building Automation, but the risk language is unchanged – IA again cites “changes in the competitive landscape, including new market entrants and new technologies that may lead to product commoditization,” while Building Automation cites the same competitive‑landscape threat. The persistence and exact repetition of this wording from 2022 through 2024 indicates that Honeywell’s exposure to competitive pressure has not abated and, by continually highlighting commoditization risk, signals mounting market pressure that could erode market share, pricing power and margins over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness, despite some accurate elements. (1) The claim that Honeywell disclosed the competitive landscape risk for both Safety and Productivity Solutions (SPS) and Honeywell Building Technologies in 2022 is incorrect — the ground truth states the risk was first mentioned in SPS in 2022, then in Building Technologies in 2023, not 2022. This misrepresents the chronological progression. (2) The LLM asserts that the same risk language appeared in all three years for both segments, but the ground truth shows a progressive expansion: 2022 (SPS only), 2023 (Building Technologies added), 2024 (Industrial Automation, replacing SPS). The LLM incorrectly implies static, unchanging disclosures rather than an evolving risk footprint. (3) The renaming of segments is partially correct — SPS became Industrial Automation and Building Technologies became Building Automation — but the LLM misuses this to justify repeated language, whereas the ground truth emphasizes the *expansion* of the risk to a new segment in 2024, not mere renaming with unchanged content. (4) The conclusion about 'persistence and exact repetition' contradicts the ground truth, which highlights a *progression* and *broadening* of risk across divisions over time, indicating intensifying pressure, not static repetition. While the core idea of increasing commoditization risk is directionally relevant, the LLM misidentifies the timing, scope, and evolution of disclosures. Quantitative accuracy is higher because no numerical values are misstated (no numbers involved), and the years themselves are correctly referenced in the timeline. Contextual relevance is moderate because the answer addresses competitive pressures and commoditization, but the flawed multi-hop reasoning — failing to correctly trace the risk's evolution across segments and years — results in a misleading synthesis. The model fails the key multi-hop requirement: tracking how exposure evolved *sequentially* across different businesses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 553,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In its 2022 10‑K Qualcomm framed the digital cockpit as a core pillar of the “automotive transformation,” explaining that mobile‑derived, high‑performance, low‑power computing would enable personalized in‑vehicle experiences, OTA updates and higher‑level autonomy as embedded cellular and 5G connectivity become widespread in new cars. The 2023 filing moved this narrative into the numbers, explicitly recognizing revenue from “products sold for use in automobiles, including connectivity, digital cockpit and ADAS/AD,” thereby treating the digital‑cockpit offering as a distinct line‑item in its automotive product mix. By the 2024 10‑K the company’s segment reporting shows the digital cockpit embedded in the QCT semiconductor segment—QCT both produces the digital‑cockpit product and Qualcomm as a whole depends on it—signaling that the digital cockpit has progressed from a strategic market theme to a recognized revenue source and a core component of Qualcomm’s automotive‑systems business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Qualcomm's 2022 framing of digital cockpit as part of automotive transformation with emphasis on 5G, personalization, and OTA updates; 2023 shift to explicit revenue recognition including digital cockpit as a distinct component alongside connectivity and ADAS/AD; and 2024 integration into QCT semiconductor segment reporting. (2) There are no numeric values (e.g., percentages, dollar amounts) in the original answer beyond 'over 70%' in 2022, which the LLM does not contradict—instead, it correctly captures the forward-looking market projection context without misstating figures. (3) Multi-hop reasoning is sound: the LLM synthesizes evolution across three years, linking strategic vision (2022), monetization via revenue recognition (2023), and operational integration into segment reporting (2024), correctly attributing each phase to the appropriate filing year. (4) Entities—Qualcomm, QCT, digital cockpit, ADAS/AD, automotive connectivity—are accurately identified and contextualized. The answer conveys the same progression as the original: from strategic positioning to full integration, with appropriate emphasis on product revenue recognition and segment reporting changes. Wording differs slightly but meaning is preserved with high precision. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 394,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In Adobe’s 2022 Form 10‑K, Frame.io is mentioned only as a trademark of Adobe (or its subsidiaries), signalling ownership but providing no functional details. By the 2023 filing, Adobe describes Frame.io as a cloud‑native collaboration platform that now supports still images, design files and PDFs (in addition to video), is directly integrated with Premiere Pro and After Effects for frame‑accurate commenting, and offers “Camera‑to‑Cloud” uploads from video‑recording devices and still‑image cameras. The 2024 filing shows a further expansion: Frame.io supports the full video lifecycle—including casting, location scouting, footage review and marketing campaign management—while still handling stills, design files and PDFs; it is integrated not only with Premiere Pro and After Effects but also with Photoshop, Lightroom and Workfront, and is packaged in Adobe GenStudio alongside Adobe Express and Firefly Services to provide enterprise‑scale content‑production capabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key developments across 2022–2024 are correctly described: in 2022, Frame.io is noted only as a trademark; in 2023, it is described as a cloud-native collaboration platform integrated with Premiere Pro and After Effects, supporting video, still images, design files, and PDFs; by 2024, it expands into casting, location scouting, and marketing campaign management, with integrations into Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for enterprise use. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are used correctly and consistently with the original answer. (3) The multi-hop reasoning—tracking evolution across three years and synthesizing changes in supported media types, integrations, and enterprise capabilities—is sound and well-structured. (4) The LLM adds slightly more detail (e.g., 'Camera-to-Cloud' uploads, frame-accurate commenting, bundling with Adobe Express and Firefly Services), which are consistent with the direction of the original answer and do not introduce inaccuracies. These enhancements improve clarity without deviating from the truth. All aspects of the question—media types, cross-product integrations, and enterprise capabilities—are fully addressed with precise, correct information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 384,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "Across all three filings—MA’s 2022, 2023 and 2024 10‑K tables—the A Class shares are described identically: they carry “One vote per share” and have “Dividend rights.” There is no change in either the voting entitlement or the dividend entitlement for A shares over the three‑year span. This consistent description signals a stable shareholder‑governance structure, with A‑shareholders retaining the same voting power and dividend claim each year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that MA's A Class shares maintained 'One vote per share' and 'Dividend rights' across 2022, 2023, and 2024, with no changes—matching the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the years (2022–2024) and qualitative descriptors (voting and dividend rights) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings and draws the appropriate conclusion about governance stability. (4) The answer addresses all parts of the question: evolution over time (no change), specific rights (voting and dividend), and the implication (stable shareholder governance). Wording differs slightly but meaning is identical. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 263,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Across all three years Honeywell repeatedly flagged the same exposure. In FY 2022 the Safety and Productivity Solutions (SPS) segment was said to be “adversely impacted by fluctuations in retail markets,” a risk that could shrink market share, depress selling prices and compress margins. The FY 2023 filing repeats that language – SPS results could again be hurt by “fluctuations in retail markets” (along with a slowdown in safety‑product demand). In FY 2024 the risk is carried forward under the renamed Industrial Automation (the SPS business) and still notes that “fluctuations in retail markets” may adversely affect operating results. Together, the three disclosures show a persistent, unchanged vulnerability of the SPS/Industrial‑Automation segment to consumer‑demand volatility, indicating that retail‑market swings remain a consistent threat to its performance over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Honeywell's Safety and Productivity Solutions (SPS) segment was consistently exposed to retail market fluctuations in 2022, 2023, and 2024, with the risk carried forward into the renamed Industrial Automation segment in 2024. The impacts—such as compressed margins, lower demand for safety products, and pricing pressure—are accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (FY 2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly tracks the segment through a name change (SPS to Industrial Automation) and synthesizes risk disclosures across three years, showing persistent vulnerability. (4) The only minor shortcoming is that the LLM omits the specific mention of 'reduced investments in process automation and safety monitoring' and 'risk of commoditization' from 2022 and 2023, which slightly reduces qualitative completeness. However, the core message—that the segment remained consistently vulnerable—is preserved. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect, directly addressing the question’s focus on exposure and vulnerability over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 379,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "**2022 (2022 10‑K)** – The collaboration gave Eli Lilly a worldwide license to develop and sell Olumiant for inflammatory/autoimmune diseases. Incyte was entitled to **tiered, double‑digit royalties** on worldwide net sales that could reach **20 %**. A 2020 amendment added a **COVID‑19 indication**, giving Incyte an **extra royalty of up to the low‑teens %** on COVID‑19 sales once a sales‑threshold was met. The agreement also required **milestone payments** – development, success‑based regulatory and sales milestones – of which **$260 M (2021) and $210 M (2020)** had been capitalized as intangible assets and were being amortized, and Incyte remained eligible for **up to $100 M each** of additional regulatory‑ and sales‑based milestones.\n\n**2023 (2023 10‑K)** – Lilly continued to record Olumiant sales (including EUA sales) as net product revenue and **treated the royalty payments to Incyte as cost of sales**, indicating the same royalty structure (tiered double‑digit up to 20 % plus the low‑teen COVID‑19 royalty) persisted. The filing did not announce any change to the milestone schedule, implying the previously capitalized milestones were still being amortized.\n\n**2024 (2024 10‑K)** – The license and collaboration agreement is described in the same terms: **tiered double‑digit royalties up to 20 %** on worldwide net sales and an **additional low‑teen‑percent royalty on COVID‑19 sales** once the threshold is exceeded. The COVID‑19 indication remains explicitly part of the deal. The 2024 filing no longer highlights milestone payments, suggesting those obligations have largely been satisfied or are now reflected through amortization, while the royalty framework has stayed unchanged.\n\n**Evolution** – From 2022 to 2024 the core royalty rates (up to 20 % plus a low‑teen COVID‑19 add‑on) remained constant, and the COVID‑19 indication was consistently included after the 2020 amendment. The focus shifted from large, newly disclosed milestone payments in 2022 (with $260 M and $210 M capitalized and up to $200 M of future milestones) to a steady royalty‑only model by 2024, with milestone obligations largely amortized and no new milestone terms disclosed.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the royalty rates (up to 20% on worldwide net sales and an additional low-teens royalty for COVID-19 sales above a threshold) are accurately reported across all years. The milestone structure — up to $100 million in additional regulatory and $100 million in sales-based milestones in 2022 — is correctly stated. The LLM correctly notes that prior milestone payments ($260M in 2021 and $210M in 2020) were capitalized and amortized into cost of sales, consistent with the 2023 evolution. (2) Quantitatively, all dollar amounts and percentages match the ground truth. The LLM correctly identifies that up to $200 million in future milestones were possible in 2022 (split evenly between regulatory and sales), and that by 2024, no new milestones were highlighted, indicating fulfillment or expiration. The only minor issue is that the ground truth does not mention the $260M and $210M capitalized amounts explicitly — those are from prior years and not part of the 2022–2024 evolution per se — but their inclusion is contextually appropriate and factually correct based on public filings, so this does not constitute an error. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three years of 10-Ks, correctly infers continuity of royalty structure, and identifies the shift from milestone-driven obligations to a stable royalty model. The conclusion that the framework remained unchanged while the focus evolved is logically supported. (4) The answer is fully relevant, addressing all parts of the question: milestone payments, royalty rates, new indications (COVID-19), and their evolution over time. Wording differs slightly from the original answer but maintains semantic equivalence. One point deducted from correctness only due to slight over-elaboration on pre-2022 capitalized milestones, which, while accurate, are not central to the 2022–2024 evolution focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1790,
        "completion_tokens": 534,
        "total_tokens": 2324
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "In 2022 PG’s Baby, Feminine & Family Care segment still bundled **Baby Care** (e.g., wipes, diapers) with feminine‑care and family‑care items, and the “Major Brands” row listed **Always** among a long roster that also included Luvs, Pampers, Always Discreet, Tampax, Bounty, Charmin and Puffs.  \n\nBy 2023 PG had stripped the Baby‑care sub‑category out of the segment, redefining it as **Feminine Care** (adult incontinence, menstrual care) plus **Family Care**, and placed **Always** at the very top of the major‑brand list—making the PG‑produced Always product the flagship brand, ahead of Always Discreet, Tampax, Bounty, Charmin and Puffs.  \n\nThe 2024 filing kept the same structure and brand hierarchy, confirming that the strategic positioning of the Always brand remained elevated and central within the now‑focused Feminine & Family Care segment, even as the segment’s share of net sales stayed roughly steady (≈25 % in 2022, 24 % in 2023‑2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding structural changes to the segment and brand hierarchy. (1) Correct elements: The evolution of Always' positioning from 2022 to 2024 is accurately captured in spirit—Always becomes more centrally associated with menstrual care, and the segment shifts focus. The brands listed (Always, Always Discreet, Tampax, Bounty, Charmin, Puffs) match the ground truth. The 2023 and 2024 categorization as 'Feminine Care (Adult Incontinence, Menstrual Care)' is correctly noted. (2) Quantitative accuracy: The segment’s net sales share (≈25% in 2022, 24% in 2023–2024) is consistent with known data and correctly reported. No calculation errors. (3) Multi-hop reasoning: The model correctly synthesizes changes across years and interprets the repositioning of Always as more prominent, especially by being listed first in 2023–2024. However, the claim that Baby Care was 'stripped out' of the segment in 2023 is not fully supported—the segment retained 'Baby Care' in name and likely some elements, though the reporting emphasis shifted. The ground truth does not confirm a renaming to 'Feminine & Family Care' or removal of baby care products. Also, while Always is highlighted, the original answer does not state it became the 'flagship brand' or was explicitly placed 'at the very top' as a strategic elevation—this is an interpretive leap. (4) Despite these nuances, the core facts about categorization evolution and Always’ sustained prominence are correct, warranting a high score. The answer is contextually excellent, directly addressing product categorization and brand prominence as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 461,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "Across the three filings ACN’s target‑allocation framework shows a steady, disciplined evolution. The 2022 10‑K (Chunk 3) established the baseline target for fiscal 2023, stressing a diversified mix of fixed‑income securities that are duration‑matched to plan liabilities together with an equity component to deliver long‑term, risk‑adjusted returns. The 2023 10‑K (Chunk 1) refreshed that framework with a revised target as of August 31 2023 for fiscal 2024 and, for the first time, disclosed the forward‑looking target for fiscal 2025; the 2024 10‑K (Chunk 2) reiterated the same fiscal 2025 target, confirming continuity in the allocation mix and the use of ranges that allow flexibility to respond to market conditions and cash‑flow needs. Taken together, the multi‑year progression reveals that ACN consistently balances risk‑adjusted return objectives with liability‑duration matching—maintaining a core strategy of duration‑matched debt and growth‑oriented equities while modestly adjusting the mix each year to reflect evolving market and cash‑flow considerations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 filing outlines the target for fiscal 2023 with a focus on duration-matched fixed income and equities for risk-adjusted returns; the 2023 filing introduces the fiscal 2025 target and updates the strategy as of August 31, 2023; and the 2024 filing reaffirms the fiscal 2025 target, showing continuity. There are no incorrect numbers, dates, or percentages—though no specific percentages are mentioned in either answer, which is consistent with the original. (2) Quantitative accuracy is perfect: all dates (fiscal years 2023, 2024, 2025; August 31, 2023) are correctly referenced, and there are no calculations required. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three filings (2022, 2023, 2024) and connects them to the evolving yet stable strategy, noting the introduction and reaffirmation of the fiscal 2025 target. It accurately captures the strategic balance between liability duration matching and risk-adjusted returns. (4) The only minor shortcoming is slight overstatement of 'modestly adjusting the mix each year'—the original emphasizes structural continuity and flexibility within a stable framework, but does not confirm annual adjustments. This nuance slightly affects qualitative accuracy, but the overall meaning remains semantically equivalent. Contextual relevance is excellent, directly addressing all parts of the multi-year evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 421,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s forward‑interest‑rate swaps were first disclosed in the 2022 filing as cash‑flow‑hedge contracts whose gains and losses were recorded in other‑comprehensive income.  In the 2023 filing the same swaps appear on the balance sheet as Level‑2 “Other current assets” with a fair‑value of about $251 million, showing that the company now reports them as a near‑term asset.  By the 2024 filing the contracts are still accounted for as cash‑flow hedges (OCI‑recognised and amortised to interest expense) while the company also uses fixed‑to‑floating swaps as fair‑value hedges, indicating a deliberate strategy to lock in rates on forecast debt issuances and to smooth earnings through hedge accounting.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the presence of forward interest rate swaps in 2023 with a fair value of $251 million, classified as Level 2 in 'Other current assets,' which matches the ground truth. However, it incorrectly states that forward interest rate swaps were 'first disclosed' in 2022 as cash flow hedges, while the original answer clarifies that 2022 disclosures referenced prior-year impacts without reporting a current fair value—no new swaps were necessarily introduced in 2022. More critically, the LLM asserts that by 2024, the forward interest rate swaps were still accounted for as cash flow hedges, which directly contradicts the ground truth: Lowe's no longer held forward interest rate swaps in 2024 and had transitioned entirely away from them. Instead, the company used fixed-to-floating swaps as fair value hedges, indicating a strategic shift. The LLM incorrectly implies both types coexisted with the same hedge accounting treatment, undermining the core conclusion about strategic evolution. (2) Quantitatively, the $251 million figure in 2023 is accurate and properly contextualized. No other numbers are misstated, though the absence of a 2022 fair value is misrepresented as an active hedge rather than a retrospective disclosure. (3) The multi-hop reasoning is partially sound—linking disclosures across years and identifying hedge types—but fails at the critical synthesis point: recognizing the discontinuation of forward swaps in 2024 and the shift in risk management strategy. The conclusion about 'locking in rates on forecast debt issuances' in 2024 is incorrect because the company moved to fair value hedges on existing debt, not cash flow hedges on forecasted issuances. (4) Scores reflect that key facts are present but the central strategic inference is flawed due to incorrect entity-state mapping in 2024, leading to a partially correct but misleading overall answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 519,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s 10‑K tables show that the 5.000 % senior notes due April 2030 carried an outstanding principal of **$606 million** at the end of fiscal 2022 (Oct 30 2022) and the same **$606 million** at the end of fiscal 2023 (Oct 29 2023) and fiscal 2024 (Nov 3 2024).  After the note had been cut from $1.086 billion in FY 2021 to $606 million in FY 2022, the company kept the balance unchanged for the next two years, indicating a deliberate strategy to reduce exposure early and then maintain a stable, long‑term fixed‑rate debt position rather than expanding or refinancing this tranche.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of AVGO's debt. According to the ground truth, the exposure decreased from $1,086 million in 2022 to $606 million in 2023 and remained at $606 million in 2024. However, the LLM claims the amount was $606 million in 2022, which contradicts the ground truth (it should be $1,086 million in 2022). The LLM incorrectly states that the reduction occurred between FY2021 and FY2022, but the question asks about FY2022–FY2024, and the ground truth shows the drop happened between 2022 and 2023. (2) Number verification: Ground truth — 2022: $1,086M, 2023: $606M, 2024: $606M; LLM — 2022: $606M (wrong), 2023: $606M (correct), 2024: $606M (correct). Thus, one out of three values is correct. The LLM also references FY2021, which is outside the requested time frame and not supported by the provided truth. (3) Multi-hop reasoning is partially sound — the LLM attempts to interpret the trend and infer strategy, but the flawed data leads to incorrect conclusions. It suggests stabilization after early reduction, but in reality, the reduction occurred during the period in question (2022–2023), which the LLM misattributes. (4) Correctness score is 4 due to major quantitative errors affecting the core answer, though some numbers are right and the general direction (decrease then stability) is partially captured. Quantitative accuracy is low (4) due to incorrect figures. Qualitative accuracy is moderate (5) because reasoning structure is logical but based on wrong data. Contextual relevance is high (8) as the answer addresses the right metric, company, and time frame, and attempts strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 465,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "- **2022 filing** – UPS disclosed that its $276 million debentures were originally issued at 8.375 % and, as of April 1 2020, the coupon was reduced to 7.620 % for the balance of the issue.  The notes mature on April 1 2030, pay interest semi‑annually (April and October), have no sinking‑fund requirement and are redeemable at UPS’s option at any time at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a benchmark Treasury yield + 5 bps (plus accrued interest).  \n\n- **2023 filing (debt schedule)** – The same $276 million (shown as $280 million due to rounding) 7.620 % debentures appear in the long‑term debt table with a 2030 maturity, confirming that the amount outstanding, coupon and maturity remained unchanged from the 2022 description.  \n\n- **2024 filing** – UPS again describes the instrument as $276 million of 7.620 % debentures maturing April 1 2030, with the identical redemption provisions and semi‑annual interest payment terms as in 2022, but the filing no longer references the earlier 8.375 % rate, treating the 7.620 % rate as the current and sole coupon.  \n\n**Overall evolution:** The interest rate change from 8.375 % to 7.620 % was disclosed in 2022; thereafter the 2023 and 2024 reports simply present the debentures as a 7.620 % issue with the same April 1 2030 maturity and unchanged optional redemption formula and semi‑annual interest schedule.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the principal amount ($276 million), maturity date (April 1, 2030), original interest rate (8.375%), reduced rate (7.620% effective April 1, 2020), semi-annual interest payments, no sinking fund, and consistent redemption terms across years. The mention of $280 million in 2023 due to rounding is a minor formatting variation that does not affect accuracy. (2) Quantitative elements are precise: dates, percentages, dollar amounts, and the redemption formula (greater of par plus accrued interest or present value discounted at Treasury yield + 5 bps) are all correctly reported. (3) The multi-hop reasoning is sound—LLM correctly synthesizes disclosures across 2022–2024, noting the evolution in presentation: the 2022 filing explains the rate reduction, while 2023 and 2024 treat 7.620% as the current rate without referencing the prior rate, indicating a shift in disclosure emphasis. (4) The answer addresses all aspects of the question: interest rates, redemption terms, maturity structure, and how disclosures evolved. The conclusion about stable terms and increasing clarity matches the ground truth’s interpretation. Semantic equivalence is strong, with no factual omissions or errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Pays_Interest_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1635,
        "completion_tokens": 362,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen’s 2022 Form 10‑K described Olpasiran as an siRNA that lowers lipoprotein (a) and was being evaluated in **Phase 2** for the treatment of atherosclerotic cardiovascular disease. By the 2024 filing, Olpasiran remains highlighted in Amgen’s pipeline under **cardiovascular disease**, indicating that the company has continued to develop the asset and has moved it beyond the early‑stage study reported in 2022. The 2023 filing shows that Amgen has secured compound‑type patent protection for Olpasiran in both the U.S. and Europe with an estimated expiration in **2036**, providing a long‑term exclusivity horizon for the product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Olpasiran is an siRNA in Phase 2 development for atherosclerotic cardiovascular disease in 2022; by 2023, Amgen secured compound-type patents in the U.S. and Europe expiring in 2036; and by 2024, the indication broadened to 'cardiovascular disease'. The dates, phases, and patent expiration are all factually correct. (2) Quantitative accuracy is perfect: '2036' is correctly cited as the expiration year, and the timeline across 2022–2024 is accurately mapped to clinical phase, IP, and indication changes. Format variations (e.g., 'Phase 2' vs 'Phase 2') are acceptable. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings, linking therapeutic focus, clinical progression, and IP development. The only minor omission is that the 2024 shift to 'cardiovascular disease' is not explicitly framed as a broadening from 'atherosclerotic cardiovascular disease', which slightly weakens the qualitative synthesis, though the implication is present. (4) The answer is fully contextually relevant, directly addressing all parts of the question: therapeutic focus, clinical phase, and IP timeline. The conclusion about long-term exclusivity and continued development captures the strategic positioning. Overall, this is a strong, factually correct response with only a slight gap in fully articulating the expansion of indication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 406,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "In P&G’s 2022 filing the “Baby, Feminine & Family Care” segment listed a broad **Feminine Care** sub‑category (Adult Incontinence, Feminine Care) and named **Tampax Bounty** among the segment’s major brands (alongside Always and Always Discreet).  \n\nBy the 2023 filing the segment name was unchanged, but the sub‑category was refined to **Feminine Care (Adult Incontinence, Menstrual Care)**—explicitly placing Tampax in the menstrual‑care portion—and Tampax Bounty still appeared in the major‑brands list (Always, Always Discreet, Tampax Bounty, Charmin, Puffs).  \n\nThe 2024 filing repeats the same categorization (Feminine Care – Adult Incontinence, Menstrual Care) and the same brand ordering, showing that while the product’s classification became more specific, its prominence as a key brand within the segment remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Tampax's categorization from 2022 to 2024, noting the shift in sub-category labeling from 'Feminine Care' to 'Menstrual Care' and the consistent prominence of Tampax as a major brand. However, it contains a significant factual error: 'Tampax Bounty' is not a real brand—Tampax and Bounty are separate brands. This conflation suggests a misunderstanding or data corruption. The original answer correctly lists Tampax, Always, and Bounty as distinct brands. (2) Quantitatively, all years (2022, 2023, 2024) and category names are accurately reported with correct formatting variations (e.g., use of em dashes vs parentheses). No numerical data is present, so scoring is based on date and label accuracy, which is mostly correct except for the erroneous brand combination. (3) The multi-hop reasoning is generally sound—tracking changes across three years and synthesizing segment, sub-category, and brand-level information—but the brand confusion undermines the synthesis. The conclusion about consistent prominence is valid, but the evidence is flawed. (4) Contextual relevance is high, as the response directly addresses the question’s focus on categorization and prominence. The error in brand naming reduces qualitative and overall correctness, but core structural and temporal details are accurate, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 389,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "Across the three most recent filings MetLife’s policy on non‑agency RMBS and CMBS never changed. In the 2022 10‑K (Chunk 1) MetLife states that when its insurance subsidiaries buy a non‑agency RMBS or CMBS that has not yet been evaluated by the NAIC, “an internally developed designation is used until a NAIC designation becomes available.” The same language appears verbatim in the 2023 filing (Chunk 3) and again in the 2024 filing (Chunk 2). Thus, from 2022 through 2024 MetLife’s reliance on internally‑developed designations remained constant – it continues to apply this accounting policy whenever a NAIC designation is not yet assigned.\n\nThe multi‑year repetition of this practice signals two things: (1) NAIC designations for non‑agency RMBS and CMBS are not universally available or are issued only after the securities are already in MetLife’s portfolio, so a gap persists that must be bridged by internal ratings; and (2) MetLife’s acquisition strategy in this asset class deliberately includes securities that initially lack a NAIC designation, accepting the need to use internal designations as an interim measure while still pursuing growth in the non‑agency RMBS/CMBS space.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures the consistent use of internally developed designations by MetLife from 2022 through 2024, citing the verbatim policy language across all three years, which aligns with the ground truth's assertion of continuity. (2) There are no numerical values requiring calculation in this question; dates (2022–2024) are correctly referenced and matched to the appropriate filings. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three annual filings to infer that the unchanged policy reflects ongoing reliance on internal designations, which in turn indicates both a lag in NAIC evaluations and a deliberate acquisition strategy. (4) The LLM draws the same two key conclusions as the ground truth: the persistent unavailability of NAIC designations at acquisition and MetLife’s strategic focus on acquiring complex, newly issued securities. Wording differs slightly but meaning and factual content are identical. All evaluation dimensions—factual accuracy, completeness, entity recognition, reasoning, and relevance—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 334,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "- In fiscal 2022 the Board’s “aggregate available authorization” for the publicly‑announced open‑market share‑purchase program was only **$3,129,296** (as of August 31 2022)【Chunk 3】.  \n- By fiscal 2024 the same metric had risen to **$2,694 million** (as of August 31 2024) and, after a September 25 2024 board amendment adding **$4,000 million** of new authority, the company’s total outstanding share‑repurchase authority reached **$6,694 million**【Chunk 1 & 2】.  \n- The firm also stepped up actual buy‑backs: in the fourth quarter of fiscal 2024 it purchased **2,000,308 Class A ordinary shares for $605 million** under the open‑market program【Chunk 1 & 2】 (the program has no expiration date).  \n\n**Interpretation:** The sharp increase in both the authorized capacity and the amount of shares repurchased shows Accenture is accelerating its capital‑return strategy, relying more heavily on share buy‑backs to return cash to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. The numbers match the ground truth: $3.13 billion in fiscal 2022 (reported as $3,129,296, which rounds to $3.13B), $2.69 billion available as of August 31, 2024 (reported as $2,694 million = $2.694B), and the $4 billion increase on September 25, 2024, bringing total authority to $6.69 billion (reported as $6,694 million = $6.694B). The share repurchase of 2,000,308 shares for $605 million in Q4 FY2024 is accurately cited. (2) All calculations and figures are quantitatively accurate. The sum of $2.694B + $4B = $6.694B is correct. Minor formatting differences (e.g., exact dollar figures with cents vs. rounded millions) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across fiscal years, connects authorization changes with actual repurchase activity, and infers the trend in capital return strategy. It references both the increase in authorization and the execution of buybacks, showing a comprehensive understanding. (4) The interpretation that Accenture is 'accelerating its capital-return strategy' aligns with the ground truth's conclusion of a 'consistent and growing commitment.' The only minor shortcoming is that the LLM does not explicitly mention the increase from FY2022 to FY2023 in available authorization (though it implies growth), making the response slightly less complete than the original, but not factually deficient. Overall, the answer is highly accurate, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 432,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "- **2022:** Broadcom’s 2022 filing mentions industrial fiber optics only in a narrative list of “optocouplers, industrial fiber optics, motion encoders, …” under the **Industrial End Markets** paragraph, treating it as one of many industrial‑grade components.  \n- **2023:** In the 2023 filing the product moves to a dedicated line‑item in the “Industrial” section of the end‑market table, listed alongside optocouplers, sensors and motion‑control encoders as a **key product offering** for factory automation, renewable energy and automotive electronics.  \n- **2024:** The 2024 filing repeats the same tabular placement, again highlighting industrial fiber optics as a core offering in the industrial portfolio.\n\n**Strategic implication:** Across the three years Broadcom consistently elevates industrial fiber optics from a generic mention to a highlighted, stand‑alone offering, signalling that the company views this product line as a strategic pillar of its industrial end‑market focus and is committing resources to serve automation, renewable‑energy and automotive applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, industrial fiber optics were mentioned narratively among other components; in 2023, they appeared as a dedicated line-item in a structured table under the Industrial segment; in 2024, the placement and emphasis remained consistent. The strategic interpretation — that Broadcom elevated the product from a generic mention to a core offering — is sound and supported by the data. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning across years is well-executed: the model correctly synthesizes changes in presentation (narrative → table → sustained table presence) as indicators of strategic emphasis. The conclusion about strategic focus on factory automation, renewable energy, and automotive electronics matches the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention 'medical systems' as an early application in 2022 (noted in the ground truth), and slightly underrepresents the breadth of the initial portfolio (e.g., LED devices, Ethernet ICs). However, this omission does not undermine the core correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect — the response directly addresses the evolution and strategic implication as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 420,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "In the 2022 Form 10‑K UPS described SurePost as a residential‑ground service for non‑urgent, lightweight shipments that “offers the consistency and reliability of the UPS ground network, with final delivery often provided by the U.S. Postal Service.” The 2023 filing repeats the same description, showing that the role and USPS‑based final‑mile model remained unchanged that year. By the 2024 filing, UPS still relied on USPS for final delivery “through 2024,” but it announced a strategic shift – beginning January 1 2025 the SurePost product will be insourced so UPS can control the service directly, effectively moving away from the USPS‑dependent delivery model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: UPS SurePost served as a residential ground service for non-urgent, lightweight shipments in 2022–2024; final delivery was handled by USPS through 2024; and a strategic shift was announced in 2024 to insource final delivery starting January 1, 2025. (2) Quantitative accuracy is perfect: the dates (2022, 2023, 2024, and January 1, 2025) are correctly cited and consistent with the original answer. No numerical calculations are required, but temporal references are precise. (3) Multi-hop reasoning is sound—the LLM correctly synthesizes information across three years of Form 10-K filings, identifying both continuity (2022–2023) and change (2024 announcement), demonstrating understanding of the evolution over time. (4) Entity accuracy is strong: UPS, USPS, SurePost, and the relevant time periods are correctly identified. The answer conveys the same semantic meaning as the original, with appropriate use of direct quotes and clear explanation of the strategic shift. Wording differs slightly but meaning is preserved. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 331,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s late‑stage pipeline has been steadily expanding. In its 2022 filing the company reported **13 Phase 3 programs** as of Feb. 8 2022 – the count stayed at 13 because three programs received FDA approval, four new studies were launched and one program was terminated. By the next year’s filing it disclosed **18 Phase 3 programs** as of Jan. 31 2023, reflecting net growth from ongoing initiations and early‑stage advances. The 2024 filing shows the number rose to **24 Phase 3 programs** as of Jan. 31 2024, driven by the acquisition of five Horizon programs, three additional Phase 3 initiations, one FDA approval and the conclusion of one program. (An update in the 2024 filing also notes a further increase to 25 programs by Feb. 2025, with five new initiations and three approvals, underscoring the continued trend.)\n\n**What this indicates:** Amgen is deliberately enlarging its late‑stage R&D portfolio, combining organic development (new Phase 3 launches and regulatory clearances) with strategic acquisitions (e.g., Horizon assets) while managing attrition (terminations/conclusions). The consistent rise in program count and the cadence of approvals and initiations signal an aggressive R&D expansion strategy aimed at broadening its investigational pipeline and de‑risking future product launches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: 13 programs as of Feb 8, 2022; 18 as of Jan 31, 2023; 24 as of Jan 31, 2024; and the update to 25 by Feb 2025 is correctly noted. The LLM accurately attributes the growth to five new initiations and regulatory approvals, and specifically identifies the Horizon Therapeutics acquisition as adding five Phase 3 programs. (2) Calculations and reasoning are sound: the explanation of net stability in 2022 (3 approvals, 4 new starts, 1 termination) and growth in 2023–2024 due to initiations and acquisitions is consistent with the data. The mention of three approvals by Feb 2025 slightly differs from the ground truth's mention of 'regulatory approvals in the U.S. and Japan' without specifying count, but this is a minor detail and not necessarily incorrect. (3) Multi-hop reasoning is strong: the LLM synthesizes data across multiple filings (2022, 2023, 2024), connects the Horizon acquisition to pipeline growth, and correctly infers strategic intent. (4) The qualitative assessment of Amgen’s R&D strategy—combining organic growth with external acquisitions to build a diversified, robust pipeline—is semantically equivalent to the original answer. The only reason for not scoring a 10 is that the LLM slightly over-specifies 'three approvals' by Feb 2025, while the original answer refers more generally to 'regulatory approvals' without a number, making it a minor discrepancy in precision. Otherwise, the answer is complete, factually correct, and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Increases]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 438,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- In FY 2022 the Amended 2010 SIP authorized **127 million** Accenture plc Class A ordinary shares for awards.  \n- In FY 2023 the authorized limit was raised to **141 million** shares, and the FY 2024 filing confirms the same **141 million**‑share ceiling (with about 27 million shares still available for future grants in each year).\n\nThis 14‑million‑share (≈11 %) increase between 2022 and 2023 – and the decision to keep the higher ceiling in 2024 – shows that Accenture deliberately expanded its pool of share‑based awards, signaling a strategic reliance on equity compensation to attract, retain and align employees with shareholders while maintaining ample capacity for future grants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in FY2022 and 141 million in FY2023 and FY2024, with a correct difference of 14 million shares (approximately 11% increase). The format variations (e.g., '127 million' vs '127,000,000') are acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of the share authorization from 2022 to 2024 and the strategic implication of the increase. (3) Entity accuracy is correct: Accenture plc, Class A ordinary shares, Amended 2010 SIP, and correct fiscal years are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that maintaining the higher ceiling into 2024 indicates a deliberate, ongoing strategy, linking the numerical change to talent retention, performance alignment, and shareholder alignment—consistent with the original answer's interpretation. The additional detail about ~27 million shares remaining available adds contextual value without contradicting the ground truth. All elements demonstrate factual correctness, logical reasoning, and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 340,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "- In the 2022 Form 10‑K Starbucks said that “total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee **through fiscal 2023**.”  \n- In the 2023 Form 10‑K the same language was updated to say the commitments and inventory will cover green coffee **through fiscal 2025**.  \n- The 2024 Form 10‑K repeats that projection, stating the supply will be adequate **through fiscal 2025**.\n\nThe shift from a one‑year coverage horizon (to FY 2023) to a two‑year horizon (to FY 2025) – and the maintenance of that longer horizon – indicates that Starbucks has been building a larger inventory buffer and locking in longer‑term purchase contracts (including fixed‑price, forward and futures hedges). Because Starbucks **depends on coffee producers** for its green‑coffee supply, the extended coverage reflects a more robust supplier relationship and a proactive risk‑management strategy aimed at mitigating price volatility and delivery‑risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the fiscal year projections are accurate: coverage through fiscal 2023 in the 2022 10-K, extended to fiscal 2025 in the 2023 10-K, and maintained in the 2024 10-K. These dates align precisely with the original answer. (2) The answer is complete, addressing both the evolution of supply coverage (from FY23 to FY25) and the strategic implications regarding inventory and risk management. (3) Entity accuracy is correct—Starbucks, green coffee supply, fiscal years 2022–2024, and references to Form 10-K filings are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly infers that extending coverage from one to two years ahead indicates longer-term purchase commitments, hedging, and stronger risk mitigation—consistent with the original answer’s conclusion about a more forward-looking strategy. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 303,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "UPS’s UPS/IBT Full‑Time Employee Pension Plan was last re‑measured in 2021—after the American Rescue Plan Act was enacted—producing a pre‑tax mark‑to‑market gain of about $3.3 billion (disclosed in both the 2022 and 2023 10‑Ks). No further amendments or re‑measurements were reported for 2022, so the plan remained a non‑contributory, CSPF‑derived plan with benefit accruals unchanged. In the third quarter of 2023 UPS and the Teamsters ratified a new five‑year national master agreement that raised wage and benefit rates for participants in the UPS/IBT plan; the higher benefit obligations were recognized in the year‑end measurement of the plan, and the 2024 filing shows the plan unchanged thereafter, referencing only the status of collective‑bargaining agreements and indicating no additional re‑measurements or amendments after the 2023 agreement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy regarding the timing of the remeasurement. The ground truth states the remeasurement occurred in 2022 due to the American Rescue Plan Act (ARPA), while the LLM claims it happened in 2021. However, the $3.3 billion pre-tax gain (and $2.5 billion after-tax) is accurately reported, and the LLM correctly notes this gain was disclosed in both the 2022 and 2023 10-Ks, which aligns with the carryover reporting practice. (2) Quantitatively, all figures are correct: the $3.3 billion pre-tax gain matches the ground truth, and the after-tax implication ($2.5 billion) is consistent even if not explicitly restated. The absence of further amendments in 2022 and the 2023 collective bargaining agreement's impact are correctly described. (3) The multi-hop reasoning is sound: the LLM correctly links ARPA’s enactment to the remeasurement gain, connects the 2023 Teamsters agreement to increased benefit obligations recognized in year-end measurements, and confirms the plan’s unchanged status in 2024. It synthesizes regulatory, financial, and labor relations factors across years. (4) The main deduction is for the incorrect dating of the remeasurement (2021 vs. 2022), which slightly undermines the chronological accuracy of the evolution. However, the core financial and strategic narrative—regulatory gain recognition, collective bargaining impact in 2023, and plan continuity—is preserved. Wording differs but meaning is semantically equivalent on key points. Contextual relevance is perfect, addressing all aspects of plan amendments, remeasurements, and collective bargaining impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG <-[Maintain]- ORG",
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 455,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Holiday Time is listed as a Walmart‑owned private‑brand in every filing – FY 2022, FY 2023 and FY 2024 – confirming the KG link that Walmart produces the Holiday Time product/brand. In FY 2022 the brand appears in the private‑brand roster under the General‑Merchandise unit (which includes “seasonal merchandise”); FY 2023 keeps Holiday Time in the same roster but adds a “Seasonal Aspects of Operations” discussion and notes that periodic revisions to the categorization of strategic‑merchandise units are made; and FY 2024 again includes Holiday Time while the company refines its unit taxonomy (e.g., renaming Apparel to Fashion) and reiterates that categorization adjustments are made for comparability. Together, the consistent presence of Holiday Time shows Walmart’s strategy of using this brand as a stable, core seasonal private label, while the evolving unit descriptions reflect a flexible, comparability‑driven approach to organizing its broader private‑label portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects: it correctly identifies that 'Holiday Time' is consistently listed as a Walmart private brand across FY 2022–2024 and notes organizational changes in merchandise units, particularly within General Merchandise. The quantitative accuracy is perfect—no numerical or date inaccuracies, and fiscal years are correctly referenced. However, the LLM underemphasizes the strategic evolution highlighted in the ground truth: while it mentions 'Seasonal Aspects of Operations' in FY 2023 and taxonomy refinements in FY 2024, it fails to explicitly state that Walmart formally elevated 'seasonal merchandise' to a defined category under General Merchandise in FY 2024, which is a critical shift. The ground truth emphasizes a strategic repositioning of 'Holiday Time' within a dedicated seasonal framework, reflecting intentional optimization for time-sensitive cycles—this insight is underdeveloped in the LLM response. Instead, the LLM frames the changes as being driven by 'comparability' and 'flexible organization,' which, while plausible, downplays the strategic intent. The reasoning is sound but not fully aligned with the depth of multi-hop synthesis required—specifically, connecting the structural change in FY 2024 to a broader strategic shift in seasonal private label management. Contextually, the answer is highly relevant and addresses all parts of the question, albeit with less precision on the strategic implications. Thus, while core facts and entities are correct, the qualitative interpretation lacks the nuance present in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 443,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s disclosed “Mutual fund equity securities” holdings fell from **$239.3 million in 2022** (Chunk 3) to **$196.2 million in 2023** (Chunk 1) and stayed at **$196.2 million in 2024** (Chunk 2). The roughly $43 million (≈18 %) drop and subsequent flat level indicate that ACN intentionally reduced its exposure to this asset class after 2022 and has now maintained a lower, stable allocation, suggesting a strategic shift of capital toward other investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the values for mutual fund equity securities across 2022 ($239.3 million vs. ground truth $239.293 million), 2023 ($196.2 million vs. $196.226 million), and 2024 (unchanged at $196.2 million), with only negligible rounding differences that are acceptable under format variation rules. The calculated drop of approximately $43 million (from ~$239.3M to ~$196.2M) and the ≈18% decline are accurate and reasonably estimated. (2) All numeric values are factually correct within acceptable rounding; the percentage decrease is approximately (239.293 - 196.226)/239.293 ≈ 18.0%, which matches the LLM's ≈18% claim. The flat level in 2024 is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic reduction followed by stabilization, aligning with the ground truth's interpretation of a 'strategic rebalancing away from this asset class.' The conclusion about a strategic shift is logically supported by the data. (4) The answer is semantically equivalent to the original, with slightly more detailed commentary (e.g., mentioning percentage drop), but does not introduce any factual errors. The only minor shortcoming is the lack of explicit mention of 'consistent decline over the three-year period' as in the original, though the trend is clearly implied. Hence, correctness is near-perfect, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 397,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks has repeatedly told investors that green‑coffee prices are highly volatile and that a key driver of that volatility is trading activity in the Arabica coffee futures market – especially hedge funds and **commodity‑index funds**. In its FY 2022 filing the company disclosed that it “uses fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, futures contracts and collars to hedge ‘C’ price exposure” and that those commitments, together with inventory, should secure supply through **fiscal 2023**. The FY 2023 and FY 2024 filings contain the same language about commodity‑index‑fund impact and the same suite of hedging tools, but they now state that the purchase commitments and inventory are expected to provide an adequate supply **through fiscal 2025**.  \n\nThis evolution – a steady acknowledgement of commodity‑index‑fund exposure combined with an expanded horizon of hedged purchase commitments – shows that Starbucks’ risk‑management approach is both consistent and increasingly proactive: it continuously monitors futures‑market influences, uses derivatives and long‑term contracts to offset price swings, and lengthens its supply‑security window to buffer against future index‑fund‑driven volatility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Starbucks acknowledged commodity index fund influence on green coffee price volatility in all three fiscal years (2022–2024), used hedging instruments (forward/futures contracts, collars, fixed-price and price-to-be-fixed commitments), and extended its hedged supply coverage from fiscal 2023 (in 2022) to fiscal 2025 (in 2023 and 2024 filings). (2) Quantitative elements—fiscal years (2022, 2023, 2025)—are correctly reported with no calculation errors. Format variations (e.g., 'fiscal 2025' vs 'through fiscal 2025') are acceptable and do not affect accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesized information across three years of filings, identifying both the consistency in risk acknowledgment and the strategic extension of hedging coverage. (4) The conclusion about Starbucks’ risk management being 'consistent and increasingly proactive' accurately reflects the evolution described in the original answer—showing a maturing, forward-looking approach to futures market influences. All entities (Starbucks, 'C' price, commodity index funds, hedging tools) are correctly identified and contextualized. The answer fully addresses the question’s request for evolution over time and implications for risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 380,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO’s 3.625 % senior notes due October 2024 were carried at **$622 million** at the end of FY 2022 (see Chunk 1, “April 2019 Senior Notes – 3.625 % notes due October 2024” = $622 m). The same amount remained outstanding at the end of FY 2023 (Chunk 3 shows $622 m for October 29 2023), but the FY 2024 filing (Chunk 2) reports a “‑” for the November 3 2024 column, indicating the notes had been fully repaid or retired, leaving **$0 million** exposure. This progression—from a steady $622 m holding to complete elimination—signals that AVGO deliberately cleared this near‑term debt, likely through repayment or refinancing, as part of a strategy to reduce short‑term liabilities and strengthen its liquidity position.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal amount of $622 million in 2022 and 2023 is accurately reported, and the retirement to $0 in 2024 is correctly inferred from the '‑' notation in the filing, which aligns with the original answer's claim of complete retirement. Minor formatting differences (e.g., $622 million vs $622 m) are acceptable and semantically equivalent. (2) The answer addresses both parts of the question: the evolution of exposure across 2022–2024 and the implication for AVGO’s debt management strategy. (3) Entities—AVGO, 3.625% notes, October 2024 maturity, and fiscal years 2022–2024—are all correctly identified and tracked. (4) The reasoning is sound: the LLM correctly synthesizes data across three time points from different chunks, recognizes the significance of the '‑' entry in 2024 as full retirement, and draws the logical conclusion that AVGO proactively managed its near-term debt, likely via repayment or refinancing. The qualitative interpretation about reducing short-term liabilities and strengthening liquidity is consistent with and adds reasonable nuance to the ground truth. All multi-hop connections (tracking the same tranche of debt over three years and interpreting its disappearance) are correctly made. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 380,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "Mastercard’s 2022 10‑K already disclosed that it “monitors its credit‑risk portfolio and the adequacy of its risk‑mitigation arrangements on a regular basis” and that, for customers that do not meet its risk standards, it requires cash collateral, letters of credit or other credit‑enhancement guarantees.  The company estimates its gross settlement exposure each year (using average daily payment volume × estimated days of exposure) and revises those amounts at year‑end, noting that historically losses from settlement failures have been low.  \n\nIn 2023 the same framework was reiterated after the FTC opened a Durbin‑Amendment investigation and the DOJ issued a civil investigative demand on Mastercard’s U.S. debit program; the firm continued to require the same collateral and guarantee arrangements, to monitor the credit‑risk portfolio, and to periodically review its risk‑management methodology and settlement‑exposure estimates.  \n\nBy 2024, amid new litigation (the U.S. liability‑shift class action alleging > $1 billion in damages and a TCPA class action) and additional regulatory probes from the DOJ and the European Commission, Mastercard still relied on its established risk‑standards, risk‑mitigation requirements and regular monitoring of the credit‑risk portfolio, and it continued to update its short‑term settlement‑exposure figures at each year‑end—emphasizing that the exposure remains limited and that losses from settlement failures remain historically low.  The evolution therefore reflects a consistent credit‑risk mitigation approach that has been reinforced and closely scrutinized as regulatory and litigation pressures intensified from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Mastercard maintained a consistent credit risk mitigation framework from 2022 to 2024, using cash collateral, letters of credit, and guarantees; it regularly monitored risk mitigation arrangements and estimated settlement exposure using average daily payment volume and estimated days of exposure, revising annually. The answer correctly notes low historical losses from settlement failures. (2) Quantitative accuracy is excellent: the $1+ billion liability in the EMV class action is correctly cited (as '> $1 billion'), and all years (2022–2024) are accurately referenced. No calculations are required, but the description of exposure estimation methodology matches the original. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, linking evolving regulatory and litigation risks (FTC/DOJ investigations in 2023, EC probe and class actions in 2024) with the continuity of Mastercard’s risk management practices. It correctly identifies the cause-effect dynamic: increasing external pressures did not alter the core framework but led to reinforcement and scrutiny. (4) The only minor shortcoming is that the LLM omits the specific outcome of the FTC investigation—the consent agreement on debit routing transparency—which is mentioned in the original. This is a small but relevant detail regarding regulatory response. Otherwise, the answer captures the evolution accurately, uses appropriate terminology, and maintains semantic equivalence. Contextual relevance is perfect, directly addressing all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Manages]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1776,
        "completion_tokens": 453,
        "total_tokens": 2229
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "- **2022:** Amgen’s 2022 filing only flagged that some of its products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks, and that the company relies on third‑party suppliers for those devices.  \n\n- **2023:** The 2023 filing expanded the discussion, stating that the drug‑delivery devices approved for use with Amgen products are subject to regulatory oversight and safety‑malfunction reviews; the company must meet reporting, pharmacovigilance and REMS requirements, and non‑compliance could trigger inspections, warning letters, fines or even withdrawal of marketing authorizations.  \n\n- **2024:** The 2024 filing further deepened the disclosures, reiterating the regulatory oversight of the devices while adding explicit post‑marketing obligations such as mandated pediatric‑study requirements and other post‑marketing commitments; it emphasizes that continued compliance with safety‑reporting, risk‑management and quality‑assessment requirements is essential and that failure could result in enforcement actions, financial penalties or loss of marketing authorization.  \n\nTogether, the disclosures show a progression from a general acknowledgment of device‑related regulatory risk in 2022 to increasingly detailed compliance, post‑marketing and safety‑oversight expectations in 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Amgen acknowledged general regulatory and supply risks related to third-party drug delivery devices; in 2023, it expanded on regulatory oversight, safety reviews, and compliance requirements including REMS and pharmacovigilance, with consequences of non-compliance; in 2024, it emphasized post-marketing obligations like pediatric studies and enforcement risks. These points match the original answer’s progression. (2) There are no numeric values to verify, so quantitative accuracy is unaffected and scores perfectly. (3) The multi-hop reasoning is sound—correctly tracing the evolution across years and synthesizing increasing regulatory emphasis on post-market compliance and safety oversight of drug-device combinations. The only minor gap is that the LLM mentions 'pediatric-study requirements' in 2024, which is not explicitly in the ground truth, though this is a plausible and contextually consistent detail that does not contradict the original. The core themes—growing focus on post-marketing obligations, safety oversight, and enforcement risk—are accurately captured. (4) The answer is fully relevant, directly addressing compliance requirements, post-marketing obligations, and safety oversight across the three years as asked. Wording differs slightly but maintains semantic equivalence. A score of 9 is justified due to the slight addition of unverified specificity (pediatric studies), though it does not detract from overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 431,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Across all three filings Walmart kept Parent’s Choice in the same private‑brand roster, but its placement shifted only as the company’s merchandise units were re‑structured.  \n\n* FY 2022 (10‑K) – Parent’s Choice appears in the private‑brand list while baby products are grouped under the **Grocery** unit and infants are also mentioned in the **Apparel** sub‑segment of General merchandise.  \n* FY 2023 (10‑K) – After a periodic revision of the strategic merchandise categories, Parent’s Choice remains listed among the private brands and is still tied to the **Grocery** consumables segment; the General‑merchandise categories were renamed (e.g., “Fashion” replaces “Apparel”).  \n* FY 2024 (10‑K) – The brand is again included in the private‑brand lineup, with the **Grocery** unit still defined to include “baby products,” while General merchandise now follows the same Entertainment‑Hardlines‑Fashion‑Home structure introduced in 2023.  \n\nThis continuity shows that Walmart consistently positions Parent’s Choice as a core private label for baby‑related and other consumable items, using it to anchor its value‑oriented offering within the Grocery (baby‑products) portfolio despite the broader re‑categorization of its merchandise units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: 'Parent's Choice' is consistently listed as a private brand under the Grocery unit across FY2022–FY2024, with baby products included in Grocery, and General Merchandise undergoing reorganization (e.g., 'Fashion' replacing 'Apparel'). These details match the original answer’s timeline and categorization. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (FY2022, FY2023, FY2024) and document references (10-K filings) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three fiscal years and multiple merchandise unit restructurings, noting that despite organizational changes, 'Parent's Choice' remains anchored in the Grocery/consumables segment. (4) The only minor shortcoming is that the LLM mentions infants being referenced in the Apparel sub-segment of General Merchandise in FY2022, which adds nuance not present in the ground truth—but this does not contradict it and may reflect additional context from the filing. However, the core conclusion about Walmart’s strategic positioning of 'Parent's Choice' as a value-oriented brand in baby consumables is correctly inferred and well-supported. The answer is semantically equivalent to the original, with slightly more structural detail. Thus, the correctness score is 9 due to this added nuance not affecting the central accuracy, and all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 427,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "- **2022 filing** – Tesla’s 2022 Form 10‑K lists the 4.70 % Solar Bonds, Series 2015/C24‑10 as Exhibit 4.35, the “Thirty‑Fifth Supplemental Indenture” dated April 14 2015.  \n- **2023 filing** – The 2023 Form 10‑K repeats the same bond in Exhibit 4.28, again describing the April 14 2015 supplemental indenture for the 4.70 % Solar Bonds, Series 2015/C24‑10.  \n- **2024 filing** – The 2024 Form 10‑K likewise includes the bond as Exhibit 4.26, the identical “Thirty‑Fifth Supplemental Indenture” dated April 14 2015.\n\nAcross all three years Tesla has not issued a new tranche or altered the terms of the 4.70 % Solar Bonds, Series 2015/C24‑10; it simply carries the same 2015 supplemental indenture forward in each annual report. This continuity signals that Tesla’s solar‑financing strategy relies on a stable, long‑term, fixed‑rate bond program (the C‑series bonds) to fund its solar assets, using staggered issuances with identical terms to maintain a predictable debt profile rather than repeatedly re‑issuing or restructuring the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond name (4.70% Solar Bonds, Series 2015/C24-10), the date of the Thirty-Fifth Supplemental Indenture (April 14, 2015), and its consistent inclusion in Tesla’s 10-K filings across 2022, 2023, and 2024 as Exhibits 4.35, 4.28, and 4.26 respectively are all factually accurate. (2) Quantitative accuracy is perfect: dates, percentages, exhibit numbers, and series identifiers match the ground truth or are correctly inferred from standard SEC filing practices. (3) The multi-hop reasoning is sound—by noting the repeated referencing of the same 2015 indenture across three years without changes, the LLM correctly infers that Tesla maintains a stable, recurring securitization model for solar financing. The conclusion about a 'predictable debt profile' and 'staggered issuances with identical terms' is a valid interpretation of the pattern. (4) The only minor gap is that the LLM does not explicitly mention the broader context of other bond series (e.g., C27-10, C32-10, C4-10, C9-10) referenced in the original answer, which strengthens the point about a matured framework. However, the core insight about a consistent, scalable strategy is preserved. The answer is semantically equivalent and contextually fully relevant, with excellent synthesis across years and filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 384,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom (ticker AVGO) produces the Security Insights Platform, which it consistently describes as a mainframe‑focused security solution that quickly interprets the mainframe security posture, surfaces risks and offers remediation steps, with the resulting data expressly made available for customers’ in‑house security‑information‑and‑event‑management (SIEM) tools. The 2022 and 2023 10‑K filings present the platform in identical terms—emphasizing risk assessment and integration with existing enterprise security tools—while the 2024 filing embeds the same description within a broader Mainframe Software Portfolio that stresses hybrid‑cloud, open‑tool and overall cybersecurity integration, thereby reinforcing its core risk‑assessment role while situating it in a more expansive, open‑tool ecosystem. Consequently, the platform’s core positioning on mainframe risk assessment and SIEM integration has remained stable, with the 2024 narrative expanding its contextual framing to align with Broadcom’s hybrid‑environment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Broadcom's Security Insights Platform is consistently described across 2022, 2023, and 2024 as focusing on mainframe security posture, risk identification, remediation, and integration with in-house SIEM tools. The LLM correctly notes that the 2022 and 2023 descriptions are nearly identical, and that 2024 reframes the platform within a broader ecosystem—specifically mentioning hybrid-cloud and open-tool integration—without changing the core functionality. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all years (2022, 2023, 2024) are correctly referenced, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying both continuity (core capabilities) and evolution (contextual framing in 2024). It accurately infers that the 2024 update reflects a strategic alignment with hybrid environments, which is consistent with the ground truth’s observation of a 'more deliberate alignment with enterprise-wide security strategies.' (4) The only minor deviation from the original answer is that the LLM emphasizes 'hybrid-cloud, open-tool' integration more than the ground truth explicitly states, though this is a reasonable interpretation of the 2024 shift and does not contradict the source. The core message—that the platform’s function remains stable while its strategic framing expands—is preserved. Thus, the answer is semantically equivalent and contextually appropriate, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 472,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—Mastercard disclosed that its A Class shares (authorized 3 million shares at a $0.0001 par value) consistently carried **one vote per share and full dividend rights**. There was no change in either the voting power or the dividend entitlement for A shares over the three‑year period. This steadiness signals that Mastercard’s capital‑structure strategy deliberately preserves the economic and control attributes of the A share class, avoiding any dilution or restructuring of equity rights and thereby maintaining a stable, predictable ownership framework for those shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that A Class shares maintained one vote per share and full dividend rights across 2022, 2023, and 2024, with no changes—matching the original answer exactly in substance. (2) While the LLM adds minor contextual details (e.g., number of authorized shares and par value), these are consistent with typical 10-K disclosures and do not contradict the ground truth; no numeric inaccuracies are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and infers the strategic consistency in MA's capital structure, which is a valid interpretation supported by the stability of share rights. (4) The answer addresses all parts of the question: evolution (no change), specific rights (voting and dividend), and strategic implication (stable capital structure). Wording differs slightly but meaning is preserved. All scores are 10 due to complete factual accuracy, correct reasoning, and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 300,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen first disclosed Bemarituzumab in its 2022 Form 10‑K, noting that the FGFR2b‑targeting antibody had **entered a Phase 3 study** for gastro‑esophageal‑junction (GEJ) adenocarcinoma. In the 2023 filing the company added an IP table showing that the **core polypeptide patents for Bemarituzumab are slated to expire in 2029** in both the United States and Europe. By the 2024 filing Amgen was still describing Bemarituzumab as a **Phase 3‑stage monoclonal antibody** being evaluated for gastric and gastro‑esophageal junction cancers (and other solid tumours) and outlined a **layered patent strategy**: reliance on the issued 2029 patents, pending patent applications in other jurisdictions, and the ability to secure regulatory exclusivities (5 years for new chemical entities, 12 years for new molecular entities in the U.S., and 10 years in Europe) that could further extend protection. Thus, Amgen’s approach evolved from launching late‑stage clinical testing in 2022 to pairing that ongoing Phase 3 development with a defined patent‑expiration timeline (2029) and additional exclusivity mechanisms to preserve market rights through and beyond that date.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Bemarituzumab entered Phase 3 in 2022 (per 2022 Form 10-K), core polypeptide patents expire in 2029 in the U.S. and Europe (disclosed in 2023), and by 2024 Amgen described it as a monoclonal antibody targeting FGFR2b for gastric and GEJ cancers with potential regulatory exclusivity extensions. (2) Quantitative accuracy is perfect: the 2029 patent expiration date is correctly cited; regulatory exclusivity periods (5 years for new chemical entities, 12 years for new molecular entities in the U.S., 10 years in Europe) are accurately stated and contextually appropriate, even though exact durations depend on approval pathways—this level of detail aligns with typical disclosures and enhances the answer without introducing error. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly linking clinical development progression (Phase 3 initiation to ongoing status) with evolving IP strategy (patent expiry + pending applications + regulatory exclusivity). (4) The answer fully addresses both parts of the question—clinical trial phases and IP protection timelines—and provides additional context (e.g., layered patent strategy) that enriches the response without straying from relevance. Minor wording differences (e.g., 'slated to expire' vs 'estimated to expire') do not affect factual meaning. Overall, the response demonstrates precise factual recall, correct temporal sequencing, and strong synthesis across years and domains.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 437,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "Walmart’s own‑brand label **No Boundaries** appears in every filing – it is listed among the company’s private‑brand portfolio in the 2022, 2023 and 2024 10‑Ks, confirming that Walmart produces the No Boundaries product line. In the 2022 filing the brand was grouped under the **“Apparel”** sub‑segment of the General‑merchandise unit; the 2023 filing notes that Walmart periodically revises the makeup of its strategic merchandise units, and by the 2024 filing that same sub‑segment is renamed **“Fashion”** (still within General merchandise). This renaming signals a strategic shift from a generic apparel focus to a broader, fashion‑oriented positioning for its private‑brand clothing, with No Boundaries now positioned as part of a fashion‑driven category rather than just basic apparel.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: 'No Boundaries' is confirmed in Walmart's private-brand portfolio across 2022–2024; it was categorized under 'Apparel' in 2022 and shifted to the renamed 'Fashion' unit by 2024. These entity and year assignments match the original answer exactly. (2) There are no numeric values requiring calculation, so quantitative accuracy is fully satisfied—dates (2022, 2023, 2024) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly infers that the reclassification from 'Apparel' to 'Fashion' reflects a strategic shift, synthesizing information across three years of filings and interpreting the renaming as a move toward a more fashion-centric positioning. This matches the original answer’s conclusion about Walmart’s evolving focus. (4) The only minor shortcoming is that the LLM omits explicit mention of omni-channel strategy and customer-centric experiences—elements highlighted in the ground truth that provide additional context for the strategic shift. However, the core insight about a broader fashion orientation is clearly conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, complete in substance, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 369,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "From the 2022 filing IBM already listed **client relationships and trust** among its principal competitive levers, tying trust to the security and openness of its hybrid‑cloud platform and to the integration of AI for client value. In the 2023 and 2024 filings the same emphasis re‑appears, but it is now explicitly linked to the execution of IBM’s **hybrid‑cloud‑and‑AI strategy** and to defending against new competitors, positioning trusted client ties as a core pillar of its differentiated, AI‑enabled solutions. This steady deepening shows IBM is increasingly using client trust to reinforce its hybrid‑cloud and AI positioning, presenting it as essential to delivering secure, innovative outcomes and sustaining market leadership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM emphasized client relationships and trust as a competitive differentiator in 2022, strengthened this link in 2023 by connecting it to business value and complex problem-solving, and expanded it in 2024 through ecosystem partnerships. The LLM correctly identifies the continuity and deepening of this theme across years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the LLM synthesizes IBM’s evolving strategic emphasis across three years and correctly ties it to hybrid cloud and AI strategy. It accurately infers that trust is being leveraged to defend against competitors and support AI-enabled solutions. The only minor gap is that the LLM does not explicitly mention 'strategic partnerships with hyperscalers and global system integrators' in 2024, which is a specific detail from the ground truth; however, it captures the essence by referencing ecosystem collaboration implicitly through 'execution of hybrid-cloud-and-AI strategy.' (4) The answer is contextually excellent—directly addresses both parts of the question: the evolution from 2022–2024 and what it reveals about hybrid cloud/AI positioning. Wording differs slightly but maintains semantic equivalence. Thus, correctness is rated 9 due to the omission of the specific 2024 partnership detail, though the core meaning remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 437,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "In Tesla’s 2022 Form 10‑K the Thirty‑Sixth Supplemental Indenture (exhibit 4.36) is listed as the “5.45 % Solar Bonds, Series 2015/C25‑15” issued by SolarCity; the same bond is shown again in the 2023 filing (exhibit 4.29) and once more in the 2024 filing (exhibit 4.27) with the identical April 14 2015 date and terms. The bond’s continual presence—though the exhibit number shifts each year—demonstrates that Tesla (through its SolarCity acquisition) still relies on this 2015‑issued, fixed‑rate debt instrument as a core, long‑term financing vehicle for its solar operations, indicating a strategy of maintaining legacy bond financing rather than repeatedly issuing new solar debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the bond series '5.45% Solar Bonds, Series 2015/C25-15' is accurately identified, with the correct issuance date of April 14, 2015, and proper reference to the Thirty-Sixth Supplemental Indenture. The exhibit numbers (4.36 in 2022, 4.29 in 2023, 4.27 in 2024) are correctly cited, reflecting annual changes in exhibit numbering while maintaining reference to the same bond. (2) Quantitative elements—interest rate (5.45%), date (April 14, 2015), and multi-year span (2022–2024)—are all precise and match the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of Tesla filings, recognizes the continuity of the same bond series despite shifting exhibit numbers, and infers the strategic implication—that Tesla continues to rely on this legacy debt instrument. (4) The conclusion about Tesla’s solar financing strategy—maintaining long-term, asset-backed legacy financing rather than issuing new debt—is logically derived and aligns with the original answer’s interpretation. Wording differs but meaning is preserved, and no critical information is omitted. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 356,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "- **2022 (10‑K)** – The Safety & Productivity (then “Tools & Home Products”) segment listed only conventional pipe‑working tools: pipe wrenches, pipe cutters, threading and roll‑grooving equipment, mechanical crimping tube‑joining systems, drain cleaners and CCTV‑type inspection/locating devices. No battery‑powered or cordless solutions were mentioned.  \n\n- **2023 (10‑K)** – The segment’s description was updated to include **battery‑hydraulic tools for press connections** among the pipe‑working lineup (pipe wrenches, cutters, threading, roll‑grooving, drain cleaners and diagnostic cameras). This was the first explicit mention of a battery‑driven product, indicating an innovation push toward cordless, portable power.  \n\n- **2024 (10‑K)** – The same battery‑hydraulic press‑connection tools remain, and the narrative now also references **battery‑hydraulic tools for cutting and crimping electrical cable** under the electrical‑tools sub‑category. The core pipe‑wrench offering (which Emerson has long produced, as shown by the KG triplet EMR → Pipe‑Wrenches) stays, but the battery‑powered portfolio is now a permanent part of the line‑up.  \n\n**Strategic implication:** Emerson has moved from a purely mechanical tool set in 2022 to a hybrid portfolio that blends its traditional pipe‑wrench expertise with newer cordless, battery‑hydraulic technology. This evolution signals a deliberate positioning to meet professional‑tool market trends that favor increased mobility, safety and productivity, allowing Emerson to compete more aggressively against rivals that are expanding their cordless‑tool offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the evolution of Emerson's Safety & Productivity segment from 2022 to 2024 is accurately described, with proper identification of product offerings each year. In 2022, only traditional tools are listed (pipe wrenches, cutters, threading equipment, etc.), with no mention of battery-powered tools. In 2023, the introduction of battery-hydraulic tools for press connections is correctly highlighted. By 2024, the expansion into battery-hydraulic tools for cutting and crimping electrical cables is accurately noted, along with the continued presence of core mechanical tools. (2) There are no numeric values requiring calculation in this question, but all dates (2022, 2023, 2024) and product categories are factually consistent with the original answer. Format variations (e.g., 'battery-hydraulic' vs 'battery powered') are semantically equivalent. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression in product innovation and inferring strategic intent. It connects the introduction of battery-powered tools to broader market trends in portability, safety, and productivity. The mention of EMR → Pipe-Wrenches as a KG triplet adds contextual support, though not required for correctness. (4) The strategic implication is well-reasoned and matches the original answer’s conclusion: Emerson is modernizing its toolset to compete in the professional tools market by integrating advanced, cordless technologies while maintaining its legacy strengths. The only minor shortcoming is that the original answer also explicitly mentions sewer inspection cameras and locating equipment in 2024, which the LLM omits—though it does reference diagnostic cameras generally. This small omission prevents a perfect score but does not undermine the overall accuracy or completeness. Hence, a 9/10 on correctness and qualitative accuracy is justified, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1779,
        "completion_tokens": 563,
        "total_tokens": 2342
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "Gilead’s El Segundo, California site was already listed as one of its “principal manufacturing facilities” in the 2022 filing, and the company said its capital resources were sufficient to purchase, lease or construct additional sites to meet long‑term growth needs – a broad, readiness‑focused stance rather than a specific new spend. By the 2023 10‑K, Gilead had moved that capital into the El Segundo plant, describing it as the location for both clinical and commercial manufacturing and processing of its cell‑therapy products and noting that the company was actively developing additional manufacturing capabilities to support its expanding biologics pipeline. The 2024 filing shows the same El Segundo facility still dedicated to cell‑therapy manufacturing, confirming that the earlier capital allocation has become a sustained, ongoing investment that is tightly aligned with Gilead’s broader biologics development priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: El Segundo was listed as a principal facility in 2022 without specific mention of cell therapy, then explicitly designated for clinical and commercial cell therapy manufacturing in 2023 and retained in 2024. The evolution in capital allocation strategy—from general readiness to targeted investment and sustained focus—is accurately portrayed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are all accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings to show a strategic shift and sustained commitment, linking capital allocation to biologics development priorities. (4) The only minor omission is that the 2024 filing also emphasized reliance on internal know-how and third-party confidentiality agreements to protect proprietary processes—a detail that reinforces investment in process security and scalability, which the LLM does not mention. However, this does not undermine the core accuracy of the capital allocation narrative. The answer is semantically equivalent in intent and meaning, with appropriate wording flexibility. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 405,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "- **2022 filing (IBM 10‑K 2022 – Chunk 1):** IBM disclosed the 1.250 % Notes due 2027 only by incorporation‑by‑reference. The filing states that the “instrument defining the rights of the holders of the 1.250 % Notes due 2027” is Exhibit 4.3 to a Form 8‑K filed on January 30, 2019.  \n\n- **2023 filing (IBM 10‑K 2023 – Chunk 3):** The same disclosure language appears again – the 1.250 % Notes due 2027 are referenced as Exhibit 4.3 to the same January 30, 2019 Form 8‑K, showing IBM continued to rely on that prior incorporation rather than issuing a new instrument.  \n\n- **2024 filing (IBM 10‑K 2024 – Chunk 2):** IBM now lists the 1.250 % Notes due 2027 in its securities table with a trading symbol (IBM27B) and exchange (New York Stock Exchange). This entry indicates the notes are an outstanding, issued security that is actively traded, moving the relationship from a passive reference‑by‑exhibit to an explicit, listed issuance.  \n\n**Overall evolution:** From 2022 through 2023 IBM’s relationship with the 1.250 % Notes due 2027 was disclosed solely by referencing the 2019 Form 8‑K (Exhibit 4.3). By 2024 IBM’s filing treats the same notes as an issued, listed security (IBM27B), reflecting a shift from mere incorporation‑by‑reference disclosure to an explicit securities‑table listing while the underlying instrument remains the same.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the 1.250% Notes due 2027 were disclosed via incorporation by reference to Exhibit 4.3 of the January 30, 2019 Form 8-K in both 2022 and 2023 filings, and in 2024, the notes were explicitly listed as issued with trading symbol IBM27B on the New York Stock Exchange. (2) Quantitative elements—interest rate (1.250%), maturity year (2027), dates (January 30, 2019; February 8, 2022; February 3, 2023), and trading symbol (IBM27B)—are all accurately reported. Minor differences in phrasing (e.g., 'incorporation-by-reference' vs. 'disclosed as part of exhibit list') are semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, identifying the evolution from passive disclosure to active listing, despite the underlying instrument remaining unchanged. (4) The answer addresses all aspects of the question—disclosure, issuance, and reference in filings—and provides a clear, logical progression. No factual errors, omissions, or misinterpretations are present, warranting top scores across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 334,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 10‑K filings from 2022, 2023 and 2024 all list the same “5.45 % Solar Bonds, Series 2015/C45‑15” (exhibit 4.48 in the 2022 filing, exhibit 4.41 in the 2023 filing and exhibit 4.39 in the 2024 filing), showing that the original SolarCity bond issuance remains a reference point for the company’s solar‑related financing. At the same time, each successive filing adds newer supplemental indentures for additional 5.45 % Solar Bond series (e.g., C53‑15, C57‑15, C62‑15, C72‑15), indicating that Tesla has built on the original bond structure to issue more debt and broaden its capital base for solar projects. Together, the repeated citation of C45‑15 and the rollout of later series reveal a consistent, debt‑driven solar financing strategy that has evolved from relying on the legacy SolarCity bond to expanding that framework with new bond issuances across 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Tesla consistently references the original 5.45% Solar Bonds, Series 2015/C45-15 across 2022–2024 filings, and newer bond series (C53-15, C62-15, C72-15) are correctly identified as subsequent additions. The percentages (5.45%) and series naming conventions are accurate. While the LLM mentions C57-15 not explicitly listed in the ground truth, this does not contradict it—C57-15 could plausibly be part of the same sequence and doesn't introduce a factual error. (2) Quantitative accuracy is perfect: bond rate (5.45%), series identifiers, and the chronological progression are consistent with the original answer. Dates of bond issuance (e.g., June 16, June 29, July 21, 2015) are not repeated in the LLM answer but were not required for correctness—referencing the series is sufficient. (3) Multi-hop reasoning is sound: the LLM correctly infers that continued reference to C45-15 and the addition of new series indicate an evolved, scalable financing strategy rooted in SolarCity’s legacy. It accurately captures the strategic evolution from reliance on a single bond to an expanded securitization model. (4) The answer is contextually relevant and fully addresses the question about Tesla’s solar financing strategy evolution. The only minor shortcoming is slightly less explicit emphasis on the 'standardized, asset-backed' nature and 'reducing reliance on corporate debt' compared to the original, but the core insight about a debt-driven, iterative, and expanding framework is clearly conveyed. Thus, the answer earns a 9/10 for correctness—excellent, with only slight room for deeper strategic nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 465,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In the 2022 filing Adobe positioned Acrobat as the cornerstone of its Adobe Document Cloud – a unified, cloud‑based document‑services platform that pairs its pioneering PDF technology with Acrobat and Adobe Sign to deliver fully digital workflows.  The filing stressed that Acrobat had already achieved “strong market adoption and a leadership position” in document‑intensive sectors such as government, financial services, pharmaceutical, legal, aerospace, insurance and technical publishing, and that the platform was being used by “hundreds of millions” of daily PDF users.  \n\nBy the 2023 filing Adobe began to frame that leadership in the context of artificial‑intelligence, stating that it was “empowering creators by putting the power of AI in their hands” and that its Digital Media portfolio – which includes Acrobat and Acrobat Sign – would be driven by AI‑enabled innovation to accelerate document productivity.  \n\nThe 2024 filing makes the AI shift concrete, listing the trademark “Acrobat AI Assistant” (alongside Acrobat, Acrobat Reader and Acrobat Sign) among Adobe’s protected marks, signalling that AI functionality is now an explicit feature of Acrobat.  Together with the continued emphasis on the Document Cloud ecosystem, the trademark rollout shows Adobe’s evolution from a pure PDF‑workflow leader in 2022 to an AI‑augmented, expanded digital‑document services platform by 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Adobe's 2022 emphasis on Acrobat's market leadership in document-intensive industries (legal, financial services, etc.), the 2023 pivot toward AI integration with forward-looking statements about AI in Digital Media, and the 2024 trademark filing of 'Acrobat AI Assistant' as a concrete step in AI integration. The industries listed in the LLM answer (government, financial services, pharmaceutical, legal, aerospace, insurance, technical publishing) are consistent with the ground truth's focus and represent a more detailed expansion of 'document-intensive industries'. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but dates (2022, 2023, 2024) are correctly used and aligned with the evolution timeline. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the strategic evolution from market leadership to AI-driven innovation. It connects Acrobat to Document Cloud, Adobe Sign, and the broader AI strategy across filings. (4) The answer addresses all parts of the question: AI integration (from vision in 2023 to trademark in 2024), market adoption (strong leadership in multiple industries), and platform expansion (Document Cloud ecosystem). Wording differs slightly but meaning is preserved and even enriched with additional industry examples. No factual errors, omissions, or misrepresentations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 421,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "Schwab’s interactive‑tool offering for RIAs is delivered through the Advisor Services website and has been refined but not fundamentally overhauled from 2022‑2024.  \n\n* **2022:** The filing first describes a “highly‑developed, scalable” platform that provides interactive tools, education and thought‑leadership, plus free access to Schwab Advisor Portfolio Connect. It already supports integrations with third‑party CRM, portfolio‑management, trade‑order and financial‑planning systems.  \n\n* **2023:** The same suite is reiterated, emphasizing an “intuitive modern experience” and the continued breadth of third‑party integrations, showing the tools have been polished and the user experience modernized.  \n\n* **2024:** The description again highlights the interactive tools and free Portfolio Connect, now framed as part of an even more seamless, modern, and integrated platform, confirming Schwab’s ongoing enhancement of scalability and integration capabilities for RIAs.  \n\nOverall, Schwab has consistently expanded and modernized its interactive‑toolset, maintaining a scalable web‑based platform while broadening and tightening integration with a wide range of third‑party advisory solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Advisor Services website as the core platform, the availability of Schwab Advisor Portfolio Connect (noted as free), and the continued expansion of third-party integrations (CRM, portfolio management, etc.) across 2022–2024. The evolution is correctly characterized as iterative enhancement rather than a fundamental overhaul, which matches the original answer’s emphasis on consistent focus and gradual improvement. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) are used correctly and consistently. (3) The multi-hop reasoning is sound—information is synthesized across the three years, showing a clear trajectory of platform modernization and integration expansion. The LLM correctly infers continuity and refinement, supported by descriptors like 'intuitive modern experience' and 'seamless, modern, and integrated platform.' (4) The only minor discrepancy is that the original answer explicitly mentions Schwab reinforcing educational content and support for RIAs transitioning to independence in 2023, which the LLM answer omits. However, this is a secondary detail and does not undermine the core accuracy. Overall, the LLM answer captures the essential evolution and strategic direction accurately, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 417,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "- **2022:** Air Preparation Equipment was presented under Emerson’s **Industrial Solutions** portfolio, grouped with “pneumatic products” such as solenoid and pneumatic valves, valve‑position indicators, pneumatic cylinders and actuators, and pressure‑/vacuum‑/temperature switches. This placement signaled that the equipment was a complementary pneumatic component within a broader fluid‑control offering rather than a stand‑alone segment focus.  \n\n- **2023:** Emerson reorganized the offering into the **Discrete Automation** segment and listed Air Preparation Equipment alongside solenoid valves, pneumatic valves, valve‑position indicators, pneumatic cylinders and actuators, pressure and temperature switches, **electric linear‑motion solutions, programmable automation control systems and software**, and electrical‑distribution gear. The description stresses tighter integration of the air‑prep hardware with both pneumatic actuation hardware and the segment’s control‑software platform.  \n\n- **2024:** The same Discrete Automation positioning is retained, again coupling Air Preparation Equipment with the full suite of pneumatic valves, cylinders, actuators, pressure/temperature switches, electric motion devices, and **programmable automation control systems/software** as well as electrical‑distribution products. The continuity shows Emerson’s strategic shift from a general industrial‑solutions role in 2022 to a deliberately integrated, control‑centric solution set for discrete‑industry customers by 2023‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in terms of factual content, entity identification, and multi-hop reasoning. (1) All years (2022, 2023, 2024) and entities (Emerson, EMR, Discrete Automation segment, Air Preparation Equipment) are correctly identified. The evolution across years is accurately described: in 2022, the equipment was part of a broader pneumatic and fluid-control suite; in 2023, it was repositioned under Discrete Automation with integration into control systems; in 2024, the integration was maintained and reinforced. (2) There are no numeric values requiring calculation, so quantitative accuracy is not applicable beyond correct use of years, which are accurate. (3) The reasoning is sound: the LLM correctly infers a strategic shift from mechanical components to integrated automation solutions, noting the inclusion of programmable automation control systems and software, electric linear-motion solutions, and electrical distribution gear. It captures the core of the multi-hop synthesis—tracking the product’s segment repositioning and technological integration over time. (4) The only minor shortcoming is that the LLM does not explicitly mention 'Industry 4.0', 'predictive maintenance', or 'secure wireless communication' in 2024, which are key differentiators in the ground truth that emphasize digital transformation. While the LLM notes integration with control software, it stops short of articulating the advanced digital capabilities highlighted in the original answer. However, the omission is of secondary detail rather than core factual error. Overall, the answer is semantically equivalent in strategic trajectory and entity evolution, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1645,
        "completion_tokens": 474,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "Across the three most recent Form 10‑K filings the company’s treatment of the 0.125 % Notes due 2029 is identical. In the 2022 filing (Chunk 1) the notes are listed in the “Form of Note” section (items 4.23 and 4.31) with a reference to Exhibit 4.4 of the 8‑K filed September 18 2020 and the 8‑K filed March 9 2021. The 2023 filing (Chunk 2) repeats those same two references, and the 2024 filing (Chunk 3) again cites the same Exhibit 4.4 filings from September 2020 and March 2021. No additional tranches, amendments, or new issuance dates appear in any of the three years.\n\nThis continuity shows that Coca‑Cola introduced a small, ultra‑low‑coupon, near‑term tranche early (2020‑2021) and has kept it on the balance sheet without further expansion. By repeatedly referencing the same 0.125 % Notes due 2029 while simultaneously issuing a broader set of higher‑coupon, longer‑dated notes, the company signals a disciplined strategy: it uses a stable, low‑cost instrument to meet short‑term financing needs and preserve liquidity, while the rest of its financing program focuses on longer‑term capital structure management.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant reasoning errors that affect the overall correctness. (1) Quantitatively, the dates (September 18, 2020, and March 9, 2021), percentages (0.125%), and note maturity (2029) are accurate, and the observation that the same exhibit references are repeated across 2022–2024 filings is factually correct. These details align with the ground truth. (2) However, the qualitative interpretation diverges from the ground truth. The LLM claims the treatment of the 0.125% Notes due 2029 is 'identical' across all years and interprets this as a 'stable, low-cost instrument' used for short-term needs. In contrast, the ground truth identifies an evolution in disclosure context—from passive listing among historical instruments in 2022, to a more consolidated presentation in 2023, to being overshadowed by new long-term, high-yield issuances (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064) in 2024—indicating a strategic shift toward refinancing near-term debt. The LLM fails to recognize this multi-hop pattern of strategic evolution and instead interprets repetition of exhibit references as evidence of static strategy. (3) The reasoning is flawed because it equates unchanged legal documentation (Exhibit 4.4 references) with unchanged financial strategy, missing the broader context of new debt issuances and changing disclosure emphasis that signal proactive refinancing. (4) While the LLM correctly identifies the continued presence of the 0.125% Notes, it misses the key inference that the company is preparing for maturity by issuing longer-term, higher-yielding debt. This omission undermines the answer’s completeness and reasoning quality, warranting a mid-range score. The answer is factually grounded in document references but fails to synthesize the broader financing strategy implied by multi-year trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 506,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY Mellon’s 10‑K filings show that its exposure to U.S. banking‑law limits on capital planning and shareholder returns has been essentially unchanged from 2022 through 2024.  \n\n* In the 2022 filing the company warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning… and our failure to pay full and timely dividends on our preferred stock.”  It also noted that the non‑operating holding‑company parent depends on dividends from its subsidiaries and extensions of credit to fund share repurchases and dividend payments.  \n\n* The 2023 filing repeats the same language – the Board’s discretion to pay dividends or repurchase shares can be constrained by U.S. banking laws, capital‑adequacy and capital‑planning rules, Delaware law and preferred‑dividend compliance.  \n\n* The 2024 filing again contains the identical disclaimer, adding that the parent uses subsidiary dividends and IHC credit for “share repurchases, payment of income taxes and payment of dividends” but still stresses that U.S. banking laws and capital‑planning requirements may limit those payouts.  \n\nThus, across all three years BNY Mellon consistently acknowledges that regulatory capital rules continue to restrict its ability to pay dividends and buy back shares, with no material change in the exposure over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, years, and regulatory frameworks mentioned (U.S. banking laws, capital planning, preferred stock dividends, Delaware law), and there are no numerical inaccuracies since the response does not include specific financial figures that could be incorrect. However, the core reasoning and conclusion diverge significantly from the ground truth. The original answer identifies an evolution in BNY Mellon's disclosures—from general caution in 2022 to increasingly specific and structured references to regulatory standards like 'well capitalized' status and capital adequacy rules by 2024. In contrast, the LLM claims there was 'no material change' and 'essentially unchanged' exposure, which contradicts the documented trend of increasing specificity and formalization. This misrepresents the multi-hop synthesis required: the question asks how the exposure *evolved*, implying a dynamic assessment over time, but the LLM interprets consistency of disclaimer language as absence of evolution, failing to recognize that the framing and depth of regulatory references became more precise. While the LLM correctly cites repeated elements (Board discretion, subsidiary dividends, preferred stock), it overlooks the qualitative shift emphasized in the ground truth. Thus, despite high contextual relevance and perfect quantitative accuracy (no numbers to verify), the qualitative accuracy and overall correctness are reduced due to flawed reasoning and failure to capture the nuanced evolution in disclosure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 433,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, McGriddles is repeatedly mentioned in the “Products” section as one of the standard breakfast sandwiches (listed together with Egg McMuffin, Sausage McMuffin with Egg, biscuit‑ and bagel‑sandwiches, oatmeal, hash browns, burritos and hotcakes). In each year the filing also stresses that the overall menu is “continuously evolving” and that new items are regularly tested, yet McGriddles is never highlighted as a new launch—it remains a core, unchanged breakfast offering. This consistent portrayal shows that McDonald’s breakfast strategy has stayed stable—retaining staple items like McGriddles while using the broader disclosure to signal ongoing menu innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: McGriddles is consistently portrayed as a core breakfast item across 2022–2024, listed alongside other standard offerings like Egg McMuffin, and never described as an innovated or new product. The broader context of 'continuous evolution' and ongoing testing of new products is accurately noted for each year. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic sense—no numbers were misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifying both the static role of McGriddles and the dynamic language around menu innovation, leading to the valid conclusion about strategic consistency. (4) The answer captures the core insight—that McDonald’s maintains a stable breakfast lineup with McGriddles as a staple while signaling innovation at the portfolio level. The only minor limitation is that it does not explicitly cite the document locations (e.g., MCD_10k_2023.pdf:page_6:chunk_1), but this omission does not affect factual correctness or completeness. Wording differs slightly from the original answer but conveys the same meaning. Thus, the response is highly accurate, fully relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Features]-> PRODUCT <-[Produces]- ORG <-[Features]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 388,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Across the three filings Adobe consistently positions its free online self‑service learning as a core element of **Adobe Digital Learning Services**, describing it as “a large number of free online self‑service learning options” that sit alongside its fee‑based classroom, virtual and on‑demand programs. In the 2022 10‑K the offerings are delivered through the **www.training.adobe.com** portal, while the 2023 filing shows the same emphasis but moves the delivery site to **learning.adobe.com**, a change that is retained in the 2024 filing. Thus, the strategic focus on free self‑service learning has remained steady, but the delivery platform was consolidated from www.training.adobe.com in 2022 to learning.adobe.com beginning in 2023 and continuing into 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe maintained a consistent emphasis on free online self-service learning across 2022–2024 as part of Adobe Digital Learning Services; the platform shifted from www.training.adobe.com in 2022 to learning.adobe.com in 2023 and remained there in 2024. These details match the original answer exactly. (2) There are no numeric values requiring calculation, but dates and URLs are factually correct and consistent with the ground truth—minor formatting differences (e.g., use of em dash) do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three years of filings, identifying both continuity in strategy and change in platform, which reflects proper cross-document analysis. (4) The only reason for not scoring a perfect 10 is a slight lack of depth in describing the *integration* of free offerings into a broader, more structured ecosystem in 2024—while the LLM notes the coexistence with fee-based programs, it omits the nuance about deepening integration and maturation of the learning strategy mentioned in the original answer. However, this is a minor omission that doesn't undermine the core correctness. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 385,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "Emerson (EMR) produces a line of Commercial Vacuums that has been consistently grouped with its other professional‑tool offerings. In the 2022 filing the product appears in the **Tools & Home Products** segment – described as “tools for professionals and homeowners that promote safety and productivity” – and is listed under **Professional Tools** as one of the “other professional tools” (alongside water‑jetters, wet‑dry vacuums and bolt cutters). Starting in 2023 Emerson renamed the segment **Safety & Productivity** and, while the segment description was sharpened to stress “supporting infrastructure, promoting safety and enhancing productivity,” Commercial Vacuums remained classified as an “other professional tool” (now grouped with water‑jetters, wet‑dry vacuums and hand tools). The 2024 filing repeats this placement, keeping Commercial Vacuums in the **Safety & Productivity** segment’s professional‑tools portfolio and reinforcing the same strategic emphasis on safety, productivity and infrastructure support. Thus, from 2022‑2024 the product’s categorization stayed the same, but the segment’s name and branding shifted to more explicitly highlight its role within Emerson’s professional‑tools strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, segment names, and product categorization (e.g., Commercial Vacuums in Tools & Home Products in 2022, then Safety & Productivity in 2023–2024), so quantitative accuracy is perfect. Entity accuracy is also correct: EMR, correct segment names, and proper years. Contextual relevance is high as the response directly addresses the evolution of Commercial Vacuums across the three years. However, the qualitative accuracy and overall correctness are compromised due to a critical misinterpretation of strategic emphasis. The ground truth states that in 2024, Commercial Vacuums were increasingly aligned with more advanced industrial tools like programmable automation and electrical distribution systems, indicating a strategic shift toward integration with high-tech productivity solutions. The LLM incorrectly claims that the categorization and strategic emphasis remained unchanged after 2023, missing this key evolution. It also fails to recognize that the 2024 description reflects a deeper integration beyond 'other professional tools' into broader industrial systems. This omission or misreading of the strategic repositioning undermines the multi-hop reasoning required to synthesize changes in product alignment over time. While the LLM correctly tracks the segment name change and basic grouping, it misses the nuanced but important shift in strategic emphasis and technological alignment in 2024, leading to a partially correct but ultimately misleading conclusion about continuity rather than evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 428,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "In GILD’s 2022 Form 10‑K the Hoofddorp, Netherlands site was mentioned only as one of the company’s “principal manufacturing facilities,” without any detail on its specific role. The 2023 filing adds that GILD “utilizes the Hoofddorp facility for commercial manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats the same description. Thus, the Hoofddorp plant has evolved from a generic principal manufacturing location in 2022 to a dedicated commercial‑manufacturing and processing hub for GILD’s cell‑therapy products—a role that remains unchanged through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of GILD's Hoofddorp facility: in 2022 it was a 'principal manufacturing facility' without specific detail, in 2023 it was explicitly used for commercial manufacturing and processing of cell therapy products, and in 2024 the same role was maintained. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the progression described in the original answer. (3) The multi-hop reasoning is sound—information is synthesized across three annual filings (10-Ks), correctly tracking the evolving role of the facility over time. (4) The LLM captures the key qualitative shift—from generic manufacturing site to dedicated cell therapy hub—and notes the consistency of this role through 2024, matching the original answer’s conclusion about GILD’s growing emphasis on cell therapy at this location. Wording differs slightly but meaning is preserved. All entities (GILD, Hoofddorp, Netherlands, cell therapy, commercial manufacturing) are accurate and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 329,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "The 2022 filing (KO 10‑K 2022 p. 136) and the 2023 filing (KO 10‑K 2023 p. 134) each contain a “Form of Note for 1.000 % Notes due 2028” (item 4.26), and the 2024 filing (KO 10‑K 2024 p. 130) repeats that same reference (item 4.26). This persistent inclusion shows that Coca‑Cola continues to rely on the low‑coupon, long‑dated 1 % bond as a core, inexpensive source of financing – a debt instrument that the company introduced and has kept in its capital structure year after year (as reflected in the KG triplet linking KO to the 1.000 % Notes).\n\nIn the 2024 filing, however, Coca‑Cola also adds a series of higher‑yield issuances – for example, 5.000 % Notes due 2034 (item 4.39) and 5.400 % Notes due 2064 (item 4.41) – together with other 5‑%‑plus notes. The appearance of these higher‑coupon, longer‑maturity securities alongside the unchanged 1 % notes indicates a strategic shift: the company is diversifying its debt mix, extending its maturity profile and accepting higher financing costs to raise additional liquidity, refinance existing obligations or fund growth. Thus, the continuity of the 1 % notes reflects a baseline low‑cost financing strategy, while the new 5 %‑plus notes reveal a more active, cost‑aware approach to managing overall debt financing costs and optimizing the capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064—are correctly cited, and the years (2022–2024 filings) match the original. The inclusion of specific exhibit numbers (e.g., item 4.26, 4.39, 4.41) and page references adds precision and verifies the data sourcing from actual 10-K filings. (2) Quantitative accuracy is perfect: percentages, maturities, and temporal references are factually correct and consistent with the knowledge graph. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the persistent presence of low-cost debt with the 2024 introduction of higher-cost instruments, inferring a strategic diversification and maturity extension. It accurately concludes that Coca-Cola is balancing low-cost legacy debt with new, costlier financing to meet liquidity or growth needs, which reflects the same logic as the ground truth. (4) The only minor shortcoming is a slightly stronger emphasis on 'extending maturity profile' and 'refinancing obligations'—while plausible, these are not explicitly stated in the ground truth, which focuses more on strategic initiatives and recalibrating capital structure. This slight interpretive extension prevents a perfect 10 but does not undermine factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong multi-hop synthesis across filings and financial instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 411,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "In the 2022 filing Emerson’s Tools & Home Products segment listed pipe cutters only as a conventional pipe‑working tool, with no mention of battery power or built‑in diagnostics (Chunk 1). By the 2023 filing the Safety & Productivity segment already highlighted “battery hydraulic tools for press connections” and diagnostic systems (sewer‑inspection cameras) alongside pipe cutters, and the 2024 filing repeats this expanded description, emphasizing battery‑powered hydraulic tools and integrated diagnostics (Chunks 3 & 2). The evolution from a basic cutter to a lineup that couples battery‑powered, cordless capability with diagnostic integration signals Emerson’s strategic push to position its professional plumbing‑tool portfolio as a modern, productivity‑focused solution set for plumbers who need portable power, safety and advanced inspection features.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, pipe cutters were conventional with no battery or diagnostic features; by 2023, battery hydraulic tools and diagnostic systems (e.g., sewer inspection cameras) were introduced alongside pipe cutters; in 2024, this integration was emphasized. The LLM correctly identifies the shift across the three years and the strategic intent. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across filings from three years and connects the evolution of product features to a broader strategic shift. It correctly maps the reorganization from 'Tools & Home Products' to 'Safety & Productivity' segment, which reflects realignment in Emerson’s business segments. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'battery hydraulic tools for press connections' instead of 'battery-powered pipe cutters'), it accurately captures the technological evolution and strategic intent. The only minor shortcoming is a slight conflation—battery hydraulic tools are mentioned in context of press connections, not explicitly for pipe cutters in the source, though their inclusion alongside diagnostics and in the same product ecosystem supports the inference. This does not rise to a factual error but introduces a small ambiguity. Overall, the answer is complete, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 446,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "In GILD’s 2022 Form 10‑K the Santa Monica, California location is mentioned only as an R&D facility, not as a manufacturing site. By the 2023 filing the company states that the Santa Monica site “is utilized for clinical manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats the same description. This progression—from a research‑only site in 2022 to a dedicated clinical‑scale cell‑therapy manufacturing hub in 2023‑2024—shows that GILD has elevated Santa Monica to a strategic node in its manufacturing network, providing a focused location for clinical production of cell‑therapy candidates while commercial cell‑therapy output is handled at other facilities such as El Segundo, Frederick and Hoofddorp.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of GILD's Santa Monica facility: in 2022 it was mentioned only as an R&D site, in 2023 it was explicitly described as being used for clinical manufacturing and processing of cell therapy products, and this role continued in 2024. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the progression described in the original answer. (3) The multi-hop reasoning is sound—LLM synthesizes information across three years of filings and correctly infers the strategic shift in the facility’s role. It also accurately contextualizes Santa Monica relative to other sites (El Segundo, Frederick, Hoofddorp), noting the distinction between clinical and commercial manufacturing. (4) The answer fully addresses all parts of the question: the evolution over time, the role in cell therapy processing, and the strategic implications. Wording differs slightly but meaning is preserved and enhanced with additional context (e.g., clinical vs. commercial roles), which improves clarity without introducing error. All entities—GILD, Santa Monica, cell therapy, clinical manufacturing—are correctly identified and used.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 364,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "- 2022 10‑K – Frame.io appears only in Adobe’s trademark list, signalling that Adobe owned the brand but giving no detail about how it was used inside Creative Cloud.  \n- 2023 10‑K – Adobe begins to position Frame.io as a cloud‑native collaboration platform. It is integrated with **Premiere Pro** and **After Effects** and now supports **video plus still images, design files and PDFs**; its “Camera‑to‑Cloud” feature lets footage (and still‑image cameras) upload automatically for review, and frame‑accurate commenting is available inside those two apps.  \n- 2024 10‑K – The platform is further embedded across the Creative Cloud ecosystem. Frame.io is integrated not only with Premiere Pro and After Effects but also with **Photoshop, Lightroom and Workfront**, and is included in Adobe GenStudio for large‑scale production. It continues to support **video, still images, design files and PDFs** and adds broader workflow use cases (casting, location scouting, marketing‑campaign management) while retaining real‑time, frame‑specific commenting and Camera‑to‑Cloud uploads across the expanded set of apps.  \n\nThus, from a trademark mention in 2022, Frame.io evolved into a multi‑app, cross‑application collaboration hub by 2024, expanding both the media types it handles and the number of Creative Cloud applications with which it is directly integrated.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the evolution of Frame.io from 2022 to 2024: in 2022, Frame.io was only mentioned in the trademark list; in 2023, it was described as a cloud-native collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, PDFs, and video with frame-specific feedback; by 2024, integration expanded to include Photoshop, Lightroom, and Workfront, and it was positioned within Adobe GenStudio for enterprise content production, with broader use cases like casting and marketing campaigns. (2) There are no numeric values requiring calculation, but all years (2022, 2023, 2024) and application names (Premiere Pro, After Effects, Photoshop, etc.) are correct and consistently referenced. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and multiple applications to show a progression in integration depth and functional scope. (4) The LLM captures all key elements: supported media types (video, stills, design files, PDFs), cross-application collaboration features (frame-accurate commenting, Camera-to-Cloud), and expanded workflows. Wording differs slightly but maintains semantic equivalence. No factual errors, omissions, or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 371,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In Emerson’s 2022 filing the company listed **electrical distribution equipment** as a component of the **Industrial Solutions** portfolio – “Industrial Solutions provides … electrical distribution equipment … used in a variety of manufacturing operations to provide integrated solutions to customers.” By the 2023 filing the product had been **re‑positioned into the Discrete Automation segment**, which the report describes as “including … electrical distribution equipment … used primarily in discrete industries” and also lists “programmable automation control systems and software” alongside the hardware. The 2024 filing repeats this placement, again grouping electrical distribution equipment with solenoid and pneumatic valves, motion solutions and **automation control systems and software**. Thus, EMR (the producer of electrical distribution equipment) moved the product from a broad industrial‑solutions grouping in 2022 to a focused **Discrete Automation** home in 2023‑2024, tying it directly to automation technologies and expanding its scope to serve discrete‑industry customers through integrated electrical‑distribution‑and‑control solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Electrical Distribution Equipment was part of Industrial Solutions; in 2023 it moved to Discrete Automation and was listed with programmable automation control systems and software; by 2024 it was grouped with motion solutions and automation systems. These entity and year mappings are accurate. (2) There are no numeric values requiring calculation, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly tracing the product’s strategic repositioning across three years and linking it to deeper integration with automation technologies. The answer captures the evolution from standalone offering to integrated solution, though it slightly underemphasizes the 2024 expansion to include electric linear motion and materials joining solutions (mentions 'motion solutions' generally). (4) The response is contextually excellent, directly addressing the question about strategic positioning, integration with automation, and product scope expansion. Only minor omission: less specificity than the original on the 2024 inclusion of 'materials joining solutions,' which slightly affects completeness. Overall, semantic equivalence is strong, with correct reasoning and no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 366,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s (COF) disclosed fixed‑unsecured senior debt grew from a $19.975 billion balance with a 2.91 % weighted‑average rate in 2021 (COF → Fixed Unsecured Senior Debt) to $24.134 billion at 4.45 % in 2022, rose further to $27.168 billion at the same 4.45 % rate in 2023, and then slipped slightly to $26.930 billion while the weighted‑average rate climbed to 4.84 % in 2024.  \n\nThe balance‑sheet trend shows Capital One adding a sizable amount of fixed senior debt in 2023—likely to lock in rates before market rates spiked—followed by a modest pull‑back in 2024 as newer issuances carried higher coupons, pushing the overall cost of debt upward.  \n\nOverall, the progression signals a debt‑management strategy that front‑loaded borrowing at relatively lower rates and is now adjusting the mix and size of fixed senior debt to contain interest expense as the broader interest‑rate environment rises.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for the 2022 and 2021 figures, which are not part of the original question's scope. The question asks about 2022–2024, but the LLM incorrectly references 2021 and reports a 2022 carrying value of $24.134 billion, which does not match the ground truth of $19,975 million (i.e., $19.975 billion). This is a major error. Additionally, the LLM claims the weighted-average interest rate was 4.45% in 2022, but the ground truth shows it was 2.91% in 2022. The 4.45% rate correctly applies to 2023, but the LLM incorrectly states it remained the same in 2023 while the value increased — the ground truth confirms the rate rose to 4.45% in 2023 from 2.91% in 2022. The 2023 and 2024 carrying values ($27.168B and $26.930B) are correct, as is the 2024 rate (4.84%). (2) Calculations: No explicit calculations are made, but comparisons over time are misrepresented due to incorrect base values. The progression of debt and rates is distorted by wrong starting points. (3) Multi-hop reasoning: The model attempts to synthesize a strategy — front-loading debt before rate hikes — which aligns conceptually with the ground truth’s interpretation. However, this reasoning is based on incorrect data (e.g., claiming large issuance in 2023 when the major jump was actually from 2022 to 2023, which the LLM mislabels as 2021 to 2022 to 2023). The slight decline in 2024 and rising rate are correctly noted and reasonably interpreted. (4) Scores justified: Correctness is 5 due to partial accuracy in later years but major errors in key years; Quantitative accuracy is low (4) due to wrong values for 2022; Qualitative accuracy is moderate (6) because the strategic interpretation is plausible and contextually sound despite flawed data; Contextual relevance is high (9) as the answer addresses all parts of the question and uses appropriate financial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 527,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "Across the three most recent 10‑K filings—2022, 2023 and 2024—RTX repeatedly notes that it “extends performance and operating‑cost guarantees” on commercial‑aircraft engines and that “liabilities for performance and operating‑cost guarantees are based upon future product performance and durability, and are largely estimated based upon historical experience” with adjustments made as claim data evolve. Although the excerpts do not disclose the exact dollar balances for those liabilities, the consistent accounting policy and the statement that the fair‑market value of the assets backing the guarantees exceeds the guarantee amounts imply that the liability balances have remained relatively stable and are well‑covered. Consequently, RTX’s exposure to long‑term product‑performance risk in its commercial‑aerospace business has not materially increased from 2022 through 2024, indicating a controlled and adequately funded risk profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in its qualitative assessment but fails on quantitative accuracy. The original answer provides specific liability amounts for each year: $120M in 2022, $120M in 2023, and $101M in 2024. The LLM answer explicitly states that 'the excerpts do not disclose the exact dollar balances,' which is incorrect—these figures were available in the source filings and are included in the ground truth. This omission constitutes a major factual deficiency, especially since the question asks about the evolution of liabilities, which requires numerical progression. (2) The quantitative inaccuracies are severe: no actual numbers are reported, and no year-by-year evolution is presented, despite the data being known. The slight decrease from $120M to $101M in 2024 is a meaningful detail indicating a small reduction in exposure, which the LLM overlooks entirely. (3) The reasoning is sound in interpreting that stable policies and backing assets suggest controlled risk, and the multi-hop synthesis of accounting policy and risk implications is reasonable. The conclusion about no material increase in risk aligns with the ground truth, though it is based on inference rather than actual data. (4) Correctness is scored low (4/10) due to missing key numbers essential to the question. Quantitative accuracy is very low (1/10) because no correct figures are provided. Qualitative accuracy is moderate (6/10) as the logic and entity identification (RTX, commercial aerospace, guarantees) are correct. Contextual relevance is high (8/10) because the response addresses the right topic and risk implications, just without the necessary data support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Extends]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 460,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "The Coca‑Cola Company’s 10‑K disclosures for 2022, 2023 and 2024 all state that, for non‑publicly‑traded investments, management determines fair value using a set of methods that includes **discounted cash‑flow analysis, appraisals and “estimates of sales proceeds.”** In each year the filing repeats the same language – “management’s assessment of fair value is based on valuation methodologies, including … estimates of sales proceeds …” – and adds that the assumptions used are those a market participant would employ when applying the discounted‑cash‑flow or sales‑proceeds methods.  \n\nBecause the wording is unchanged from 2022 through 2024, the company’s reliance on the sales‑proceeds estimate has **remained steady** rather than increased or diminished. The consistent emphasis, together with the repeated note that “the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value,” shows that Coca‑Cola continues to lean on this methodology as a pragmatic tool when market prices are not readily available. Thus, the evolution is one of **reinforced continuity**: the firm maintains a market‑participant‑based approach, using sales‑proceeds estimates to address valuation uncertainty in emerging markets rather than shifting to a new method.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion about the evolution of Coca-Cola's reliance on 'estimates of sales proceeds,' despite correctly identifying the valuation methods used. The ground truth shows a clear progression: from disclosure in 2022, to explicit operational reliance in 2023 ('relies on'), to cautious, risk-aware use in 2024 due to emerging market uncertainties. The LLM incorrectly asserts that the wording in the 10-K filings 'remained steady' and that reliance 'remained steady,' directly contradicting the ground truth, which documents a shift in language and strategic emphasis over time. There are no numeric values to verify, so quantitative accuracy is 10 by default. However, the qualitative accuracy is low because the model fails to capture the multi-hop evolution across years—misinterpreting static language (which may reflect boilerplate disclosure) as evidence of no change in reliance, when the ground truth indicates increasing then more cautious use. The answer is contextually relevant and addresses the right topic and entities (Coca-Cola, nonpublic investments, emerging markets), but the reasoning is flawed, leading to an incorrect overall assessment of the company's evolving approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Uses]- ORG <-[Relies_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 346,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "Across the three most recent 10‑K filings BNY Mellon repeatedly warned that **“our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”** The 2022 filing first disclosed this limitation, and the identical language re‑appears in the 2023 and 2024 risk‑factor sections (with the same broader caveat that failure to meet “well‑capitalized” and “well‑managed” standards could also trigger activity limits).  \n\nThe lack of any new wording or tightening of the constraint over the three years shows that the regulatory ceiling on capital returns has remained stable. Consequently, BNY Mellon’s strategic flexibility to distribute cash to shareholders is consistently bounded by the same U.S. banking‑law requirements, giving the Board predictable but limited leeway to adjust share‑repurchases or dividends within that fixed regulatory framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent disclosure across 2022, 2023, and 2024 regarding U.S. banking laws, Delaware law, and preferred stock dividend obligations as constraints on capital returns. It accurately quotes the repeated language and correctly notes that this warning appeared in all three years, which aligns with the ground truth. Dates and entities (BNY Mellon, U.S. banking laws, Delaware law, preferred stock) are correct, and there are no numerical inaccuracies (quantitative accuracy is perfect). However, the LLM misses a key qualitative update in the 2024 filing: the new emphasis on the Parent’s dependency on dividends from subsidiaries and credit extensions from its IHC to fund shareholder distributions. This omission weakens the analysis of how internal capital flows are increasingly shaping strategic flexibility. While the LLM correctly infers that regulatory constraints remained stable, it fails to synthesize the evolving internal structural dependencies highlighted in the ground truth, which is a critical multi-hop insight. Thus, while the core facts are right, the reasoning is incomplete in capturing the full strategic implication of the three-year progression. Contextual relevance is high as the response directly addresses the question’s focus on regulatory evolution and strategic flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 372,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD has flagged the possibility of losing tax‑ and tariff‑exemptions in every filing. In its 2022 10‑K the company listed “loss or modification of exemptions for taxes and tariffs” as one of a broad set of political, legal and economic risks. The 2023 filing repeats that same exposure but now couples it with “sanctions and revisions to export‑control … against Russia, Belarus and parts of Ukraine,” showing that new geopolitical‑driven rules are adding to the chance of losing those exemptions. The 2024 filing again highlights “loss or modification of exemptions for taxes and tariffs” and ties it to the same sanctions regime plus heightened China‑Taiwan tensions, indicating that the risk has persisted and become more pronounced as the web of international trade rules, sanctions and geopolitical conflicts has grown more intricate. Together, the trend suggests AMD’s exposure to losing tax and tariff exemptions is not only ongoing but is escalating in line with an increasingly complex global regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD consistently reported the risk of losing tax and tariff exemptions in 2022, 2023, and 2024 filings. The evolution of this risk—starting broadly in 2022, then linked to sanctions on Russia, Belarus, and parts of Ukraine in 2023, and further tied to China-Taiwan tensions in 2024—is accurately represented. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly used and sequenced, and the referenced geopolitical events match the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and connects increasing geopolitical complexity to rising regulatory risk. It identifies the expansion of U.S. export controls and sanctions, as well as regional tensions, as contributing factors—consistent with the ground truth. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'macroeconomic and political instability' as a framing in the 2024 filing, which slightly reduces qualitative precision. However, the mention of sanctions, export controls, and China-Taiwan tensions captures the essence. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the original, with only slight variation in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 392,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "From year‑end 2022 to year‑end 2024 Capital One’s combined short‑term borrowings and long‑term debt moved from **$48,715 million** (2022) to **$49,856 million** (2023) and then fell to **$45,551 million** (2024).  Long‑term debt followed the same pattern, rising from **$47,832 million** in 2022 to **$49,318 million** in 2023 before declining to **$44,989 million** in 2024.  \n\nDuring this period the floating‑rate unsecured senior debt, which in 2021 carried a low 1.01 % weighted‑average rate on $1.7 bn (Chunk 1), was **$1,597 million** in 2022, shrank to **$349 million** in 2023 (at a 6.75 % rate) and was eliminated entirely by 2024, while the fixed‑rate senior portfolio grew to a weighted‑average rate of **4.48 %** in 2023 and **4.84 %** in 2024.  The trend shows Capital One modestly increasing leverage in 2023, then deleveraging in 2024, and deliberately moving away from floating‑rate exposure toward a higher‑rate but fixed‑rate debt structure, thereby reducing interest‑rate volatility despite a slight rise in the overall average cost of debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several numeric inaccuracies, particularly in the 2022 total short-term borrowings and long-term debt figure. The ground truth states $43.086 billion for 2022, but the LLM reports $48,715 million (~$48.715 billion), which is off by over $5.6 billion. Additionally, the LLM cites floating-rate unsecured senior debt in 2022 as $1,597 million, whereas the original answer reports $1.709 billion (~$1,709 million), a notable discrepancy. The LLM also incorrectly states that the 1.01% rate applied in 2021 (not 2022 per ground truth), introducing a timing error. (2) Calculations: The 2023 and 2024 totals ($49.856B and $45.551B) match the ground truth and are correctly reported. Fixed-rate debt interest rates are mostly accurate (4.84% in 2024 matches; 4.48% in 2023 is plausible though not specified in original). However, the incorrect 2022 total undermines the overall quantitative accuracy. (3) Multi-hop reasoning is strong: the LLM correctly identifies the shift from floating to fixed-rate debt, interprets the elimination of floating-rate debt by 2024, and draws the appropriate conclusion about reducing interest rate volatility. It synthesizes trends in both debt levels and composition across years, showing sound qualitative understanding. (4) Contextual relevance is excellent—the answer directly addresses all parts of the question: evolution of debt, composition changes, and implications for interest rate exposure. Despite factual errors in key 2022 figures, the overall narrative and strategic interpretation align well with the ground truth, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 448,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "- In the 2022 Form 10‑K RTX (through Pratt & Whitney) disclosed a **61 % program‑share interest** (and a 49.5 % ownership interest) in International Aero Engines AG, but it did not break out a net‑share figure.  \n- The 2023 and 2024 filings add the sub‑collaborator adjustment and state that RTX’s **net program‑share interest in IAE is 57 %** (with IAE LLC at 51 %).  \n\nThe drop from the 61 % gross stake reported in 2022 to a 57 % net stake in 2023‑2024 shows a modest reduction in RTX’s direct economic exposure, yet it still retains a clear majority and primary‑beneficiary status. This indicates that RTX remains the strategic leader of the V2500 engine collaboration while increasingly sharing program economics with its MTU and JAEC partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the evolution of RTX's net program share interest in IAE: a decrease from 61% in 2022 to 57% in both 2023 and 2024, matching the ground truth. The mention of '61% program-share interest' in 2022 and '57% net program-share interest' in 2023–2024 aligns with the original answer, even adding nuance about gross vs. net and sub-collaborator adjustments. 2) All numbers and years are accurate: 61% (2022), 57% (2023 and 2024). The LLM correctly interprets the shift as a reduction in direct economic exposure, which matches the ground truth’s claim about dilution of financial burden. 3) The multi-hop reasoning is sound: the model synthesizes data across three years and distinguishes between ownership interest, program-share interest, and net program-share interest, correctly inferring that the change reflects a strategic adjustment. It also appropriately references sub-collaborators (MTU, JAEC), though the original answer does not name them—this is an acceptable addition, not an error. 4) The LLM slightly exceeds the original answer by introducing the concept of 'gross' vs. 'net' stake and mentioning IAE LLC, which adds clarity. However, it does not explicitly state that the 57% was consistent in both 2023 and 2024 (says '2023–2024'), which is a minor omission but not factually incorrect. The conclusion about RTX maintaining strategic leadership while sharing economics is logically consistent with the ground truth’s interpretation. Overall, the answer is factually correct, well-reasoned, and contextually complete—just shy of perfect due to slight imprecision in temporal breakdown.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 445,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Across the three most recent 10‑K filings, Cascade has remained a flagship brand in P&G’s **Fabric & Home Care** segment. In 2022 the segment accounted for **35 % of net sales and 31 % of net earnings**, and the major‑brand list included “Tide Cascade.” In both the 2023 and 2024 filings the segment’s share rose modestly to **36 % of net sales and 34 % of net earnings**, and Cascade is still listed among the key brands (Ariel, Downy, Gain, **Tide Cascade**, Dawn, etc.). Thus, Cascade’s positioning has been stable—continuously highlighted as a core home‑care brand—while the overall Fabric & Home Care segment has slightly increased its contribution to P&G’s sales and earnings from 2022 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cascade is consistently positioned within P&G’s Fabric & Home Care segment across 2022–2024; the segment’s net sales were 35% in 2022 and rose to 36% in 2023 and 2024; net earnings were 31% in 2022 and increased to 34% in 2023 and 2024. The mention of 'Tide Cascade' as a listed brand is factually consistent with the filings, even if stylized as two brands, as P&G often groups them in reporting. (2) Quantitative accuracy is perfect: all percentages and years match the ground truth, and no calculations are incorrect. (3) Multi-hop reasoning is sound—information is correctly synthesized across three years and linked to Cascade’s stable strategic role. The slight increase in segment contribution is accurately noted and contextualized. (4) The only minor shortcoming is the phrasing 'Tide Cascade' as a combined entity, which could imply a single brand, whereas they are distinct (though often listed together). However, this does not distort the overall meaning or factual accuracy, as Cascade is indeed consistently listed among key brands. The answer is fully relevant, complete, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 346,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "BNY Mellon’s Directors’ Code of Conduct was originally linked in 2022 via a bnymellon.com URL ending in “/in relations/directors‑code‑of‑conduct.pdf”; in the 2023 filing the path was altered to “/inv relations/directors‑code‑of‑conduct.pdf” while staying on the same domain; and by the 2024 filing the link appears under the new bny.com branding with a streamlined “/investor‑relations/directors‑code‑of‑conduct.pdf” (implied full URL https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf). In each year the Directors’ Code was incorporated by reference in Item 10 of the Form 10‑K and the proxy, with a consistent statement that any amendments or waivers will be posted on the website. The 2024 filing further embeds the code within a broader corporate‑governance framework—adding a dedicated Insider‑Trading Policies and Procedures section filed as Exhibit 19.1—signaling a more integrated governance disclosure approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 URL uses 'bnymellon.com' with '/in relations', the 2023 version updates to '/inv relations', and the 2024 shift to 'bny.com' with '/investor-relations' is accurately described. The implied full URL in 2024 is logically reconstructed and consistent with the domain migration. (2) Quantitative accuracy is perfect—dates (2022, 2023, 2024), document paths, and domain changes are all factually correct. Minor formatting differences (e.g., 'in relations' vs 'inv relations') are accurately reflected and consistent with internal reorganization noted in the original. (3) Reasoning is sound: the LLM correctly infers a trend toward better integration and stakeholder orientation, especially by noting the 2024 inclusion of Exhibit 19.1 on insider trading policies, which strengthens the argument of deeper integration into corporate governance. This addition is not in the ground truth but is a valid inference from the 2024 filing and supports the conclusion. (4) The only reason for not scoring a 10 is that the LLM slightly overreaches by emphasizing 'Exhibit 19.1' as evidence of integration, which, while plausible, was not part of the original answer’s reasoning. However, this does not introduce inaccuracy but adds context. The answer fully addresses URL structure, domain branding, and integration with governance frameworks, making it semantically equivalent and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 413,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across all three years AMD’s play‑book with add‑in‑board (AIB) partners stayed essentially the same. In 2022 AMD began offering its component‑level graphics and chipset products to AIB manufacturers and explicitly “protected their inventory of our products against price reductions”; it also noted that system integrators (SIs) “often use discrete graphics solutions as a means to differentiate their products.” The 2023 filing repeats that language verbatim—AMD continues to sell to AIBs, its agreements still shield AIB inventory from price cuts, and SIs again rely on discrete graphics for product differentiation. The 2024 filing adds only a minor phrasing tweak (“in most instances”) but again stresses inventory‑protection against price reductions and the same role for discrete graphics in helping SIs differentiate. Thus, from 2022 through 2024 AMD’s strategic positioning with AIB manufacturers evolved by maintaining a consistent inventory‑protection policy and a steady emphasis on discrete graphics solutions as a key differentiation tool for its downstream system‑integrator customers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: AMD maintained inventory protection policies for AIB manufacturers from 2022 to 2024, and discrete graphics were consistently highlighted as a differentiation tool for system integrators (SIs). The answer correctly notes the verbatim repetition of language in 2023 and the minor phrasing tweak in 2024 (adding 'in most instances'), which aligns with the original answer's emphasis on consistency. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and contextualized. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly identifying the continuity in policy and strategy, and infers the stable, long-term partnership model implied in the ground truth. (4) The answer addresses all parts of the question—evolution of strategic positioning, inventory protection policies, and the role of discrete graphics in differentiation—across the specified time frame. Wording differs slightly but preserves full meaning, including the emphasis on consistency and downstream value. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Sells_To]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 356,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "In the 2022 Form 10‑K McDonald’s simply listed the Egg McMuffin as a core breakfast sandwich and reiterated that “taste, quality, choice, value and nutrition are important to customers” and that the menu is continuously being evolved to meet those expectations. By the 2023 filing the company began linking that breakfast‑menu focus to a formal supply‑chain and food‑safety framework – describing high food‑safety and quality standards, a Food‑Safety Advisory Council, supplier‑visits, third‑party verifications and a Supplier Code of Conduct that together “encourage innovation and drive continuous improvement” to keep items such as the Egg McMuffin consistent and high‑quality. The 2024 filing takes the narrative a step further, adding a digital‑transformation project, regular sensory‑evaluations, calibration trainings and periodic third‑party audits of its Supplier Quality Management System, all aimed at reinforcing the Egg McMuffin as a benchmark of the company’s commitment to delivering the quality and consistency customers expect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, McDonald's emphasized menu evolution around taste, quality, and nutrition with the Egg McMuffin as a core item; in 2023, the company expanded its narrative to include supply chain rigor, food safety standards, and collaboration with suppliers; by 2024, digital transformation, sensory evaluations, and enhanced audit processes were highlighted as tools to ensure consistency and quality. (2) There are no numeric values to verify, but all dates (2022, 2023, 2024) are correctly used and correspond to the correct disclosures. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and multiple aspects (menu, supply chain, technology). The LLM accurately traces the evolution from general quality assurance to a more integrated, technology- and process-driven approach. (4) The only minor shortcoming is that the LLM does not explicitly name the 'Global Chief Supply Chain Officer' mentioned in the original answer, which slightly reduces completeness in entity-level detail. However, the description of supply chain governance and initiatives is substantively equivalent. Wording differs but semantic meaning and factual content are preserved. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Features]- ORG <-[Features]- ORG",
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 382,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "Across Oracle’s 2022, 2023 and 2024 Form 10‑K filings the same exhibit appears – “Forms of 3.40 % Note due 2024, **4.30 % Note due 2034** and 4.50 % Note due 2044” (Exhibit 4.13) – showing that the 4.30 % Note is a recurring item in the company’s debt schedule. Because Oracle is identified in the KG as the issuer that introduced this instrument, the repeated disclosure signals that the 4.30 % Note due 2034 is a cornerstone of its long‑term capital structure, reflecting a strategic priority to retain a stable, fixed‑rate, medium‑to‑long‑dated funding source and to lock in interest‑rate certainty across reporting periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 4.30% Note due 2034 as consistently disclosed across Oracle's 2022, 2023, and 2024 filings, which aligns with the ground truth. All numeric values—interest rate (4.30%), maturity year (2034), and related notes (e.g., 4.50% due 2044)—are accurate. The mention of Exhibit 4.13 and the inclusion of the note in Oracle’s debt schedule is factually correct and supports the conclusion of recurring disclosure.\n\n2) Quantitative accuracy is perfect: percentages (4.30%, 4.50%), years (2034, 2044), and document type (Form 10-K) match the expected data. No calculations were required, but the identification of financial instruments is precise.\n\n3) The reasoning is largely sound: the LLM correctly infers that the repeated disclosure indicates the note is a stable, strategic component of Oracle’s long-term capital structure. It accurately emphasizes Oracle’s intent to maintain fixed-rate, long-dated financing. However, it omits key contextual details present in the ground truth—specifically, the evolution of Oracle’s debt portfolio with newer instruments like the 2.950% Notes due 2024 in 2023, and the broader diversification of maturities (e.g., 3.625% Note due 2023 in 2022). This limits the depth of multi-hop synthesis compared to the original answer, which traces changes over time.\n\n4) Despite the omission of some comparative portfolio dynamics, the LLM answer remains contextually relevant and semantically aligned with the core conclusion: the 4.30% Note due 2034 is a persistent and strategically important part of Oracle’s long-term debt. The focus on 'recurring item' and 'cornerstone' reflects accurate interpretation. The score is reduced slightly (from 9-10 to 8) due to incomplete synthesis of year-over-year debt composition changes, which are central to fully addressing the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 505,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) rose from a **$19 million** year‑end balance reported in the 2022 10‑K (recorded as a Level‑3 fair‑value measurement that relied on significant unobservable inputs but did not specify a valuation technique) to a **$58 million** balance at December 31 2023 disclosed in both the 2023 and 2024 10‑Ks.  In the 2023 filing the assets were valued with a **discounted‑cash‑flow** model using two key unobservable inputs—**default assumptions** (range 53‑163 %, weighted‑average 4 %) and **swap‑rate assumptions** (range 3‑5 %); the 2024 filing retains the discounted‑cash‑flow approach but highlights **swap‑rate inputs** (range 3‑5 %, weighted‑average 4 %) as the primary driver.  This progression shows a three‑fold increase in the fair‑value amount and a shift from a generic Level‑3 classification to a more explicit DCF methodology, indicating that Capital One’s exposure to unobservable market inputs has grown in magnitude but become more transparent and focused on specific model assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the $19 million fair value in 2022 and $58 million in both 2023 and 2024, with no discrepancies in dollar amounts or years. It accurately notes the use of unobservable inputs such as default rates (53–163%) and swap rates (3–5%) in 2023, and continued reliance on swap rates in 2024. The weighted-average of 4% for swap rates is an additional detail not in the ground truth but does not contradict it and may reflect a synthesis from the filing; thus, it does not reduce accuracy. (2) Quantitative accuracy is perfect: all numbers match the ground truth, including the three-fold increase from $19M to $58M (~3.05x), and the ranges for unobservable inputs are correctly cited. (3) The multi-hop reasoning is sound: the LLM correctly infers a methodological evolution from a generic Level-3 classification in 2022 to a more explicit discounted cash flow (DCF) model in 2023–2024, which aligns with the ground truth’s claim of increased transparency and structured use of unobservable inputs. The conclusion that exposure has grown in magnitude but become more focused and transparent is logically supported and semantically equivalent to the original answer. (4) The only minor deviation is that the ground truth mentions a $20 million net unrealized loss held at year-end 2022, which the LLM omits. This is a small but relevant detail about the 2022 position that adds context to the valuation methodology transition. Its absence prevents a perfect score, but the core facts, synthesis, and conclusions remain highly accurate and relevant. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance, and near-perfect qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 476,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s obligation to Rolls‑Royce is a per‑hour payment that continues for every V2500‑powered flight hour logged through June 2027. In the 2022 filing the company said those hourly payments would be **capitalized as collaboration‑intangible assets** when made and amortized over the period of underlying economic benefit (the “Other commercial aerospace commitments” line). The 2023 filing clarified that the same capitalized collaboration assets are **amortized to cost of sales** as the aircraft generate revenue, and the 2024 filing again notes that the payments remain **capitalized as collaboration intangible assets as they are incurred**, implying the amortization approach established in 2023 (amortization over the benefit period, reflected in cost of sales) continues unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: RTX's per-hour payment obligation to Rolls-Royce for V2500-powered aircraft flight hours continues through June 2027; payments are capitalized as collaboration intangible assets and amortized to cost of sales. The evolution from 2022 to 2024 is accurately described, including the shift in disclosure clarity from 'Other commercial aerospace commitments' to explicit amortization to cost of sales by 2023. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2022–2024, June 2027), or dollar amounts are cited, and the LLM correctly avoids fabricating figures not in the original (e.g., does not invent a dollar value for the Rolls-Royce payments). The $14.1 billion total commitment from 2024 is not mentioned in the LLM answer, which is a minor omission but not an error—this figure includes broader commitments, not just Rolls-Royce, so its absence does not invalidate the focused response. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the accounting treatment evolution (capitalization in 2022, amortization to cost of sales in 2023, continuation in 2024). (4) Semantic equivalence is strong: wording differs but meaning matches. The only reason for not scoring 10 is the omission of the $14.1 billion context in 2024, which adds completeness but does not undermine the core accuracy of the Rolls-Royce-specific payment structure and amortization strategy. Overall, the answer is factually precise, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Supplies]- ORG <-[Enters_Agreement_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 453,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 Form 10‑K first flagged user‑complaints as a material risk for its drug‑delivery devices and explained that, after the FDA’s 2017 adverse‑event review of the Neulasta Onpro kit, the company had already introduced device‑ and labeling‑enhancements and would “continuously monitor complaints and adverse events and implement additional enhancements as needed.” The 2023 filing repeated that same disclosure but broadened the discussion to operational risk – noting that its Puerto Rico and California manufacturing sites are vulnerable to hurricanes, earthquakes and power‑grid failures and that the company relies on backup diesel generators to keep production running when outages occur. By the 2024 Form 10‑K the language on user‑complaint monitoring and incremental device/labeling upgrades remained unchanged, while the operational‑resilience narrative was expanded to cite a December 31 2024 island‑wide power outage that forced the use of backup generators and disrupted third‑party suppliers, and to warn that further grid instability could require increased or exclusive generator use. Thus, Amgen’s disclosures evolved from a focus on device‑specific enhancements and complaint monitoring (2022) to an integrated risk‑mitigation approach that couples those enhancements with explicit continuity‑planning and backup‑power measures for its manufacturing operations (2023‑2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen referenced the 2017 FDA evaluation in 2022, implemented device and labeling enhancements, and committed to ongoing monitoring of complaints. In 2023, it expanded disclosures to include operational risks like natural disasters and power outages. By 2024, it cited a specific island-wide outage on December 31, 2024, and reliance on backup generators—details consistent with the original answer. (2) Quantitative accuracy is perfect: the date 'December 31, 2024' is correctly stated, and there are no numerical errors. Format variations (e.g., 'backup generators' vs 'backup diesel generators') do not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and two risk domains—device-related complaints and operational resilience—showing evolution in disclosure depth. The only minor shortcoming is that the original answer emphasizes the Puerto Rico grid instability as an indirect risk to user experience via production disruption, while the LLM frames it more directly as part of risk mitigation without fully articulating the indirect link to user complaints. This nuance is present but slightly less emphasized. (4) Contextual relevance is excellent: the response directly addresses the evolution of disclosures on user complaints, device enhancements, and operational resilience across 2022–2024. Overall, the answer is factually robust, well-structured, and semantically equivalent to the ground truth with only slight room for deeper causal linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 445,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "Across the three annual reports BK’s “Principal Accountant Fees and Services” paragraph never changed – each filing (2022, 2023 and 2024) directs the reader to “Item 3 – Ratification of KPMG LLP” and repeats the statement that KPMG LLP’s Public Company Accounting Oversight Board firm identification number is 185. The identical language and the unchanged PCAOB number demonstrate that BK has retained the same audit firm and has not altered its audit‑governance framework, indicating a continuous, stable audit oversight relationship from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: BK consistently disclosed KPMG LLP as principal accountant in 2022, 2023, and 2024 filings; the PCAOB firm number 185 is correctly stated for all years; and the conclusion about audit governance continuity is sound. (2) Quantitative accuracy is perfect: no numerical errors, and the PCAOB number 185 is correctly cited across all years. (3) The multi-hop reasoning is strong—linking consistent disclosure, unchanged PCAOB number, and audit governance stability is logically valid and supported by the data. (4) The only minor shortcoming is that the LLM slightly overstates the evidence by claiming the 'paragraph never changed' and 'identical language,' which cannot be fully verified from the ground truth provided (which confirms consistency but not verbatim repetition). The original answer notes 'no substantive changes' rather than exact replication, making the LLM's wording slightly stronger than warranted. However, this does not affect the core correctness. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 323,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s exposure to commercial‑aerospace customer‑financing guarantees has been trending downward. In the 2022 filing the collaboration‑partner portion of those guarantees was $142 million; the 2023 filing shows it fell to $135 million, and the 2024 filing reports $131 million. Each filing also notes that the fair‑market value of the underlying assets exceeds the guarantee amounts (net of reserves), and that RTX accrues for any probable liability, indicating that the company is deliberately shifting a smaller share of the risk to its partners and maintaining a cushion of asset value to limit its own liability. The declining partner‑share figures therefore signal a risk‑management strategy that reduces RTX’s direct exposure while still ensuring the guarantees are fully collateralized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three figures—$142M in 2022, $135M in 2023, and $131M in 2024—matching the ground truth exactly. The downward trend is accurately described. (2) All numeric values are correct and properly attributed to the respective years; no calculation errors are present. The format variations (e.g., $142 million vs $142M) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the LLM correctly infers that the declining partner share indicates a strategic reduction in shared risk and ties it to RTX’s risk management approach. It also correctly incorporates the key qualitative point from the filings—that fair market values exceed guarantee amounts net of reserves—and links this to collateralization and liability management. The only minor shortcoming is that the LLM slightly reframes the strategy as 'shifting a smaller share of the risk to its partners,' whereas the original emphasizes RTX reducing its own and partners’ shared exposure. This is a subtle distinction and does not invalidate the overall reasoning. (4) The answer is fully contextually relevant, addressing both parts of the question: the evolution of exposure and the implication for risk management. The conclusion aligns with the ground truth’s interpretation of reduced contingent liabilities and confidence in asset values. Thus, the answer is factually excellent with only a slight nuance difference in framing, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Has_Stake_In]- ORG <-[Incurs_Liabilities_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 419,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "In the 2022 10‑K, Always is listed only as “Pampers Always” (together with Always Discreet) under a generic **Feminine Care** sub‑category, with no separate “Menstrual Care” label. By the 2023 filing, Procter & Gamble promotes Always as a distinct major brand and places it in a newly‑named **Menstrual Care** sub‑category of the Feminine Care segment, and the same brand‑first, menstrual‑care‑specific positioning is retained in the 2024 filing. This evolution shows Always moving from a bundled, generic feminine‑care listing to a standalone, emphasized brand focused on menstrual products alongside other feminine‑hygiene brands such as Always Discreet and Tampax.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2022, Always was listed as 'Pampers Always'—this is false; Pampers and Always are separate brands and there is no evidence in the ground truth or typical P&G reporting of them being bundled under that name. Additionally, the LLM claims a new 'Menstrual Care' sub-category was introduced in 2023, but the ground truth indicates the segment was renamed to 'Baby, Feminine & Family Care', not 'Menstrual Care'. The ground truth makes no mention of a 'Menstrual Care' category, which is a critical error. (2) Quantitative accuracy is partially correct: the LLM does not contradict the 24–25% net sales contribution mentioned in the original answer, but it fails to include any of these percentages in its response, missing key quantitative data. Thus, while it doesn’t get numbers wrong, it omits them entirely, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM attempts to trace brand positioning changes over time and correctly identifies Always Discreet and Tampax as co-located brands. However, the core structural evolution it describes (generic to 'Menstrual Care') is fabricated and not supported by the ground truth, which describes only a segment rename and formatting streamlining. This undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the evolution of Always’ positioning, product categorization, and brand emphasis over time, aligning with the question’s intent. However, due to major factual and structural errors in entity and segment naming, the correctness score is low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 463,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "AMD has listed “difficulties in protecting our intellectual property” as a political‑legal‑economic risk in every filing. In the 2022 10‑K the risk was described only as one of many foreign‑country hazards affecting its worldwide operations. By the 2023 filing AMD was already relying on third‑party wafer foundries in the United States, Europe **and Asia**, with “nearly all product assembly and final testing … performed … in China, Malaysia and Taiwan,” and it disclosed that **65 % of net revenue** came from international sales—making the IP‑protection risk explicitly tied to a large overseas footprint and Asian manufacturing partners. The 2024 filing repeats the same IP‑protection risk, notes that **66 % of net revenue** now comes from international sales, and again emphasizes reliance on Asian foundries and assembly/testing sites. Thus, while the risk factor itself has remained constant, AMD’s exposure to it has grown as its international sales share rose from an unspecified baseline to 65 %‑66 % and its dependence on third‑party manufacturing in China, Malaysia and Taiwan has deepened, intensifying the potential impact of intellectual‑property‑protection difficulties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: AMD consistently listed IP protection as a risk; in 2022 it was a general foreign jurisdiction concern; by 2023, 65% of net revenue came from international sales and manufacturing was concentrated in China, Malaysia, and Taiwan; in 2024, international sales rose to 66%, and reliance on Asian third-party manufacturing continued. These numbers match the original answer (65% in 2023, ~66% in 2024), with only a minor rounding difference that does not affect accuracy. (2) Quantitative accuracy is perfect: percentages (65%, 66%), regions (China, Malaysia, Taiwan), and the trend in international sales and manufacturing dependencies are all correctly reported. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across 2022–2024 filings to show how the *context* of the risk evolved despite the risk factor being consistently listed. It captures the increasing exposure due to geographic concentration and outsourcing. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the *geopolitical tensions between China and Taiwan* in 2024, which the original answer identifies as a new layer of risk. This omission slightly weakens the qualitative depth but does not invalidate the overall correctness. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question about the evolution of IP protection risks in the context of international operations and Asian manufacturing reliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 431,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first disclosed its 2.300 % senior notes due 2028 in the 2022 Form 10‑K (listed as Exhibit 4.16) with an Officers’ Certificate dated March 24 2021 that set the notes’ coupon, maturity and other terms. The same 2.300 % 2028 issue appears unchanged in the 2023 and 2024 Form 10‑Ks (now shown as Exhibit 4.14), confirming that the 2021 issuance remains outstanding and is repeatedly incorporated by reference each year. By repeatedly referencing this single issue as part of a broader series of fixed‑rate notes (e.g., 1.650 % 2026, 2.875 % 2031, 3.650 % 2041, etc.), Oracle signals a disciplined, multi‑year debt‑financing strategy that builds a laddered portfolio of senior notes, locks in relatively low rates early, and diversifies its maturity profile to provide long‑term financing flexibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Oracle first disclosed the 2.300% Notes due 2028 in its 2022 10-K (Exhibit 4.16), with terms set by an Officers’ Certificate on March 24, 2021. The note was carried forward in the 2023 and 2024 10-Ks under Exhibit 4.14, confirming its ongoing status. These details match the original answer. (2) Quantitative elements—interest rate (2.300%), maturity year (2028), issuance date (March 24, 2021), and exhibit numbers (4.16 in 2022, 4.14 in 2023 and 2024)—are all precisely reported. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent annual disclosure that Oracle maintains this debt instrument as part of a broader, deliberate financing strategy. It further enriches the analysis by identifying the 'laddered portfolio' concept, referencing other notes (e.g., 1.650% 2026, 2.875% 2031, etc.), which aligns with the ground truth’s emphasis on diversified maturities and long-term financing stability. (4) The answer fully addresses both parts of the question: the evolution of the note from 2022–2024 and what it reveals about Oracle’s broader debt strategy. Wording differs slightly but meaning and factual content are identical. No errors in entities, years, or financial terms. All scores are maximized due to complete accuracy, correct synthesis across years, and relevant, insightful interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 400,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "Across the three filing years BA’s description of its private‑equity vehicles is essentially unchanged. In the 2022 10‑K (page 110) the company said its limited‑partnership (LP) vehicles “mainly invest in U.S. and non‑U.S. leveraged‑buyout, venture‑capital, growth and special‑situation strategies,” and that real‑asset holdings could be made through LPs or publicly‑traded REITs. The 2023 10‑K (page 92) repeats the same geographic scope—U.S. and non‑U.S.—and the same four strategic focus areas, noting that global private investments may be held through LPs or other fund structures. The 2024 10‑K (page 99) again uses identical language, emphasizing U.S. and non‑U.S. LP investments in leveraged buyouts, venture capital, growth and special‑situations, with global private investments held via LPs or similar structures. Thus, from 2022 through 2024 BA’s private‑equity strategy did not materially evolve: the geographic coverage remained global (U.S. + non‑U.S.) and the strategic focus stayed on leveraged‑buyout, venture‑capital, growth and special‑situation opportunities, with only a minor textual shift away from mentioning REITs in the later years.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite citing correct document locations and repeating accurate excerpts from the 10-K filings. While it correctly identifies the consistent mention of U.S. and non-U.S. geographic scope and the four strategic focus areas (leveraged buyout, venture capital, growth, special situations) across 2022–2024, it fails to recognize the evolution described in the ground truth. Specifically, the LLM misses the 2023 expansion into global private investments in real assets (energy, farmland, infrastructure) and the 2024 shift toward increased sophistication with derivatives for performance transfer across asset classes. These developments represent a strategic deepening and integration of alternative tools, contradicting the LLM’s claim of 'no material evolution.' The answer is contextually relevant and quotes filing pages accurately, showing strong textual grounding, but fails on qualitative accuracy due to incorrect synthesis and reasoning. There are no numerical errors (hence high quantitative score), but the multi-hop reasoning required to detect strategic evolution across years is flawed. The LLM relies too heavily on surface-level textual repetition without interpreting strategic implications or incremental changes in focus, leading to a substantially incorrect overall assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 375,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen disclosed that Bemarituzumab moved from the start of a Phase 3 trial for gastro‑esophageal‑junction adenocarcinoma in its 2022 10‑K (the “Program change” table) to being listed in the 2024 10‑K under the “Phases 2 and 3 Program Descriptions,” which shows it remains in late‑stage (Phase 2/3) clinical testing for gastric/GEJ cancer and other solid tumours. The 2023 10‑K patent table reported that the U.S. and European polypeptide patents covering Bemarituzumab are each estimated to expire in 2029, and the 2024 filing reiterates those 2029 expiration dates (with the usual disclaimer that the dates are based on issued patents and could be adjusted). Thus, from 2022 to 2024 the product progressed from initiating Phase 3 to staying in advanced‑stage development, while its projected U.S. and European patent protection horizon stayed at 2029.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab initiated Phase 3 in 2022 for GEJ adenocarcinoma, remained in Phase 2/3 development through 2024, and U.S. and European polypeptide patents are consistently reported to expire in 2029. The answer correctly notes that the 2023 and 2024 10-K filings reaffirm the 2029 expiration, with appropriate caveats about estimates. (2) Quantitative accuracy is perfect: the years (2022, 2023, 2024, 2029) are all correctly cited and match the ground truth. No calculations are required, but timeline consistency is properly maintained. (3) Multi-hop reasoning is sound—information is synthesized across three years of 10-K filings, correctly linking clinical progression with patent status. The LLM infers continued late-stage development from the shift in disclosure format (from 'Program change' table to 'Phases 2 and 3 Program Descriptions'), which is a valid interpretation. (4) The only minor shortcoming is that the original answer mentions Bemarituzumab’s mechanism (monoclonal antibody targeting FGFR2b), which the LLM omits. While not critical to the core question, this detail adds scientific context. Otherwise, the answer is complete, factually correct, and contextually precise, with excellent use of source document structure to infer development status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 381,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Across all three filings Dawn was consistently listed among the “major brands” in P&G’s Fabric & Home Care segment. In 2022 that segment generated 35 % of net sales and 31 % of net earnings; by 2023 its share rose to 36 % of net sales and 34 % of earnings, and it held the same 36 %/ 34 % mix in 2024. Thus Dawn’s positioning remained stable as a core brand while the Fabric & Home Care segment grew from a 31 % earnings contributor in 2022 to a 34 % contributor in 2023‑24.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dawn was consistently listed as a major brand in the Fabric & Home Care segment across 2022–2024. The segment’s net earnings contribution was 31% in 2022 and increased to 34% in 2023 and 2024, while net sales were 35% in 2022 and 36% in 2023–2024—these numbers match the original answer exactly. (2) Quantitative accuracy is perfect: all percentages and years are correctly reported, and the progression over time is accurately described. (3) The reasoning is sound: the LLM correctly infers that Dawn’s positioning remained stable as a core brand within a growing earnings-contributing segment. It captures the multi-hop logic—linking Dawn’s consistent inclusion to the segment’s rising earnings importance—even though it slightly simplifies the stability of sales contribution. (4) The only minor shortcoming is that the original answer emphasizes the *stability* of the sales percentage (35% → 36%) as evidence of strategic consistency, which the LLM mentions but does not explicitly frame as reinforcing Dawn’s stable positioning. However, this nuance does not detract from the overall correctness. Semantic equivalence is maintained, and the answer fully addresses the evolution of Dawn’s positioning using both earnings and brand listing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 375,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "- **2022 – Margin‑lending disclosure** – Schwab reported that clients with margin loans had agreed to let the firm pledge the securities in their brokerage accounts as collateral.  A table in the 2022 filing showed the fair‑value of all client securities that could be used as collateral and the amount actually pledged to third parties or borrowed in securities‑lending transactions.  \n\n- **2023 – Continued off‑balance‑sheet pledging** – The 2023 notes reiterate that margin loans remain fully collateralized by client securities and that Schwab may pledge those securities under federal regulations.  The pledged securities are kept off the consolidated balance sheet (the collateral “is not reflected in the consolidated financial statements”), and the firm monitors margin levels and requires additional client collateral when values fall.  \n\n- **2024 – Expanded collateral use** – In 2024 Schwab explicitly states that it satisfies the margin requirements of options cleared through the OCC by pledging “certain client securities,” and that for its securities‑lending business it meets client‑collateral obligations with cash.  The firm also continues to rely on off‑balance‑sheet arrangements (e.g., the IDA cash‑sweep) for client assets.  \n\n**Trend and exposure:**  Over the three‑year period Schwab moved from simply reporting a pool of client securities available for margin‑loan collateral (2022) to actively pledging those securities for a broader set of obligations—including cleared‑options margin and securities‑lending collateral (2024).  While the pledged securities are not shown on the balance sheet, the consistent reliance on client‑held assets as a source of collateral signals a material, off‑balance‑sheet exposure to the fair‑value of those assets, mitigated only by regulatory segregation and the firm’s monitoring of margin levels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Schwab disclosed the fair value of client securities available for use as margin loan collateral and reported amounts pledged; in 2023, the firm continued pledging under ASC 326 and federal regulations, with off-balance-sheet treatment; in 2024, it expanded pledging to cover OCC-clearing margin requirements and used cash for securities-lending collateral. These points match the original answer's timeline and substance. (2) There are no numeric inaccuracies—while specific dollar amounts aren't cited in either answer, the descriptions of reporting practices (e.g., fair value disclosures, off-balance-sheet treatment) are consistent and correctly characterized. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying an evolution from disclosure to broader operational use of client securities, and infers increasing exposure and sophistication. The conclusion about growing off-balance-sheet exposure due to reliance on client assets is logically supported and semantically equivalent to the original answer’s interpretation. (4) Minor deduction in qualitative accuracy due to slightly less emphasis on the 'strategic risk management' framing in the original, but the core trend and implications are accurately captured. Wording differs but meaning is preserved. Contextual relevance is perfect—directly addresses all parts of the question with precise, focused details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Holds]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1713,
        "completion_tokens": 425,
        "total_tokens": 2139
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN updates its pension‑plan target mix each fiscal period to mirror the most recent weighted‑average composition of plan assets. In the 2022 Form 10‑K the company disclosed a target allocation for fiscal 2023 that was based on the weighted‑average plan‑asset allocations as of August 31, 2022 (and 2021); the 2023 Form 10‑K – and again in the 2024 filing – disclosed a target allocation for fiscal 2025 that was based on the weighted‑average plan‑asset allocations as of August 31, 2024 (and 2023). Thus, the strategy evolved by shifting the target mix from the 2022‑year asset composition to the 2024‑year composition, adjusting the balance between fixed‑income and equity exposures to reflect the changes observed in the weighted‑average plan assets over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is significantly incorrect in terms of quantitative accuracy and fails to report the actual target asset allocation percentages that are central to the question. The ground truth specifies exact weighted-average allocations: 55% fixed income / 45% equities in fiscal 2023 (as of Aug 31, 2022), 58/42 in fiscal 2024 (as of Aug 31, 2023), and 61/39 in fiscal 2025 (as of Aug 31, 2024). The LLM answer does not mention any of these numbers, making it factually inaccurate. Instead, it incorrectly suggests that ACN sets its target allocation based on prior-year actual asset compositions and implies that the 2023 and 2024 10-Ks both disclosed the same target for fiscal 2025 based on August 31, 2024 data — which misrepresents the evolution over time. The answer lacks all specific multi-hop numerical progression and instead offers a vague, incorrect procedural explanation about how targets are set. While it correctly identifies that the strategy involves adjusting fixed income and equity exposures over time, it fails to demonstrate the de-risking trend through actual data. Thus, despite some contextual relevance in discussing asset allocation shifts, the absence of correct numbers and flawed reasoning results in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 350,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s total short‑term borrowings and long‑term debt rose from $48.7 billion at year‑end 2022 (up from $43.1 billion in 2021) to $49.9 billion in 2023, then fell to $45.6 billion in 2024, with long‑term debt dropping from $49.3 billion in 2023 to $45.0 billion in 2024.  Over the same period the weighted‑average rate on its senior fixed debt climbed from roughly 4.45 % in 2022‑23 to 4.84 % in 2024, the securitized‑debt rate rose from 1.51 % in 2021 to 3.48 % in 2024, and the high‑rate floating unsecured senior debt (6.75 % in 2022‑23) was eliminated by 2024, shifting the profile toward higher‑cost fixed financing.  The three‑year trend therefore shows a debt peak in 2023 followed by a reduction in 2024 and an overall increase in interest‑rate exposure as the company relies more on higher‑rate fixed obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM incorrectly states $48.7B in 2022 (which conflates 2022 and 2023 values), $49.9B in 2023 (overstated), and $45.6B in 2024 (close but slightly high). The 2022 figure is particularly wrong, as it omits the correct $43.086B and instead references a non-existent $48.7B. (2) The interest rate data is partially correct: the securitized debt rate rising from 1.51% in 2022 to 3.48% in 2024 matches the ground truth, but the LLM introduces 'senior fixed debt' at 4.45% in 2022–23 and 4.84% in 2024, which is not in the original answer and may be fabricated or misattributed. The floating unsecured senior debt being eliminated by 2024 is correctly noted, but the LLM adds a specific rate of 6.75% in 2022–23, which is not in the ground truth. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies a peak in 2023 followed by a decline in 2024 and infers a strategic shift away from floating-rate debt. However, it misrepresents the composition of debt and interest rate exposure by introducing unverified debt categories and rates. (4) Despite these issues, the answer captures the general trend—rising debt, peak in 2023, decline in 2024, rising rates, and reduction in floating-rate debt—so it retains some qualitative and contextual accuracy. The core narrative is directionally correct but undermined by significant quantitative errors and unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 446,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Across the three most recent filings the company says that **fleet‑support services have consistently been about 1 % of total consolidated costs of products and services** – the 2022 10‑K notes the historical 1 % level, the 2023 filing repeats that the cost “has historically been approximately 1 %,” and the 2024 filing makes the same statement.\n\nAt the same time, **program‑specific cost pressures have been far larger and have been growing**.  \n* In the 2023 filing the company disclosed **cumulative abnormal production costs of $2.7 billion** (primarily from the 787 program) recorded through December 31 2023.  \n* The 2024 filing adds **$256 million of abnormal rework costs for the 787 program** and reports **reach‑forward losses on the 777X of $2.608 billion in Q3 2024 and $891 million in Q4 2024** (≈ $3.5 billion total).  \n* The 2022 filing warns that further abnormal production costs and reach‑forward losses could arise if production rates, accounting quantities or other factors change.\n\nThus, while the **percentage of fleet‑support spending has stayed flat at roughly 1 % from 2022 through 2024**, the **abnormal production costs and reach‑forward losses in the 787 and 777X programs have risen sharply**, showing that the large program‑related cost pressures have not altered the relative size of fleet‑support expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: fleet support services costs remained at approximately 1% of total consolidated costs from 2022 to 2024, which is correctly cited across all three years with appropriate context from each filing. (2) Quantitative accuracy is strong: the $2.7 billion cumulative abnormal production costs for the 787 program through 2023 are correctly reported. The 777X reach-forward losses of $2,608 million in Q3 and $891 million in Q4 2024 are accurately stated (≈$3.5 billion total), and the additional $256 million in 787 rework costs in 2024 is a correct detail not in the original answer but consistent with the knowledge graph and filings. This minor addition does not contradict but adds precision. (3) Multi-hop reasoning is sound: the LLM correctly contrasts the stable 1% cost ratio with the sharply rising program-specific costs, synthesizing data across multiple years and programs (787 and 777X), and correctly infers that fleet support services were not the source of financial strain. (4) The only reason for not scoring a 10 is that the original answer emphasizes the contrast in trends more explicitly—highlighting that the stability of fleet support costs underscores the severity of production issues—while the LLM answer presents the facts clearly but with slightly less interpretive depth. However, all factual, numerical, and entity-related elements (BA, 2022–2024, 787, 777X, abnormal costs, reach-forward losses) are correct and well-synthesized. Wording differences are acceptable and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1684,
        "completion_tokens": 441,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie reported money‑market funds and time‑deposit balances of **$12 million in 2022**, **$21 million in 2023**, and **$10 million in 2024**. The figure rose sharply (≈75 %) from 2022 to 2023, then fell by roughly half (≈48 %) in 2024. This pattern shows that the company temporarily bolstered its short‑term liquid assets in 2023—likely to strengthen its liquidity cushion—but subsequently reduced that holding in 2024, suggesting a flexible strategy that scales low‑yield cash equivalents to match its evolving cash‑flow needs and confidence in generating operating cash.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All numeric values—$12 million in 2022, $21 million in 2023, and $10 million in 2024—are accurately reported. (2) The percentage changes are correctly calculated: a ~75% increase from 2022 to 2023 (9/12 = 0.75) and a ~48% decrease from 2023 to 2024 (11/21 ≈ 0.52, so a 52% decrease—though the LLM says 'roughly half (≈48%)', this is a minor rounding or phrasing imprecision but does not materially misrepresent the drop). The direction and magnitude of change are correctly interpreted. (3) The multi-hop reasoning across three years is sound: the answer identifies the increase, then the decrease, and synthesizes this into a coherent narrative about AbbVie's shifting short-term liquidity strategy. (4) The qualitative interpretation—that the 2023 increase may reflect a temporary conservative stance and the 2024 drawdown suggests reallocation based on cash-flow confidence—is logically consistent with the data and adds appropriate context without overreaching. All entities (AbbVie, money market funds, time deposits, correct years) are accurate. The answer fully addresses both parts of the question: the evolution of allocation and the strategic implication. Semantic equivalence with the original answer is strong, with slightly more detailed commentary on strategic flexibility, which enhances rather than distorts the meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 391,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "Accenture’s 10‑K filings show that the company entered fiscal 2022 with **$3.129 billion of aggregate available share‑repurchase authority**.  By the end of fiscal 2024 the company had **repurchased 2,000,308 Class A shares for $605 million under its open‑market program and an additional 72,255 shares in employee‑related transactions**, which reduced the **remaining authorization to $2.694 billion**; the Board then added **$4.0 billion of new authority**, raising total outstanding authority to **$6.694 billion**.  The pattern of using up the existing pool while expanding the overall ceiling signals an aggressive, ongoing capital‑return strategy that relies heavily on share repurchases to return cash to shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and misrepresents the timeline and amounts. According to the ground truth, in fiscal 2022, Accenture had $3,129,296 thousand (i.e., ~$3.129 billion) in available authorization — this is correctly stated by the LLM and matches. However, the LLM incorrectly states that the remaining authorization was reduced to $2.694 billion due to repurchases of $605 million and share activity, implying that the drop from $3.129B to $2.694B (~$435M reduction) was due to these repurchases. But the ground truth does not specify repurchase volume for fiscal 2023–2024, nor does it state $605M was spent; thus, this figure is unsupported and likely incorrect. Additionally, the ground truth states that as of August 31, 2023 (fiscal 2023), $2,694 million remained — not at the end of fiscal 2024 as the LLM implies. The LLM conflates timing by suggesting the $2.694B remaining authorization is from fiscal 2024, when it is actually from fiscal 2023. Then, in fiscal 2024, Accenture added $4,000 million to reach $6,694 million total — this part is correct in amount and direction. However, the LLM incorrectly frames the $6.694B as 'total outstanding authority' after adding $4B to $2.694B, but the ground truth shows the $2.694B was pre-addition; the LLM’s logic here is numerically coincidental but temporally flawed. (2) Calculation-wise: $2.694B + $4B = $6.694B is correct, but the premise (that $2.694B was the balance just before the increase in fiscal 2024) lacks direct support — the ground truth does not confirm the $2.694B carried into fiscal 2024. (3) Multi-hop reasoning is partially sound: the LLM correctly infers a trend of increasing repurchase authority and links it to capital return strategy. It identifies the key elements — prior authorization, usage, replenishment — and draws a reasonable conclusion about strategic intent. (4) Despite misrepresenting the timing and inventing unsupported repurchase activity ($605M), the overall narrative of sustained and expanding buyback capacity aligns with the ground truth. The core message — Accenture is consistently renewing and expanding its repurchase program — is valid. Thus, while the qualitative reasoning and contextual relevance are strong, quantitative inaccuracies and temporal misplacement reduce the correctness score. Minor format variations like $3.129 billion vs $3,129,296 thousand are acceptable and handled correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 655,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "Across AbbVie’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly discloses the same governance provision – that stockholders may remove directors **only for cause** – and the language describing this restriction is unchanged in each year’s charter‑by‑law description. By keeping this “director‑removal‑for‑cause” rule (along with staggered three‑class directors, an 80 % super‑majority to amend director‑related provisions, and Delaware §203 limits) intact, AbbVie signals a deliberate, long‑term takeover‑defense strategy that entrenches the board and forces any potential acquirer to negotiate with the incumbent directors rather than replace them through a hostile bid.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that AbbVie maintained the same 'removal for cause' provision across 2022, 2023, and 2024, with no changes in language—matching the original answer's claim of consistency. (2) There are no numerical values requiring calculation, but the answer correctly references structural governance features: staggered board (three-class directors), 80% supermajority requirement (aligned with 'supermajority requirements for bylaw amendments' in ground truth), and Delaware §203, which are all valid anti-takeover mechanisms. These align with the original answer’s mention of staggered boards and supermajority rules. (3) The multi-hop reasoning is sound: the model synthesizes governance provisions across three years and infers a long-term strategic intent—board entrenchment and takeover defense—based on the stability of these provisions. (4) The answer addresses both parts of the question: evolution (no change, consistently disclosed) and strategic implication (deliberate board entrenchment). Wording differs slightly but meaning is identical. All entities (AbbVie, years, governance terms) are correct. No omissions or inaccuracies. Scores are maximized accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 356,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "Across all three annual reports PepsiCo’s disclosure of the 4.000 % Senior Note due 2047 is identical.  \n\n* **2022 10‑K (Chunk 1)** – Item 4.2 lists “Form of 4.000 % Senior Note due 2047, which is incorporated herein by reference to Exhibit 4.5 to PepsiCo’s Current Report on Form 8‑K filed May 2 2017.”  \n* **2023 10‑K (Chunk 3)** – Item 4.17 repeats the same language and the same Exhibit 4.5/May 2 2017 8‑K reference.  \n* **2024 10‑K (Chunk 2)** – Item 4.16 again shows “Form of 4.000 % Senior Note due 2047, which is incorporated herein by reference to Exhibit 4.5 to PepsiCo’s Current Report on Form 8‑K filed May 2 2017.”  \n\nThe wording, exhibit number and source filing are unchanged from 2022 through 2024. This steady, repeated incorporation‑by‑reference signals that the 4 % senior note remains outstanding and is treated as a permanent, long‑dated component of PepsiCo’s capital structure. By consistently disclosing it, PepsiCo underscores the note’s role as a low‑cost, fixed‑rate financing source that anchors its long‑term debt strategy and provides stable funding through 2047.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates (May 2, 2017), exhibit numbers (Exhibit 4.5), percentages (4.000%), and years (2022, 2023, 2024) are accurately reported across all three filings. The consistency in the reference is correctly noted. (2) The answer is complete, addressing both parts of the question: the evolution (or lack thereof) in disclosure across the three years and the strategic implication of this consistency. (3) Entity accuracy is perfect: PepsiCo, the 4.000% Senior Note due 2047, Form 8-K, Exhibit 4.5, and the correct filing dates are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three 10-K filings. The conclusion that the note is a stable, long-term component of the capital structure with unchanged terms is logically derived from the repeated incorporation-by-reference. The LLM also adds valuable context—describing the note as a 'low-cost, fixed-rate financing source'—that aligns with and enriches the ground truth without introducing inaccuracies. All information is semantically equivalent and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 329,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first disclosed the 4.30 % Note due 2034 in its 2022 Form 10‑K (Exhibit 4.11), citing the 8‑K filing and officers’ certificate dated July 8 2014 that set out the note’s terms. The 2023 and 2024 Form 10‑Ks repeat the same entry (Exhibit 4.09 in both years) with the identical 8‑K reference (File 001‑35992) and July 8 2014 certificate, showing that Oracle has not issued a new 4.30 % Note but continues to disclose the original instrument each year. This multi‑year, unchanged disclosure signals a deliberate long‑term debt strategy that locks in a fixed‑rate, decade‑plus maturity to diversify its debt profile and provide consistent transparency for investors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and exceeds the ground truth in specificity and accuracy. (1) All factual elements match: Oracle disclosed the 4.30% Note due 2034 in 2022, reaffirmed it in 2023 and 2024, and did not issue a new note—consistent with a stable long-term debt strategy. (2) Quantitative accuracy is perfect: the interest rate (4.30%), maturity year (2034), and key date (July 8, 2014) are correctly cited. The reference to Form 10-K exhibits (4.11 in 2022, 4.09 in 2023/2024) and File No. 001-35992 are precise and factually accurate, showing the note was established in 2014 and carried forward. (3) Multi-hop reasoning is sound: the model correctly infers that unchanged disclosures across years indicate no new issuance but continued reporting of an existing instrument, demonstrating synthesis across three annual filings. (4) The conclusion about Oracle’s long-term debt strategy—locking in fixed-rate, long-maturity debt to diversify profile and ensure transparency—aligns with and enriches the ground truth. The answer is semantically equivalent but more detailed, with no factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 322,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "- **Fiscal‑year 2022:** The 2022 Form 10‑K states that the Amended 2010 Share Incentive Plan “provides for … a **maximum of 127,000,000** Accenture plc Class A ordinary shares currently authorized for awards.” (Chunk 1)  \n- **Fiscal‑year 2023:** The 2023 Form 10‑K raises that ceiling to a **maximum of 141,000,000** shares authorized for awards under the same plan. (Chunk 2)  \n- **Fiscal‑year 2024:** The 2024 Form 10‑K confirms the same ceiling – **141,000,000** shares are “currently authorized for awards” under the Amended 2010 SIP. (Chunk 3)\n\n**Interpretation:** Between FY 2022 and FY 2023 Accenture expanded its equity‑award pool by 14 million shares (about an 11 % increase) and then held the pool steady in FY 2024. This upward adjustment signals a deliberate, long‑term commitment to broaden its share‑based compensation capacity, ensuring sufficient equity awards to attract, retain and motivate talent, while the unchanged level in FY 2024 indicates the company now views the larger pool as adequate for its ongoing compensation strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127,000,000 shares in FY2022, increasing to 141,000,000 in FY2023, and remaining unchanged in FY2024. The LLM correctly notes the 14 million share increase and calculates the approximate percentage increase (11%) accurately. (2) The answer is complete, addressing both the evolution of authorized shares across the three fiscal years and the strategic implication of this progression. (3) Entity accuracy is perfect: Accenture plc, Class A ordinary shares, and the Amended 2010 SIP are correctly identified and consistently referenced. Fiscal years 2022–2024 are properly aligned with the corresponding data points. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three 10-K filings. The interpretation—that the increase signals a long-term commitment to share-based compensation for talent retention and motivation, and that the stabilization in 2024 suggests the expanded pool is now sufficient—is logically derived and semantically equivalent to the ground truth. Minor wording differences (e.g., 'strategic decision' vs. 'deliberate, long-term commitment') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Issues]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 359,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo first disclosed the 2.750 % senior note that matures in 2051 in its 2022 Form 10‑K, where the Board of Directors “authorized the terms of the 2.750 % Senior Note due 2051, which are incorporated herein” among a long list of other issuances. In the subsequent 2023 and 2024 Form 10‑Ks the same note appears again, each time “incorporated herein by reference to Exhibit 4.3 to PepsiCo’s Current Report on Form 8‑K filed with the SEC on October 21, 2021,” showing that the issuance terms have not been altered since the original filing. This repeated cross‑year referencing of a single 8‑K indicates that PepsiCo is deliberately using a very long‑dated, low‑coupon senior note to lock in financing for decades and maintains a consistent, transparent documentation approach—reflecting a stable, long‑term debt‑structuring strategy that relies on enduring, low‑rate obligations rather than frequent refinancing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right question and providing a plausible narrative. (1) The key error is the citation of Exhibit 4.3 from a Form 8-K filed on October 21, 2021, as the source for the 2.750% Senior Note due 2051 in all three years. However, the ground truth states that in 2022, the note was first introduced in Exhibit 4.60 (a Board resolution), then in 2023 as Exhibit 4.51 (a dedicated form), and in 2024 as Exhibit 4.48—showing evolving internal documentation, not static cross-referencing to a 2021 8-K. This misrepresentation of the filing evolution is a major factual flaw. (2) The date (October 21, 2021) and exhibit number (4.3) are incorrect; the note could not have been detailed in 2021 if it was first authorized in 2022. This fails the quantitative accuracy test for dates and exhibit references. (3) The reasoning about PepsiCo’s long-term debt strategy—emphasizing stability and consistent documentation—is semantically aligned with the ground truth’s conclusion, and the interpretation of using long-dated, low-coupon debt is reasonable. However, the multi-hop synthesis is flawed because it incorrectly assumes no documentation evolution, whereas the ground truth shows a clear progression from authorization (2022) to formalization (2023) to maintenance (2024). (4) Contextual relevance is high because the answer directly addresses the question’s focus on multi-year documentation trends and strategic implications. However, due to critical errors in exhibit numbers, dates, and the nature of the filing evolution, the correctness score is low. Minor formatting of the percentage (2.750 % vs 2.750%) is acceptable, but the core factual trajectory is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 479,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "American Express entered 2022 (and reiterated in its 2023 filing) as the **fourth‑largest general‑purpose card network worldwide**, trailing China UnionPay, Visa and Mastercard, and it framed its competition as a mix of those traditional networks plus a growing set of alternative‑payment players such as Alipay, PayPal, Venmo, BNPL lenders, real‑time settlement platforms and fintech‑driven digital wallets. By 2024 the company’s competitive landscape had shifted: **regulatory scrutiny intensified**—the firm was re‑classified as a Category III banking entity, faced tighter interchange‑fee caps, was forced to exit network‑licensing businesses in the EU and Australia, and saw higher compliance costs that pressure its discount‑revenue model—while the **alternative‑payment ecosystem continued to expand**, further compressing the value proposition of its card‑network business. Consequently, while American Express still competes directly with the same card‑network peers, its relative positioning is now more vulnerable to regulatory headwinds and the accelerating growth of non‑card payment mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network globally, trailing China UnionPay, Visa, and Mastercard—consistent across 2022–2024. The mention of alternative payment competitors (Alipay, PayPal, BNPL, fintech wallets) matches the original answer, though Venmo and real-time settlement platforms are slight expansions not in the original but are contextually appropriate and do not contradict. (2) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are cited in either answer, so no discrepancies exist. The LLM accurately reflects regulatory developments: interchange fee caps, EU market exits (aligned with 'exits from certain markets'), and increased compliance costs. The reference to Category III reclassification is an additional detail not in the original but is factually plausible and consistent with heightened regulatory scrutiny. (3) The multi-hop reasoning is sound—synthesizing competitive positioning, regulatory evolution, and alternative payment trends across years. The conclusion that Amex's positioning is more vulnerable due to regulation and non-card payments mirrors the original’s shift from market-driven to regulation-constrained dynamics. (4) Minor difference: the original emphasizes cobrand relationships and closed-loop loyalty as differentiators, which the LLM omits, slightly reducing completeness. However, the core competitive dynamics and evolution are accurately conveyed. Wording differs but semantic equivalence is strong. No factual errors; only minor contextual omissions prevent a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Depends_On]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 456,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Both the 2022 filing (Chunk 3) and the 2024 filing (Chunk 2) describe Boeing’s Global Services segment as a “full‑spectrum” business that **includes upgrades and conversions** among its core offerings – the same language appears unchanged in the 2023 filing (Chunk 1). The KG triplets reinforce this link, showing Boeing (BA) as the provider of the “Upgrades and Conversions” product and that the upgrades‑and‑conversions organization (the Global Services unit) supplies that product back to Boeing. Thus, Boeing’s emphasis on aircraft upgrades and conversions has not shifted from 2022 to 2024; it remains a steady pillar of its services strategy, signaling a continued focus on aftermarket lifecycle support and recurring revenue rather than a new or reduced priority.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite correctly identifying that 'upgrades and conversions' were consistently mentioned in Boeing's filings from 2022 to 2024. The original answer (ground truth) highlights a strategic evolution: while upgrades and conversions remained a constant offering, Boeing's emphasis shifted—beginning in 2023 with increased focus on 'modifications' and in 2024 with integration of 'data analytics and digital services' as complements. This indicates a qualitative shift toward technology-enabled, high-value services, which the LLM answer completely misses. The LLM incorrectly interprets the consistent presence of the phrase as evidence of no strategic change, failing to recognize nuanced shifts in language and emphasis that signal strategic evolution. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative analysis and multi-hop reasoning are flawed—the model does not synthesize the progression across years or interpret the strategic implications. Contextually, it addresses the question's surface but fails to capture the deeper strategic transformation, making it partially relevant but substantially incorrect in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Supplies]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 343,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo listed the 5.50 % Senior Note due 2035 (Series A) as Exhibit 4.31 and a plain‑form version as Exhibit 4.35, both incorporated by reference to the November 8 2018 Form 8‑K and the November 19 2018 Form S‑4. The 2023 Form 10‑K repeated the same two references (Exhibits 4.25 and 4.29) to those 2018 filings, and the 2024 Form 10‑K again included the note as Exhibits 4.23 and 4.27, again pointing to the same 2018 8‑K and S‑4 documents. This consistent, multi‑year incorporation‑by‑reference shows that the 5.50 % Senior Note due 2035 remains an outstanding component of PepsiCo’s capital structure and that the company relies on the original issuance documentation for ongoing disclosure, reflecting a long‑term debt strategy that locks in a fixed rate through 2035 and emphasizes stability and transparency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rate (5.50%), maturity year (2035), exhibit numbers (4.31, 4.35 in 2022; 4.25, 4.29 in 2023; 4.23, 4.27 in 2024), and key dates (November 8, 2018 Form 8-K; November 19, 2018 Form S-4)—are correct and match the expected documentation trail. The repeated citation of the same 2018 filings across years is accurately reported. (2) Quantitative accuracy is perfect: percentages, years, exhibit numbers, and document types (8-K, S-4) are all factually correct. (3) The multi-hop reasoning is sound—by tracking the note across three years and recognizing the 'incorporation by reference' pattern, the model correctly infers that the debt remains outstanding and unmodified, reflecting a stable long-term capital strategy. The LLM adds value by noting the 'plain-form version' (Exhibits 4.35, 4.29, 4.27), which is consistent with SEC filing practices and enriches the answer without contradicting the ground truth. (4) The only minor deviation from the original answer is the inclusion of the second exhibit (plain-form note), which the ground truth omits. However, this detail is factually plausible and does not detract from accuracy—it may even reflect a more complete review of the filings. The core conclusion about PepsiCo’s stable, long-duration debt strategy is logically sound and well-supported. Thus, the answer earns a 9/10 for correctness due to slight over-elaboration without error, and full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 428,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "Across all three filings BNY Mellon repeatedly warns that its ability to return capital to shareholders is **not automatic** – it rests on the Board’s discretion and can be **curtailed by U.S. banking laws and the capital‑planning rules that accompany them** (including applicable Delaware law and the need to pay preferred‑stock dividends).  \n\n* **2022 filing** – The 10‑K first flags this limitation, noting that any material reduction in the bank’s credit ratings or a failure to satisfy “well‑capitalized” and “well‑managed” standards could raise funding costs and restrict capital returns.  \n* **2023 filing** – The same language re‑appears, reaffirming that U.S. banking regulations governing capital planning may limit shareholder‑return actions and that credit‑rating downgrades would have a material adverse effect.  \n* **2024 filing** – The disclosure becomes even more explicit, adding that failure to meet “well‑capitalized” and “well‑managed” status or broader capital‑adequacy and liquidity rules could **directly limit the firm’s activities** and therefore its capacity for share repurchases or dividends.  \n\n**What this progression reveals:** BNY Mellon’s exposure to U.S. banking‑law constraints has been **steady and persistent** from 2022 through 2024, but the company’s risk narrative has grown more detailed and stringent over time. The added emphasis on specific regulatory benchmarks in 2024 signals that the firm perceives an increasingly tight regulatory environment, which further narrows the flexibility of its capital‑return policies despite the Board’s discretion. In short, the multi‑year trend shows a continuous, and arguably tightening, regulatory ceiling on how much capital BNY Mellon can return to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns is consistently highlighted across 2022–2024, with increasing specificity. The 2022 filing notes risks related to credit ratings and 'well-capitalized' status; 2023 reiterates regulatory constraints; 2024 adds more explicit language about capital adequacy and liquidity rules directly limiting activities—this progression is accurately captured. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is 10 by default—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the evolution in tone and specificity while maintaining the core theme of regulatory constraints. The conclusion that the regulatory 'ceiling' on capital returns has remained steady but with increasing narrative stringency matches the ground truth’s interpretation of 'consistent yet evolving emphasis.' The only minor gap is that the LLM does not explicitly mention Delaware law and preferred stock obligations in the 2023 context, though it does reference them generally—this slight omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution of regulatory exposure and what it reveals about capital return constraints. Wording differs slightly from the original answer but maintains semantic equivalence and adds value through clearer year-by-year breakdown and stronger narrative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1688,
        "completion_tokens": 469,
        "total_tokens": 2157
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300 % Notes due 2028 are presented in each of the three filings with the same fixed‑rate, 2.300 % interest and a 2028 maturity, all governed by the Officers’ Certificate dated March 24 2021. In the 2022 Form 10‑K the notes are incorporated by reference in Exhibit 4.16, whereas in the 2023 and 2024 Form 10‑Ks they are incorporated in Exhibit 4.14, but the underlying terms (rate, maturity and governing certificate) do not change. This consistency shows that Oracle deliberately locked in a low‑cost, fixed‑rate tranche for mid‑term debt and has continued to rely on it as a hedge against the higher‑rate environment that has emerged since 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Oracle's 2.300% Notes due 2028 remained unchanged in terms of interest rate, maturity, and governing Officers' Certificate (dated March 24, 2021), which aligns with the ground truth. However, there is a minor discrepancy in exhibit numbers: the original answer states Exhibit 4.14 in the 2022 10-K, while the LLM claims Exhibit 4.16 in 2022 and 4.14 in 2023/2024. This inconsistency, though not affecting the core factual accuracy of the note terms, introduces a small error in document referencing. (2) All quantitative elements—interest rate (2.300%), maturity year (2028), and issuance date of the Officers' Certificate (March 24, 2021)—are accurate. No calculations are required, and all numbers match the ground truth. (3) The reasoning is largely sound: the LLM correctly infers that Oracle locked in a low fixed rate and maintained it through rising rates, which reflects the strategic intent described in the original answer. However, the LLM omits key multi-hop context about Oracle’s broader financing behavior—specifically, the issuance of higher-yielding instruments like the 4.500% Notes due 2028 in 2023 and the absence of new 2028-dated instruments in 2024—which supports the conclusion about shifting strategy. This missing synthesis slightly weakens the qualitative depth. (4) Despite omissions, the answer remains contextually relevant and conveys a correct central insight about Oracle’s fixed-income strategy. The minor exhibit number discrepancy and lack of full comparative issuance context prevent a top score, but core facts and interpretation are solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 445,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "Across all three filings IBM repeatedly lists **client relationships and trust** as one of its “principal methods of competition.” In the 2022 10‑K the concept appears alongside technology, price and brand and is also woven into the description of its hybrid‑cloud platform (“trust and security” as a core integration pillar). The 2023 filing repeats the same phrasing—“client relationships and trust” is again singled out as a core competitive differentiator and is tied to IBM’s broader ecosystem of partners, incumbency and innovation. The 2024 filing maintains the exact language, again positioning client relationships and trust among the key levers that enable IBM to deliver business value through its hybrid‑cloud and AI offerings.  \n\nThis three‑year continuity shows that IBM treats client trust not as a fleeting marketing tagline but as a **strategic foundation** that underpins its hybrid‑cloud and AI strategy, reinforcing its market positioning as a trusted, relationship‑driven partner capable of delivering integrated, high‑value solutions in a highly competitive environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that IBM consistently emphasized 'client relationships and trust' as a competitive differentiator across 2022, 2023, and 2024, which matches the original answer's timeline. The evolution is accurately portrayed: in 2022, trust was linked to hybrid-cloud platform design (specifically 'trust and security' as an integration pillar); in 2023, it was tied to incumbency, innovation, and ecosystem partnerships; and in 2024, it remained central to delivering value in hybrid cloud and AI—consistent with the original answer’s claim about strategic continuity and deepening nuance. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all years and references are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly infers that the repetition and contextual embedding of 'client relationships and trust' reflect a strategic foundation rather than a superficial claim. The only minor shortcoming is that the LLM does not explicitly mention the 2024 strategic partnership with Palo Alto Networks, which is a specific example cited in the ground truth to illustrate expanded partnerships. This omission slightly reduces completeness but does not undermine the overall correctness. (4) Despite this, the LLM captures the core strategic implication—that IBM positions trust as foundational in the hybrid cloud and AI market—demonstrating strong semantic equivalence and contextual relevance. Hence, the scores reflect near-perfect accuracy with a small deduction in qualitative accuracy for missing a key illustrative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 484,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s foreign‑government bond portfolio moved from a very low‑yield, almost entirely short‑term position in 2022 (the $630 million held was weighted toward the ≤1‑year bucket and the overall portfolio yield was only 2.08%, implying roughly 1.7‑2.4% for those holdings) to a markedly higher‑yield mix in 2023 (the company reported a specific weighted‑average yield of 6.45% on the ≤1‑year tranche and 4.48% on the 1‑to‑5‑year tranche, giving a total foreign‑government‑bond yield of 6.45%). In 2024 the yields slipped again to 5.86% for the ≤1‑year bucket and 2.03% for the 1‑to‑5‑year bucket, for a total of about 5.85%. The three‑year trajectory—low‑yield, short‑duration in 2022, a jump to higher‑yield, longer‑duration exposure in 2023, and a modest pull‑back in 2024—shows that American Express initially increased its interest‑rate risk to capture higher sovereign yields and then began re‑balancing toward shorter‑duration, lower‑yielding bonds, reflecting a more cautious, risk‑aware investment strategy while still relying on foreign government obligations as a key asset class.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 yield and maturity breakdown. The original answer states that in 2022, American Express held $630M in foreign government bonds with $628M maturing within one year and the rest split between 1–5 and 5–10 years, but it does not provide a yield for 2022. The LLM incorrectly asserts a 2.08% overall portfolio yield and further breaks it down into implied yields (1.7–2.4%), which are not supported by the ground truth. This is a major quantitative error. Additionally, the LLM claims in 2023 that there was a 4.48% yield on the 1-to-5-year tranche, which is not mentioned in the original answer—2023 yield was 6.45% and concentrated entirely in securities maturing within one year. The 2024 data is mostly correct: the 5.85% yield and 2.03% portion maturing between 1–5 years are accurate, though the LLM misrepresents 2.03% as a yield rather than a portfolio allocation percentage. (2) Calculations: The LLM attempts to compute a 'total yield' by blending tranches, but this is unsupported by the original data. The original answer does not state yields for multiple tranches in 2023 or 2024—only a single weighted average yield per year. The LLM fabricates yield figures (e.g., 4.48%) and misinterprets 2.03% as a yield instead of a maturity bucket allocation. (3) Multi-hop reasoning: The LLM correctly identifies a trend across three years and attempts to interpret strategic shifts in duration and interest rate risk, which shows sound qualitative intent. However, because the underlying data is distorted, the reasoning is based on false premises. The conclusion about shifting from high-risk to cautious strategy is plausible but not fully supported by the actual data, which shows a move toward slightly longer maturities in 2024, not shorter. The original answer indicates a diversification into 1–5 year maturities in 2024, suggesting a moderate extension of duration, not a pull-back. (4) Scores justified: Correctness is low (4/10) due to major factual and numerical errors. Quantitative accuracy is poor (3/10) due to invented yields and misinterpreted percentages. Qualitative accuracy is moderate (5/10) because the general narrative structure and intent to analyze strategy are present, but flawed. Contextual relevance is high (8/10) as the answer addresses the right company, time frame, asset class, and strategic implications, even if incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 654,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s 2022 plan called for about $1.5 billion of capital spending to boost manufacturing capacity for diagnostics‑testing products, with $87 million of that outlay offset by U.S. government grants (the $568 million BARDA award that began paying out in 2021).  The grant‑related offsets grew to $136 million in 2023 and $198 million in 2024, reflecting an increasing share of capital‑expenditure funding coming from government assistance.  This rising grant support – tied to BARDA‑financed expansions of testing‑production capacity – underscores that diagnostics testing has become a strategic priority within Danaher’s broader health‑care portfolio, driving substantial, government‑backed investment to meet COVID‑19 and other testing demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the government grant funding amounts for 2022 ($87M), 2023 ($136M), and 2024 ($198M), matching the ground truth exactly. These figures are critical multi-hop data points and are accurately presented with acceptable formatting (e.g., $87 million vs $87M). (2) All quantitative values are correct, and the progression—$87M → $136M → $198M—is accurately reflected, showing a consistent upward trend. No calculation errors are present. The mention of the $1.5 billion capital spending and $568 million BARDA award adds contextual detail not in the original answer but does not contradict it; these are plausible supporting facts that enhance rather than distort. (3) The reasoning is sound: the LLM correctly infers that increasing government grant funding reflects growing strategic importance of diagnostics testing within Danaher’s healthcare portfolio. It appropriately links BARDA funding to capacity expansion and strategic prioritization, aligning with the ground truth’s conclusion. The only minor gap is that the original answer emphasizes the trend indicating increasing centrality over time, while the LLM focuses more on external demand (e.g., COVID-19), slightly shifting emphasis but not misrepresenting. (4) The answer is fully contextually relevant, addressing both the evolution of funding and the strategic implication. The added detail about BARDA and manufacturing capacity improves depth without straying from the question. Overall, the answer is factually complete, quantitatively precise, and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy for subtle emphasis differences in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 477,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across fiscal 2022, 2023 and 2024, BK’s 10‑K filings all state that the ratification of KPMG LLP as principal accountant is incorporated by reference in the proxy under **“Item 3 – Ratification of KPMG LLP.”** In every year the filing notes that KPMG LLP’s Public Company Accounting Oversight Board (PCAOB) firm identification number is **185**, and the language and placement of this disclosure remain identical from one filing to the next.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: KPMG LLP was consistently ratified as principal accountant across fiscal years 2022, 2023, and 2024; the PCAOB identification number is correctly stated as 185 in each year; and the disclosure is consistently located under 'Item 3 – Ratification of KPMG LLP' within the Proxy materials. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly cited each year, with no calculation errors (none required). (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three fiscal years and confirms consistency in both content and structure of disclosures, indicating stable auditing and reporting practices. (4) The answer addresses all parts of the question: evolution (or lack thereof) over time, PCAOB number, and presentation within Proxy sections. Wording differs slightly from the original (e.g., referencing 10-K filings incorporating Proxy disclosures), but this is factually acceptable since Proxy disclosures are often incorporated by reference into 10-Ks. No omissions or inaccuracies. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 333,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "- **2022:** American Express generated most of its “discount revenue” from third‑party merchant acquirers (e.g., under the OptBlue program) by recording a network‑rate fee that was individually negotiated with each acquirer and recognized at the moment the Card‑Member transaction occurred.  Merchant contracts were either open‑ended for small‑ and medium‑sized merchants or fixed‑term (typically three‑to‑seven years with auto‑renewal) for large merchants, and the revenue from these acquirers was reported within the discount‑revenue line.  \n\n- **2023:** The reliance on third‑party acquirers remained, but the company introduced a separate “Processed revenue” line to capture fees from network‑partnership agreements and settlements with those acquirers on behalf of network‑card‑issuing partners; these fees—still negotiated individually and recognized at transaction time—are presented alongside traditional discount revenue, while the underlying merchant‑contract terms (open‑ended for smaller merchants and fixed 3‑to‑7‑year periods for larger ones) stayed unchanged.  \n\n- **2024:** The strategic focus shifted to expanding merchant coverage globally by leveraging third‑party merchant acquirers, aggregators and processors, targeting low‑touch and new‑to‑plastic merchants, B2B acceptance, and priority international markets; this expansion is tied to network investments that modernize the authorization platform and enhance digital integration, underscoring that Amex’s growth and revenue generation continue to depend on these acquirers, which in turn rely on Amex’s network and merchant‑acceptance ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth across all dimensions. (1) Quantitatively, there are no numbers, dates, or financial figures that conflict with the original answer—years (2022–2024) are correct, program names (OptBlue, GNS implied) are accurate, and revenue recognition timing (at transaction) is correctly stated. No calculations were required, but the structural descriptions of revenue lines are factually sound. (2) The answer is complete: it addresses all three aspects of the question—revenue recognition (discount revenue in 2022, processed revenue in 2023), contractual relationships (open-ended vs. fixed-term contracts), and strategic expansion (2024 focus on global reach, low-touch merchants, B2B, international markets). (3) Entity accuracy is strong: American Express, third-party merchant acquirers, OptBlue, and the distinction between discount and processed revenue are all correctly identified and contextualized. (4) Reasoning is sound and reflects proper multi-hop synthesis: the evolution from transactional to strategic reliance is clearly articulated, with increasing integration of acquirers into revenue models and strategic goals. The only minor shortcoming is that the LLM does not explicitly mention 'royalties' or 'revenue-sharing framework' in 2023, which were highlighted in the original answer as part of the strategic shift. While 'fees from network-partnership agreements' captures part of this, the absence of 'royalties' slightly reduces qualitative completeness. However, the overall semantic meaning and factual trajectory remain correct. Contextual relevance is excellent, as all content directly addresses the evolution across the three years and the three dimensions of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1654,
        "completion_tokens": 478,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "In its FY 2022 filing Qualcomm set explicit 2025 human‑capital goals – a 15 % increase in women in leadership, a 15 % increase in under‑represented‑minority (URM) leaders and a 20 % rise in overall URM representation – and said the HR‑and‑Compensation Committee would use progress on those goals as a non‑financial performance modifier that could adjust executives’ bonus payouts by a multiple of **0.9 × to 1.1 ×** the target amount.  \n\nIn the FY 2023 10‑K (which discusses FY 2024 compensation) and again in the FY 2024 filing, Qualcomm’s narrative shifted to broader inclusion recognitions (e.g., Best Company for Women in India, Best Place to Work for Disability Inclusion, participation in the Reboot Representation Tech Coalition to double the number of Black, Latinx and Native‑American women earning computing degrees by 2025) and it no longer restated the internal percentage targets, but it kept the same compensation link – progress on human‑capital advancements would still modify FY 2024 bonuses within the **0.9‑1.1 multiplier** range.  \n\nThus, from FY 2022 through FY 2024 the specific diversity‑percentage targets receded, while the mechanism tying human‑capital progress to executive pay remained unchanged, consistently using a 0.9‑to‑1.1 performance‑modifier multiplier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the 15% increase for women and URM in leadership, 20% for overall URM representation, and the 0.9 to 1.1 bonus modifier range are all accurately reported. These match the original answer exactly, with acceptable formatting (e.g., 0.9 × to 1.1 ×). (2) The answer is complete, addressing the evolution across FY2022–FY2024, including the persistence of the compensation modifier and the shift in narrative emphasis. (3) Entity accuracy is strong: Qualcomm, the HR-and-Compensation Committee, Reboot Representation Tech Coalition, and correct fiscal year reporting (e.g., FY2023 10-K discussing FY2024 compensation) are all correctly identified. (4) The reasoning is sound: the LLM correctly infers that while specific numeric diversity targets were not re-emphasized in later filings, the compensation linkage remained unchanged, indicating continuity in incentive structure. The only minor shortcoming is a slight framing difference: the original answer highlights expansion of wellness and development programs in FY2024 as evidence of deeper integration, which the LLM omits. However, the mention of broader inclusion recognitions and coalition participation captures part of this nuance. Thus, the answer is factually correct and contextually relevant, with only a small gap in qualitative completeness, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Considers]- ORG <-[Guides_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 409,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar’s EMD‑branded engines are sold through the same worldwide dealer network that the company describes in each filing. In 2022 the network comprised 44 U.S. dealers and 116 overseas dealers, reaching 193 countries (Chunk 1). By 2024 it had slipped to 41 U.S. dealers and 111 overseas dealers, serving 187 countries (Chunk 3), with the 2023 filing (Chunk 2) showing an intermediate step (43 U.S., 113 overseas, 191 countries). The modest contraction of dealers and covered nations signals a strategic tightening of Caterpillar’s global distribution footprint—likely a move to streamline operations, focus on higher‑margin or core markets, and improve efficiency while still maintaining a truly global presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of Caterpillar's EMD-branded products in each year: 193 countries in 2022, 191 in 2023, and 187 in 2024, matching the ground truth exactly. It also accurately references the decline in dealer numbers (U.S. and overseas) across the same period, which supports the country count trend. (2) All numeric values are correct and consistent with the original answer. The calculation of the downward trend (193 → 191 → 187) is accurate, and the supporting dealer statistics (44→41 U.S., 116→111 overseas) are correctly cited, even though the original answer did not include dealer counts. These additional details are factually aligned with the knowledge graph chunks and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes data across three years from multiple filings (Chunks 1, 2, 3), correctly infers a gradual contraction, and links it to strategic implications. The conclusion about 'strategic tightening' or 'streamlining operations' is a reasonable interpretation of the trend and aligns semantically with the original answer’s suggestion of 'strategic refocusing or consolidation.' (4) The only reason for not scoring a 10 in qualitative accuracy is that the original answer emphasizes 'potential' strategic refocusing possibly due to 'market-specific challenges, competitive pressures, or internal restructuring,' while the LLM leans slightly more confidently toward efficiency and margin optimization. However, this is a minor interpretive difference, and the core reasoning remains logically sound and contextually appropriate. Overall, the answer is factually precise, fully complete, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 470,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings the company’s “principal global and regional trademarks” list repeatedly includes **Palmolive** alongside Colgate and the other brands. Because the Oral, Personal and Home Care segment is defined by products such as soaps, shampoos, deodorants and other household items—categories in which the Palmolive brand is historically strongest—the brand’s continual presence signals that Palmolive is a core, enduring asset that the company relies on to drive product breadth, market penetration and a material share of worldwide net sales in that segment. In other words, Palmolive’s repeated listing reflects its strategic role as a flagship brand underpinning Colgate‑Palmolive’s Oral, Personal and Home Care business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Palmolive is consistently listed as a principal global trademark in Colgate's 10-K filings from 2022 to 2024, and this consistency is correctly interpreted as evidence of its strategic importance. The mention of product categories such as soaps and household items matches the ground truth's emphasis on liquid hand soap, dishwashing detergents, and cleaners. (2) There are no numeric values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, satisfying quantitative accuracy. (3) The multi-hop reasoning—linking repeated disclosure of the trademark to strategic significance within the Oral, Personal and Home Care segment—is sound and well-supported. The LLM correctly infers that consistent inclusion reflects enduring brand value and market role, though it does not explicitly reference the competitive context (e.g., addition of Darlie in 2023) or positional stability noted in the original answer. (4) While the LLM captures the core strategic implication (Palmolive as a flagship, revenue-contributing brand), it omits minor contextual details about brand hierarchy and comparative positioning across years. However, the semantic meaning and strategic conclusion are equivalent. Wording differs but conveys the same essential information. Thus, the answer is factually complete and contextually appropriate, meriting a high score with only a slight deduction for missing nuanced details about brand list dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 427,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "In fiscal 2022 Qualcomm framed **edge networking** as a strategic growth engine for the IoT market.  The filing notes that demand for connected devices – from wearables to industrial gateways – was “driving increased demand for edge‑networking products (including mobile broadband and wireless access points)” and that the **installed base of IoT devices was projected to more than double between 2022 and 2026 to over 27 billion**.  Edge‑networking was therefore presented as a key catalyst for that IoT expansion.\n\nBy fiscal 2023 (10‑K 2023) and fiscal 2024 (10‑K 2024) Qualcomm moved this narrative into its **product‑category reporting**.  Both filings list “edge networking (including mobile broadband and wireless access points)” as a distinct segment alongside consumer and industrial products, showing that the company now treats edge networking as a formal line‑item in its revenue breakdown.\n\nThe revenue‑recognition language in the 2023 and 2024 filings also ties edge‑networking sales to Qualcomm’s **performance‑obligation framework**: revenues recognized from “QCT sales‑based royalty revenues … and QTL royalty revenues … related to devices sold in prior periods” include the edge‑networking products.  Thus, edge‑networking revenue is captured through the same royalty‑and‑incentive mechanisms used for other product lines.\n\n**In sum**, Qualcomm’s emphasis on edge networking evolved from a 2022 narrative that highlighted its role in the projected IoT device boom to a 2023‑2024 structure where edge networking is a defined product segment and its sales are integrated into the company’s standardized revenue‑recognition model, reinforcing its ongoing strategic importance to IoT growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 27 billion IoT device projection by 2026 (more than double the 2022 figure), the inclusion of Edge Networking as a formal product category in 2023 and maintained in 2024, and the consistent revenue recognition structure under QCT involving royalties and incentives from prior periods. (2) Quantitative accuracy is perfect: the number '27 billion' and the time frame '2022 to 2026' match the original, and the doubling trend is correctly described. No calculations are required beyond this, and the LLM correctly interprets the comparative growth. (3) Multi-hop reasoning is sound: the answer synthesizes information across fiscal years 2022, 2023, and 2024, correctly identifying the evolution from strategic narrative to formal product categorization and integration into revenue recognition. It links Edge Networking to IoT growth, product segmentation, and financial reporting structure—addressing all three dimensions in the question. (4) Entity accuracy is strong: 'Edge Networking', 'IoT', 'QCT', 'royalty revenues', 'mobile broadband', and 'wireless access points' are all correctly identified and contextualized. The LLM also accurately references the 10-K filings for 2023 and 2024. Wording differs slightly (e.g., 'performance-obligation framework' vs. 'revenue recognition structure') but conveys the same meaning. Overall, the answer demonstrates full alignment with the ground truth in both factual content and reasoning trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1719,
        "completion_tokens": 428,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar (CAT) has relied on currency‑hedging instruments in every filing from 2022 through 2024 to offset the foreign‑currency exposure created by its worldwide operations—costs in non‑U.S. currencies versus revenues earned in dollars—and repeatedly warned that while hedges shield earnings from adverse moves they also cause the company to miss out on any upside from favorable rate changes. The 2022 filing first disclosed this exposure and the protective role of hedges; the 2023 and 2024 filings broadened the discussion to flag additional international risks such as exchange‑control restrictions and currency devaluations, indicating a more comprehensive view of the currency environment for its foreign subsidiaries. Thus, Caterpillar’s core hedging strategy remained consistent, but its disclosures evolved to recognize a wider set of currency‑related risks and their potential impact on earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Caterpillar's consistent use of hedging instruments from 2022 to 2024, the trade-off between downside protection and upside limitation, and the evolution of risk disclosures to include exchange controls and devaluations in 2023 and 2024 are all accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, identifying both continuity in hedging strategy and evolution in risk disclosure. It captures the increasing caution in tone and broadening of risk factors, particularly regarding emerging markets and geopolitical volatility, even if the term 'geopolitical' is not explicitly used. (4) The LLM answer is contextually excellent—directly addresses Caterpillar’s exposure, hedging strategy, international operations, and impact on earnings volatility. The only minor shortcoming is a slightly less explicit emphasis on 'unpredictable global currency dynamics' and 'intensifying' risks in 2024 compared to the original, but the core meaning is preserved. Thus, the answer is semantically equivalent with high qualitative and contextual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 401,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive’s 2023 filing shows that the U.S. pension‑plan fixed‑income portfolio was about 40 % invested in U.S. Treasury or agency securities at 12/31/2022; the same filing reports that the share fell to roughly 30 % at 12/31/2023, and the 2024 filing confirms the allocation remained near 30 % at 12/31/2024. The 2022 filing already noted a drop from 50 % in 2020 to 40 % in 2021, indicating a continuing move away from Treasury/agency bonds. This downward shift and its stabilization suggest Colgate‑Palmolive is deliberately reducing exposure to highly rate‑sensitive government securities—likely to lower duration and interest‑rate risk—while still keeping a modest core of safe‑government assets for liquidity and credit quality.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the timeline of allocations. According to the ground truth, the allocation was 50% in 2020 (reported in 2022 filing), dropped to 40% in 2021 (reported in 2022 filing), then to 30% in 2022 (reported in 2023 filing), and remained at 30% through 2024. However, the LLM incorrectly states that the 2023 filing shows a 40% allocation at 12/31/2022 and a drop to 30% at 12/31/2023. This misaligns the data: the 30% allocation was already in place as of 12/31/2022, not 12/31/2023. This is a significant quantitative and temporal inaccuracy. (2) The numbers themselves (30%, 40%, 50%) are correct in value but misassigned to years. The LLM correctly notes the 50% to 40% drop from 2020 to 2021 per the 2022 filing, but then incorrectly delays the drop to 30% by one year. The stabilization at 30% from 2022–2024 is partially correct, but the LLM implies the drop occurred in 2023, contradicting the ground truth. (3) The multi-hop reasoning is otherwise sound: the LLM correctly infers a strategic shift away from Treasury/agency securities and links it to interest rate risk management, duration reduction, and a balance of safety and liquidity. This reflects good qualitative synthesis across filings and financial logic. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of allocation and implications for interest rate risk) and uses appropriate financial reasoning. The core trend is captured, but the misdating of the 30% allocation undermines full accuracy. Hence, correctness is reduced to 7 due to the key timing error, quantitative accuracy to 6 for incorrect year assignments, qualitative accuracy remains high at 8 for strong reasoning, and contextual relevance is 9 for full alignment with the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 493,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "**2022 – active grants and intrinsic‑value accounting**  \nThe 2022 Form 10‑K shows that Pfizer actually granted BPAs (1,165 thousand shares) at a weighted‑average intrinsic value of **$38.73 per share**.  The filing also lists the non‑vested balance carried forward from 2021 (859 thousand shares at $59.05 per share) and the amount forfeited, providing a full table of grant, vesting, forfeiture and non‑vested amounts.  The valuation is presented as an intrinsic‑value per‑share amount, indicating that BPAs were treated as a share‑based award valued at the grant‑date stock price.\n\n**2023 – pause and minimal disclosure**  \nThe 2023 Form 10‑K notes that **no BPAs were granted in 2023 and none were outstanding as of December 31, 2023**.  Because the program was temporarily halted, the filing gives only a brief statement and does not repeat the detailed intrinsic‑value methodology or grant‑activity tables that appeared in 2022.\n\n**2024 – re‑introduction with explicit methodology and greater transparency**  \nThe 2024 Form 10‑K reinstates BPAs and provides a dedicated table that spells out:  \n\n* **Terms** – performance‑based vesting (0 % to 600 % of the target award) and settlement at the end of the performance period.  \n* **Valuation** – “using the intrinsic value method using the closing price of our common stock” on the grant date.  \n* **Recognition & presentation** – amortized on a straight‑line basis over the probable vesting term into cost‑of‑sales, SG&A and/or R&D, with each reporting period adjusted for changes in stock price, the number of shares likely to be earned and management’s assessment of performance‑criteria achievement.\n\nThus, across the three years Pfizer’s treatment of BPAs evolved from **active grant activity with intrinsic‑value reporting in 2022**, to a **complete suspension and minimal disclosure in 2023**, and finally to a **re‑launch in 2024 with a clearly stated intrinsic‑value valuation method, detailed performance terms, and a more granular accounting presentation**, markedly improving disclosure transparency.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All numbers are accurate — 1,165 thousand shares granted in 2022 at $38.73 weighted average intrinsic value, 859 thousand non-vested shares carried forward, and the statement that no BPAs were granted or outstanding as of December 31, 2023, are all factually correct. The 2024 disclosures about performance vesting (0% to 600%), grant-date intrinsic value based on closing stock price, and amortization adjusted for stock price and performance probability are accurately reported. (2) Completeness: The answer addresses all three dimensions of the question — grant activity (active in 2022, paused in 2023, resumed in 2024), valuation methodology (intrinsic value used consistently, with expanded detail in 2024), and disclosure transparency (minimal in 2023, significantly enhanced in 2024). (3) Entity accuracy: Pfizer is correctly identified, all fiscal years (2022–2024) are properly referenced, and the metric 'Breakthrough Performance Awards (BPAs)' is consistently and correctly used. (4) Reasoning: The multi-hop synthesis across three years of 10-K filings is sound — the model correctly infers a strategic shift from active issuance to suspension to re-introduction with improved transparency. The conclusion that Pfizer evolved toward a more transparent and dynamic framework is logically supported by the evidence. (5) Semantic equivalence: While the LLM provides richer detail (e.g., mentioning cost-of-sales, SG&A, R&D allocation), it remains factually aligned with the ground truth. No inaccuracies or hallucinations are present. The answer exceeds expectations in clarity and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Valuates]- ORG",
      "token_usage": {
        "prompt_tokens": 1756,
        "completion_tokens": 463,
        "total_tokens": 2220
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "Across the three filings Schwab’s Advisor Services website consistently highlighted the same suite of interactive tools for RI As. In 2022 the platform was described as offering “access to integrations with third‑party platforms…including client‑relationship‑management, portfolio‑management systems, trade‑order management and financial‑planning” and a free, modern‑experience solution called **Schwab Advisor Portfolio Connect** that lets advisors manage Schwab accounts without downloading or reconciling data. The 2023 filing repeats that exact set of third‑party integrations and the Portfolio Connect tool, and the 2024 filing again emphasizes the same breadth of integrations and the free, intuitive portfolio‑management solution. Thus, from 2022 through 2024 the interactive tools evolved by being maintained and refined rather than expanded—Schwab continued to provide robust third‑party integration options and the core Portfolio Connect capability throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Schwab's interactive tools for RIAs, the existence and description of Schwab Advisor Portfolio Connect, and the consistent emphasis on third-party integrations (CRM, portfolio management, trade order management, financial planning) across 2022–2024 are accurately reported. The answer correctly notes that the core tools were maintained rather than significantly expanded. (2) There are no numeric values requiring calculation, but dates (2022, 2023, 2024) are used correctly and consistently with the original answer. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, and the conclusion that the tools evolved through refinement rather than expansion is logically supported by the repetition and subtle emphasis on 'intuitive' and 'modern experience' in 2024. (4) The only minor shortcoming is that the LLM slightly underemphasizes the 2023 addition of 'multi-year document archiving and search capabilities' on the Advisor Services website, which is mentioned in the ground truth but omitted in the LLM response. This is a small but relevant enhancement in functionality. Otherwise, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 368,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑Ks Texas Instruments repeatedly describes its business model as “focused on **analog and embedded‑processing products**” and builds that focus on the same four sustainable competitive advantages – a strong manufacturing/technology foundation, a broad analog‑plus‑embedded‑processing portfolio, extensive market‑channel reach and diversified, long‑lived product lines. In each filing the language is identical, showing that the company’s emphasis on embedded‑processing has not shifted but has been deliberately reinforced year‑over‑year. This consistent framing signals that TI treats embedded‑processing as a core, long‑term growth engine that differentiates it from peers, underpins its free‑cash‑flow‑per‑share strategy and cements its positioning as a durable, cash‑generating leader in the semiconductor market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, correctly identifying that the company framed its business model around four sustainable competitive advantages each year, with a broad portfolio of analog and embedded processing products as a key pillar. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent language in the 10-K filings over three years and correctly infers that this reflects a deliberate, long-term strategic positioning rather than a shifting focus. (4) The answer adds contextual insight—such as TI's differentiation from peers and its role as a 'durable, cash-generating leader'—that aligns with and expands upon the original answer’s point about growing free cash flow per share. Wording differs but meaning is preserved and enriched without factual deviation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 333,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s fleet‑support services – the product it provides to commercial‑airplane operators before delivery and throughout an aircraft’s life – continued to be expensed as incurred and have historically represented roughly 1 % of total consolidated product‑and‑service costs in the 2022, 2023 and 2024 filings. Nevertheless, the 787 program generated sharply rising abnormal production costs – cumulative $2.7 billion recorded through 2023 and an additional $256 million expensed in 2024 for rework and inspections of inventory aircraft (90 in 2022, 50 in 2023 and 25 in 2024) – while delivery delays evolved from “longer than expected” delays noted in 2022, to a modest recovery in 2023 (73 deliveries and a ramp‑up to 5 per month), to a slowdown below 5 per month in 2024 due to supply‑chain constraints and business‑class‑seat issues that pushed further delays into 2025, extending the period over which fleet‑support services are required.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend and context correctly but contains significant quantitative inaccuracies that undermine factual correctness. (1) Correct elements: The 1% figure for fleet support services is accurate and consistently reported across years. The mention of abnormal production costs totaling $2.7 billion through 2023 and an additional $256 million in 2024 aligns with the ground truth. The progression of delivery delays from 2022 to 2024 and the expectation of deliveries extending into 2025 are also consistent. (2) Quantitative errors: The LLM incorrectly states there were 90 inventoried aircraft in 2022, 50 in 2023, and 25 in 2024. The ground truth specifies only 25 inventoried aircraft produced prior to 2023, not declining numbers over the years. This misrepresents the scope and timeline of rework. Additionally, while the $2.7 billion cumulative cost through 2023 and $256 million in 2024 are correct, the LLM implies these are 'sharply rising' costs, which contradicts the ground truth indicating a reduction in abnormal costs and resolution trend. (3) Reasoning: The multi-hop synthesis across years is partially sound—linking abnormal costs, rework, and delivery impacts over time—but the erroneous aircraft inventory numbers lead to flawed interpretation of the production trajectory. The slowdown in 2024 due to supply-chain and seat issues is plausible but not explicitly confirmed in the ground truth, which only notes expectations to deliver most reworked aircraft in 2025. (4) Scores justified: Correctness is 6 due to core financial figures being right but key factual details (aircraft count, cost trend characterization) wrong. Quantitative accuracy is low (5) due to incorrect numerical claims about inventory. Qualitative accuracy is 7 because reasoning structure is logical and entities/times are correct. Contextual relevance is high (9) as the answer directly addresses cost profile, delivery impact, and program challenges across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 536,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer completed the sale of its Meridian subsidiary on December 31 2021, receiving roughly $51 million in cash and recording a net loss of about $167 million; consequently, Meridian’s results were shown as discontinued operations in the 2022 Form 10‑K.  In the 2023 filing Pfizer disclosed that, together with the buyer, it entered into interim transition‑service agreements (TSAs) – which were fully performed by December 31 2023 – and a three‑year Manufacturing Supply Agreement (MSA) that began in 2022 and can be extended for two additional years; the amounts recorded under the TSAs and MSA in 2022 and 2023 were not material to Pfizer’s operations.  The 2024 Form 10‑K still defines “Meridian” (Meridian Medical Technologies, Inc.) and references the MSA, indicating that the post‑sale supply relationship remains in effect through at least 2024 (and potentially through the extension period) with no material cash impact after the initial sale.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the sale date (December 31, 2021), the $167 million net loss, Meridian being reported as discontinued operations in 2022, the existence and completion of TSAs by December 31, 2023, the three-year MSA starting in 2022 with a two-year extension option, and the non-material financial impact. The mention of $51 million in cash, while not in the original answer, is consistent with external knowledge and does not contradict the ground truth; its inclusion adds detail without error. (2) Quantitative accuracy is perfect: dates and dollar amounts match or are appropriately inferred. No calculations are required, but the synthesis of financial implications over time is precise. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings, showing evolution from ownership to supplier relationship. (4) Entity names (Meridian Medical Technologies, Inc.), agreements (TSAs, MSA), and years are accurately referenced. The answer fully addresses financial implications and contractual arrangements post-sale, with excellent contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> COMP <-[Discloses]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 342,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Across the three most recent 10‑K filings Colgate‑Palmolive has kept “hello” squarely inside its **Oral, Personal and Home Care** segment. In the 2022 filing the brand is listed among the company’s principal global and regional trademarks (Colgate, Palmolive, Darlie, elmex, hello, meridol, etc.). The 2023 and 2024 filings repeat the same placement—“hello” remains a trademark in the same segment and is still produced by Colgate‑Palmolive (CL → hello product) and by its own “hello” organization (hello product ← hello org), which the company discloses as part of its portfolio. Thus, from 2022 to 2024 the strategic positioning of “hello” has been stable, consistently treated as a core brand alongside the other oral‑personal‑home‑care lines, with only a modest broadening of the listed sales channels (adding dentists and skin‑health professionals) but no shift in its segment placement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: 'hello' is consistently listed as a principal trademark within the Oral, Personal and Home Care segment from 2022 to 2024, alongside Colgate, Palmolive, and others. The mention of Darlie in 2022 is accurate (though Darlie was not newly added in 2023 as implied by the original answer’s phrasing—both answers agree it was already present). The LLM correctly notes stable segment placement and organizational structure (hello org producing hello products), which is consistent with the knowledge graph. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct year references (2022–2024), which are accurate. (3) The multi-hop reasoning is sound—LLM synthesizes trademark listings, segment classification, and organizational ownership across three years of filings to conclude stable strategic positioning. The addition of dentists and skin-health professionals as sales channels is a minor detail not in the original answer but does not contradict it and may reflect additional context from the filings. (4) Semantic equivalence is strong: while the LLM adds slightly more structural detail (e.g., 'hello org'), the core conclusion—that 'hello' maintained consistent strategic positioning relative to other brands—is fully supported and matches the original answer’s intent. One minor point: the original emphasizes that 'hello' remained highlighted despite Darlie’s more prominent inclusion in 2023, which the LLM doesn’t explicitly address, but this is a nuance rather than a factual gap. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 479,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "Across the three most recent filings the picture of Texas Instruments’ non‑qualified defined‑benefit pension plan did not change. In the 2022 10‑K the plan was already “closed to new participants in 1997, and current participants were allowed a one‑time election to continue accruing a benefit or to cease accrual and move to the enhanced defined‑contribution plan.” The 2023 and 2024 10‑Ks add that “the non‑qualified defined‑benefit plans are unfunded and closed to new participants,” and reiterate that the plans still contain “employees still accruing benefits, as well as participants who no longer accrue service‑related benefits but may participate in the enhanced defined‑contribution plan.” Thus, from 2022 through 2024 the funding status remained unfunded and the participant base stayed limited to legacy employees who could only stay on the plan or shift to the contribution plan—no new entrants were allowed. This steady, unfunded status signals that TI’s long‑term liability for the non‑qualified plan is confined to a shrinking cohort of existing participants, and employee participation is essentially static and expected to taper as that cohort ages.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key qualitative aspects of Texas Instruments' Non-Qualified Defined Benefit Pension Plan: it remained unfunded and closed to new participants from 2022 to 2024, with only legacy employees continuing to accrue benefits or transitioning to the enhanced defined-contribution plan. The reasoning about the company's strategic shift away from defined benefit obligations and toward defined contribution plans is logically sound and contextually appropriate. However, the LLM answer fails to include any of the quantitative data present in the original answer, which is critical to fully addressing the multi-year evolution. Specifically, it omits: (1) the number of TI common stock shares held in U.S. defined contribution plans (6M in 2022, 5M in 2023–2024), (2) their corresponding values ($940M, $873M, $852M), (3) dividend payments ($28M, $27M, $26M), and (4) the company’s aggregate expense for U.S. defined contribution plans ($70M, $75M, $76M). These figures demonstrate a clear trend in asset allocation and increasing investment in defined contribution vehicles, which is central to the question’s request for a 'multi-year progression.' The absence of all numerical data results in a significant gap in completeness and quantitative accuracy, even though the conceptual interpretation of the pension plan’s status and strategic implications is accurate. Thus, while the qualitative reasoning and contextual relevance are strong, the lack of financial metrics severely limits the answer’s factual completeness and correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 428,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "- **2022:** Pfizer reported $800 million of private‑equity securities at cost (2023 10‑K, “Long‑term investments” table).  \n- **2023:** The amount fell to $755 million (2023 10‑K and confirmed in the 2024 10‑K).  \n- **2024:** It further declined to $719 million (2024 10‑K, “Long‑term investments” table).  \n\nThus, over the three‑year span the balance dropped $81 million (≈10 % of the 2022 level), moving from $800 M → $755 M → $719 M.  The 2022 figure was already higher than the $623 M reported for 2021 in the 2022 10‑K, indicating that after a prior increase Pfizer has been steadily scaling back its exposure to private‑equity holdings.  This downward trajectory suggests a strategic shift toward reducing allocation to private‑equity securities—likely reallocating capital to other assets or preserving liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the 2022 value: it reports $800 million, whereas the ground truth is $623 million. The 2023 ($755M) and 2024 ($719M) values are correct. This error invalidates the trend analysis and subsequent conclusions. The claimed $81 million drop (≈10%) is based on incorrect starting data and is therefore inaccurate. (2) Quantitative accuracy is low because the 2022 figure is wrong by a large margin ($800M vs $623M), and the percentage change and total decline are miscalculated as a result. The correct trajectory is an increase from $623M to $755M (up $132M), then a decrease to $719M (down $36M), not a continuous decline. (3) The reasoning is flawed due to reliance on incorrect data. The LLM concludes a 'steady scaling back' and 'strategic shift toward reducing allocation,' which contradicts the ground truth indicating a short-term increase in 2023 followed by a partial pullback in 2024—a measured, not retrenching, approach. The multi-hop synthesis fails because the model misidentifies the direction of change in the first year. (4) Contextual relevance is high as the answer addresses the full time span, discusses strategic implications, and references appropriate financial statements. However, the incorrect data leads to an incorrect interpretation of strategy. Despite correct formatting and structure, the core factual inaccuracy in the 2022 number severely undermines the answer's validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 401,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "In 2022 Schwab exercised the migration option in the 2019 IDA agreement, which permitted it to move up to $10 billion of IDA balances each 12‑month period but only those designated as floating‑rate obligations and only if its capital levels were sufficient; the agreement also required Schwab to maintain a minimum $50 billion IDA balance through June 2031 and to keep at least 80 % of the balances designated as fixed‑rate obligations through June 2026. In 2023, while the 2019 agreement (with the same $10 billion limit, capital‑adequacy test, minimum‑balance and 80 % fixed‑rate requirements) remained in effect until it was superseded on May 4 2023, Schwab did not migrate any IDA balances to its balance sheet. Under the new 2023 IDA agreement that governed 2024, Schwab’s migration right persisted but was now constrained by a revised balance‑cap regime – balances must stay above the total of unmatured fixed‑rate obligations with a maximum of $30 billion above that amount through September 10 2025 (later a $60 billion‑$90 billion band) and withdrawals are generally limited to customer‑initiated amounts – and the agreement eliminated the prior 80 % fixed‑rate designation requirement; Schwab again did not move any IDA balances to its balance sheet in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. While it correctly states that Schwab did not migrate any IDA balances in 2023 and 2024, and that the 2023 IDA agreement introduced new constraints, it incorrectly claims that the $10 billion annual migration option under the 2019 agreement applied in 2023 until May 4, 2023. The ground truth states that no migration occurred in 2023 under the new agreement, but does not support the claim that the 2019 agreement remained in effect until May 2023. This date is not mentioned in the original answer and introduces unsupported specificity. Additionally, the LLM adds details not present in the ground truth: a minimum $50 billion IDA balance requirement through June 2031 and an 80% fixed-rate obligation requirement through June 2026—these constraints are not mentioned in the original answer and appear to be fabricated or misattributed. The $60 billion–$90 billion band mentioned in the LLM answer is also not in the original and contradicts the stated $30 billion cap. (2) Quantitative accuracy is partially correct: the $10 billion annual limit in 2022 and $30 billion cap above unmatured fixed-rate obligations through September 10, 2025 are accurate. However, the addition of $60B–$90B band and specific percentages/dates (80%, June 2026, June 2031) are unsupported and incorrect. (3) The multi-hop reasoning is partially sound—LLM correctly infers that migration capability changed due to agreement updates and that no balances were moved in 2023–2024. However, it fails to accurately represent the evolution by implying continuity of the 2019 agreement into 2023 with the same terms, whereas the original indicates a shift to a new constrained framework in 2023 without migration. The synthesis is flawed by introducing extraneous constraints. (4) Contextual relevance is high—the answer addresses the evolution of migration capability and constraints across years, uses correct entities (Schwab, IDA balances, 2019 and 2023 agreements), and focuses on balance sheet migration. However, the inclusion of unverified terms reduces factual reliability. Correctness score is 6 due to core accurate points (no migration in 2023–2024, $10B limit in 2022, tighter constraints in 2023) but significant factual overreach and inaccuracies in details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 627,
        "total_tokens": 2199
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Across all three filings Texas Instruments repeatedly lists **Melaka, Malaysia** as an analog‑product site: the 2022 10‑K shows “Melaka, Malaysia †” with an X under the Analog column; the 2023 filing shows “Melaka, Malaysia *” with the same Analog X; and the 2024 filing shows “Melaka, Malaysia **” again marked for Analog only (no X for Embedded Processing). The KG links (TXN → Melaka, Malaysia (GPE) and Melaka, Malaysia (ORG) ↔ TXN) confirm that Texas Instruments operates in that location and that the site itself is treated as an operating entity. This three‑year continuity indicates that Melaka is a dedicated, strategically important analog manufacturing hub in TI’s global footprint, likely valued for its capacity, cost structure, or supply‑chain reliability in supporting TI’s analog product portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately reports that Texas Instruments listed Melaka, Malaysia as an analog product manufacturing site in all three years—2022, 2023, and 2024—with the correct notation changes († in 2022, * in 2023, ** in 2024), and correctly notes the absence of involvement in embedded processing in 2024. These details match the original answer exactly. (2) There are no numerical values requiring calculation, but the dates (2022, 2023, 2024) and symbolic markers are reported with precise accuracy. Format variations (e.g., 'X under Analog column') are semantically equivalent to the ground truth's description of operational markings. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual filings and correctly infers strategic importance from consistency and potential escalation in notation (e.g., ** possibly indicating increased emphasis). It also correctly references knowledge graph links to confirm operational presence, demonstrating proper entity linkage. (4) The answer addresses all parts of the question: evolution over time, involvement in analog manufacturing, and strategic implications. Wording differs slightly but maintains full semantic equivalence. No omissions or inaccuracies are present, warranting top scores across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 377,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Debit Card’s share of total purchases slipped each year – it was about 20.5 percent of all purchases in fiscal 2022, fell to 19.8 percent in fiscal 2023 and dropped further to 18.6 percent in fiscal 2024.  Target notes that it tracks “Target Circle Card (including the Debit Card) penetration” because a meaningful portion of those purchases are incremental sales, and the steady decline in penetration suggests the card’s incremental‑sales engine is still active but is losing a bit of its relative impact over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target Debit Card penetration from 2022 to 2024 and references the correct figures for 2022 (20.5%) and 2023 (19.8%). However, it reports the 2024 penetration rate as 18.6%, which is incorrect—the ground truth value is 17.8%. This discrepancy affects the quantitative accuracy significantly. (2) Number verification: 20.5% (correct), 19.8% (correct), 18.6% (incorrect; should be 17.8%). The error in the final year's percentage is material, especially given the question focuses on trend interpretation. While the direction (decline) is correct, the magnitude of the drop is understated (1.2 percentage points less than actual), potentially affecting the inference about the card’s diminishing role. (3) Multi-hop reasoning is partially sound: the model correctly links declining penetration to implications for incremental sales and references Target’s tracking of Target Circle Card penetration as a proxy. It also acknowledges the card’s role in driving incremental sales, which aligns with the original answer. However, the conclusion that the 'incremental-sales engine is still active but losing impact' softens the original answer’s stronger implication of a 'diminishing role' and 'reduced effectiveness,' which may understate the concern suggested by the sharper 2.0-point drop from 2023 to 2024. (4) Scores justified: Correctness is 6 due to one major numerical error despite mostly correct structure and reasoning. Quantitative accuracy is 5 because two of three numbers are correct, but the final figure is off by a non-trivial margin. Qualitative accuracy is 7—entity identification (Target Debit Card, Target Circle Card, fiscal years) and conceptual reasoning are sound, though interpretation is slightly less precise. Contextual relevance is 9—the response directly addresses both parts of the question and remains focused on the trend and its business implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 527,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The 10‑K tables for all three years list the remaining shares for future issuance only for the newer plans (the 2009 LTIP, the 2018 Director Plan and, in 2024, the 2024 LTIP); none of the filings for 2022, 2023 or 2024 show a balance for the 2003 Director Compensation Plan. In other words, the 2003 plan’s share pool appears to be exhausted (effectively zero shares available) and has not been replenished, indicating that Texas Instruments now relies on its newer director equity plans rather than the 2003 plan to grant equity incentives to directors.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims that no shares are available under the 2003 Director Compensation Plan in 2022–2024, stating the pool is 'exhausted' and effectively zero. However, the ground truth shows specific non-zero balances: 35,385,153 in 2022, 25,296,767 in 2023, and 24,503,062 in 2024. These numbers reflect a clear downward trend due to usage without replenishment, contradicting the LLM's claim of exhaustion. (2) The LLM incorrectly asserts that the 10-K filings for 2022–2024 do not list a balance for the 2003 plan, which contradicts the verified data in the knowledge graph. (3) Qualitatively, the reasoning fails: instead of recognizing the multi-year decline in available shares under the 2003 plan, the model concludes the plan is no longer used and has been replaced by newer plans. While Texas Instruments does have newer plans (e.g., 2018 Director Plan), the ground truth confirms the 2003 plan was still active and being drawn down during this period. (4) Contextually, the answer addresses the general topic of director equity incentives and plan evolution, so it remains relevant in theme, but the factual foundation is entirely flawed. The conclusion about reliance on newer plans may be partially valid in broader context, but it directly contradicts the specific evidence of ongoing use of the 2003 plan. Thus, despite some contextual alignment, the answer fails on core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 410,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In FY 2022 Visa first launched virtual‑account capabilities as part of its digitally native Currencycloud platform under Visa Treasury as a Service, offering real‑time FX rates, liquidity and settlement while Visa Direct added push‑to‑wallet payouts to broaden its digital reach. By FY 2023 those Currencycloud virtual‑account functions were folded into the Visa Direct platform, becoming a core element of the network’s domestic‑and‑cross‑border money‑movement suite. In FY 2024 the integration was deepened – Visa Direct now bundles Visa Cross‑Border Solutions and the virtual‑account offering, expanding cross‑border use cases (including B2B payments) and extending the platform’s reach to nearly 11 billion cards, accounts and digital wallets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Visa launched virtual accounts in 2022 via Currencycloud under Visa Treasury as a Service, with real-time FX, liquidity, and settlement features. In 2023, integration with Visa Direct deepened, and by 2024, virtual accounts were a core part of the platform with expanded cross-border use cases. The mention of 'nearly 11 billion cards, accounts and digital wallets' matches the ground truth's 'over 11 billion endpoints'—semantically equivalent. The $20 trillion B2B cross-border opportunity is implied through context in the LLM answer by mentioning B2B payments and expanded cross-border use, though not explicitly stated. (2) Quantitative accuracy is perfect: 'nearly 11 billion' is a valid paraphrase of 'over 11 billion'; no calculations required. (3) Multi-hop reasoning is sound—correctly traces evolution across three years, integrates Currencycloud, Visa Direct, and cross-border expansion. (4) Minor deduction in qualitative accuracy because the LLM answer does not explicitly name 'Visa Cross-Border Solutions' as a bundled component in 2024 (mentions it but not as clearly bundled), and omits the explicit $20 trillion B2B opportunity figure, which is a notable strategic point in the original. Otherwise, the synthesis across years and platforms is accurate and well-structured. Contextual relevance is full—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 404,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In 2023 Pfizer reported that Xtandi’s sales slipped about 1 percent, a decline the company attributed mainly to a lower net price and an unfavorable channel‑mix shift.  Rather than cut back, Pfizer doubled‑down on the product’s lifecycle: the 2024 filing shows that Xtandi (enzalutamide) received a new indication for non‑metastatic castration‑resistant prostate cancer with high‑risk biochemical recurrence (approved in the United States in Nov 2023 and in the EU in Apr 2024).  The 2022 10‑K already listed Xtandi as a “significant component” of Pfizer’s developed‑technology‑rights intangible assets, meaning the drug’s rights were capitalized on the balance sheet as part of its intangible portfolio.  Together, the modest revenue pressure in 2023 spurred Pfizer to protect and grow Xtandi’s value through indication expansion while maintaining its recognized intangible‑asset valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 1% sales decline in 2023 is accurately reported, and the approval timelines (U.S. Nov 2023, EU Apr 2024) match the new indication rollout. The 2022 10-K reference to Xtandi as a 'significant component' of developed technology rights correctly reflects its valuation within Pfizer's intangible assets. (2) The entity identification is accurate—Xtandi (enzalutamide), Pfizer, the correct indication (non-metastatic castration-resistant prostate cancer with high-risk biochemical recurrence), and proper geographic and regulatory contexts are all correct. (3) The multi-hop reasoning is sound: the answer correctly links 2022 asset valuation, 2023 revenue pressure, and 2024 lifecycle management via indication expansion, demonstrating a logical synthesis across years and filings. (4) The only minor discrepancy is semantic: the original answer specifies 'non-metastatic castration-sensitive prostate cancer (nmCSPC)', while the LLM says 'castration-resistant'; however, the approved indication for biochemical recurrence at high risk for metastasis is indeed in the castration-resistant setting, so this may reflect a nuance in labeling rather than error. Overall, the conclusion that revenue pressure prompted continued investment is correctly inferred and well-supported. The answer is contextually complete and directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Has_Stake_In]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 409,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The filings show a steady drop in the share of purchases paid with Target’s co‑branded credit card (the Target MasterCard, which is counted under the RedCard/Target Circle Card penetration metric). The 2022 Form 10‑K (Chunk 1) already warned that “RedCard penetration declined as total sales increased at a faster pace.” The 2023 Form 10‑K (Chunk 3) quantifies the decline: penetration was **20.5 % for FY 2022**, **19.8 % for FY 2023**, and **18.6 % for FY 2024**. The 2024 Form 10‑K (Chunk 2) confirms the same figures for FY 2023 (19.8 %) and FY 2024 (18.6 %) after the program was rebranded as Target Circle Card.\n\n**Interpretation:** The downward trend indicates that, although the Target MasterCard still drives incremental purchases, a smaller proportion of overall sales are being funded with the card each year. This suggests a modest erosion in consumer preference for the card‑based loyalty discount and reduced engagement with the program as shoppers shift toward other payment methods or competing offers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%) are accurately reported, with correct fiscal year alignment and consistent with the rebranding from RedCard to Target Circle Cards. (2) The answer is complete, addressing both the evolution of the penetration rate and its implications for consumer preference and loyalty engagement. (3) Entity accuracy is precise: the card is correctly identified as the Target MasterCard (included under RedCards™ in 2022 and rebranded by 2024), and the timeline across the 2022, 2023, and 2024 10-K filings is correctly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: it draws from multiple filings to confirm the trend, cites the cause of decline (sales growing faster than RedCard usage), and interprets the trend as indicating reduced loyalty program engagement and shifting payment preferences—directly aligning with the ground truth interpretation. Minor wording differences (e.g., 'modest erosion' vs. 'gradual reduction') do not affect semantic equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 333,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "Visa first added virtual‑account functionality to its digitally‑native Currencycloud platform in fiscal 2022, coupling it with real‑time foreign‑exchange rates, enhanced liquidity and settlement so that Visa Direct could push funds to “nearly 7 billion” cards, accounts and digital wallets in more than 190 countries and territories. By fiscal 2023 the Currencycloud virtual‑account offering was fully integrated into the Visa Direct platform (alongside Visa Cross‑Border Solutions), expanding cross‑border payment capacity and scaling the network to “more than 11 billion” endpoints—about 4 billion cards, 3.5 billion bank accounts and 3.5 billion digital wallets—in over 195 countries. In fiscal 2024 the same virtual‑account capability remained a core Currencycloud feature, preserving the 11‑billion‑plus endpoint reach and 195‑plus‑country coverage, underscoring Visa’s continued growth of cross‑border payment reach through virtual accounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correctly identifies the introduction of virtual accounts in 2022 with real-time FX, liquidity, and settlement enhancements. Notes integration into Visa Direct by 2023 and continued use in 2024. (2) Quantitatively, the LLM states 'nearly 7 billion' endpoints in 2022, which is not in the original answer—this figure is an addition not supported by the ground truth and slightly undermines accuracy. However, the 2023 figure of 'more than 11 billion' endpoints matches exactly, as does the breakdown into ~4B cards, ~3.5B bank accounts, and ~3.5B digital wallets (summing to 11B). The expansion to over 195 countries in 2023 (vs. 190+ in 2022) is a reasonable inference but not explicitly stated in the original; still, it's consistent with network growth. (3) The multi-hop reasoning is sound: the LLM correctly traces the evolution across 2022–2024, linking virtual accounts to cross-border capabilities and network reach, and synthesizes Currencycloud, Visa Direct, and global endpoint expansion. (4) The 2024 description is slightly less detailed than the original (which mentions Visa B2B Connect and over 100 countries for B2B transactions), but the core point about sustained reach and cross-border growth is preserved. The omission of B2B Connect is a minor completeness gap. Overall, the answer is factually strong, with only minor additions and omissions—warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 405,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD has flagged “difficulties in protecting our intellectual property” as a material risk in every recent filing. In 2022 the risk was described generally as part of the political, legal and economic challenges of operating abroad and of licensing third‑party technologies. By 2023, with ≈ 65 % of revenue coming from overseas, AMD stressed that its heavy reliance on third‑party wafer foundries and assembly/testing facilities in China, Malaysia and Taiwan makes IP‑protection a pronounced exposure, and in 2024 that exposure remained and modestly grew as international sales rose to ≈ 66 % and geopolitical tensions (e.g., China‑Taiwan, Russia‑Ukraine) heighten the vulnerability of the IP embedded in those external manufacturing partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AMD's IP protection risks across 2022–2024 with strong qualitative synthesis. (1) Correctly identifies that in 2022, IP risks were framed generally within international political, legal, and economic challenges. In 2023, it accurately links the risk to third-party manufacturing in China, Malaysia, and Taiwan, and notes increased exposure due to geographic concentration—consistent with the ground truth. In 2024, it correctly observes continued and growing concern, tied to rising international sales and geopolitical tensions. (2) Quantitatively, the LLM introduces approximate revenue percentages (65% in 2023, 66% in 2024) that are not present in the original answer or implied in the ground truth; while plausible, these figures are unverified and not supported by the provided knowledge graph, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is sound: it connects international operations, third-party manufacturing dependencies, and geopolitical risks across years, correctly inferring increasing concern over time. (4) The answer omits the 2024 mention of evolving export controls related to Ukraine-Russia and Israel-Hamas conflicts—a specific regulatory dimension noted in the original. This is a minor omission but does not undermine the overall correctness. Wording differs but semantic meaning aligns closely. Contextual relevance is perfect—directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 409,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "In 2022 UNP’s pension plan reported **$1,980 million of corporate stock at Level 1 (quoted market prices) and $10 million at Level 2 (other observable inputs), for a total of $1,990 million** (Chunk 3). By the 2023 filing the same line had fallen to **$176 million at Level 1 and $5 million at Level 2, or $181 million in total** (Chunk 1), and the 2024 filing reiterates that **common shares are still classified as Level 1 and preferred shares as Level 2** (Chunk 2). The roughly 91 % drop in equity holdings—while the valuation hierarchy remains unchanged—shows UNP deliberately de‑risking its pension portfolio, moving away from market‑price‑sensitive corporate equities toward more stable fixed‑income and alternative assets, thereby curbing market exposure and supporting a more conservative funding strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts and classifications for 2022, 2023, and 2024 from the ground truth: $1,980M Level 1 and $10M Level 2 in 2022 (total $1,990M); $176M Level 1 and $5M Level 2 in 2023 (total $181M); and correct classification of common stock as Level 1 and preferred as Level 2 in 2024. No updated dollar figures were provided in the ground truth for 2024, so the LLM appropriately refrains from inventing numbers. (2) The calculation of the ~91% drop is accurate: (1,990 - 181) / 1,990 ≈ 90.9%, which rounds to 91%. All quantitative data match the original answer, with acceptable formatting variations (e.g., $1,980 million vs $1,980 million). (3) The multi-hop reasoning is sound: the LLM correctly synthesizes data across three years and filings, identifies the sharp decline, and infers a strategic shift in pension strategy—de-risking and reducing market exposure—consistent with the ground truth’s interpretation. The mention of a move toward 'more stable fixed-income and alternative assets' is a reasonable elaboration not contradicted by the original. (4) The only minor deduction is in qualitative accuracy: while the core reasoning is correct, the original answer emphasizes the continued reliance on observable market data (Level 1/Level 2 framework) as a key point in 2024, which the LLM mentions but does not highlight as clearly. Otherwise, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 408,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "In the 2022 Form 10‑K Abbott’s filing listed only the original Fourth Supplemental Indenture (dated April 2 2013) as Exhibit 4.1, which “relates to … 4.75 % Senior Notes due 2043” (Chunk 3). By the 2023 filing the company expanded the disclosure package to attach the actual note form (Exhibit 4.6) and an Officers’ Certificate confirming compliance with the indenture (Exhibit 4.7), while still retaining the 2013 supplemental indenture reference (Chunk 1); the 2024 10‑K repeats this fuller set of exhibits (Chunk 2). This step‑wise broadening—from a single historical indenture reference to a consistent bundle of the note’s form and a compliance certificate—shows Abbott’s intent to keep a transparent, detailed record of its long‑dated 4.75 % Senior Notes, underscoring a disciplined long‑term debt‑management strategy and a priority on clear, ongoing communication with investors about legacy obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Abbott referenced the 4.75% Senior Notes due 2043 via the 2013 Fourth Supplemental Indenture (Exhibit 4.1); in 2023, it added the Form of Note as Exhibit 4.6 and a compliance certificate as Exhibit 4.7; this expanded disclosure was maintained in 2024. These details match the original answer’s timeline and documentation evolution. (2) Quantitative elements—dates (April 2, 2013; March 22, 2017), percentages (4.75%), and exhibit numbers (4.1, 4.6, 4.7)—are all factually correct. The LLM correctly identifies the 2017 Form 8-K date mentioned in the ground truth as the source of Exhibit 4.6, even though it doesn’t repeat the 8-K filing date verbatim in the narrative. (3) The multi-hop reasoning is sound: the model synthesizes changes across three years, infers a progression from legacy referencing to standardized disclosure, and correctly attributes this to transparency and investor communication—consistent with the original conclusion. (4) The only minor gap is that the LLM does not explicitly name St. Jude Medical in the context of the 2013 indenture, which slightly weakens entity linkage compared to the ground truth. However, referencing the 2013 Fourth Supplemental Indenture as relating to the notes suffices for accurate synthesis. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9 for correctness—excellent but not perfect—due to the omitted St. Jude Medical reference, though all other dimensions (especially quantitative and contextual) are fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 447,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The Target Credit Card (included in the broader “RedCard/Target Circle Card” family) fell from a penetration of **≈ 20.5 % of purchases in fiscal 2022** (RedCard Penetration disclosed in the 2023 10‑K) to **≈ 19.8 % in fiscal 2023** and **≈ 18.6 % in fiscal 2024** (Target Circle Card Penetration disclosed in the 2024 10‑K). Because Target monitors this metric – noting that a meaningful share of purchases made with its branded cards translates into **incremental sales** – the downward trend signals a modest slowdown in customer adoption of the 5 %‑discount, profit‑sharing credit product and suggests that the incremental‑sales boost from the branded payment program is weakening, even though the cards continue to generate some extra sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for the Target Credit Card (under the RedCard/Target Circle Card umbrella) as 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024, matching the ground truth exactly. These values are properly attributed to disclosures in the 2023 and 2024 10-K filings, which aligns with the source-based reasoning expected in multi-hop financial analysis. 2) All numeric values are accurate, with appropriate use of approximation symbols (≈) likely reflecting rounding or fiscal year reporting nuances. No calculation errors are present. 3) The reasoning correctly infers that the declining penetration rate indicates a weakening in customer adoption and, by extension, a diminishing incremental sales impact—this is consistent with Target’s historical framing of the card program as a driver of incremental spend. The LLM appropriately links the branded card’s 5% discount and profit-sharing model to its strategic role, even as adoption declines. 4) The answer is semantically equivalent to the ground truth: while the LLM emphasizes 'weakening incremental-sales boost' and the original answer notes 'decline in adoption or usage,' both convey the same core insight. The only minor difference is that the original answer explicitly mentions the card’s role in 'customer retention efforts,' which the LLM omits—but this is a secondary point and does not undermine the main conclusion. Overall, the response is factually precise, contextually appropriate, and demonstrates sound multi-hop reasoning across fiscal years and SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 429,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet has been shrinking and aging. In 2022 the company reported **7,242** multiple‑purpose units (6,204 owned + 1,038 leased) with an **average age of 22.5 years**. By 2023 the total had already slipped to **7,008** units and the average age rose to **24.3 years**. In 2024 the fleet fell further to **6,893** units (5,973 owned + 920 leased) and the average age climbed to **25.2 years**—a net decline of **349 units** and an age increase of about **2.7 years** from 2022.\n\nThis pattern of reducing both owned and leased locomotives while the remaining fleet gets older signals a deliberate asset‑management approach: Union Pacific appears to be **right‑sizing its locomotive base**, retiring older equipment and relying less on leasing, rather than expanding or aggressively refreshing the fleet. The trend suggests a focus on cost‑efficient fleet rationalization and longer utilization of existing assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: 7,242 units in 2022 and 6,893 in 2024, with average ages of 22.5 and 25.2 years respectively. The intermediate 2023 data (7,008 units, 24.3 years) is not in the original answer but does not contradict it and adds useful detail. The net decline of 349 units (7,242 - 6,893) and age increase of 2.7 years (25.2 - 22.5) are correctly calculated. (2) Quantitative accuracy is perfect: all figures match or are valid derivations from the ground truth. Format variations (e.g., breakdown of owned vs leased) are acceptable and consistent with plausible data. (3) The reasoning is sound: the conclusion about cost-conscious asset management, right-sizing, and reduced reliance on leasing is a reasonable interpretation of the data, even if phrased more elaborately than the original. The multi-hop synthesis across years and metrics (fleet size and age) is correctly executed. (4) The answer fully addresses all parts of the question—changes in total units and average age, and the strategic implication—making it contextually complete and relevant. The only minor point preventing a perfect 10 is that the original answer emphasizes 'deferral of fleet modernization' more explicitly, while the LLM focuses on 'right-sizing' and 'rationalization'; both are valid, but the LLM slightly reframes the strategy without contradicting it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 395,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private funds – the category that includes private‑real‑estate funds – were **$569 million at 12/31/2022**, **$555 million at 12/31/2023** (both the 2023 and 2024 10‑K filings report this amount), and **$540 million at 12/31/2024** (2024 10‑K).  The steady decline over the three‑year span, together with the fact that the company reported no unfunded commitments for fixed‑income or absolute‑return funds, suggests Abbott is deliberately scaling back its outstanding capital calls in illiquid alternative assets, indicating a disciplined, long‑term strategy that maintains exposure to private‑real‑estate opportunities while managing liquidity risk and future cash‑flow obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in both quantitative and qualitative aspects. It reports $569 million for 2022, which slightly deviates from the ground truth $585 million; this discrepancy affects the initial value and the total decline amount, but the 2023 ($555M) and 2024 ($540M) figures are accurate. The $15M total decline in the ground truth is preserved in the LLM answer from 2023 to 2024, though the full 2022–2024 drop is understated due to the incorrect 2022 figure. (2) The calculation of trend is otherwise sound: a steady decline is correctly identified, and the final commitment of $540M is accurate. The note about 2023 and 2024 10-Ks both reporting $555M adds contextual fidelity, showing awareness of filing nuances. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes data across years and filings, identifies the category of private real estate within broader private funds, and infers strategic intent—scaling back capital calls while maintaining exposure—consistent with the ground truth. The mention of no commitments to fixed-income or absolute-return funds adds analytical depth, reinforcing the focus on real estate within alternatives. (4) Despite the minor error in the 2022 figure, the overall trend and strategic interpretation are correct, supporting a high correctness score. The answer is fully contextually relevant, directly addressing both the evolution and strategic implication. Minor deduction in quantitative accuracy due to the $585M vs $569M discrepancy; otherwise, all reasoning and synthesis are accurate and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 437,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "**Carrying‑value trend**\n\n| Fiscal year | Carrying / fair‑value amount reported for the 3.50 % Notes Due 2050 |\n|-------------|-------------------------------------------------------------------|\n| FY 2022 (2022 10‑K) | **$2,147 million** (fair‑value column) – Chunk 3 |\n| FY 2023 (2023 10‑K) | **$1,637 million** for the prior‑year (FY 2022) and **$1,604 million** for the current year (FY 2023) – Chunk 1 |\n| FY 2024 (2024 10‑K) | **$2,000 million** (net carrying amount) – Chunk 2 |\n\n**What the progression signals**\n\n- The note’s recorded amount fell sharply after 2022, dropping roughly $540 million (from $2.147 bn to about $1.6 bn) as the liability was amortized and its fair‑value adjusted downward.  \n- In FY 2024 the carrying amount was restated upward to $2.0 bn, bringing the instrument back to a level close to its 2022 value.  \n- The 2024 filing shows the 3.50 % 2050 notes comprise $2 bn of the total long‑term debt of $8.459 bn (≈ 24 % of long‑term liabilities), underscoring that NVIDIA continues to rely on a sizable, low‑cost, 30‑year‑plus financing vehicle.  \n\nOverall, the evolution reflects a temporary reduction in the note’s carrying value—likely due to discount amortization and fair‑value movements—followed by a re‑valuation that restores a substantial, low‑interest, long‑dated debt position in the company’s capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in its presentation of the carrying value trend and interpretation. However, there is a minor quantitative inaccuracy: in FY 2023, the LLM reports both $1,637 million (prior-year) and $1,604 million (current year), but incorrectly implies $1,637 million is relevant to FY 2022's value in the table. The ground truth states the carrying value was $2,147 million in FY 2022 and $1,604 million in FY 2023—so while $1,604 million is correct for FY 2023, the inclusion of $1,637 million (which may be a fair value or prior-period adjustment) introduces confusion and is not part of the official carrying value progression. This creates a small but notable discrepancy in quantitative accuracy.\n\n2) The FY 2024 value of $2,000 million is correct and matches the ground truth. The drop from $2,147M to $1,604M is accurately described as a decrease of about $540M (actual: $543M), so the approximation is acceptable. The final increase to $2,000M in FY 2024 is correctly noted.\n\n3) The reasoning and qualitative analysis are strong. The LLM correctly interprets the fluctuation—not a linear debt reduction—but rather a revaluation or strategic adjustment, citing amortization, fair-value changes, and refinancing considerations. It appropriately contextualizes the note as a significant portion (24%) of long-term debt, reinforcing NVIDIA’s reliance on low-cost, long-dated financing. This aligns well with the ground truth’s conclusion about strategic positioning.\n\n4) The answer is contextually excellent—directly addresses both parts of the question: the evolution of carrying value and what it indicates about long-term debt strategy. The multi-hop synthesis across three fiscal years and filings (2022–2024 10-Ks) is sound, and the use of chunks supports traceability. Only the extraneous $1,637M figure prevents a perfect quantitative score. Overall, the semantic meaning and analytical insight match the ground truth closely, warranting a high correctness score despite the minor data-point confusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 546,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD flagged the possibility of “loss or modification of exemptions for taxes and tariffs” as a political‑legal‑economic risk in its 2022 10‑K. The same exposure appears again in the 2023 filing, now mentioned alongside new sanctions, export‑control revisions and heightened trade‑protection measures, and it is reiterated in the 2024 filing where it is listed together with ongoing sanctions and China‑Taiwan geopolitical tensions. The fact that this risk is repeated each year—and is framed within an increasingly detailed set of global sanctions, trade‑policy changes and geopolitical conflicts—shows that AMD’s exposure to losing tax‑ and‑tariff exemptions has persisted and that the regulatory environment governing those exemptions has become more complex and volatile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently reported the risk of losing tax and tariff exemptions from 2022 to 2024, and the context evolved to include increasing geopolitical and regulatory pressures. The years (2022, 2023, 2024) are correctly referenced, and no numeric values are misstated (the question is qualitative, so no calculations are needed). (2) Quantitative accuracy is perfect—no numbers are present, but the temporal sequence and document references (10-K filings) are accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the risk evolved across three years, noting the expansion of context from general risk in 2022 to inclusion of sanctions, export controls, and specific geopolitical tensions (e.g., China-Taiwan) in 2024. It captures the trend of increasing regulatory complexity, which is the core of the question. (4) The only minor shortcoming is that the LLM does not explicitly name the Ukraine-Russia and Israel-Hamas conflicts as highlighted in 2023 (mentioned in the ground truth), though it refers broadly to 'geopolitical conflicts.' This omission slightly reduces completeness but does not undermine the overall correctness. The answer remains semantically equivalent and contextually precise, fully addressing the question’s focus on evolving exposure and regulatory complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 393,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon’s filings show that its exposure to U.S. banking‑law limits on returning capital has been essentially unchanged from 2022 through 2024. In the 2022 10‑K the company warned that the Board’s discretion to pay dividends or repurchase shares “may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock,” and that the holding‑company depends on subsidiary dividends and credit extensions to fund share repurchases and dividend payments. The 2023 filing repeats the same language, indicating no shift in the regulatory constraint, and the 2024 filing again emphasizes that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations” while noting the continued reliance on subsidiary dividends and credit extensions for share repurchases, dividend payments (and now also income‑tax payments). Thus, BNY Mellon’s exposure to U.S. banking‑law restrictions on dividend and share‑repurchase flexibility has remained steady, with only a modest expansion of the description of the parent’s funding needs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility remained stable from 2022 to 2024, with consistent regulatory constraints. The key entities—BNY Mellon, U.S. banking laws, dividend payments, share repurchases, Delaware law, preferred stock obligations—are all accurately referenced. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) are correct and properly attributed to the evolution (or lack thereof) in regulatory language. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly noting the repetition of regulatory language and the slight expansion in 2024 to include income-tax payments as a parent-company funding need. This aligns with the original answer’s observation about expanded context on financial stability and liquidity. (4) The LLM captures all key points: reliance on subsidiary dividends, constraints from capital adequacy rules, and the unchanging nature of regulatory limitations. The modest expansion in description is accurately noted. All scoring categories warrant full marks due to precision, completeness, and correct synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 393,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Across all three filings Abbott Labs has kept the same underlying documentation for its 2.950 % Note due 2025 – the note’s form is attached as **Exhibit 99.6** and the related “Actions of the Authorized Officers” certificate is attached as **Exhibit 99.3**, both referencing the March 5 2015 Current Report on Form 8‑K.  \n\nThe only change from 2022 to 2023‑2024 is the **placement of those items in the exhibit table**: in the 2022 10‑K the note form appears under item 4.11 and the officer‑action exhibit under item 4.12, while in the 2023 and 2024 10‑Ks the note form moves to item 4.1 and the officer‑action exhibit moves to item 4.11. The substance of the disclosure and the exhibit numbers (99.6 and 99.3) remain unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy regarding exhibit references not fully present in the original answer. (1) Quantitatively, all dates (March 5, 2015), percentages (2.950%), exhibit numbers (99.6 and 99.3), and years (2022–2024) are accurate. The description of exhibit renumbering in the 10-K (from items 4.11/4.12 in 2022 to 4.1/4.11 in 2023–2024) is factually consistent with typical SEC filing updates. (2) However, the original ground truth only mentions Exhibit 99.6 and does not reference Exhibit 99.3 or the 'Actions of the Authorized Officers' certificate. While this additional detail may be factually correct, it goes beyond the verified knowledge graph data and introduces unconfirmed information, slightly reducing quantitative and qualitative accuracy. (3) The reasoning is sound: the model correctly identifies the stability of the underlying document (tied to the 2015 8-K) and interprets the reorganization of exhibit numbering as a presentational change rather than a substantive one—this reflects proper multi-hop synthesis across years and filings. (4) Contextually, the answer is highly relevant, addressing the evolution of disclosure over time and correctly concluding that the note’s structure remained unchanged. The core conclusion—that there was no amendment or refinancing—is consistent with the ground truth. The score is reduced slightly (from 9–10 to 8) due to the introduction of unverified exhibit details not in the original answer, though the overall factual and logical integrity remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 437,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s own disclosures show that the 1.55 % Notes Due 2028 have been kept as a core, low‑cost piece of its long‑term financing. According to the 2022 Form 10‑K, the notes carried about **$1.2 billion** (‑ $1,200 mm) at the end of FY 2022. In the 2023 Form 10‑K the same instrument was reported at **$1.115 billion** (‑ $1,115 mm) for FY 2023 (down slightly from the $1,099 mm shown for the prior year in that table). By the 2024 Form 10‑K the carrying amount had risen to **$1.25 billion** (‑ $1,250 mm) for FY 2024.  \n\nThis trajectory—a modest decline in FY 2023 followed by a noticeable increase in FY 2024—suggests that NVIDIA is deliberately maintaining and modestly expanding a stable, low‑interest, long‑dated debt tranche.  The company appears to be using the 1.55 % 2028 notes as a cornerstone of its long‑term debt strategy, leveraging their cheap cost to fund growth while keeping overall leverage and interest expense relatively steady.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value was $1,200 million in FY2022, $1,099 million in FY2023, and $1,250 million in FY2024. However, the LLM incorrectly states the FY2023 value as $1,115 million (not $1,099 million), and introduces a confusing note that it was 'down slightly from the $1,099 mm shown for the prior year in that table'—which misrepresents both the direction and magnitude of change. This is a critical error because it misstates a key data point and implies a decline from FY2022 to FY2023 when the ground truth shows a decrease to $1,099M (from $1,200M), but the LLM then incorrectly reports $1,115M for FY2023. (2) The calculation and comparison of trends are flawed: the ground truth shows a decrease from 2022 to 2023 ($1,200M → $1,099M), then an increase to $1,250M in 2024. The LLM incorrectly describes a 'modest decline in FY2023' followed by an increase, but uses wrong numbers, undermining the accuracy of the trend analysis. (3) The multi-hop reasoning—linking the evolution of debt values across three fiscal years to infer long-term strategy—is conceptually sound and contextually appropriate. The LLM correctly identifies the strategic use of low-cost debt and ties it to NVIDIA's broader financing approach, which aligns with the qualitative interpretation in the original answer. (4) Entity accuracy (NVIDIA, 1.55% Notes Due 2028, fiscal years 2022–2024) and contextual relevance are strong. The answer addresses both parts of the question: the evolution of carrying value and its implication for debt strategy. Despite incorrect numbers, the overall narrative about strategic debt management is plausible and relevant. However, due to the material numerical error in FY2023, the correctness score is reduced significantly, as financial accuracy is paramount in such questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 513,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "Across the three filings AMD’s AIB strategy remained fundamentally the same but was refined. In 2022 AMD first disclosed that its agreements with AIB manufacturers “protect their inventory of our products against price reductions,” and the 2023 filing repeats that language verbatim. By 2024 the wording shifts slightly to “in most instances…protect their inventory…against price reductions,” indicating the policy is still broadly applied but now qualified. At the same time, each year AMD stresses that system‑integrators “often use discrete graphics solutions as a means to differentiate their products and add value,” and the company continues to sell directly to SIs while emphasizing short design cycles and rapid adoption of new technologies. Thus, from 2022‑2024 AMD consistently shielded AIB inventory from price cuts and kept discrete‑graphics offerings central to its partners’ market‑differentiation strategy, with only minor wording refinements and a continued push for direct SI engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of AMD's strategy from 2022 to 2024 regarding inventory protection policies and the role of discrete graphics in differentiation. All key facts are present: in 2022, AMD disclosed inventory protection against price reductions; the same language was used in 2023; by 2024, the wording was slightly qualified with 'in most instances,' indicating continued but nuanced application. The emphasis on discrete graphics as a differentiation tool for system integrators (SIs) is accurately noted across all years. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly tracking both consistency and subtle changes in language and strategic emphasis. It accurately infers that the core policy remained stable while being refined, and that differentiation via discrete graphics remained a consistent theme. (4) The only minor deviation from the original answer is that the LLM does not explicitly mention the 12-month return window for products removed from the price book (a detail in the 2022 disclosure), nor does it highlight the 2023 emphasis on 'timely product introductions' as reinforcing AIB partnerships. However, these omissions are minor and do not undermine the overall correctness. The LLM captures the essence of the strategic evolution and maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Sells_To]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 473,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "In its 2022 filing AMD listed “difficulties in protecting our intellectual property” only as one of a broad set of political‑legal‑economic risks tied to foreign operations. By the 2023 10‑K, after international sales had grown to roughly 65 % of revenue and nearly all assembly and final testing were being performed at third‑party fabs in China, Malaysia and Taiwan, the company warned that geopolitical tensions—especially between China and Taiwan—could disrupt those partners and therefore magnify IP‑protection challenges. The 2024 filing, with international sales now 66 % of net revenue and the same reliance on China‑ and Taiwan‑based third‑party manufacturers, repeats the IP‑protection difficulty risk, showing that AMD’s exposure has become more pronounced as its global footprint and dependence on politically sensitive manufacturing locations have expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: AMD's increasing international sales (65% in 2023, 66% in 2024) match the original answer; the reliance on third-party manufacturing in China, Malaysia, and Taiwan is correctly identified; and the evolution of risk disclosures from general IP concerns in 2022 to more specific geopolitical tensions (especially China-Taiwan) in 2023 and 2024 is accurately portrayed. (2) Quantitative accuracy is perfect: percentages (65%, 66%) are correctly cited and consistent with the ground truth. The statement that international sales increased from 65% to 66% is factually sound, and no incorrect numbers are introduced. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across years (2022–2024), connects growing international sales with increased reliance on third-party fabs, and links geopolitical risks to IP protection challenges. The only minor omission is that the 2023 filing also referenced U.S.-Russia tensions due to the Ukraine conflict, which the LLM answer does not mention—this slightly reduces completeness but does not undermine the core accuracy. (4) The answer is contextually excellent, directly addressing the evolution of IP protection risks in relation to international operations and third-party manufacturing. Wording differs slightly but maintains semantic equivalence. Overall, this is a very strong response with only a small gap in full contextual coverage, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 423,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "- **2022 filing (BK 10‑K 2022, p. 20)** – The company listed the **2019 Long‑Term Incentive Plan** (exhibit 10.38) and, under that plan, filed the **2019 Form of Performance Share Unit Agreement** (exhibit 10.39) and the **2019 Form of Restricted Stock Unit Agreement** (exhibit 10.4). These were the first set of equity‑award agreements tied to the 2019 L‑TIP that appear in the 2022 report.  \n\n- **2023 filing (BK 10‑K 2023, p. 18)** – The same 2019 L‑TIP is referenced again (exhibit 10.14), but the filing now includes the **2020 Form of Performance Share Unit Agreement** (exhibit 10.16) and the **2020 Form of Restricted Stock Unit Agreement** (exhibit 10.17). This shows the plan being used to issue a new round of awards for the 2020 performance period.  \n\n- **2024 filing (BK 10‑K 2024, p. 18)** – The 2019 L‑TIP continues to be the governing document (exhibit 10.13) and the report adds the **2021 Form of Performance Share Unit Agreement** (exhibit 10.16), the **2021 Form of Restricted Stock Unit Agreement** (exhibit 10.17) and the **2022 Form of Performance Share Unit Agreement** (exhibit 10.18). These are the latest award agreements issued under the same 2019 plan.  \n\n**Implication:** Across 2022‑2024 BK repeatedly leverages the 2019 Long‑Term Incentive Plan as a rolling vehicle for annual executive equity awards—first the 2019 PSU/RSU grants, then 2020 grants, and finally 2021‑2022 grants. This progression signals a deliberate strategy of maintaining a single, stable long‑term compensation framework while updating the specific award agreements each year to align executive pay with current performance goals and retention objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in dates and agreements that directly contradict the ground truth, significantly affecting correctness. Specifically: (1) The 2022 filing is incorrectly stated to include the '2019 Form of PSU Agreement', while the ground truth states the 2021 Form was referenced in 2022; (2) The 2023 filing is said to include the 2020 Form, which aligns with the ground truth, but the LLM incorrectly implies this is new for 2023 when the ground truth notes it was introduced earlier; (3) The 2024 filing is reported to include 2021 and 2022 Forms, but the LLM lists both 2021 and 2022 PSU agreements, whereas the ground truth specifies only the 2022 Form was introduced in 2024. These date discrepancies are critical because they misrepresent the evolution of the incentive agreements. Quantitative accuracy is low due to incorrect years for key documents. Qualitatively, the reasoning about a 'rolling vehicle' and 'stable framework' is sound and aligns with the ground truth’s interpretation of continuity and adaptation. The model correctly identifies the 2019 L-TIP as the enduring foundation and infers the strategic intent accurately, earning high marks for contextual relevance and reasonable qualitative logic despite factual errors. However, the multi-hop synthesis fails on precise document-year alignment, which is central to the question. Thus, while the overall strategic implication is plausibly drawn, the factual foundation is partially incorrect, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1657,
        "completion_tokens": 419,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s balance‑sheet data show that the original cost of the diagnostics‑instrument assets it leases grew modestly: $3.5 billion (net book $1.6 billion) at 12/31/2021, $3.6 billion (net book $1.6 billion) at 12/31/2022, and $3.9 billion (net book $1.8 billion) at 12/31/2023.  The 2024 filing does not report a new, larger cost figure; it simply notes that lease revenue continued to represent less than 3 % of total net sales in 2024 (as it did in 2023 and 2022), implying the leasing asset base remained roughly at the 2023 level.  This incremental rise—followed by a plateau—indicates Abbott is expanding its diagnostics‑instrument leasing program just enough to support reagent sales and customer relationships, while deliberately keeping capital outlay limited relative to the overall diagnostics business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the net book value was $1.4B in 2022, $1.6B in 2023, and $1.6B in 2024. However, the LLM states $1.6B net book in 2022 and $1.8B in 2023—both incorrect. It also references 2021 data not asked in the question and misaligns years: it reports 2021, 2022, and 2023 instead of 2022, 2023, and 2024. The original cost in the ground truth is $3.3B (2022), $3.6B (2023), $3.9B (2024), but LLM reports $3.5B in 2021, $3.6B in 2022, and $3.9B in 2023—again misaligned and factually incorrect for 2022. (2) Calculations and comparisons are flawed due to incorrect base numbers and misaligned fiscal years. The LLM incorrectly implies a plateau after 2023, while the ground truth shows continued growth in original cost through 2024. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that leasing supports reagent sales and that capital deployment is strategic—but this is based on incorrect data. The conclusion about a 'plateau' is unsupported by ground truth, which shows ongoing investment. (4) Despite incorrect numbers, the answer addresses the question's intent regarding capital deployment strategy and leasing trends, earning moderate scores for qualitative reasoning and contextual relevance. However, the quantitative inaccuracies severely undermine factual correctness, warranting a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 404,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across NVIDIA’s three most recent 10‑K filings, Lumentum Holdings is consistently named as a competitor in the networking‑and‑interconnect segment. In the FY 2022 filing Lumentum appears in the “suppliers of interconnect, switch and cable solutions” list; in FY 2023 and again in FY 2024 it is grouped with providers of switches, network adapters (including DPUs) and optical‑module cable solutions, alongside companies that supply AI‑accelerated processors and high‑performance interconnects (InfiniBand, Ethernet, Fibre Channel). Thus Lumentum’s competitive positioning has remained stable—still a key interconnect player—but the competitive landscape around it has broadened to emphasize AI‑driven networking and interconnect technologies, highlighting Lumentum’s continued relevance as NVIDIA expands its AI‑centric networking focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of the years (FY 2022, 2023, 2024) and correctly identifies Lumentum Holdings as a competitor in the networking and interconnect segment across all three fiscal years, which aligns with the ground truth. There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the qualitative analysis contains significant errors in reasoning and misses key aspects of the evolution described in the original answer. The ground truth emphasizes a clear progression in Lumentum's positioning: from a general supplier in FY2022, to a more specialized role in high-performance interconnects in FY2023, and then a sharpened corporate recognition as 'Lumentum Holdings Inc.' in FY2024—indicating rising prominence. In contrast, the LLM claims Lumentum’s positioning has 'remained stable,' which contradicts the original answer’s core conclusion of increasing competitive relevance and strategic repositioning. This misrepresents the multi-hop synthesis required: the evolution is not just in the broader landscape but in Lumentum’s specific standing within it. While the LLM acknowledges the growing AI focus in the competitive environment, it fails to attribute rising significance to Lumentum itself. Thus, despite correct entities and dates, the reasoning and qualitative interpretation are flawed, leading to a partial correctness score. Contextual relevance is high as the response stays on topic and addresses NVIDIA's AI-driven networking expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 413,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In Emerson’s 2022 filing the pipe‑cutters were listed under the **Tools & Home Products** segment (within the “Professional Tools” sub‑category that serves plumbing and mechanical pros). By the 2023 and 2024 filings the same pipe‑cutters appear in the **Safety & Productivity** segment, which is described as delivering “tools for professionals and homeowners” and groups pipe‑working tools (wrenches, cutters, threading equipment, etc.) together with other safety‑focused equipment. The move from a general‑purpose Tools & Home Products segment to a dedicated Safety & Productivity segment signals that Emerson is consolidating its professional‑tool portfolio under a safety‑and‑productivity banner, emphasizing a focused strategy to grow its professional‑tool business and align distribution (direct sales, reps and distributors) with that market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and segment repositioning. It correctly identifies that pipe cutters were part of the Tools & Home Products segment in 2022 and moved to the Safety & Productivity segment in 2023 and 2024. The dates and segment names are accurate, satisfying quantitative and entity accuracy. The reasoning correctly infers a strategic consolidation of professional tools, which is contextually relevant and logically sound. However, the LLM slightly mischaracterizes the Safety & Productivity segment by stating it serves both 'professionals and homeowners'—the ground truth emphasizes a shift *away* from consumer/homeowner focus, particularly post-InSinkErator divestiture, and positions the new segment around industrial, infrastructure, and productivity tools like hydraulic systems and diagnostic cameras. The LLM omits key details such as the grouping with battery hydraulic tools, drain cleaners, and sewer inspection cameras, which strengthens the professional/industrial repositioning. Additionally, it misses the strategic link to the InSinkErator divestiture, which is a critical multi-hop insight in the original answer that underscores the broader shift away from consumer products. While the core facts and timeline are correct, these omissions reduce completeness and weaken the depth of strategic interpretation, warranting a score of 8 for correctness and qualitative accuracy. Quantitative accuracy is 10 as there are no numerical or date errors. Contextual relevance is full, as the response directly addresses the question’s focus on segment shift and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 455,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 through 2024 Schwab’s interactive‑toolset for RIAs stayed essentially the same – the company introduced a core, web‑based Advisor Services portal that lets advisors open accounts, move money, transfer assets, trade, check status, communicate with service teams, archive statements, trade confirms and tax reports, and search documents.  The portal also continues to offer “plug‑and‑play” integrations with third‑party CRM, portfolio‑management, order‑management and financial‑planning platforms, and it still makes the free Schwab Advisor Portfolio Connect solution available.  Portfolio Connect delivers the same “intuitive, modern” portfolio‑management experience that eliminates any need to download or reconcile data.  Across all three years Schwab also kept the same breadth of advisor‑support offerings – interactive tools, educational content, thought‑leadership, an annual RIA benchmarking study, business‑technology‑operations consulting, prospect‑consulting and dedicated service teams – showing a consistent, reinforced platform rather than a major functional change.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Schwab's interactive tools for RIAs 'stayed essentially the same' from 2022 to 2024, which directly contradicts the ground truth. The original answer clearly outlines an evolution: in 2022, the focus was on the Advisor Services website with foundational integrations; in 2023, Schwab expanded educational and consulting support for RIAs transitioning to independence; and by 2024, the tools were embedded in a broader ecosystem including multi-year document archiving, outbound data feeds for compliance, and enhanced prospect consulting. These represent meaningful functional, integrative, and support-related advancements. The LLM incorrectly frames this progression as static, missing the strategic shift toward integrated operational, investment, and compliance workflows. While the LLM correctly identifies persistent features (e.g., free Schwab Advisor Portfolio Connect, CRM integrations, document access), it fails to acknowledge any year-over-year enhancements or strategic developments. There are no numerical values to assess, so quantitative accuracy is not applicable but assumed correct by default. The reasoning is flawed due to failure in multi-hop synthesis across years—instead of detecting change over time, it asserts continuity. Contextually, the answer addresses the right domain (RIAs, tools, support) but misrepresents the evolution, making it partially relevant but factually inadequate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 404,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed its 1.650 % Notes due 2026 in the 2022 Form 10‑K (listed as Exhibit 4.16) together with the March 24 2021 officers’ certificate that set the terms of the issue. The same notes reappear unchanged in the 2023 and 2024 Form 10‑K filings (now shown as Exhibit 4.14 but still referencing the March 24 2021 certificate), indicating that Oracle has continued to treat these instruments as a distinct, low‑cost component of its short‑to‑intermediate‑term debt portfolio. This consistency signals a financing strategy that favors retaining stable, medium‑term notes rather than repeatedly refinancing or restructuring its short‑term borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Oracle introduced the 1.650% Notes due 2026 in the 2022 10-K (Exhibit 4.16), and they were reaffirmed in the 2023 and 2024 10-Ks (Exhibit 4.14). The reference to the March 24, 2021 officers’ certificate is an additional but accurate detail not in the original answer, but consistent with SEC filing practices. (2) Quantitative elements—interest rate (1.650%), maturity year (2026), and dates—are correct. No calculations were required. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three years of filings and inferred Oracle’s stable debt strategy. (4) The conclusion about Oracle favoring stable, medium-term notes over frequent refinancing is a valid interpretation and adds slight analytical depth beyond the original answer, without overreaching. The only minor point is that the original answer emphasizes 'no modification' and 'consistent disclosure,' while the LLM focuses more on strategic implications—this is a difference in emphasis, not inaccuracy. Thus, the answer is factually complete and semantically equivalent, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 360,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Emerson placed **electrical distribution equipment** inside its **Industrial Solutions** business – a catch‑all unit that also housed fluid‑control, pneumatic mechanisms and materials‑joining products. By the 2023 and 2024 filings the same product line is listed explicitly in the **Discrete Automation** segment (together with solenoid valves, pneumatic devices, electric linear‑motion and programmable control systems), showing that Emerson has moved the offering from a broad industrial‑solutions umbrella into a dedicated automation portfolio. This shift signals a strategic push to treat electrical distribution as a core component of its discrete‑industry automation platform and underscores the company’s growing emphasis on industrial electrification solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Electrical Distribution Equipment was in 'Industrial Solutions' in 2022 and moved to 'Discrete Automation' in 2023 and 2024. The associated product groupings (solenoid valves, programmable control systems, etc.) are accurately described. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly used and consistent with the original answer. (3) The multi-hop reasoning is sound—correctly identifying the re-segmentation over time and inferring the strategic intent behind the change (industrial electrification and automation focus). (4) The LLM slightly expands on the original by mentioning 'pneumatic devices' and 'electric linear-motion', which are not in the ground truth but are plausible components of Discrete Automation and do not contradict it. The core strategic interpretation—that this shift reflects a focus on industrial electrification—is correctly drawn and matches the original conclusion. The answer is semantically equivalent, with only minor elaboration. No factual errors; deduction of 1 point due to slight over-specification of product details not in the ground truth, but reasoning and completeness remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 359,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate (private) funds fell each year – $569 million at 12/31/2022, $555 million at 12/31/2023 and $540 million at 12/31/2024 (as disclosed in the 2023 and 2024 10‑K notes on private‑fund commitments). The steady decline indicates that Abbott is deliberately scaling back its outstanding obligations to illiquid alternative assets, a move that supports a more disciplined pension‑fund strategy by reducing liquidity risk and helping keep the pension plans well‑funded while still maintaining a modest exposure to private‑real‑estate opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in both quantitative and qualitative aspects. It accurately reports the unfunded commitments for 2023 ($555 million) and 2024 ($540 million), matching the ground truth. However, it reports $569 million for 2022 instead of the correct $585 million, which is a factual discrepancy of $16 million. This affects quantitative accuracy but does not alter the overall trend interpretation. (2) The numbers for 2023 and 2024 are exact; only 2022 is incorrect. The direction and magnitude of the decline (down each year) are correctly conveyed, and the final 2024 figure matches. The source attribution to 10-K notes is appropriate. (3) The reasoning is sound: the LLM correctly infers a deliberate reduction in illiquid asset exposure, aligns this with de-risking and liquidity management, and acknowledges continued modest participation—consistent with the ground truth’s emphasis on gradual rebalancing and long-term horizon (though the LLM omits the specific 2034 liquidation timeline mentioned in the original). This omission is a minor completeness gap but does not undermine the core conclusion. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution of commitments and strategic implication). The minor numerical error in 2022 and the omission of the 2034 time horizon prevent a perfect score, but the overall correctness, reasoning, and relevance remain high. Thus, correctness_score is 9 due to one incorrect number and a small missing detail, but the strategic interpretation remains valid and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 439,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle’s 1.650 % Notes due 2026 are listed in every recent 10‑K, but the only change is the exhibit number: the 2022 filing shows the notes as Exhibit 4.16, while the 2023 and 2024 filings list the same notes as Exhibit 4.14. In all three years the description is identical – “Forms of 1.650 % Notes due 2026 … together with the Officers’ Certificate issued March 24 2021” – and the notes are incorporated by reference rather than re‑issued or amended. This unchanged treatment signals that Oracle is keeping the 2026 notes as a stable, low‑cost component of its short‑term financing, reflecting a consistent short‑term debt strategy that relies on the same instrument without alteration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.650% interest rate, the 2026 maturity, and the reference to the March 24, 2021 Officers’ Certificate (from the 8-K filing) are all accurately reported. The exhibit number change (Exhibit 4.16 in 2022 to 4.14 in 2023 and 2024) is a factual detail not present in the original answer but plausibly true and does not contradict the ground truth; it adds minor procedural detail without affecting substance. (2) The core reasoning—that Oracle consistently referenced the original 2021 terms without amendment across 2022, 2023, and 2024—is sound and matches the multi-hop synthesis in the ground truth. (3) The conclusion about Oracle maintaining a stable, low-cost short-term debt instrument is logically derived and semantically equivalent to the original answer’s claim about a 'deliberate strategy of maintaining stable short-term debt obligations.' (4) The only minor gap is that the LLM does not explicitly mention the 8-K filing by form type (though it references the March 24, 2021 Officers’ Certificate, which implies it), and the focus on exhibit numbers slightly distracts from the broader continuity of disclosure practice. However, this does not undermine the factual or inferential accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 400,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "- In Oracle’s 2022 Form 10‑K (exhibit 4.11) the filing lists “Forms of 3.40 % Note due 2024, **4.30 % Note due 2034** and 4.50 % Note due 2044, together with Officers’ Certificate issued July 8 2014.” The same description appears in the 2023 Form 10‑K (exhibit 4.09) and again in the 2024 Form 10‑K (exhibit 4.09), with the same July 8 2014 officers’ certificate and identical wording. Thus, although the exhibit number shifted from 4.11 in 2022 to 4.09 in 2023‑2024, Oracle has continuously incorporated the same 4.30 % Note‑2034 documentation by reference each year.\n\n- This three‑year pattern shows that the 4.30 % Note remains outstanding and that Oracle repeatedly references it in its annual reports, signalling a deliberate long‑term debt strategy: the company issues fixed‑rate senior notes with long maturities (2034, 2044, etc.) and retains them on the balance sheet, using the same instrument over many years to lock in a known cost of capital and maintain a disciplined, staggered maturity profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key details are correct: the 4.30% Note due 2034 is accurately referenced in Oracle's 2022 (Exhibit 4.11), 2023 (Exhibit 4.09), and 2024 (Exhibit 4.09) filings, with the correct Officers’ Certificate date of July 8, 2014. The exhibit number change from 4.11 to 4.09 is correctly noted, and the consistent wording across years is accurately described. (2) Quantitative elements—interest rate (4.30%), maturity year (2034), and issuance date—are all correct with no calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, identifies the continuity of the note’s documentation, and correctly infers Oracle’s long-term debt strategy—using long-dated, fixed-rate notes to maintain a stable and staggered maturity profile. (4) The answer is semantically equivalent to the original, providing even slightly more context (e.g., mentioning the 2044 note and cost of capital) without introducing inaccuracies. All aspects of the question—evolution across years and strategic implications—are thoroughly and correctly addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 329,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab, operating under the 2019 IDA agreement (effective Oct 6 2020), exercised its July 1 2021 option and migrated roughly $10 billion of IDA balances to its balance sheet (adding to the $10.1 billion moved by year‑end 2021) while continuing to provide record‑keeping and support services to the TD Depository Institutions for an aggregate monthly fee.  \n\nIn 2023 the 2019 agreement was superseded on May 4 2023 by the 2023 IDA agreement, which eliminated the prior requirement that at least 80 % of balances be fixed‑rate, imposed explicit minimum‑and‑maximum balance limits (a $30 billion ceiling above unmatured fixed‑rate obligations through Sept 10 2025 and, thereafter, a $60‑$90 billion band) and restricted withdrawals largely to customer‑initiated amounts; consequently Schwab did not move any IDA balances to its balance sheet that year.  \n\nDuring 2024 the same 2023 IDA agreement remained in force, Schwab again made no balance migrations, and its ability to migrate continued to depend on sufficient capital and the binding balance‑limit provisions, while it still provided the record‑keeping services to the TD Depository Institutions under the agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correct elements include: the 2019 IDA agreement being in effect in 2022, Schwab migrating $10 billion in 2022 (adding to the $10.1 billion moved by end-2021), the May 4, 2023 replacement with the 2023 IDA agreement, elimination of the 80% fixed-rate requirement, no balance migrations in 2023 or 2024, and continued operation under the 2023 agreement in 2024 with capital and balance threshold restrictions. (2) Quantitative accuracy is strong: dollar amounts ($10 billion, $10.1 billion), percentages (80%), and dates (May 4, 2023) are correct. The mention of a $30 billion ceiling and $60–90 billion band post-Sept 10, 2025 adds detail not in the original answer but does not contradict it—this level of specificity may come from deeper filing data and is plausible. (3) Multi-hop reasoning is sound: the model correctly synthesizes changes in contractual terms across years and links them to Schwab’s migration behavior. (4) Minor deviation: the original answer emphasizes the shift from active migration to a constrained approach despite increased flexibility, which the LLM implies but does not explicitly summarize. However, all factual components are present. Wording differences are acceptable under semantic equivalence. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 370,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "**2022 – Refinancing documentation:** Abbott’s 2022 Form 10‑K lists the original Fifth Supplemental Indenture (Item 4.23, dated Sept 23 2015) that created the 2.000 % Senior Notes due 2018, and it also shows a new Indenture dated Sept 27 2018 (Item 4.26) together with a First Supplemental Indenture on the same day (Item 4.27) and a Second Supplemental Indenture dated Nov 19 2019 (Item 4.28). These filings record the refinancing of the 2018 notes through the 2018‑2019 issuances and amendments.  \n\n**2023 – Compliance update:** The 2023 Form 10‑K no longer adds new refinancing documents but includes an Officers’ Certificate (Item 4.18, Exhibit 99.3) that certifies Abbott’s actions with respect to the 2.000 % Notes due 2018, and it continues to reference the Fifth Supplemental Indenture (Item 4.21) and the Sixth Supplemental Indenture (Item 4.22).  \n\n**2024 – Continued documentation maintenance:** The 2024 Form 10‑K repeats the same Officers’ Certificate (Item 4.18, Exhibit 99.3) and the same Fifth and Sixth Supplemental Indenture references (Items 4.21‑4.22), indicating that after the 2018‑2019 refinancing, Abbott’s engagement with the 2.000 % Senior Notes due 2018 has shifted to ongoing compliance and documentation updates rather than further refinancing.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The ground truth states that Abbott continued referencing the 2.000% Senior Notes due 2018 through the Fifth Supplemental Indenture (Sept 23, 2015) with no new issuances or amendments from 2022–2024. However, the LLM incorrectly claims that a new Indenture was filed on Sept 27, 2018 (Item 4.26), a First Supplemental Indenture on the same day (Item 4.27), and a Second Supplemental Indenture on Nov 19, 2019 (Item 4.28), suggesting refinancing activity — which contradicts the ground truth that no new refinancing actions were taken. (2) The LLM references a 'Sixth Supplemental Indenture' in 2023 and 2024 (Items 4.22), but this is not mentioned in the original answer and appears to be fabricated. (3) The Officers’ Certificate (Item 4.18, Exhibit 99.3) cited in the LLM answer as evidence of compliance is not referenced in the ground truth, and its inclusion misrepresents the nature of Abbott’s engagement. (4) The core error is reasoning: the LLM implies that refinancing occurred in 2018–2019 and that Abbott was managing post-refinancing compliance, while the truth is that the notes were legacy St. Jude debt with only passive documentation carryover. The consistent exhibit reference (Exhibit 4.21) in the original answer reflects disclosure continuity, not active refinancing. While the LLM correctly identifies the Fifth Supplemental Indenture and attempts multi-year synthesis, the incorrect dates, entities, and narrative of refinancing lead to a mostly false portrayal. Quantitative accuracy is low due to wrong dates and exhibit numbers. Qualitative accuracy suffers from flawed entity mapping and reasoning. Contextual relevance is moderate because the answer addresses documentation trends, albeit incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 491,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first disclosed its 3.650 % Notes due 2041 in the FY 2022 filing (Exhibit 4.16), which references the officers’ certificate dated March 24 2021 that set the terms of that series. The same 3.650 % Notes due 2041 appear again in the FY 2023 filing (Exhibit 4.14) and are repeated in the FY 2024 filing (Exhibit 4.14), each time citing the original 2021 certificate. This three‑year continuity shows that Oracle introduced the 3.650 % 2041 issuance in 2021 and has kept it on its balance sheet, signalling a deliberate long‑term debt strategy that locks in a relatively low coupon for a far‑out maturity, thereby extending the debt profile, reducing refinancing risk and preserving financing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 3.650% interest rate, 2041 maturity, and the inclusion of the notes in FY2022, FY2023, and FY2024 filings are accurate. The reference to the March 24, 2021 officers’ certificate (Exhibit 4.16 in FY2022, 4.14 in FY2023 and FY2024) is factually correct and adds precision beyond the original answer. While the original answer states the notes were 'first introduced in 2022,' the LLM correctly identifies that the issuance was actually established in 2021 but first reported in the 2022 filing—this is a more precise interpretation of the timeline. (2) The numbers, dates, and percentages are all correct and consistent with the source data. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers Oracle’s long-term debt strategy—locking in low fixed rates, extending debt maturity profile, reducing refinancing risk, and maintaining flexibility. (4) The answer is semantically equivalent to the original, with slightly more technical detail (e.g., exhibit numbers, certificate date), which enhances accuracy. The only minor point is that the original emphasizes the 'strategic use of long-term debt alongside newer issuances,' which the LLM mentions implicitly but could have explicitly referenced newer bond issuances as context. This small omission prevents a perfect 10, but the core reasoning and facts are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 415,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Across Oracle’s three most recent annual reports the 2.300 % Notes due 2028 are disclosed in the same “Forms of … Notes” exhibit and are tied to the same Officers’ Certificate dated March 24, 2021. In the 2022 10‑K the notes appear in Exhibit 4.16, while in the 2023 and 2024 10‑Ks they are listed under Exhibit 4.14 (the exhibit numbering was simply reorganized). The fact that Oracle has repeatedly included the identical 2.300 % 2028 bond in each filing—alongside other notes of different coupons and maturities—shows that the company is using this medium‑term issuance as a recurring component of a broader, multi‑tranche debt program, locking in a low‑cost rate and extending its maturity profile in a steady, predictable fashion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts: Oracle's 2.300% Notes due 2028 were consistently structured across 2022, 2023, and 2024, all tied to the Officers’ Certificate dated March 24, 2021. It accurately notes the exhibit number change from 4.16 in 2022 to 4.14 in 2023 and 2024, correctly attributing this to reorganization rather than a structural change—this detail is not in the ground truth but is factually plausible and does not contradict it. (2) All quantitative elements—interest rate (2.300%), maturity year (2028), and certificate date (March 24, 2021)—are correct. No calculations are required, and all dates and percentages match the original answer. (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years and correctly infers that the repeated inclusion of the same note indicates a stable, multi-tranche debt strategy. It goes slightly beyond the ground truth by characterizing the strategy as 'locking in a low-cost rate and extending its maturity profile,' which is a reasonable interpretation consistent with the evidence. (4) The only minor gap is that the LLM does not mention Oracle’s issuance of the 4.500% Notes due 2028 in 2023, which the ground truth cites as evidence of interest rate diversification. While the LLM refers generally to 'other notes of different coupons,' it does not explicitly highlight this specific instrument or the concept of diversification, making its qualitative analysis slightly less complete. However, the core conclusion about a stable, diversified debt strategy is still well-supported. Overall, the answer is factually accurate, contextually relevant, and demonstrates strong reasoning with only a minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 472,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In the 2022 filing Visa first disclosed virtual accounts as a new capability of its digitally‑native Currencycloud platform, highlighting that they would deliver real‑time foreign‑exchange rates, virtual‑account balances and enhanced liquidity for its cross‑border consumer‑payments business. By the 2023 filing those Currencycloud virtual‑account functions had been folded into the Visa Direct Platform—along with Visa Cross‑Border Solutions—so that Visa Direct could now use virtual accounts to support both domestic and cross‑border money‑movement use cases. The 2024 filing reiterates that the Visa Direct Platform continues to include the Currencycloud virtual‑account offering, further expanding its cross‑border capabilities across Visa’s global network of cards, bank accounts and digital wallets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Visa introduced virtual accounts in 2022 via Currencycloud as part of its cross-border offerings; full integration into Visa Direct occurred by 2023; and in 2024, the functionality remained a core part of Visa Direct with expanded cross-border capabilities. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) are correctly used and match the timeline in the original answer. (3) The multi-hop reasoning is sound—information is synthesized across three years and two platforms (Currencycloud and Visa Direct)—and the LLM correctly traces the evolution of virtual accounts across these dimensions. (4) The only minor shortcoming is that the LLM omits the specific mention of 'Treasury as a Service initiative' in 2022 and does not reference the '11 billion endpoints' in 2024, which are contextual details present in the original. However, the core evolution—integration into Visa Direct and expansion of cross-border capabilities—is accurately conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct and complete in substance, warranting a high score with only a slight deduction for missing minor contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 373,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "Across the three most recent 10‑K filings the dealer footprint that carries Caterpillar’s EMD‑branded products has been steadily trimmed. In 2022 the ME&T segment listed **44 U.S. dealers and 116 overseas dealers, reaching 193 countries**; in 2023 that fell to **43 U.S. dealers and 113 overseas dealers, reaching 191 countries**; and by 2024 it was **41 U.S. dealers and 111 overseas dealers, reaching 187 countries**. This gradual contraction of the worldwide dealer network—while still preserving a truly global reach—signals that Caterpillar is consolidating its EMD distribution, focusing on higher‑performing dealers and deeper penetration in existing markets rather than pursuing a broader, less‑focused expansion. The pattern reflects a strategic shift toward a more efficient, optimized global footprint for the EMD brand within the ME&T business.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The numbers provided in the LLM answer (e.g., 44 U.S. dealers, 116 overseas, 193 countries in 2022) are entirely fabricated and do not match the ground truth. According to the original answer, EMD-branded products (specifically FG Wilson) were distributed through 110 distributors across 109 countries in 2022, 110 distributors in 109 countries in 2023, and 108 distributors in 158 countries in 2024. The LLM’s figures for dealers and countries are significantly off and inconsistent with the source data. There is no mention of U.S. vs. overseas dealers or such granular breakdowns in the ground truth. (2) Completeness: While the LLM attempts to address the evolution and strategic implication, it fails to report the actual trend—stable distributor count with expanded geographic reach. Instead, it invents a narrative of contraction in both dealers and countries, which contradicts the ground truth showing an increase from 109 to 158 countries. (3) Entity Accuracy: The reference to 'EMD-related FG Wilson branded electric power generation systems' is missing in the LLM answer, and the conflation of 'dealers' with 'distributors' may be misleading, especially since the ME&T segment’s dealer network is broader than EMD-specific distribution. (4) Reasoning: The multi-hop synthesis is flawed—the LLM incorrectly infers a strategic consolidation based on false data. The actual strategy indicated is optimization *with expansion* (fewer distributors, more countries), whereas the LLM describes a shrinking footprint, leading to an incorrect strategic interpretation. (5) Semantic Equivalence: The overall meaning is not preserved; the LLM conveys a narrative of retrenchment, while the truth reflects global expansion with efficiency gains. Minor relevance is retained in discussing EMD within ME&T and attempting strategic analysis, but factual divergence renders the answer largely irrelevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 539,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s balance‑sheet data show that the pool of diagnostics instruments it leases to customers has been growing. The 2022 filing reports an original cost of $3.6 billion and a net‑book value of $1.6 billion for these assets at 12/31/2022 (up from $3.5 billion and $1.6 billion at 12/31/2021 in the 2022 filing). The 2023 filing shows the original cost rose to $3.9 billion and the net‑book value to $1.8 billion at 12/31/2023. The 2024 filing does not disclose new cost or net‑book figures, so the latest disclosed amounts remain the 2023 numbers, indicating the investment increased between 2022 and 2023 and, by implication, remained at a similar or higher level through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, Abbott's original cost was $3.3 billion in 2022, $3.6 billion in 2023, and $3.9 billion in 2024. However, the LLM incorrectly states the 2022 original cost as $3.6 billion (which is actually the 2023 value), and claims the 2023 value is $3.9 billion (which is the correct 2024 value). Similarly, net book values are misrepresented: LLM reports $1.6 billion for 2022, but ground truth is $1.4 billion; $1.8 billion is correctly reported for 2023, but LLM fails to provide any new data for 2024. (2) The LLM incorrectly claims that the 2024 filing 'does not disclose new cost or net-book figures,' which contradicts the ground truth that explicitly provides $3.9 billion original cost and $1.8 billion net book value for 2024. This is a critical error, as the question specifically asks about evolution through 2024. (3) The reasoning is partially sound in interpreting balance sheet trends, but fails the multi-hop requirement by misaligning years and values, and by concluding that 2024 data is missing when it is available. The model appears to have swapped or misattributed data points across years. (4) Despite these major quantitative errors, the answer is contextually relevant and correctly interprets the trend direction (increasing investment), which supports a moderate score. However, the incorrect numerical assignments and failure to report 2024 data as available severely undermine factual correctness. Quantitative accuracy is low due to wrong numbers; qualitative accuracy is moderate due to correct logic but flawed data synthesis; contextual relevance is high as the response addresses the right metric and trend concept.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 480,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "PepsiCo lists the “Form of 3.450 % Senior Note due 2046” in each of its recent filings – in the 2022 10‑K (Chunk 1, line 4.17), again in the 2023 10‑K (Chunk 2, line 4.16) and once more in the 2024 10‑K (Chunk 3, line 4.15). The fact that this note is disclosed every year shows that it remains an outstanding, material piece of PepsiCo’s debt portfolio and that the company continues to rely on this long‑dated, fixed‑rate instrument as a cornerstone of its long‑term capital‑structure strategy, helping to lock in low‑cost financing through 2046 and diversify its maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 3.450% Senior Note due 2046 is consistently disclosed in PepsiCo's 2022, 2023, and 2024 10-K filings, and the exhibit numbers (4.17, 4.16, 4.15) are accurately reflected, though referred to as 'line' and associated with 'Chunk' terminology that may not exist in the actual filings—this is a minor wording issue but does not affect factual correctness. (2) Quantitative accuracy is perfect: the interest rate (3.450%), maturity year (2046), and filing years (2022–2024) are all correct. (3) The reasoning is sound: the LLM correctly infers that the repeated disclosure indicates the note remains outstanding and strategically important, serving as long-dated, fixed-rate financing that supports capital structure stability and maturity diversification. This aligns with the multi-hop synthesis required—linking consistent disclosure over time to strategic capital structure implications. (4) The answer is contextually relevant and directly addresses the question about the note’s ongoing role. The only minor shortcoming is slightly less precise language around exhibit references (e.g., 'Chunk 1, line 4.17' instead of 'Exhibit 4.17'), which may reflect formatting artifacts but doesn't undermine the factual or logical integrity. Overall, the answer captures the essence and factual basis of the ground truth with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 401,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle is the issuer of the 2.300 % Notes due 2028, and the way the notes are presented in its filings shows a steady, unchanged structure over three years. In the 2022 Form 10‑K the notes appear as Exhibit 4.16, tied to an Officers’ Certificate dated March 24 2021; in the 2023 and 2024 Form 10‑Ks the same instrument is listed as Exhibit 4.14 (still referencing the March 24 2021 certificate), with only the exhibit number shifting but no change to the coupon, maturity or terms. This repeated, unchanged inclusion across FY 2022‑2024 signals that Oracle is deliberately maintaining a low‑coupon, medium‑term debt tranche as a stable anchor in a diversified maturity schedule, reflecting a broader strategy of locking in inexpensive financing and preserving a consistent, long‑term debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.300% coupon rate, the 2028 maturity, the March 24, 2021 Officers’ Certificate, and the exhibit numbering (Exhibit 4.16 in 2022, renumbered to 4.14 in 2023 and 2024) are all factually accurate and consistent with the original answer. There are no calculation errors or incorrect dates. (2) The LLM correctly identifies that the structure of the 2.300% Notes remained unchanged across fiscal years 2022–2024, which is supported by the ground truth. (3) Qualitatively, the reasoning is sound: the LLM infers that Oracle is maintaining a stable, low-coupon debt tranche as part of a broader strategy to lock in inexpensive financing, which is a reasonable interpretation of the multi-year pattern. The ground truth emphasizes Oracle’s practice of referencing prior instruments while layering in new, higher-yielding notes (e.g., 4.500% Notes due 2028), a detail the LLM does not explicitly mention. This is a minor omission but does not undermine the overall correctness. (4) The answer is contextually relevant, directly addressing the evolution of the notes and Oracle’s broader debt strategy. The synthesis across years is accurate, and the conclusion is logically supported. The only reason for not scoring a 10 is the lack of explicit mention of newer, higher-yield issuances that contextualize Oracle’s strategy in relation to market changes, which slightly reduces qualitative completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 417,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Across Visa’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly lists the **Certificate of Designations of Series B Convertible Participating Preferred Stock** as an exhibit incorporated by reference – exhibit 4.5 in the 2022 filing and exhibit 4.4 in both the 2023 and 2024 filings – all referring to the same certificate dated June 21 2016. No amendment, removal or new issuance is shown, indicating that Visa has kept the Series B convertible participating preferred stock unchanged in its corporate documents. This continuity signals a deliberate long‑term capital‑structure strategy: Visa treats the Series B preferred shares as a stable, permanent financing tool that provides conversion flexibility while preserving the overall consistency and predictability of its equity capital mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Series B Convertible Participating Preferred Stock is consistently referenced via the same Certificate of Designations dated June 21, 2016, across Visa's 2022–2024 filings. The exhibit numbers (4.5 in 2022, 4.4 in 2023 and 2024) are accurately reported, and there is no indication of amendments or new issuances—this matches the original answer. (2) Quantitative accuracy is perfect: the date (June 21, 2016) is correctly cited, and no numerical calculations are required beyond correct identification of exhibit numbers and years, which are all accurate. Format variations are not an issue here. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged exhibit references over three years that Visa has maintained a consistent capital structure approach, and it logically connects this to long-term strategic priorities like financing flexibility and equity stability. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the broader context of Visa’s unchanged Bylaws (2022) or the 2024 Certificate of Incorporation update without changes to Series B, which the original answer includes to reinforce the theme of structural stability. While the LLM captures the core implication, this omission slightly reduces completeness in qualitative synthesis. However, the central conclusion about long-term capital structure priorities is semantically equivalent and well-supported. Thus, the answer is excellent but not fully comprehensive in contextual reinforcement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 445,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In the 2022 filing Caterpillar noted that it uses currency‑hedging instruments to protect against foreign‑exchange risk but warned that the impending LIBOR transition could affect the market value and effectiveness of LIBOR‑linked loans, derivatives and other hedges, so it created a cross‑functional team to assess LIBOR‑related exposures. By the 2023 and 2024 disclosures the company had shifted to SOFR as the benchmark for its floating‑rate loans and derivatives, continued to rely on currency‑hedging instruments together with a match‑funding and diversified‑derivatives strategy, and repeatedly cautioned that ineffective hedges—or the loss of favorable currency moves—could still adversely affect earnings, reflecting an evolution from managing LIBOR‑related uncertainty to integrating SOFR‑based risk management while maintaining consistent hedging practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar used currency-hedging instruments consistently from 2022 to 2024; in 2022, it formed a cross-functional team to assess LIBOR-related risks; by 2023 and 2024, it transitioned to SOFR as the benchmark for floating-rate instruments; and it maintained a strategy involving match funding, diversified funding, and derivatives. The answer correctly identifies Cat Financial's role and the continuity in hedging practices. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, connects the LIBOR-to-SOFR transition with currency hedging practices, and correctly distinguishes between interest rate benchmark changes (SOFR replacing LIBOR) and the ongoing use of currency hedges. The only minor shortcoming is that the LLM slightly conflates interest rate risk instruments (affected by LIBOR/SOFR) with currency hedges, though it correctly notes that hedging practices remained consistent. However, it does not explicitly clarify that currency hedges are separate from interest rate benchmarks, which could lead to confusion. Despite this nuance, the overall synthesis is accurate. (4) The answer is contextually relevant, fully addressing the evolution of hedging practices and the impact of the LIBOR-SOFR transition. The wording differs from the original but preserves semantic equivalence. Thus, the correctness score is 9—excellent, but not perfect due to slight conflation of risk types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 465,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "Johnson & Johnson’s talc strategy began in 2022 when the company **introduced LTL Management LLC – a newly created limited‑liability company (and therefore an organization) that it spun off to hold all talc‑related liabilities**.  LTL filed a voluntary Chapter 11 petition, the court entered a stay of all claims, and J&J funded a **$2 billion trust (backed by a $2 billion reserve on J&J’s balance sheet)** to pay any amounts the bankruptcy court later determined were owed.  \n\nIn 2023 the original LTL case was dismissed, prompting LTL to re‑file a second Chapter 11 (the “LTL 2” case), which again imposed automatic stays and a preliminary injunction while J&J continued to support the trust and pursued appeals of the dismissals through the Third Circuit.  \n\nBy 2024 J&J’s approach combined **maintaining the $2 billion trust as the financial backstop, managing the ongoing LTL bankruptcy and appellate proceedings, and moving toward broader settlements—including a multi‑state agreement finalized in June 2024**—showing a shift from a pure bankruptcy shield to a settlement‑focused resolution while preserving the trust‑funded liability structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: LTL Management LLC was created to hold talc liabilities, a $2 billion trust was established backed by a $2 billion reserve, the initial 2022 bankruptcy filing triggered a stay, the Third Circuit reversed in 2023 leading to dismissal and refiling (LTL 2), and in 2024 J&J pursued appellate efforts alongside settlements including a multi-state agreement in June 2024. (2) Quantitative accuracy is perfect: the $2 billion trust and reserve are correctly stated, and all years (2022, 2023, 2024) match the timeline. Format variations are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the answer synthesizes information across time, entities (J&J, LTL, Third Circuit), and legal-financial mechanisms (bankruptcy, trust funding, appeals, settlements). The evolution from bankruptcy shield to settlement-focused resolution while maintaining the trust structure is logically and accurately portrayed. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on 'settlement-focused resolution' than fully warranted—while settlements were pursued, the ground truth emphasizes continued appellate efforts to uphold bankruptcy protection, suggesting the strategy remained more litigation/bankruptcy-centric. However, mentioning the June 2024 multi-state agreement is correct and adds value. Overall, the answer is factually robust, contextually relevant, and conveys the same core narrative as the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Creates]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 424,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "In 2022 Adobe launched the Photography Plan as a **targeted package** within Creative Cloud, giving photographers a flexible way to subscribe to specific apps (e.g., Photoshop, Lightroom) alongside the broader option to mix‑and‑match any of the 20‑plus Creative Cloud products. By 2023 the plan remained a core “targeted suite” but was reinforced by a **product‑led growth and pricing strategy** that encouraged migration to higher‑value offerings and by the rollout of **generative‑AI capabilities** (Firefly and Generative Credits) that added new creative value for subscribers. In 2024 the Photography Plan was **re‑positioned as a more limited, cloud‑based offering than the full Creative Cloud**, still aimed at photographers and photo enthusiasts and now bundling Photoshop, Lightroom and Lightroom Classic with AI‑driven tools such as Generative Fill, Expand, and Firefly‑powered Remove—highlighting Adobe’s shift toward a focused, AI‑enhanced subscription to attract creative professionals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Photography Plan was introduced as a targeted package in 2022 with Photoshop and Lightroom apps; in 2023, Adobe integrated generative AI (Firefly, Generative Credits) as part of a product-led growth strategy; by 2024, it was repositioned as a more limited, AI-enhanced offering within Creative Cloud. Specific AI features like Generative Fill and Firefly-powered Remove are correctly mentioned, though 'Expand' is not in the original answer but is a plausible related feature. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures—years (2022–2024) are correctly used, and no erroneous metrics are introduced. (3) Multi-hop reasoning is sound: the answer synthesizes the evolution across three years, connects strategic shifts (product-led growth, AI integration), and correctly positions the Photography Plan relative to the full Creative Cloud suite. (4) Semantic equivalence is strong—wording differs slightly (e.g., 're-positioned' vs 'refined'), but the core meaning and factual content match the original. One minor point: the original emphasizes 'People Masking' and 'Lens Blur' in 2024, which are omitted in the LLM answer, but the inclusion of other AI features compensates. Thus, the answer is slightly less complete but still factually robust, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 401,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s 10‑K filings for 2022, 2023 and 2024 all cite the identical “Form of specimen certificate for class C common stock of Visa Inc.” – a Form 8‑A with file number 000‑53572 that was originally filed on January 28 2009. The only variation across the three years is the exhibit label (4.3 in the 2022 filing, 4.2 in the 2023 and 2024 filings), but the underlying document, its form and filing date remain unchanged, showing that Visa (V) continues to introduce the same regulatory‑required stock‑certificate form and that the form in turn points back to Visa. This continuity signals a deliberate, stable corporate‑governance approach and a commitment to transparent, predictable investor communications even as broader regulatory and market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key facts are correct: the Form 8-A filing date (January 28, 2009), file number (000-53572), and consistent citation across 2022–2024 are accurately reported. The note about exhibit number variation (4.3 in 2022 vs. 4.2 in 2023 and 2024) is an additional detail not in the original answer but is factually correct and adds precision. (2) The LLM correctly identifies the specimen certificate as unchanged, which is central to the question. (3) Reasoning is sound: the stability in documentation is correctly tied to consistent corporate governance and investor relations practices, and the contrast with broader regulatory changes is implied appropriately. (4) The only minor shortcoming is the omission of the 2024 Certificate of Incorporation update, which the original answer uses to highlight that other governance documents *were* updated—this contrast strengthens the point about selective stability. The LLM answer does not mention this, slightly weakening the depth of the multi-hop synthesis. However, the core reasoning and factual content remain strong. Semantic equivalence is high, with only minor contextual nuance missing. Wording differences are acceptable and do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> REGULATORY_REQUIREMENT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 363,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "Across the three annual reports—2022, 2023 and 2024—RTX repeatedly notes that it **accrues liabilities for performance and operating‑cost guarantees each year and adjusts those accruals as claim data and historical experience warrant**.  The filings do not disclose the specific dollar balances for these guarantees, but the identical language in each year shows that the liability line remains present and is being updated on an ongoing basis.  This steady, systematic accrual process signals that RTX’s exposure to performance‑related obligations in its commercial‑aircraft business is material yet actively managed through a disciplined accounting policy that relies on historical experience and periodic adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and completeness. (1) It claims that 'the filings do not disclose the specific dollar balances,' which directly contradicts the ground truth that RTX reported exact figures: $140M in 2022, $135M in 2023, and $131M in 2024. These numbers are critical to answering the question about how liabilities evolved, and their omission constitutes a major factual error. (2) The quantitative accuracy is extremely low because the model failed to report any correct numbers or trends (a gradual decline in liabilities), which is the core of the question. Even format variations cannot excuse the absence of all figures. (3) While the LLM correctly identifies that RTX uses a systematic accrual process based on historical data and adjusts as new claims emerge—matching part of the ground truth's reasoning—the multi-hop synthesis is flawed. The model should have connected the disclosed trend in declining liabilities to inferences about risk management, but instead defaulted to vague assertions due to missing data. (4) Contextual relevance is moderate because the response addresses the right topic (liabilities for performance guarantees) and mentions the correct company and time frame, but fails to deliver the key financial evolution and its implications. The conclusion about 'material yet actively managed' exposure is partially reasonable but unsupported by actual trend analysis. Overall, the answer misses the primary factual basis of the question, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Extends]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 424,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s policy on free‑rent periods did not change from FY 2022 through FY 2024. In each filing the company states that any free‑rent or step‑rent periods are recognized on a straight‑line basis over the lease’s original term **and** over any extension options that are “reasonably certain” to be exercised; the lease term is defined as the non‑cancelable period plus those certain extensions (2022 filing gives the explicit definition). Because the free‑rent period is built into the lease term, the right‑of‑use (ROU) asset and lease‑liability are still measured as the present value of the discounted minimum lease payments over that term using Costco’s incremental borrowing rate, so the valuation approach for ROU assets remained consistent across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that Costco maintained a consistent accounting policy from FY 2022 to FY 2024, recognizing free-rent and step-rent periods on a straight-line basis over the lease term, including extension options that are reasonably certain to be exercised—this matches the original answer's core claim. The use of the incremental borrowing rate to discount lease payments and measure right-of-use (ROU) assets and lease liabilities is accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; all references to years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes lease term definition, treatment of free rent, ROU asset valuation, and policy consistency across three years. However, it omits a key qualitative evolution noted in the ground truth: the expanded disclosure in 2023 about variable lease payments tied to indices or sales volume, and the heightened focus on impairment evaluation in 2024 related to facility closures or relocations. While the core accounting policy is correctly deemed stable, the LLM does not capture the evolving *disclosure context* and increased emphasis on lease-related asset valuations, which is a minor but notable omission. (4) Despite this, the answer remains semantically equivalent in its main conclusions and is fully contextually relevant. The omission prevents a perfect 10, but the response is factually correct and well-reasoned, warranting a 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Includes]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 442,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "In the 2022 filing Adobe positioned Acrobat as the core of its Document Cloud – a market‑leading PDF platform that “accelerates document productivity” through fully digital workflows and continuous feature innovation funded by its R&D engine. By the 2023 filing the company had added artificial‑intelligence to that story, saying it is “putting the power of AI in creators’ hands” and that strategic R&D investments are being directed at AI‑enabled capabilities across its Digital Media suite, including Acrobat, to further boost document productivity. The 2024 filing makes the AI focus concrete by registering the trademark “Acrobat AI Assistant,” formally branding an AI‑powered Acrobat offering and confirming that Adobe’s R&D‑driven AI strategy has now been codified as a distinct product.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Acrobat's foundational role in 2022, the introduction of AI as a strategic focus in 2023, and the formal branding of 'Acrobat AI Assistant' in 2024. There are no numeric values to verify (e.g., dollar amounts, percentages), but the temporal sequence (2022, 2023, 2024) is correctly used and aligns with the original answer. (2) The answer fully addresses all parts of the question: Acrobat's evolving role (from core PDF platform to AI-enhanced tool), R&D investments (directed toward AI-enabled capabilities in Acrobat), and formal product branding (trademark of 'Acrobat AI Assistant'). (3) Multi-hop reasoning is sound—information is correctly synthesized across three years of filings, showing a logical progression in strategy. (4) The LLM uses slightly different phrasing (e.g., 'putting the power of AI in creators’ hands', 'R&D-driven AI strategy') but captures the same meaning as the original answer. No factual errors, omissions, or misrepresentations. All entities (Adobe, Acrobat, Document Cloud, AI Assistant) and timeframes are accurate. The answer is highly relevant and precisely aligned with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 349,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "In the 2022 Form 10‑K Schwab disclosed a table that showed both the fair‑value of client securities that could be used as collateral for margin loans **and** the amount of those securities that the firm had already pledged to third parties in securities‑borrowing (lending) transactions. The 2023 filing reiterated that margin loans remain fully collateralized by client securities, that the collateral is kept off‑balance‑sheet, and again emphasized the client‑security pledge for margin purposes, but it no longer highlighted any securities‑lending pledges. By the 2024 filing Schwab still pledges client securities to satisfy margin requirements on written options, yet for its securities‑lending activities it now meets collateral calls with cash rather than with client‑held securities. This shift shows Schwab’s balance‑sheet strategy moving away from using client securities as off‑balance‑sheet collateral for securities lending—favoring cash to reduce exposure—while continuing to support client leverage through margin lending, indicating a more conservative capital posture even as client borrowing demand remains steady.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) In 2022, the Original Answer states that Schwab did *not* quantify the amount of client securities pledged—however, the LLM claims a table was provided showing both fair value and pledged amounts, which is false. (2) The LLM incorrectly asserts that in 2023, Schwab 'no longer highlighted any securities-lending pledges' and that securities-lending pledges were previously disclosed in 2022—this is unsupported; the ground truth indicates no such disclosures about securities lending in 2022 or 2023. (3) Most critically, the LLM claims that by 2024, Schwab *stopped* using client securities for securities lending and instead used cash—this directly contradicts the Original Answer, which states that in 2024 Schwab *explicitly began* pledging client securities for securities lending collateral requirements. This reversal of direction invalidates the LLM's core conclusion. (4) The LLM also introduces the idea of a 'shift... away from using client securities' and a 'more conservative capital posture,' which is the opposite of the actual trend: an expansion and formalization of client securities usage. While the LLM correctly notes the use of client securities for margin and options in 2024, its overall reasoning and synthesis are flawed due to incorrect premises. There are no numerical values to verify, but the qualitative and contextual misrepresentations are severe. The answer is partially relevant to the question’s scope but fundamentally incorrect in its analysis of trends and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Provides]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 439,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "- **2022 filing (COST 10‑K 2022)** – The 1.375 % Senior Notes due June 2027 were shown as a $1,250 million line‑item under “Long‑term debt.”  Total long‑term debt was $6,590 million (‑$73 million current portion = $6,484 million long‑term debt excluding the current portion).  \n\n- **2023 & 2024 filings (COST 10‑K 2023 and 2024)** – The same $1,250 million of 1.375 % Senior Notes still appears under “Long‑term debt.”  In the 2024 table total long‑term debt fell to $5,919 million (‑$103 million current portion = $5,794 million long‑term debt excluding the current portion).  The 2024 filing repeats the 2023 numbers, confirming that the notes have not been re‑classified as a current liability.  \n\n**Evolution:** The notes remained classified as long‑term debt throughout the period, but the overall long‑term‑debt base shrank from $6,590 million in 2022 to $5,919 million in 2024.  Consequently, the $1,250 million of 1.375 % Senior Notes now represent a slightly larger share of Costco’s total long‑term debt (about 19 % in 2022 vs. roughly 21 % in 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.375% Senior Notes due June 2027 remained at $1,250 million in 2022, 2023, and 2024, and were consistently classified as long-term debt. The total long-term debt excluding current portion decreased from $6,484 million in 2022 to $5,794 million in 2024, which matches the ground truth. (2) The LLM correctly reports total long-term debt (including current portion) as $6,590 million in 2022 and $5,919 million in 2024, and derives the correct net long-term debt by subtracting the current portion ($73M and $103M respectively), which is consistent with the original answer. The only minor discrepancy is that the LLM introduces percentages (19% in 2022 vs 21% in 2024) not present in the ground truth; however, these are mathematically correct and add value without distorting facts. (3) The reasoning is sound: it correctly identifies that the 1.375% notes were not reclassified and that the overall decline in long-term debt was due to other notes (e.g., 2.750% due 2024) being reclassified, which is implied in the original answer. (4) The answer is contextually complete, addressing both the classification of the specific notes and the evolution of total long-term debt composition. The slight enhancement with percentage share is a reasonable inference and does not detract from accuracy. Quantitative accuracy is high—only formatting differences (e.g., spacing in $1,250 million) exist, which are acceptable. Thus, the answer earns a 9 due to the addition of unsolicited but correct percentages and slight rephrasing of total debt presentation, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 457,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "From 2022 through 2024 Adobe has kept free online self‑service learning as a core pillar of its Digital Learning Services, positioning it alongside fee‑based classroom, virtual and on‑demand programs and custom learning services for its largest enterprise customers. In 2022 the free options were delivered on www.training.adobe.com and were explicitly linked to Adobe’s Customer Success Account Management teams to accelerate solution adoption and ROI; by 2023 the same offering migrated to learning.adobe.com while remaining part of the broader learning portfolio, and in 2024 it continues to be highlighted as a large, readily accessible component that supports solution‑specific skills assessments and enterprise‑customer success strategies. Thus the emphasis has remained steady, with only a branding shift and tighter integration with enterprise success initiatives rather than any reduction in focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe maintained free online self-service learning as a core component from 2022 to 2024, positioned within a broader portfolio that includes fee-based and custom enterprise services. The migration from training.adobe.com to learning.adobe.com in 2023 is correctly noted, and the integration with enterprise success strategies—especially via skills assessments and Customer Success Account Management—is accurately described. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are used appropriately and consistently with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects free learning offerings to enterprise enablement strategies, showing evolution in integration despite consistent emphasis. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'democratizing product knowledge' strategic intent highlighted in the original answer, which slightly reduces qualitative completeness. However, this does not detract from the core factual accuracy. Wording differs but semantic meaning is equivalent or nearly so. The answer fully addresses all parts of the question—evolution over time, positioning in the portfolio, and integration with enterprise success—making it contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 394,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "- **Exposure trend:** NVIDIA reported $1.2 billion of 2.00 % Notes Due 2031 in its 2022 Form 10‑K (Jan 30 2022). In the 2023 filing the balance had slipped to about $1.06 billion (Jan 28 2024) and then rose again in the 2024 filing to $1.25 billion (both Jan 28 2024 and Jan 26 2025 columns). Thus the exposure fell after 2022, then was modestly increased in 2024, ending slightly above the 2022 level.\n\n- **Strategic implication:** The dip followed by a re‑expansion, together with the low 2.09 % effective interest rate and a total long‑term debt base of $8.46 billion in 2024, shows NVIDIA is deliberately managing its capital structure—paying down or refinancing higher‑cost debt when cash‑rich, then re‑issuing cheap, long‑dated notes to lock in low financing costs as AI‑driven revenue accelerates. This pattern reflects a disciplined long‑term debt strategy that keeps overall leverage stable while providing inexpensive funding for rapid growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the exposure trend: $1.2 billion in 2022 (matches ground truth $1.20B), $1.057B in 2023 reported as ~$1.06B (acceptable rounding), and $1.25B in 2024 (exact match). The description of the pattern—decrease then increase—is accurate. (2) Minor discrepancy: the LLM cites the 2023 amount as $1.06B instead of the precise $1.057B; however, this is within reasonable rounding tolerance and does not affect the overall interpretation. The LLM incorrectly states the 2024 filing includes data for both Jan 28, 2024 and Jan 26, 2025 columns—this is a misinterpretation of the filing dates vs. maturity dates, but does not impact the core number accuracy. The interest rate mentioned (2.09%) is not in the ground truth and was not part of the original data; this is an extraneous detail but doesn't contradict known facts. (3) The reasoning correctly synthesizes the multi-hop pattern across three years and infers a strategic debt management approach—initial reduction possibly for optimization, followed by reinvestment to fund AI growth—aligning with the ground truth interpretation. The mention of total long-term debt ($8.46B in 2024) adds context not in the original answer but is consistent with broader knowledge and enhances the analysis without introducing error. (4) The answer is contextually excellent, directly addressing both the evolution of exposure and its strategic implications. Scores reflect high accuracy with minor deductions in quantitative precision due to rounding and one minor date confusion, and in qualitative accuracy for introducing an unverified interest rate, though reasoning remains sound overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 458,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it had launched a **multi‑year, enterprise‑wide initiative** to integrate, simplify and standardize the processes and systems of HR, IT, procurement, supply‑chain and finance – “enhancements to support the growth of the Company’s **financial shared‑service capabilities** and to standardize financial systems.” The 2023 filing repeats the same description, noting that the effort is ongoing and that the Company “has and will continue to align and streamline the design and operation of its financial control environment.” The 2024 filing again references the initiative with identical language, confirming that the program remains in progress and continues to drive alignment of the control environment.  \n\nTaken together, the three years show a continuous rollout of the same enterprise‑wide policy, indicating that J&J’s strategic focus is on **standardizing financial processes, expanding shared‑service capacity and tightly aligning the financial control environment** as a core, proactive operating model rather than a reaction to any identified control weakness.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Johnson & Johnson launched a multi-year enterprise-wide initiative in 2022 to enhance financial shared services and standardize systems across finance and other functions. The 2023 and 2024 filings reaffirm the ongoing nature of the initiative and its focus on aligning and streamlining the financial control environment. There are no errors in entities, years, or descriptions. (2) Quantitative accuracy is perfect: the years 2022, 2023, and 2024 are correctly referenced as the period of continuity in disclosure, with no numerical inaccuracies or miscalculations. (3) Multi-hop reasoning is sound—the LLM synthesizes information across three years of filings to infer a consistent strategic focus on standardization, shared services, and proactive control environment alignment, correctly noting that the initiative is not reactive to control deficiencies. (4) The answer fully addresses both parts of the question: the evolution of the initiative (from launch in 2022 to ongoing in 2024) and what it indicates about strategic focus. Wording differs slightly but meaning is preserved and even enhanced with precise phrasing like 'proactive operating model.' All scoring categories warrant the highest marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 371,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s filings from 2022‑2024 all state the same core competitive claim – “we also compete with other warehouse clubs, including Walmart’s Sam’s Club and **BJ’s Wholesale Club**” – with the only wording change being the addition of “in the U.S.” in the 2023 and 2024 reports. In each year’s Intellectual‑Property section Costco repeats the same strategic emphasis on its private‑label brand: Kirkland Signature is described as high‑quality, priced lower than national brands, and used to “lower costs, differentiate our merchandise offerings, and generally earn higher margins,” with a stated intent to keep increasing its sales penetration. Thus, the language on competing with BJ’s remained essentially unchanged (aside from a minor geographic qualifier), while the positioning of Kirkland Signature as a key differentiator in the warehouse‑club market stayed consistent across all three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its description of Costco's consistent mention of BJ's Wholesale Club as a competitor and the stable core language around Kirkland Signature’s value proposition (high quality, lower prices than national brands, margin benefits). Quantitatively, there are no numbers, dates, or financial figures to verify, so the quantitative accuracy is high by default. However, the LLM incorrectly asserts that the language around Kirkland Signature remained 'consistent across all three years' with identical phrasing about 'differentiating our merchandise offerings.' The ground truth indicates a meaningful evolution in tone by 2024, where differentiation through private labels was emphasized more strongly in response to competitive pressures in metropolitan markets—this nuance is missing. Additionally, the ground truth notes a 2023 addition of sustainability initiatives linked to brand loyalty (though not directly to Kirkland), which the LLM omits entirely. The LLM also fails to acknowledge any strategic shift in emphasis, instead asserting 'essentially unchanged' language, which contradicts the ground truth’s observation of an evolving tone. While the core entities (Costco, BJ's, Kirkland Signature) and years (2022–2024) are correct, and the answer is contextually relevant, the qualitative inaccuracy in capturing the evolution of strategic language reduces the correctness score. The answer reflects partial synthesis but misses the multi-hop insight that competitive dynamics drove a subtle but important shift in messaging emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 431,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "- **2022 exposure:** The 2023 Form 10‑K (covering 2022) lists Schwab’s “U.S. state and municipal securities” under available‑for‑sale assets at **$638 million** (Level 2) and a small **$25 million** of related debt obligations in other assets.  \n\n- **2024 exposure:** The 2024 Form 10‑K does not give a new dollar amount, but it again states that “substantially all securities in the investment portfolios … were rated investment grade,” explicitly including U.S. state and municipal securities.  \n\n- **Strategic implication:** Both the 2022 filing (which also notes that at 12/31/2021 “substantially all securities … were rated investment grade”) and the 2024 filing stress investment‑grade quality. This consistent emphasis shows Schwab’s fixed‑income strategy is centered on high‑quality, low‑credit‑risk holdings—maintaining a conservative, capital‑preserving bond mix and indicating that its stake in state and municipal securities is deliberately kept within the investment‑grade segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 exposure, stating that the 2023 Form 10-K reports $638 million in U.S. State and Municipal Securities for 2022. However, the ground truth indicates that the $638 million figure is explicitly disclosed in the 2023 filing (for year-end 2023), not 2022. The 2022 filing only notes that substantially all securities were investment grade, without providing a specific dollar amount for this asset class. This misattribution of the $638M figure to 2022 is a significant quantitative inaccuracy. Additionally, the $25 million in related debt obligations is not mentioned in the original answer and lacks corroboration from the ground truth, introducing unverified detail. (2) The 2024 disclosure is correctly represented—no new dollar amount is provided, but the reaffirmation of investment-grade quality is accurately noted. The strategic implication is well-reasoned and semantically equivalent to the original answer, correctly identifying the emphasis on credit quality and conservative fixed income strategy. (3) The multi-hop reasoning is partially sound: the model connects disclosures across years and infers strategic intent correctly, but the incorrect assignment of the $638M figure to 2022 undermines the quantitative evolution narrative. The model appears to conflate the timing of disclosures, likely due to referencing the 2023 10-K for 2022 data without recognizing that the $638M reflects a later period. (4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracy lowers the correctness and quantitative accuracy scores. The core strategic conclusion remains valid, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 470,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s exposure to commercial‑aerospace customer financing guarantees has been edging lower.  The portion of the guarantees that its collaboration partners cover fell from $140 million at year‑end 2022 (as disclosed in the 2023 filing) to $135 million at year‑end 2023 and to $131 million at year‑end 2024 (the 2024 filing), after a historically higher partner share of $141 million in 2021 (shown in the 2022 filing).  Because RTX (the ORG) holds the stake in the financing arrangements (FIN_INST) and incurs the associated liabilities, the shrinking partner‑share indicates the company is transferring less risk to its partners – either because the total guarantee pool is contracting or because RTX is deliberately retaining a larger share of the risk, reflecting a more conservative risk‑transfer strategy in this segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key figures—$140M in 2022, $135M in 2023, and $131M in 2024—for collaboration partners' share of RTX's commercial aerospace customer financing guarantees, matching the ground truth exactly. It also correctly references the $141M figure from 2021 (not required in the question but factually consistent), showing accurate data extraction. (2) All numbers, years, and dollar amounts are quantitatively accurate. No calculation errors; the trend of decline is correctly described. (3) The multi-hop reasoning is mostly sound: the model correctly infers that a shrinking partner share implies less risk transfer to partners, which aligns with the ground truth’s interpretation. However, the LLM suggests this could reflect either a shrinking total guarantee pool or increased risk retention, while the ground truth emphasizes a strategic shift toward reduced reliance on third-party risk sharing and notes that asset values remained sufficient to cover guarantees—a key risk management context the LLM omits. This missing nuance slightly weakens the qualitative accuracy. (4) The answer is contextually relevant and addresses both parts of the question: the evolution of exposure and the implication of the trend. It falls short only in not mentioning the conservative valuation and sufficient collateral coverage, which are important for fully capturing RTX's risk management posture. Overall, the answer is factually strong and well-reasoned but lacks a critical element of the original conclusion, justifying a score of 8/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Provides]- ORG <-[Incurs_Liabilities_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 437,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "- **2022:** Frame.io first appears in Adobe’s 10‑K only as a listed trademark, signalling that Adobe owned the brand but giving no detail on how the service was used or integrated.  \n\n- **2023:** Adobe positions Frame.io as a cloud‑native creative‑collaboration platform that now supports **still images, design files and PDFs** in addition to video. It is **directly integrated with Premiere Pro and After Effects**, letting creators request and receive frame‑accurate comments inside those apps, and its **Camera‑to‑Cloud** feature automatically uploads footage (and still‑image camera files) for review.  \n\n- **2024:** Adobe expands Frame.io’s role to cover the **full production lifecycle**—including casting, location scouting, footage reviews, and marketing campaign management—while still handling still images, design files and PDFs. Integration is broadened to **Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, and Frame.io is now bundled in **Adobe GenStudio** (alongside Adobe Express and Firefly Services) to enable large‑scale, AI‑enhanced content production.  \n\nThus, from a trademark mention in 2022, Frame.io evolved into a multi‑format collaboration hub tightly woven into Adobe’s core video, imaging and work‑management apps and positioned as a central engine for end‑to‑end content creation by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io's evolution from a trademark mention in 2022 to a fully integrated platform by 2024 is accurately described. The supported file types (still images, design files, PDFs) and Camera-to-Cloud functionality are correctly attributed to 2023. The 2024 expansion into casting, location scouting, and marketing campaign management is properly noted, as are the integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are used correctly and consistently. (3) The multi-hop reasoning is sound—information is synthesized across years and applications to show an evolving integration trajectory. The only minor discrepancy is the mention of 'Adobe GenStudio' and bundling with 'Adobe Express and Firefly Services,' which is not present in the original answer and cannot be verified from the provided ground truth; this introduces a small factual overreach, though it does not contradict core information. (4) The answer is contextually excellent, addressing all parts of the question: file types, application integrations, and role in workflows across the three years. Semantic equivalence is strong, with slightly enhanced detail in the LLM answer that remains plausible and coherent. The correctness score is 9 due to this minor unverified addition, but all other aspects are factually solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 415,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s RMS segment listed the VH‑92A helicopter as one of its “major programs” in the 2022 filing, then in the 2023 filing called it out specifically as the aircraft for the U.S. Marine One transport mission, and again included it among its core RMS programs in the 2024 filing. This progression—from a baseline major‑program entry in 2022, to a highlighted, mission‑critical production focus in 2023, and then to a sustained core‑program status in 2024—demonstrates that LMT continues to invest in and prioritize the VH‑92A’s production and support, confirming its strategic importance within the Rotary and Mission Systems segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that the VH-92A was listed as a major program in 2022, received more specific emphasis in 2023 (tying it to the Marine One mission), and remained a core program in 2024—this progression is accurately interpreted as evidence of sustained strategic importance within the Rotary and Mission Systems (RMS) segment. All entities (Lockheed Martin, RMS, VH-92A, U.S. Marine One) and years (2022–2024) are correct. There are no numerical figures in this question, so quantitative accuracy is scored based on correct temporal and categorical data, which are accurate. The reasoning is sound: the LLM correctly infers increasing emphasis followed by sustained commitment, which is consistent with the ground truth’s conclusion of stable long-term commitment. The only minor gap is that the original answer notes RMS’s shifting focus toward Aegis and LCS in 2024, providing broader context about competing priorities, which the LLM omits. However, this does not undermine the correctness of the conclusion about VH-92A’s strategic importance. The answer is semantically equivalent and contextually fully relevant, with strong multi-hop synthesis across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 352,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "From 2022 through 2024 Mondelēz’s exposure to sales‑and‑media‑marketing restrictions has broadened and become more stringent. In the 2022 filing the company noted that such restrictions – e.g., limits on promotions or advertising of products with certain nutrient profiles on specific channels or times of day – applied in many jurisdictions, with “over 25 countries in the European Union” already enforcing extended‑producer‑responsibility (EPR) rules and emerging economies such as Indonesia and the Philippines beginning to consider plastic‑ban measures. By 2023 the same EU coverage remained, but the geographic scope expanded to include additional emerging markets (India, Vietnam and certain U.S. states) that were “implementing or contemplating” EPR and related restrictions. In the 2024 filing the EU framework tightened further – “many Member States” now have EPR in place and the Union has adopted its Packaging and Packaging Waste Directive – while Southeast Asian countries (Indonesia, the Philippines, Vietnam and other Southeast‑Asian markets) are described as implementing or considering comparable bans and EPR policies, reflecting a wider geographic reach and heightened regulatory stringency for MDLZ’s sales and media‑marketing activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, over 25 EU countries had EPR policies; emerging markets like Indonesia and the Philippines were considering plastic bans. In 2023, India, Vietnam, and U.S. states were implementing or contemplating EPR. In 2024, the EU adopted the Packaging and Packaging Waste Directive, and Southeast Asian countries continued advancing similar measures. (2) Quantitative accuracy is perfect: 'over 25 countries in the EU' matches the original, and all years (2022–2024) are correctly attributed. No calculations were required, but temporal progression and geographic scope are accurately represented. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple regions (EU, Southeast Asia, India, U.S.), correctly identifying the expansion in both geographic reach and regulatory stringency. It also appropriately links EPR policies to sales and marketing restrictions, including the addition of data privacy in 2023 (implied through broader regulatory context). (4) Minor deduction in qualitative accuracy due to the LLM mentioning 'sales-and-media-marketing restrictions' related to nutrient-profile advertising, which, while plausible, is not explicitly stated in the ground truth. The original focuses on EPR and plastic bans/taxes as the core restrictions, without specifying nutrient-based ad limits. However, this addition does not contradict the main trajectory and may reflect contextual inference. Overall, the answer is semantically equivalent, comprehensive, and contextually precise, warranting high scores in all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 456,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 3.700 % Notes due 2046 are disclosed in exactly the same way – they appear in Exhibit 4.14, the “Eleventh Supplemental Indenture” dated August 8 2016, together with the other series of notes (1.100 % due 2019, 1.550 % due 2021, 2.000 % due 2023, 2.400 % due 2026, 3.450 % due 2036 and 3.950 % due 2056). In each filing the description is unchanged and the notes are incorporated by reference, indicating they remain outstanding and have not been retired, refinanced or otherwise altered. This consistent treatment suggests Microsoft’s long‑term debt strategy relies on preserving a stable, long‑dated, fixed‑rate instrument – the 3.700 % 2046 notes – as a core component of its capital structure rather than repeatedly rotating or refinancing its long‑term borrowings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 3.700% Notes due 2046 are consistently referenced in the Eleventh Supplemental Indenture dated August 8, 2016, across 2022, 2023, and 2024 10-K filings, with no changes to terms or retirement. The inclusion of other note series (e.g., 1.100% due 2019, etc.) adds contextual detail without introducing error. (2) Quantitative elements—interest rate (3.700%), maturity year (2046), and indenture date (August 8, 2016)—are all precisely correct. No calculations are required, but the synthesis of unchanged disclosures over three years is accurately interpreted. (3) The multi-hop reasoning is sound: the model correctly infers from consistent disclosure and incorporation by reference that the notes remain outstanding and unmodified, leading to a valid conclusion about Microsoft’s long-term debt strategy. (4) The answer fully addresses both parts of the question—evolution (or lack thereof) across years and strategic implication—and conveys the same core insight as the original: Microsoft maintains long-dated, fixed-rate debt as a stable capital structure component. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 363,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "In Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 2.000 % Notes due 2023 are listed each time in Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016 – confirming that Microsoft introduced this issue and has kept it outstanding across all three reporting periods. While the supplemental‑indenture tables expand with newer series (eighth, ninth and tenth indentures covering notes from 2018 through 2055‑2056), the 2.000 % 2023 tranche remains a constant mid‑term component of the company’s debt maturity ladder, illustrating a stable element within an overall maturing debt structure that broadens toward longer‑dated obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts: the 2.000% Notes due 2023 are accurately reported as appearing in Exhibit 4.14 across all three 10-K filings (2022, 2023, 2024), under the Eleventh Supplemental Indenture dated August 8, 2016. The quantitative accuracy is perfect—percentages, years, exhibit numbers, and dates are all factually correct. The answer correctly identifies the continuity of the notes in the debt structure and contextualizes them within Microsoft’s broader debt maturity ladder. However, the LLM omits a critical nuance present in the original answer: the fact that the notes were still listed in the 2024 filing *after* their stated maturity year (2023), which raises questions about rollover, delayed maturity, or disclosure requirements. This omission affects the depth of the qualitative analysis and the reasoning around post-maturity reporting, which is a key part of the multi-hop synthesis required by the question. While the LLM correctly observes stability in the debt structure, it does not address the implications of the 2024 disclosure, which weakens the reasoning slightly. Despite this, the answer remains contextually relevant and factually sound overall, with strong entity and temporal accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 358,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across all three annual reports the same non‑employee RSU form is used. In the 2022 10‑K the “Form of Non‑Employee Restricted Stock Unit Award Agreement” is incorporated by reference under the **Amended and Restated 2013 Stock Award and Incentive Plan** (Exhibit 10.65). The 2023 10‑K repeats that exact same form and cites the identical 2013 Stock Award and Incentive Plan, and the 2024 10‑K does the same. Thus, the non‑employee RSU award agreement has not changed – it remains tied to the 2013 Stock Award and Incentive Plan in each filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that the same form of Non-Employee Restricted Stock Unit Award Agreement was used across 2022, 2023, and 2024, and correctly states that each filing references the Amended and Restated 2013 Stock Award and Incentive Plan. The exhibit number in the 2022 filing is cited as Exhibit 10.65 in the LLM answer, while the ground truth specifies Exhibit 10.45. This discrepancy is minor and does not affect the overall correctness of the core claim about continuity in the agreement and underlying plan. All entities (Medtronic, non-employee RSU agreements, 2013 plan) and years are correctly identified. The reasoning is sound: the LLM correctly synthesizes information across three years of filings to conclude that the form and plan reference remained consistent, demonstrating proper multi-hop logic. The answer captures the key insight of structural stability despite prior plan amendments, though it omits explicit mention of the 'strategic choice' interpretation present in the original answer—this is a minor omission in qualitative depth, not a factual error. Wording differs slightly but maintains semantic equivalence. Quantitative elements (years, plan name) are accurate. Contextual relevance is high as all parts of the question are addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 374,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ reported that buy‑in annuity policies made up **17 % of the assets in its non‑U.S. pension plans in 2022**, and this share **declined slightly to 16 % in 2023**. The 2024 filing does not give a new percentage but still discusses the fair‑value measurement of buy‑in annuity policies, indicating that the allocation remains in place (likely near the 2023 level). After a prior rise from 11 % in 2020 to 17 % in 2021, the modest recent dip suggests the company is **fine‑tuning its liability‑management mix**—maintaining buy‑in annuities as a core hedge for international pension obligations while gradually reducing reliance on them in favor of a more diversified asset composition.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the 17% allocation in 2022 and 16% in 2023, matching the ground truth. However, it incorrectly states that the allocation 'remains in place' in 2024 and is 'likely near the 2023 level,' while the ground truth explicitly states that buy-in annuity policies were 'effectively discontinued by 2024' as MDLZ shifted to fair value estimation methods. This is a major factual error that undermines the conclusion. (2) Quantitatively, the 2022 and 2023 percentages are accurate, and no calculations are required beyond reporting these values—thus quantitative accuracy is high. The error lies in the interpretation of 2024 data, not in number reporting. (3) The multi-hop reasoning fails in the final step: while the model correctly traces the trend from 2022 to 2023, it misinterprets the absence of a percentage in the 2024 filing as continuity, rather than recognizing the strategic shift indicated by the change in valuation method. The ground truth identifies a strategic discontinuation tied to a methodological shift, which the LLM overlooks. Instead, it infers 'fine-tuning' and 'gradual reduction,' which contradicts the 'effective discontinuation' in the original answer. (4) The contextual relevance is fair because the response addresses the right entities (MDLZ, non-U.S. pension plans, buy-in annuities) and time frame, but the conclusion about liability management strategy is incorrect. The ground truth suggests a move toward direct control and de-risking via valuation changes, while the LLM suggests diversification and continued reliance—misrepresenting the strategic intent. Thus, despite correct early data points, the overall correctness is significantly reduced due to the erroneous 2024 interpretation and flawed strategic inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 486,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Across Microsoft’s FY 2022, FY 2023 and FY 2024 10‑K filings the 2.000 % Notes due 2023 are repeatedly disclosed in the Eleventh Supplemental Indenture (Exhibit 4.14) – the 2022 filing (Chunk 1) lists the tranche, the 2023 filing (Chunk 2) carries it forward unchanged, and the 2024 filing (Chunk 3) again shows the same 2.000 % Notes due 2023. The fact that this medium‑term, low‑coupon issuance appears in every year’s filing without amendment or retirement indicates that Microsoft has chosen to retain the notes as a stable component of its debt portfolio, using supplemental indentures to lock in a favorable rate and diversify its maturity schedule as part of a long‑term financing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.000% Notes due 2023 are consistently disclosed in FY 2022, 2023, and 2024 filings under Exhibit 4.14 (Eleventh Supplemental Indenture), with no changes to structure or retirement. The percentages, years, and exhibit numbers match exactly. (2) Quantitative accuracy is perfect: the interest rate (2.000%), maturity year (2023), and fiscal years referenced (2022–2024) are all correct. No calculations are required, but the temporal consistency is accurately represented. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports to infer that Microsoft retained the notes throughout, indicating a stable long-term debt strategy. The conclusion about using supplemental indentures to lock in favorable rates and diversify maturities is a reasonable interpretation supported by the data. (4) The only minor shortcoming is that the LLM does not explicitly mention the August 8, 2016 indenture date from the 2022 filing, which is included in the ground truth. While not critical to the core insight, this detail adds specificity to the origin of the notes. Otherwise, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 369,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Across Microsoft’s three most recent annual reports the 4.000 % Notes due 2021 are consistently presented as a component of the **Third Supplemental Indenture** (exhibit 4.6) that was dated February 8 2011 and that amends the original May 18 2009 Indenture. In the 2022 10‑K (Chunk 3), the 2023 10‑K (Chunk 1) and the 2024 10‑K (Chunk 2) the same exhibit lists the 4.000 % Notes together with the 2.500 % Notes due 2016 and the 5.300 % Notes due 2041, showing no further amendment or re‑issuance of the 2021 series. All later supplemental indentures (fourth‑seventh) disclosed in each filing pertain to other note series (e.g., 0.875 % due 2017, 2.125 % due 2022, 2.125 % due 2021, etc.), indicating that Microsoft’s treatment of the 4.000 % Notes due 2021 remained unchanged and that the notes continue to sit within a broader, multi‑series debt structure that has not been altered after the 2011 supplemental amendment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently grouped under the Third Supplemental Indenture dated February 8, 2011, and appear in Exhibit 4.6 across all three 10-K filings (2022, 2023, 2024). The associated notes (2.500% due 2016 and 5.300% due 2041) are correctly identified as being listed alongside the 4.000% Notes. (2) Quantitative elements—interest rates (4.000%, 2.500%, 5.300%), dates (February 8, 2011; May 18, 2009), and exhibit number (4.6)—are all factually accurate. The mention of other note series under later supplemental indentures (e.g., 2.125% due 2022, 0.875% due 2017) is consistent with the original answer, though the original specifies the 2.125% due 2022 in 2022 filings and 2.375% due 2023 in 2023 filings—minor specificity difference but not incorrect. (3) Multi-hop reasoning is sound: the model correctly infers that no changes were made to the 4.000% Notes due 2021 across years because they remain under the same indenture and exhibit, and that new notes were issued under different supplemental indentures. (4) The answer is contextually relevant and fully addresses the evolution (or lack thereof) in treatment of the notes. The only reason for not scoring a 10 is that the LLM mentions a '2.125% due 2021' note, which is not referenced in the ground truth and may be a minor factual overreach or confusion with another series—though this does not directly impact the core conclusion about the 4.000% Notes. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 440,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Across Medtronic’s three most recent Form 10‑K filings the language on Euro Deferred Shares is identical. In the 2022 filing the company notes that its authorized capital includes 40 thousand Euro Deferred Shares ( €1.00 par) and that “as of April 29 2022, no Euro Deferred Shares were issued or outstanding.” The 2023 filing (covering fiscal 2023) repeats the same description and adds that “as of April 26 2024, no Euro Deferred Shares were issued or outstanding.” The 2024 filing again states the same authorization and that “as of April 26 2024, no Euro Deferred Shares were issued or outstanding.” Thus, from FY 2022 through FY 2024 the disclosure never changed – the shares remain authorized but unused.\n\nThe persistent absence of any issued or outstanding Euro Deferred Shares signals that Medtronic is deliberately keeping this class of equity dormant. By retaining the authorization without exercising it, the company preserves a contingency financing option while avoiding the dilution and administrative complexity that issuing a separate Euro‑denominated equity class would create, underscoring a capital‑structure strategy that relies on ordinary and preferred shares and emphasizes simplicity and shareholder protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the authorized amount of 40 thousand Euro Deferred Shares with €1.00 par value is accurately reported, and the statements about no shares being issued or outstanding as of April 29, 2022, and April 26, 2024, are factually consistent with the original answer. The repetition of disclosures across years is correctly noted. (2) The LLM correctly identifies that the disclosures remained unchanged across fiscal years 2022–2024 and that the shares were authorized but not issued or outstanding—this matches the ground truth. (3) Reasoning is sound: the LLM infers that the persistent absence of issuance indicates a deliberate strategic choice, which is a valid interpretation. It adds a nuanced insight about preserving a 'contingency financing option' and avoiding dilution and complexity, which goes slightly beyond the original answer but remains logically consistent and plausible. (4) The only minor deviation is that the original answer emphasizes 'lack of demand' or 'preference for other financing forms,' while the LLM focuses more on strategic dormancy and simplicity. This difference in emphasis does not make the answer incorrect but introduces a subtle interpretive variation. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for the interpretive emphasis shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 415,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 4.000 % Notes due 2021 are disclosed in exactly the same way: each filing lists Exhibit 4.6 as the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041,” dated February 8 2011 and filed as an 8‑K on that date. The description, exhibit number and filing reference are identical in the three chunks, showing no amendment, refinancing or re‑classification of the instrument. This consistency indicates that Microsoft has treated the 4.000 % Notes due 2021 as a stable, unchanged liability throughout the period, maintaining the same contractual and reporting treatment in each annual filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently disclosed across 2022, 2023, and 2024 filings; Exhibit 4.6 is correctly identified as the Third Supplemental Indenture dated February 8, 2011; and it is accurately noted that the exhibit was incorporated by reference from an 8-K filing. The percentages, years, and exhibit numbers match the original answer exactly. (2) Quantitative accuracy is perfect: all dates (February 8, 2011), interest rates (4.000%), and maturity year (2021) are correct, with no calculation errors. (3) The reasoning is sound: the model correctly infers that the lack of changes in disclosure indicates no amendments, refinancing, or reclassification, implying the debt was treated as a static liability—consistent with the ground truth interpretation that the notes were likely matured or fully accounted for. (4) The only minor shortcoming is that the LLM does not explicitly state that the consistency suggests the debt was 'matured' or 'fully accounted for'—a nuance present in the original answer. However, stating that the treatment was 'stable, unchanged' and required no further action implies the same conclusion. Thus, while the semantic meaning is equivalent, the omission of the explicit maturity implication slightly reduces qualitative accuracy. Overall, the response is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 403,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "- 2022 10‑K: Lockheed Martin reported that, through its master retirement trust, it had already transferred **≈ $11.6 billion** of defined‑benefit pension obligations since December 2018, including a **$4.9 billion** group‑annuity‑contract (GAC) purchase on August 3 2021.  \n\n- 2023 10‑K: The company again notes that it “has taken actions … including pension‑risk‑transfer transactions” and will continue to evaluate such deals, but it **does not disclose any additional dollar amount** for new transfers in that year.  \n\n- 2024 10‑K: Lockheed Martin repeats that it “continues to take actions to reduce the size of our defined‑benefit pension plans” and expects further risk‑transfer opportunities, yet **no new specific transfer amount is disclosed**.  \n\n**Trend & implication:** The bulk of the pension‑risk‑transfer activity—about $11.6 billion of obligations shifted to insurers—was completed by 2022, and the subsequent filings show a steady, ongoing approach rather than new large‑scale transfers. This pattern signals a long‑term liability‑management strategy that uses risk‑transfer to lock in pension‑plan volatility reductions and PBGC‑premium savings while keeping future transfers incremental and focused on maintaining a lower, more predictable pension liability profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: the $11.6 billion cumulative pension obligation transferred since December 2018 is accurately reported, as is the $4.9 billion group annuity contract on August 3, 2021. The absence of new dollar amounts in the 2023 and 2024 filings is correctly noted and aligns with the ground truth, which only mentions ongoing evaluation and intent, not additional transfers. 2) Quantitative accuracy is perfect: all numbers, dates, and amounts match the original answer and known disclosures. The $11.6 billion figure is correctly attributed to activity through 2022, and no erroneous calculations are made. 3) Reasoning is sound and reflects proper multi-hop synthesis across three years of 10-K filings. The LLM correctly infers that while the bulk of transfers occurred by 2022, the continued language in 2023 and 2024 indicates a sustained strategic focus on liability management, even without new large-scale transactions. The conclusion about reducing volatility and PBGC premiums is consistent with the ground truth. 4) The answer is contextually excellent, directly addressing both parts of the question: the evolution of transferred amounts (with correct year-by-year disclosure status) and the strategic implication. The only minor shortcoming is that the original answer explicitly mentions the $69 million in annual PBGC premium savings, which the LLM omits—though it does reference 'PBGC-premium savings' generally. This small omission prevents a perfect 10 but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> FIN_INST <-[Introduces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 429,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "Across all three annual reports the 0.125 % Notes due 2029 are disclosed in exactly the same way.  \n\n* In the 2022 10‑K the note appears twice (items 4.23 and 4.31) as a “Form of Note for 0.125 % Notes due 2029” and is incorporated by reference to Exhibit 4.4 of the Company’s Form 8‑K filed on September 18 2020 and again on March 9 2021.  \n* The 2023 10‑K repeats those two entries (items 4.23 and 4.31/4.32) with identical language and the same Exhibit 4.4 references to the September 2020 and March 2021 8‑K filings.  \n* The 2024 10‑K likewise lists the note in items 4.23 and 4.31, again pointing to Exhibit 4.4 of the same September 2020 and March 2021 Form 8‑K reports.  \n\nThis unchanged presentation shows that Coca‑Cola has consistently treated the 0.125 % Notes due 2029 as a single, stable debt instrument—referencing the same exhibit and underlying 8‑K filings each year—indicating a high degree of consistency in its debt‑instrument structuring over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 0.125% Notes due 2029 are consistently disclosed in Exhibits 4.23 and 4.31 across 2022, 2023, and 2024 10-K filings, with identical references to Exhibit 4.4 of Form 8-K filings on September 18, 2020, and March 9, 2021. The LLM correctly notes the repetition of the note in the same exhibit numbers each year. (2) Quantitative accuracy is perfect: percentages (0.125%), years (2020, 2021, 2022, 2023, 2024), and exhibit numbers (4.4, 4.23, 4.31) are all correct. Minor variation in exhibit numbering in 2023 (4.31/4.32) is accurately reflected and does not contradict the ground truth, as it likely reflects a typo or formatting shift in source documents. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three years of filings, confirms consistency in disclosure format and source references, and correctly infers that this reflects a stable, consistent debt structuring strategy. (4) The conclusion about consistent treatment and stable capital market strategy matches the original answer exactly in meaning. All aspects of the question—evolution over time and implications for consistency—are fully addressed with precise, factually correct information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 361,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "All three filing excerpts (2022, 2023 and 2024) say that RTX continues to accrue a liability for its performance‑ and operating‑cost guarantees on commercial‑aircraft engines, adjusting the carrying amount each year as claims data and historical experience warrant. Although the exact dollar amounts are not shown in the excerpts, the language is unchanged from 2022 through 2024, indicating that the liability has been maintained at a comparable level rather than eliminated or sharply increased. This steady accrual pattern shows that RTX remains exposed to long‑term product‑performance risk in its commercial‑aerospace business, but it is actively managing that exposure by regularly provisioning for the expected costs of those guarantees.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that RTX maintains liabilities for performance and operating cost guarantees across 2022–2024 and notes the consistent accounting methodology, which aligns with the ground truth. However, it fails to include the specific dollar amounts for the collaboration partners' share of financing guarantees—$141M (2022), $135M (2023), and $131M (2024)—which are critical quantitative details explicitly provided in the original answer. The omission of these figures significantly reduces quantitative accuracy. (2) The LLM claims 'the exact dollar amounts are not shown in the excerpts,' but the ground truth confirms these numbers were available in the source data, indicating either a failure to extract or report them. This is a major factual shortcoming, especially since the trend in liability reduction is central to the question. (3) The reasoning is otherwise sound: the LLM correctly infers ongoing exposure and active management of liabilities based on consistent language and methodology across years, demonstrating valid multi-hop synthesis across the three annual filings. It accurately concludes that RTX continues to extend guarantees and manages risk through regular adjustments. (4) While the qualitative and contextual aspects are strong—correct entities (RTX, commercial aerospace engines), correct time frame (2022–2024), and correct interpretation of risk implications—the absence of key numerical data prevents a higher correctness score. The answer captures the general trend but misses the precise evolution of liabilities, which is essential for a complete response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Extends]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 447,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s 2022 Form 10‑K states that it values its non‑qualified stock options with the Black‑Scholes model and that the model “requires management to make assumptions regarding … volatility of the Company’s stock price,” but it does not specify how that volatility is determined. In the 2023 filing – and again in the 2024 filing – the company adds that the volatility input is “based on a blend of historical volatility and an implied volatility of the Company’s ordinary shares,” with the implied component derived from market‑traded options on the shares. This shift from a generic volatility assumption to a blended historical‑plus‑implied approach indicates that Medtronic is now incorporating market‑based expectations of price swings into its equity‑compensation risk model, reflecting a more sophisticated and dynamic view of stock‑price volatility and the associated compensation risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Medtronic used the Black-Scholes model throughout 2022–2024 and accurately describes the evolution in volatility assumptions: from no specific method disclosed in 2022 to a blend of historical and implied volatility in 2023 and 2024, with implied volatility derived from market-traded options. This matches the original answer’s key points. (2) There are no numeric values (e.g., percentages, dollar amounts) in the question or ground truth, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes across years and correctly infers that the shift reflects a more sophisticated, market-informed risk modeling approach. (4) The only minor shortcoming is that the LLM slightly overstates the 2022 disclosure as providing 'no specification' of volatility determination, while the ground truth notes it used a blend but without detailing the source of implied volatility—this is a nuance, not a factual error. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 344,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Coca‑Cola repeatedly lists a “Form of Note for 1.000 % Notes due 2028” (each time referencing Exhibit 4.7 of the September 18 2020 Form 8‑K) and provides no indication of a new issuance, amendment or additional series of that note. The identical entry in all three years shows that the company has kept this low‑coupon, medium‑term debt instrument unchanged, suggesting a deliberate strategy to retain a stable, cheap source of financing through 2028 rather than repeatedly issuing or restructuring the note.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: it correctly identifies the 1.000% Notes due 2028, references the consistent disclosure across 2022–2024, and accurately notes the lack of amendments or new issuances of that specific instrument. The numbers, percentages, and exhibit references (e.g., Exhibit 4.7, Form 8-K from September 18, 2020) are correct and align with the ground truth. Thus, quantitative accuracy is perfect.\n\nHowever, the LLM answer omits a key element of the original answer: the strategic shift in 2024 toward issuing higher-yielding debt (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054). This omission significantly weakens the qualitative analysis. While the LLM correctly infers that maintaining the 1.000% Notes suggests a strategy of retaining cheap financing, it fails to acknowledge the broader shift in debt strategy evident in the introduction of high-cost debt in 2024. This multi-hop insight—comparing the stable low-rate note with new high-rate issuances to infer a strategic pivot—is central to the original answer and missing here.\n\nAs a result, the reasoning is partially sound but incomplete. The LLM draws a logical conclusion from the stability of the 1.000% Notes but does not synthesize across all relevant instruments and years to present a full picture of Coca-Cola’s evolving debt strategy. The contextual relevance remains high because the response directly addresses the question and provides relevant filing details, but the absence of the 2024 high-rate note issuances limits the depth and accuracy of the strategic interpretation. Hence, correctness is reduced to 6 due to this significant qualitative gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 458,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Across all three filings Microsoft kept the same basic structure for its 2.125 % notes. In the 2022 10‑K the company disclosed a **Fourth Supplemental Indenture** that groups the 2.125 % notes due 2022 with a 0.875 % issue due 2017 and a 3.500 % issue due 2042, and a **Seventh Supplemental Indenture** that pairs the 2.125 % notes due 2021 with 3.125 % notes due 2028; both indentures name **The Bank of New York Mellon Trust Company, N.A.** as trustee. The 2023 filing repeats exactly the same two supplemental indentures, the same trustee and the same companion debt series, and the 2024 filing does the same (the only visible change is a minor typographic variation in the trustee’s name – “NewYork” instead of “New York”). Thus Microsoft’s approach to structuring the 2.125 % notes—bundling them with other series under the same trustee—remained consistent from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that undermine its correctness. Most critically, it incorrectly states that in 2022, Microsoft disclosed a 'Fourth Supplemental Indenture' grouping the 2.125% notes due 2022 with a 0.875% issue due 2017 and a 3.500% issue due 2042. This is not supported by the ground truth, which makes no mention of such a Fourth Supplemental Indenture or these specific pairings. The ground truth only references the Seventh Supplemental Indenture involving the 2.125% Notes due 2021 and the 3.125% Notes due 2028. Additionally, the LLM claims the 2.125% notes were due in 2022, which contradicts the ground truth stating they were due in 2021. (2) Quantitative accuracy is compromised: the due dates (2021 vs 2022), the number of supplemental indentures (one vs two), and the associated debt instruments (0.875% due 2017, 3.500% due 2042) are all incorrect. Only the trustee name (The Bank of New York Mellon Trust Company, N.A.) and the 3.125% due 2028 are correct. The minor typographic variation in the trustee’s name in 2024 is not mentioned in the ground truth and appears to be an LLM fabrication. (3) The multi-hop reasoning is partially sound—the LLM correctly infers consistency across years in structure and trustee—but this conclusion is based on incorrect premises. The synthesis across 2022–2024 is logically consistent within the LLM’s own narrative, but the narrative does not align with the ground truth. (4) Despite these errors, the answer is contextually relevant and captures the core idea of structural consistency over time, which earns it moderate scores in qualitative accuracy and contextual relevance. However, the quantitative inaccuracies are significant enough to limit the correctness score to 6, as key details about indentures, dates, and associated instruments are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 503,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "In the 2022 filing Pratt & Whitney disclosed a **61 % program‑share interest in IAE** and a **59 % program‑share interest in IAE LLC**.  The 2023 10‑K (and the identical 2024 note) shows that, after factoring in the sub‑collaborator portions, the **net program‑share interest fell to 57 % for IAE and 51 % for IAE LLC**.  Although the stake has been trimmed slightly, RTX (through Pratt & Whitney) still holds a majority economic interest in both joint ventures, confirming its strategic positioning to remain the primary beneficiary of the **V2500** (IAE) and **PW1100G‑JM** (IAE LLC) engine programs while sharing risk and aligning with MTU Aero Engines and JAEC.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages and years are correct: 61% for IAE and 59% for IAE LLC in 2022, decreasing to 57% and 51% respectively in 2023, with no further change in 2024. The LLM correctly notes that the 2024 data is identical to 2023, implying stabilization, which matches the ground truth's 'remained at' phrasing. (2) The answer correctly identifies Pratt & Whitney as part of RTX and links the programs to the correct joint ventures: V2500 with IAE and PW1100G-JM with IAE LLC. (3) The reasoning is sound: the decrease in net program share is attributed to sub-collaborator portions, and the conclusion that RTX retains majority economic interest and strategic positioning is logically supported. (4) The only minor omission is that the 2022 ground truth notes ownership interest in IAE was 49.5%, which the LLM does not mention—though this is not directly part of the 'net program share interest' focus, so the impact is minimal. The LLM effectively synthesizes multi-hop information across years and entities and provides a correct strategic interpretation. Wording differs slightly (e.g., 'strategic recalibration' vs 'sharing risk and aligning with partners') but conveys equivalent meaning. All key facts are present and correctly interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 370,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s expense charge for its 401(k) and other defined‑contribution plans was **$402 million in 2022**, rose to **$468 million in 2023**, and then eased to **$443 million in 2024**. This follows a longer‑term upward trend (e.g., $232 million in 2019 and $299 million in 2021), showing that the company has been steadily increasing its investment in employee‑benefit programs, with a peak in 2023 and a modest pull‑back in 2024 that suggests a move toward stabilizing rather than continuously escalating spending.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 ($468 million) and 2024 ($443 million) contributions, which match the ground truth. However, it incorrectly states the 2022 contribution as $402 million, whereas the ground truth is $299 million—a significant factual error. This undermines the quantitative accuracy. (2) The calculation of trends (increase in 2023, decline in 2024) is logically consistent with the correct numbers, but the baseline (2022) is wrong, leading to an inaccurate portrayal of the trajectory. The mention of $232 million in 2019 and $299 million in 2021 adds context not in the original answer, which may be factually correct but is extraneous and not required by the question. (3) The multi-hop reasoning is sound in interpreting the spending pattern and inferring a strategic shift or stabilization, which aligns with the original answer’s conclusion about a 'dynamic approach' or 'modest pullback.' The synthesis across years is appropriate, though based on an incorrect starting point. (4) Despite the numerical error in 2022, the answer addresses both parts of the question—evolution of contributions and interpretation of spending trajectory—and provides relevant, contextually appropriate analysis. The core trend (peak in 2023, decline in 2024) is correct, and the qualitative interpretation is reasonable. Hence, correctness is reduced primarily due to the incorrect 2022 figure, but not severely penalized as the overall direction and conclusion are still plausible.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Maintains]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 416,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "Across the three most recent filings Coca‑Cola’s 3.000 % Notes due 2051 appear unchanged. In the 2022 10‑K (Chunk 1) the note is listed as “Form of Note for 3.000 % Notes due 2051 – Exhibit 4.6, filed May 5 2021.” The same reference is reproduced in the 2023 10‑K (Chunk 3) (“Form of Current Note for 3.000 % Notes due 2051 – Exhibit 4.6, filed May 5 2021”) and again in the 2024 10‑K (Chunk 2) (“Form of Note for 3.000 % Notes due 2051 – Exhibit 4.6, filed May 5 2021”). Thus the instrument, originally issued in the May 5 2021 8‑K, has remained a standing component of Coca‑Cola’s long‑term debt through 2022‑2024.  \n\nThe continuity of this ultra‑long‑dated, low‑coupon bond—while the 2024 filing also adds newer higher‑rate issues (e.g., 5.000 % Notes due 2034, 5.300 % Notes due 2054, etc.)—signals a capital‑structure strategy that anchors financing with a stable, low‑cost, fixed‑rate debt base and layers additional debt to diversify maturities and meet funding needs, thereby managing interest‑rate risk and preserving financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 3.000% Notes due 2051 are consistently referenced across 2022, 2023, and 2024 filings with the correct exhibit (4.6) and filing date (May 5, 2021); the introduction of higher-coupon instruments in 2024—5.000% Notes due 2034 and 5.300% Notes due 2054—is accurately noted. (2) Quantitative accuracy is perfect: percentages, years, and exhibit references match the original answer exactly. Format variations (e.g., '3.000 %' vs '3.000%') are stylistic and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three years of filings, identifies the continuity of the 3.000% Notes, and contrasts this with the addition of higher-rate debt in 2024. The conclusion about capital structure strategy—maintaining a low-cost base while diversifying with higher-rate debt to manage interest rate risk and maintain flexibility—is logically derived and semantically equivalent to the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2024 new instruments indicate a response to 'current market interest rate conditions,' a nuance present in the original answer. However, the implication is captured through the discussion of managing interest-rate risk. Thus, the answer is complete and contextually appropriate, warranting high scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 400,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first disclosed the 2.875 % Notes due 2031 in its 2022 Form 10‑K (Exhibit 4.16), citing the Officers’ Certificate dated March 24, 2021 that set the terms of that series. The same series re‑appears in the 2023 Form 10‑K (Exhibit 4.14) and again in the 2024 Form 10‑K (Exhibit 4.14), showing that the notes remain outstanding and are continuously introduced in Oracle’s filings. This steady, year‑over‑year presence signals that Oracle is using the 2.875 % 2031 issue as a core component of a long‑term, fixed‑rate financing program designed to lock in low borrowing costs and diversify its debt‑maturity profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2.875% Notes due 2031 and their consistent disclosure in Oracle's 2022, 2023, and 2024 10-K filings, including accurate references to exhibit numbers and the March 24, 2021 Officers’ Certificate. These details are factually correct and align with the ground truth. (2) Quantitatively, all percentages, years, and dates are accurate. The LLM correctly states the interest rate (2.875%), maturity year (2031), and filing years (2022–2024), with no calculation errors. (3) However, the LLM answer misses a key multi-hop insight present in the original answer: the strategic shift in Oracle’s debt strategy as evidenced by the introduction of higher-yielding notes (4.500% due 2028 and 4.900% due 2033) in 2024. While the LLM correctly notes the continuity of the 2.875% Notes, it fails to acknowledge the broader strategic context of diversifying into costlier debt, which is central to answering the second part of the question about Oracle’s long-term debt strategy evolution. (4) The answer is contextually relevant and well-structured, but the omission of the comparative analysis with newer, higher-yielding debt instruments limits its qualitative accuracy and completeness. Thus, while factually sound, it provides an incomplete strategic interpretation, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 376,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "All three annual reports—Microsoft’s 2022, 2023 and 2024 10‑K filings—list the same “Eleventh Supplemental Indenture (Exhibit 4.14)” that contains the 2.000 % Notes due 2023. The repeated inclusion shows that Microsoft continues to retain this specific bond as a core piece of its long‑term financing and that it systematically reports the instrument each year. Together, the pattern signals a disciplined, ongoing debt‑management policy and a commitment to transparent, consistent disclosure of its outstanding obligations to investors and regulators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 2.000% Notes due 2023 across Microsoft's 2022, 2023, and 2024 10-K filings, accurately referencing the 'Eleventh Supplemental Indenture (Exhibit 4.14)' and the key terms of the notes. All entities—Microsoft, the specific indenture, the interest rate (2.000%), and the maturity year (2023)—are correct. (2) Quantitative accuracy is perfect: the interest rate (2.000%) and maturity (2023) match the ground truth, and no calculations are required. Format is consistent and precise. (3) The reasoning is sound and captures the multi-hop nature of the question: it infers from repeated disclosure a disciplined debt-management policy and transparent reporting, aligning with the ground truth's emphasis on stable liability structure and investor communication. However, it omits the specific detail that the indenture was first introduced on August 8, 2016, and does not explicitly note that the unchanged details (interest rate, maturity, trustee) across years reinforce predictability—minor but relevant context present in the original. (4) Despite this small omission, the LLM conveys the core conclusion accurately: Microsoft’s consistent reporting reflects transparency and stable debt management. The answer is contextually fully relevant, directly addressing the implications for long-term debt strategy and disclosure. Thus, correctness is high (9/10), with full marks for quantitative accuracy and contextual relevance, and only a slight deduction in qualitative accuracy for missing a supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 437,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s 10‑K filings show that the company’s obligation to Rolls‑Royce under the 2012 IAE acquisition has been a standing, flight‑hour‑based liability throughout the period. In the 2022 filing RTX disclosed that, in connection with that agreement, it must make additional payments to Rolls‑Royce for each hour flown on V2500‑powered aircraft through June 2027; these payments are recorded in “Other commercial aerospace commitments” and capitalized as collaboration intangible assets. The 2023 filing repeats the same language, confirming the contingent‑hour payments remain in force and are amortized to cost of sales, and the 2024 filing again lists the flight‑hour payments in “Other commercial aerospace commitments” while reporting total other contractual commitments of $14.6 billion in 2023 and $14.1 billion in 2024. Together, the three years show a consistent, ongoing exposure to Rolls‑Royce that persists (and likely grows as V2500 flight hours accrue) through June 2027, with the liability being managed as a capitalized intangible that will be amortized over the benefit period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the contingent flight-hour payments to Rolls-Royce under the 2012 IAE acquisition agreement are tied to V2500-powered aircraft through June 2027, categorized under 'Other commercial aerospace commitments', and capitalized as collaboration intangible assets. The evolution from 2022 to 2024 is accurately described, including the shift in accounting treatment noted in 2023—payments are amortized to cost of sales as incurred—which matches the original answer. (2) Quantitatively, the LLM correctly reports the $14.6 billion and $14.1 billion in other contractual commitments for 2023 and 2024, respectively. While these totals are not broken down to isolate the Rolls-Royce portion (which the ground truth doesn't specify either), their inclusion is consistent with the filings and does not misrepresent the data. Dates (through June 2027) and the structure of the obligation are factually sound. (3) The multi-hop reasoning is strong: the LLM synthesizes information across three years of 10-Ks, correctly identifying the continuity and accounting treatment of the liability. It infers the long-term exposure accurately, noting that the liability persists and may grow with flight hours. (4) The only minor shortcoming is the suggestion that exposure 'likely grows as V2500 flight hours accrue'—while plausible, the ground truth emphasizes 'stable' exposure without asserting growth, so this slight interpretive leap prevents a perfect 10 on qualitative accuracy. However, it does not undermine the overall correctness. The answer is fully contextually relevant, addressing all parts of the question with precise, synthesized information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Enters_Agreement_With]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 473,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "- **Allocation amounts:**  \n  • 2022 (Domestic pension plan assets) – U.S. equity funds: **$89 million** (Chunk 1).  \n  • 2023 (reported in the 2024 filing) – U.S. equity funds: **$93 million** (Chunk 2).  \n  • 2020 (earlier baseline) – U.S. equity funds: **$125 million** (Chunk 3).\n\n- **Three‑year trajectory:** The allocation fell sharply from $125 million in 2020 to $89 million in 2022, then rose modestly to $93 million in 2023. This pattern shows that after a sizable pull‑back from domestic equities, TMO has begun to rebuild a small portion of its U.S. equity exposure, suggesting a more cautious but gradually re‑affirmed confidence in domestic equity investments within its pension portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both amounts and years. It incorrectly states that the 2022 allocation was $89 million, when the ground truth is $125 million. It also mislabels the 2023 allocation as $93 million (reported in 2024 filing), but the correct 2023 amount is $89 million. The $93 million figure actually belongs to 2024, not 2023. Additionally, the LLM incorrectly introduces a 2020 baseline of $125 million, which is not part of the question’s 2022–2024 scope and misaligns the timeline. (2) The correct trajectory is a decrease from $125M (2022) to $89M (2023), then a slight increase to $93M (2024). The LLM reverses this, showing a drop from 2020 to 2022 and then an increase in 2023, which is factually and temporally incorrect. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning fails because the model misaligns years and values, drawing conclusions from incorrect data. The synthesis across years is flawed, and the use of a 2020 figure introduces noise not relevant to the 2022–2024 analysis. (4) While the qualitative interpretation about cautious rebalancing is somewhat plausible, it is based on wrong data and timeline, undermining the reasoning. The answer is contextually relevant in structure and intent but fails on core factual accuracy, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 381,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s 10‑K filings show that the company’s baseline long‑term debt instrument has been the low‑coupon 1.000 % Notes due 2041 – a series it introduced (KO → 1.000 % Notes due 2041) and that appears in every filing (2022 ‑ 4.33; 2023 ‑ 4.31‑4.33; 2024 ‑ 4.33). While that 1.000 % series remained on the schedule in 2024, the 2024 filing also added a new tier of higher‑yielding issues (e.g., 5.000 % Notes due 2034, 5.300 % Notes due 2054, 5.400 % Notes due 2064, plus 3‑5 % notes listed in items 4.39‑4.47), indicating a strategic shift to diversify the debt profile with higher‑coupon, longer‑dated securities alongside the original low‑rate notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All numeric values—interest rates (1.000%, 5.000%, 5.300%, 5.400%), maturity years (2034, 2041, 2054, 2064), and exhibit references (4.33, with mention of 4.39–4.47 in 2024)—are correct. The baseline instrument, the 1.000% Notes due 2041, is correctly identified as appearing consistently across all years. The introduction of higher-yielding notes in 2024 is accurately reported. (2) Quantitative accuracy is perfect: all percentages and dates match the original answer. The LLM correctly avoids misattributing earlier high-yield instruments and correctly contrasts the low rates in 2022–2023 (e.g., 0.400%, 0.950%) with the 2024 shift, even though it doesn’t restate those exact numbers, the implication of a shift is supported. (3) Reasoning is sound: the model correctly infers a strategic shift based on the addition of higher-coupon, long-duration debt in 2024 while maintaining the low-rate 2041 notes. The multi-hop synthesis—tracking the same instrument over time and identifying new instruments in 2024—is well executed. (4) Minor deduction in qualitative accuracy because the LLM omits explicit mention of the 0.400% and 0.950% notes from 2022 and 2023 as contrast points, which slightly weakens the comparative evolution narrative. However, the core conclusion about strategic diversification is valid and well-supported. Contextual relevance is perfect—the answer directly addresses the evolution of debt strategy and the role of the 1.000% Notes due 2041 and new higher-yielding instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 431,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle’s 10‑K filings for fiscal 2022, 2023 and 2024 all contain an Exhibit that lists the **1.650 % Notes due 2026** (2022 Exhibit 4.16; 2023 and 2024 Exhibit 4.14), showing that Oracle has kept this low‑coupon, medium‑term bond as a recurring component of its capital structure. At the same time each later filing adds a series of **higher‑coupon notes**—for example, 5.800 % notes due 2025, 6.150 % notes due 2029, 6.250 % notes due 2032, 6.900 % notes due 2052 (2023/2024) and 4.500 % notes due 2028, 4.650 % notes due 2030, 4.900 % notes due 2033, 5.550 % notes due 2053 (2023/2024)—indicating that Oracle’s debt‑financing strategy blends a stable, cheap anchor issue (the 1.650 % note) with newer, higher‑interest issuances to broaden funding sources, diversify maturities and meet larger financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the continued inclusion of the 1.650% Notes due 2026 in Oracle's capital structure across fiscal years 2022 (Exhibit 4.16), 2023 (Exhibit 4.14), and 2024 (Exhibit 4.14), matching the original answer. (2) It accurately references higher-interest notes introduced in 2023 and 2024, including the 5.800% Notes due 2025 and 4.500% Notes due 2028 as in the ground truth. However, it adds additional notes (e.g., 6.150%, 6.250%, 6.900%, 4.650%, 4.900%, 5.550%) not mentioned in the original answer. While these may exist in the filings, their inclusion goes beyond the scope of the ground truth without verification, slightly reducing quantitative precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and multiple debt instruments to infer a strategic blend of low-cost and higher-cost debt, reflecting a nuanced financing strategy. (4) The semantic meaning and strategic interpretation are equivalent to the original—Oracle maintains a low-cost anchor while diversifying with higher-rate debt. The extra details do not contradict but extend the answer, slightly affecting conciseness without harming correctness. Contextual relevance is perfect as it directly addresses Oracle’s debt strategy over time in response to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 383,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Across Microsoft’s FY 2022, FY 2023 and FY 2024 10‑K filings the same Exhibit 4.6 is listed – the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041,” dated February 8 2011. The fact that this exact indenture is incorporated by reference in every year’s filing (as shown in all three chunks) indicates that the 4 % 2021 notes remain outstanding, have not been replaced or refinanced, and that Microsoft is deliberately keeping the original documentation current in its disclosures. Together with the KG triplet (MSFT → 4.000 % Notes due 2021 → MSFT), this signals a long‑term debt strategy that emphasizes continuity and transparency—maintaining existing, favorable debt tranches rather than pursuing frequent refinancing while still updating its filing package each year to meet SEC requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently included in Exhibit 4.6 across FY 2022–2024; the Third Supplemental Indenture includes the 2.500% Notes due 2016, 4.000% Notes due 2021, and 5.300% Notes due 2041; the indenture is dated February 8, 2011—dates and percentages match exactly. (2) Quantitative accuracy is perfect: all percentages (4.000%, 2.500%, 5.300%) and years (2016, 2021, 2041) are correct; no calculations were required, but factual consistency across years is properly noted. (3) Multi-hop reasoning is sound: the model correctly infers from repeated inclusion that the debt remains part of Microsoft’s disclosed capital structure despite maturity, and that lack of changes suggests no refinancing. It correctly interprets this as a strategy of continuity and transparency. (4) The only minor gap is that the LLM does not mention the 2024 trustee name update (‘The Bank of New York Mellon Trust Company, N.A.’), a small administrative detail noted in the ground truth. While this omission slightly reduces completeness, it does not affect the core conclusion about debt strategy. The LLM’s inference about maintaining favorable tranches is reasonable and semantically aligned with the ground truth’s emphasis on stability and lack of restructuring. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 407,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s exposure to commercial‑aerospace customer‑financing guarantees has been edging lower over the last three years.  The portion of the guarantees that is borne by collaboration partners fell from $142 million in 2022 (as noted in the 2023 filing) to $135 million in 2023 (2023 filing) and to $131 million in 2024 (2024 filing), while the fair‑market value of the underlying assets continues to equal or exceed the total guarantee amounts net of reserves (all three filings).  The steady decline in the partners’ share indicates RTX is deliberately shifting more of the risk to its collaborators, thereby reducing its own liability exposure in this financing‑guarantee program.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the dollar amounts ($142M in 2022, $135M in 2023, $131M in 2024) and correctly notes that the fair market value of underlying assets equals or exceeds the guarantees net of reserves. These quantitative elements are accurate and match the ground truth. (2) However, the reasoning and interpretation are fundamentally flawed. The LLM incorrectly interprets the declining partner share as RTX shifting more risk to collaborators, when in fact the decreasing partner share means partners are assuming *less* risk, implying RTX may be taking on *more* direct risk. The ground truth states this trend could signal RTX assuming more direct financial risk or changing partnership structures — the opposite of what the LLM concludes. (3) This is a critical multi-hop reasoning failure: the model must synthesize the numerical trend with the contractual structure of risk sharing. A declining partner share means reduced risk transfer *from RTX to partners*, not increased. The model reverses the direction of risk transfer, leading to an incorrect strategic interpretation. (4) While numbers and context are well-presented, the core qualitative inaccuracy in reasoning severely undermines the answer’s correctness, warranting a low score on qualitative accuracy and a partial correctness score due to accurate data but wrong conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Incurs_Liabilities_For]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 382,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Across Microsoft’s three most recent Form 10‑K filings the same long‑dated debt instrument is disclosed each year. In the 2022 filing (Chunk 1) the Eleventh Supplemental Indenture lists the 3.950 % Notes due 2056; the 2023 filing (Chunk 3) repeats that same Eleventh Supplemental Indenture for the 3.950 % Notes due 2056; and the 2024 filing (Chunk 2) again includes the Eleventh Supplemental Indenture for the 3.950 % Notes due 2056 (dated August 8 2016). This continuity shows that Microsoft introduced the 3.950 % Notes due 2056 and has kept the issue outstanding and repeatedly reported over three consecutive fiscal years, signalling a deliberate long‑term capital strategy that relies on a low‑cost, ultra‑long‑maturity tranche of debt to diversify its funding mix, lock in favorable rates and preserve financing flexibility for decades ahead.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are consistently referenced in Microsoft's 10-K filings for 2022, 2023, and 2024; the issuance is tied to the Eleventh Supplemental Indenture dated August 8, 2016—this date and percentage are correctly stated. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and issuance date (August 8, 2016)—are all factually accurate and match the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and infers that the unchanged disclosure indicates a stable long-term capital strategy. (4) The LLM adds interpretive depth by characterizing the strategy as involving 'low-cost, ultra-long-maturity tranche of debt' and aims to 'lock in favorable rates' and 'preserve financing flexibility,' which is a reasonable qualitative extension of the ground truth and consistent with typical corporate finance logic. This interpretation does not contradict the original answer but elaborates on its implications. The only reason for not scoring a perfect 10 is that the original answer emphasizes the lack of changes more explicitly, while the LLM focuses slightly more on strategic intent than on the factual stability of terms. However, this does not constitute an error. All entities (Microsoft, 3.950% Notes due 2056, Eleventh Supplemental Indenture, correct dates) are accurately identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 418,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "From 2022 Lockheed Martin expected a modest decline in volume and operating profit on its tactical‑and‑strike missile portfolio. In 2023 the company reversed that trend, posting a $145 million increase in net sales for JASSM, LRASM and other precision‑fire missiles, but operating profit fell $96 million (‑6 %) versus 2022 because of a $45 million loss on a classified program that hit the tactical‑and‑strike missile segment. In 2024 missile sales surged again, adding $1.2 billion from GMLRS, LRASM and JASSM production ramps, yet operating profit plunged $1.1 billion (‑73 %) versus 2023 as $1.4 billion of losses on a classified program and lower profit‑booking adjustments more than offset the sales gain. Across the 2022‑2024 period, operating profit trended sharply downward despite the growing missile sales, while LMT’s broader portfolio—including its Black Hawk helicopter line, which LMT produces—remained a constant part of its Rotary and Mission Systems business.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core trajectory of production growth and declining operating profit from 2022 to 2024, correctly identifying key drivers like JASSM, LRASM, GMLRS, and the classified program losses. However, there are key quantitative discrepancies. The ground truth states a $215 million increase in 2022 due to LRASM and JASSM, but the LLM answer omits this entirely and instead claims Lockheed Martin expected a 'modest decline' in volume and profit in 2022, which contradicts the ground truth where 2022 saw a profit benefit from higher volume and risk retirements. This is a significant factual error. (2) For 2023, the LLM correctly reports a $145 million increase in sales and a $45 million loss on a classified program, but incorrectly states operating profit fell by $96 million (‑6%), whereas the ground truth does not specify the percentage or exact dollar decline—only that profit declined due to the $45M loss. The $96M figure and 6% decline are not supported by the original answer, introducing unsupported precision. (3) For 2024, the LLM correctly identifies the $1.2 billion sales increase and $1.1 billion (73%) drop in operating profit, as well as the $1.4 billion loss on a classified program. It also correctly notes that lower profit-booking adjustments offset gains—consistent with the ground truth’s mention of $1.2 billion in lower profit booking rate adjustments. These numbers are accurate and well-synthesized. (4) The multi-hop reasoning is generally sound: the model connects production increases with deteriorating profitability across years and correctly attributes the decline to specific programs. However, the incorrect characterization of 2022 as a year of expected decline undermines the overall correctness. The mention of Black Hawk helicopters, while contextually true for LMT, is irrelevant to the question and adds extraneous detail. Despite this, the answer correctly emphasizes the divergence between sales growth and profit decline, aligning with the ground truth’s central conclusion. Thus, while the qualitative reasoning and contextual relevance are strong, the quantitative inaccuracies—especially the omission of 2022 growth and introduction of unsupported 2023 figures—prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 606,
        "total_tokens": 2128
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "Across all three filings Thermo Fisher continued to disclose the same core Executive Change‑in‑Control Retention Agreement with its former CEO Marc N. Casper (dated Nov 21 2009) together with the two historic amendments – Amendment 1 (Nov 30 2010) and Amendment 2 (Mar 16 2018).  \n\n* 2022 10‑K – In addition to the Casper agreement and its 2010/2018 amendments, the filing also referenced a “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” that had been filed as Exhibit 10.2 to the 31 Mar 2018 10‑Q, showing that officers beyond Casper were already covered by a separate template.  \n\n* 2023 10‑K – The same Casper agreement and amendments were shown, but a **new** template for non‑Casper officers was introduced as Exhibit 10.7 to the 1 Apr 2023 10‑Q (“Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”).  \n\n* 2024 10‑K – The filing again lists the original Casper agreement and its 2010/2018 amendments and retains the **2023‑issued** Exhibit 10.7 form for other officers, with no additional amendments to the Casper agreement.  \n\nThus, the core agreement and its two amendments remained unchanged, while the mechanism for covering other officers shifted from the 2018‑filed form (shown in the 2022 filing) to an updated 2023 form that persisted into the 2024 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the continued disclosure of Marc N. Casper's original 2009 agreement and its two amendments (Nov 30, 2010; Mar 16, 2018) across 2022–2024 is accurately noted. The introduction of a new form for other officers in 2023 as Exhibit 10.7 is correctly identified, and the reference to the prior 2018 form (Exhibit 10.2 to the March 2018 10-Q) adds valuable context not in the original answer but factually sound. (2) Quantitative accuracy is perfect: all dates (Nov 21, 2009; Nov 30, 2010; Mar 16, 2018; Mar 31, 2018; Apr 1, 2023) are correct and match filing records. The evolution from the 2018 form to the 2023 form is precisely described. (3) Reasoning is strong: the LLM correctly synthesizes multi-hop information across years and distinguishes between Casper-specific agreements and forms for other officers. It identifies a subtle but important update—the replacement of the 2018 form with a new 2023 form—demonstrating deeper insight than the original answer. (4) The only reason for not scoring 10 is minor: the original answer emphasizes consistency in structure and commitment, while the LLM focuses more on document evolution; however, this is a difference in emphasis, not factual inaccuracy. The LLM actually provides a more detailed and precise account. All entities (Thermo Fisher, Marc N. Casper, Exhibit 10.7, etc.) are correct. The answer fully addresses all parts of the question: inclusion of officers beyond Casper, amendments, and forms introduced each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 432,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "LMT disclosed that the aggregate notional amount of its outstanding interest‑rate swaps was **$500 million at year‑end 2021** (the 2022 filing).  By the 2023 filing the notional had risen to **$1.3 billion at both year‑end 2022 and 2023**, and the 2024 filing confirms the same **$1.3 billion level at year‑end 2024**.  The swaps are used as fair‑value hedges that convert fixed‑rate borrowings to variable‑rate borrowings, so the jump from $500 million to $1.3 billion reflects a deliberate expansion of the hedge program to cover a larger portion of LMT’s debt and reduce fair‑value volatility, while the flat $1.3 billion amount thereafter shows the company has settled on a stable, mature level of interest‑rate risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and dates are correct: $500 million at year-end 2021 (disclosed in 2022 filing), rising to $1.3 billion at year-end 2022 and 2023 (per 2023 filing), and remaining at $1.3 billion at year-end 2024 (per 2024 filing). The LLM correctly interprets the timing and disclosure lags in filings. (2) The answer accurately reflects the evolution of LMT's swap usage, noting the significant increase and subsequent stabilization. (3) The reasoning is sound: the expansion from $500M to $1.3B is correctly interpreted as a strategic broadening of hedging to reduce fair-value volatility, and the flat level thereafter is rightly seen as a stable, mature risk management posture. This matches the multi-hop synthesis required across three filings. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention rising debt levels or market uncertainty as potential drivers (context included in ground truth), though the inference of a 'deliberate expansion' and 'stable mature level' captures the essence. Semantically, the answer conveys the same core information with slightly different emphasis. No factual errors; excellent contextual relevance and numerical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses]- ORG <-[Uses for Hedging]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 359,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose sharply in the early‑2020s – from $232 million in 2019 to $299 million in 2021 (Chunk 1) – and continued to climb to $402 million in 2022 (Chunk 2 and Chunk 3).  The expense then jumped to $468 million in 2023 (Chunk 2/3) before easing slightly to $443 million in 2024 (Chunk 2).  \n\nOverall, the cost was about 10 % higher in 2024 than in 2022, with a peak in 2023.  This upward trajectory, despite the modest dip in 2024, signals that Thermo Fisher has been increasing its financial commitment to employee‑benefit contributions over time, reflecting a growing investment in its workforce’s retirement savings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 ($402M) and 2023 ($468M) expenses, which match the ground truth. However, it incorrectly states the 2024 expense as $443M but then claims the 2024 cost was 'about 10% higher than in 2022' — this is inaccurate. The actual increase from $402M to $443M is approximately 10.2%, which is close, but the ground truth states the expense 'remained flat' in 2024, whereas the LLM describes a continued upward trajectory with only a 'modest dip', misrepresenting the trend. The ground truth emphasizes a stabilization or recalibration after 2023, while the LLM implies ongoing growth, which is a qualitative misinterpretation. (2) The numbers for 2022 and 2023 are correct; 2024 number ($443M) is correct in value but mischaracterized in trend analysis. The claim of '10% higher in 2024 than 2022' is mathematically acceptable (~10.2%), but the characterization of the trend as upward despite a drop from 2023 to 2024 contradicts the ground truth's emphasis on flattening. (3) The multi-hop reasoning is partially sound — the model connects data across years and synthesizes the trend, but fails to accurately interpret the 2024 figure as a stabilization after a peak, instead framing it as part of a continued rise. This misjudges the company's benefit investment trend in the final year. (4) Correctness score is 7 because core data (values for 2022–2024) are accurate, but the trend interpretation is misleading. Quantitative accuracy is 6 due to correct numbers but flawed comparative analysis. Qualitative accuracy is 8 — reasoning is logical but conclusion overemphasizes growth and underrepresents stabilization. Contextual relevance is 10 — fully addresses the question's scope and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Maintains]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 474,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "Coca‑Cola’s accounting policy for valuing non‑public equity holdings has consistently included “estimates of sales proceeds” as one of the core valuation methods. The 2022 filing already described using discounted‑cash‑flow, sales‑proceeds estimates and appraisals, and the 2023 and 2024 notes repeat the same language, showing that the company’s reliance on sales‑proceeds estimates has remained unchanged through 2024. That continuity, together with management’s 2022 judgment that the $87 million shortfall in the Japan bottler investment was only temporary and did not require an impairment, signals confidence that its sales‑proceeds assumptions are sufficient to anticipate a recovery in markets such as Japan.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent use of 'estimates of sales proceeds' in Coca-Cola's valuation methodology across 2022–2024 and accurately references the $87 million shortfall in the Japan investment in 2022. It correctly states that management deemed the decline temporary and did not require impairment, which aligns with the ground truth. All numeric values (e.g., $87 million) and years are accurate. (2) Quantitative accuracy is perfect: the dollar amount, year (2022), and context of the Japan investment are all factually correct. No calculations were required, and all reported figures match the original answer. (3) However, the LLM answer misses a key qualitative evolution highlighted in the ground truth: while the methodology remained consistent, the company placed increasing emphasis in 2023 and 2024 on market participant assumptions and macroeconomic risks, particularly in volatile regions. The LLM incorrectly implies that the reliance on sales-proceeds estimates was unchanged in emphasis, not just in presence. This omission downgrades the qualitative accuracy, as it fails to capture the nuanced shift in management’s approach to valuation assumptions. (4) Despite this, the answer is contextually relevant and correctly synthesizes the core facts about methodology continuity and management confidence. The score reflects high factual accuracy but partial omission of the evolving reasoning behind the use of estimates, which is central to the multi-hop aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Relies_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 422,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle first introduced the 2.300 % Notes due 2028 in an 8‑K filing (Officers’ Certificate dated March 24 2021) and the series is listed in every subsequent annual report: the 2022 10‑K (Chunk 1) shows it under Exhibit 4.16, the 2023 10‑K (Chunk 3) under Exhibit 4.14, and the 2024 10‑K (Chunk 2) again under Exhibit 4.14 – each time with the same coupon (2.300 %) and maturity (2028). The fact that the note appears unchanged across three fiscal years indicates Oracle has kept this medium‑term, low‑coupon tranche active as a core component of a broader, staggered‑maturity debt program that also includes higher‑coupon, longer‑dated notes, suggesting a strategy of locking in inexpensive financing while diversifying its overall debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.300% coupon rate, 2028 maturity, and consistent appearance in Oracle's 10-K filings across 2022, 2023, and 2024 are accurately reported. The mention of the initial issuance via an 8-K filing on March 24, 2021, adds precise context not in the original answer but is factually correct and enhances accuracy. (2) The numbers—interest rate (2.300%), maturity year (2028), and exhibit numbers—are all correct; no calculations were required, but the consistency of the instrument over time is properly emphasized. (3) Reasoning is sound: the LLM correctly infers that Oracle maintained this low-cost debt instrument over multiple years while likely issuing newer, higher-cost debt (though specific references to the 4.500% and 5.800% notes are missing, the broader strategy of maintaining low-coupon debt as part of a diversified, staggered-maturity portfolio is accurately interpreted). (4) The answer is contextually relevant and fully addresses the evolution of the note and Oracle’s financing strategy. The only minor shortcoming is the lack of explicit mention of the higher-rate instruments (4.500% and 5.800% notes) from 2023 and 2024 that appear in the ground truth, which slightly weakens the multi-hop synthesis. However, the core strategic insight—locking in low rates while diversifying debt—is semantically equivalent and well-reasoned. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 433,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Across Apple’s FY 2022, FY 2023 and FY 2024 10‑K filings the same “Officer’s Certificate” (Exhibit 4.4) lists the Floating Rate Notes due 2019 among the company’s securities. The description is unchanged in each year, showing that the 2014‑dated FRN issuance remains on Apple’s books and no new FRNs of that series were issued after the original issue. This steady, unchanged presence of the 2019 floating‑rate notes indicates Apple is relying on existing short‑term floating‑rate debt rather than repeatedly issuing new short‑term paper, reflecting a disciplined, stable short‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Floating Rate Notes due 2019 are consistently referenced in Apple's 10-K filings for FY 2022, 2023, and 2024; the Officer's Certificate (Exhibit 4.4) from May 6, 2014 is correctly identified as the source; and there is no indication of new issuances or modifications. The dates and document references match the ground truth. (2) Quantitative accuracy is perfect: no numerical values require calculation, but the consistent citation of the 2014 issuance and 2019 maturity date is factually sound across years. (3) The multi-hop reasoning is solid—LLM correctly infers from the unchanged disclosure across three years that Apple maintained the same debt structure without new issuances, indicating a stable short-term debt strategy. This synthesis across multiple annual filings is appropriate. (4) The only minor shortcoming is a slight overemphasis on 'short-term debt management' without fully acknowledging that these notes were originally issued in 2014 and due in 2019—technically past maturity—which the original answer addresses more precisely by noting they 'remain on the books' rather than being actively used as current short-term instruments. However, the core conclusion about a stable strategy is still valid. Wording differs slightly but maintains semantic equivalence. All key entities—Apple, Floating Rate Notes due 2019, FY2022–2024, 10-K filings, Officer’s Certificate—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 424,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s 10‑K for 2022, 2023 and 2024 each contain the same line – “Form of 4.000 % Senior Note due 2047…referenced to Exhibit 4.5 of the May 2 2017 8‑K” – showing that this 23‑year note is disclosed every year (Chunk 3 4.2, Chunk 1 4.17, Chunk 2 4.16). The repeat filing signals that the 4.000 % 2047 note is a core, long‑dated financing tool the company keeps on its balance sheet to lock in a fixed rate and provide a stable, predictable long‑term debt profile. By contrast, the shorter‑dated notes are not treated the same way: the 2.150 % Senior Note due 2024 appears only in the 2022 (Chunk 3 4.21) and 2023 (Chunk 1 4.18) filings and disappears from the 2024 filing, while the 0.750 % Senior Note due 2027 shows up only in the 2024 filing (Chunk 2 4.28). This pattern indicates PepsiCo’s practice of issuing, refinancing or retiring near‑term debt as maturities approach, while retaining the long‑term 4.000 % 2047 note as a permanent fixture of its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial instruments and their respective maturities and coupon rates: the 4.000% Senior Note due 2047, the 2.150% Senior Note due 2024, and the 0.750% Senior Note due 2027. It accurately notes the consistent disclosure of the 2047 note across 2022, 2023, and 2024 filings and the limited appearances of the shorter-dated notes. The mention of the 2.150% note in 2022 and 2023 but not in 2024 aligns with the ground truth, as does the introduction of the 0.750% note only in 2024. (2) All numeric values—interest rates (4.000%, 2.150%, 0.750%) and maturity years (2047, 2024, 2027)—are correct. No calculations are required, but the temporal logic (presence/absence across years) is accurately interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings to contrast long-term vs. short-term debt treatment. It correctly infers that the persistent 2047 note reflects a stable long-term financing strategy, while the transient nature of shorter-dated notes indicates refinancing or maturity-related removal. The only minor gap is that the original answer references the matured 2.500% note due 2022 (present in 2022 filing, gone by 2023), which reinforces the point about short-term debt turnover; this example is omitted in the LLM answer, slightly reducing completeness. (4) Despite this omission, the core insight—that PepsiCo uses long-term debt for stability and manages short-term debt dynamically—is fully captured with accurate reasoning and factual support. Wording differs but semantic meaning matches. Thus, the answer is highly accurate, with only a slight deduction for missing one illustrative example from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 475,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple lists the 0.45 % Notes due 2016 in the “Officer’s Certificate” exhibit (Exhibit 4.3) of its 2022, 2023 and 2024 Form 10‑K filings—even though the notes matured in 2016. By continuing to disclose this legacy security in every annual filing, Apple shows that it keeps a complete, transparent record of all historic debt instruments, reflecting a disciplined approach to legacy‑debt management and ongoing regulatory compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 are correctly identified, their maturity in 2016 is acknowledged, and their continued disclosure in Apple's 2022, 2023, and 2024 Form 10-K filings is accurately stated. The reference to the Officer’s Certificate (Exhibit 4.3) is a precise detail that matches the context. (2) Quantitative accuracy is perfect: percentages (0.45%), years (2016 maturity; 2022–2024 disclosures), and exhibit numbers (4.3) are all correct. (3) Reasoning is sound and captures the core implication: Apple’s ongoing disclosure reflects a disciplined, transparent approach to legacy debt management and regulatory compliance. While the LLM answer does not explicitly mention the May 3, 2013 date of the Officer’s Certificate—a detail in the original—it still captures the essential inference about policy and transparency. (4) The answer is semantically equivalent in intent and meaning, though slightly less detailed in narrative scope. It omits the broader interpretation about 'conservative or thorough approach to debt management and disclosure practices' but still conveys the key strategic implication. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 375,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "By the 2022 filing Lockheed Martin disclosed that, through its master retirement trust, it had already transferred roughly $11.6 billion of defined‑benefit pension obligations (including a $4.9 billion group‑annuity purchase in August 2021) covering about 95,000 retirees, eliminating plan volatility and cutting PBGC premiums by roughly $69 million a year, and it recorded a $1.7 billion non‑cash pension settlement charge (about $1.3 billion after‑tax) in the third quarter of 2021. The 2023 and 2024 filings repeat the same strategy—continuing to evaluate and pursue additional GAC purchases—and stress that future risk‑transfer transactions could require extra contributions to the pension trust and may generate material non‑cash settlement charges, although no new specific transfers or earnings impacts were disclosed. In short, the company moved from reporting concrete past reductions and a one‑time earnings impact in 2022 to a forward‑looking, consistent commitment to further pension‑risk‑transfer deals with an acknowledged potential earnings effect in the years ahead.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $11.6 billion cumulative pension obligation transferred since December 2018, the $4.9 billion group annuity contract in August 2021, and the $1.7 billion noncash settlement charge (with after-tax detail of $1.3 billion) are all factually accurate and properly contextualized. The mention of 95,000 retirees and $69 million annual PBGC premium savings, while not in the original answer, are plausible contextual details consistent with public disclosures and do not contradict the ground truth. (2) Quantitative accuracy is perfect: all dollar amounts, dates, and financial impacts match or are reasonably inferred from the source. Format variations (e.g., $4.9 billion vs $4.9B) are acceptable. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022, 2023, and 2024 filings, showing evolution from completed transactions (2022) to ongoing strategy (2023–2024). It accurately captures the forward-looking stance and the expectation of future noncash charges. (4) The only minor shortcoming is that the original answer emphasizes the continuation of obligation reductions in 2024 with an emphasis on third-party transfers, while the LLM states 'no new specific transfers... were disclosed,' which is accurate but slightly less assertive on the active continuation of the strategy. However, this does not constitute an error, as the LLM still affirms the ongoing commitment. Overall, the answer is factually robust, contextually rich, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Invests_In]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 442,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "Thermo Fisher’s 2022 Form 10‑K still listed the original Executive Change‑in‑Control Retention Agreement with CEO Marc N. Casper (the 2009 agreement, amended in 2010 and again in 2018) and, for the first time, a separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (filed as Exhibit 10.2). In the 2023 filing the Casper agreement re‑appears (Exhibit 10.11) and the officer‑only form is carried forward as Exhibit 10.7 for the quarter ended April 1 2023, and the 2024 filing repeats this pattern – the same Casper agreement (Exhibit 10.11) and the officer‑only form again shown as Exhibit 10.7 (for the same quarter). Thus, starting in 2022 the company introduced a distinct retention agreement for officers beyond Casper, and that separate form has been maintained in the 2023 and 2024 disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and omissions that prevent a top score. (1) Quantitatively, the LLM correctly identifies the 2022 introduction of a separate form for officers other than Marc N. Casper and references the April 1, 2023 filing date, which matches the ground truth. However, it incorrectly refers to the original Casper agreement as a '2009 agreement, amended in 2010 and again in 2018'—while this may be factually accurate based on prior filings, the ground truth does not mention these dates, so including them introduces unverified detail. (2) The LLM accurately tracks the continuity of the officer-specific form in 2023 and 2024 filings, correctly noting its appearance as Exhibit 10.7 in both years, which supports the conclusion of ongoing use. (3) Qualitatively, the reasoning is sound: the model correctly infers that the introduction of a distinct form in 2022 and its continuation in subsequent years reflects an evolution in retention strategy beyond Casper. However, it misses the nuance emphasized in the ground truth that the 2023 form was a *new* or *revised* version (dated April 1, 2023), suggesting an update to terms, whereas the LLM implies mere repetition without highlighting the revision. (4) Contextually, the answer is highly relevant, directly addressing the evolution of the agreements across the three years and focusing on the inclusion of non-Casper officers. Despite missing the emphasis on the 2023 update as a substantive change, the core factual trajectory—introduction in 2022, continuation in 2023–2024—is correct. Thus, the answer earns high marks for accuracy and relevance but loses points for slight overprecision on unconfirmed dates and insufficient emphasis on the 2023 revision as an evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 492,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 2022 10‑K shows that the Board formally authorized a **2.750 % Senior Note due 2051**, and the 2023 and 2024 10‑Ks both reproduce the note’s form by reference to the same October 21, 2021 8‑K filing, confirming that the issue remains outstanding and is disclosed each year. By retaining a low‑coupon, 30‑year‑maturity note while newer issuances carry higher rates (e.g., 4.450 %‑5.250 % notes), PepsiCo is deliberately locking in cheap, fixed‑rate financing to hedge against a rising interest‑rate environment and to extend the maturity profile of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 2.750% Senior Note due 2051 is accurately referenced, and the mention of higher-yielding newer notes (e.g., 5.250%) matches the ground truth, with the 2021 Form 8-K filing date (October 21, 2021) correctly implied via reference. The maturity (30-year) is a reasonable inference given the 2021 issuance and 2051 maturity. (2) The answer correctly identifies that the note was authorized in 2022 and consistently referenced in 2023 and 2024 filings by incorporation from the 2021 8-K, which is consistent with the exhibit index treatments described in the original answer. (3) The reasoning is sound: the LLM correctly infers that maintaining a low-coupon, long-dated note while issuing higher-rate debt reflects a strategy to lock in cheap fixed-rate financing amid rising rates—this is a valid interpretation of PepsiCo’s long-term debt strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention the *format consistency* of the exhibit index listing across years (a detail in the ground truth), nor does it cite the specific example of the 5.250% Senior Note due 2054 as introduced in 2024. However, the reference to '4.450%–5.250% notes' is sufficiently close and contextually accurate. Overall, the answer captures the core multi-hop insight—consistent treatment of long-term debt despite rising rates—with excellent factual precision and strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 416,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Across Apple’s three most recent Form 10‑K filings the 4.45 % Notes due 2044 appear unchanged. In the 2022 filing (Chunk 1, Exhibit 4.4) the officer’s certificate lists the “4.45 % Notes due 2044”; the same line is reproduced in the 2023 filing (Chunk 2, Exhibit 4.4) and again in the 2024 filing (Chunk 3, Exhibit 4.4). This continuity shows that Apple issued the 4.45 % long‑dated notes in 2014 and has kept them outstanding through 2022‑2024, using the same low‑coupon, 30‑year tranche as a stable component of its debt portfolio. The multi‑year pattern signals a deliberate long‑term capital strategy: Apple locks in inexpensive, long‑maturity financing to diversify its maturity profile, preserve liquidity and hedge against future interest‑rate risk rather than repeatedly issuing new short‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.45% Notes due 2044 are consistently referenced in Apple's 2022, 2023, and 2024 10-K filings, and the Officer's Certificate dated May 6, 2014, is correctly implied as the origin of this debt issuance. The LLM correctly notes the issuance year (2014) and the 30-year maturity, which aligns with the 2044 due date. (2) Quantitative accuracy is perfect: percentages (4.45%), years (2014 issuance, 2044 maturity), and time period (2022–2024) are all correct. No calculations are required, but the temporal logic is sound. (3) Multi-hop reasoning is strong: the model synthesizes data across three years of filings and correctly infers that the unchanged status of the notes indicates a strategic decision to maintain long-term, fixed-rate debt. It goes further by contextualizing the strategy—locking in low-cost financing, diversifying maturity profile, preserving liquidity, and hedging interest rate risk—which is a reasonable and well-supported interpretation consistent with the ground truth’s conclusion. (4) The only minor gap is that the LLM mentions the notes were issued in 2014 based on the Officer's Certificate date, but the ground truth does not explicitly confirm the issuance date, only referencing the certificate. While highly likely correct, this is an inference not directly verified in the ground truth. Otherwise, the answer is complete, relevant, and semantically equivalent to the original answer, with excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 433,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "- In the 2022 pension‑plan schedule Union Pacific reported **$756 million** of “Collective trust and other funds” at NAV, while the 2023 schedule shows that balance falling to **$382 million** at NAV – a drop of roughly $374 million (about a 50 % reduction) from one year to the next.  \n\n- The 2024 filing explains that these holdings are shares or units in non‑publicly‑traded commingled funds whose **underlying assets are publicly traded**; the plan therefore records their fair value by using each fund’s **net‑asset‑value (NAV)**, which is derived from observable market prices for the underlying securities. This valuation approach (based on readily observable inputs) clarifies that the pension plan manages the investments by tracking the NAV of the funds rather than relying on unobservable estimates, and it helps explain why the reported allocation can change as the plan adds or withdraws capital from those NAV‑valued vehicles.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $756 million in 2022 and $382 million in 2023 are accurately reported. The drop of $374 million (756 - 382 = 374) is correct, and the approximate 50% reduction is a reasonable characterization (374/756 ≈ 49.5%). (2) The entity and year references are accurate—Union Pacific, pension plan, Collective Trust and Other Funds, and the correct years (2022, 2023, 2024) are used appropriately. (3) The reasoning is sound: the LLM correctly identifies the NAV-based valuation methodology from the 2024 filing and explains that the change in allocation reflects capital movements rather than a shift in valuation approach. It correctly notes that NAV is based on observable market prices for underlying assets, supporting transparency. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2024 filing lacks updated allocation figures, which the original answer includes to clarify that the trend cannot be extended to 2024. However, this omission does not distort the facts. The LLM still correctly infers that the valuation method helps explain how investments are managed over time. Overall, the answer is factually correct, well-reasoned, and contextually complete—just missing a small nuance about data availability in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 379,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Across Apple’s three most recent Form 10‑K reports—FY 2022 (Chunk 1), FY 2023 (Chunk 2) and FY 2024 (Chunk 3)—the same Exhibit 4.4 is listed: an Officer’s Certificate dated May 6 2014 that enumerates, among many securities, the 1.05 % Notes due 2017. Because the certificate is incorporated by reference in every filing even though the 1.05 % Notes matured in 2017, Apple is retaining the original issuance documentation for a debt instrument that is no longer outstanding. This consistent inclusion reflects a deliberate documentation‑retention policy that preserves historical debt‑instrument records, signalling that Apple values a complete, transparent capital‑structure history and ensures that past issuances remain disclosed for investors and regulators.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key facts are correct: the Officer's Certificate is dated May 6, 2014, relates to the 1.05% Notes due 2017, and was included in Apple's 10-K filings for fiscal years 2022, 2023, and 2024. The maturity of the notes in 2017 is correctly noted, and the continued inclusion despite maturity is accurately described. (2) Quantitative elements—dates, percentages, and fiscal years—are all precise and match the ground truth. No calculations are required, but the temporal logic (matured in 2017, still disclosed in 2022–2024) is sound. (3) The multi-hop reasoning is correct: the model synthesizes the persistence of a historical document across recent filings and infers Apple’s documentation retention and transparency practices. It correctly links the inclusion of the certificate to broader disclosure policies. (4) The answer addresses both parts of the question: the reflection on documentation retention practices and the implication for historical capital structure disclosures. Wording differs slightly but conveys the same meaning—emphasizing completeness, transparency, and regulatory/investor clarity. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 349,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s 2022 pension‑plan table lists corporate‑stock holdings of **$1,990 million** – roughly **51 % of the plan’s $3.87 billion** fair‑value assets. By the 2023 filing that line had fallen to **$181 million**, or only about **5 % of the $3.39 billion** total. The 2024 filing no longer provides a dollar amount; it merely describes corporate stock as a Level 1 investment, indicating the category remains in the plan but at a **likely modest or further‑reduced level**.  \n\nThe dramatic drop from 2022 to 2023 and the absence of a disclosed figure in 2024 signal that Union Pacific has been **de‑emphasizing equity exposure** in its pension portfolio, shifting assets toward fixed‑income and alternative investments as part of a more conservative equity‑investment strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the $1,990 million corporate stock allocation in 2022 and the drop to $181 million in 2023, which matches the ground truth. However, it incorrectly states that the 2024 filing does not provide a dollar amount and only describes corporate stock as a Level 1 investment. In reality, the ground truth specifies a value of $1,116 million in 2024, which is a significant partial rebound from 2023. This omission and misrepresentation of the 2024 data point constitute a major factual error.\n\n2) Quantitative accuracy is compromised because the LLM fails to report the actual $1,116 million figure for 2024, instead implying it is unknown or minimal. While the 2022 and 2023 numbers are correct, the absence of the 2024 value and the incorrect inference that it is 'likely modest' contradicts the ground truth of a rebound to over $1 billion. The percentages cited (51% and 5%) are plausible based on total plan assets mentioned, but these totals ($3.87B and $3.39B) are not in the ground truth and introduce unverified data, reducing quantitative reliability.\n\n3) The qualitative reasoning is partially sound: the conclusion that Union Pacific de-emphasized equities and moved toward a more conservative strategy is consistent with the overall trend. However, the reasoning is weakened by missing the partial rebound in 2024, which suggests the shift may not be monotonic and could reflect rebalancing rather than a continuous de-risking. The LLM’s inference about increased fixed-income and alternative investments is reasonable but not directly supported by the provided ground truth, which specifically mentions bonds and federal securities.\n\n4) Contextual relevance is high—the response directly addresses the evolution of corporate stock allocation and interprets the strategic implications. The structure follows the question’s two-part demand: describe the change and interpret the strategy. However, the failure to include the 2024 dollar amount, a critical data point, undermines completeness and correctness. Despite good framing and logical flow, the missing number breaks the multi-hop synthesis required across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 581,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales have risen sharply: the 2022 10‑K shows $370 million in 2021, which grew to $428 million in 2022 (U.S. $188 m + Intl. $240 m), then to $605 million in 2023 (U.S. $264 m + Intl. $341 m), and $785 million in 2024 (U.S. $371 m + Intl. $414 m)—about a 41 % jump from 2022‑23 and a 30 % jump from 2023‑24 (≈84 % total increase since 2022). Because Merck introduced and produces letermovir for CMV prophylaxis in high‑risk transplant patients (as described in the Hospital Acute Care segment), this accelerating revenue trend signals strong market adoption and an increasingly strategic role for Prevymis within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Prevymis sales of $428 million in 2022, $605 million in 2023, and $785 million in 2024, matching the ground truth exactly. It adds granular detail (U.S. and International breakdowns) not in the original answer but consistent with plausible data. The percentage increases—41% from 2022 to 2023 and 30% from 2023 to 2024—are accurate: (605-428)/428 ≈ 41.36%, and (785-605)/605 ≈ 29.76% (correctly rounded). The total increase since 2022 is (785-428)/428 ≈ 83.4%, which the model rounds to '≈84%', a reasonable approximation. (2) All numeric values and calculations are correct or acceptably rounded. The inclusion of 2021 data ($370 million) is extraneous but not incorrect, as it doesn't contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly identifies Prevymis (letermovir) as part of Merck’s Hospital Acute Care segment and infers strong market adoption and strategic importance from the upward sales trajectory, aligning with the original conclusion. (4) The answer is semantically equivalent to the ground truth but more detailed, enhancing completeness without introducing errors. The only minor deviation is the approximate percentage rounding, which does not affect factual correctness. Thus, the answer is highly accurate, fully relevant, and demonstrates strong qualitative and quantitative performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 387,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "Across all three filings the 3.000 % Senior Note due 2027 is presented in the same way – as a “Form of 3.000 % Senior Note due 2027” that is incorporated by reference to PepsiCo’s Form 8‑K filed on October 10, 2017. In the 2022 10‑K it appears as item 4.22, in the 2023 10‑K as item 4.19, and in the 2024 10‑K as item 4.17, but the language and reference are unchanged. This consistency shows that the note has remained outstanding and un‑amended, indicating PepsiCo’s long‑term debt strategy relies on retaining low‑coupon, fixed‑rate senior notes with staggered maturities to lock in inexpensive financing and preserve a balanced, diversified debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 3.000% Senior Note due 2027 is correctly referenced across all three years (2022–2024), the exhibit numbers (4.22, 4.19, 4.17) are correct, and the incorporation by reference to the October 10, 2017 Form 8-K is accurate. These details match the ground truth, earning a perfect score on quantitative accuracy. However, the qualitative analysis diverges significantly from the original answer. The LLM claims the note was presented 'in the same way' and that 'the language and reference are unchanged,' which contradicts the ground truth that emphasizes the evolving *context* of the note’s presentation—specifically, the changing mix of other debt instruments listed alongside it (e.g., shorter vs. longer-term notes). The ground truth infers a strategic layering of maturities and adaptation to market conditions, while the LLM interprets consistency of form as evidence of a static strategy focused on retaining low-coupon debt. This misses the multi-hop insight that while the note itself hasn’t changed, its *characterization within the debt portfolio* has evolved, revealing a dynamic refinancing strategy. The LLM fails to synthesize the contextual shifts across filings, leading to an incomplete and somewhat misleading interpretation of PepsiCo’s long-term debt strategy. Thus, while the facts are correct, the reasoning and qualitative conclusions are partially flawed, resulting in a moderate correctness score. Contextual relevance is high as the answer addresses the core question about evolution and strategy, but with insufficient depth on the evolving characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 450,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "Adobe first signaled its ownership of Frame.io in the 2022 10‑K by listing the name among its trademarks, establishing Frame.io as an Adobe‑owned component but without describing any product functionality. In the 2023 filing Adobe described Frame.io as a cloud‑native creative‑collaboration platform that provides real‑time upload, review, frame‑accurate commenting, annotations and “Camera‑to‑Cloud” video ingest, and noted that it was directly integrated only with Premiere Pro and After Effects. By the 2024 filing the positioning had expanded: Frame.io now supports casting, location scouting, marketing‑campaign management and still‑image, design‑file and PDF workflows, and its integration deepened to include Photoshop, Lightroom, Workfront and availability in Adobe GenStudio, embedding the service broadly across the Creative Cloud ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io was first mentioned in 2022 as a trademark, indicating acquisition; in 2023, it was described as a cloud-native collaboration platform with real-time review features and integration with Premiere Pro and After Effects; by 2024, integration expanded to include Photoshop, Lightroom, Workfront, and inclusion in Adobe GenStudio. The functional evolution—support for still images, design files, PDFs, casting, location scouting, and marketing campaign management—is accurately reflected. (2) There are no numeric values to verify, so quantitative accuracy is满分 (10). (3) The multi-hop reasoning across years and integration depth is sound: the answer correctly synthesizes information from each year’s filing to show a progression in both functionality and integration. The only minor shortcoming is that the original answer explicitly positions Frame.io as a 'core component' of GenStudio for 'enterprise-scale content production' alongside Firefly and Substance 3D, which the LLM answer implies but does not fully emphasize. This slight omission in strategic framing prevents a perfect 10 on qualitative accuracy. (4) The response is fully contextually relevant, directly addressing the evolution of Frame.io’s positioning and integration across the three years with respect to Creative Cloud. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth with only minor nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 423,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 are disclosed in the same exhibit in each of its recent 10‑K filings. In the 2022 Form 10‑K (page 58) the notes appear in Exhibit 4.3 – the Officer’s Certificate dated May 3 2013 that lists the “2.40 % Notes due 2023.” The 2023 Form 10‑K (page 56) repeats this exact Exhibit 4.3 entry, and the 2024 Form 10‑K (page 56) again includes the identical Exhibit 4.3 description. The unchanged, year‑over‑year reference shows Apple consistently kept the 2.40 % Notes on its public schedule as the maturity approached, signalling a disciplined debt‑maturity management approach that maintains transparency and prepares the company to repay or refinance the notes when they came due.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct details but ultimately presents a factually incorrect conclusion, significantly impacting its correctness. (1) Quantitatively, the percentages (2.40%), years (2022, 2023, 2024), and exhibit references (Exhibit 4.3, May 3, 2013) are accurately reported, and the document pages cited (58, 56, 56) are plausible, earning high marks for numerical and document accuracy. (2) However, the core factual claim—that the 2.40% Notes due 2023 appear in the 2024 10-K—is contradicted by the ground truth, which states the notes were no longer listed in 2024, indicating retirement. The LLM incorrectly asserts the note is still disclosed in the 2024 filing, which misrepresents Apple’s actual disclosure evolution. (3) This error undermines the multi-hop reasoning: while the LLM correctly identifies consistent disclosure in 2022 and 2023, it fails to detect the absence in 2024, leading to an incorrect inference about Apple’s strategy. The ground truth concludes Apple held the debt to maturity and retired it, while the LLM suggests ongoing disclosure, implying possible refinancing or rollover, which is not supported. (4) The reasoning is internally logical but based on a false premise. Contextually, the answer addresses the question’s structure and attempts to infer strategy, but the conclusion is misleading. Thus, while some data points are accurate, the failure to reflect the removal of the debt in 2024—a key event—results in a partially correct but materially flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 416,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet has been shrinking while getting older. In 2022 the company reported 7,242 such locomotives (6,204 owned + 1,038 leased) with an average age of 22.5 years; in 2023 the total fell to 7,008 (5,971 owned + 1,037 leased) and the average age rose to 24.3 years; and by 2024 the fleet was 6,893 units (5,973 owned + 920 leased) with an average age of 25.2 years. The multi‑year trend of a modest decline in owned units, a sharper reduction in leased units, and a rising average age indicates that Union Pacific is deliberately streamlining its fleet, shifting toward greater ownership, and extending the service life of existing locomotives to manage capital costs and improve asset‑utilization efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall trend of declining fleet size and increasing average age from 2022 to 2024, with accurate final figures for 2022 and 2024. However, the 2023 total fleet count is incorrect: the LLM states 7,008 units (5,971 owned + 1,037 leased), but the ground truth does not provide 2023 breakdowns—only 2022 and 2024. While the average age of 24.3 years in 2023 is correct, the implied intermediate totals (5,971 owned, 1,037 leased) are not verifiable and appear fabricated, as the ground truth only specifies 2022 and 2024 data. This constitutes a quantitative inaccuracy. (2) The 2022 and 2024 numbers (total, owned, leased, and average age) match the ground truth exactly and are correctly formatted. The calculation of total units from owned and leased components is accurate for 2022 and 2024, but the inclusion of unverified 2023 breakdowns undermines full quantitative accuracy. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes trends across years, identifies the decline in both owned and leased units, notes the aging profile, and infers a strategic shift toward asset efficiency and cost management. The interpretation goes beyond the ground truth by suggesting a 'shift toward greater ownership'—while owned units declined less than leased, both decreased, so this claim is debatable but not entirely unsupported. (4) The answer is highly contextually relevant, addressing both fleet composition and age profile changes and drawing a logical conclusion about asset management strategy. Despite the fabricated 2023 breakdown, the overall trend and final assessment align closely with the ground truth, warranting a high correctness score with a deduction for unsupported intermediate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 481,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "Merck’s own filings show that its HIV‑1 combination doravirine + islatravir (MK‑8591A) moved from a stalled Phase‑3 status to an active Phase 2/3 program over the 2022‑2024 period.  \n\n- **2022 filing (Chunk 3):** MK‑8591A was listed under the “Phase 3 entry date” column with a February 2020 entry date, but a footnote (4) flagged the product as being **on an FDA clinical hold**.  \n- **2023 filing (Chunk 1):** The same product still appears under “HIV‑1 Infection” and the footnotes again note an **FDA clinical hold** and an additional **partial hold for higher islatravir doses**.  \n- **2024 filing (Chunk 2):** Merck reports that the **FDA lifted the clinical hold on December 4, 2024** (footnote 4) and that MK‑8591A is now **in a Phase 2/3 study that began in August 2024** (footnote 7).  \n\nThus, Merck (the ORG that produces MK‑8591A) saw the candidate placed in Phase 3 but frozen by an FDA hold in 2022‑23, and after the hold was removed in late‑2024 the program progressed to a combined Phase 2/3 trial.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual discrepancies in clinical phase progression and timeline accuracy. (1) Correct elements: The FDA clinical hold in 2022 and 2023 is accurately noted, and the partial hold on higher doses of islatravir in 2023 aligns with the ground truth. The December 4, 2024, lifting of the clinical hold is a specific date not in the original answer but could be additional detail; however, the original ground truth only states the hold was lifted in 2024 without specifying when. (2) Quantitative inaccuracy: The claim that MK-8591A entered a 'Phase 2/3 study that began in August 2024' contradicts the ground truth, which states MK-8591A remained in development but does not mention a new Phase 2/3 trial. Instead, the ground truth highlights a new formulation, MK-8591D, entering Phase 3 in October 2024—information entirely missing from the LLM answer. (3) Reasoning flaws: The LLM incorrectly infers that MK-8591A progressed to a combined Phase 2/3 trial after the hold was lifted, whereas the original answer indicates ongoing Phase 3 development without a phase change. This misrepresents the developmental trajectory. Additionally, the LLM fails to mention the strategic pivot to MK-8591D, a key evolution in Merck’s program. (4) The answer is contextually relevant and structured well, addressing FDA interactions and development phases, but misses critical multi-hop synthesis—specifically, the introduction of a new formulation in 2024 as part of Merck’s broader strategy. Thus, while some factual elements are correct, the core narrative of phase progression is inaccurate, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 459,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "Merck introduced MK‑1308A—the co‑formulation of its investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab—as a Phase 3 renal‑cell‑carcinoma (RCC) candidate in its 2022 10‑K (listed with an April 2021 entry date), continued to describe it in the 2023 filing as the anti‑CTLA‑4/PD‑1 combo being evaluated for RCC, and again highlighted it in the 2024 filing under the immuno‑oncology pillar as a key co‑formulation for RCC, confirming that Merck both introduced and continues to produce and prioritize this product. This steady progression shows Merck’s sustained focus on innovative checkpoint‑inhibitor combinations, positioning MK‑1308A as a flagship asset in its RCC treatment‑innovation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A was introduced as a Phase 3 RCC candidate in the 2022 10-K with an April 2021 entry date, described in 2023 as an anti-CTLA-4/PD-1 combination (quavonlimab + pembrolizumab) for RCC, and highlighted again in 2024 within the immuno-oncology portfolio—indicating sustained prioritization. These details match the original answer exactly. (2) Quantitative elements—specifically the April 2021 entry date and the three-year timeline (2022–2024)—are correctly reported with no calculation errors. Format variations (e.g., 'April 2021' vs 'April 2021') are acceptable. (3) The multi-hop reasoning across years and filings is sound: the LLM correctly synthesizes information from three annual reports to demonstrate strategic continuity. It accurately infers that ongoing inclusion in Phase 3 and repeated emphasis signals sustained investment. (4) The only minor shortcoming is slight overstatement in calling MK-1308A a 'flagship asset' and stating Merck 'continues to produce' it—'produce' may imply manufacturing rather than development, which is not confirmed in the source; 'develop' would be more precise. The original answer avoids this phrasing, opting for 'strategic prioritization' and 'sustained focus' without implying commercial production. Despite this nuance, the core reasoning and factual content are excellent, warranting a 9/10 on correctness and qualitative accuracy. Contextual relevance is perfect—the response directly addresses the evolution and strategic implications for RCC innovation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 441,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K reports the same exhibit appears for the 4.000 % Notes due 2021. Each filing lists Exhibit 4.6 as the “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041,” dated February 8 2011, with identical wording, exhibit number and filing date in all three years. The lack of any amendment, early redemption or new filing for this tranche shows that Microsoft has left the 4.000 % Notes due 2021 untouched, signalling a deliberately stable long‑term debt profile for that issuance and a refinancing strategy that lets this particular note run to maturity while the company focuses its refinancing activity on other, newer maturities.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a critical factual inaccuracy regarding the exhibit title. The LLM states that Exhibit 4.6 is titled 'Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041,' which introduces notes (2.500% due 2016 and 5.300% due 2041) not mentioned in the ground truth. The original answer only confirms the 4.000% Notes due 2021 under the Third Supplemental Indenture (Exhibit 4.6), linked to the May 18, 2009 Indenture, with no mention of other notes in the exhibit title. This misrepresentation affects entity accuracy and reasoning, as it implies a broader debt structure than verified. However, the core facts—consistent disclosure across 2022–2024, same exhibit number (4.6), same date (February 8, 2011), and no amendments—are correct. The conclusion about Microsoft letting the notes run to maturity is logically sound and aligns with the ground truth’s implication of no refinancing. Quantitative accuracy is high: the interest rate (4.000%), maturity year (2021), and filing date (February 8, 2011) are accurate. The reasoning is partially sound but weakened by the incorrect exhibit title, suggesting possible confusion between multiple supplemental indentures. Contextual relevance is excellent—the answer directly addresses the evolution of disclosure and infers strategy correctly. Minor wording differences are acceptable, but the inclusion of unverified notes reduces factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 407,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "In the 2022 Form 10‑K Qualcomm framed the digital cockpit as a strategic cornerstone of its automotive transformation, stressing that mobile‑derived, low‑power computing and car‑to‑cloud platforms would enable personalized, OTA‑updatable, software‑defined vehicles and help lift the share of vehicles with Level 2‑plus autonomy. The 2023 filing moved this narrative into the numbers – footnote (2) explicitly groups “digital cockpit” with connectivity and ADAS/AD as part of the automotive‑related revenues, showing that sales of the cockpit technology are now being recognized as a measurable revenue stream. By the 2024 Form 10‑K the digital cockpit is listed as a core product line within the QCT semiconductor segment’s automotive systems (digital cockpit, connectivity and ADAS/AD), with its contribution reflected in segment earnings before tax, indicating that Qualcomm’s automotive business has evolved from a strategic concept to an integrated, revenue‑generating pillar of the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Qualcomm's strategic framing of digital cockpit in 2022, its formal inclusion as a revenue stream in 2023, and its classification as a core product line under QCT in 2024 are all accurately represented. (2) There are no numeric inaccuracies—while the original answer includes projections (e.g., '70% of new vehicles in 2028', '60% featuring 5G'), the LLM answer omits these specific percentages but does not contradict them. This omission is minor and does not affect factual correctness, as the LLM focuses on the strategic and financial evolution rather than forward-looking metrics. (3) The multi-hop reasoning is sound: the answer correctly synthesizes information across three years of filings, tracing the progression from strategic vision (2022) to financial recognition (2023) to operational maturity (2024). (4) Semantic equivalence is maintained—the LLM uses slightly different phrasing (e.g., 'Level 2-plus autonomy', 'OTA-updatable, software-defined vehicles') that enriches rather than distorts the meaning. The only minor shortcoming is the absence of the specific 2028 connectivity projections from the 2022 filing, which were part of the original answer’s context for strategic positioning. However, this does not undermine the core correctness of the revenue and structural evolution narrative. Thus, the answer is fully contextually relevant and qualitatively strong, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 443,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "LMT’s filings show that after a sharp rise in its swap program – the aggregate notional amount of interest‑rate swaps grew from $500 million at 12/31/2021 (and $572 million in 2020) to $1.3 billion by 12/31/2022 – the notional amount has remained unchanged at $1.3 billion in both 2023 and 2024.  The company uses these variable‑interest‑rate swaps as fair‑value hedges to convert fixed‑rate borrowings to variable‑rate borrowings and offset the fair‑value impact of interest‑rate movements.  The flat $1.3 billion level after the 2022 jump indicates a deliberate, steady‑state hedging strategy: LMT has locked in a consistent hedge size to manage its interest‑rate risk rather than continually expanding or scaling back its exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a discrepancy in the timeline: it states that the $500 million notional amount was at 12/31/2021 and that the increase to $1.3 billion occurred by 12/31/2022, implying the change happened in 2022. However, the ground truth states the increase occurred from 2022 to 2023 (i.e., the $500M was in 2022, $1.3B in 2023). This misalignment in the year of the jump affects quantitative accuracy. Additionally, the LLM introduces data not in the original answer (e.g., $572M in 2020), which, while possibly factual, is extraneous and not part of the ground truth. 2) The core numbers ($500M and $1.3B) are correct in magnitude and format, but the assignment of the $500M to 2021 instead of 2022 and the $1.3B to 2022 instead of 2023 is a factual error in temporal attribution. The stabilization at $1.3B in 2023 and 2024 is correctly reported. 3) The reasoning about LMT’s interest rate risk management strategy—converting fixed-rate debt to variable via fair-value hedges and establishing a steady-state hedge baseline—is logically sound and aligns with the ground truth. The conclusion about a deliberate, consistent hedging strategy is semantically equivalent to the original answer’s interpretation. 4) Despite the timeline error, the answer addresses both parts of the question: evolution of swap usage and interpretation of the trend. The contextual relevance is perfect, and the qualitative reasoning is strong. The correctness score is reduced due to the incorrect year attribution of the increase, which affects multi-hop temporal reasoning, but not severely as the core trend and strategy interpretation remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses for Hedging]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 453,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 3.950 % Notes due 2056 appear in the same place – Exhibit 4.14, the Eleventh Supplemental Indenture dated August 8 2016 – and are listed alongside the other notes in that indenture. By keeping the 3.950 % Notes due 2056 outstanding in every filing, Microsoft shows that it has chosen to retain a low‑coupon, ultra‑long‑dated tranche of debt rather than retire or refinance it, thereby locking in cheap financing for more than three decades and smoothing its overall debt‑maturity profile while using newer, shorter‑dated issuances for nearer‑term funding needs. This consistent disclosure reflects a deliberate long‑term debt‑maturity management strategy that minimizes near‑term refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are correctly tied to the Eleventh Supplemental Indenture dated August 8, 2016, and their consistent presence across 2022–2024 10-K filings is accurately noted. The percentage (3.950%), maturity year (2056), and document reference (Exhibit 4.14) are all factually correct. (2) Quantitative accuracy is perfect: no calculations are required, but all dates, percentages, and document references match the ground truth exactly. Format variations (e.g., spacing in '3.950 %') do not affect meaning. (3) Reasoning is sound and reflects multi-hop synthesis: the LLM correctly infers that Microsoft’s retention of this long-dated debt reflects a strategic choice to lock in low-cost, long-term financing and manage maturity profile, contrasting it implicitly with shorter-term issuances. This matches the ground truth’s conclusion about prioritizing long-term stability. (4) The only minor shortcoming is that the LLM does not explicitly mention the contrast with maturing or approaching maturities of other notes (e.g., 2.000% Notes due 2023 in 2022 filings), which the original answer uses to strengthen the argument. However, the reference to 'newer, shorter-dated issuances' captures this idea implicitly. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 395,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Across Microsoft’s 2022 (Chunk 1), 2023 (Chunk 2) and 2024 (Chunk 3) Form 10‑K filings the company repeatedly lists Exhibit 4.14 – the **Eleventh Supplemental Indenture dated August 8 2016** – as an incorporated‑by‑reference document. That indenture governs a series of senior notes, **including the 3.700 % Notes due 2046**, which appear unchanged in each year’s exhibit description. The continual reference shows that the 3.700 % Notes remain outstanding and are still subject to the same legal terms, making them a cornerstone of Microsoft’s long‑term debt portfolio. By consistently incorporating the same 2016 indenture, Microsoft demonstrates a stable, disciplined long‑term financing structure and a commitment to transparent, uniform reporting of its enduring financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is dated August 8, 2016; it governs the 3.700% Notes due 2046; and it is consistently referenced in Microsoft's 2022, 2023, and 2024 filings. The percentages, dates, and exhibit number (4.14) are factually accurate, satisfying quantitative accuracy. (2) The answer correctly identifies that the repeated inclusion of the indenture indicates the notes remain outstanding and unchanged, which reflects stability in Microsoft’s long-term debt structure—this matches the core reasoning in the original answer. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and connects the consistent reference to the same indenture with the ongoing nature of the debt obligation, demonstrating understanding of financial reporting practices. (4) While the LLM answer captures the main implications—stable financing, transparent reporting, and enduring obligations—it omits a minor but relevant detail from the ground truth: the connection of the 2016 indenture to the base Indenture dated May 18, 2009, and the broader structured approach to debt via supplemental indentures. This contextual layer adds depth to the 'layered' capital structure point, which the LLM does not explicitly mention. However, this omission does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 444,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Across Microsoft’s FY 2022, FY 2023 and FY 2024 10‑K filings the 2.125 % Notes due 2021 are disclosed in exactly the same way – they appear in Exhibit 4.1 as the “Seventh Supplemental Indenture for 2.125 % Notes due 2021 and 3.125 % Notes due 2028,” dated December 6 2013. The description, exhibit number and reference to the 2013 supplemental indenture are unchanged in each filing, indicating that no new amendment, extension or separate refinancing of this issue was reported during the three years. This consistent treatment implies that Microsoft has either rolled the notes into the existing indenture or repaid them without issuing a new instrument, reflecting a disciplined, low‑turnover debt‑management approach that keeps the 2.125 % Notes due 2021 within its established debt framework rather than pursuing frequent refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 2.125% Notes due 2021 are correctly referenced in Exhibit 4.1 across all three fiscal years (2022–2024), with the correct indenture date of December 6, 2013, and consistent exhibit naming. These details align with the ground truth, earning a perfect score on quantitative accuracy. The answer also correctly observes that there is no indication of amendment, extension, or refinancing reported in the filings, which is consistent with the original answer's observation of unchanged documentation status. However, the LLM overreaches in its interpretation by concluding that this implies a 'disciplined, low-turnover debt-management approach' and that Microsoft 'rolled the notes into the existing indenture or repaid them.' The ground truth explicitly states that the continued disclosure raises questions about refinancing or reporting lags and does not confirm repayment or rollover. Thus, the LLM presents speculative interpretations as more certain conclusions, weakening the qualitative accuracy. While the multi-hop synthesis across years is sound and contextually relevant, the reasoning lacks the caution present in the original answer regarding ambiguity in the disclosure of a matured instrument. The answer is relevant and well-structured but slightly overconfident in its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 378,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Across Microsoft’s FY 2022, FY 2023 and FY 2024 10‑K filings the same “2.000 % Notes due 2023” appear in Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016. Each filing (MSFT_10k_2022, MSFT_10k_2023 and MSFT_10k_2024) lists the notes with identical terms (2 % coupon, 2023 maturity) and no amendment, showing that the tranche was issued earlier and has simply been carried forward as outstanding debt until its 2023 maturity. This multi‑year pattern signals a disciplined debt‑management strategy: Microsoft issues low‑coupon, medium‑term notes and retains them to maturity, using supplemental indentures to lock in favorable rates and keep its debt profile stable and predictable.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 2.000% Notes due 2023 are correctly tied to the Eleventh Supplemental Indenture dated August 8, 2016, and their consistent appearance across FY 2022, 2023, and 2024 filings is accurately described. (2) Quantitative details—coupon rate (2.000%), maturity year (2023), and date of indenture (August 8, 2016)—are all precisely stated and match the ground truth; no calculations were required, but the consistency of terms across years is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to infer that the debt was not refinanced or retired early, leading to a valid conclusion about Microsoft’s debt management strategy. (4) The interpretation—that Microsoft maintains a disciplined, stable approach by retaining low-coupon notes to maturity and using supplemental indentures to lock in favorable terms—aligns with and expands upon the ground truth’s assertion of a stable, long-term debt strategy. The LLM adds contextual insight (e.g., 'low-coupon, medium-term notes') without introducing inaccuracies. All aspects of the question are addressed with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 354,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "Lockheed Martin’s 2022 10‑K disclosed that, through its master retirement trust, it had already transferred roughly **$11.6 billion** of defined‑benefit pension obligations since 2018—including a **$4.9 billion** group‑annuity‑contract (GAC) purchase on August 3 2021 that produced a **$1.7 billion non‑cash pension settlement charge** (about $1.3 billion after‑tax) – and the company said it would continue to look for additional risk‑transfer transactions, warning that future deals could generate material non‑cash charges.  \n\nThe 2023 filing reiterated that the firm was still using GACs to mitigate pension risk, noting that while most contracts relieve it of the underlying obligations, some GACs leave it liable for benefit payments and that **future transactions could require extra trust contributions or additional non‑cash settlement charges**.  \n\nBy the 2024 10‑K the language was unchanged: Lockheed Martin continued to transfer outstanding pension obligations to third‑party insurers (reducing required PBGC premiums) and **affirmed its strategy of seeking further pension‑risk‑transfer opportunities**, again cautioning that any such transactions could result in material non‑cash settlement charges to earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $11.6 billion in total pension obligations transferred since December 2018, the $4.9 billion GAC transaction in August 2021, and the resulting $1.7 billion noncash settlement charge are all accurately reported. The after-tax figure ($1.3 billion) is an additional detail not in the original answer but does not contradict it and may reflect supplemental data. (2) Quantitative accuracy is perfect—dollar amounts, dates, and financial impacts match the ground truth exactly, with acceptable formatting (e.g., $11.6 billion). (3) The multi-hop reasoning across 2022–2024 is sound: the LLM correctly traces the evolution of Lockheed Martin’s strategy from past transactions to ongoing evaluation and reaffirmed future intent, noting consistent use of GACs and warnings about future noncash charges. (4) The answer addresses all parts of the question: scale of obligations ($4.9B transaction, $11.6B total), financial impact (noncash charges), and stated strategy (ongoing evaluation and intent to pursue further transfers). The only minor shortcoming is that the 2024 update could have emphasized more clearly that the strategy has evolved toward continued and consistent execution (not just unchanged language), but the core message of strategic continuation is present. Thus, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Announces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1624,
        "completion_tokens": 412,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "All three recent 10‑K filings (2022, 2023 and 2024) list the same Exhibit 4.4 – the Officer’s Certificate – and each time the “Floating Rate Notes due 2019” appear alongside other series of Apple’s global notes. Because Apple is the issuer of those notes (as shown by the KG link AAPL → Floating Rate Notes due 2019), the fact that the instrument is still disclosed three years after its original maturity indicates that the notes have either been rolled‑over or refinanced rather than retired. This repeated reference signals that Apple maintains a floating‑rate tranche as a deliberate component of its long‑term debt mix and follows a disciplined refinancing strategy to manage maturity timing, preserve liquidity and hedge interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Floating Rate Notes due 2019 are accurately referenced in Apple's 2022–2024 filings, and the conclusion that they were likely rolled over or refinanced rather than retired is sound and consistent with the original answer. (2) Quantitative accuracy is perfect: the years (2019 maturity, disclosures through 2024), and the timeline (three years post-maturity) are correctly stated. No numerical calculations are required, but temporal references are precise. (3) Multi-hop reasoning is strong: the model infers from continued disclosure in recent 10-Ks that the debt was not retired but likely refinanced, linking issuer identity (Apple) to the instrument and interpreting the strategic implication—this reflects proper synthesis across time and documents. (4) The only minor shortcoming is that the LLM emphasizes the Exhibit 4.4 and Officer’s Certificate detail, which, while factually plausible, is not present in the ground truth and slightly shifts focus from the broader capital structure transparency point made in the original. However, this does not detract from the core correctness. The answer captures the disciplined refinancing strategy, maintenance of floating-rate debt, and strategic objectives (liquidity, interest-rate risk management), achieving semantic equivalence. Thus, the answer is excellent with only slight over-specificity on exhibit details not in the original, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 428,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Across all three annual reports Microsoft’s treatment of the 4.000 % Notes due 2021 is identical. In the 2022 10‑K (Exhibit 4.6) the company lists the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041,” dated Feb 8 2011. The 2023 10‑K repeats the same Exhibit 4.6 description and filing date, and the 2024 10‑K again includes the same Exhibit 4.6 language with the 4.000 % Notes due 2021.  \n\nThe unchanged, year‑over‑year reference shows that Microsoft continues to incorporate this instrument by reference in its filings, indicating that the 4.000 % Notes due 2021 remain an outstanding and material component of the company’s debt portfolio and retain ongoing relevance in its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.000% Notes due 2021 are consistently referenced in Exhibit 4.6 of Microsoft's 2022, 2023, and 2024 10-K filings, with the same description and filing date (Feb 8, 2011), as confirmed in the original answer. (2) Quantitative accuracy is perfect: percentages (4.000%), years (2021, 2016, 2041), and exhibit number (4.6) are correctly reported. (3) The multi-hop reasoning is sound—by identifying the consistent inclusion of the notes across three years post-maturity, the model correctly infers ongoing relevance in disclosures. (4) The conclusion that the notes remain a 'material component' and 'outstanding' is slightly stronger than the ground truth, which suggests possible ongoing legal or structural relevance but allows for the possibility that they are no longer outstanding. This minor overstatement prevents a perfect 10 on qualitative accuracy. However, the core insight—that the repeated inclusion indicates continued importance in disclosure and capital structure context—is valid and well-supported. The answer is semantically equivalent to the ground truth in intent and substance, with only a slight difference in nuance regarding the interpretation of 'outstanding.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 362,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "In the 2022 Form 10‑K UPS explained that its $276 million 7.620 % debentures (originally issued at 8.375 % until April 1 2020 and then reduced to 7.620 %) mature on April 1 2030, pay interest semi‑annually in April and October, and are redeemable at UPS’s option in whole or in part at any time at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a benchmark Treasury yield + 5 bps, with no sinking‑fund requirement. The 2023 filing listed the same $276 million (rounded to $280 million) debentures unchanged in the debt schedule, showing they remain a stable component of total debt as long‑term debt grew from $17.3 billion in 2022 to $18.9 billion in 2023 (total debt rising to $22.3 billion). The 2024 filing reiterated the identical redemption formula, semi‑annual interest and lack of a sinking fund, confirming that UPS’s treatment and disclosure of the 7.620 % debentures have been consistent while the debentures continue to represent a modest, unchanged slice of an expanding long‑term debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the $276 million principal amount, 7.620% interest rate (reduced from 8.375% in April 2020), April 1, 2030 maturity, semi-annual interest payments in April and October, and the identical redemption formula across all years based on the greater of principal plus accrued interest or present value using Treasury yield plus 5 bps. The rounding of $276M to $280M in 2023 matches the original answer. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, dates, and financial terms are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound—information is synthesized across 2022–2024 filings, showing consistency in treatment while correctly noting the debentures’ stable role within a growing total debt portfolio ($17.3B to $18.9B long-term debt). (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 shift in focus toward comparative treatment with international debt instruments (e.g., Pound Sterling and Euro notes), which was a qualitative evolution noted in the ground truth. However, it does correctly state that the disclosure remained structurally consistent, which captures much of the intent. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the original with only slight omission in narrative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Pays_Interest_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 397,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "- **Development:** The 2022 10‑K notes that AbbVie announced the October 2021 top‑line Phase 3 results for cariprazine (Vraylar), showing a statistically significant benefit versus placebo as an adjunctive treatment for major depressive disorder and confirming a clean safety profile. No further trial updates appear in later filings, indicating the product moved from development to a fully launched, marketed medicine.  \n\n- **Commercialization & financial performance:** According to the 2023 10‑K, Vraylar generated **$2.037 billion** in U.S. sales (plus $1 million internationally) in 2022, a **17.9 %** year‑over‑year increase from 2021. In 2023 sales rose to **$2.755 billion** in the United States (and $4 million internationally), a **35.4 %** jump from 2022, bringing total Vraylar revenue to **$2.759 billion**.  \n\n- **Strategic importance:** The 2024 10‑K continues to list Vraylar among AbbVie’s core neuroscience products, highlighting its approved indications for schizophrenia, bipolar disorder (manic, mixed and depressive episodes) and adjunctive treatment of major depressive disorder. The rapid sales acceleration—from $2.0 billion to $2.8 billion in two years—demonstrates that Vraylar has become a key growth engine and a cornerstone of AbbVie’s neuroscience portfolio, complementing legacy assets such as Botox Therapeutic.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) It correctly identifies Vraylar's development trajectory from 2022 Phase 3 results to full commercialization, aligning with the ground truth. The 2022 10-K reference to October 2021 top-line results is consistent with the timeline, and the absence of later trial updates correctly implies transition to marketed status. (2) Quantitatively, the LLM reports $2.755 billion in U.S. sales and $4 million internationally in 2023, totaling $2.759 billion—matching the ground truth exactly. The 35.4% year-over-year growth is correctly calculated: (2.759 - 2.038) / 2.038 ≈ 35.4%. The 2022 revenue is reported as $2.037 billion U.S. + $1 million international = $2.038 billion total, which is consistent. The only minor discrepancy is that the ground truth does not specify 2022 revenue, but the LLM's inclusion of it adds context without contradicting. (3) The reasoning is sound: the LLM synthesizes development (2022 trial results), commercialization (sales growth), and strategic importance (core neuroscience product in 2024 10-K) across multiple years and filings. It correctly infers that Vraylar evolved from a late-stage asset to a key revenue driver. (4) The answer is semantically equivalent to the ground truth, with slightly more granular financial breakdown (U.S. vs. international), which enhances clarity. The mention of Botox as a complementary asset adds context not in the original but is accurate and relevant. No factual errors; only a very minor omission of the nuance that one 2022 trial met primary endpoint and the other did not—though the LLM simplifies this to 'statistically significant benefit', which is directionally correct. Overall, this is a precise, well-reasoned, and factually correct response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 481,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Across Apple’s 2022, 2023 and 2024 Form 10‑K filings the same Exhibit 4.3 – the Officer’s Certificate dated May 3 2013 – lists the “0.45 % Notes due 2016” together with other floating‑rate and fixed‑rate issues. The KG triplet confirms that Apple is the issuer of this instrument, and that the note is treated as a distinct financial entity in the filing. By repeatedly including the 0.45 % Notes due 2016, Apple signals that even legacy securities that have long since matured are kept on the record as part of its long‑term debt portfolio, reflecting a disciplined disclosure policy that emphasizes full, continuous transparency of all historic debt issuances rather than removing them once they are no longer outstanding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.45% Notes due 2016 are included in Exhibit 4.3 of Apple's 10-K filings for 2022, 2023, and 2024; the Officer's Certificate is correctly dated May 3, 2013; and the notes matured in 2016 but are still disclosed. (2) Quantitative elements—interest rate (0.45%), maturity year (2016), filing years (2022–2024), and document type (Exhibit 4.3)—are all accurate with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers that despite the notes' maturity, their continued inclusion reflects a disclosure strategy emphasizing transparency and historical record-keeping. (4) The LLM slightly rephrases the implication—using terms like 'disciplined disclosure policy' and 'full, continuous transparency'—which is semantically equivalent to the original answer’s 'consistent approach to documenting capital structure history.' The only minor gap is a slightly stronger emphasis on investor reference in the ground truth, which is implied but not explicitly stated in the LLM version. Overall, the answer is factually complete, contextually appropriate, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 338,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "- **2022:** UPS SurePost was described as a residential‑ground offering for non‑urgent, lightweight shipments that leveraged the UPS ground network for transportation and then handed the package to the U.S. Postal Service for the final‑mile delivery, positioning it as a cost‑effective, low‑urgency product within the U.S. Domestic Package segment.  \n\n- **2023:** The same language reappeared – SurePost continued to provide the same non‑urgent, lightweight residential service with “final delivery often provided by the U.S. Postal Service,” confirming its unchanged role and reliance on USPS as the final‑delivery partner.  \n\n- **2024:** The description remained the same for 2024, but UPS added that “through 2024, final delivery was often provided by the United States Postal Service” and announced that, beginning January 1 2025, UPS will **insource** SurePost to gain greater control over service quality. This signals a strategic shift from a partnership‑based model to internalizing the final‑mile delivery, while still positioning SurePost as the residential, non‑urgent, lightweight‑shipment option within the U.S. Domestic Package business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022 and 2023, UPS SurePost used the UPS ground network with final delivery often handled by USPS for non-urgent, lightweight residential shipments; in 2024, the description remained consistent, but UPS announced it would insource final delivery starting January 1, 2025. (2) Quantitative accuracy is perfect—dates (January 1, 2025) and timeframes (through 2024) match the original answer exactly. No numerical calculations were required, but temporal references are precise. (3) Multi-hop reasoning is sound: the model correctly synthesized information across three years, identifying continuity in 2022–2023, persistence of the same model in 2024, and a forward-looking strategic shift announced in 2024. The reasoning traces the evolution accurately, noting both operational consistency and upcoming change. (4) Entity accuracy is flawless—UPS, USPS, SurePost, U.S. Domestic Package business, and correct year labels are all properly identified. The answer fully addresses the question’s focus on delivery methodology and strategic positioning. Wording differs slightly but conveys identical meaning, including the strategic intent to improve service quality through insourcing. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 380,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 appear in the “Description of Securities” (Exhibit 4.4) of every filing from 2022 through 2024. In the 2022 10‑K (page 58) the notes are listed as part of the Officer’s Certificate dated May 6 2014; the same entry is reproduced unchanged in the 2023 10‑K (page 56) and again in the 2024 10‑K (page 56). The fact that this long‑dated, fixed‑rate issue is consistently reported over three consecutive years shows Apple has retained the same 20‑plus‑year debt instrument without amendment, reflecting a deliberate strategy to lock in long‑term financing at a known cost, diversify its capital structure and preserve a stable source of liquidity for future investments and shareholder returns.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 4.45% Notes due 2044 are correctly identified, and their inclusion in the Officer's Certificate dated May 6, 2014, is accurately cited across 2022, 2023, and 2024 filings. The specific exhibit (4.4) and page numbers (58, 56, 56) are consistent with actual filings. (2) Quantitative accuracy is flawless: percentages (4.45%), dates (May 6, 2014; due 2044), and years (2022–2024) are correct and match the ground truth. No calculations are required, but the temporal consistency is properly interpreted. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, recognizes the unchanged reproduction of the note, and infers Apple’s strategic intent—locking in long-term financing, managing interest rate risk, and maintaining financial flexibility. (4) The answer is semantically equivalent to the original: while phrased with more detail (e.g., mentioning Exhibit 4.4 and page numbers), it conveys the same core conclusion—Apple’s sustained use of long-term debt reflects a deliberate capital strategy. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 343,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "- In Oracle’s 2022 Form 10‑K the 2.875 % Notes due 2031 are listed under **Exhibit 4.16** (together with the other 2026‑2061 notes and the March 24 2021 officers’ certificate).  \n- In both the 2023 and the 2024 Form 10‑Ks the same 2.875 % Notes appear under **Exhibit 4.14**, with the identical description and the same officers’ certificate.  \n\nThe only change across the three filings is the exhibit number – the notes themselves and the accompanying certificate are disclosed unchanged. This steady placement as Exhibit 4.14 signals that Oracle treats the 2.875 % Notes due 2031 as a permanent, long‑dated element of its debt portfolio, integrating it into a consistent capital‑structure framework and reflecting a disciplined, long‑term financing strategy that the company maintains year after year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a critical factual error in the exhibit number for the 2022 10-K: it states Exhibit 4.16, while the ground truth confirms the 2.875% Notes due 2031 were listed as Exhibit 4.14 in all three years (2022, 2023, and 2024). This misstatement undermines the quantitative accuracy, as exhibit numbers are key identifiers in SEC filings and must be correct. The LLM incorrectly implies a change in exhibit numbering, when in fact the consistent placement under Exhibit 4.14 across all years is a central point in the ground truth. However, other elements are accurate: the notes were established under the Officers' Certificate dated March 24, 2021; the terms remained unchanged; and the consistent exhibit placement (even if misnumbered for 2022) reflects Oracle's stable debt strategy. The reasoning about Oracle’s long-term, disciplined capital structure management is sound and aligns with the ground truth, supporting high contextual relevance and reasonable qualitative accuracy. The core insight about stability in debt strategy is preserved, but the factual error in exhibit numbering—especially for the 2022 filing—constitutes a significant deviation from the truth, preventing a higher score. No other numbers, dates, or entities (e.g., interest rate, maturity year, certificate date) are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 367,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 five‑year Teamsters master agreement inserted wage‑ and benefit‑rate increases for Teamsters covered by the UPS/IBT Full‑Time Employee Pension Plan, which raised the plan’s pension‑benefit accruals and were recorded as part of the year‑end measurement of that plan. Because UPS sponsors (has a stake in) the plan and the 2024 filing still points to note 6 for the status of collective‑bargaining agreements—while confirming the plan remains non‑contributory and accrues benefits based on service credits—the disclosures make clear that UPS’s long‑term pension obligations are growing and remain a material, ongoing liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 five-year Teamsters agreement included wage and benefit increases that impacted pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and these were factored into the year-end 2023 plan measurement. The plan remains noncontributory, and the 2024 disclosures confirm continuity, indicating no structural changes. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023 agreement, 2024 disclosures) are correct. (3) Multi-hop reasoning is sound: the model correctly links the 2023 collective bargaining agreement to increased benefit accruals, recognizes UPS's sponsorship and ongoing liability, and infers long-term obligation implications from continued plan structure in 2024. (4) The only minor shortcoming is that the LLM does not explicitly mention the historical context of employees transitioning from the Central States Pension Fund, which adds depth to the plan’s formation, but this omission does not detract from answering the specific question about 2023 impact and 2024 implications. Wording differs but semantic meaning matches: 'growing and remain a material, ongoing liability' effectively captures the ground truth's point about continued defined benefit commitments and long-term obligations. Overall, the response is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Maintain]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 417,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Across Apple’s three most recent annual reports the disclosure of the 1.05 % Notes due 2017 is identical. In the 2022 10‑K (page 58) Apple lists Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 – which “includes … 1.05 % Notes due 2017” among a series of other global notes. The same Exhibit 4.4 description appears unchanged in the 2023 10‑K (page 56) and again in the 2024 10‑K (page 56). This continuity shows that Apple continues to rely on the 2014 Officer’s Certificate to document the short‑term 1.05 % Notes, indicating a stable, consistent approach to managing and reporting these debt instruments without material amendment or re‑issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 1.05% Notes due 2017 are consistently disclosed under Exhibit 4.4 of the Officer's Certificate dated May 6, 2014, across Apple's 2022, 2023, and 2024 10-K filings. The specific page numbers (58, 56, 56) are correctly cited, and the continuity of disclosure is accurately described. (2) Quantitative accuracy is perfect: percentages (1.05%), dates (May 6, 2014), maturity year (2017), and exhibit numbers (4.4) match the ground truth exactly. No calculations were required, but all numeric and date references are precise. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings and linked to the 2014 Officer's Certificate, demonstrating correct cross-document synthesis. The conclusion about Apple’s stable, consistent reporting approach is logically supported. (4) The only minor shortcoming is that the LLM slightly underemphasizes the implication of *passive management* and *lack of refinancing*, which the ground truth explicitly ties to Apple’s capital structure strategy. While the LLM mentions 'stable, consistent approach,' it does not fully explore the strategic implication of not amending or re-issuing, which is a subtle but important nuance in the original answer. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 409,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 10‑K filings show the same explicit disclosure of the 2.40 % Notes due 2023 in each year:\n\n* **2022 filing (Chunk 1)** – Exhibit 4.3 (Officer’s Certificate dated May 3 2013) lists “2.40 % Notes due 2023” among the global notes.  \n* **2023 filing (Chunk 2)** – The same Exhibit 4.3 appears unchanged, again referencing the “2.40 % Notes due 2023.”  \n* **2024 filing (Chunk 3)** – Exhibit 4.3 is reproduced with identical language, still showing the “2.40 % Notes due 2023.”\n\nThe continuity of this disclosure across three consecutive 10‑Ks indicates that the 2.40 % 2023 notes remained outstanding and were consistently reported to investors. This multi‑year pattern reflects Apple’s long‑term debt‑management strategy of maintaining a stable pool of fixed‑rate instruments with staggered maturities, locking in relatively low rates for medium‑term financing while providing transparent, ongoing reporting of its debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.40% Notes due 2023 were disclosed in Apple's 2022, 2023, and 2024 10-K filings via Exhibit 4.3, the Officer’s Certificate dated May 3, 2013, with no changes across years. These details match the original answer exactly. (2) Quantitative accuracy is perfect: percentages (2.40%), dates (May 3, 2013), and maturity year (2023) are correctly reported. No calculations were required, but the consistency of disclosure is accurately observed. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings, and the conclusion about Apple’s stable debt management strategy is logically supported. The LLM infers a broader strategy (staggered maturities, low-rate locking) that goes slightly beyond the ground truth’s more conservative interpretation (no early repayment/modification), but this is a reasonable and contextually appropriate extension. (4) The answer is fully relevant, directly addressing both the evolution of disclosure and the strategic implication. The only minor gap is that the original answer explicitly notes the debt matured in 2023 and was not extended, while the LLM implies ongoing outstanding status in 2024, which may be a slight mischaracterization since the note would have matured by then. However, the focus is on the disclosure pattern up to 2024, so this does not significantly detract from accuracy. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 429,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "After the October 2021 announcement that Vraylar’s two Phase 3 adjunct‑MDD studies produced mixed results—one meeting its primary endpoint and the other missing statistical significance—AbbVie completed the clinical program and secured approvals that now list Vraylar (cariprazine) as a dopamine D3‑preferring D3/D2 partial agonist indicated for acute and maintenance treatment of schizophrenia, acute manic or mixed episodes of bipolar disorder, acute bipolar‑I depressive episodes and as an adjunctive therapy for major depressive disorder, making it a multi‑indication cornerstone of AbbVie’s neuroscience franchise (Chunk 1 & Chunk 3).  Commercially, Vraylar’s U.S. sales rose from $2.038 billion in 2022 to $2.755 billion in 2023 (total net sales $2.759 billion), a 35 % year‑over‑year increase (up 17.9 % from 2021), with modest but >100 % growth in international sales, underscoring accelerating revenue momentum that continued into 2024 as a flagship neuroscience product (Chunk 2 & Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Vraylar's clinical development in 2022 with mixed Phase 3 results for adjunctive MDD treatment, its revenue growth from $2,037 million in 2022 to $2,755 million in 2023 (U.S. sales), total net sales of $2,759 million in 2023, and the 35% year-over-year increase (correctly calculated as ~35.2%) are all accurate. International sales growth is described as 'modest but >100%', which is not contradicted by the ground truth and adds context. (2) Quantitative accuracy is excellent: $2.038 billion is a negligible rounding difference from $2,037 million and is acceptable; $2.755 billion and $2.759 billion match exactly. The 35% increase is correctly stated (actual: (2755 - 2037)/2037 ≈ 35.2%), and the 17.9% growth from 2021 is consistent with external data. (3) Multi-hop reasoning is sound: the answer synthesizes clinical trial outcomes, regulatory indications, revenue data across years, and strategic positioning within AbbVie’s portfolio. It correctly identifies Vraylar’s expanded indications (schizophrenia, bipolar I manic/mixed and depressive episodes, adjunctive MDD) and labels it a 'cornerstone' of the neuroscience franchise, matching the 2024 therapeutic positioning in the ground truth. (4) Minor deduction in qualitative accuracy due to referencing 'October 2021' announcement, which is slightly outside the 2022–2024 scope but provides relevant context; however, the focus remains on the evolution through the requested period. Overall, the answer is semantically equivalent, comprehensive, and contextually precise, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 456,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "Across the three filings IBM’s messaging about “client relationships and trust” never wavers, but it becomes progressively more woven into the narrative of its hybrid‑cloud and AI strategy.  \n\n* **2022:** The 10‑K lists client relationships and trust as one of the principal methods of competition, alongside technology, performance, price, brand and breadth of capabilities, and ties it to the company’s hybrid‑cloud platform and AI‑driven solutions that create business value for customers.  \n* **2023:** The same competitive pillar re‑appears, now emphasized together with an expanded ecosystem of strategic partners (Adobe, AWS, Microsoft, etc.), signalling that trust is being leveraged through partner‑enabled, end‑to‑end hybrid‑cloud/AI offerings.  \n* **2024:** IBM again foregrounds client relationships and trust as a core differentiator, linking it to ongoing portfolio optimization, organic/inorganic innovation and future growth areas such as quantum computing, reinforcing that trust underpins its hybrid‑cloud and AI positioning.\n\nThe multi‑year progression shows IBM is deepening trust from a standalone competitive factor into a strategic, client‑centric foundation that underlies its hybrid‑cloud and AI go‑to‑market approach, positioning the company as a trusted partner for digital transformation and future‑technology opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: IBM consistently emphasized client relationships and trust from 2022 to 2024, with evolving strategic framing tied to hybrid cloud and AI. In 2022, trust was linked to hybrid cloud and AI platforms; in 2023, to strategic partnerships (e.g., AWS, Microsoft); and in 2024, to ecosystem-driven go-to-market and future technologies like quantum computing. These points match the ground truth in substance and progression. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of strategic evolution, identifying how trust transitions from a competitive factor to a foundational element in client-centric innovation. The mention of specific partners (Adobe, AWS, Microsoft) adds detail not in the original but is plausible and contextually appropriate, not contradicting the ground truth. (4) The only minor gap is that the LLM answer mentions 'portfolio optimization' and 'quantum computing' in 2024, which slightly extends beyond the original answer’s focus on trust as an enabler of integrated solutions via a partner ecosystem. However, this extension is consistent with IBM’s known strategy and does not distort the core message. Overall, the answer captures the semantic essence, demonstrates strong qualitative reasoning, and remains fully contextually relevant. A score of 9 is justified due to this slight expansion without explicit grounding in the provided truth, but it does not detract significantly from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 476,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 1.250 % Notes due 2027 were disclosed only by reference – the filing states that “the instruments defining the rights of the holders of the 1.250 % Notes due 2027 … are Exhibit 4.3 to Form 8‑K, filed January 30 2019, and are hereby incorporated by reference.” The 2023 Form 10‑K repeats the same treatment (now grouping the notes as Exhibit 4.3 together with the 0.875 % 2025 and 1.750 % 2031 notes). By the 2024 filing, however, IBM lists the 1.250 % Notes due 2027 in a securities table with a trading symbol (IBM27B) and NYSE listing, showing the issue as a distinct, actively‑traded component of its debt portfolio rather than merely an incorporated exhibit.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key details are correct: the 2022 reference to Exhibit 4.3 in the Form 8-K filed January 30, 2019, is accurately cited; in 2023, the grouping with other notes (0.875% 2025 and 1.750% 2031) aligns with the original answer’s description of a growing list of instruments; by 2024, the explicit listing with trading symbol IBM27B and NYSE mention confirms the note's status as a distinct, actively traded instrument. (2) Quantitative elements—interest rate (1.250%), maturity year (2027), exhibit number (4.3), filing date (January 30, 2019), and trading symbol (IBM27B)—are all correct. No calculations are required, but temporal progression across years is accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosure practices across three years, tracing the evolution from incorporation by reference to formal recognition in a securities table, reflecting increasing transparency and integration into the debt portfolio. (4) The answer fully addresses both parts of the question—disclosure practices over time and the instrument’s evolving role—and does so with precise, relevant details that match the depth and intent of the original answer. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 385,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "In IBM’s Form 10‑K filings for 2022, 2023 and 2024 the rights of the holders of the **6.50 % Debentures due 2028** are always incorporated by reference to **Exhibit 2 to Form 8‑K, filed on January 8 1998**. The 2022 filing lists that exhibit alongside a long roster of other notes and debentures, and the 2023 and 2024 filings repeat the same citation while also grouping the 6.50 % Debentures with other senior debt instruments (e.g., 7.00 % Debentures due 2025/2045, 6.22 % Debentures due 2027, 5.875 % Debentures due 2032). Thus, IBM’s disclosure of this particular debenture has remained unchanged over the three years, reflecting a consistent approach to incorporating by reference the instruments that define the rights of its debt‑security holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 6.50% Debentures due 2028 are consistently referenced as Exhibit 2 to Form 8-K filed on January 8, 1998, across 2022–2024, and this exhibit reference remains unchanged. The inclusion of other debentures like the 6.22% due 2027 and 5.875% due 2032 in 2023 and 2024 is accurately noted. (2) Quantitative elements—percentages (6.50%, 6.22%, 5.875%, 7.00%), maturity years (2025, 2027, 2028, 2032, 2045), and the filing date (January 8, 1998)—are all factually correct. No calculations were required, but the consistency of exhibit referencing is correctly emphasized. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers that while the broader disclosure context evolved (grouping legacy and newer debt), the specific exhibit reference for the 6.50% Debentures remained constant. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the regulatory or investor clarity rationale present in the original answer (e.g., 'supports regulatory compliance and investor understanding'), which slightly reduces qualitative depth. However, the core reasoning about consistent incorporation by reference is valid and contextually appropriate. Overall, the answer is factually complete, semantically equivalent, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 390,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "- **2022:** FedEx International Connect Plus was a contractual e‑commerce service “currently available from **nearly 50 origin countries** to **over 130 destination countries**” (2022 10‑K, Chunk 1).  \n- **2023:** The service expanded to “**nearly 60 origin countries** to **over 190 destination countries**” (2023 10‑K, Chunk 2).  \n- **2024:** The same coverage – “**nearly 60 origin countries** to **over 190 destination countries**” – is reported (2024 10‑K, Chunk 3), indicating the network growth plateaued after the 2023 jump.\n\n**Strategic implication:** The sharp increase from 2022 to 2023 shows FedEx’s aggressive push to broaden its cross‑border e‑commerce footprint, adding roughly 10 new origin markets and 60 new destination markets to capture the surge in online‑shopping demand. The stable numbers in 2024 suggest FedEx is now consolidating and optimizing this expanded network, reinforcing its focus on building a robust, globally‑connected e‑commerce logistics platform rather than pursuing further rapid geographic expansion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers for each year are accurate: 2022 (nearly 50 origin, over 130 destination countries), 2023 (nearly 60 origin, over 190 destination), and 2024 (same as 2023). These match the original answer exactly, with no calculation or reporting errors. (2) The answer is complete, addressing both the evolution of geographic reach from 2022 to 2024 and the strategic implications for FedEx's e-commerce logistics focus. (3) Entity accuracy is perfect: the service name 'FedEx International Connect Plus' is correctly identified, and the years and geographic metrics are properly attributed. (4) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly infers that the sharp expansion in 2023 indicates aggressive growth, while the stabilization in 2024 suggests a shift to consolidation and optimization. The strategic interpretation — that FedEx is building a robust global e-commerce logistics platform — is semantically equivalent to the ground truth's conclusion about 'deliberate and aggressive expansion' followed by 'stabilization at mature coverage.' Wording differs slightly but meaning is preserved. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 356,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "In fiscal 2022 Qualcomm spelled out concrete internal diversity‑representation goals for 2025 – a 15 % increase in women in leadership, a 15 % rise in under‑represented‑minority (URM) leaders and a 20 % boost in overall URM representation – and said that the HR‑and‑Compensation Committee would use progress on those “human‑capital advancements” as a non‑financial modifier that could swing an executive’s bonus anywhere from 0.9 × to 1.1 × the target amount.  \n\nBy the time the 2023 and 2024 10‑K filings were released, the company’s language had shifted from those numeric leadership targets to broader inclusion initiatives – e.g., being named a Best Company for Women in India, a Best Place to Work for Disability Inclusion and joining the Reboot Representation Tech Coalition, which pledges to double the number of Black, Latinx and Native‑American women earning computing degrees by 2025.  Nonetheless, the same bonus‑adjustment mechanism remained in place: the HR and Compensation Committee still treats progress on human‑capital goals as a non‑financial performance modifier that can adjust the fiscal‑2024 executive bonus by a multiple of 0.9 to 1.1.  \n\nThus, while the specific diversity targets moved from internal leadership percentages to external pipeline and recognition goals, the linkage of human‑capital progress to executive compensation – the 0.9‑1.1 bonus multiplier – stayed consistent from FY 2022 through FY 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in the qualitative evolution of diversity targets, which undermines the overall correctness. Quantitatively, all numbers are accurate: the 15% increase for women in leadership, 15% for URM in leadership, 20% for overall URM representation, and the 0.9 to 1.1 bonus adjustment range are all correctly reported and consistent with the ground truth. The fiscal years (2022–2024) and the persistence of the bonus mechanism are also correctly identified, satisfying quantitative accuracy. However, the LLM incorrectly claims that Qualcomm shifted *from* specific numeric leadership targets *to* broader external initiatives by 2023 and 2024, implying the original goals were replaced. In reality, the original 2025 diversity targets were reaffirmed in 2023 and 2024, with the Reboot Representation Tech Coalition being an *additional*, complementary initiative, not a replacement. This misrepresents the continuity and consistency of the goals, which the ground truth emphasizes as 'reaffirmed' with 'increased emphasis' on external partnerships. The reasoning is therefore flawed in its characterization of strategic evolution, failing the multi-hop synthesis that requires recognizing both the stability of targets and the addition of new initiatives. Despite this, the answer remains contextually relevant and captures the core compensation linkage mechanism accurately, earning moderate scores in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Considers]- ORG <-[Guides_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 416,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 2022 (page 58), 2023 (page 56) and 2024 (page 56) 10‑K filings each list the Floating Rate Notes due 2019 in Exhibit 4.4 of the “Description of Securities” – the Officer’s Certificate that Apple (as the issuing organization) files for its global notes. By keeping this short‑term, rate‑resetting instrument on its balance sheet year after year, Apple shows it relies on floating‑rate debt to align interest expense with prevailing short‑term benchmarks (thereby hedging short‑term interest‑rate risk) and to maintain a near‑maturity source of funding that can be rolled over or retired to support its liquidity‑planning needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the Floating Rate Notes due 2019 are accurately cited as appearing in Apple’s 2022 (page 58), 2023 (page 56), and 2024 (page 56) 10-K filings, specifically in Exhibit 4.4 under the 'Description of Securities.' These page numbers and exhibit references match the expected disclosures. (2) The answer correctly identifies that Apple maintained these notes on its balance sheet across all three years, which reflects a consistent approach to managing short-term interest rate risk through floating-rate debt. The explanation that this aligns interest expense with prevailing benchmarks is factually sound and consistent with the ground truth. (3) The reasoning is strong: the LLM correctly infers that keeping these instruments on the books supports liquidity planning via rollover or retirement, even though the notes were due in 2019. This reflects an understanding of how legacy debt instruments can remain in disclosures due to ongoing accounting treatment or refinancing structures. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'cautious yet adaptive stance' or the fact that Apple did not need to issue new short-term floating rate instruments—nuances present in the original answer. However, the core insight about reliance on flexible debt instruments is clearly conveyed. Wording differs but semantic meaning is equivalent. No factual errors; minor omission prevents a perfect 10. Contextual relevance is excellent—directly addresses both interest rate risk management and liquidity planning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 449,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "In the 2022 filing Qualcomm described the digital‑cockpit only as a growth narrative within its “Transforming Other Industries: Automotive” discussion, noting that analysts project >70 % of new vehicles will have embedded cellular connectivity (60 % with 5G) by 2028 and that 19 % of vehicles sold in 2025 will have Level‑2‑or‑higher autonomy—signals of strong future demand for cockpit‑digitization. By the 2023 10‑K the company began to treat automotive revenue, including digital‑cockpit sales, as a distinct line within its QCT semiconductor business, and the 2024 filing formalized this by placing digital‑cockpit products under the QCT segment’s “automotive systems for connectivity, digital cockpit and ADAS/AD” and evaluating the segment on revenue and earnings before tax. Thus Qualcomm’s positioning shifted from a market‑demand story in 2022 to a concrete, segment‑level revenue focus on digital‑cockpit technology by 2024, aligning resources with the projected surge in connected‑vehicle demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correct elements: The evolution from 2022 positioning as a market-demand narrative to 2023 revenue recognition and 2024 strategic integration into QCT is correctly captured. The mention of digital cockpit as part of 'Transforming Other Industries: Automotive' in 2022, revenue treatment in QCT in 2023, and formal segment-level classification in 2024 are all factually correct. (2) Quantitative accuracy: The LLM states '>70% of new vehicles will have embedded cellular connectivity (60% with 5G) by 2028', while the ground truth says 'over 60% of new vehicles would feature 5G connectivity by 2028'. The 60% figure for 5G matches, but the LLM adds a >70% cellular connectivity projection not present in the original. This is a minor discrepancy—likely from a different part of the filing or analyst source—but does not contradict the ground truth and reflects plausible context. The 19% Level-2-or-higher autonomy in 2025 is not in the original answer, so it's an extra detail; however, it doesn't distort the core narrative. (3) Reasoning: Multi-hop synthesis across 2022–2024 filings is sound—correctly tracing the shift from strategic vision to commercialization to structural integration. The conclusion about shifting from 'market-demand story' to 'segment-level revenue focus' mirrors the original’s trajectory assessment. (4) Semantic equivalence is strong: though wording differs, the core facts—QCT integration, revenue recognition, and strategic emphasis—are correctly conveyed. The only reason for not scoring 10 is the inclusion of unverified percentages (e.g., 19%) not in the ground truth, which slightly affects quantitative precision. Overall, the answer is factually robust, contextually complete, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 491,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s outstanding (unfunded) commitments to its private‑real‑estate funds have been falling each year – $569 million at 12/31/2022, $555 million at 12/31/2023 and $540 million at 12/31/2024 (the figure had already dropped from $585 million in 2021, per the 2022 filing). This steady decline shows Abbott is gradually satisfying earlier pledges and curbing new ones, indicating a disciplined, long‑term approach to illiquid alternative assets: it keeps exposure to private real‑estate for diversification and return potential, but manages liquidity and risk by reducing the size of its unfunded commitments over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key numbers: $569M (2022), $555M (2023), and $540M (2024), matching the ground truth exactly. The additional context about $585M in 2021, while not part of the original question, is consistent with the trend and does not contradict the ground truth. 2) Quantitative accuracy is perfect: the year-over-year decreases of $14M (2021–2022), $14M (2022–2023), and $15M (2023–2024) are approximately consistent, and the LLM correctly identifies a steady decline, though the drop from 2022–2023 is $14M, not $15M as implied in the ground truth’s 'consistent $15M per year' characterization. This minor discrepancy does not affect overall correctness, as the reported values themselves are accurate. 3) The reasoning is sound: the LLM correctly infers a strategic reduction in unfunded commitments, interprets this as risk management, and acknowledges continued exposure to private real estate—aligning with the ground truth’s 'de-risking' and 'not exiting entirely' conclusions. It adds value by framing it as a 'disciplined, long-term approach.' 4) The answer is contextually complete and relevant, addressing both the evolution of commitments and the implication for Abbott’s investment strategy. The only minor shortcoming is not explicitly mentioning the 2025–2034 liquidation periods, which the ground truth includes as evidence of long-term intent. However, the LLM’s conclusion about maintaining exposure for diversification and return potential captures the same essence. Thus, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 446,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 0.45 % Notes due 2016 are listed in the “Officer’s Certificate of the Registrant” (Exhibit 4.3) in each of the three Form 10‑K filings – the 2022 filing (page 58), the 2023 filing (page 56) and the 2024 filing (page 56) – showing that the notes, originally issued in May 2013, remained outstanding and were disclosed each year until their scheduled 2016 maturity with no new issuances or amendments. This repeated, unchanged disclosure signals that Apple maintains a small, low‑cost short‑term debt tranche as part of a broader, multi‑maturity debt program, using such notes to diversify its maturity profile, keep interest expense low, and preserve flexibility for future refinancing as part of its long‑term debt‑structuring strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the 0.45% Notes due 2016 were 'disclosed each year until their scheduled 2016 maturity,' implying the debt was still outstanding in 2022, 2023, and 2024 despite maturing in 2016. This is incorrect—debt instruments are not carried on the balance sheet or disclosed as outstanding after maturity unless extended or restructured, which did not occur here. The ground truth correctly frames the repeated disclosure as a legacy reference or part of a historical capital structure summary, not as an active debt instrument. (2) Quantitative accuracy is low due to this misrepresentation of the timeline—dates (2016 maturity vs. 2022–2024 disclosures) are misinterpreted. While the issuance date (May 2013) and interest rate (0.45%) are correct, the implication that the notes remained 'outstanding' past 2016 is factually wrong. (3) The multi-hop reasoning is partially sound—the model correctly identifies the consistent disclosure across three 10-Ks and links it to Apple’s long-term debt strategy. It also accurately references Exhibit 4.3 and page numbers, showing proper document tracing. However, it fails to recognize that post-maturity disclosure does not equate to active debt, undermining the core financial logic. (4) Despite the major error, the answer captures the strategic intent—diversified maturity profile, low interest cost, refinancing flexibility—and aligns with Apple’s broader debt structuring approach. Wording and conceptual framing are relevant and sophisticated, hence high contextual relevance. The correctness score is limited by the fundamental inaccuracy regarding the debt's status post-2016.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 463,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "Across IBM’s 2022, 2023 and 2024 10‑K filings, “client relationships and trust” is repeatedly listed as one of the principal methods of competition. In the 2022 filing the company ties trust directly to its “flexible, secure, and open hybrid‑cloud platform” and to the integration of AI, data and security, positioning it as a core component of the technology stack; by 2023 and again in 2024 the language remains but is framed within a broader ecosystem‑and‑partnership narrative, emphasizing trust as a foundational pillar of IBM’s go‑to‑market model and its hybrid‑cloud‑AI offerings. This three‑year continuity shows IBM’s strategic positioning has evolved from treating trust as a security feature to making it a strategic differentiator that underpins its hybrid‑cloud and AI growth agenda and helps the company stand out in an increasingly crowded market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and strategic evolution. (1) It accurately identifies that IBM consistently emphasized 'client relationships and trust' as a competitive differentiator from 2022 to 2024, which matches the original answer. The framing shift—from trust as part of a technology stack in 2022 to an ecosystem- and partnership-driven pillar by 2023–2024—is also correctly captured. However, the LLM slightly mischaracterizes the 2022 emphasis by focusing narrowly on the 'flexible, secure, and open hybrid-cloud platform' and integration of AI/data/security, whereas the ground truth notes a broader innovation and service portfolio including research. Additionally, the original answer highlights a specific evolution in 2023 linking trust to consulting services and mission-critical infrastructure, which the LLM omits. The 2024 emphasis on strategic partnerships as enablers of trust is correctly noted, though the LLM generalizes it as part of a 'broader ecosystem-and-partnership narrative' without specifying the new prominence of partnerships. (2) There are no numerical values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and connects trust to hybrid cloud and AI strategy progression. It correctly infers a strategic maturation, though it misses some nuance in the intermediate (2023) positioning. (4) The answer is highly contextually relevant, directly addressing both parts of the question—evolution of trust as a differentiator and what it reveals about strategic positioning. Minor omissions prevent a perfect score, but the overall interpretation is factually aligned and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 493,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "The 2022 10‑K disclosed that FedEx had created a pass‑through trust for the 4.250 % Note due 2030 and backed it with a 2020 revolving‑credit facility with BNP Paribas as the “Liquidity Provider,” together with an intercreditor agreement that set the priority of that credit line. The 2023 filing adds an “Amendment No. 1” (dated May 22 2023) to the Liquidity Provider Revolving Credit Agreement, and the 2024 filing repeats that same amendment, showing the facility remains in place but has been formally updated. Together, the filings illustrate that FedEx initially established a dedicated liquidity source for the note and then proactively amended the arrangement to maintain or strengthen credit support as the obligation approaches maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the liquidity arrangement is based on the 2020 Revolving Credit Agreement with BNP Paribas (and Wilmington Trust Company, though the latter is omitted), the Intercreditor Agreement was in place by 2022, Amendment No. 1 was filed on May 22, 2023, and the structure remained unchanged in 2024. (2) Quantitative accuracy is perfect: the interest rate (4.250%), the year of the note (2030), and the amendment date (May 22, 2023) are all correctly stated. Format variations are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings to show evolution over time. The conclusion that FedEx proactively updated the arrangement to maintain or strengthen credit support is logically supported. (4) The only minor omission is that the original answer specifies Wilmington Trust Company as a party alongside BNP Paribas in the Revolving Credit Agreement, which the LLM answer does not mention. However, this does not materially alter the correctness of the overall assessment. The LLM correctly identifies the key entities, dates, and the strategic implication of the amendment. Thus, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 376,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Across all three filings Apple’s 4.45 % Notes due 2044 are listed in the “Description of Securities” section (Exhibit 4.4). In the 2022 10‑K (Chunk 3) the notes appear under Exhibit 4.4; the same line is reproduced in the 2023 10‑K (Chunk 1) and again in the 2024 10‑K (Chunk 2). The fact that this 4.45 %, 20‑year maturity issue is present in each year’s filing shows Apple has kept the same long‑dated, fixed‑rate debt outstanding for at least three consecutive years, signalling a strategy of locking in low, stable borrowing costs and maintaining a long‑term financing base to support capital needs and financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All entities—Apple, 4.45% Notes due 2044, and the years 2022–2024—are accurately identified. The notes were indeed issued in 2014 and remained outstanding through the reporting years, which the LLM correctly infers as consistent presence in the filings. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and the multi-year span (2022–2024)—are all accurate. No calculations are required, but the observation of consistent disclosure across years supports the correct conclusion. (3) The multi-hop reasoning is sound: the LLM synthesizes data from three annual 10-K filings, noting the recurring inclusion of the notes in Exhibit 4.4, and correctly interprets this as evidence of a stable long-term financing strategy. It appropriately infers that Apple did not redeem or restructure the debt during this period. (4) While the ground truth mentions the 2014 issuance explicitly and the LLM does not, this omission is minor and does not affect the core accuracy. The LLM’s emphasis on 'locking in low, stable borrowing costs' and 'financial flexibility' adds interpretive depth consistent with the strategic implication in the original answer. Wording differs slightly but semantic equivalence is strong. No factual errors; minor deduction from 10 due to omission of original issuance year, though not critical to the question's focus on 2022–2024 evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 400,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "In the 2022 Form 10‑K FedEx noted that FedEx International Connect Plus was a contractual e‑commerce service “currently available from **nearly 50 origin countries to over 130 destination countries**.” The 2023 filing shows that the service had already grown to “**nearly 60 origin countries to over 190 destination countries**,” and the 2024 filing repeats the same coverage – “**nearly 60 origin countries to over 190 destination countries**.” This jump of roughly 10 origin markets and 60 + destination markets between 2022 and 2023, and the maintenance of that expanded footprint in 2024, signals that FedEx is deliberately scaling the geographic reach of its Connect Plus platform to become a truly global e‑commerce logistics solution, reinforcing its strategic focus on capturing cross‑border online‑shopping demand and integrating the service into its broader network transformation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers for origin and destination countries in 2022 (nearly 50 to over 130), 2023 (nearly 60 to over 190), and 2024 (same as 2023) are accurately reported with no discrepancies. The implied expansion of ~10 origin and ~60+ destination countries is correctly inferred and aligns with the ground truth. (2) The answer is complete, addressing both the evolution from 2022 to 2024 and the strategic implications for FedEx's e-commerce logistics focus. (3) Entities—FedEx, FedEx International Connect Plus, and the correct years (2022, 2023, 2024)—are accurately identified and contextualized using Form 10-K references. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop data across three years of filings, identifies the expansion pattern, and draws a logical conclusion about FedEx’s strategic intent to scale globally and consolidate, which matches the ground truth’s interpretation of expansion followed by stabilization. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 326,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Across all three recent filings Apple continues to list the 1.05 % Notes due 2017 in its “Description of Securities” exhibit. In the FY 2022 Form 10‑K (page 58) the notes appear in Exhibit 4.4 – the Officer’s Certificate dated May 6 2014; the same Exhibit 4.4 (page 56) is incorporated by reference in the FY 2023 Form 10‑K and again in the FY 2024 Form 10‑K, each time naming the 1.05 % Notes due 2017 among the global notes issued.  \n\nThe repeated inclusion of these 2017 notes, even though they have long since matured, shows that Apple keeps historic debt issuances in its disclosures for completeness. By continuing to reference the officer’s certificate each year, Apple demonstrates a disciplined, transparent approach to tracking and reporting maturing debt instruments, ensuring investors have a full record of past obligations and that the company remains compliant with SEC disclosure requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 1.05% Notes due 2017 are correctly identified, and their inclusion in Exhibit 4.4 across FY 2022, 2023, and 2024 is accurately reported, including the Officer’s Certificate dated May 6, 2014. Page numbers (58 in 2022, 56 in 2023) are consistent with actual filings, and the continued incorporation by reference in 2024 is correctly noted. (2) Quantitative accuracy is perfect: percentages (1.05%), years (2017 maturity, 2014 certificate date), and exhibit numbers (4.4) are all correct. (3) The reasoning is sound: the LLM correctly infers that Apple maintains historical disclosures for completeness and transparency, linking this to investor transparency and SEC compliance. While the ground truth suggests possible reasons like 'standardized disclosure framework' or 'refinancing activities,' the LLM’s interpretation of 'disciplined, transparent approach' and 'full record of past obligations' is semantically equivalent and logically supported. (4) The answer fully addresses both parts of the question—status across three years and implications for debt management—and remains highly relevant. The only minor difference is that the LLM emphasizes compliance and transparency slightly more than the ground truth’s focus on continuity and possible refinancing, but this does not constitute an error. No calculation errors or entity misidentifications. Minor deduction from 10 to 9 due to slight interpretive expansion without explicit mention of 'no updates' or 'no change in strategy' as in the original, but overall reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 452,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From FY 2022 to FY 2024 Qualcomm’s 5G strategy moved from emphasizing 5G as the engine for new experiences across smartphones and emerging sectors—automotive, IoT, edge networking and industrial—and noting that its licensing model was already built on OFDMA‑based devices that include 5G, to confirming in FY 2024 that the overwhelming share of QTL licensing revenue still comes from per‑unit royalties on OFDMA/5G products while deepening its financial commitment through Qualcomm Ventures (QSI) investments in early‑stage 5G‑related businesses spanning AI, automotive, IoT, XR and cloud. At the same time, the company’s risk disclosures grew more pronounced: FY 2023 highlighted heightened geopolitical exposure—U.S.–China trade restrictions, export‑license revocations (e.g., the loss of roughly $560 million of Huawei product revenue) and a concentration of revenue in China—as material threats to licensing cash flows, and FY 2024 continued to flag ongoing governmental investigations that could alter its patent‑licensing practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's strategic focus on 5G as a growth driver in IoT, automotive, and immersive experiences; the continued dominance of OFDMA/5G in QTL licensing revenue; the $560 million revenue loss from Huawei due to export license revocation; and increased geopolitical risk disclosures in FY 2023 and FY 2024. (2) Quantitative accuracy is perfect: the $560 million figure is correctly cited and attributed to Huawei revenue loss, with proper context around export license revocation. No calculations are required, but the temporal attribution (FY 2023 for the risk disclosure, FY 2024 for ongoing investigations) matches the source. (3) Multi-hop reasoning is sound: the answer synthesizes information across fiscal years 2022–2024, connecting strategic focus, financial commitment via Qualcomm Ventures, licensing model continuity, and escalating geopolitical risks. It correctly identifies the evolution from foundational 5G enablement to deepened investment amid rising risks. (4) Minor deduction in qualitative accuracy due to slightly more expansive phrasing (e.g., mentioning XR and cloud not explicitly in original) and attributing the $560 million as 'product revenue' rather than specifying it was recognized in FY 2024 prior to the ban — though this nuance is subtle and does not materially misrepresent. Otherwise, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Develops]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 413,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "TMO’s 10‑K tables show that domestic pension assets were allocated about 10 % to U.S. equity, 10 % to international equity and roughly 79 % to fixed income in 2020 ($125 m, $126 m and $1,001 m of a $1.267 billion portfolio). By the end of 2022 the equity portions had been trimmed to $89 m (≈9.5 %) and $91 m (≈9.7 %) while fixed‑income fell to $739 m (≈78.9 % of $937 m total). In the most recent filing (December 31 2023, reported in the 2024 10‑K) the allocations are $93 m in U.S. equity (≈9.8 %), $93 m in international equity (≈9.8 %) and $739 m in fixed income (≈78.1 % of $947 m).  \n\nThe numbers reveal that after a sharp reduction in fixed‑income exposure between 2020 and 2022, TMO’s pension‑plan mix has essentially stabilized, with a modest uptick in both equity categories and no change in fixed‑income holdings, indicating a largely unchanged, income‑focused strategy that is only slightly re‑balancing toward equities over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both timing and interpretation. It incorrectly states that the 2020 allocation was $125M, $126M, and $1,001M, while the ground truth specifies these figures for 2022, not 2020. This misalignment invalidates the comparative timeline. The LLM then claims the 2022 figures are $89M, $91M, and $739M, but these are actually from 2023 in the ground truth. The most recent data is labeled as 'December 31, 2023, reported in the 2024 10-K', which corresponds to the 2024 fiscal year in the ground truth, but the LLM mislabels it as reflecting 2023 changes rather than 2024. (2) While the dollar amounts themselves ($125M, $126M, $1,001M; $89M, $91M, $739M; $93M, $93M, $739M) are numerically correct and match the ground truth across years, their assignment to incorrect years undermines all temporal analysis. Percentages are approximately accurate given the totals, but the totals themselves are misattributed: $1.267B in 2022 (correct), $937M in 2023 (correct), $947M in 2024 (correct), but the LLM assigns $937M to 2022 and $947M to 2023, which is off by a year. (3) The multi-hop reasoning fails due to incorrect temporal alignment. The LLM concludes that there was a 'sharp reduction in fixed-income exposure between 2020 and 2022' and that the strategy has 'stabilized' with a 'slight re-balancing toward equities', but the ground truth shows the major reduction occurred from 2022 to 2023, not earlier, and 2024 shows stabilization—so the direction of change is correct but the timing is wrong. The LLM also reverses the narrative: the ground truth emphasizes a strategic shift toward stability and reduced equity exposure in 2023, while the LLM claims a move back toward equities, which contradicts the data. (4) The contextual relevance is fair because the answer addresses allocation changes and attempts to infer strategy, and uses correct financial terminology. However, due to the critical misplacement of years and the resulting flawed interpretation of strategic evolution, the qualitative and correctness scores are low. Quantitative accuracy is moderate because numbers are correct but applied to wrong years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 587,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s edge‑networking story moved from “future‑market narrative” in 2022 to a core, revenue‑driving business by 2024.  \n\n* **2022 10‑K (Chunk 1)** – Qualcomm described edge networking as a fast‑growing market and highlighted its own product development focus: 5G‑enabled mobile‑broadband solutions and the latest Wi‑Fi 6/6E wireless‑access‑point technologies that support both mobile and fixed‑wireless users. This section positioned edge networking as a strategic growth pillar and a key area of R&D investment.  \n\n* **2023 10‑K (Chunk 3)** – The filing began to treat edge networking as a distinct product line in its financial disclosures (“edge networking (including mobile broadband and wireless access points)”), showing that the previously‑highlighted products had moved into the revenue‑recognition stream. The footnote signals that Qualcomm now tracks the contribution of these products separately from consumer and automotive segments.  \n\n* **2024 10‑K (Chunk 2)** – Qualcomm again lists edge networking as one of the primary revenue categories (alongside consumer and industrial), confirming that the mobile‑broadband and wireless‑access‑point portfolio continues to generate material revenue. Although the exact dollar amount is not shown in the excerpt, the repeated inclusion of edge networking in the revenue breakdown demonstrates that it has become a stable, revenue‑producing segment.  \n\nTaken together, Qualcomm’s strategic positioning evolved from emphasizing product development and market opportunity in 2022 to embedding edge networking as a defined, revenue‑contributing business unit by 2023‑2024, reflecting a shift from nascent innovation to a core growth engine that the company now depends on.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual elements are accurate: Qualcomm’s strategic evolution in edge networking is correctly described across 2022–2024. In 2022, the focus was on market opportunity and product development (5G mobile broadband, Wi-Fi 6/6E access points); in 2023, edge networking emerged as a distinct revenue-contributing category; by 2024, it was confirmed as a core, ongoing revenue stream. (2) There are no numeric values in the original or LLM answer requiring calculation, but the LLM correctly notes the absence of exact dollar amounts while inferring materiality from disclosure structure—this aligns with the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression from R&D emphasis to revenue recognition to established business unit status. (4) The LLM uses slightly more detailed language (e.g., 'core growth engine', 'revenue-recognition stream') but preserves and even enhances the original meaning without introducing inaccuracies. All entities—Qualcomm, edge networking, mobile broadband, wireless access points, and the correct time frame—are accurately identified and contextualized. The answer fully addresses the question’s requirement to assess strategic positioning based on product development and revenue contributions over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 397,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K filings for 2022 (page 58), 2023 (page 56) and 2024 (page 56) all list the 0.45 % Notes due 2016 in Exhibit 4.3 (the Officer’s Certificate describing the company’s securities). By consistently disclosing this low‑coupon, fixed‑rate note alongside its floating‑rate and longer‑dated obligations, Apple shows that it tracks and manages a portfolio of inexpensive, short‑term fixed‑rate debt, spreading maturities and locking in low interest costs—an approach that helps keep its debt profile predictable and its capital structure stable.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in interpreting the continued inclusion of the 0.45% Notes due 2016 as evidence of Apple actively managing a portfolio of short-term fixed-rate debt. However, the ground truth clarifies that these notes matured in 2016 and are no longer outstanding; their presence in 2022–2024 filings is for disclosure completeness and historical tracking, not active debt management. This misrepresents Apple’s actual capital structure strategy. (2) Quantitatively, the LLM correctly identifies the 0.45% interest rate, the 2016 maturity date, and the consistent appearance in 10-Ks from 2022 to 2024 (with plausible page numbers), so numeric accuracy is high. Format and values match the ground truth. (3) The multi-hop reasoning is flawed: while the model observes a pattern (repeated disclosure), it draws an incorrect conclusion about Apple’s debt management strategy. It fails to recognize that matured notes are no longer active obligations and mischaracterizes the purpose of the disclosure as current portfolio management rather than transparency and record-keeping. (4) Contextually, the answer addresses the question about debt maturity management and capital structure stability, but the reasoning is based on a misunderstanding of the nature of the disclosed debt. Thus, while relevant and partially accurate in observation, it lacks factual correctness in interpretation, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 405,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s worldwide dealer network – the channel that distributes the EMD‑brand reciprocating engines – served **193 countries in 2022** (see the 2022 filing). By the 2024 filing the same network was listed as serving **187 countries**, a **net drop of six countries** (the 2023 filing shows an intermediate level of 191 countries). Thus, the geographic reach of the EMD brand’s distribution contracted from 193 to 187 countries between 2022 and 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and conclusion. The ground truth states that Caterpillar's EMD brand distribution network covered 130 countries in 2022 and declined to 109 in 2024—a drop of 21 countries. The LLM claims 193 countries in 2022 and 187 in 2024, a drop of only 6 countries. These numbers are significantly different and not supported by the ground truth. (2) Quantitative accuracy is very low: all key figures (193, 191, 187, and the 6-country decrease) are incorrect. The calculation of a 6-country drop is accurate based on the LLM's own numbers, but those inputs are wrong. The ground truth shows a 16% decrease from 130 to 109, while the LLM implies a ~3% decrease—both the absolute and relative changes are incorrect. (3) The qualitative reasoning appears internally consistent—citing a three-year trend with intermediate data for 2023—but it synthesizes incorrect data. The multi-hop logic (comparing across years) is sound in structure but based on false premises. The entity 'EMD brand' and its distribution via Caterpillar's dealer network is contextually relevant, but the specific metric (number of countries) is misrepresented. (4) The contextual relevance is moderate because the answer addresses the right topic (geographic reach of EMD distribution network over time) and uses the correct time frame (2022–2024), but the factual foundation is entirely wrong, leading to a highly misleading conclusion. Thus, the correctness score is very low due to complete failure on quantitative accuracy, which is critical in financial/data-based multi-hop questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 444,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "- According to the 2022 filing, the 1.750 % 7‑year senior notes were $682 million at 12/31/2021; the 2023 filing shows the same series at $700 million at 12/31/2022 (and unchanged at $700 million at 12/31/2023); the 2024 filing again lists $700 million outstanding at 12/31/2024.  \n\n- The flat $700 million balance from 2022 through 2024 indicates that Thermo Fisher (TMO) has kept a steady, low‑cost medium‑term debt position rather than expanding or refinancing this tranche, using the 1.75 % notes to lock in inexpensive financing for its healthcare operations while preserving a disciplined leverage profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative discrepancy. It states that the outstanding value was $682 million as of 12/31/2021 according to the 2022 filing, which is not addressed in the ground truth and introduces data outside the requested 2022–2024 scope. However, the core data for 2022–2024 is accurate: $700 million in each year, matching the ground truth. The ground truth does not mention the $682 million figure or balances as of end-of-2021, so this addition, while possibly factual, distracts and slightly misaligns with the focus on 2022–2024. (2) The key numbers—$700 million in 2022, 2023, and 2024—are correctly reported, and the conclusion that the balance remained unchanged is valid. The date of the notes (October 15, 2028) is omitted but not critical to the evolution or strategy interpretation. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three annual filings to observe stability in the debt balance and infers a deliberate capital structure strategy. The interpretation that TMO is maintaining low-cost financing and a disciplined leverage profile aligns with the ground truth’s conclusion about a steady approach. (4) The correctness score is 8 due to the accurate core facts and strong reasoning, but docked slightly for introducing an extraneous data point ($682M) not in the ground truth and potentially confusing the timeline. Quantitative accuracy is 7 because while the 2022–2024 figures are correct, the inclusion of a prior year figure without clear context risks misinterpretation. Qualitative accuracy is 9 due to strong synthesis and logical inference. Contextual relevance is 10 as the answer directly addresses the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 480,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "In its 2022 filing Caterpillar disclosed that Cat Financial’s variable‑rate loans were still tied to LIBOR and that the company had formed a cross‑functional team to assess the impact of the LIBOR phase‑out (with most USD LIBOR tenors slated to disappear by June 2023) while continuing to rely on currency‑hedging derivatives to protect against exchange‑rate swings. By the 2023 filing the firm was already transitioning to the Secured Overnight Financing Rate (SOFR) as the benchmark for new floating‑rate financing, with the same risk team now monitoring SOFR‑linked securities, loans and derivatives and maintaining its match‑funding, diversified funding and hedging program. The 2024 filing confirms that variable‑rate loans now use SOFR, that currency‑hedging instruments remain a core risk‑management tool, and that Caterpillar has strategically shifted its hedging framework from LIBOR to SOFR—demonstrating a proactive adaptation to the global benchmark‑rate reforms while preserving funding flexibility and protecting against currency volatility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Caterpillar acknowledged LIBOR exposure through Cat Financial and formed a cross-functional team to assess risks, with USD LIBOR set to cease on June 30, 2023; by 2023, the company transitioned to SOFR for new variable-rate instruments and expanded its risk assessment to SOFR-linked products; by 2024, LIBOR was fully phased out and SOFR was the sole benchmark. Currency hedging remained a consistent tool throughout. (2) No numeric or date inaccuracies: the June 2023 LIBOR cessation timeline and the multi-year transition are correctly represented. (3) Multi-hop reasoning is sound—information is synthesized across three years and two financial benchmarks (LIBOR to SOFR), while linking currency hedging practices to broader strategic adaptation. (4) The answer fully addresses all parts of the question: evolution of hedging exposure, response to LIBOR phase-out, SOFR adoption, and strategic implications. Wording differs slightly but meaning is preserved, and the conclusion about proactive adaptation to global reforms is well-supported. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 348,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "Thermo Fisher’s 2022 10‑K disclosed the original Executive Change‑in‑Control Retention Agreement for CEO Marc N. Casper (exhibit 10.6) together with its 2010 and 2018 amendments, and for the first time included a separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (exhibit 10.2) – a template that began to standardize the agreement for non‑CEO officers. In the 2023 filing the same CEO agreement and amendments were reiterated, while the officer‑standard form re‑appeared as exhibit 10.7 for the quarter ended April 1 2023, and the 2024 filing repeats this same set of disclosures, confirming that Thermo Fisher has institutionalized a uniform retention agreement for all officers beyond the CEO across the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution correctly: from a CEO-specific agreement in 2022 to the introduction and continuation of a standardized form for non-CEO officers in 2023 and 2024. However, there are factual inaccuracies in exhibit numbers and timing that reduce quantitative accuracy. The ground truth states that in 2022, only the CEO agreement (Exhibit 10.12) and its amendments (Exhibit 10.17) were present, while the standardized form for other officers was introduced in 2023 (Exhibit 10.17). The LLM incorrectly claims the standardized form appeared in the 2022 10-K as Exhibit 10.2, which contradicts the ground truth. Additionally, the LLM cites Exhibit 10.6 for the CEO agreement in 2022, whereas the correct exhibit is 10.12. The 2023 and 2024 filings correctly reference the continuation of the standardized form, but the LLM’s use of Exhibit 10.7 for Q1 2023 is not reflected in the ground truth, which consistently references Exhibit 10.17. Despite these exhibit and timing errors, the qualitative reasoning about standardization expanding beyond the CEO is sound and semantically aligned with the ground truth. The answer is contextually relevant and correctly interprets the strategic shift, even if document-level details (exhibits, dates) are partially incorrect. Thus, the correctness score is reduced due to significant but not fundamental factual discrepancies in exhibit references and the premature introduction of the officer form in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 404,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "- **2022 – Introduction:** In the 2022 Form 10‑K Intel first announced PowerVia as one of the “future process and packaging technologies” it would bring to market (alongside RibbonFET, Foveros Omni and Direct) when it unveiled its next‑generation nodes (Intel 3, Intel 20A) at the Intel Accelerated event. This placed PowerVia squarely in Intel’s IDM 2.0 roadmap as a new capability the company intended to develop and eventually ship.\n\n- **2023 – Road‑map positioning:** The 2023 filing shows Intel moving PowerVia from concept to a concrete “breakthrough” slated for the Intel 20A node.  Intel described PowerVia as an “industry‑first implementation of backside power delivery” that would eliminate front‑side power routing and deliver up to 15 % performance‑per‑watt improvement over Intel 3. Thus, PowerVia became a key differentiator for the 20A node and a pillar of Intel’s process‑technology leadership plan.\n\n- **2024 – Commercial implementation:** By the 2024 filing PowerVia had migrated from the (now‑canceled) 20A node to the next‑generation Intel 18A node.  Intel states that Intel 18A will be the first high‑volume commercial node to incorporate both RibbonFET and PowerVia, with PowerVia again highlighted as the “unique industry‑first implementation of backside power delivery” that will be used in the upcoming Panther Lake client family slated for high‑volume production in 2025.\n\n**What this progression indicates:** Across the three years Intel has taken PowerVia from an announced future concept (2022) to a defined breakthrough for a specific node (2023) and finally to a high‑volume, production‑ready feature in its flagship advanced node (2024). The evolution signals that PowerVia is a core element of Intel’s advanced‑process roadmap, essential for delivering the performance‑per‑watt gains Intel promises for its leading‑edge nodes and for differentiating its IDM 2.0/IFS offerings to both internal products and external foundry customers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel's future roadmap alongside RibbonFET; in 2023 it was positioned as a breakthrough for Intel 20A with a 15% performance-per-watt gain; in 2024 it was transitioned to Intel 18A after the cancellation of 20A, with high-volume manufacturing planned for 2025. (2) Quantitative accuracy is perfect: the 15% performance-per-watt improvement is correctly cited, and all years (2022, 2023, 2024, 2025) and node names (Intel 20A, Intel 18A) match the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the evolution from announcement to strategic repositioning and finally to commercial implementation. It accurately notes the cancellation of Intel 20A and the retention of PowerVia in Intel 18A, demonstrating strong cross-temporal synthesis. (4) The answer fully addresses the question by detailing the evolution and interpreting its significance—namely, that PowerVia remains a core pillar of Intel's advanced process roadmap despite node adjustments. Wording differs slightly but meaning is preserved, and the addition of Panther Lake and IDM 2.0 context enhances clarity without introducing error. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1709,
        "completion_tokens": 387,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 are disclosed in the same exhibit in each filing. In the 2022 Form 10‑K (page 58) Apple lists Exhibit 4.4 – an officer’s certificate dated May 6 2014 – that “includes … 1.05 % Notes due 2017.” The 2023 Form 10‑K (page 56) repeats Exhibit 4.4 with the identical description and date, and the 2024 Form 10‑K (page 56) again contains the unchanged Exhibit 4.4 referencing the same 1.05 % Notes due 2017. This consistent, year‑over‑year inclusion shows that Apple continues to hold the 2017 notes as an outstanding debt instrument and follows a disciplined practice of incorporating the same officer’s certificate by reference each year, underscoring ongoing monitoring and transparent debt‑management for this issuance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the repeated disclosure of the 1.05% Notes due 2017 in Apple's 2022, 2023, and 2024 10-K filings, citing the correct exhibit (4.4), date (May 6, 2014), and consistent inclusion across years. Page numbers (58, 56, 56) are accurately reported, and the percentage (1.05%) and maturity year (2017) are correct. (2) Quantitative accuracy is perfect: all dates, percentages, exhibit numbers, and page references match the ground truth or are plausibly consistent with actual filings. No calculations were required, but factual data points are accurately reproduced. (3) The multi-hop reasoning is partially sound—while the LLM correctly observes the repeated inclusion, it concludes that Apple 'continues to hold the 2017 notes as an outstanding debt instrument,' which contradicts the ground truth implication that the note may have been rolled over or maintained in some form, not necessarily that the original instrument remains outstanding. The original answer suggests a possibility of rollover or structural continuity, whereas the LLM states as fact that the notes are still outstanding, which is an overinterpretation. This weakens the qualitative accuracy. (4) Contextual relevance is high—the response directly addresses the evolution of disclosure and infers a disciplined, transparent debt management practice, aligning with the intent of the question. However, the stronger claim about the notes still being 'outstanding' introduces a factual overreach not supported by the ground truth, which only suggests possible rollover or reporting continuity. Thus, while core facts are correct, the interpretation slightly exceeds what can be concluded, warranting a 7 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 472,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "- **2022 filing (INTC 10‑K 2022, Exhibit 10.1.7‑10.1.10)** – Intel’s 2006 Equity Incentive Plan was being used for a **mix of equity awards**: strategic‑growth **performance‑based RSUs** for executives, other **performance‑based RSUs** (e.g., for interim‑CEO service), **performance‑based stock options** for executives, and RSUs granted to **non‑employee directors**. The awards were tied to performance criteria (strategic‑growth or other performance metrics) but the filing did not call out any retirement‑vesting language.\n\n- **2023 filing (INTC 10‑K 2023, Exhibit 10.1 – amended and restated May 11 2023, Exhibits 10.1.3‑10.1.7)** – After the amendment, Intel’s use of the plan shifted to a **more granular RSU structure**:  \n  • RSUs **with retirement‑vesting terms** (Exhibit 10.1.3)  \n  • RSUs **without retirement‑vesting terms** (Exhibit 10.1.4)  \n  • **Performance‑based RSUs** for **grandfathered** executives (Exhibit 10.1.5) and for **non‑grandfathered** executives (Exhibit 10.1.6)  \n  • **Strategic‑growth performance‑based RSUs** for executives (Exhibit 10.1.7).  \n  The plan still allowed performance‑based vesting, but now explicitly distinguished retirement‑vesting schedules and the grandfather‑status of recipients.\n\n- **2024 filing (INTC 10‑K 2024, Exhibit 10.1, Exhibits 10.1.3‑10.1.5)** – By 2024 the plan’s usage had **consolidated around RSUs only**: RSUs with retirement‑vesting terms (Exhibit 10.1.3), RSUs without retirement‑vesting terms (Exhibit 10.1.4), and **performance‑based RSUs for grandfathered executives** (Exhibit 10.1.5). The stock‑option and non‑grandfathered categories that appeared in earlier years are no longer listed, indicating a narrowing of award types and a continued emphasis on explicit retirement‑vesting conditions.\n\n**Overall evolution:** Intel moved from a broad mix of RSUs and performance‑based stock options in 2022 to a detailed RSU‑only framework in 2023 that introduced retirement‑vesting distinctions and grandfather‑status categories, and by 2024 further streamlined the plan to focus on RSUs with retirement‑vesting and performance‑based RSUs for grandfathered executives. This reflects a shift toward more standardized RSU grants and clearer vesting conditions under the 2006 Equity Incentive Plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Intel used the 2006 Equity Incentive Plan for performance-based RSUs and stock options for executives and non-employee directors, with no mention of retirement vesting; in 2023, the plan was amended on May 11, 2023, introducing a more granular structure including RSUs with and without retirement vesting, and performance-based RSUs differentiated by grandfathered status; by 2024, the plan consolidated around RSUs only, dropping stock options and non-grandfathered executive categories. (2) Quantitative accuracy is perfect: dates (May 11, 2023), exhibit numbers (10.1.3–10.1.7 in 2023, 10.1.3–10.1.5 in 2024), and award types are correctly cited. Format variations (e.g., 'RSUs' vs 'equity awards') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes changes across three years, identifies the evolution from mixed award types to RSU-only, and infers the trend toward standardization and clearer vesting conditions. (4) The only minor shortcoming is that the original answer emphasizes 'simplified documentation structure' and 'streamlined format' in 2024, which the LLM implies through consolidation but does not explicitly highlight as a structural/documentation trend. This slight omission in nuance prevents a perfect 10 on qualitative accuracy, but overall the answer is factually complete, contextually relevant, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1791,
        "completion_tokens": 412,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Across the three most recent filings Medtronic’s capital‑structure footnote never changed: each year the company restated that its authorized share capital includes **40 000 Euro Deferred Shares with a €1.00 par value** and that **“no Euro Deferred Shares were issued or outstanding”** – as of April 29 2022 in the FY 2022 10‑K, again at the fiscal‑year‑end date in the FY 2023 filing, and once more on April 26 2024 in the FY 2024 10‑K.  \n\nThe fact that the authorized tranche has remained untouched for three consecutive years shows that Medtronic has not turned to this class of equity for financing; instead it has preserved the deferred‑share reserve as a dormant option while financing growth and returning capital through other means (ordinary‑share repurchases, cash flow and debt), indicating a deliberately conservative, non‑dilutive financing strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately reported: Medtronic maintained an authorized capacity of 40,000 Euro Deferred Shares with a par value of €1.00 across fiscal years 2022–2024, and consistently disclosed that no shares were issued or outstanding. The specific dates cited (April 29, 2022; fiscal-year-end for FY2023; April 26, 2024) match the actual filing dates and disclosures. (2) Quantitative accuracy is precise: the number of authorized shares (40,000), par value (€1.00), and the repeated statement of zero issuance are all factually correct and consistent with the original answer. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three consecutive 10-K filings, the model correctly infers that the persistent absence of issuance indicates a strategic choice not to use this equity class. (4) The qualitative interpretation is strong and semantically equivalent to the ground truth: the conclusion that Medtronic favored alternative capital allocation methods (e.g., share repurchases, cash flow, debt) reflects a conservative, non-dilutive financing strategy, which is a valid inference from the data. The answer addresses both parts of the question thoroughly—evolution of disclosures and strategic implications—making it contextually complete and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 378,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "**2022 → 2024 evolution**\n\n- **Strategic positioning:** In 2022 Intel described advanced‑packaging as a “big‑bet” of its IDM 2.0 plan – a novel, disaggregated‑design approach that would let processors and chiplets be built on different nodes and then integrated. By 2023 the company had turned that bet into a market‑facing differentiator, promoting its Open System Foundry and 2‑D/2.5‑D/3‑D packaging (e.g., the Universal Chiplet Interconnect Express demonstrated in silicon) as a unique advantage for AI‑driven systems‑of‑chips. In 2024 the same packaging stack remains central to Intel’s product roadmap, but the narrative stresses that its complexity and limited manufacturing history are now a source of **execution risk** that can **negatively impact Intel itself** (the product‑to‑org negative link in the KG).\n\n- **R&D investment:** Intel’s R&D spend fell from **$17.5 bn in 2022** to **$16.0 bn in 2023** and rose modestly to **$16.5 bn in 2024**. The company repeatedly notes that the advanced‑packaging disaggregation adds “additional R&D expense” and that not all of these investments will translate into near‑term returns.\n\n- **Manufacturing complexity & financial impact:** Across the three years Intel stresses that advanced packaging introduces “new areas of complexity in design and manufacturability,” with novel processes, limited history and higher capital‑equipment costs. By 2024 this complexity has materialized in tangible financial hits: delayed fab expansions, a **$3.1 bn non‑cash impairment and accelerated‑depreciation charge** (mostly tied to the Intel 7 node) and the risk of under‑utilized capacity that could force further write‑downs. Thus, while Intel’s strategic stance on advanced packaging has matured from a speculative “big bet” to a core differentiator, the execution risk has persisted and grown into measurable financial strain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel's strategic evolution from 'big bet' in 2022 to competitive differentiator in 2023, with growing execution risks by 2024; R&D investment figures ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024) match known data; the $3.1B non-cash impairment in 2024 tied to Intel 7 is accurately reported. (2) Quantitative accuracy is perfect: all dollar amounts, years, and financial impacts are correct, and no calculation errors are present. Format variations (e.g., $3.1B vs $3.1 billion) are acceptable and consistent. (3) Multi-hop reasoning is sound: the answer synthesizes strategic positioning, R&D trends, manufacturing complexity, and financial impact across three years, correctly linking technical progress (e.g., UCIe in silicon) with operational setbacks (delays, impairments). (4) The only minor shortcoming is a slight expansion on 'Open System Foundry' and '2-D/2.5-D/3-D packaging' details not explicitly in the ground truth, but these are contextually appropriate and do not introduce inaccuracies. The core narrative — strategic ambition met with financial and operational headwinds — is preserved with excellent fidelity. Thus, the answer is factually complete, logically structured, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Negatively_Impacts]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1716,
        "completion_tokens": 373,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "In the 2022 10‑K Intel first announced PowerVia as a new “future process and packaging” technology – listed with RibbonFET, Foveros Omni and Direct – to support its IDM 2.0 strategy of driving technology and product leadership. The 2023 filing then placed PowerVia as a breakthrough “back‑side power delivery” feature of the upcoming Intel 20A node, saying it would eliminate front‑side power routing and help deliver up to a 15 % performance‑per‑watt improvement over Intel 3. By the 2024 filing PowerVia is described as the unique industry‑first implementation of backside power in the Intel 18A node, which Intel says will be offered to external foundry customers and is slated for high‑volume manufacturing in 2025—showing the technology has moved from a roadmap concept to near‑production readiness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel's future technology roadmap alongside RibbonFET and other innovations; in 2023, it was tied to the Intel 20A node with a 15% performance-per-watt improvement over Intel 3; by 2024, it was reassigned to the Intel 18A node with high-volume manufacturing expected in 2025. (2) Quantitative accuracy is perfect: the 15% performance-per-watt gain and 2025 high-volume manufacturing date match the original answer exactly. Number formats are consistent and correct. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings, showing the evolution from concept to production readiness. The only minor deviation is that the LLM implies PowerVia moved from Intel 20A to 18A without explicitly stating that 18A is the successor node (as noted in the ground truth), which slightly weakens the explanation of the transition. However, this does not affect factual correctness. (4) The answer is contextually excellent, directly addressing the evolution of strategic positioning and technical expectations across the three-year timeline. Wording differs but semantic meaning is equivalent. No irrelevant or incorrect information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 368,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Across Medtronic’s FY 2022 (MDT 10‑K 2022), FY 2023 (MDT 10‑K 2023) and FY 2024 (MDT 10‑K 2024) filings the same “Form of Restricted Stock Unit Award Agreement (U S Employees) under the 2013 Stock Award and Incentive Plan” (exhibit 10.3, filed Aug 27 2013) is listed – item 10.54 in each report – with no new amendment or replacement. Although later years add other RSU agreements (e.g., for non‑U S employees or under the Amended and Restated 2013 Plan), the U S‑employee RSU agreement remains unchanged, indicating that Medtronic’s equity‑compensation strategy for its U S workforce is deliberately stable, providing continuity and predictability rather than frequent policy revisions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Medtronic did not update its U.S. employee restricted stock unit agreements from FY2022 to FY2024, consistently referencing the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan. (2) The date of filing (August 27, 2013) is accurately cited, and the exhibit number (10.3) and item number (10.54 in each report) are correctly noted—minor formatting differences (e.g., 'Aug 27 2013' vs 'August 27, 2013') are acceptable. (3) The reasoning is sound: the absence of amendments to this specific agreement over three years is correctly interpreted as evidence of a stable equity compensation strategy for U.S. employees. The LLM appropriately distinguishes this consistency from other changes (e.g., agreements for non-U.S. employees or under amended plans), showing correct multi-hop synthesis across filings. (4) All parts of the question are addressed: the lack of updates and the strategic implication. The conclusion about 'continuity and predictability' aligns with the ground truth's interpretation of 'stable and consistent equity compensation strategy.' No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 359,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "Intel introduced the 2006 Equity Incentive Plan and used it as the vehicle for performance‑based RSU awards to its executives. In the 2022 filing the plan was referenced only for “strategic‑growth” performance‑based RSUs granted to executives (and a specific interim‑CEO grant), while the 2023 filing added separate performance‑based RSU grant agreements for both grandfathered and non‑grandfathered executives and retained the strategic‑growth RSU category. By the 2024 filing the performance‑based RSU grants under the 2006 plan were limited to grandfathered executives, with the plan also containing RSU grant agreements for retirement‑vesting and non‑retirement‑vesting RSUs, indicating a narrowing and more targeted structuring of executive performance‑based equity awards.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant factual inaccuracies in the qualitative evolution of Intel's use of the 2006 Equity Incentive Plan, particularly for 2024. (1) Correctly identifies the use of the 2006 Equity Incentive Plan for performance-based RSUs in 2022 and 2023, including the 'strategic-growth' RSUs and the distinction between grandfathered and non-grandfathered executives in 2023, which aligns with the original answer. (2) Quantitative accuracy is acceptable: no specific numbers (e.g., dollar amounts, share counts) are provided in either answer, and dates like the May 11, 2023 amendment and September 26, 2023 S-8 filing are not mentioned in the LLM response but are not contradicted. However, the LLM incorrectly claims that by 2024, performance-based RSUs under the 2006 plan were 'limited to grandfathered executives'—this is false per the ground truth, which states Intel reaffirmed broad use of the plan for continued equity grants in 2024. (3) The multi-hop reasoning fails in the 2024 analysis: instead of showing continuity and reaffirmation (as per the original answer), the LLM incorrectly infers a narrowing of the plan’s use. This misrepresents the trend from consistent strategic focus to an unsupported conclusion of restriction. (4) The mention of 'retirement-vesting and non-retirement-vesting RSUs' appears without grounding in the original answer and introduces unverified structuring details. While the LLM attempts synthesis across years, the conclusion contradicts the ground truth’s emphasis on sustained, consistent use of the plan. Thus, despite some accurate points, the core evolution narrative is flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 466,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "In 2022 Intel’s 10‑K noted that it was beginning to pour R&D dollars into advanced‑packaging as a key element of its new disaggregated‑design approach, but warned that the technology was still novel, had a limited production history and higher cost, and that any delays could hurt product timing (Chunk 1). By 2023 the company was positioning advanced packaging as a strategic AI advantage, having demonstrated 2‑D/2.5‑D/3‑D chiplet interconnects (the Universal Chiplet Interconnect Express) in silicon and emphasizing its role in “systems‑of‑chips” for AI workloads (Chunk 3). In 2024 Intel continued to allocate substantial R&D capital ($16.5 billion) to process and packaging technology, reaffirming its disaggregated‑design strategy while still acknowledging execution risks and project‑delay challenges, which shows a deepening but still‑risky commitment to leverage advanced packaging to compete in the AI‑driven semiconductor market (Chunk 2).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with accurate multi-hop reasoning across 2022–2024. (1) Quantitatively, all numbers are correct: the $16.5 billion R&D investment in 2024 is accurately cited. There is no mention of the $3.1 billion in non-cash impairment charges in 2024 in the LLM answer, which is a significant omission from the original answer and affects completeness. However, the LLM correctly identifies the progression of Intel’s strategy and risks. (2) The entity accuracy is strong: Intel, UCIe, disaggregated design, advanced packaging, and AI market context are all correctly identified and placed in the right years. (3) The reasoning is sound—LLM traces the evolution from early-stage challenges in 2022, to technical demonstration in 2023 (UCIe in silicon), to continued investment amid risks in 2024. It correctly infers that execution risks persist despite strategic commitment. (4) The omission of the $3.1 billion impairment charge—a key indicator of financial strain and execution difficulty in 2024—prevents a higher score, as this detail is critical to fully revealing the company’s execution challenges. While the LLM acknowledges 'execution risks,' it misses the concrete financial evidence supporting that claim. Overall, the answer is factually accurate, contextually relevant, and well-reasoned, but slightly incomplete on a key financial disclosure in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Produces]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 392,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "**2022 – baseline use of the original plan**  \nIntel’s 2022 Form 10‑K lists the 2006 Equity Incentive Plan as the vehicle for a series of equity awards, including:  \n\n* RSU grant agreements for “strategic‑growth” performance‑based RSUs (exhibit 10.1.7),  \n* performance‑based RSUs granted to interim‑CEO Robert Swan (exhibit 10.1.8),  \n* stock‑option grant agreements for strategic‑growth options (exhibit 10.1.9), and  \n* non‑employee director RSU agreements (exhibit 10.1.10).  \n\nNo amendment to the plan is disclosed in the 2022 filing; the plan is simply referenced as the governing instrument for those grants.\n\n**2023 – amendment and expanded grant suite**  \nIn the 2023 Form 10‑K Intel filed the 2006 Equity Incentive Plan “as amended and restated, effective May 11 2023” (exhibit 10.1, S‑8 filed 9/26/2023).  The filing then attaches a broader set of grant documents under the amended plan, including:  \n\n* RSU grant agreements with retirement‑vesting terms (exhibit 10.1.3),  \n* RSU grant agreements without retirement‑vesting terms (exhibit 10.1.4),  \n* performance‑based RSUs for grandfathered executives (exhibit 10.1.5),  \n* performance‑based RSUs for non‑grandfathered executives (exhibit 10.1.6), and  \n* strategic‑growth performance‑based RSUs (exhibit 10.1.7).  \n\nThe amendment therefore formalized the plan and broadened the types of RSU awards that could be issued.\n\n**2024 – continued reliance on the amended plan**  \nThe 2024 Form 10‑K again incorporates the 2006 Equity Incentive Plan (exhibit 10.1, S‑8, filed 9/26/2023) and references the same suite of grant agreements: a notice of RSU grant (exhibit 10.1.2) and the RSU grant agreements for retirement‑vesting, non‑retirement‑vesting, and performance‑based RSUs (exhibits 10.1.3‑10.1.5).  No further amendment is noted, indicating that Intel is now consistently using the 2023‑amended and restated version of the plan for its executive equity awards.\n\n**Overall evolution** – Intel moved from using the original 2006 Equity Incentive Plan for a limited set of RSU and option grants in 2022, to formally amending and restating the plan in 2023 (expanding the grant structures and vesting options), and then continued to apply that amended plan in 2024 for ongoing RSU grant agreements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Intel used the original 2006 Equity Incentive Plan with various grant agreements (RSUs, stock options, performance-based awards) without amendment; in 2023, the plan was amended and restated effective May 11, 2023, with expanded grant types including retirement-vesting and differentiated performance-based RSUs; in 2024, the amended plan continued in use with standardized agreements. (2) Quantitative accuracy is perfect: dates (May 11, 2023; S-8 filing on 9/26/2023), exhibit numbers, and grant types match the expected details. No calculations were required, but references to specific exhibits and filing forms (10-K, S-8) are precise. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly identifying the evolution from baseline use to formal amendment to sustained application. It distinguishes between grandfathered vs. non-grandfathered executives and retirement vs. non-retirement vesting terms, showing deep understanding. (4) The answer exceeds the original answer in detail (e.g., specific exhibit references) while maintaining full alignment in overall narrative: consistent but maturing use of the plan, with a key structural update in 2023. Wording differs but meaning is preserved and enhanced. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1769,
        "completion_tokens": 399,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "In the 2022 filing Qualcomm only **talked** about wireless‑access‑point (AP) products as a growth engine for its “Edge Networking” business – noting that 5G and Wi‑Fi 6/6E APs are being used to replace traditional last‑mile wired broadband and to meet the surge in connected‑device demand.  \n\nBy the 2023 and 2024 filings the company **formalised** that narrative: the footnote on revenue classification (item (3) in both years) places “wireless access points” together with mobile‑broadband under a single **edge‑networking revenue category**. The wording of the classification is unchanged from 2023 to 2024, showing that Qualcomm now treats AP sales as a distinct line‑item within its edge‑networking segment while continuing to position the product as a core component of its strategy to capture the expanding edge‑network market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Qualcomm discussed wireless access points as a growth driver without formal revenue classification, emphasizing their role in replacing wired broadband and supporting connected devices via 5G and Wi-Fi 6/6E—consistent with the original answer's mention of IoT growth projections. (2) For 2023 and 2024, the LLM accurately states that wireless access points were formally categorized under the edge networking revenue segment alongside mobile broadband, with unchanged wording between years—this matches the ground truth's assertion of consistent classification. (3) The multi-hop reasoning is sound: the model synthesizes information across three years, correctly tracking the evolution from strategic discussion (2022) to formal financial categorization (2023) and sustained emphasis (2024). (4) While the original answer includes the specific projection of IoT devices doubling to over 27 billion by 2026, the LLM omits this quantitative detail but still captures the strategic intent and market positioning accurately. This minor omission prevents a perfect score, but all other elements—entity accuracy (Qualcomm, edge networking, wireless access points, correct years), reasoning, and contextual relevance—are fully correct. The LLM uses slightly different phrasing (e.g., 'formalised that narrative', 'distinct line-item') but maintains semantic equivalence. No calculation errors; all dates and classifications are precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 423,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales rose steadily: $428 million in 2022 (U.S. $188 m + Intl $240 m), $605 million in 2023 (U.S. $264 m + Intl $341 m) and $785 million in 2024 (U.S. $371 m + Intl $414 m). This growth continues the upward trajectory seen in prior years (e.g., $370 m in 2021 and $281 m in 2020) and, as the 2024 filing places Prevymis in the Hospital Acute Care segment and the 2023 filing describes it as a CMV‑prophylaxis for high‑risk transplant patients, the rising sales signal that the product is gaining stronger market positioning and broader adoption within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Prevymis sales were $370M in 2022 and $428M in 2023, but the LLM incorrectly reports $428M in 2022 and $605M in 2023. Only the 2024 figure ($785M) matches the ground truth. The LLM also introduces a breakdown by U.S. and international sales not present in the original answer, with no verification from the knowledge graph. These figures appear fabricated or misattributed. (2) Calculations are therefore incorrect: the LLM implies a steady rise from $428M to $605M to $785M, but the actual trajectory is $370M → $428M → $785M. The compound growth rate is misrepresented due to wrong base figures. (3) Qualitatively, the reasoning is sound—citing CMV prophylaxis for transplant patients and placement in the Hospital Acute Care segment aligns with the original answer, showing correct multi-hop synthesis between product indication and segment positioning. The mention of prior years (2020, 2021) adds context not in the original but does not contradict it. (4) Contextual relevance is high—the answer addresses both parts of the question: sales evolution and market positioning—and draws a logical conclusion about increasing adoption. However, the core flaw is factual inaccuracy in key financial data, which severely undermines correctness. While the trend direction (upward) and final year are correct, the misstatement of early-year figures leads to an inaccurate portrayal of the growth pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 416,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "From 2022 through 2024 Intel’s R&D outlays for process and packaging stayed at the top of its capital budget (≈ $17.5 bn in 2022, $16.0 bn in 2023 and $16.5 bn in 2024) and the company moved its advanced‑packaging agenda from an early‑stage “disaggregated‑design” approach (2022) to a commercial‑ready offering that includes 2‑D, 2.5‑D/3‑D chiplet interconnects and a silicon‑demonstrated Universal Chiplet Interconnect Express (2023), while continuing to flag advanced packaging as a core pillar of its IDM 2.0 and Open System Foundry strategy (2024). However, each filing also stresses that the novelty, limited manufacturing history and high cost of these packaging technologies—combined with broader manufacturing delays (e.g., 10 nm, 7 nm, 4th‑Gen Xeon) and capital‑constrained fab expansions in Ohio, Germany, Poland, Malaysia and Israel—have created complexity and cost overruns that negatively impact Intel’s ability to deliver IDM 2.0 on schedule. Thus, the multi‑year trajectory shows a strong, escalating strategic commitment to advanced packaging that both fuels Intel’s IDM 2.0 vision and simultaneously hampers its execution because the very technologies it is building generate delays and financial strain.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth, with only minor discrepancies in quantitative details. (1) Quantitatively, the LLM reports R&D investments as $17.5B (2022), $16.0B (2023), and $16.5B (2024). The ground truth confirms $16.5B in 2024 but does not specify 2022 and 2023 figures—however, the trend and 2024 figure are correct, and the slight variance in earlier years may reflect broader R&D vs. packaging-specific spend; this is a minor issue given the context. (2) The LLM correctly identifies the evolution: from acknowledging complexity in 2022, to demonstrating UCIe in silicon in 2023, to continued strategic emphasis in 2024 despite execution challenges. It accurately references delays in Intel 7, 10nm, 7nm, and 4th Gen Xeon processors, aligning with the ground truth. (3) The $3.1B non-cash impairment in Q3 2024 is omitted in the LLM answer, which is a notable but not critical omission—it weakens completeness slightly but does not distort the overall conclusion. (4) Multi-hop reasoning is strong: the LLM synthesizes Intel's strategic intent (IDM 2.0, Open System Foundry), technological progress (2D/2.5D/3D, UCIe), financial commitment, and operational challenges (delays, capital constraints) across years. (5) The conclusion—that advanced packaging both enables and hampers IDM 2.0—is logically sound and matches the ground truth’s assessment. Contextual relevance is perfect: all information directly addresses the question’s focus on evolution and execution challenges. Overall, the answer reflects excellent understanding and synthesis, meriting a 9 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Produces]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 444,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "Across IBM’s 2022, 2023 and 2024 10‑K filings, “client relationships and trust” is repeatedly listed as one of the company’s principal methods of competition. In the 2022 filing the concept is linked directly to the hybrid‑cloud platform’s “trust and security” pillar; in 2023 it re‑appears alongside talent, breadth of capabilities and the ability to deliver business value to clients; and the 2024 filing repeats the same language, reaffirming it as a core differentiator as IBM executes its hybrid‑cloud and AI strategy. This steady, reinforced emphasis signals that IBM is embedding trust and deep client ties into the foundation of its hybrid‑cloud and AI offerings, positioning them as secure, client‑centric solutions that differentiate the company in an increasingly competitive market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: IBM consistently emphasized client relationships and trust as a competitive differentiator from 2022 to 2024, with evolving framing tied to hybrid cloud and AI strategy. The 2022 linkage to 'trust and security' in hybrid cloud, 2023 reinforcement alongside talent and capabilities, and 2024 continuation of the theme are all accurately represented. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings and connected to IBM’s strategic positioning in hybrid cloud and AI. The only minor omission is the specific mention of the Palo Alto Networks partnership in 2024, which appears in the original answer as evidence of deepening trust-based collaboration. While the LLM notes the continued emphasis, it misses this concrete example, slightly weakening the completeness of the 2024 update. (4) Despite this omission, the LLM captures the core progression and strategic implication—embedding trust into the foundation of hybrid cloud and AI offerings—demonstrating strong qualitative accuracy and full contextual relevance to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 382,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "In the 2022 Form 10‑K (Chunk 3), IBM disclosed the 0.950 % Notes due 2025 by incorporating by reference the original Form 8‑K filed on May 22 2017 (Exhibits 4.1 & 4.2). The 2023 Form 10‑K (Chunk 1) repeats the same incorporation, showing that IBM continued to rely on the 2017 filing for the notes’ terms rather than issuing a new prospectus. By the 2024 Form 10‑K (Chunk 2), the 0.950 % Notes due 2025 appear as a listed security (ticker IBM25B) in the securities table, indicating the notes remain outstanding and are now presented more transparently alongside IBM’s other debt issuances—an evolution that reflects a broader debt‑management approach of maintaining low‑cost, long‑dated financing while progressively enhancing market‑visible disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the 0.950% Notes due 2025 were disclosed in 2022 and 2023 by incorporation of the May 22, 2017 Form 8-K (Exhibits 4.1 & 4.2), and in 2024 the notes were listed on the NYSE under ticker IBM25B. These match the ground truth exactly. (2) Quantitative accuracy is perfect: percentages (0.950%), dates (May 22, 2017), and ticker symbol (IBM25B) are all correct. No calculations required, but references to filings and exhibits are precise. (3) Multi-hop reasoning is sound—LLM synthesizes information across three years of 10-K filings, correctly inferring that continued incorporation by reference indicates regulatory continuity, and the 2024 listing reflects increased transparency and ongoing market presence. The conclusion about IBM’s broader debt management strategy—maintaining low-cost, long-dated financing with enhanced disclosure—is a reasonable interpretation supported by the progression. (4) The only minor shortcoming is that the original answer emphasizes 'consistent disclosure framework' and 'stable strategy,' while the LLM adds interpretive language about 'progressively enhancing market-visible disclosure' and 'low-cost, long-dated financing.' While plausible and contextually justified, these characterizations go slightly beyond the explicit evidence in the ground truth, which sticks to observable facts. This prevents a perfect 10 but does not undermine correctness. Overall, the answer is factually accurate, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 420,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "- In the 2022 10‑K Intel first **introduced** PowerVia as a new “back‑side power delivery” concept in its future‑node roadmap (the then‑planned Intel 20A node) 【Chunk 3】.  \n- The 2023 filing then described PowerVia as an industry‑first technology that would **debut** in Intel 20A, delivering up to a 15 % performance‑per‑watt improvement over Intel 3 【Chunk 1】.  \n- By the 2024 filing Intel had **canceled** the Intel 20A productization and moved PowerVia into the next‑generation Intel 18A node, calling it the “first high‑volume commercial implementation of backside power” with high‑volume production of Panther Lake processors slated for 2025, and it will continue into Intel 14A 【Chunk 2】.  \n\n**What this shows:** Intel’s strategy has shifted PowerVia from a future‑node concept (2022) to a scheduled feature of Intel 20A (2023) and finally to a production‑ready element of the earlier‑than‑planned Intel 18A node (2024), indicating that Intel is accelerating and cementing backside‑power delivery as a core part of its advanced‑node roadmap to boost performance‑per‑watt and scaling in upcoming process generations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A (concept phase), positioned as debuting in Intel 20A in 2023 with a 15% performance-per-watt improvement over Intel 3, and then moved to Intel 18A in 2024 with high-volume production planned for 2025. The cancellation of Intel 20A productization and shift to Intel 18A is accurately reported. (2) Quantitative accuracy is perfect: the 15% performance-per-watt improvement is correctly cited, and all dates (2022, 2023, 2024, 2025) match the ground truth. The mention of Panther Lake and continuation into Intel 14A adds contextual detail consistent with Intel's roadmap. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly tracing the evolution from concept to commercial deployment. The conclusion that Intel is accelerating and cementing backside power delivery as a core roadmap element aligns with the ground truth’s interpretation of strategic progression. (4) The answer fully addresses both parts of the question: the evolution of PowerVia from 2022–2024 and what it reveals about Intel’s broader roadmap. Wording differs slightly but meaning is preserved, including the strategic pivot from Intel 20A to 18A. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 389,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Across Medtronic’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly references the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” (exhibit 10.54) under the Amended and Restated 2013 Stock Award and Incentive Plan. Because the exact RSU agreement – an accounting policy introduced by Medtronic – appears unchanged in each year’s exhibit list, it signals that Medtronic’s U.S. equity‑compensation framework has remained consistent and stable from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. It accurately identifies that Medtronic's Form of Restricted Stock Unit Award Agreement (U.S. Employees), referenced as Exhibit 10.54 under the Amended and Restated 2013 Stock Award and Incentive Plan, remained unchanged across the 2022, 2023, and 2024 Form 10-K filings. This correctly supports the conclusion of stability in the U.S. equity compensation strategy. The date of the original filing (August 27, 2013) is not explicitly mentioned in the LLM answer, which is a minor omission, but the reference to the 2013 plan implies continuity and aligns with the ground truth. No numerical or date inaccuracies are present—years (2022–2024), exhibit number (10.54), and plan name are all correct. The reasoning is sound: unchanged documentation over multiple years implies strategic consistency. The answer synthesizes information across years correctly (multi-hop reasoning) and maintains semantic equivalence with the original answer. The only reason it is not a 10 is the lack of explicit mention of the August 27, 2013 filing date, which adds precision to the stability claim. However, this does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 345,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "Intel’s advanced‑packaging story has moved from an early‑stage, high‑risk bet to a headline strategic pillar that is now being throttled by execution shortfalls.  \n\n*In 2022* Intel first disclosed that it was adopting a **disaggregated‑design approach** – stitching together processors and components built on different process nodes with advanced‑packaging (chiplet) interconnects. The filing warned that the **novelty, limited manufacturing history and higher cost** of these packaging technologies could cause **delays or failures**, and it cited earlier setbacks such as the 10 nm and Intel 4 (formerly 7 nm) node delays.  \n\n*By 2023* the company had repositioned advanced packaging as a **core differentiator of its IDM 2.0 / Open System Foundry (OSF) strategy**, touting 2‑D, 2.5‑D/3‑D solutions for AI‑driven chip‑of‑chips and the **Universal Chiplet Interconnect Express (UCIe) standard demonstrated in silicon**. Intel said it would make **significant capital investments** to build the ecosystem needed for these “systems‑of‑chips” offerings.  \n\n*In the 2024 filing* the narrative turns to **execution constraints**. Intel reports that **financial results and a “shell‑ahead” status have forced it to delay fab‑construction or expansion projects in Ohio, Germany, Poland, Malaysia and Israel**, and it recorded **$3.1 billion of non‑cash impairment and accelerated‑depreciation charges**, largely tied to the Intel 7 node. While R&D spending remains high ($16.5 bn in 2024, down from $17.5 bn in 2022), the **disaggregated‑design approach continues to add design‑manufacturing complexity and cost**, heightening the risk of further packaging delays.  \n\nThus, Intel continues to **produce advanced‑packaging technologies** that underpin its strategic vision, but **capital constraints, delayed facility builds and the inherent complexity of disaggregated designs have increasingly hampered timely execution**, turning a strategic advantage into a source of internal pressure from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel's 2022 acknowledgment of risks in advanced packaging due to process delays (Intel 4/7nm), the 2023 strategic pivot emphasizing UCIe and advanced packaging as a differentiator, and the 2024 execution challenges including $3.1 billion in impairment charges and fab delays across multiple geographies. (2) Quantitative accuracy is excellent: the $3.1 billion impairment charge is correctly stated, and R&D figures ($16.5B in 2024, down from $17.5B in 2022) are consistent with known filings (though R&D amounts were not in the original answer, they are not contradicted and add context without error). No calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes Intel’s evolving strategy across three years, connects delays in process nodes to packaging execution, links capital constraints to fab delays, and correctly identifies the strategic importance of UCIe and disaggregated design. (4) The only minor shortcoming is that the original answer emphasizes the underutilization of Intel 7 node assets as a cause of the impairment, while the LLM attributes the broader execution issues to 'shell-ahead' status and delays without fully specifying Intel 7 as the primary node affected—this nuance is present but slightly less precise. Otherwise, semantic equivalence is strong, and the answer fully addresses the question’s focus on strategic positioning, delays, capital constraints, and disaggregated design evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1764,
        "completion_tokens": 424,
        "total_tokens": 2188
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s Asset‑Allocation Decisions policy for its defined‑benefit pension plans consistently calls for a diversified portfolio that is “primarily consisting of fixed‑income instruments and equities,” with debt securities used to match the duration of plan liabilities and equities diversified between U.S. and non‑U.S. index funds to provide long‑term capital appreciation. In the 2022 filing (target for fiscal 2023) the narrative stresses a larger fixed‑income base and a modest equity slice; the 2023 and 2024 filings (target for fiscal 2025) repeat the same framework but the forward‑looking targets suggest a gradual, measured increase in the equity portion to boost returns while still anchoring the portfolio in liability‑matching fixed income. This steady, slightly equity‑tilted evolution signals that Accenture is pursuing a disciplined, risk‑adjusted‑return approach—preserving the safety of fixed‑income exposure while incrementally raising growth potential through equities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Accenture's asset allocation across fiscal years 2022–2024. It accurately captures the consistent use of fixed income to match liability duration and equities for long-term appreciation. The mention of a 'gradual, measured increase in the equity portion' in the 2023 and 2024 filings (targeting fiscal 2025) reflects a reasonable interpretation of the increased flexibility and return-seeking behavior noted in the original answer, though the ground truth does not explicitly state an actual increase in equity targets—only greater flexibility within ranges. This is a minor overinterpretation but does not invalidate the overall reasoning. The LLM correctly identifies the forward-looking nature of the targets (e.g., 2022 filing targeting fiscal 2023, etc.), which demonstrates sound multi-hop understanding across time periods. All entities (Accenture, defined benefit pension plans, fixed income, equities) and fiscal years are correctly referenced. There are no numerical inaccuracies, as the response avoids specific percentages and instead uses qualitative descriptors ('modest equity slice', 'gradual increase'), which is acceptable given the source material's lack of exact figures. The conclusion about a disciplined, risk-adjusted return approach is semantically equivalent to the original’s emphasis on balancing return objectives with volatility management. The only shortcoming is a slightly stronger implication of an equity tilt than directly supported by the ground truth, which emphasizes flexibility rather than directional shift. Thus, the answer earns high marks for quantitative accuracy (no errors), strong qualitative reasoning, and full contextual relevance, with a small deduction in correctness and qualitative accuracy for interpretive overreach on the equity weighting trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 515,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the 1.05 % Notes due 2017 in Exhibit 4.4 (“Description of Securities”), showing that Apple, as the issuer of those notes, deliberately keeps every past issuance on the public record even after the securities have matured—a sign of a meticulous, transparent debt‑disclosure practice. By contrast, the same exhibits reveal that Apple’s broader financing strategy from 2022‑2024 is highly active and diversified, with new floating‑rate and fixed‑rate notes spanning a wide range of maturities and rates (e.g., 2.40 % due 2023, 3.85 % due 2043, 2.10 % due 2019, 3.45 % due 2024, 4.45 % due 2044, etc.), indicating a proactive capital‑raising program that complements its comprehensive reporting of legacy debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's continued disclosure of the 1.05% Notes due 2017 in its 2023 and 2024 filings as a sign of transparent, comprehensive historical reporting. The broader debt issuance strategy is accurately described as active and diversified. (2) Quantitatively, the LLM lists several correct debt instruments with accurate interest rates and maturities (e.g., 3.45% due 2024, which matches the ground truth). However, it includes some additional examples not in the original answer (e.g., 3.85% due 2043, 4.45% due 2044), which may be factually correct but are not confirmed in the ground truth; this introduces minor uncertainty but does not contradict known facts. The 2.40% due 2023 and 2.10% due 2019 are plausible but not referenced in the original, slightly reducing quantitative precision. (3) The multi-hop reasoning is sound: the model correctly contrasts the persistence of a matured note in disclosures with Apple’s ongoing issuance of new debt, demonstrating synthesis across time and instruments. (4) The answer is semantically equivalent to the original, with slightly more detail on specific notes. Wording differs but meaning and intent are preserved. The answer fully addresses both parts of the question—disclosure approach and strategic comparison—making it contextually excellent. Minor deduction in quantitative accuracy due to inclusion of unverified debt instruments, but core facts and logic are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 417,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "- **Fiscal 2022:** The 2022 Form 10‑K disclosed that, as of August 31 2022, Accenture had an aggregate available authorization of **$3.129 billion** for its publicly announced open‑market share‑purchase program and related share‑purchase/redemption activities. No specific quarterly repurchase amount was reported in that filing.  \n\n- **Fiscal 2023:** The 2023 filing repeats the same disclosure language, confirming that the open‑market program remained in place and that the board continued to rely on the existing authorization (the filing does not give a new “available” balance, but it shows the program is still active).  \n\n- **Fiscal 2024:** In the fourth quarter of fiscal 2024 the company bought **2,000,308 Class A ordinary shares** for an aggregate **$605 million**. As of August 31 2024 the remaining unspent authorization was **$2.694 billion**; the board then approved an additional **$4 billion**, raising total outstanding authority to **$6.694 billion**.  \n\n**Strategic implication:** Across the three‑year span Accenture has consistently used its share‑repurchase program (evidenced by the 2024 purchase activity) while the pool of unused authority has gradually declined from $3.129 bn to $2.694 bn, prompting the board to top‑up the program with a $4 bn increase. This pattern of regular buybacks combined with periodic replenishment of authorization signals a deliberate, long‑term capital‑return strategy that aims to return cash to shareholders through sustained share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: fiscal 2022 available authorization is $3.129 billion (matches $3.13 billion in ground truth, minor rounding difference), fiscal 2024 repurchase of $605 million, remaining authorization of $2.694 billion (vs $2.69 billion, acceptable rounding), and the $4.0 billion new authorization bringing total to $6.694 billion (vs $6.69 billion). These minor decimal differences are within acceptable formatting variation. (2) Calculations are sound: the decrease in available authorization from ~$3.13B to ~$2.69B is correctly noted, and the addition of $4B to reach ~$6.69B is accurate. (3) Multi-hop reasoning is strong: the LLM synthesizes data across 2022, 2023, and 2024 filings, correctly infers continuity in the program from the repeated disclosure language in 2023, and links the replenishment to sustained capital return strategy. (4) The strategic implication is well-reasoned and semantically equivalent to the ground truth: 'deliberate, long-term capital-return strategy' aligns with 'sustained but measured strategy'. The only minor shortcoming is that the 2023 filing could have more explicitly stated that no new authorization balance was disclosed, but the LLM correctly notes the program's continuation without asserting a specific number. Overall, the answer is factually precise, contextually complete, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1593,
        "completion_tokens": 395,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "Across the three most recent filings the 4.350 % Senior Notes due 2047 appear unchanged. In the 2022 10‑K (page 181) BMY lists the notes as part of the Eleventh Supplemental Indenture dated Nov 22 2019; the 2023 10‑K (page 134) repeats the same Form 4.350 % Senior Notes due 2047 reference, and the 2024 10‑K (page 136) again includes the identical note (Form 4.350 % Senior Notes due 2047, Exhibit 4.19, 8‑K Nov 22 2019). The fact that this 2019‑issued, fixed‑rate, 25‑year‑maturity tranche is carried forward in each filing without amendment or refinancing shows BMY’s deliberate use of long‑dated, low‑coupon senior debt to lock in financing costs, extend its maturity profile and secure stable, long‑term funding for its strategic needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 4.350% Senior Notes due 2047 are correctly cited across 2022, 2023, and 2024 filings, with accurate references to the Eleventh Supplemental Indenture dated November 22, 2019, and correct exhibit and form references (e.g., Exhibit 4.19, 8-K). The maturity (25-year from 2019 implies 2044, though 'due 2047' is accepted as per document) and fixed-rate nature are consistent with ground truth. No calculation errors. On completeness, the LLM correctly identifies the persistence of the 2047 notes across years and infers a strategic use of long-dated debt. However, it omits key context from the ground truth: the issuance of new debt tranches in 2023 ($1.75B 2.950% due 2032, $2B 3.700% due 2052) and 2024 ($3.75B 4.250% due 2049), which are critical to the multi-hop reasoning about BMY’s diversified, staggered maturity strategy. The LLM correctly infers a strategy of stable long-term financing but misses the comparative dimension—maintaining the 4.350% notes *alongside* newer, lower- and higher-coupon issuances—which supports the ground truth conclusion about portfolio diversification. Thus, while the core facts and reasoning are sound, the answer lacks full synthesis of the evolving debt structure, slightly weakening the qualitative accuracy. Contextual relevance is excellent, directly addressing the question’s focus on evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 392,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Across Apple’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly disclosed the 2.40 % Notes due 2023 in the same way – by listing Exhibit 4.3, the “Officer’s Certificate of the Registrant, dated May 3 2013,” which enumerates those notes (along with other securities). The exhibit number, description and reference to the May 3 2013 certificate are identical in each filing, showing that Apple’s disclosure approach for the 2.40 % Notes remained consistent and unchanged as the notes approached maturity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Apple disclosed the 2.40% Notes due 2023 consistently across 2022, 2023, and 2024 filings; the disclosure was made via Exhibit 4.3; and it referenced the Officer’s Certificate dated May 3, 2013. (2) Quantitative elements—interest rate (2.40%), maturity year (2023), exhibit number (4.3), and date (May 3, 2013)—are all correct with no discrepancies. Format variations (e.g., spacing in '2.40 %') do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three years of filings to conclude that the disclosure approach did not change over time, despite the notes nearing and reaching maturity. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in disclosure approach. No relevant details are omitted, and the conclusion of a consistent, unchanging strategy aligns perfectly with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 291,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "- In FY 2022 the Amended 2010 Share Incentive Plan authorized **127 million** Accenture Class A ordinary shares for awards (with about 27.38 million still available for future grants).  \n- In FY 2023 the authorized amount was raised to **141 million** shares (the filing still references the same pool of roughly 27.27 million shares available for future grants).  \n- In FY 2024 the plan continues to authorize **141 million** shares, again with about 27.27 million shares available for future grants.  \n\nThe 14‑million‑share increase between 2022 and 2023 – followed by a steady level in 2024 – shows Accenture deliberately expanded its equity‑based compensation capacity to meet anticipated grant needs and then stabilized the pool, signalling a long‑term strategy that relies on a robust, ongoing share‑based award program to attract, retain and incentivize talent.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in FY2022, 141 million in FY2023 and FY2024, with a 14-million-share increase from 2022 to 2023—correctly calculated and reported. Minor variations in the 'available for future grants' figures (27.38M vs 27.27M) are acceptable as they reflect timing differences in reporting within fiscal years and do not contradict the core authorized share totals. (2) The answer is complete, addressing both the evolution of authorized shares across all three fiscal years and the strategic implication of the change. (3) Entity accuracy is perfect: Accenture plc, Class A ordinary shares, Amended 2010 SIP, and correct fiscal years are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the increase followed by stabilization is correctly interpreted as a strategic expansion of equity compensation capacity to support long-term talent incentives, aligning exactly with the ground truth's conclusion. (5) Semantic equivalence is achieved—wording differs slightly but conveys identical meaning and insight. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 342,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "- In the 2022 filing Intel first **introduced PowerVia** as a “future process and packaging technology” alongside other next‑generation concepts such as RibbonFET, signaling that it was part of the company’s long‑term roadmap (Chunk 3).  \n- By the 2023 filing Intel was **positioning PowerVia as a breakthrough feature of the upcoming Intel 20A node**, describing it as an industry‑first backside‑power delivery method that would contribute up to a 15 % performance‑per‑watt gain over Intel 3 (Chunk 1).  \n- In the 2024 filing Intel **moved PowerVia into the next‑generation Intel 18A node**, calling it the “first high‑volume commercial implementation of backside power” and noting that Intel 18A will ship its first client products (Panther Lake) in 2025; the company also cancelled the earlier Intel 20A plan to focus on 18A (Chunk 2).  \n\n**What this progression indicates:** PowerVia has moved from a roadmap concept (2022) to a highlighted breakthrough (2023) and finally to a core, high‑volume technology in Intel’s leading‑edge node (2024), underscoring its growing strategic importance as a key enabler of performance‑per‑watt improvements and a differentiator in Intel’s advanced process roadmap.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key developments of PowerVia from 2022 to 2024 are correctly described: introduced in 2022 as part of the roadmap alongside RibbonFET; positioned in 2023 as an industry-first backside power delivery for Intel 20A with a 15% performance-per-watt gain over Intel 3 (specific figure not in ground truth but does not contradict it and adds precision plausibly); and in 2024, transitioned to Intel 18A with Panther Lake slated for 2025, following cancellation of Intel 20A productization. (2) Quantitative elements are accurate: the 15% performance-per-watt improvement is a specific detail not contradicted by the ground truth and fits within the described strategic importance. Dates (2022, 2023, 2024, 2025) and node transitions (20A to 18A) are correct. (3) Multi-hop reasoning is sound—information is synthesized across three years of filings, correctly tracing the evolution from concept to high-volume implementation. (4) The concluding analysis accurately captures the strategic significance of PowerVia as a foundational technology for Intel’s advanced process roadmap, emphasizing performance-per-watt and competitive positioning. The LLM answer matches the original in semantic content, adds minor but plausible detail, and maintains full factual consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 374,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "- **FY 2022:** The 2022 Form 10‑K shows Accenture held **$239,293 thousand** in mutual‑fund equity securities (Level 1 $4,954 k + Level 2 $234,339 k).  \n- **FY 2023:** The 2023 Form 10‑K reports a total of **$196,226 thousand** (Level 1 $7,430 k + Level 2 $188,796 k).  \n- **FY 2024:** The 2024 Form 10‑K lists the same total of **$196,226 thousand** (Level 1 $7,430 k + Level 2 $188,796 k).  \n\n**Interpretation:** The allocation fell by roughly **$43 million** from FY 2022 to FY 2023 and then held steady in FY 2024. This downward‑then‑flat trajectory signals that Accenture deliberately reduced its exposure to equity‑based mutual‑fund investments after 2022 and has now stabilized at a lower, more controlled level, reflecting a strategic shift toward a more balanced or risk‑adjusted investment posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values from the ground truth: $239,293 million in FY2022, $196,226 million in FY2023, and the same amount in FY2024. It accurately converts 'million' to 'thousand' (e.g., $239,293 million = $239,293,000,000 = $239,293 thousand in millions), which is a common reporting convention in 10-Ks where values are often listed in thousands. The breakdown by Level 1 and Level 2 assets is consistent with the source data and adds detail not required but enhances credibility. (2) The calculation of the decrease—$239,293M to $196,226M—is a reduction of $43,067 million (~$43 billion, not million as stated), but the LLM incorrectly says 'fell by roughly $43 million', which is off by a factor of 1,000. This is a significant error in magnitude, though the direction (decrease) and final stabilization are correct. This single miscalculation prevents a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years from respective 10-K filings, identifies the trend (decrease then stabilization), and infers strategic intent. The conclusion about a 'strategic shift toward a more balanced or risk-adjusted investment posture' is semantically equivalent to the ground truth's 'strategic rebalancing away from mutual fund equity securities', though slightly less precise in terminology. (4) All entities—Accenture, mutual fund equity securities, fiscal years 2022–2024—are correct. The answer fully addresses both parts of the question: the evolution of allocation and its strategic implication. Despite the unit error in the dollar change, the core facts, trends, and synthesis are accurate, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 473,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "- **Asset‑valuation side** – In the 2022 Form 10‑K Merck listed Dificid (fidaxomicin) among its acquired intangibles with a net carrying amount of **$145 million** at 31 Dec 2021. No impairment charge for Dificid was disclosed, so the $145 million valuation was carried forward into the 2023 filing.  \n\n- **Therapeutic positioning** – The 2023 filing places Dificid in the **Hospital Acute‑Care** franchise and describes it as the fidaxomicin therapy for **C. difficile‑associated diarrhea**, confirming its role as an acute‑care antibiotic rather than a chronic‑therapy product.  \n\n- **Global revenue contribution** – The 2024 Form 10‑K shows Dificid’s sales rising from **$263 million in 2022** (U.S. $241 m + Intl $22 m) to **$302 million in 2023** and **$340 million in 2024** (U.S. $303 m + Intl $37 m). This growth reflects an expanding share of Merck’s worldwide pharmaceutical revenue while the underlying intangible asset value remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, with only a minor discrepancy in the presentation of 2022 revenue. (1) Quantitatively, the LLM correctly reports Dificid's 2024 global sales as $340 million ($303M U.S., $37M international), matching the ground truth. It also accurately states the $145 million intangible asset value from 2022 carried into 2023. However, the LLM cites $263 million in 2022 sales (with $241M U.S. + $22M international), which is not mentioned in the ground truth; the original answer does not provide 2022 revenue, so this addition, while plausible, introduces data not confirmed by the source. (2) The asset valuation and therapeutic positioning details are factually correct and well-supported: Dificid was indeed listed as a $145M intangible asset in 2022 and positioned in the Hospital Acute-Care franchise in 2023 for treating C. difficile-associated diarrhea. (3) The multi-hop reasoning is sound—LLM synthesizes balance sheet data (2022), strategic framing (2023), and revenue trends (2024) across years and filings, correctly inferring Dificid's growing strategic importance. (4) Contextually, the answer fully addresses asset valuation, therapeutic positioning, and revenue evolution, going beyond the original by including 2022 and 2023 sales trends, which enriches the narrative but slightly exceeds the provided ground truth. The core facts and synthesis are correct, warranting a high score, but the unverified 2022 revenue figure prevents a perfect 10 due to minor overreach in quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 429,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "From 2022 onward Intel made advanced‑packaging the centerpiece of its IDM 2.0/Open‑System‑Foundry strategy, investing heavily in R&D ( $17.5 bn in 2022 ) and warning that the new disaggregated‑design approach adds “new areas of complexity” and could cause schedule slips. By 2023 the company turned that positioning into a competitive advantage – it demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon and continued to tout advanced‑packaging as a unique AI‑driven differentiator, even as R&D spend fell to $16.0 bn as capital constraints began to bite. In 2024 the execution challenges grew: R&D remained constrained at $16.5 bn, multiple fab expansions were delayed, Intel repeatedly flagged that novel packaging processes could delay product introductions, and it recorded $3.1 bn of non‑cash impairments (largely tied to the Intel 7 node) together with higher leverage and the risk of under‑utilized capacity, underscoring the heightened financial risk from its advanced‑packaging investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies Intel's strategic focus on Advanced Packaging Technologies from 2022–2024 within the IDM 2.0 and foundry context. It accurately captures the evolution: initial complexity warnings in 2022, competitive positioning via UCIe in 2023, and growing execution/financial risks in 2024. (2) Quantitatively, the $3.1 billion impairment charge is correctly stated. R&D figures ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024) are plausible and consistent with public filings, though the original answer does not specify exact R&D numbers—so these are not contradicted but added detail. The mention of Intel 7 node impairments adds specificity not in the original but is factually aligned with 2024 asset write-downs. (3) Multi-hop reasoning is sound: synthesizes R&D trends, technical progress (UCIe), delays, and financial risks across years. Only minor point is the emphasis on 'Intel 7 node' for impairments, while the original attributes it more broadly to manufacturing assets—this is a slight over-specificity but not incorrect. (4) Semantic equivalence is strong: conveys the shift from strategic optimism to operational strain. All sub-questions (R&D investment, implementation delays, financial risk) are addressed across the time frame. One small caveat: the original does not mention R&D dollar amounts, so including them, while reasonable, introduces unverified precision—but not inaccuracies. Overall, excellent factual alignment, minor deduction only because R&D figures, while plausible, are not confirmed in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 443,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "In the 2022 Form 10‑K Merck listed MK‑8591A (doravirine + islatravir) with a February 2020 entry and flagged it with footnote 4 as “on FDA clinical hold.” The 2023 filing repeats the same February 2020 entry and the same footnote, indicating the hold remained unchanged through that year. By the 2024 filing the company reports that the FDA lifted the clinical hold on MK‑8591A on December 4 2024 (while a partial hold persists for higher islatravir doses) and adds a next‑generation combination, MK‑8591D (islatravir + lenacapavir) slated for October 2024, showing Merck is moving the product forward and expanding its HIV pipeline—evidence of a sustained, long‑term strategy to develop novel, potentially long‑acting HIV‑1 therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and events are correct: February 2020 Phase 3 entry, FDA lifting the clinical hold on December 4, 2024, and the persistence of a partial hold on higher doses—all match the original answer. The mention of footnote 4 in the 10-K filings adds contextual precision not in the ground truth but does not contradict it. (2) The LLM correctly identifies the progression across 2022–2024: ongoing Phase 3 status with clinical hold in 2022 and 2023, followed by partial resolution in 2024. (3) The reasoning is sound: the persistence of the hold and its partial lifting indicate regulatory challenges, and the introduction of MK-8591D (next-generation combo) supports the conclusion of a long-term strategic commitment to HIV therapeutics. This synthesis across years and compounds constitutes valid multi-hop reasoning. (4) The only minor deviation is that the original answer emphasizes Merck's 'persistent commitment despite challenges' without mentioning MK-8591D, while the LLM infers strategic expansion from the new combination. This is a reasonable and contextually supported extension, not a factual error. Thus, the answer is semantically equivalent and slightly richer in strategic interpretation. All entities (MK-8591A, doravirine, islatravir, FDA, clinical hold) are correct. The answer fully addresses both the timeline/regulatory status and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 406,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "**2022 10‑K:** MK‑1308A (quavonlimab + pembrolizumab) was listed under “Advanced Solid Tumors” with a broad set of indications – colorectal, hepatocellular, melanoma and small‑cell lung – and the filing also noted that the product had entered Phase 3 for renal‑cell carcinoma (RCC) in April 2021.\n\n**2023 10‑K:** The description was narrowed to a single indication: the co‑formulation of quavonlimab with pembrolizumab is “being evaluated for the treatment of RCC.” No new tumor types or additional partners were added, and the program remained in Phase 3.\n\n**2024 10‑K:** The same wording appears – MK‑1308A is the quavonlimab + pembrolizumab co‑formulation “for RCC” within Merck’s immuno‑oncology pillar. The filing does not report any new regulatory actions (e.g., FDA/EMA submissions or approvals), indicating the product is still in its Phase 3 development phase.\n\n**Overall evolution:** Merck moved from a multi‑tumor exploratory approach in 2022 to a focused RCC strategy by 2023, retaining the anti‑CTLA‑4 + PD‑1 combination throughout. Regulatory progress shows the program entered Phase 3 in 2021 and, as of the 2023‑2024 filings, remains in that stage with no additional regulatory milestones disclosed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is a co-formulation of quavonlimab and pembrolizumab; it entered Phase 3 for renal cell carcinoma (RCC) in 2021 (April per LLM, consistent with 2022 context); clinical focus shifted from multiple solid tumors in 2022 to exclusively RCC by 2023; and as of 2024, it remains in Phase 3 with no regulatory approval or submissions reported. (2) Quantitative accuracy is perfect: dates (2021 entry into Phase 3), years (2022–2024 filings), and phase status (Phase 3) are all factually correct and consistent with the original answer. Minor enhancement: the original answer notes MK-1308A was 'listed as part of Merck's oncology pipeline' in 2022, while the LLM specifies broader indications—this is not contradictory but adds detail not in the ground truth; however, it does not introduce error. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes evolution across three years of filings, identifying narrowing of clinical focus, consistency in combination therapy (anti-CTLA-4 + PD-1 via quavonlimab + pembrolizumab), and absence of regulatory progress beyond Phase 3. (4) The only reason for not scoring 10 is that the original answer emphasizes 'increasing specificity in formulation and therapeutic strategy,' which the LLM captures implicitly but could have highlighted more directly—though the co-formulation detail is clearly stated. Overall, the LLM provides richer contextual detail while maintaining factual fidelity, making it slightly more informative than the ground truth without introducing inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 446,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "- **Fiscal 2022:**  The 2022 Form 10‑K notes that, as of August 31 2022, Accenture had **$3.13 billion of aggregate available authorization** for its publicly announced open‑market share‑purchase program and related share‑purchase/redemption activities.  No specific repurchase volume is disclosed in the 2022 excerpt, but the authorization figure establishes the baseline pool of capital set aside for buy‑backs.\n\n- **Fiscal 2023‑2024:**  The 2023 and 2024 filings (which repeat the same data) show that in the **fourth quarter of fiscal 2024** the company bought **2,000,308 Class A ordinary shares for $605 million** under the open‑market program and **an additional 72,255 shares** in employee‑related transactions (these latter purchases do not draw on the authorized pool).  By August 31 2024 the **available authorization had fallen to $2.694 billion**, reflecting the use of the prior pool.  To keep the buy‑back capacity robust, the Board on September 25 2024 approved an **extra $4.0 billion of repurchase authority**, raising the **total outstanding authority to $6.694 billion** (while the cumulative authorized amount since 2001 remains $50.1 billion).\n\n- **What the pattern shows:**  Over the three‑year span Accenture has steadily **exercised its buy‑back program** (evidenced by the $605 million purchase in Q4 2024) and **reduced the unused authorization** from $3.13 bn to $2.69 bn, but it simultaneously **replenished and expanded the authority** with a $4 bn top‑up.  This indicates a **disciplined, ongoing capital‑return strategy**: the company is actively returning cash to shareholders through share repurchases while maintaining a sizable, refreshed authorization cushion to support future buy‑backs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $3.13 billion available authorization in fiscal 2022, the $605 million share purchases in fiscal 2024 (for 2,000,308 shares), the 72,255 employee-related shares, the drop in available authorization to $2.694 billion, and the $4 billion replenishment approved in September 2024 bringing total outstanding authority to $6.694 billion. Number formats are consistent and acceptable ($3.13 billion = $3,129,296 thousand). (2) Calculations are sound: the reduction in authorization reflects usage, and the addition of $4 billion to $2.694 billion correctly yields $6.694 billion. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes data across fiscal 2022, 2023, and 2024 filings, noting that the 2023 and 2024 filings repeat the same forward-looking disclosure about fiscal 2024 activity, which supports the interpretation of consistent strategic messaging. (4) The qualitative interpretation accurately captures the sustained but measured capital return strategy, emphasizing both active repurchases and periodic replenishment for flexibility. The only minor shortcoming is that the LLM does not explicitly note the forward-looking nature of the 2023 filing as a deliberate pattern in disclosure strategy, which slightly weakens the depth of the multi-year analysis. However, this does not detract significantly from the overall correctness. The answer is contextually excellent, directly addressing all parts of the question with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1672,
        "completion_tokens": 431,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "Bristol‑Myers Squibb’s $750 million 2.350 % senior notes due 2040 are listed in every capital‑structure filing for the three most recent years – the 2022 10‑K (Chunk 3), the 2023 10‑K (Chunk 1) and the 2024 10‑K (Chunk 2) – each time as “Form of $750,000,000 2.350 % Notes due 2040” incorporated by reference to Exhibit 4.6 of the Twelfth Supplemental Indenture dated November 13 2020.  The note’s repeated inclusion shows that BMS deliberately keeps a sizable, low‑coupon, long‑dated fixed‑rate bond in its debt portfolio, using it to lock in inexpensive financing for the next two decades, smooth its maturity profile and preserve predictability of interest‑expense as part of its long‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million 2.350% Notes due 2040 are accurately described and consistently referenced across 2022, 2023, and 2024 filings. The dollar amount ($750 million vs $750,000,000) is semantically equivalent, and the interest rate (2.350%) and maturity year (2040) match exactly. (2) The LLM correctly identifies the notes' inclusion in each year’s 10-K and references the correct exhibit and supplemental indenture (Exhibit 4.6, Twelfth Supplemental Indenture, November 13, 2020), which adds precision beyond the ground truth. (3) The reasoning is sound: the model infers a strategic intent—locking in low-cost, long-term fixed-rate debt to ensure interest expense predictability and smooth maturity profile—which is logically supported by the persistent inclusion of the notes. This reflects correct multi-hop synthesis across three years of filings and understanding of debt management strategy. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention that the lack of refinancing/retirement in 2024 reflects a strategic choice amid market fluctuations, a nuance present in the original answer. However, the core strategic rationale is well captured. Contextual relevance is perfect—the response directly addresses the question about persistence in filings and strategic implications. Overall, this is a factually correct, well-reasoned answer with only slight omission of a contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 419,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Across the 2022 10‑K (page 181), the 2023 10‑K (page 134) and the 2024 10‑K (page 136), Bristol‑Myers Squibb repeatedly references the same “4.350% Senior Notes due 2047” (Exhibit 4.19, filed Nov 22 2019). In every filing the coupon remains 4.350 percent—there is no change to the interest‑rate commitment. This consistency shows BMY’s deliberate strategy of locking in a fixed‑rate, long‑dated tranche and maintaining a stable, predictable cost of capital for its long‑term debt rather than repeatedly refinancing or altering the terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the interest rate commitment for Bristol-Myers Squibb's 4.350% Senior Notes due 2047 has remained unchanged across the 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. The rate of 4.350% is accurately reported in all years, and the note's maturity in 2047 is correct. (2) Quantitatively, all percentages and years are accurate. The LLM references the correct filing dates (Nov 22, 2019) and consistently reports the 4.350% rate across all three years. While the LLM cites Exhibit 4.19 in all years, the ground truth specifies different exhibit labels over time (Exhibit 4bbb in 2022, Exhibit 4ff in 2023 and 2024), and references supplemental indentures (Twelfth and Fourteenth) not mentioned in the LLM answer. This is a minor discrepancy in document-level detail but does not affect the core factual accuracy of the interest rate or the company's financing approach. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three years of filings and correctly infers that the unchanging rate reflects a stable, long-term debt strategy focused on predictable capital costs. The conclusion about fixed-rate locking and avoidance of refinancing aligns with the ground truth’s interpretation of transparency and predictability. (4) The answer is contextually excellent, directly addressing both parts of the question—evolution of the rate (no change) and what it reveals about financing strategy. The minor omission of evolving exhibit numbers and supplemental indentures slightly affects qualitative completeness but does not undermine the correctness of the core financial fact or strategic interpretation. Hence, a score of 9 is justified—very high accuracy with only minor detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 483,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "In Nike’s FY 2022 10‑K the FlyEase system was mentioned only in a narrative list of its innovation portfolio – “FlyEase” appears alongside Nike Air, Zoom, Flyknit, etc., with no detail on how it is made. By FY 2024 the filing still cites FlyEase as part of that technology suite, but it is now embedded in a detailed manufacturing disclosure that quantifies Nike’s global production capacity: 96 finished‑goods footwear factories in 11 countries operated by 15 contract manufacturers, the largest single factory accounting for about 9 % of total Nike‑brand footwear output, and factories in Vietnam, Indonesia and China delivering roughly 50 %, 27 % and 18 % of total footwear production respectively. Those figures provide the quantitative evidence that FlyEase products are being produced at scale and are fully integrated into Nike’s worldwide contract‑manufacturing network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 50%, 27%, and 18% production shares from Vietnam, Indonesia, and China respectively match the original answer exactly. The additional details—96 factories, 11 countries, 15 contract manufacturers, and the largest factory accounting for ~9%—are factually consistent with Nike’s FY2024 10-K and provide useful context without contradicting the ground truth. (2) The evolution of FlyEase reporting is accurately portrayed: from a named technology in FY2022 with no production details, to inclusion in broader innovation discussions by FY2023 (implied by continuity into FY2024), and finally tied to global manufacturing data in FY2024. (3) The multi-hop reasoning is sound—linking the persistence of FlyEase in the technology list to its inclusion in detailed manufacturing disclosures demonstrates integration into global operations. (4) The only minor shortcoming is that the original answer explicitly references FY2023 as a transitional year where FlyEase was grouped with major technologies, which the LLM omits. While this doesn’t affect the core conclusion, it slightly reduces completeness in tracing the full evolution. However, the LLM still captures the key progression and provides strong quantitative evidence for scale and integration. Wording differs but semantic meaning and factual content are equivalent. No calculation errors or entity inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Expands]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 411,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s own data show that the share of purchases paid with its branded debit/RedCard product fell each year – 20.5 % of purchases in the fiscal year ended January 29 2022, 19.8 % in the year ended January 28 2023, and 18.6 % in the year ended February 3 2024. The 2024 filing notes that the RedCards have been rebranded as “Target Circle Cards,” but the penetration still slipped from 19.8 % to 18.6 % over the same period. Because Target monitors this metric as a proxy for incremental, loyalty‑driven sales, the downward trend suggests the 5 % discount and related benefits (free shipping, etc.) are becoming less effective at expanding card usage and may be weakening the incremental sales boost the program once delivered.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in RedCard penetration from 2022 to 2024 and attributes it to weakening effectiveness of Target's loyalty strategy, which aligns with the ground truth. However, there is a factual discrepancy in the 2024 penetration rate: the LLM reports 18.6%, while the ground truth states 17.8%. This error affects quantitative accuracy. The 2022 (20.5%) and 2023 (19.8%) figures are correct. (2) The fiscal year-end dates (e.g., January 29, 2022) are consistent with Target’s reporting calendar and add contextual precision, though not required. The rebranding to 'Target Circle Cards' is an accurate detail not in the ground truth but plausibly correct and adds value. (3) The multi-hop reasoning is sound: the model connects declining penetration to loyalty strategy effectiveness, correctly interpreting the metric as a proxy for incremental sales. It synthesizes the implication that the 5% discount and benefits are losing traction, which is a logical inference. (4) Despite the incorrect 2024 percentage, the overall conclusion about weakening strategy effectiveness matches the ground truth. The answer is highly relevant and well-reasoned, but the numerical inaccuracy in the final year limits correctness. Quantitative accuracy is reduced due to the 0.8 percentage point error in 2024, though other numbers are correct. Qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 406,
        "total_tokens": 1708
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 8.23,
    "average_quantitative_accuracy": 8.78,
    "average_qualitative_accuracy": 8.41,
    "average_contextual_relevance": 9.59,
    "score_distribution": {
      "excellent": 546,
      "good": 108,
      "fair": 120,
      "poor": 26
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 24377.81,
    "timestamp": "2026-02-02T22:26:43.550367"
  }
}